{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Costco, in 2022 Q1, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  |  |  |  | \nWashington |  | 91-1223280\n(State or other jurisdiction ofincorporation or organization) |  | (I.R.S. Employer Identification No.)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of each class |  | Trading symbol(s) |  | Name of each exchange on which registered\nCommon Stock, $.01 Par Value |  | COST |  | The Nasdaq Global Select Market  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \n |  | Page\nPART\u00a0I | FINANCIAL INFORMATION | \nItem\u00a01. | Financial Statements | 3\n | Condensed Consolidated Statements of Income | 3\n | Condensed Consolidated Statements of Comprehensive Income | 4\n | Condensed Consolidated Balance Sheets | 5\n | Condensed Consolidated Statements of Equity | 6\n | Condensed Consolidated Statements of Cash Flows | 8\n | Notes to Condensed Consolidated Financial Statements | 9\nItem 2. | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 18\nItem 3. | Quantitative and Qualitative Disclosures About Market Risk | 27\nItem 4. | Controls and Procedures | 28\n |  | \nPART\u00a0II | OTHER INFORMATION | \nItem 1. | Legal Proceedings | 28\nItem\u00a01A. | Risk Factors | 28\nItem 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 28\nItem 3. | Defaults Upon Senior Securities | 29\nItem 4. | Mine Safety Disclosures | 29\nItem 5. | Other Information | 29\nItem 6. | Exhibits | 29\n | Signatures | 30  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 13,2022 |  | February 14,2021 |  | February 13,2022 |  | February 14,2021\nREVENUE |  |  |  |  |  |  | \nNet sales | $ | 50,937 |  |  | $ | 43,888 |  |  | $ | 100,354 |  |  | $ | 86,235 | \nMembership fees | 967 |  |  | 881 |  |  | 1,913 |  |  | 1,742 | \nTotal revenue | 51,904 |  |  | 44,769 |  |  | 102,267 |  |  | 87,977 | \nOPERATING EXPENSES |  |  |  |  |  |  | \nMerchandise costs | 45,517 |  |  | 39,078 |  |  | 89,469 |  |  | 76,536 | \nSelling, general and administrative | 4,575 |  |  | 4,351 |  |  | 9,293 |  |  | 8,671 | \nOperating income | 1,812 |  |  | 1,340 |  |  | 3,505 |  |  | 2,770 | \nOTHER INCOME (EXPENSE) |  |  |  |  |  |  | \nInterest expense | (36) |  |  | (40) |  |  | (75) |  |  | (79) | \nInterest income and other, net | 25 |  |  | 19 |  |  | 67 |  |  | 48 | \nINCOME BEFORE INCOME TAXES | 1,801 |  |  | 1,319 |  |  | 3,497 |  |  | 2,739 | \nProvision for income taxes | 481 |  |  | 348 |  |  | 832 |  |  | 587 | \nNet income including noncontrolling interests | 1,320 |  |  | 971 |  |  | 2,665 |  |  | 2,152 | \nNet income attributable to noncontrolling interests | (21) |  |  | (20) |  |  | (42) |  |  | (35) | \nNET INCOME ATTRIBUTABLE TO COSTCO | $ | 1,299 |  |  | $ | 951 |  |  | $ | 2,623 |  |  | $ | 2,117 | \nNET INCOME PER COMMON SHARE ATTRIBUTABLE TO COSTCO: |  |  |  |  |  |  | \nBasic | $ | 2.93 |  |  | $ | 2.15 |  |  | $ | 5.91 |  |  | $ | 4.78 | \nDiluted | $ | 2.92 |  |  | $ | 2.14 |  |  | $ | 5.90 |  |  | $ | 4.76 | \nShares used in calculation (000s): |  |  |  |  |  |  | \nBasic | 443,623 |  |  | 443,134 |  |  | 443,500 |  |  | 443,043 | \nDiluted | 444,916 |  |  | 444,494 |  |  | 444,760 |  |  | 444,440 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 13,2022 |  | February 14,2021 |  | February 13,2022 |  | February 14,2021\nNET INCOME INCLUDING NONCONTROLLING INTERESTS | $ | 1,320 |  |  | $ | 971 |  |  | $ | 2,665 |  |  | $ | 2,152 | \nForeign-currency translation adjustment and other, net | (35) |  |  | 148 |  |  | (107) |  |  | 357 | \nComprehensive income | 1,285 |  |  | 1,119 |  |  | 2,558 |  |  | 2,509 | \nLess: Comprehensive income attributable to noncontrolling interests | 21 |  |  | 28 |  |  | 44 |  |  | 56 | \nCOMPREHENSIVE INCOME ATTRIBUTABLE TO COSTCO | $ | 1,264 |  |  | $ | 1,091 |  |  | $ | 2,514 |  |  | $ | 2,453 |   |  |  |  |  |  |  |  |  |  |  | \n | February 13,2022 |  | August 29,2021\nASSETS |  |  | \nCURRENT ASSETS |  |  | \nCash and cash equivalents | $ | 11,819 |  |  | $ | 11,258 | \nShort-term investments | 477 |  |  | 917 | \nReceivables, net | 2,232 |  |  | 1,803 | \nMerchandise inventories | 16,485 |  |  | 14,215 | \nOther current assets | 1,552 |  |  | 1,312 | \nTotal current assets | 32,565 |  |  | 29,505 | \nOTHER ASSETS |  |  | \nProperty and equipment, net | 24,052 |  |  | 23,492 | \nOperating lease right-of-use assets | 2,840 |  |  | 2,890 | \nOther long-term assets | 3,621 |  |  | 3,381 | \nTOTAL ASSETS | $ | 63,078 |  |  | $ | 59,268 | \nLIABILITIES AND EQUITY |  |  | \nCURRENT LIABILITIES |  |  | \nAccounts payable | $ | 17,089 |  |  | $ | 16,278 | \nAccrued salaries and benefits | 4,347 |  |  | 4,090 | \nAccrued member rewards | 1,798 |  |  | 1,671 | \nDeferred membership fees | 2,244 |  |  | 2,042 | \nCurrent portion of long-term debt | \u2014 |  |  | 799 | \nOther current liabilities | 6,067 |  |  | 4,561 | \nTotal current liabilities | 31,545 |  |  | 29,441 | \nOTHER LIABILITIES |  |  | \nLong-term debt, excluding current portion | 6,658 |  |  | 6,692 | \nLong-term operating lease liabilities | 2,588 |  |  | 2,642 | \nOther long-term liabilities | 2,311 |  |  | 2,415 | \nTOTAL LIABILITIES | 43,102 |  |  | 41,190 | \nCOMMITMENTS AND CONTINGENCIES |  |  | \nEQUITY |  |  | \nPreferred stock $0.01par value;100,000,000shares authorized; no shares issued and outstanding | \u2014 |  |  | \u2014 | \nCommon stock $0.01par value;900,000,000shares authorized;443,279,000and441,825,000shares issued and outstanding | 4 |  |  | 4 | \nAdditional paid-in capital | 7,186 |  |  | 7,031 | \nAccumulated other comprehensive loss | (1,246) |  |  | (1,137) | \nRetained earnings | 13,474 |  |  | 11,666 | \nTotal Costco stockholders\u2019 equity | 19,418 |  |  | 17,564 | \nNoncontrolling interests | 558 |  |  | 514 | \nTOTAL EQUITY | 19,976 |  |  | 18,078 | \nTOTAL LIABILITIES AND EQUITY | $ | 63,078 |  |  | $ | 59,268 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended February 13, 2022\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT NOVEMBER 21, 2021 | 443,434 |  |  | $ | 4 |  |  | $ | 7,064 |  |  | $ | (1,211) |  |  | $ | 12,606 |  |  | $ | 18,463 |  |  | $ | 537 |  |  | $ | 19,000 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1,299 |  |  | 1,299 |  |  | 21 |  |  | 1,320 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (35) |  |  | \u2014 |  |  | (35) |  |  | \u2014 |  |  | (35) | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 129 |  |  | \u2014 |  |  | \u2014 |  |  | 129 |  |  | \u2014 |  |  | 129 | \nRelease of vested restricted stock units (RSUs), including tax effects | 4 |  |  | \u2014 |  |  | (4) |  |  | \u2014 |  |  | \u2014 |  |  | (4) |  |  | \u2014 |  |  | (4) | \nRepurchases of common stock | (159) |  |  | \u2014 |  |  | (3) |  |  | \u2014 |  |  | (80) |  |  | (83) |  |  | \u2014 |  |  | (83) | \nCash dividend declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (351) |  |  | (351) |  |  | \u2014 |  |  | (351) | \nBALANCE AT FEBRUARY 13, 2022 | 443,279 |  |  | $ | 4 |  |  | $ | 7,186 |  |  | $ | (1,246) |  |  | $ | 13,474 |  |  | $ | 19,418 |  |  | $ | 558 |  |  | $ | 19,976 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended February 14, 2021\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT NOVEMBER 22, 2020 | 442,955 |  |  | $ | 4 |  |  | $ | 6,725 |  |  | $ | (1,101) |  |  | $ | 9,232 |  |  | $ | 14,860 |  |  | $ | 449 |  |  | $ | 15,309 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 951 |  |  | 951 |  |  | 20 |  |  | 971 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 140 |  |  | \u2014 |  |  | 140 |  |  | 8 |  |  | 148 | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 123 |  |  | \u2014 |  |  | \u2014 |  |  | 123 |  |  | \u2014 |  |  | 123 | \nRelease of vested RSUs, including tax effects | 7 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nRepurchases of common stock | (308) |  |  | \u2014 |  |  | (5) |  |  | \u2014 |  |  | (107) |  |  | (112) |  |  | \u2014 |  |  | (112) | \nCash dividend declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (310) |  |  | (310) |  |  | \u2014 |  |  | (310) | \nBALANCE AT FEBRUARY 14, 2021 | 442,654 |  |  | $ | 4 |  |  | $ | 6,843 |  |  | $ | (961) |  |  | $ | 9,766 |  |  | $ | 15,652 |  |  | $ | 477 |  |  | $ | 16,129 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended February 13, 2022\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT AUGUST 29, 2021 | 441,825 |  |  | $ | 4 |  |  | $ | 7,031 |  |  | $ | (1,137) |  |  | $ | 11,666 |  |  | $ | 17,564 |  |  | $ | 514 |  |  | $ | 18,078 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 2,623 |  |  | 2,623 |  |  | 42 |  |  | 2,665 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (109) |  |  | \u2014 |  |  | (109) |  |  | 2 |  |  | (107) | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 518 |  |  | \u2014 |  |  | \u2014 |  |  | 518 |  |  | \u2014 |  |  | 518 | \nRelease of vested restricted stock units (RSUs), including tax effects | 1,690 |  |  | \u2014 |  |  | (359) |  |  | \u2014 |  |  | \u2014 |  |  | (359) |  |  | \u2014 |  |  | (359) | \nRepurchases of common stock | (236) |  |  | \u2014 |  |  | (4) |  |  | \u2014 |  |  | (114) |  |  | (118) |  |  | \u2014 |  |  | (118) | \nCash dividends declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (701) |  |  | (701) |  |  | \u2014 |  |  | (701) | \nBALANCE AT FEBRUARY 13, 2022 | 443,279 |  |  | $ | 4 |  |  | $ | 7,186 |  |  | $ | (1,246) |  |  | $ | 13,474 |  |  | $ | 19,418 |  |  | $ | 558 |  |  | $ | 19,976 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended February 14, 2021\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT AUGUST 30, 2020 | 441,255 |  |  | $ | 4 |  |  | $ | 6,698 |  |  | $ | (1,297) |  |  | $ | 12,879 |  |  | $ | 18,284 |  |  | $ | 421 |  |  | $ | 18,705 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 2,117 |  |  | 2,117 |  |  | 35 |  |  | 2,152 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 336 |  |  | \u2014 |  |  | 336 |  |  | 21 |  |  | 357 | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 465 |  |  | \u2014 |  |  | \u2014 |  |  | 465 |  |  | \u2014 |  |  | 465 | \nRelease of vested RSUs, including tax effects | 1,920 |  |  | \u2014 |  |  | (311) |  |  | \u2014 |  |  | \u2014 |  |  | (311) |  |  | \u2014 |  |  | (311) | \nRepurchases of common stock | (521) |  |  | \u2014 |  |  | (9) |  |  | \u2014 |  |  | (180) |  |  | (189) |  |  | \u2014 |  |  | (189) | \nCash dividends declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (5,050) |  |  | (5,050) |  |  | \u2014 |  |  | (5,050) | \nBALANCE AT FEBRUARY 14, 2021 | 442,654 |  |  | $ | 4 |  |  | $ | 6,843 |  |  | $ | (961) |  |  | $ | 9,766 |  |  | $ | 15,652 |  |  | $ | 477 |  |  | $ | 16,129 |   |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | February 13,2022 |  | February 14,2021\nCASH FLOWS FROM OPERATING ACTIVITIES |  |  | \nNet income including noncontrolling interests | $ | 2,665 |  |  | $ | 2,152 | \nAdjustments to reconcile net income including noncontrolling interests to net cash provided by operating activities: |  |  | \nDepreciation and amortization | 868 |  |  | 820 | \nNon-cash lease expense | 145 |  |  | 124 | \nStock-based compensation | 516 |  |  | 463 | \nOther non-cash operating activities, net | 104 |  |  | (6) | \nDeferred income taxes | (15) |  |  | (21) | \nChanges in operating assets and liabilities: |  |  | \nMerchandise inventories | (2,322) |  |  | (1,480) | \nAccounts payable | 970 |  |  | 191 | \nOther operating assets and liabilities, net | 728 |  |  | 442 | \nNet cash provided by operating activities | 3,659 |  |  | 2,685 | \nCASH FLOWS FROM INVESTING ACTIVITIES |  |  | \nPurchases of short-term investments | (325) |  |  | (384) | \nMaturities of short-term investments | 753 |  |  | 823 | \nAdditions to property and equipment | (1,778) |  |  | (1,466) | \nOther investing activities, net | (43) |  |  | (10) | \nNet cash used in investing activities | (1,393) |  |  | (1,037) | \nCASH FLOWS FROM FINANCING ACTIVITIES |  |  | \nChange in bank payments outstanding | (10) |  |  | (67) | \nRepayments of long-term borrowings | (800) |  |  | \u2014 | \nTax withholdings on stock-based awards | (359) |  |  | (311) | \nRepurchases of common stock | (115) |  |  | (186) | \nCash dividend payments | (350) |  |  | (4,740) | \nOther financing activities, net | (33) |  |  | (46) | \nNet cash used in financing activities | (1,667) |  |  | (5,350) | \nEFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | (38) |  |  | 62 | \nNet change in cash and cash equivalents | 561 |  |  | (3,640) | \nCASH AND CASH EQUIVALENTS BEGINNING OF YEAR | 11,258 |  |  | 12,277 | \nCASH AND CASH EQUIVALENTS END OF PERIOD | $ | 11,819 |  |  | $ | 8,637 | \n |  |  | \nSUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: |  |  | \nCash paid during the first half of the year for: |  |  | \nInterest | $ | 76 |  |  | $ | 78 | \nIncome taxes, net | $ | 469 |  |  | $ | 755 | \nSUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES: |  |  | \nCash dividend declared, but not yet paid | $ | 351 |  |  | $ | 310 | \nFinancing lease assets obtained in exchange for new or modified leases | $ | 172 |  |  | $ | 135 | \nOperating lease assets obtained in exchange for new or modified leases | $ | 60 |  |  | $ | 140 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nFebruary 13, 2022: | CostBasis |  | UnrealizedGains, Net |  | RecordedBasis\nAvailable-for-sale: |  |  |  |  | \nGovernment and agency securities | $ | 364 |  |  | $ | 1 |  |  | $ | 365 | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \nHeld-to-maturity: |  |  |  |  | \nCertificates of deposit | 112 |  |  | \u2014 |  |  | 112 | \n |  |  |  |  | \n |  |  |  |  | \nTotal short-term investments | $ | 476 |  |  | $ | 1 |  |  | $ | 477 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAugust 29, 2021: | CostBasis |  | UnrealizedGains, Net |  | RecordedBasis\nAvailable-for-sale: |  |  |  |  | \nGovernment and agency securities | $ | 375 |  |  | $ | 6 |  |  | $ | 381 | \nHeld-to-maturity: |  |  |  |  | \nCertificates of deposit | 536 |  |  | \u2014 |  |  | 536 | \nTotal short-term investments | $ | 911 |  |  | $ | 6 |  |  | $ | 917 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Available-For-Sale |  | Held-To-Maturity\n | Cost\u00a0Basis |  | Fair\u00a0Value | \nDue in one year or less | $ | 247 |  |  | $ | 247 |  |  | $ | 112 | \nDue after one year through five years | 117 |  |  | 118 |  |  | \u2014 | \n |  |  |  |  | \nTotal | $ | 364 |  |  | $ | 365 |  |  | $ | 112 |   |  |  |  |  |  |  |  |  |  |  | \n | Level 2\n | February 13,2022 |  | August 29,2021\n |  |  | \nInvestment in government and agency securities(1) | $ | 373 |  |  | $ | 393 | \n |  |  | \n |  |  | \n |  |  | \nForward foreign-exchange contracts, in asset position(2) | 13 |  |  | 17 | \nForward foreign-exchange contracts, in (liability) position(2) | (1) |  |  | (2) | \nTotal | $ | 385 |  |  | $ | 408 |   |  |  |  |  |  |  |  |  |  |  | \n | February 13,2022 |  | August 29,2021\n2.300% Senior Notes due May 2022 | $ | \u2014 |  |  | $ | 800 | \n2.750% Senior Notes due May 2024 | 1,000 |  |  | 1,000 | \n3.000% Senior Notes due May 2027 | 1,000 |  |  | 1,000 | \n1.375% Senior Notes due June 2027 | 1,250 |  |  | 1,250 | \n1.600% Senior Notes due April 2030 | 1,750 |  |  | 1,750 | \n1.750% Senior Notes due April 2032 | 1,000 |  |  | 1,000 | \nOther long-term debt | 694 |  |  | 731 | \nTotal long-term debt | 6,694 |  |  | 7,531 | \nLess unamortized debt discounts and issuance costs | 36 |  |  | 40 | \nLess current portion(1) | \u2014 |  |  | 799 | \nLong-term debt, excluding current portion | $ | 6,658 |  |  | $ | 6,692 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Shares Repurchased (000s) |  | Average Price per Share |  | Total Cost\nSecond quarter of 2022 | 159 |  |  | $ | 518.73 |  |  | $ | 83 | \nFirst half of 2022 | 236 |  |  | $ | 498.00 |  |  | $ | 118 | \n |  |  |  |  | \nSecond quarter of 2021 | 308 |  |  | $ | 362.95 |  |  | $ | 112 | \nFirst half of 2021 | 521 |  |  | $ | 361.52 |  |  | $ | 189 |   |  |  |  |  |  |  |  |  |  |  | \n | Number\u00a0ofUnits (in\u00a0000s) |  | Weighted-AverageGrant Date Fair Value\nOutstanding at August 29, 2021 | 4,349 |  |  | $ | 257.88 | \nGranted | 1,679 |  |  | 476.06 | \nVested and delivered | (2,438) |  |  | 290.20 | \nForfeited | (66) |  |  | 320.88 | \nOutstanding at February 13, 2022 | 3,524 |  |  | $ | 338.29 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 13,2022 |  | February 14,2021 |  | February 13,2022 |  | February 14,2021\nStock-based compensation expense | $ | 128 |  |  | $ | 122 |  |  | $ | 516 |  |  | $ | 463 | \nLess recognized income tax benefits | 23 |  |  | 22 |  |  | 108 |  |  | 97 | \nStock-based compensation expense, net | $ | 105 |  |  | $ | 100 |  |  | $ | 408 |  |  | $ | 366 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 13,2022 |  | February 14,2021 |  | February 13,2022 |  | February 14,2021\nNet income attributable to Costco | $ | 1,299 |  |  | $ | 951 |  |  | $ | 2,623 |  |  | $ | 2,117 | \nWeighted average basic shares | 443,623 |  |  | 443,134 |  |  | 443,500 |  |  | 443,043 | \nRSUs | 1,293 |  |  | 1,360 |  |  | 1,260 |  |  | 1,397 | \nWeighted average diluted shares | 444,916 |  |  | 444,494 |  |  | 444,760 |  |  | 444,440 | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | United\u00a0StatesOperations |  | CanadianOperations |  | OtherInternationalOperations |  | Total\n12 Weeks Ended February 13, 2022 |  |  |  |  |  |  | \nTotal revenue | $ | 37,567 |  |  | $ | 7,017 |  |  | $ | 7,320 |  |  | $ | 51,904 | \nOperating income | 1,179 |  |  | 301 |  |  | 332 |  |  | 1,812 | \n12 Weeks Ended February 14, 2021 |  |  |  |  |  |  | \nTotal revenue | $ | 32,127 |  |  | $ | 6,001 |  |  | $ | 6,641 |  |  | $ | 44,769 | \nOperating income | 826 |  |  | 226 |  |  | 288 |  |  | 1,340 | \n24 Weeks Ended February 13, 2022 |  |  |  |  |  |  | \nTotal revenue | $ | 73,884 |  |  | $ | 14,138 |  |  | $ | 14,245 |  |  | $ | 102,267 | \nOperating income | 2,297 |  |  | 594 |  |  | 614 |  |  | 3,505 | \n |  |  |  |  |  |  | \n24 Weeks Ended February 14, 2021 |  |  |  |  |  |  | \nTotal revenue | $ | 63,419 |  |  | $ | 12,012 |  |  | $ | 12,546 |  |  | $ | 87,977 | \nOperating income | 1,763 |  |  | 473 |  |  | 534 |  |  | 2,770 | \n |  |  |  |  |  |  | \n52 Weeks Ended August 29, 2021 |  |  |  |  |  |  | \nTotal revenue | $ | 141,398 |  |  | $ | 27,298 |  |  | $ | 27,233 |  |  | $ | 195,929 | \nOperating income | 4,470 |  |  | 1,093 |  |  | 1,145 |  |  | 6,708 | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 13,2022 |  | February 14,2021 |  | February 13,2022 |  | February 14,2021\nFoods and Sundries | $ | 19,489 |  |  | $ | 17,624 |  |  | $ | 39,052 |  |  | $ | 35,643 | \nNon-Foods | 15,105 |  |  | 13,723 |  |  | 29,267 |  |  | 26,107 | \nFresh Foods | 6,959 |  |  | 6,254 |  |  | 13,398 |  |  | 12,117 | \nAncillary and Other Businesses | 9,384 |  |  | 6,287 |  |  | 18,637 |  |  | 12,368 | \nTotal net sales | $ | 50,937 |  |  | $ | 43,888 |  |  | $ | 100,354 |  |  | $ | 86,235 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 13,2022 |  | February 14,2021 |  | February 13,2022 |  | February 14,2021\nNet Sales | $ | 50,937 |  |  | $ | 43,888 |  |  | $ | 100,354 |  |  | $ | 86,235 | \nChanges in net sales: |  |  |  |  |  |  | \nU.S | 17 | % |  | 13 | % |  | 17 | % |  | 14 | %\nCanada | 17 | % |  | 15 | % |  | 18 | % |  | 16 | %\nOther International | 10 | % |  | 25 | % |  | 14 | % |  | 24 | %\nTotal Company | 16 | % |  | 15 | % |  | 16 | % |  | 16 | %\nChanges in comparable sales: |  |  |  |  |  |  | \nU.S | 16 | % |  | 11 | % |  | 15 | % |  | 13 | %\nCanada | 16 | % |  | 13 | % |  | 17 | % |  | 15 | %\nOther International | 6 | % |  | 22 | % |  | 10 | % |  | 20 | %\nTotal Company | 14 | % |  | 13 | % |  | 15 | % |  | 14 | %\nChanges in comparable sales excluding the impact of changes in foreign-currency and gasoline prices: |  |  |  |  |  |  | \nU.S | 11 | % |  | 13 | % |  | 11 | % |  | 15 | %\nCanada | 12 | % |  | 11 | % |  | 10 | % |  | 14 | %\nOther International | 9 | % |  | 18 | % |  | 10 | % |  | 18 | %\nTotal Company | 11 | % |  | 13 | % |  | 11 | % |  | 15 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 13,2022 |  | February 14,2021 |  | February 13,2022 |  | February 14,2021\nMembership fees | $ | 967 |  |  | $ | 881 |  |  | $ | 1,913 |  |  | $ | 1,742 | \nMembership fees increase | 10 | % |  | 8 | % |  | 10 | % |  | 8 | %\nTotal paid members (000s) | 63,400 |  |  | 59,700 |  |  | \u2014 |  |  | \u2014 | \nTotal cardholders (000s) | 114,800 |  |  | 108,300 |  |  | \u2014 |  |  | \u2014 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 13,2022 |  | February 14,2021 |  | February 13,2022 |  | February 14,2021\nNet sales | $ | 50,937 |  |  | $ | 43,888 |  |  | $ | 100,354 |  |  | $ | 86,235 | \nLess merchandise costs | 45,517 |  |  | 39,078 |  |  | 89,469 |  |  | 76,536 | \nGross margin | $ | 5,420 |  |  | $ | 4,810 |  |  | $ | 10,885 |  |  | $ | 9,699 | \nGross margin percentage | 10.64 | % |  | 10.96 | % |  | 10.85 | % |  | 11.25 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 13,2022 |  | February 14,2021 |  | February 13,2022 |  | February 14,2021\nSG&A expenses | $ | 4,575 |  |  | $ | 4,351 |  |  | $ | 9,293 |  |  | $ | 8,671 | \nSG&A expenses as a percentage of net sales | 8.98 | % |  | 9.92 | % |  | 9.26 | % |  | 10.06 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 13,2022 |  | February 14,2021 |  | February 13,2022 |  | February 14,2021\nInterest expense | $ | 36 |  |  | $ | 40 |  |  | $ | 75 |  |  | $ | 79 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 13,2022 |  | February 14,2021 |  | February 13,2022 |  | February 14,2021\nInterest income | $ | 6 |  |  | $ | 11 |  |  | $ | 15 |  |  | $ | 21 | \nForeign-currency transaction gains (losses), net | 12 |  |  | (1) |  |  | 38 |  |  | 7 | \nOther, net | 7 |  |  | 9 |  |  | 14 |  |  | 20 | \nInterest income and other, net | $ | 25 |  |  | $ | 19 |  |  | $ | 67 |  |  | $ | 48 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 13,2022 |  | February 14,2021 |  | February 13,2022 |  | February 14,2021\nProvision for income taxes | $ | 481 |  |  | $ | 348 |  |  | $ | 832 |  |  | $ | 587 | \nEffective tax rate | 26.7 | % |  | 26.4 | % |  | 23.8 | % |  | 21.5 | %  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | February 13,2022 |  | February 14,2021\nNet cash provided by operating activities | $ | 3,659 |  |  | $ | 2,685 | \nNet cash used in investing activities | (1,393) |  |  | (1,037) | \nNet cash used in financing activities | (1,667) |  |  | (5,350) | \n |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number of Shares Purchased |  | Average Price Paid Per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Programs(1) |  | Maximum Dollar Value of Shares that May Yet be Purchased Under the Programs(1)\nNovember 21, 2021 \u2014 December 19, 2021 | 7,000 |  |  | $ | 551.14 |  |  | 7,000 |  |  | $ | 3,211 | \nDecember 20, 2021 \u2014 January 16, 2022 | 61,000 |  |  | 540.43 |  |  | 61,000 |  |  | 3,178 | \nJanuary 17, 2022 \u2014 February 13, 2022 | 91,000 |  |  | 501.58 |  |  | 91,000 |  |  | 3,132 | \nTotal second quarter | 159,000 |  |  | $ | 518.73 |  |  | 159,000 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  | Incorporated by Reference\nExhibitNumber |  | Exhibit\u00a0Description |  | FiledHerewith |  | Form |  | PeriodEnding |  | Filing\u00a0Date\n |  |  |  |  |  |  |  |  |  | \n3.1 |  | Articles of Incorporation as amended of Costco Wholesale Corporation |  |  |  | 10-Q |  | 2/16/2020 |  | 3/12/2020\n |  |  |  |  |  |  |  |  |  | \n3.2 |  | Bylaws as amended of Costco Wholesale Corporation |  |  |  | 8-K |  |  |  | 1/29/2020\n |  |  |  |  |  |  |  |  |  | \n3.2.1 |  | Amendments to Sections 3.3, 3.4 and 3.6 of the Bylaws of Costco Wholesale Corporation, (to be effective and first apply with respect to the Company\u2019s 2022 Annual Meeting of Shareholders) |  |  |  | 8-K |  |  |  | 9/16/2020\n |  |  |  |  |  |  |  |  |  | \n10.1 |  | Eighth Amendment to Citi, N.A. Co-Branded Credit Card Agreement |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n31.1 |  | Rule 13(a) \u2013 14(a) Certifications |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n32.1 |  | Section 1350 Certifications |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.INS |  | Inline XBRL Instance Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.SCH |  | Inline XBRL Taxonomy Extension Schema Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n104 |  | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |  | x |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n |  |  | COSTCOWHOLESALECORPORATION(Registrant)\n |  | \nMarch 9, 2022 | By |  | /s/ W. CRAIG JELINEK\nDate |  |  | W. Craig JelinekChief Executive Officer and Director\n |  |  | \nMarch 9, 2022 | By |  | /s/ RICHARD A. GALANTI\nDate |  |  | Richard\u00a0A. GalantiExecutive Vice President, Chief Financial Officer and Director"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Costco, in 2022 Q2, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  |  |  |  | \nWashington |  | 91-1223280\n(State or other jurisdiction ofincorporation or organization) |  | (I.R.S. Employer Identification No.)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of each class |  | Trading symbol(s) |  | Name of each exchange on which registered\nCommon Stock, $.01 Par Value |  | COST |  | The Nasdaq Global Select Market  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \n |  | Page\nPART\u00a0I | FINANCIAL INFORMATION | \nItem\u00a01. | Financial Statements | 3\n | Condensed Consolidated Statements of Income | 3\n | Condensed Consolidated Statements of Comprehensive Income | 4\n | Condensed Consolidated Balance Sheets | 5\n | Condensed Consolidated Statements of Equity | 6\n | Condensed Consolidated Statements of Cash Flows | 8\n | Notes to Condensed Consolidated Financial Statements | 9\nItem 2. | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 18\nItem 3. | Quantitative and Qualitative Disclosures About Market Risk | 27\nItem 4. | Controls and Procedures | 28\n |  | \nPART\u00a0II | OTHER INFORMATION | \nItem 1. | Legal Proceedings | 28\nItem\u00a01A. | Risk Factors | 28\nItem 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 29\nItem 3. | Defaults Upon Senior Securities | 29\nItem 4. | Mine Safety Disclosures | 29\nItem 5. | Other Information | 29\nItem 6. | Exhibits | 30\n | Signatures | 31  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 8,2022 |  | May 9,2021 |  | May 8,2022 |  | May 9,2021\nREVENUE |  |  |  |  |  |  | \nNet sales | $ | 51,612 |  |  | $ | 44,376 |  |  | $ | 151,966 |  |  | $ | 130,611 | \nMembership fees | 984 |  |  | 901 |  |  | 2,897 |  |  | 2,643 | \nTotal revenue | 52,596 |  |  | 45,277 |  |  | 154,863 |  |  | 133,254 | \nOPERATING EXPENSES |  |  |  |  |  |  | \nMerchandise costs | 46,355 |  |  | 39,415 |  |  | 135,824 |  |  | 115,951 | \nSelling, general and administrative | 4,450 |  |  | 4,199 |  |  | 13,743 |  |  | 12,870 | \nOperating income | 1,791 |  |  | 1,663 |  |  | 5,296 |  |  | 4,433 | \nOTHER INCOME (EXPENSE) |  |  |  |  |  |  | \nInterest expense | (35) |  |  | (40) |  |  | (110) |  |  | (119) | \nInterest income and other, net | 71 |  |  | 27 |  |  | 138 |  |  | 75 | \nINCOME BEFORE INCOME TAXES | 1,827 |  |  | 1,650 |  |  | 5,324 |  |  | 4,389 | \nProvision for income taxes | 455 |  |  | 417 |  |  | 1,287 |  |  | 1,004 | \nNet income including noncontrolling interests | 1,372 |  |  | 1,233 |  |  | 4,037 |  |  | 3,385 | \nNet income attributable to noncontrolling interests | (19) |  |  | (13) |  |  | (61) |  |  | (48) | \nNET INCOME ATTRIBUTABLE TO COSTCO | $ | 1,353 |  |  | $ | 1,220 |  |  | $ | 3,976 |  |  | $ | 3,337 | \nNET INCOME PER COMMON SHARE ATTRIBUTABLE TO COSTCO: |  |  |  |  |  |  | \nBasic | $ | 3.05 |  |  | $ | 2.75 |  |  | $ | 8.96 |  |  | $ | 7.53 | \nDiluted | $ | 3.04 |  |  | $ | 2.75 |  |  | $ | 8.94 |  |  | $ | 7.51 | \nShares used in calculation (000s): |  |  |  |  |  |  | \nBasic | 443,700 |  |  | 443,043 |  |  | 443,567 |  |  | 443,043 | \nDiluted | 444,886 |  |  | 444,127 |  |  | 444,802 |  |  | 444,336 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 8,2022 |  | May 9,2021 |  | May 8,2022 |  | May 9,2021\nNET INCOME INCLUDING NONCONTROLLING INTERESTS | $ | 1,372 |  |  | $ | 1,233 |  |  | $ | 4,037 |  |  | $ | 3,385 | \nForeign-currency translation adjustment and other, net | (388) |  |  | 54 |  |  | (495) |  |  | 411 | \nComprehensive income | 984 |  |  | 1,287 |  |  | 3,542 |  |  | 3,796 | \nLess: Comprehensive income (loss) attributable to noncontrolling interests | (13) |  |  | 15 |  |  | 31 |  |  | 71 | \nCOMPREHENSIVE INCOME ATTRIBUTABLE TO COSTCO | $ | 997 |  |  | $ | 1,272 |  |  | $ | 3,511 |  |  | $ | 3,725 |   |  |  |  |  |  |  |  |  |  |  | \n | May 8,2022 |  | August 29,2021\nASSETS |  |  | \nCURRENT ASSETS |  |  | \nCash and cash equivalents | $ | 11,193 |  |  | $ | 11,258 | \nShort-term investments | 638 |  |  | 917 | \nReceivables, net | 1,991 |  |  | 1,803 | \nMerchandise inventories | 17,623 |  |  | 14,215 | \nOther current assets | 1,563 |  |  | 1,312 | \nTotal current assets | 33,008 |  |  | 29,505 | \nOTHER ASSETS |  |  | \nProperty and equipment, net | 24,143 |  |  | 23,492 | \nOperating lease right-of-use assets | 2,731 |  |  | 2,890 | \nOther long-term assets | 3,970 |  |  | 3,381 | \nTOTAL ASSETS | $ | 63,852 |  |  | $ | 59,268 | \nLIABILITIES AND EQUITY |  |  | \nCURRENT LIABILITIES |  |  | \nAccounts payable | $ | 17,651 |  |  | $ | 16,278 | \nAccrued salaries and benefits | 4,090 |  |  | 4,090 | \nAccrued member rewards | 1,828 |  |  | 1,671 | \nDeferred membership fees | 2,251 |  |  | 2,042 | \nCurrent portion of long-term debt | 77 |  |  | 799 | \nOther current liabilities | 5,948 |  |  | 4,561 | \nTotal current liabilities | 31,845 |  |  | 29,441 | \nOTHER LIABILITIES |  |  | \nLong-term debt, excluding current portion | 6,507 |  |  | 6,692 | \nLong-term operating lease liabilities | 2,452 |  |  | 2,642 | \nOther long-term liabilities | 2,535 |  |  | 2,415 | \nTOTAL LIABILITIES | 43,339 |  |  | 41,190 | \nCOMMITMENTS AND CONTINGENCIES |  |  | \nEQUITY |  |  | \nPreferred stock $0.01par value;100,000,000shares authorized; no shares issued and outstanding | \u2014 |  |  | \u2014 | \nCommon stock $0.01par value;900,000,000shares authorized;443,029,000and441,825,000shares issued and outstanding | 4 |  |  | 4 | \nAdditional paid-in capital | 7,272 |  |  | 7,031 | \nAccumulated other comprehensive loss | (1,602) |  |  | (1,137) | \nRetained earnings | 14,294 |  |  | 11,666 | \nTotal Costco stockholders\u2019 equity | 19,968 |  |  | 17,564 | \nNoncontrolling interests | 545 |  |  | 514 | \nTOTAL EQUITY | 20,513 |  |  | 18,078 | \nTOTAL LIABILITIES AND EQUITY | $ | 63,852 |  |  | $ | 59,268 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended May 8, 2022\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT FEBRUARY 13, 2022 | 443,279 |  |  | $ | 4 |  |  | $ | 7,186 |  |  | $ | (1,246) |  |  | $ | 13,474 |  |  | $ | 19,418 |  |  | $ | 558 |  |  | $ | 19,976 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1,353 |  |  | 1,353 |  |  | 19 |  |  | 1,372 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (356) |  |  | \u2014 |  |  | (356) |  |  | (32) |  |  | (388) | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 91 |  |  | \u2014 |  |  | \u2014 |  |  | 91 |  |  | \u2014 |  |  | 91 | \nRelease of vested restricted stock units (RSUs), including tax effects | 4 |  |  | \u2014 |  |  | (1) |  |  | \u2014 |  |  | \u2014 |  |  | (1) |  |  | \u2014 |  |  | (1) | \nRepurchases of common stock | (254) |  |  | \u2014 |  |  | (4) |  |  | \u2014 |  |  | (135) |  |  | (139) |  |  | \u2014 |  |  | (139) | \nCash dividend declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (398) |  |  | (398) |  |  | \u2014 |  |  | (398) | \nBALANCE AT MAY 8, 2022 | 443,029 |  |  | $ | 4 |  |  | $ | 7,272 |  |  | $ | (1,602) |  |  | $ | 14,294 |  |  | $ | 19,968 |  |  | $ | 545 |  |  | $ | 20,513 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended May 9, 2021\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT FEBRUARY 14, 2021 | 442,654 |  |  | $ | 4 |  |  | $ | 6,843 |  |  | $ | (961) |  |  | $ | 9,766 |  |  | $ | 15,652 |  |  | $ | 477 |  |  | $ | 16,129 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1,220 |  |  | 1,220 |  |  | 13 |  |  | 1,233 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 52 |  |  | \u2014 |  |  | 52 |  |  | 2 |  |  | 54 | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 87 |  |  | \u2014 |  |  | \u2014 |  |  | 87 |  |  | \u2014 |  |  | 87 | \nRelease of vested RSUs, including tax effects | 6 |  |  | \u2014 |  |  | (1) |  |  | \u2014 |  |  | \u2014 |  |  | (1) |  |  | \u2014 |  |  | (1) | \nRepurchases of common stock | (519) |  |  | \u2014 |  |  | (8) |  |  | \u2014 |  |  | (171) |  |  | (179) |  |  | \u2014 |  |  | (179) | \nCash dividend declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (349) |  |  | (349) |  |  | \u2014 |  |  | (349) | \nBALANCE AT MAY 9, 2021 | 442,141 |  |  | $ | 4 |  |  | $ | 6,921 |  |  | $ | (909) |  |  | $ | 10,466 |  |  | $ | 16,482 |  |  | $ | 492 |  |  | $ | 16,974 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended May 8, 2022\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT AUGUST 29, 2021 | 441,825 |  |  | $ | 4 |  |  | $ | 7,031 |  |  | $ | (1,137) |  |  | $ | 11,666 |  |  | $ | 17,564 |  |  | $ | 514 |  |  | $ | 18,078 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3,976 |  |  | 3,976 |  |  | 61 |  |  | 4,037 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (465) |  |  | \u2014 |  |  | (465) |  |  | (30) |  |  | (495) | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 609 |  |  | \u2014 |  |  | \u2014 |  |  | 609 |  |  | \u2014 |  |  | 609 | \nRelease of vested restricted stock units (RSUs), including tax effects | 1,694 |  |  | \u2014 |  |  | (360) |  |  | \u2014 |  |  | \u2014 |  |  | (360) |  |  | \u2014 |  |  | (360) | \nRepurchases of common stock | (490) |  |  | \u2014 |  |  | (8) |  |  | \u2014 |  |  | (249) |  |  | (257) |  |  | \u2014 |  |  | (257) | \nCash dividends declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (1,099) |  |  | (1,099) |  |  | \u2014 |  |  | (1,099) | \nBALANCE AT MAY 8, 2022 | 443,029 |  |  | $ | 4 |  |  | $ | 7,272 |  |  | $ | (1,602) |  |  | $ | 14,294 |  |  | $ | 19,968 |  |  | $ | 545 |  |  | $ | 20,513 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended May 9, 2021\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT AUGUST 30, 2020 | 441,255 |  |  | $ | 4 |  |  | $ | 6,698 |  |  | $ | (1,297) |  |  | $ | 12,879 |  |  | $ | 18,284 |  |  | $ | 421 |  |  | $ | 18,705 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3,337 |  |  | 3,337 |  |  | 48 |  |  | 3,385 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 388 |  |  | \u2014 |  |  | 388 |  |  | 23 |  |  | 411 | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 552 |  |  | \u2014 |  |  | \u2014 |  |  | 552 |  |  | \u2014 |  |  | 552 | \nRelease of vested RSUs, including tax effects | 1,926 |  |  | \u2014 |  |  | (312) |  |  | \u2014 |  |  | \u2014 |  |  | (312) |  |  | \u2014 |  |  | (312) | \nRepurchases of common stock | (1,040) |  |  | \u2014 |  |  | (17) |  |  | \u2014 |  |  | (351) |  |  | (368) |  |  | \u2014 |  |  | (368) | \nCash dividends declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (5,399) |  |  | (5,399) |  |  | \u2014 |  |  | (5,399) | \nBALANCE AT MAY 9, 2021 | 442,141 |  |  | $ | 4 |  |  | $ | 6,921 |  |  | $ | (909) |  |  | $ | 10,466 |  |  | $ | 16,482 |  |  | $ | 492 |  |  | $ | 16,974 |   |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | May 8,2022 |  | May 9,2021\nCASH FLOWS FROM OPERATING ACTIVITIES |  |  | \nNet income including noncontrolling interests | $ | 4,037 |  |  | $ | 3,385 | \nAdjustments to reconcile net income including noncontrolling interests to net cash provided by operating activities: |  |  | \nDepreciation and amortization | 1,306 |  |  | 1,222 | \nNon-cash lease expense | 240 |  |  | 189 | \nStock-based compensation | 606 |  |  | 550 | \nOther non-cash operating activities, net | 49 |  |  | 19 | \nDeferred income taxes | (2) |  |  | (16) | \nChanges in operating assets and liabilities: |  |  | \nMerchandise inventories | (3,633) |  |  | (1,531) | \nAccounts payable | 1,766 |  |  | 1,256 | \nOther operating assets and liabilities, net | 517 |  |  | 944 | \nNet cash provided by operating activities | 4,886 |  |  | 6,018 | \nCASH FLOWS FROM INVESTING ACTIVITIES |  |  | \nPurchases of short-term investments | (588) |  |  | (802) | \nMaturities of short-term investments | 840 |  |  | 955 | \nAdditions to property and equipment | (2,632) |  |  | (2,494) | \nOther investing activities, net | (48) |  |  | (39) | \nNet cash used in investing activities | (2,428) |  |  | (2,380) | \nCASH FLOWS FROM FINANCING ACTIVITIES |  |  | \nChange in bank payments outstanding | (99) |  |  | 1 | \nRepayments of long-term borrowings | (800) |  |  | \u2014 | \nTax withholdings on stock-based awards | (360) |  |  | (312) | \nRepurchases of common stock | (254) |  |  | (367) | \nCash dividend payments | (701) |  |  | (5,050) | \nOther financing activities, net | (129) |  |  | (41) | \nNet cash used in financing activities | (2,343) |  |  | (5,769) | \nEFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | (180) |  |  | 80 | \nNet change in cash and cash equivalents | (65) |  |  | (2,051) | \nCASH AND CASH EQUIVALENTS BEGINNING OF YEAR | 11,258 |  |  | 12,277 | \nCASH AND CASH EQUIVALENTS END OF PERIOD | $ | 11,193 |  |  | $ | 10,226 | \n |  |  | \nSUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: |  |  | \nCash paid during the first thirty-six weeks of the year for: |  |  | \nInterest | $ | 102 |  |  | $ | 98 | \nIncome taxes, net | $ | 1,121 |  |  | $ | 867 | \nSUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES: |  |  | \nCash dividend declared, but not yet paid | $ | 398 |  |  | $ | 349 | \nFinancing lease assets obtained in exchange for new or modified leases | $ | 631 |  |  | $ | 265 | \nOperating lease assets obtained in exchange for new or modified leases | $ | 67 |  |  | $ | 208 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMay 8, 2022: | CostBasis |  | UnrealizedLosses, Net |  | RecordedBasis\nAvailable-for-sale: |  |  |  |  | \nGovernment and agency securities | $ | 390 |  |  | $ | (1) |  |  | $ | 389 | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \nHeld-to-maturity: |  |  |  |  | \nCertificates of deposit | 249 |  |  | \u2014 |  |  | 249 | \n |  |  |  |  | \n |  |  |  |  | \nTotal short-term investments | $ | 639 |  |  | $ | (1) |  |  | $ | 638 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAugust 29, 2021: | CostBasis |  | UnrealizedGains, Net |  | RecordedBasis\nAvailable-for-sale: |  |  |  |  | \nGovernment and agency securities | $ | 375 |  |  | $ | 6 |  |  | $ | 381 | \nHeld-to-maturity: |  |  |  |  | \nCertificates of deposit | 536 |  |  | \u2014 |  |  | 536 | \nTotal short-term investments | $ | 911 |  |  | $ | 6 |  |  | $ | 917 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Available-For-Sale |  | Held-To-Maturity\n | Cost\u00a0Basis |  | Fair\u00a0Value | \nDue in one year or less | $ | 296 |  |  | $ | 295 |  |  | $ | 249 | \nDue after one year through five years | 94 |  |  | 94 |  |  | \u2014 | \n |  |  |  |  | \nTotal | $ | 390 |  |  | $ | 389 |  |  | $ | 249 |   |  |  |  |  |  |  |  |  |  |  | \n | Level 2\n | May 8,2022 |  | August 29,2021\n |  |  | \nInvestment in government and agency securities(1) | $ | 389 |  |  | $ | 393 | \n |  |  | \n |  |  | \n |  |  | \nForward foreign-exchange contracts, in asset position(2) | 54 |  |  | 17 | \nForward foreign-exchange contracts, in (liability) position(2) | (1) |  |  | (2) | \nTotal | $ | 442 |  |  | $ | 408 |   |  |  |  |  |  |  |  |  |  |  | \n | May 8,2022 |  | August 29,2021\n2.300% Senior Notes due May 2022 | $ | \u2014 |  |  | $ | 800 | \n2.750% Senior Notes due May 2024 | 1,000 |  |  | 1,000 | \n3.000% Senior Notes due May 2027 | 1,000 |  |  | 1,000 | \n1.375% Senior Notes due June 2027 | 1,250 |  |  | 1,250 | \n1.600% Senior Notes due April 2030 | 1,750 |  |  | 1,750 | \n1.750% Senior Notes due April 2032 | 1,000 |  |  | 1,000 | \nOther long-term debt | 618 |  |  | 731 | \nTotal long-term debt | 6,618 |  |  | 7,531 | \nLess unamortized debt discounts and issuance costs | 34 |  |  | 40 | \nLess current portion(1) | 77 |  |  | 799 | \nLong-term debt, excluding current portion | $ | 6,507 |  |  | $ | 6,692 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Shares Repurchased (000s) |  | Average Price per Share |  | Total Cost\nThird quarter of 2022 | 254 |  |  | $ | 547.38 |  |  | $ | 139 | \nFirst thirty-six weeks of 2022 | 490 |  |  | $ | 523.61 |  |  | $ | 257 | \n |  |  |  |  | \nThird quarter of 2021 | 519 |  |  | $ | 346.19 |  |  | $ | 179 | \nFirst thirty-six weeks of 2021 | 1,040 |  |  | $ | 353.87 |  |  | $ | 368 |   |  |  |  |  |  |  |  |  |  |  | \n | Number\u00a0ofUnits (in\u00a0000s) |  | Weighted-AverageGrant Date Fair Value\nOutstanding at August 29, 2021 | 4,349 |  |  | $ | 257.88 | \nGranted | 1,679 |  |  | 476.06 | \nVested and delivered | (2,443) |  |  | 290.20 | \nForfeited | (89) |  |  | 324.80 | \nOutstanding at May 8, 2022 | 3,496 |  |  | $ | 338.37 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 8,2022 |  | May 9,2021 |  | May 8,2022 |  | May 9,2021\nStock-based compensation expense | $ | 90 |  |  | $ | 87 |  |  | $ | 606 |  |  | $ | 550 | \nLess recognized income tax benefits | 20 |  |  | 18 |  |  | 128 |  |  | 115 | \nStock-based compensation expense, net | $ | 70 |  |  | $ | 69 |  |  | $ | 478 |  |  | $ | 435 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 8,2022 |  | May 9,2021 |  | May 8,2022 |  | May 9,2021\nNet income attributable to Costco | $ | 1,353 |  |  | $ | 1,220 |  |  | $ | 3,976 |  |  | $ | 3,337 | \nWeighted average basic shares | 443,700 |  |  | 443,043 |  |  | 443,567 |  |  | 443,043 | \nRSUs | 1,186 |  |  | 1,084 |  |  | 1,235 |  |  | 1,293 | \nWeighted average diluted shares | 444,886 |  |  | 444,127 |  |  | 444,802 |  |  | 444,336 | \nAnti-dilutive RSUs | \u2014 |  |  | 1,046 |  |  | \u2014 |  |  | \u2014 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | United\u00a0StatesOperations |  | CanadianOperations |  | OtherInternationalOperations |  | Total\n12 Weeks Ended May 8, 2022 |  |  |  |  |  |  | \nTotal revenue | $ | 38,534 |  |  | $ | 7,268 |  |  | $ | 6,794 |  |  | $ | 52,596 | \nOperating income | 1,205 |  |  | 324 |  |  | 262 |  |  | 1,791 | \n12 Weeks Ended May 9, 2021 |  |  |  |  |  |  | \nTotal revenue | $ | 32,759 |  |  | $ | 6,299 |  |  | $ | 6,219 |  |  | $ | 45,277 | \nOperating income | 1,135 |  |  | 260 |  |  | 268 |  |  | 1,663 | \n36 Weeks Ended May 8, 2022 |  |  |  |  |  |  | \nTotal revenue | $ | 112,418 |  |  | $ | 21,406 |  |  | $ | 21,039 |  |  | $ | 154,863 | \nOperating income | 3,502 |  |  | 918 |  |  | 876 |  |  | 5,296 | \n |  |  |  |  |  |  | \n36 Weeks Ended May 9, 2021 |  |  |  |  |  |  | \nTotal revenue | $ | 96,178 |  |  | $ | 18,311 |  |  | $ | 18,765 |  |  | $ | 133,254 | \nOperating income | 2,898 |  |  | 733 |  |  | 802 |  |  | 4,433 | \n |  |  |  |  |  |  | \n52 Weeks Ended August 29, 2021 |  |  |  |  |  |  | \nTotal revenue | $ | 141,398 |  |  | $ | 27,298 |  |  | $ | 27,233 |  |  | $ | 195,929 | \nOperating income | 4,470 |  |  | 1,093 |  |  | 1,145 |  |  | 6,708 | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 8,2022 |  | May 9,2021 |  | May 8,2022 |  | May 9,2021\nFoods and Sundries | $ | 19,594 |  |  | $ | 17,551 |  |  | $ | 58,646 |  |  | $ | 53,194 | \nNon-Foods | 13,810 |  |  | 12,899 |  |  | 43,077 |  |  | 39,006 | \nFresh Foods | 6,813 |  |  | 6,296 |  |  | 20,211 |  |  | 18,413 | \nAncillary and Other Businesses | 11,395 |  |  | 7,630 |  |  | 30,032 |  |  | 19,998 | \nTotal net sales | $ | 51,612 |  |  | $ | 44,376 |  |  | $ | 151,966 |  |  | $ | 130,611 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 8,2022 |  | May 9,2021 |  | May 8,2022 |  | May 9,2021\nNet Sales | $ | 51,612 |  |  | $ | 44,376 |  |  | $ | 151,966 |  |  | $ | 130,611 | \nChanges in net sales: |  |  |  |  |  |  | \nU.S | 18 | % |  | 19 | % |  | 17 | % |  | 16 | %\nCanada | 16 | % |  | 34 | % |  | 17 | % |  | 22 | %\nOther International | 9 | % |  | 27 | % |  | 12 | % |  | 25 | %\nTotal Company | 16 | % |  | 22 | % |  | 16 | % |  | 18 | %\nChanges in comparable sales: |  |  |  |  |  |  | \nU.S | 17 | % |  | 18 | % |  | 16 | % |  | 15 | %\nCanada | 15 | % |  | 32 | % |  | 16 | % |  | 20 | %\nOther International | 6 | % |  | 23 | % |  | 8 | % |  | 21 | %\nTotal Company | 15 | % |  | 21 | % |  | 15 | % |  | 16 | %\nChanges in comparable sales excluding the impact of changes in foreign-currency and gasoline prices: |  |  |  |  |  |  | \nU.S | 11 | % |  | 15 | % |  | 11 | % |  | 15 | %\nCanada | 13 | % |  | 17 | % |  | 11 | % |  | 15 | %\nOther International | 9 | % |  | 13 | % |  | 10 | % |  | 16 | %\nTotal Company | 11 | % |  | 15 | % |  | 11 | % |  | 15 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 8,2022 |  | May 9,2021 |  | May 8,2022 |  | May 9,2021\nMembership fees | $ | 984 |  |  | $ | 901 |  |  | $ | 2,897 |  |  | $ | 2,643 | \nMembership fees increase | 9 | % |  | 11 | % |  | 10 | % |  | 9 | %\nTotal paid members (000s) | 64,400 |  |  | 60,600 |  |  | \u2014 |  |  | \u2014 | \nTotal cardholders (000s) | 116,600 |  |  | 109,800 |  |  | \u2014 |  |  | \u2014 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 8,2022 |  | May 9,2021 |  | May 8,2022 |  | May 9,2021\nNet sales | $ | 51,612 |  |  | $ | 44,376 |  |  | $ | 151,966 |  |  | $ | 130,611 | \nLess merchandise costs | 46,355 |  |  | 39,415 |  |  | 135,824 |  |  | 115,951 | \nGross margin | $ | 5,257 |  |  | $ | 4,961 |  |  | $ | 16,142 |  |  | $ | 14,660 | \nGross margin percentage | 10.19 | % |  | 11.18 | % |  | 10.62 | % |  | 11.22 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 8,2022 |  | May 9,2021 |  | May 8,2022 |  | May 9,2021\nSG&A expenses | $ | 4,450 |  |  | $ | 4,199 |  |  | $ | 13,743 |  |  | $ | 12,870 | \nSG&A expenses as a percentage of net sales | 8.62 | % |  | 9.46 | % |  | 9.04 | % |  | 9.85 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 8,2022 |  | May 9,2021 |  | May 8,2022 |  | May 9,2021\nInterest expense | $ | 35 |  |  | $ | 40 |  |  | $ | 110 |  |  | $ | 119 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 8,2022 |  | May 9,2021 |  | May 8,2022 |  | May 9,2021\nInterest income | $ | 6 |  |  | $ | 8 |  |  | $ | 21 |  |  | $ | 29 | \nForeign-currency transaction gains, net | 56 |  |  | 6 |  |  | 94 |  |  | 13 | \nOther, net | 9 |  |  | 13 |  |  | 23 |  |  | 33 | \nInterest income and other, net | $ | 71 |  |  | $ | 27 |  |  | $ | 138 |  |  | $ | 75 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 8,2022 |  | May 9,2021 |  | May 8,2022 |  | May 9,2021\nProvision for income taxes | $ | 455 |  |  | $ | 417 |  |  | $ | 1,287 |  |  | $ | 1,004 | \nEffective tax rate | 24.9 | % |  | 25.2 | % |  | 24.2 | % |  | 22.9 | %  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | May 8,2022 |  | May 9,2021\nNet cash provided by operating activities | $ | 4,886 |  |  | $ | 6,018 | \nNet cash used in investing activities | (2,428) |  |  | (2,380) | \nNet cash used in financing activities | (2,343) |  |  | (5,769) | \n |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number of Shares Purchased |  | Average Price Paid Per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Programs(1) |  | Maximum Dollar Value of Shares that May Yet be Purchased Under the Programs(1)\nFebruary 14, 2022 \u2014 March 13, 2022 | 88,000 |  |  | $ | 517.63 |  |  | 88,000 |  |  | $ | 3,086 | \nMarch 14, 2022 \u2014 April 10, 2022 | 85,000 |  |  | 563.93 |  |  | 85,000 |  |  | 3,038 | \nApril 11, 2022 \u2014 May 8, 2022 | 81,000 |  |  | 562.33 |  |  | 81,000 |  |  | 2,993 | \nTotal third quarter | 254,000 |  |  | $ | 547.38 |  |  | 254,000 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  | Incorporated by Reference\nExhibitNumber |  | Exhibit\u00a0Description |  | FiledHerewith |  | Form |  | PeriodEnding |  | Filing\u00a0Date\n |  |  |  |  |  |  |  |  |  | \n3.1 |  | Articles of Incorporation as amended of Costco Wholesale Corporation |  |  |  | 10-Q |  | 2/16/2020 |  | 3/12/2020\n |  |  |  |  |  |  |  |  |  | \n3.2 |  | Bylaws as amended of Costco Wholesale Corporation |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n31.1 |  | Rule 13(a) \u2013 14(a) Certifications |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n32.1 |  | Section 1350 Certifications |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.INS |  | Inline XBRL Instance Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.SCH |  | Inline XBRL Taxonomy Extension Schema Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n104 |  | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |  | x |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n |  |  | COSTCOWHOLESALECORPORATION(Registrant)\n |  | \nJune 1, 2022 | By |  | /s/ W. CRAIGJELINEK\nDate |  |  | W. Craig JelinekChief Executive Officer and Director\n |  |  | \nJune 1, 2022 | By |  | /s/ RICHARDA. GALANTI\nDate |  |  | Richard\u00a0A. GalantiExecutive Vice President, Chief Financial Officer and Director"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Costco, in 2022 Q4, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  |  |  |  | \nWashington |  | 91-1223280\n(State or other jurisdiction ofincorporation or organization) |  | (I.R.S. Employer Identification No.)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of each class |  | Trading symbol(s) |  | Name of each exchange on which registered\nCommon Stock, $.005 Par Value |  | COST |  | The Nasdaq Global Select Market  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \n |  | Page\nPART\u00a0I | FINANCIAL INFORMATION | \nItem\u00a01. | Financial Statements | 3\n | Condensed Consolidated Statements of Income | 3\n | Condensed Consolidated Statements of Comprehensive Income | 4\n | Condensed Consolidated Balance Sheets | 5\n | Condensed Consolidated Statements of Equity | 6\n | Condensed Consolidated Statements of Cash Flows | 7\n | Notes to Condensed Consolidated Financial Statements | 8\nItem 2. | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 17\nItem 3. | Quantitative and Qualitative Disclosures About Market Risk | 25\nItem 4. | Controls and Procedures | 25\n |  | \nPART\u00a0II | OTHER INFORMATION | \nItem 1. | Legal Proceedings | 25\nItem\u00a01A. | Risk Factors | 25\nItem 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 26\nItem 3. | Defaults Upon Senior Securities | 26\nItem 4. | Mine Safety Disclosures | 26\nItem 5. | Other Information | 26\nItem 6. | Exhibits | 27\n | Signatures | 28  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 20,2022 |  | November 21,2021 |  |  |  | \nREVENUE |  |  |  |  |  |  | \nNet sales | $ | 53,437 |  |  | $ | 49,417 |  |  |  |  | \nMembership fees | 1,000 |  |  | 946 |  |  |  |  | \nTotal revenue | 54,437 |  |  | 50,363 |  |  |  |  | \nOPERATING EXPENSES |  |  |  |  |  |  | \nMerchandise costs | 47,769 |  |  | 43,952 |  |  |  |  | \nSelling, general and administrative | 4,917 |  |  | 4,718 |  |  |  |  | \nOperating income | 1,751 |  |  | 1,693 |  |  |  |  | \nOTHER INCOME (EXPENSE) |  |  |  |  |  |  | \nInterest expense | (34) |  |  | (39) |  |  |  |  | \nInterest income and other, net | 53 |  |  | 42 |  |  |  |  | \nINCOME BEFORE INCOME TAXES | 1,770 |  |  | 1,696 |  |  |  |  | \nProvision for income taxes | 406 |  |  | 351 |  |  |  |  | \nNet income including noncontrolling interests | 1,364 |  |  | 1,345 |  |  |  |  | \nNet income attributable to noncontrolling interests | \u2014 |  |  | (21) |  |  |  |  | \nNET INCOME ATTRIBUTABLE TO COSTCO | $ | 1,364 |  |  | $ | 1,324 |  |  |  |  | \nNET INCOME PER COMMON SHARE ATTRIBUTABLE TO COSTCO: |  |  |  |  |  |  | \nBasic | $ | 3.07 |  |  | $ | 2.99 |  |  |  |  | \nDiluted | $ | 3.07 |  |  | $ | 2.98 |  |  |  |  | \nShares used in calculation (000s): |  |  |  |  |  |  | \nBasic | 443,837 |  |  | 443,377 |  |  |  |  | \nDiluted | 444,531 |  |  | 444,604 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 20,2022 |  | November 21,2021 |  |  |  | \nNET INCOME INCLUDING NONCONTROLLING INTERESTS | $ | 1,364 |  |  | $ | 1,345 |  |  |  |  | \nForeign-currency translation adjustment and other, net | (96) |  |  | (72) |  |  |  |  | \nComprehensive income | 1,268 |  |  | 1,273 |  |  |  |  | \nLess: Comprehensive income attributable to noncontrolling interests | \u2014 |  |  | 23 |  |  |  |  | \nCOMPREHENSIVE INCOME ATTRIBUTABLE TO COSTCO | $ | 1,268 |  |  | $ | 1,250 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | November 20,2022 |  | August 28,2022\nASSETS |  |  | \nCURRENT ASSETS |  |  | \nCash and cash equivalents | $ | 10,856 |  |  | $ | 10,203 | \nShort-term investments | 817 |  |  | 846 | \nReceivables, net | 2,312 |  |  | 2,241 | \nMerchandise inventories | 18,571 |  |  | 17,907 | \nOther current assets | 1,594 |  |  | 1,499 | \nTotal current assets | 34,150 |  |  | 32,696 | \nOTHER ASSETS |  |  | \nProperty and equipment, net | 25,144 |  |  | 24,646 | \nOperating lease right-of-use assets | 2,787 |  |  | 2,774 | \nOther long-term assets | 3,946 |  |  | 4,050 | \nTOTAL ASSETS | $ | 66,027 |  |  | $ | 64,166 | \nLIABILITIES AND EQUITY |  |  | \nCURRENT LIABILITIES |  |  | \nAccounts payable | $ | 18,348 |  |  | $ | 17,848 | \nAccrued salaries and benefits | 4,317 |  |  | 4,381 | \nAccrued member rewards | 1,959 |  |  | 1,911 | \nDeferred membership fees | 2,322 |  |  | 2,174 | \nCurrent portion of long-term debt | 71 |  |  | 73 | \nOther current liabilities | 6,050 |  |  | 5,611 | \nTotal current liabilities | 33,067 |  |  | 31,998 | \nOTHER LIABILITIES |  |  | \nLong-term debt, excluding current portion | 6,472 |  |  | 6,484 | \nLong-term operating lease liabilities | 2,503 |  |  | 2,482 | \nOther long-term liabilities | 2,509 |  |  | 2,555 | \nTOTAL LIABILITIES | 44,551 |  |  | 43,519 | \nCOMMITMENTS AND CONTINGENCIES |  |  | \nEQUITY |  |  | \nPreferred stock $0.005par value;100,000,000shares authorized; no shares issued and outstanding | \u2014 |  |  | \u2014 | \nCommon stock $0.005par value;900,000,000shares authorized;443,841,000and442,664,000shares issued and outstanding | 2 |  |  | 2 | \nAdditional paid-in capital | 6,982 |  |  | 6,884 | \nAccumulated other comprehensive loss | (1,925) |  |  | (1,829) | \nRetained earnings | 16,412 |  |  | 15,585 | \nTotal Costco stockholders\u2019 equity | 21,471 |  |  | 20,642 | \nNoncontrolling interests | 5 |  |  | 5 | \nTOTAL EQUITY | 21,476 |  |  | 20,647 | \nTOTAL LIABILITIES AND EQUITY | $ | 66,027 |  |  | $ | 64,166 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended November 20, 2022\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT AUGUST 28, 2022 | 442,664 |  |  | $ | 2 |  |  | $ | 6,884 |  |  | $ | (1,829) |  |  | $ | 15,585 |  |  | $ | 20,642 |  |  | $ | 5 |  |  | $ | 20,647 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1,364 |  |  | 1,364 |  |  | \u2014 |  |  | 1,364 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (96) |  |  | \u2014 |  |  | (96) |  |  | \u2014 |  |  | (96) | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 403 |  |  | \u2014 |  |  | \u2014 |  |  | 403 |  |  | \u2014 |  |  | 403 | \nRelease of vested restricted stock units (RSUs), including tax effects | 1,462 |  |  | \u2014 |  |  | (301) |  |  | \u2014 |  |  | \u2014 |  |  | (301) |  |  | \u2014 |  |  | (301) | \nRepurchases of common stock | (285) |  |  | \u2014 |  |  | (4) |  |  | \u2014 |  |  | (137) |  |  | (141) |  |  | \u2014 |  |  | (141) | \nCash dividend declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (400) |  |  | (400) |  |  | \u2014 |  |  | (400) | \nBALANCE AT NOVEMBER 20, 2022 | 443,841 |  |  | $ | 2 |  |  | $ | 6,982 |  |  | $ | (1,925) |  |  | $ | 16,412 |  |  | $ | 21,471 |  |  | $ | 5 |  |  | $ | 21,476 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended November 21, 2021\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT AUGUST 29, 2021 | 441,825 |  |  | $ | 4 |  |  | $ | 7,031 |  |  | $ | (1,137) |  |  | $ | 11,666 |  |  | $ | 17,564 |  |  | $ | 514 |  |  | $ | 18,078 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1,324 |  |  | 1,324 |  |  | 21 |  |  | 1,345 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (74) |  |  | \u2014 |  |  | (74) |  |  | 2 |  |  | (72) | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 389 |  |  | \u2014 |  |  | \u2014 |  |  | 389 |  |  | \u2014 |  |  | 389 | \nRelease of vested RSUs, including tax effects | 1,686 |  |  | \u2014 |  |  | (355) |  |  | \u2014 |  |  | \u2014 |  |  | (355) |  |  | \u2014 |  |  | (355) | \nRepurchases of common stock | (77) |  |  | \u2014 |  |  | (1) |  |  | \u2014 |  |  | (34) |  |  | (35) |  |  | \u2014 |  |  | (35) | \nCash dividend declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (350) |  |  | (350) |  |  | \u2014 |  |  | (350) | \nBALANCE AT NOVEMBER 21, 2021 | 443,434 |  |  | $ | 4 |  |  | $ | 7,064 |  |  | $ | (1,211) |  |  | $ | 12,606 |  |  | $ | 18,463 |  |  | $ | 537 |  |  | $ | 19,000 |   |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | November 20,2022 |  | November 21,2021\nCASH FLOWS FROM OPERATING ACTIVITIES |  |  | \nNet income including noncontrolling interests | $ | 1,364 |  |  | $ | 1,345 | \nAdjustments to reconcile net income including noncontrolling interests to net cash provided by operating activities: |  |  | \nDepreciation and amortization | 447 |  |  | 432 | \nNon-cash lease expense | 111 |  |  | 72 | \nStock-based compensation | 402 |  |  | 388 | \nOther non-cash operating activities, net | 123 |  |  | 111 | \nDeferred income taxes | (2) |  |  | (2) | \nChanges in operating assets and liabilities: |  |  | \nMerchandise inventories | (737) |  |  | (2,760) | \nAccounts payable | 487 |  |  | 3,389 | \nOther operating assets and liabilities, net | 415 |  |  | 283 | \nNet cash provided by operating activities | 2,610 |  |  | 3,258 | \nCASH FLOWS FROM INVESTING ACTIVITIES |  |  | \nPurchases of short-term investments | (253) |  |  | (258) | \nMaturities of short-term investments | 274 |  |  | 444 | \nAdditions to property and equipment | (1,057) |  |  | (1,055) | \nOther investing activities, net | (21) |  |  | (43) | \nNet cash used in investing activities | (1,057) |  |  | (912) | \nCASH FLOWS FROM FINANCING ACTIVITIES |  |  | \n |  |  | \nTax withholdings on stock-based awards | (301) |  |  | (355) | \nRepurchases of common stock | (141) |  |  | (37) | \nCash dividend payments | (400) |  |  | (350) | \nOther financing activities, net | (21) |  |  | (97) | \nNet cash used in financing activities | (863) |  |  | (839) | \nEFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | (37) |  |  | (14) | \nNet change in cash and cash equivalents | 653 |  |  | 1,493 | \nCASH AND CASH EQUIVALENTS BEGINNING OF YEAR | 10,203 |  |  | 11,258 | \nCASH AND CASH EQUIVALENTS END OF PERIOD | $ | 10,856 |  |  | $ | 12,751 | \n |  |  | \nSUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: |  |  | \nCash paid during the first 12 weeks of the year for: |  |  | \nInterest | $ | 52 |  |  | $ | 64 | \nIncome taxes, net | $ | 214 |  |  | $ | 206 | \nSUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES: |  |  | \n |  |  | \nFinancing lease assets obtained in exchange for new or modified leases | $ | 49 |  |  | $ | 118 | \nOperating lease assets obtained in exchange for new or modified leases | $ | 68 |  |  | $ | 61 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNovember 20, 2022: | CostBasis |  | UnrealizedLosses, Net |  | RecordedBasis\nAvailable-for-sale: |  |  |  |  | \nGovernment and agency securities | $ | 570 |  |  | $ | (12) |  |  | $ | 558 | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \nHeld-to-maturity: |  |  |  |  | \nCertificates of deposit | 259 |  |  | \u2014 |  |  | 259 | \n |  |  |  |  | \n |  |  |  |  | \nTotal short-term investments | $ | 829 |  |  | $ | (12) |  |  | $ | 817 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAugust 28, 2022: | CostBasis |  | UnrealizedLosses, Net |  | RecordedBasis\nAvailable-for-sale: |  |  |  |  | \nGovernment and agency securities | $ | 534 |  |  | $ | (5) |  |  | $ | 529 | \nHeld-to-maturity: |  |  |  |  | \nCertificates of deposit | 317 |  |  | \u2014 |  |  | 317 | \nTotal short-term investments | $ | 851 |  |  | $ | (5) |  |  | $ | 846 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Available-For-Sale |  | Held-To-Maturity\n | Cost\u00a0Basis |  | Fair\u00a0Value | \nDue in one year or less | $ | 220 |  |  | $ | 217 |  |  | $ | 259 | \nDue after one year through five years | 264 |  |  | 259 |  |  | \u2014 | \nDue after five years | 86 |  |  | 82 |  |  | \u2014 | \nTotal | $ | 570 |  |  | $ | 558 |  |  | $ | 259 |   |  |  |  |  |  |  |  |  |  |  | \n | Level 2\n | November 20,2022 |  | August 28,2022\n |  |  | \nInvestment in government and agency securities | $ | 558 |  |  | $ | 529 | \n |  |  | \n |  |  | \n |  |  | \nForward foreign-exchange contracts, in asset position(1) | 19 |  |  | 34 | \nForward foreign-exchange contracts, in (liability) position(1) | (25) |  |  | (2) | \nTotal | $ | 552 |  |  | $ | 561 |   |  |  |  |  |  |  |  |  |  |  | \n | November 20,2022 |  | August 28,2022\n2.750% Senior Notes due May 2024 | $ | 1,000 |  |  | $ | 1,000 | \n3.000% Senior Notes due May 2027 | 1,000 |  |  | 1,000 | \n1.375% Senior Notes due June 2027 | 1,250 |  |  | 1,250 | \n1.600% Senior Notes due April 2030 | 1,750 |  |  | 1,750 | \n1.750% Senior Notes due April 2032 | 1,000 |  |  | 1,000 | \nOther long-term debt | 574 |  |  | 590 | \nTotal long-term debt | 6,574 |  |  | 6,590 | \nLess unamortized debt discounts and issuance costs | 31 |  |  | 33 | \nLess current portion(1) | 71 |  |  | 73 | \nLong-term debt, excluding current portion | $ | 6,472 |  |  | $ | 6,484 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Shares Repurchased (000s) |  | Average Price per Share |  | Total Cost\nFirst quarter of 2023 | 285 |  |  | $ | 495.94 |  |  | $ | 141 | \n |  |  |  |  | \n |  |  |  |  | \nFirst quarter of 2022 | 77 |  |  | $ | 455.08 |  |  | $ | 35 | \n |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | Number\u00a0ofUnits (in\u00a0000s) |  | Weighted-AverageGrant Date Fair Value\nOutstanding at August 28, 2022 | 3,449 |  |  | $ | 338.41 | \nGranted | 1,678 |  |  | 470.47 | \nVested and delivered | (2,090) |  |  | 352.56 | \nForfeited | (20) |  |  | 385.02 | \nOutstanding at November 20, 2022 | 3,017 |  |  | $ | 401.75 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 20,2022 |  | November 21,2021 |  |  |  | \nStock-based compensation expense | $ | 402 |  |  | $ | 388 |  |  |  |  | \nLess recognized income tax benefits | 89 |  |  | 85 |  |  |  |  | \nStock-based compensation expense, net | $ | 313 |  |  | $ | 303 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 20,2022 |  | November 21,2021 |  |  |  | \nNet income attributable to Costco | $ | 1,364 |  |  | $ | 1,324 |  |  |  |  | \nWeighted average basic shares | 443,837 |  |  | 443,377 |  |  |  |  | \nRSUs | 694 |  |  | 1,227 |  |  |  |  | \nWeighted average diluted shares | 444,531 |  |  | 444,604 |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | United\u00a0StatesOperations |  | CanadianOperations |  | OtherInternationalOperations |  | Total\n12 Weeks Ended November 20, 2022 |  |  |  |  |  |  | \nTotal revenue | $ | 40,145 |  |  | $ | 7,356 |  |  | $ | 6,936 |  |  | $ | 54,437 | \nOperating income | 1,236 |  |  | 288 |  |  | 227 |  |  | 1,751 | \n12 Weeks Ended November 21, 2021 |  |  |  |  |  |  | \nTotal revenue | $ | 36,317 |  |  | $ | 7,121 |  |  | $ | 6,925 |  |  | $ | 50,363 | \nOperating income | 1,118 |  |  | 293 |  |  | 282 |  |  | 1,693 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n52 Weeks Ended August 28, 2022 |  |  |  |  |  |  | \nTotal revenue | $ | 165,294 |  |  | $ | 31,675 |  |  | $ | 29,985 |  |  | $ | 226,954 | \nOperating income | 5,268 |  |  | 1,346 |  |  | 1,179 |  |  | 7,793 | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 20,2022 |  | November 21,2021 |  |  |  | \nFoods and Sundries | $ | 21,448 |  |  | $ | 19,563 |  |  |  |  | \nNon-Foods | 14,032 |  |  | 14,162 |  |  |  |  | \nFresh Foods | 6,717 |  |  | 6,439 |  |  |  |  | \nWarehouse Ancillary and Other Businesses | 11,240 |  |  | 9,253 |  |  |  |  | \nTotal net sales | $ | 53,437 |  |  | $ | 49,417 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 20,2022 |  | November 21,2021 |  |  |  | \nNet Sales | $ | 53,437 |  |  | $ | 49,417 |  |  |  |  | \nChanges in net sales: |  |  |  |  |  |  | \nU.S | 11 | % |  | 16 | % |  |  |  | \nCanada | 3 | % |  | 19 | % |  |  |  | \nOther International | \u2014 | % |  | 17 | % |  |  |  | \nTotal Company | 8 | % |  | 17 | % |  |  |  | \nChanges in comparable sales: |  |  |  |  |  |  | \nU.S | 9 | % |  | 15 | % |  |  |  | \nCanada | 2 | % |  | 17 | % |  |  |  | \nOther International | (3) | % |  | 13 | % |  |  |  | \nTotal Company | 7 | % |  | 15 | % |  |  |  | \nE-commerce | (4) | % |  | 14 | % |  |  |  | \nChanges in comparable sales excluding the impact of changes in foreign-currency and gasoline prices: |  |  |  |  |  |  | \nU.S | 7 | % |  | 10 | % |  |  |  | \nCanada | 8 | % |  | 8 | % |  |  |  | \nOther International | 9 | % |  | 11 | % |  |  |  | \nTotal Company | 7 | % |  | 10 | % |  |  |  | \nE-commerce | (2) | % |  | 13% |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 20,2022 |  | November 21,2021 |  |  |  | \nMembership fees | $ | 1,000 |  |  | $ | 946 |  |  |  |  | \nMembership fees increase | 6 | % |  | 10 | % |  |  |  | \nTotal paid members (000s) | 66,900 |  |  | 62,500 |  |  |  |  | \nTotal cardholders (000s) | 120,900 |  |  | 113,100 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 20,2022 |  | November 21,2021 |  |  |  | \nNet sales | $ | 53,437 |  |  | $ | 49,417 |  |  |  |  | \nLess merchandise costs | 47,769 |  |  | 43,952 |  |  |  |  | \nGross margin | $ | 5,668 |  |  | $ | 5,465 |  |  |  |  | \nGross margin percentage | 10.61 | % |  | 11.06 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 20,2022 |  | November 21,2021 |  |  |  | \nSG&A expenses | $ | 4,917 |  |  | $ | 4,718 |  |  |  |  | \nSG&A expenses as a percentage of net sales | 9.20 | % |  | 9.55 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 20,2022 |  | November 21,2021 |  |  |  | \nInterest expense | $ | 34 |  |  | $ | 39 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 20,2022 |  | November 21,2021 |  |  |  | \nInterest income | $ | 54 |  |  | $ | 8 |  |  |  |  | \nForeign-currency transaction gains (losses), net | (9) |  |  | 26 |  |  |  |  | \nOther, net | 8 |  |  | 8 |  |  |  |  | \nInterest income and other, net | $ | 53 |  |  | $ | 42 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 20,2022 |  | November 21,2021 |  |  |  | \nProvision for income taxes | $ | 406 |  |  | $ | 351 |  |  |  |  | \nEffective tax rate | 23.0 | % |  | 20.7 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | November 20,2022 |  | November 21,2021\nNet cash provided by operating activities | $ | 2,610 |  |  | $ | 3,258 | \nNet cash used in investing activities | (1,057) |  |  | (912) | \nNet cash used in financing activities | (863) |  |  | (839) | \n |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number of Shares Purchased |  | Average Price Paid Per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Programs(1) |  | Maximum Dollar Value of Shares that May Yet be Purchased Under the Programs(1)\nAugust 29, 2022 \u2014 September 25, 2022 | 89,000 |  |  | $ | 513.91 |  |  | 89,000 |  |  | $ | 2,762 | \nSeptember 26, 2022 \u2014 October 23, 2022 | 101,000 |  |  | 473.85 |  |  | 101,000 |  |  | 2,714 | \nOctober 24, 2022 \u2014 November 20, 2022 | 95,000 |  |  | 502.66 |  |  | 95,000 |  |  | 2,667 | \nTotal first quarter | 285,000 |  |  | $ | 495.94 |  |  | 285,000 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  | Incorporated by Reference\nExhibitNumber |  | Exhibit\u00a0Description |  | FiledHerewith |  | Form |  | PeriodEnding |  | Filing\u00a0Date\n |  |  |  |  |  |  |  |  |  | \n3.1 |  | Articles of Incorporation as amended of Costco Wholesale Corporation |  |  |  | 10-K |  | 8/28/2022 |  | 10/5/2022\n |  |  |  |  |  |  |  |  |  | \n3.2 |  | Bylaws as amended of Costco Wholesale Corporation |  |  |  | 10-Q |  | 5/8/2022 |  | 6/2/2022\n |  |  |  |  |  |  |  |  |  | \n10.1* |  | Fiscal 2023 Executive Bonus Plan |  |  |  | 8-K |  |  |  | 11/9/2022\n |  |  |  |  |  |  |  |  |  | \n10.2* |  | Extension of the Term of the Executive Employment Agreement effective January 1, 2023, between W. Craig Jelinek and Costco Wholesale Corporation |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n10.3 |  | Ninth Amendment to Citi, N.A. Co-Branded Credit Card Agreement |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n10.4 |  | Tenth Amendment to Citi, N.A. Co-Branded Credit Card Agreement |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n31.1 |  | Rule 13(a) \u2013 14(a) Certifications |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n32.1 |  | Section 1350 Certifications |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.INS |  | Inline XBRL Instance Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.SCH |  | Inline XBRL Taxonomy Extension Schema Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n104 |  | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |  | x |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n |  |  | COSTCOWHOLESALECORPORATION(Registrant)\n |  | \nDecember 29, 2022 | By |  | /s/ W. CRAIGJELINEK\nDate |  |  | W. Craig JelinekChief Executive Officer and Director\n |  |  | \nDecember 29, 2022 | By |  | /s/ RICHARDA. GALANTI\nDate |  |  | Richard\u00a0A. GalantiExecutive Vice President, Chief Financial Officer and Director"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Costco, in 2023 Q1, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  |  |  |  | \nWashington |  | 91-1223280\n(State or other jurisdiction ofincorporation or organization) |  | (I.R.S. Employer Identification No.)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of each class |  | Trading symbol(s) |  | Name of each exchange on which registered\nCommon Stock, $.005 Par Value |  | COST |  | The Nasdaq Global Select Market  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \n |  | Page\nPART\u00a0I | FINANCIAL INFORMATION | \nItem\u00a01. | Financial Statements | 3\n | Condensed Consolidated Statements of Income | 3\n | Condensed Consolidated Statements of Comprehensive Income | 4\n | Condensed Consolidated Balance Sheets | 5\n | Condensed Consolidated Statements of Equity | 6\n | Condensed Consolidated Statements of Cash Flows | 8\n | Notes to Condensed Consolidated Financial Statements | 9\nItem 2. | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 18\nItem 3. | Quantitative and Qualitative Disclosures About Market Risk | 27\nItem 4. | Controls and Procedures | 27\n |  | \nPART\u00a0II | OTHER INFORMATION | \nItem 1. | Legal Proceedings | 27\nItem\u00a01A. | Risk Factors | 27\nItem 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 28\nItem 3. | Defaults Upon Senior Securities | 28\nItem 4. | Mine Safety Disclosures | 28\nItem 5. | Other Information | 28\nItem 6. | Exhibits | 29\n | Signatures | 30  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 12,2023 |  | February 13,2022 |  | February 12,2023 |  | February 13,2022\nREVENUE |  |  |  |  |  |  | \nNet sales | $ | 54,239 |  |  | $ | 50,937 |  |  | $ | 107,676 |  |  | $ | 100,354 | \nMembership fees | 1,027 |  |  | 967 |  |  | 2,027 |  |  | 1,913 | \nTotal revenue | 55,266 |  |  | 51,904 |  |  | 109,703 |  |  | 102,267 | \nOPERATING EXPENSES |  |  |  |  |  |  | \nMerchandise costs | 48,423 |  |  | 45,517 |  |  | 96,192 |  |  | 89,469 | \nSelling, general and administrative | 4,940 |  |  | 4,575 |  |  | 9,857 |  |  | 9,293 | \nOperating income | 1,903 |  |  | 1,812 |  |  | 3,654 |  |  | 3,505 | \nOTHER INCOME (EXPENSE) |  |  |  |  |  |  | \nInterest expense | (34) |  |  | (36) |  |  | (68) |  |  | (75) | \nInterest income and other, net | 114 |  |  | 25 |  |  | 167 |  |  | 67 | \nINCOME BEFORE INCOME TAXES | 1,983 |  |  | 1,801 |  |  | 3,753 |  |  | 3,497 | \nProvision for income taxes | 517 |  |  | 481 |  |  | 923 |  |  | 832 | \nNet income including noncontrolling interests | 1,466 |  |  | 1,320 |  |  | 2,830 |  |  | 2,665 | \nNet income attributable to noncontrolling interests | \u2014 |  |  | (21) |  |  | \u2014 |  |  | (42) | \nNET INCOME ATTRIBUTABLE TO COSTCO | $ | 1,466 |  |  | $ | 1,299 |  |  | $ | 2,830 |  |  | $ | 2,623 | \nNET INCOME PER COMMON SHARE ATTRIBUTABLE TO COSTCO: |  |  |  |  |  |  | \nBasic | $ | 3.30 |  |  | $ | 2.93 |  |  | $ | 6.37 |  |  | $ | 5.91 | \nDiluted | $ | 3.30 |  |  | $ | 2.92 |  |  | $ | 6.37 |  |  | $ | 5.90 | \nShares used in calculation (000s): |  |  |  |  |  |  | \nBasic | 443,877 |  |  | 443,623 |  |  | 443,857 |  |  | 443,500 | \nDiluted | 444,475 |  |  | 444,916 |  |  | 444,503 |  |  | 444,760 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 12,2023 |  | February 13,2022 |  | February 12,2023 |  | February 13,2022\nNET INCOME INCLUDING NONCONTROLLING INTERESTS | $ | 1,466 |  |  | $ | 1,320 |  |  | $ | 2,830 |  |  | $ | 2,665 | \nForeign-currency translation adjustment and other, net | 253 |  |  | (35) |  |  | 157 |  |  | (107) | \nComprehensive income | 1,719 |  |  | 1,285 |  |  | 2,987 |  |  | 2,558 | \nLess: Comprehensive income attributable to noncontrolling interests | \u2014 |  |  | 21 |  |  | \u2014 |  |  | 44 | \nCOMPREHENSIVE INCOME ATTRIBUTABLE TO COSTCO | $ | 1,719 |  |  | $ | 1,264 |  |  | $ | 2,987 |  |  | $ | 2,514 |   |  |  |  |  |  |  |  |  |  |  | \n | February 12,2023 |  | August 28,2022\nASSETS |  |  | \nCURRENT ASSETS |  |  | \nCash and cash equivalents | $ | 12,970 |  |  | $ | 10,203 | \nShort-term investments | 735 |  |  | 846 | \nReceivables, net | 2,714 |  |  | 2,241 | \nMerchandise inventories | 16,081 |  |  | 17,907 | \nOther current assets | 1,830 |  |  | 1,499 | \nTotal current assets | 34,330 |  |  | 32,696 | \nOTHER ASSETS |  |  | \nProperty and equipment, net | 25,724 |  |  | 24,646 | \nOperating lease right-of-use assets | 2,859 |  |  | 2,774 | \nOther long-term assets | 3,935 |  |  | 4,050 | \nTOTAL ASSETS | $ | 66,848 |  |  | $ | 64,166 | \nLIABILITIES AND EQUITY |  |  | \nCURRENT LIABILITIES |  |  | \nAccounts payable | $ | 16,407 |  |  | $ | 17,848 | \nAccrued salaries and benefits | 4,483 |  |  | 4,381 | \nAccrued member rewards | 2,016 |  |  | 1,911 | \nDeferred membership fees | 2,412 |  |  | 2,174 | \nCurrent portion of long-term debt | 76 |  |  | 73 | \nOther current liabilities | 7,122 |  |  | 5,611 | \nTotal current liabilities | 32,516 |  |  | 31,998 | \nOTHER LIABILITIES |  |  | \nLong-term debt, excluding current portion | 6,506 |  |  | 6,484 | \nLong-term operating lease liabilities | 2,557 |  |  | 2,482 | \nOther long-term liabilities | 2,470 |  |  | 2,555 | \nTOTAL LIABILITIES | 44,049 |  |  | 43,519 | \nCOMMITMENTS AND CONTINGENCIES |  |  | \nEQUITY |  |  | \nPreferred stock $0.005par value;100,000,000shares authorized; no shares issued and outstanding | \u2014 |  |  | \u2014 | \nCommon stock $0.005par value;900,000,000shares authorized;443,550,000and442,664,000shares issued and outstanding | 2 |  |  | 2 | \nAdditional paid-in capital | 7,123 |  |  | 6,884 | \nAccumulated other comprehensive loss | (1,672) |  |  | (1,829) | \nRetained earnings | 17,341 |  |  | 15,585 | \nTotal Costco stockholders\u2019 equity | 22,794 |  |  | 20,642 | \nNoncontrolling interests | 5 |  |  | 5 | \nTOTAL EQUITY | 22,799 |  |  | 20,647 | \nTOTAL LIABILITIES AND EQUITY | $ | 66,848 |  |  | $ | 64,166 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended February 12, 2023\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT NOVEMBER 20, 2022 | 443,841 |  |  | $ | 2 |  |  | $ | 6,982 |  |  | $ | (1,925) |  |  | $ | 16,412 |  |  | $ | 21,471 |  |  | $ | 5 |  |  | $ | 21,476 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1,466 |  |  | 1,466 |  |  | \u2014 |  |  | 1,466 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 253 |  |  | \u2014 |  |  | 253 |  |  | \u2014 |  |  | 253 | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 148 |  |  | \u2014 |  |  | \u2014 |  |  | 148 |  |  | \u2014 |  |  | 148 | \nRelease of vested restricted stock units (RSUs), including tax effects | 3 |  |  | \u2014 |  |  | (1) |  |  | \u2014 |  |  | \u2014 |  |  | (1) |  |  | \u2014 |  |  | (1) | \nRepurchases of common stock | (294) |  |  | \u2014 |  |  | (6) |  |  | \u2014 |  |  | (138) |  |  | (144) |  |  | \u2014 |  |  | (144) | \nCash dividend declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (399) |  |  | (399) |  |  | \u2014 |  |  | (399) | \nBALANCE AT FEBRUARY 12, 2023 | 443,550 |  |  | $ | 2 |  |  | $ | 7,123 |  |  | $ | (1,672) |  |  | $ | 17,341 |  |  | $ | 22,794 |  |  | $ | 5 |  |  | $ | 22,799 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended February 13, 2022\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT NOVEMBER 21, 2021 | 443,434 |  |  | $ | 4 |  |  | $ | 7,064 |  |  | $ | (1,211) |  |  | $ | 12,606 |  |  | $ | 18,463 |  |  | $ | 537 |  |  | $ | 19,000 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1,299 |  |  | 1,299 |  |  | 21 |  |  | 1,320 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (35) |  |  | \u2014 |  |  | (35) |  |  | \u2014 |  |  | (35) | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 129 |  |  | \u2014 |  |  | \u2014 |  |  | 129 |  |  | \u2014 |  |  | 129 | \nRelease of vested RSUs, including tax effects | 4 |  |  | \u2014 |  |  | (4) |  |  | \u2014 |  |  | \u2014 |  |  | (4) |  |  | \u2014 |  |  | (4) | \nRepurchases of common stock | (159) |  |  | \u2014 |  |  | (3) |  |  | \u2014 |  |  | (80) |  |  | (83) |  |  | \u2014 |  |  | (83) | \nCash dividend declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (351) |  |  | (351) |  |  | \u2014 |  |  | (351) | \nBALANCE AT FEBRUARY 13, 2022 | 443,279 |  |  | $ | 4 |  |  | $ | 7,186 |  |  | $ | (1,246) |  |  | $ | 13,474 |  |  | $ | 19,418 |  |  | $ | 558 |  |  | $ | 19,976 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended February 12, 2023\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT AUGUST 28, 2022 | 442,664 |  |  | $ | 2 |  |  | $ | 6,884 |  |  | $ | (1,829) |  |  | $ | 15,585 |  |  | $ | 20,642 |  |  | $ | 5 |  |  | $ | 20,647 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 2,830 |  |  | 2,830 |  |  | \u2014 |  |  | 2,830 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 157 |  |  | \u2014 |  |  | 157 |  |  | \u2014 |  |  | 157 | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 551 |  |  | \u2014 |  |  | \u2014 |  |  | 551 |  |  | \u2014 |  |  | 551 | \nRelease of vested restricted stock units (RSUs), including tax effects | 1,465 |  |  | \u2014 |  |  | (302) |  |  | \u2014 |  |  | \u2014 |  |  | (302) |  |  | \u2014 |  |  | (302) | \nRepurchases of common stock | (579) |  |  | \u2014 |  |  | (10) |  |  | \u2014 |  |  | (275) |  |  | (285) |  |  | \u2014 |  |  | (285) | \nCash dividends declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (799) |  |  | (799) |  |  | \u2014 |  |  | (799) | \nBALANCE AT FEBRUARY 12, 2023 | 443,550 |  |  | $ | 2 |  |  | $ | 7,123 |  |  | $ | (1,672) |  |  | $ | 17,341 |  |  | $ | 22,794 |  |  | $ | 5 |  |  | $ | 22,799 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended February 13, 2022\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT AUGUST 29, 2021 | 441,825 |  |  | $ | 4 |  |  | $ | 7,031 |  |  | $ | (1,137) |  |  | $ | 11,666 |  |  | $ | 17,564 |  |  | $ | 514 |  |  | $ | 18,078 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 2,623 |  |  | 2,623 |  |  | 42 |  |  | 2,665 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (109) |  |  | \u2014 |  |  | (109) |  |  | 2 |  |  | (107) | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 518 |  |  | \u2014 |  |  | \u2014 |  |  | 518 |  |  | \u2014 |  |  | 518 | \nRelease of vested RSUs, including tax effects | 1,690 |  |  | \u2014 |  |  | (359) |  |  | \u2014 |  |  | \u2014 |  |  | (359) |  |  | \u2014 |  |  | (359) | \nRepurchases of common stock | (236) |  |  | \u2014 |  |  | (4) |  |  | \u2014 |  |  | (114) |  |  | (118) |  |  | \u2014 |  |  | (118) | \nCash dividends declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (701) |  |  | (701) |  |  | \u2014 |  |  | (701) | \nBALANCE AT FEBRUARY 13, 2022 | 443,279 |  |  | $ | 4 |  |  | $ | 7,186 |  |  | $ | (1,246) |  |  | $ | 13,474 |  |  | $ | 19,418 |  |  | $ | 558 |  |  | $ | 19,976 |   |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | February 12,2023 |  | February 13,2022\nCASH FLOWS FROM OPERATING ACTIVITIES |  |  | \nNet income including noncontrolling interests | $ | 2,830 |  |  | $ | 2,665 | \nAdjustments to reconcile net income including noncontrolling interests to net cash provided by operating activities: |  |  | \nDepreciation and amortization | 917 |  |  | 868 | \nNon-cash lease expense | 216 |  |  | 145 | \nStock-based compensation | 549 |  |  | 516 | \nOther non-cash operating activities, net | 163 |  |  | 104 | \nDeferred income taxes | (18) |  |  | (15) | \nChanges in operating assets and liabilities: |  |  | \nMerchandise inventories | 1,849 |  |  | (2,322) | \nAccounts payable | (1,417) |  |  | 970 | \nOther operating assets and liabilities, net | 713 |  |  | 728 | \nNet cash provided by operating activities | 5,802 |  |  | 3,659 | \nCASH FLOWS FROM INVESTING ACTIVITIES |  |  | \nPurchases of short-term investments | (396) |  |  | (325) | \nMaturities of short-term investments | 512 |  |  | 753 | \nAdditions to property and equipment | (1,947) |  |  | (1,778) | \nOther investing activities, net | (34) |  |  | (43) | \nNet cash used in investing activities | (1,865) |  |  | (1,393) | \nCASH FLOWS FROM FINANCING ACTIVITIES |  |  | \nRepayments of short-term borrowings | (520) |  |  | (87) | \nProceeds from short-term borrowings | 479 |  |  | 80 | \nRepayments of long-term borrowings | \u2014 |  |  | (800) | \nTax withholdings on stock-based awards | (302) |  |  | (359) | \nRepurchases of common stock | (284) |  |  | (115) | \nCash dividend payments | (400) |  |  | (350) | \nOther financing activities, net | (188) |  |  | (36) | \nNet cash used in financing activities | (1,215) |  |  | (1,667) | \nEFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | 45 |  |  | (38) | \nNet increase in cash and cash equivalents | 2,767 |  |  | 561 | \nCASH AND CASH EQUIVALENTS BEGINNING OF YEAR | 10,203 |  |  | 11,258 | \nCASH AND CASH EQUIVALENTS END OF PERIOD | $ | 12,970 |  |  | $ | 11,819 | \n |  |  | \nSUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: |  |  | \nCash paid during the first half of the year for: |  |  | \nInterest | $ | 62 |  |  | $ | 76 | \nIncome taxes, net | $ | 636 |  |  | $ | 469 | \nSUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES: |  |  | \nCash dividend declared, but not yet paid | $ | 399 |  |  | $ | 351 | \nFinancing lease assets obtained in exchange for new or modified leases | $ | 47 |  |  | $ | 172 | \nOperating lease assets obtained in exchange for new or modified leases | $ | 131 |  |  | $ | 60 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nFebruary 12, 2023: | CostBasis |  | UnrealizedLosses, Net |  | RecordedBasis\nAvailable-for-sale: |  |  |  |  | \nGovernment and agency securities | $ | 595 |  |  | $ | (11) |  |  | $ | 584 | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \nHeld-to-maturity: |  |  |  |  | \nCertificates of deposit | 151 |  |  | \u2014 |  |  | 151 | \n |  |  |  |  | \n |  |  |  |  | \nTotal short-term investments | $ | 746 |  |  | $ | (11) |  |  | $ | 735 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAugust 28, 2022: | CostBasis |  | UnrealizedLosses, Net |  | RecordedBasis\nAvailable-for-sale: |  |  |  |  | \nGovernment and agency securities | $ | 534 |  |  | $ | (5) |  |  | $ | 529 | \nHeld-to-maturity: |  |  |  |  | \nCertificates of deposit | 317 |  |  | \u2014 |  |  | 317 | \nTotal short-term investments | $ | 851 |  |  | $ | (5) |  |  | $ | 846 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Available-For-Sale |  | Held-To-Maturity\n | Cost\u00a0Basis |  | Fair\u00a0Value | \nDue in one year or less | $ | 177 |  |  | $ | 175 |  |  | $ | 151 | \nDue after one year through five years | 287 |  |  | 282 |  |  | \u2014 | \nDue after five years | 131 |  |  | 127 |  |  | \u2014 | \nTotal | $ | 595 |  |  | $ | 584 |  |  | $ | 151 |   |  |  |  |  |  |  |  |  |  |  | \n | Level 2\n | February 12,2023 |  | August 28,2022\n |  |  | \nInvestment in government and agency securities | $ | 584 |  |  | $ | 529 | \n |  |  | \n |  |  | \n |  |  | \nForward foreign-exchange contracts, in asset position(1) | 6 |  |  | 34 | \nForward foreign-exchange contracts, in (liability) position(1) | (18) |  |  | (2) | \nTotal | $ | 572 |  |  | $ | 561 |   |  |  |  |  |  |  |  |  |  |  | \n | February 12,2023 |  | August 28,2022\n2.750% Senior Notes due May 2024 | $ | 1,000 |  |  | $ | 1,000 | \n3.000% Senior Notes due May 2027 | 1,000 |  |  | 1,000 | \n1.375% Senior Notes due June 2027 | 1,250 |  |  | 1,250 | \n1.600% Senior Notes due April 2030 | 1,750 |  |  | 1,750 | \n1.750% Senior Notes due April 2032 | 1,000 |  |  | 1,000 | \nOther long-term debt | 612 |  |  | 590 | \nTotal long-term debt | 6,612 |  |  | 6,590 | \nLess unamortized debt discounts and issuance costs | 30 |  |  | 33 | \nLess current portion(1) | 76 |  |  | 73 | \nLong-term debt, excluding current portion | $ | 6,506 |  |  | $ | 6,484 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Shares Repurchased (000s) |  | Average Price per Share |  | Total Cost\nSecond quarter of 2023 | 294 |  |  | $ | 488.30 |  |  | $ | 144 | \nFirst half of 2023 | 579 |  |  | $ | 492.06 |  |  | $ | 285 | \n |  |  |  |  | \nSecond quarter of 2022 | 159 |  |  | $ | 518.73 |  |  | $ | 83 | \nFirst half of 2022 | 236 |  |  | $ | 498.00 |  |  | $ | 118 |   |  |  |  |  |  |  |  |  |  |  | \n | Number\u00a0ofUnits (in\u00a0000s) |  | Weighted-AverageGrant Date Fair Value\nOutstanding at August 28, 2022 | 3,449 |  |  | $ | 338.41 | \nGranted | 1,814 |  |  | 471.47 | \nVested and delivered | (2,094) |  |  | 352.57 | \nForfeited | (72) |  |  | 394.40 | \nOutstanding at February 12, 2023 | 3,097 |  |  | $ | 405.46 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 12,2023 |  | February 13,2022 |  | February 12,2023 |  | February 13,2022\nStock-based compensation expense | $ | 147 |  |  | $ | 128 |  |  | $ | 549 |  |  | $ | 516 | \nLess recognized income tax benefits | 24 |  |  | 23 |  |  | 113 |  |  | 108 | \nStock-based compensation expense, net | $ | 123 |  |  | $ | 105 |  |  | $ | 436 |  |  | $ | 408 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 12,2023 |  | February 13,2022 |  | February 12,2023 |  | February 13,2022\nNet income attributable to Costco | $ | 1,466 |  |  | $ | 1,299 |  |  | $ | 2,830 |  |  | $ | 2,623 | \nWeighted average basic shares | 443,877 |  |  | 443,623 |  |  | 443,857 |  |  | 443,500 | \nRSUs | 598 |  |  | 1,293 |  |  | 646 |  |  | 1,260 | \nWeighted average diluted shares | 444,475 |  |  | 444,916 |  |  | 444,503 |  |  | 444,760 | \nAnti-dilutive RSUs | 6 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | United\u00a0StatesOperations |  | CanadianOperations |  | OtherInternationalOperations |  | Total\n12 Weeks Ended February 12, 2023 |  |  |  |  |  |  | \nTotal revenue | $ | 40,145 |  |  | $ | 7,299 |  |  | $ | 7,822 |  |  | $ | 55,266 | \nOperating income | 1,295 |  |  | 284 |  |  | 324 |  |  | 1,903 | \n12 Weeks Ended February 13, 2022 |  |  |  |  |  |  | \nTotal revenue | $ | 37,567 |  |  | $ | 7,017 |  |  | $ | 7,320 |  |  | $ | 51,904 | \nOperating income | 1,179 |  |  | 301 |  |  | 332 |  |  | 1,812 | \n24 Weeks Ended February 12, 2023 |  |  |  |  |  |  | \nTotal revenue | $ | 80,290 |  |  | $ | 14,655 |  |  | $ | 14,758 |  |  | $ | 109,703 | \nOperating income | 2,531 |  |  | 572 |  |  | 551 |  |  | 3,654 | \n |  |  |  |  |  |  | \n24 Weeks Ended February 13, 2022 |  |  |  |  |  |  | \nTotal revenue | $ | 73,884 |  |  | $ | 14,138 |  |  | $ | 14,245 |  |  | $ | 102,267 | \nOperating income | 2,297 |  |  | 594 |  |  | 614 |  |  | 3,505 | \n |  |  |  |  |  |  | \n52 Weeks Ended August 28, 2022 |  |  |  |  |  |  | \nTotal revenue | $ | 165,294 |  |  | $ | 31,675 |  |  | $ | 29,985 |  |  | $ | 226,954 | \nOperating income | 5,268 |  |  | 1,346 |  |  | 1,179 |  |  | 7,793 | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 12,2023 |  | February 13,2022 |  | February 12,2023 |  | February 13,2022\nFoods and Sundries | $ | 21,926 |  |  | $ | 19,489 |  |  | $ | 43,374 |  |  | $ | 39,052 | \nNon-Foods | 14,741 |  |  | 15,105 |  |  | 28,773 |  |  | 29,267 | \nFresh Foods | 7,376 |  |  | 6,959 |  |  | 14,093 |  |  | 13,398 | \nWarehouse Ancillary and Other Businesses | 10,196 |  |  | 9,384 |  |  | 21,436 |  |  | 18,637 | \nTotal net sales | $ | 54,239 |  |  | $ | 50,937 |  |  | $ | 107,676 |  |  | $ | 100,354 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 12,2023 |  | February 13,2022 |  | February 12,2023 |  | February 13,2022\nNet Sales | $ | 54,239 |  |  | $ | 50,937 |  |  | $ | 107,676 |  |  | $ | 100,354 | \nChanges in net sales: |  |  |  |  |  |  | \nU.S | 7 | % |  | 17 | % |  | 9 | % |  | 17 | %\nCanada | 4 | % |  | 17 | % |  | 4 | % |  | 18 | %\nOther International | 7 | % |  | 10 | % |  | 4 | % |  | 14 | %\nTotal Company | 6 | % |  | 16 | % |  | 7 | % |  | 16 | %\nChanges in comparable sales: |  |  |  |  |  |  | \nU.S | 6 | % |  | 16 | % |  | 8 | % |  | 15 | %\nCanada | 4 | % |  | 16 | % |  | 3 | % |  | 17 | %\nOther International | 4 | % |  | 6 | % |  | \u2014 | % |  | 10 | %\nTotal Company | 5 | % |  | 14 | % |  | 6 | % |  | 15 | %\nE-commerce | (10) | % |  | 13 | % |  | (7) | % |  | 13 | %\nChanges in comparable sales excluding the impact of changes in foreign-currency and gasoline prices: |  |  |  |  |  |  | \nU.S | 6 | % |  | 11 | % |  | 6 | % |  | 11 | %\nCanada | 10 | % |  | 12 | % |  | 9 | % |  | 10 | %\nOther International | 10 | % |  | 9 | % |  | 9 | % |  | 10 | %\nTotal Company | 7 | % |  | 11 | % |  | 7 | % |  | 11 | %\nE-commerce | (9) | % |  | 13 | % |  | (6) | % |  | 13 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 12,2023 |  | February 13,2022 |  | February 12,2023 |  | February 13,2022\nMembership fees | $ | 1,027 |  |  | $ | 967 |  |  | $ | 2,027 |  |  | $ | 1,913 | \nMembership fees increase | 6 | % |  | 10 | % |  | 6 | % |  | 10 | %\nTotal paid members (000s) | 68,100 |  |  | 63,400 |  |  | \u2014 |  |  | \u2014 | \nTotal cardholders (000s) | 123,000 |  |  | 114,800 |  |  | \u2014 |  |  | \u2014 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 12,2023 |  | February 13,2022 |  | February 12,2023 |  | February 13,2022\nNet sales | $ | 54,239 |  |  | $ | 50,937 |  |  | $ | 107,676 |  |  | $ | 100,354 | \nLess merchandise costs | 48,423 |  |  | 45,517 |  |  | 96,192 |  |  | 89,469 | \nGross margin | $ | 5,816 |  |  | $ | 5,420 |  |  | $ | 11,484 |  |  | $ | 10,885 | \nGross margin percentage | 10.72 | % |  | 10.64 | % |  | 10.67 | % |  | 10.85 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 12,2023 |  | February 13,2022 |  | February 12,2023 |  | February 13,2022\nSG&A expenses | $ | 4,940 |  |  | $ | 4,575 |  |  | $ | 9,857 |  |  | $ | 9,293 | \nSG&A expenses as a percentage of net sales | 9.11 | % |  | 8.98 | % |  | 9.15 | % |  | 9.26 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 12,2023 |  | February 13,2022 |  | February 12,2023 |  | February 13,2022\nInterest expense | $ | 34 |  |  | $ | 36 |  |  | $ | 68 |  |  | $ | 75 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 12,2023 |  | February 13,2022 |  | February 12,2023 |  | February 13,2022\nInterest income | $ | 105 |  |  | $ | 6 |  |  | $ | 159 |  |  | $ | 15 | \nForeign-currency transaction gains (losses), net | 3 |  |  | 12 |  |  | (6) |  |  | 38 | \nOther, net | 6 |  |  | 7 |  |  | 14 |  |  | 14 | \nInterest income and other, net | $ | 114 |  |  | $ | 25 |  |  | $ | 167 |  |  | $ | 67 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 24 Weeks Ended\n | February 12,2023 |  | February 13,2022 |  | February 12,2023 |  | February 13,2022\nProvision for income taxes | $ | 517 |  |  | $ | 481 |  |  | $ | 923 |  |  | $ | 832 | \nEffective tax rate | 26.1 | % |  | 26.7 | % |  | 24.6 | % |  | 23.8 | %  |  |  |  |  |  |  |  |  |  |  | \n | 24 Weeks Ended\n | February 12,2023 |  | February 13,2022\nNet cash provided by operating activities | $ | 5,802 |  |  | $ | 3,659 | \nNet cash used in investing activities | (1,865) |  |  | (1,393) | \nNet cash used in financing activities | (1,215) |  |  | (1,667) | \n |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number of Shares Purchased |  | Average Price Paid Per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Programs(1) |  | Maximum Dollar Value of Shares that May Yet be Purchased Under the Programs(1)\nNovember 21, 2022 \u2014 December 18, 2022 | 91,000 |  |  | $ | 499.57 |  |  | 91,000 |  |  | $ | 2,621 | \nDecember 19, 2022 \u2014 January 15, 2023 | 96,000 |  |  | 465.99 |  |  | 96,000 |  |  | 2,576 | \nJanuary 16, 2023 \u2014 February 12, 2023 | 107,000 |  |  | 498.61 |  |  | 107,000 |  |  | 3,955 | \nTotal second quarter | 294,000 |  |  | $ | 488.30 |  |  | 294,000 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  | Incorporated by Reference\nExhibitNumber |  | Exhibit\u00a0Description |  | FiledHerewith |  | Form |  | PeriodEnding |  | Filing\u00a0Date\n |  |  |  |  |  |  |  |  |  | \n3.1 |  | Articles of Incorporation as amended of Costco Wholesale Corporation |  |  |  | 10-K |  | 8/28/2022 |  | 10/5/2022\n |  |  |  |  |  |  |  |  |  | \n3.2 |  | Bylaws as amended of Costco Wholesale Corporation |  |  |  | 10-Q |  | 5/8/2022 |  | 6/2/2022\n |  |  |  |  |  |  |  |  |  | \n10.1 |  | Eleventh Amendment to Citi, N.A. Co-Branded Credit Card Agreement |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n31.1 |  | Rule 13(a) \u2013 14(a) Certifications |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n32.1 |  | Section 1350 Certifications |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.INS |  | Inline XBRL Instance Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.SCH |  | Inline XBRL Taxonomy Extension Schema Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n104 |  | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |  | x |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n |  |  | COSTCOWHOLESALECORPORATION(Registrant)\n |  | \nMarch 8, 2023 | By |  | /s/ W. CRAIGJELINEK\nDate |  |  | W. Craig JelinekChief Executive Officer and Director\n |  |  | \nMarch 8, 2023 | By |  | /s/ RICHARDA. GALANTI\nDate |  |  | Richard\u00a0A. GalantiExecutive Vice President, Chief Financial Officer and Director"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Costco, in 2023 Q2, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  |  |  |  | \nWashington |  | 91-1223280\n(State or other jurisdiction ofincorporation or organization) |  | (I.R.S. Employer Identification No.)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of each class |  | Trading symbol(s) |  | Name of each exchange on which registered\nCommon Stock, $.005 Par Value |  | COST |  | The Nasdaq Global Select Market  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \n |  | Page\nPART\u00a0I | FINANCIAL INFORMATION | \nItem\u00a01. | Financial Statements | 3\n | Condensed Consolidated Statements of Income | 3\n | Condensed Consolidated Statements of Comprehensive Income | 4\n | Condensed Consolidated Balance Sheets | 5\n | Condensed Consolidated Statements of Equity | 6\n | Condensed Consolidated Statements of Cash Flows | 8\n | Notes to Condensed Consolidated Financial Statements | 9\nItem 2. | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 18\nItem 3. | Quantitative and Qualitative Disclosures About Market Risk | 27\nItem 4. | Controls and Procedures | 27\n |  | \nPART\u00a0II | OTHER INFORMATION | \nItem 1. | Legal Proceedings | 28\nItem\u00a01A. | Risk Factors | 28\nItem 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 28\nItem 3. | Defaults Upon Senior Securities | 28\nItem 4. | Mine Safety Disclosures | 28\nItem 5. | Other Information | 28\nItem 6. | Exhibits | 29\n | Signatures | 30  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 7,2023 |  | May 8,2022 |  | May 7,2023 |  | May 8,2022\nREVENUE |  |  |  |  |  |  | \nNet sales | $ | 52,604 |  |  | $ | 51,612 |  |  | $ | 160,280 |  |  | $ | 151,966 | \nMembership fees | 1,044 |  |  | 984 |  |  | 3,071 |  |  | 2,897 | \nTotal revenue | 53,648 |  |  | 52,596 |  |  | 163,351 |  |  | 154,863 | \nOPERATING EXPENSES |  |  |  |  |  |  | \nMerchandise costs | 47,175 |  |  | 46,355 |  |  | 143,367 |  |  | 135,824 | \nSelling, general and administrative | 4,794 |  |  | 4,450 |  |  | 14,651 |  |  | 13,743 | \nOperating income | 1,679 |  |  | 1,791 |  |  | 5,333 |  |  | 5,296 | \nOTHER INCOME (EXPENSE) |  |  |  |  |  |  | \nInterest expense | (36) |  |  | (35) |  |  | (104) |  |  | (110) | \nInterest income and other, net | 128 |  |  | 71 |  |  | 295 |  |  | 138 | \nINCOME BEFORE INCOME TAXES | 1,771 |  |  | 1,827 |  |  | 5,524 |  |  | 5,324 | \nProvision for income taxes | 469 |  |  | 455 |  |  | 1,392 |  |  | 1,287 | \nNet income including noncontrolling interests | 1,302 |  |  | 1,372 |  |  | 4,132 |  |  | 4,037 | \nNet income attributable to noncontrolling interests | \u2014 |  |  | (19) |  |  | \u2014 |  |  | (61) | \nNET INCOME ATTRIBUTABLE TO COSTCO | $ | 1,302 |  |  | $ | 1,353 |  |  | $ | 4,132 |  |  | $ | 3,976 | \nNET INCOME PER COMMON SHARE ATTRIBUTABLE TO COSTCO: |  |  |  |  |  |  | \nBasic | $ | 2.94 |  |  | $ | 3.05 |  |  | $ | 9.31 |  |  | $ | 8.96 | \nDiluted | $ | 2.93 |  |  | $ | 3.04 |  |  | $ | 9.30 |  |  | $ | 8.94 | \nShares used in calculation (000s): |  |  |  |  |  |  | \nBasic | 443,814 |  |  | 443,700 |  |  | 443,843 |  |  | 443,567 | \nDiluted | 444,360 |  |  | 444,886 |  |  | 444,455 |  |  | 444,802 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 7,2023 |  | May 8,2022 |  | May 7,2023 |  | May 8,2022\nNET INCOME INCLUDING NONCONTROLLING INTERESTS | $ | 1,302 |  |  | $ | 1,372 |  |  | $ | 4,132 |  |  | $ | 4,037 | \nForeign-currency translation adjustment and other, net | (8) |  |  | (388) |  |  | 149 |  |  | (495) | \nComprehensive income | 1,294 |  |  | 984 |  |  | 4,281 |  |  | 3,542 | \nLess: Comprehensive (loss) income attributable to noncontrolling interests | \u2014 |  |  | (13) |  |  | \u2014 |  |  | 31 | \nCOMPREHENSIVE INCOME ATTRIBUTABLE TO COSTCO | $ | 1,294 |  |  | $ | 997 |  |  | $ | 4,281 |  |  | $ | 3,511 |   |  |  |  |  |  |  |  |  |  |  | \n | May 7,2023 |  | August 28,2022\nASSETS |  |  | \nCURRENT ASSETS |  |  | \nCash and cash equivalents | $ | 12,493 |  |  | $ | 10,203 | \nShort-term investments | 1,215 |  |  | 846 | \nReceivables, net | 2,502 |  |  | 2,241 | \nMerchandise inventories | 16,324 |  |  | 17,907 | \nOther current assets | 1,755 |  |  | 1,499 | \nTotal current assets | 34,289 |  |  | 32,696 | \nOTHER ASSETS |  |  | \nProperty and equipment, net | 25,931 |  |  | 24,646 | \nOperating lease right-of-use assets | 2,806 |  |  | 2,774 | \nOther long-term assets | 3,726 |  |  | 4,050 | \nTOTAL ASSETS | $ | 66,752 |  |  | $ | 64,166 | \nLIABILITIES AND EQUITY |  |  | \nCURRENT LIABILITIES |  |  | \nAccounts payable | $ | 16,853 |  |  | $ | 17,848 | \nAccrued salaries and benefits | 4,117 |  |  | 4,381 | \nAccrued member rewards | 2,076 |  |  | 1,911 | \nDeferred membership fees | 2,436 |  |  | 2,174 | \nCurrent portion of long-term debt | \u2014 |  |  | 73 | \nOther current liabilities | 6,226 |  |  | 5,611 | \nTotal current liabilities | 31,708 |  |  | 31,998 | \nOTHER LIABILITIES |  |  | \nLong-term debt, excluding current portion | 6,497 |  |  | 6,484 | \nLong-term operating lease liabilities | 2,507 |  |  | 2,482 | \nOther long-term liabilities | 2,467 |  |  | 2,555 | \nTOTAL LIABILITIES | 43,179 |  |  | 43,519 | \nCOMMITMENTS AND CONTINGENCIES |  |  | \nEQUITY |  |  | \nPreferred stock $0.005par value;100,000,000shares authorized; no shares issued and outstanding | \u2014 |  |  | \u2014 | \nCommon stock $0.005par value;900,000,000shares authorized;443,222,000and442,664,000shares issued and outstanding | 2 |  |  | 2 | \nAdditional paid-in capital | 7,211 |  |  | 6,884 | \nAccumulated other comprehensive loss | (1,680) |  |  | (1,829) | \nRetained earnings | 18,035 |  |  | 15,585 | \nTotal Costco stockholders\u2019 equity | 23,568 |  |  | 20,642 | \nNoncontrolling interests | 5 |  |  | 5 | \nTOTAL EQUITY | 23,573 |  |  | 20,647 | \nTOTAL LIABILITIES AND EQUITY | $ | 66,752 |  |  | $ | 64,166 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended May 7, 2023\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT FEBRUARY 12, 2023 | 443,550 |  |  | $ | 2 |  |  | $ | 7,123 |  |  | $ | (1,672) |  |  | $ | 17,341 |  |  | $ | 22,794 |  |  | $ | 5 |  |  | $ | 22,799 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1,302 |  |  | 1,302 |  |  | \u2014 |  |  | 1,302 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (8) |  |  | \u2014 |  |  | (8) |  |  | \u2014 |  |  | (8) | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 94 |  |  | \u2014 |  |  | \u2014 |  |  | 94 |  |  | \u2014 |  |  | 94 | \nRelease of vested restricted stock units (RSUs), including tax effects | 1 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nRepurchases of common stock | (329) |  |  | \u2014 |  |  | (6) |  |  | \u2014 |  |  | (156) |  |  | (162) |  |  | \u2014 |  |  | (162) | \nCash dividend declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (452) |  |  | (452) |  |  | \u2014 |  |  | (452) | \nBALANCE AT MAY 7, 2023 | 443,222 |  |  | $ | 2 |  |  | $ | 7,211 |  |  | $ | (1,680) |  |  | $ | 18,035 |  |  | $ | 23,568 |  |  | $ | 5 |  |  | $ | 23,573 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended May 8, 2022\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT FEBRUARY 13, 2022 | 443,279 |  |  | $ | 4 |  |  | $ | 7,186 |  |  | $ | (1,246) |  |  | $ | 13,474 |  |  | $ | 19,418 |  |  | $ | 558 |  |  | $ | 19,976 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1,353 |  |  | 1,353 |  |  | 19 |  |  | 1,372 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (356) |  |  | \u2014 |  |  | (356) |  |  | (32) |  |  | (388) | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 91 |  |  | \u2014 |  |  | \u2014 |  |  | 91 |  |  | \u2014 |  |  | 91 | \nRelease of vested RSUs, including tax effects | 4 |  |  | \u2014 |  |  | (1) |  |  | \u2014 |  |  | \u2014 |  |  | (1) |  |  | \u2014 |  |  | (1) | \nRepurchases of common stock | (254) |  |  | \u2014 |  |  | (4) |  |  | \u2014 |  |  | (135) |  |  | (139) |  |  | \u2014 |  |  | (139) | \nCash dividend declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (398) |  |  | (398) |  |  | \u2014 |  |  | (398) | \nBALANCE AT MAY 8, 2022 | 443,029 |  |  | $ | 4 |  |  | $ | 7,272 |  |  | $ | (1,602) |  |  | $ | 14,294 |  |  | $ | 19,968 |  |  | $ | 545 |  |  | $ | 20,513 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended May 7, 2023\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT AUGUST 28, 2022 | 442,664 |  |  | $ | 2 |  |  | $ | 6,884 |  |  | $ | (1,829) |  |  | $ | 15,585 |  |  | $ | 20,642 |  |  | $ | 5 |  |  | $ | 20,647 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 4,132 |  |  | 4,132 |  |  | \u2014 |  |  | 4,132 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 149 |  |  | \u2014 |  |  | 149 |  |  | \u2014 |  |  | 149 | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 645 |  |  | \u2014 |  |  | \u2014 |  |  | 645 |  |  | \u2014 |  |  | 645 | \nRelease of vested restricted stock units (RSUs), including tax effects | 1,466 |  |  | \u2014 |  |  | (302) |  |  | \u2014 |  |  | \u2014 |  |  | (302) |  |  | \u2014 |  |  | (302) | \nRepurchases of common stock | (908) |  |  | \u2014 |  |  | (16) |  |  | \u2014 |  |  | (431) |  |  | (447) |  |  | \u2014 |  |  | (447) | \nCash dividends declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (1,251) |  |  | (1,251) |  |  | \u2014 |  |  | (1,251) | \nBALANCE AT MAY 7, 2023 | 443,222 |  |  | $ | 2 |  |  | $ | 7,211 |  |  | $ | (1,680) |  |  | $ | 18,035 |  |  | $ | 23,568 |  |  | $ | 5 |  |  | $ | 23,573 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended May 8, 2022\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT AUGUST 29, 2021 | 441,825 |  |  | $ | 4 |  |  | $ | 7,031 |  |  | $ | (1,137) |  |  | $ | 11,666 |  |  | $ | 17,564 |  |  | $ | 514 |  |  | $ | 18,078 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3,976 |  |  | 3,976 |  |  | 61 |  |  | 4,037 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (465) |  |  | \u2014 |  |  | (465) |  |  | (30) |  |  | (495) | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 609 |  |  | \u2014 |  |  | \u2014 |  |  | 609 |  |  | \u2014 |  |  | 609 | \nRelease of vested RSUs, including tax effects | 1,694 |  |  | \u2014 |  |  | (360) |  |  | \u2014 |  |  | \u2014 |  |  | (360) |  |  | \u2014 |  |  | (360) | \nRepurchases of common stock | (490) |  |  | \u2014 |  |  | (8) |  |  | \u2014 |  |  | (249) |  |  | (257) |  |  | \u2014 |  |  | (257) | \nCash dividends declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (1,099) |  |  | (1,099) |  |  | \u2014 |  |  | (1,099) | \nBALANCE AT MAY 8, 2022 | 443,029 |  |  | $ | 4 |  |  | $ | 7,272 |  |  | $ | (1,602) |  |  | $ | 14,294 |  |  | $ | 19,968 |  |  | $ | 545 |  |  | $ | 20,513 |   |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | May 7,2023 |  | May 8,2022\nCASH FLOWS FROM OPERATING ACTIVITIES |  |  | \nNet income including noncontrolling interests | $ | 4,132 |  |  | $ | 4,037 | \nAdjustments to reconcile net income including noncontrolling interests to net cash provided by operating activities: |  |  | \nDepreciation and amortization | 1,389 |  |  | 1,299 | \nNon-cash lease expense | 300 |  |  | 240 | \nStock-based compensation | 643 |  |  | 606 | \nOther non-cash operating activities, net | 72 |  |  | (62) | \nImpairment of assets | 391 |  |  | 118 | \nDeferred income taxes | (22) |  |  | (2) | \nChanges in operating assets and liabilities: |  |  | \nMerchandise inventories | 1,596 |  |  | (3,633) | \nAccounts payable | (872) |  |  | 1,766 | \nOther operating assets and liabilities, net | (286) |  |  | 517 | \nNet cash provided by operating activities | 7,343 |  |  | 4,886 | \nCASH FLOWS FROM INVESTING ACTIVITIES |  |  | \nPurchases of short-term investments | (947) |  |  | (588) | \nMaturities of short-term investments | 594 |  |  | 840 | \nAdditions to property and equipment | (2,767) |  |  | (2,632) | \nOther investing activities, net | (27) |  |  | (48) | \nNet cash used in investing activities | (3,147) |  |  | (2,428) | \nCASH FLOWS FROM FINANCING ACTIVITIES |  |  | \nRepayments of short-term borrowings | (698) |  |  | (195) | \nProceeds from short-term borrowings | 667 |  |  | 175 | \nRepayments of long-term borrowings | (75) |  |  | (800) | \nTax withholdings on stock-based awards | (302) |  |  | (360) | \nRepurchases of common stock | (446) |  |  | (254) | \nCash dividend payments | (799) |  |  | (701) | \nOther financing activities, net | (297) |  |  | (208) | \nNet cash used in financing activities | (1,950) |  |  | (2,343) | \nEFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | 44 |  |  | (180) | \nNet increase (decrease) in cash and cash equivalents | 2,290 |  |  | (65) | \nCASH AND CASH EQUIVALENTS BEGINNING OF YEAR | 10,203 |  |  | 11,258 | \nCASH AND CASH EQUIVALENTS END OF PERIOD | $ | 12,493 |  |  | $ | 11,193 | \n |  |  | \nSUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: |  |  | \nCash paid during the first thirty-six weeks of the year for: |  |  | \nInterest | $ | 86 |  |  | $ | 102 | \nIncome taxes, net | $ | 1,443 |  |  | $ | 1,121 | \nSUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES: |  |  | \nCash dividend declared, but not yet paid | $ | 452 |  |  | $ | 398 | \nFinancing lease assets obtained in exchange for new or modified leases | $ | 101 |  |  | $ | 631 | \nOperating lease assets obtained in exchange for new or modified leases | $ | 160 |  |  | $ | 67 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMay 7, 2023: | CostBasis |  | UnrealizedLosses, Net |  | RecordedBasis\nAvailable-for-sale: |  |  |  |  | \nGovernment and agency securities | $ | 602 |  |  | $ | (2) |  |  | $ | 600 | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \nHeld-to-maturity: |  |  |  |  | \nCertificates of deposit | 615 |  |  | \u2014 |  |  | 615 | \n |  |  |  |  | \n |  |  |  |  | \nTotal short-term investments | $ | 1,217 |  |  | $ | (2) |  |  | $ | 1,215 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAugust 28, 2022: | CostBasis |  | UnrealizedLosses, Net |  | RecordedBasis\nAvailable-for-sale: |  |  |  |  | \nGovernment and agency securities | $ | 534 |  |  | $ | (5) |  |  | $ | 529 | \nHeld-to-maturity: |  |  |  |  | \nCertificates of deposit | 317 |  |  | \u2014 |  |  | 317 | \nTotal short-term investments | $ | 851 |  |  | $ | (5) |  |  | $ | 846 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Available-For-Sale |  | Held-To-Maturity\n | Cost\u00a0Basis |  | Fair\u00a0Value | \nDue in one year or less | $ | 126 |  |  | $ | 125 |  |  | $ | 615 | \nDue after one year through five years | 324 |  |  | 324 |  |  | \u2014 | \nDue after five years | 152 |  |  | 151 |  |  | \u2014 | \nTotal | $ | 602 |  |  | $ | 600 |  |  | $ | 615 |   |  |  |  |  |  |  |  |  |  |  | \n | Level 2\n | May 7,2023 |  | August 28,2022\n |  |  | \nInvestment in government and agency securities | $ | 600 |  |  | $ | 529 | \n |  |  | \n |  |  | \n |  |  | \nForward foreign-exchange contracts, in asset position(1) | 6 |  |  | 34 | \nForward foreign-exchange contracts, in (liability) position(1) | (11) |  |  | (2) | \nTotal | $ | 595 |  |  | $ | 561 |   |  |  |  |  |  |  |  |  |  |  | \n | May 7,2023 |  | August 28,2022\n2.750% Senior Notes due May 2024 | $ | 1,000 |  |  | $ | 1,000 | \n3.000% Senior Notes due May 2027 | 1,000 |  |  | 1,000 | \n1.375% Senior Notes due June 2027 | 1,250 |  |  | 1,250 | \n1.600% Senior Notes due April 2030 | 1,750 |  |  | 1,750 | \n1.750% Senior Notes due April 2032 | 1,000 |  |  | 1,000 | \nOther long-term debt | 525 |  |  | 590 | \nTotal long-term debt | 6,525 |  |  | 6,590 | \nLess unamortized debt discounts and issuance costs | 28 |  |  | 33 | \nLess current portion(1) | \u2014 |  |  | 73 | \nLong-term debt, excluding current portion | $ | 6,497 |  |  | $ | 6,484 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Shares Repurchased (000s) |  | Average Price per Share |  | Total Cost\nThird quarter of 2023 | 329 |  |  | $ | 492.71 |  |  | $ | 162 | \nFirst thirty-six weeks of 2023 | 908 |  |  | $ | 492.30 |  |  | $ | 447 | \n |  |  |  |  | \nThird quarter of 2022 | 254 |  |  | $ | 547.38 |  |  | $ | 139 | \nFirst thirty-six weeks of 2022 | 490 |  |  | $ | 523.61 |  |  | $ | 257 |   |  |  |  |  |  |  |  |  |  |  | \n | Number\u00a0ofUnits (in\u00a0000s) |  | Weighted-AverageGrant Date Fair Value\nOutstanding at August 28, 2022 | 3,449 |  |  | $ | 338.41 | \nGranted | 1,814 |  |  | 471.47 | \nVested and delivered | (2,096) |  |  | 352.56 | \nForfeited | (93) |  |  | 396.50 | \nOutstanding at May 7, 2023 | 3,074 |  |  | $ | 405.51 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 7,2023 |  | May 8,2022 |  | May 7,2023 |  | May 8,2022\nStock-based compensation expense | $ | 94 |  |  | $ | 90 |  |  | $ | 643 |  |  | $ | 606 | \nLess recognized income tax benefits | 21 |  |  | 20 |  |  | 134 |  |  | 128 | \nStock-based compensation expense, net | $ | 73 |  |  | $ | 70 |  |  | $ | 509 |  |  | $ | 478 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 7,2023 |  | May 8,2022 |  | May 7,2023 |  | May 8,2022\nNet income attributable to Costco | $ | 1,302 |  |  | $ | 1,353 |  |  | $ | 4,132 |  |  | $ | 3,976 | \nWeighted average basic shares | 443,814 |  |  | 443,700 |  |  | 443,843 |  |  | 443,567 | \nRSUs | 546 |  |  | 1,186 |  |  | 612 |  |  | 1,235 | \nWeighted average diluted shares | 444,360 |  |  | 444,886 |  |  | 444,455 |  |  | 444,802 | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | United\u00a0StatesOperations |  | CanadianOperations |  | OtherInternationalOperations |  | Total\n12 Weeks Ended May 7, 2023 |  |  |  |  |  |  | \nTotal revenue | $ | 39,049 |  |  | $ | 7,268 |  |  | $ | 7,331 |  |  | $ | 53,648 | \nOperating income | 1,027 |  |  | 327 |  |  | 325 |  |  | 1,679 | \n12 Weeks Ended May 8, 2022 |  |  |  |  |  |  | \nTotal revenue | $ | 38,534 |  |  | $ | 7,268 |  |  | $ | 6,794 |  |  | $ | 52,596 | \nOperating income | 1,205 |  |  | 324 |  |  | 262 |  |  | 1,791 | \n36 Weeks Ended May 7, 2023 |  |  |  |  |  |  | \nTotal revenue | $ | 119,339 |  |  | $ | 21,923 |  |  | $ | 22,089 |  |  | $ | 163,351 | \nOperating income | 3,558 |  |  | 899 |  |  | 876 |  |  | 5,333 | \n |  |  |  |  |  |  | \n36 Weeks Ended May 8, 2022 |  |  |  |  |  |  | \nTotal revenue | $ | 112,418 |  |  | $ | 21,406 |  |  | $ | 21,039 |  |  | $ | 154,863 | \nOperating income | 3,502 |  |  | 918 |  |  | 876 |  |  | 5,296 | \n |  |  |  |  |  |  | \n52 Weeks Ended August 28, 2022 |  |  |  |  |  |  | \nTotal revenue | $ | 165,294 |  |  | $ | 31,675 |  |  | $ | 29,985 |  |  | $ | 226,954 | \nOperating income | 5,268 |  |  | 1,346 |  |  | 1,179 |  |  | 7,793 | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 7,2023 |  | May 8,2022 |  | May 7,2023 |  | May 8,2022\nFoods and Sundries | $ | 21,298 |  |  | $ | 19,594 |  |  | $ | 64,672 |  |  | $ | 58,646 | \nNon-Foods | 13,087 |  |  | 13,810 |  |  | 41,860 |  |  | 43,077 | \nFresh Foods | 7,194 |  |  | 6,813 |  |  | 21,287 |  |  | 20,211 | \nWarehouse Ancillary and Other Businesses | 11,025 |  |  | 11,395 |  |  | 32,461 |  |  | 30,032 | \nTotal net sales | $ | 52,604 |  |  | $ | 51,612 |  |  | $ | 160,280 |  |  | $ | 151,966 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 7,2023 |  | May 8,2022 |  | May 7,2023 |  | May 8,2022\nNet Sales | $ | 52,604 |  |  | $ | 51,612 |  |  | $ | 160,280 |  |  | $ | 151,966 | \nChanges in net sales: |  |  |  |  |  |  | \nU.S. | 1 | % |  | 18 | % |  | 6 | % |  | 17 | %\nCanada | \u2014 | % |  | 16 | % |  | 2 | % |  | 17 | %\nOther International | 8 | % |  | 9 | % |  | 5 | % |  | 12 | %\nTotal Company | 2 | % |  | 16 | % |  | 5 | % |  | 16 | %\nChanges in comparable sales: |  |  |  |  |  |  | \nU.S. | \u2014 | % |  | 17 | % |  | 5 | % |  | 16 | %\nCanada | (1) | % |  | 15 | % |  | 2 | % |  | 16 | %\nOther International | 4 | % |  | 6 | % |  | 2 | % |  | 8 | %\nTotal Company | \u2014 | % |  | 15 | % |  | 4 | % |  | 15 | %\nE-commerce | (10) | % |  | 7 | % |  | (8) | % |  | 11 | %\nChanges in comparable sales excluding the impact of changes in foreign-currency and gasoline prices: |  |  |  |  |  |  | \nU.S. | 2 | % |  | 11 | % |  | 5 | % |  | 11 | %\nCanada | 7 | % |  | 13 | % |  | 8 | % |  | 11 | %\nOther International | 8 | % |  | 9 | % |  | 9 | % |  | 10 | %\nTotal Company | 3 | % |  | 11 | % |  | 6 | % |  | 11 | %\nE-commerce | (9) | % |  | 8 | % |  | (7) | % |  | 11 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 7,2023 |  | May 8,2022 |  | May 7,2023 |  | May 8,2022\nMembership fees | $ | 1,044 |  |  | $ | 984 |  |  | $ | 3,071 |  |  | $ | 2,897 | \nMembership fees increase | 6 | % |  | 9 | % |  | 6 | % |  | 10 | %\nTotal paid members (000s) | 69,100 |  |  | 64,400 |  |  | \u2014 |  |  | \u2014 | \nTotal cardholders (000s) | 124,700 |  |  | 116,600 |  |  | \u2014 |  |  | \u2014 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 7,2023 |  | May 8,2022 |  | May 7,2023 |  | May 8,2022\nNet sales | $ | 52,604 |  |  | $ | 51,612 |  |  | $ | 160,280 |  |  | $ | 151,966 | \nLess merchandise costs | 47,175 |  |  | 46,355 |  |  | 143,367 |  |  | 135,824 | \nGross margin | $ | 5,429 |  |  | $ | 5,257 |  |  | $ | 16,913 |  |  | $ | 16,142 | \nGross margin percentage | 10.32 | % |  | 10.19 | % |  | 10.55 | % |  | 10.62 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 7,2023 |  | May 8,2022 |  | May 7,2023 |  | May 8,2022\nSG&A expenses | $ | 4,794 |  |  | $ | 4,450 |  |  | $ | 14,651 |  |  | $ | 13,743 | \nSG&A expenses as a percentage of net sales | 9.11 | % |  | 8.62 | % |  | 9.14 | % |  | 9.04 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 7,2023 |  | May 8,2022 |  | May 7,2023 |  | May 8,2022\nInterest expense | $ | 36 |  |  | $ | 35 |  |  | $ | 104 |  |  | $ | 110 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 7,2023 |  | May 8,2022 |  | May 7,2023 |  | May 8,2022\nInterest income | $ | 110 |  |  | $ | 6 |  |  | $ | 269 |  |  | $ | 21 | \nForeign-currency transaction gains (losses), net | 9 |  |  | 56 |  |  | 3 |  |  | 94 | \nOther, net | 9 |  |  | 9 |  |  | 23 |  |  | 23 | \nInterest income and other, net | $ | 128 |  |  | $ | 71 |  |  | $ | 295 |  |  | $ | 138 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | 36 Weeks Ended\n | May 7,2023 |  | May 8,2022 |  | May 7,2023 |  | May 8,2022\nProvision for income taxes | $ | 469 |  |  | $ | 455 |  |  | $ | 1,392 |  |  | $ | 1,287 | \nEffective tax rate | 26.5 | % |  | 24.9 | % |  | 25.2 | % |  | 24.2 | %  |  |  |  |  |  |  |  |  |  |  | \n | 36 Weeks Ended\n | May 7,2023 |  | May 8,2022\nNet cash provided by operating activities | $ | 7,343 |  |  | $ | 4,886 | \nNet cash used in investing activities | (3,147) |  |  | (2,428) | \nNet cash used in financing activities | (1,950) |  |  | (2,343) | \n |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number of Shares Purchased |  | Average Price Paid Per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Programs(1) |  | Maximum Dollar Value of Shares that May Yet be Purchased Under the Programs(1)\nFebruary 13, 2022 \u2014 March 12, 2023 | 108,000 |  |  | $ | 490.87 |  |  | 108,000 |  |  | $ | 3,902 | \nMarch 13, 2023 \u2014 April 9, 2023 | 109,000 |  |  | 489.45 |  |  | 109,000 |  |  | 3,849 | \nApril 10, 2023 \u2014 May 7, 2023 | 112,000 |  |  | 497.64 |  |  | 112,000 |  |  | 3,793 | \nTotal third quarter | 329,000 |  |  | $ | 492.71 |  |  | 329,000 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  | Incorporated by Reference\nExhibitNumber |  | Exhibit\u00a0Description |  | FiledHerewith |  | Form |  | PeriodEnding |  | Filing\u00a0Date\n |  |  |  |  |  |  |  |  |  | \n3.1 |  | Articles of Incorporation as amended of Costco Wholesale Corporation |  |  |  | 10-K |  | 8/28/2022 |  | 10/5/2022\n |  |  |  |  |  |  |  |  |  | \n3.2 |  | Bylaws as amended of Costco Wholesale Corporation |  |  |  | 10-Q |  | 5/8/2022 |  | 6/2/2022\n |  |  |  |  |  |  |  |  |  | \n31.1 |  | Rule 13(a) \u2013 14(a) Certifications |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n32.1 |  | Section 1350 Certifications |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.INS |  | Inline XBRL Instance Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.SCH |  | Inline XBRL Taxonomy Extension Schema Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n104 |  | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |  | x |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n |  |  | COSTCOWHOLESALECORPORATION(Registrant)\n |  | \nMay 31, 2023 | By |  | /s/ W. CRAIGJELINEK\nDate |  |  | W. Craig JelinekChief Executive Officer and Director\n |  |  | \nMay 31, 2023 | By |  | /s/ RICHARDA. GALANTI\nDate |  |  | Richard\u00a0A. GalantiExecutive Vice President, Chief Financial Officer and Director"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Costco, in 2023 Q4, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  |  |  |  | \nWashington |  | 91-1223280\n(State or other jurisdiction ofincorporation or organization) |  | (I.R.S. Employer Identification No.)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of each class |  | Trading symbol(s) |  | Name of each exchange on which registered\nCommon Stock, $.005 Par Value |  | COST |  | The Nasdaq Global Select Market  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \n |  | Page\nPART\u00a0I | FINANCIAL INFORMATION | \nItem\u00a01. | Financial Statements | 3\n | Condensed Consolidated Statements of Income | 3\n | Condensed Consolidated Statements of Comprehensive Income | 4\n | Condensed Consolidated Balance Sheets | 5\n | Condensed Consolidated Statements of Equity | 6\n | Condensed Consolidated Statements of Cash Flows | 7\n | Notes to Condensed Consolidated Financial Statements | 8\nItem 2. | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 17\nItem 3. | Quantitative and Qualitative Disclosures About Market Risk | 25\nItem 4. | Controls and Procedures | 25\n |  | \nPART\u00a0II | OTHER INFORMATION | \nItem 1. | Legal Proceedings | 25\nItem\u00a01A. | Risk Factors | 25\nItem 2. | Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities | 26\nItem 3. | Defaults Upon Senior Securities | 26\nItem 4. | Mine Safety Disclosures | 26\nItem 5. | Other Information | 26\nItem 6. | Exhibits | 27\n | Signatures | 28  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 26,2023 |  | November 20,2022 |  |  |  | \nREVENUE |  |  |  |  |  |  | \nNet sales | $ | 56,717 |  |  | $ | 53,437 |  |  |  |  | \nMembership fees | 1,082 |  |  | 1,000 |  |  |  |  | \nTotal revenue | 57,799 |  |  | 54,437 |  |  |  |  | \nOPERATING EXPENSES |  |  |  |  |  |  | \nMerchandise costs | 50,457 |  |  | 47,769 |  |  |  |  | \nSelling, general and administrative | 5,358 |  |  | 4,917 |  |  |  |  | \nOperating income | 1,984 |  |  | 1,751 |  |  |  |  | \nOTHER INCOME (EXPENSE) |  |  |  |  |  |  | \nInterest expense | (38) |  |  | (34) |  |  |  |  | \nInterest income and other, net | 160 |  |  | 53 |  |  |  |  | \nINCOME BEFORE INCOME TAXES | 2,106 |  |  | 1,770 |  |  |  |  | \nProvision for income taxes | 517 |  |  | 406 |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nNET INCOME | $ | 1,589 |  |  | $ | 1,364 |  |  |  |  | \nNET INCOME PER COMMON SHARE: |  |  |  |  |  |  | \nBasic | $ | 3.58 |  |  | $ | 3.07 |  |  |  |  | \nDiluted | $ | 3.58 |  |  | $ | 3.07 |  |  |  |  | \nShares used in calculation (000s): |  |  |  |  |  |  | \nBasic | 443,827 |  |  | 443,837 |  |  |  |  | \nDiluted | 444,403 |  |  | 444,531 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 26,2023 |  | November 20,2022 |  |  |  | \nNET INCOME | $ | 1,589 |  |  | $ | 1,364 |  |  |  |  | \nForeign-currency translation adjustment and other, net | (38) |  |  | (96) |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nCOMPREHENSIVE INCOME | $ | 1,551 |  |  | $ | 1,268 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | November 26,2023 |  | September 3,2023\nASSETS |  |  | \nCURRENT ASSETS |  |  | \nCash and cash equivalents | $ | 17,011 |  |  | $ | 13,700 | \nShort-term investments | 853 |  |  | 1,534 | \nReceivables, net | 2,542 |  |  | 2,285 | \nMerchandise inventories | 18,001 |  |  | 16,651 | \nOther current assets | 1,673 |  |  | 1,709 | \nTotal current assets | 40,080 |  |  | 35,879 | \nOTHER ASSETS |  |  | \nProperty and equipment, net | 27,168 |  |  | 26,684 | \nOperating lease right-of-use assets | 2,672 |  |  | 2,713 | \nOther long-term assets | 3,803 |  |  | 3,718 | \nTOTAL ASSETS | $ | 73,723 |  |  | $ | 68,994 | \nLIABILITIES AND EQUITY |  |  | \nCURRENT LIABILITIES |  |  | \nAccounts payable | $ | 20,357 |  |  | $ | 17,483 | \nAccrued salaries and benefits | 4,474 |  |  | 4,278 | \nAccrued member rewards | 2,207 |  |  | 2,150 | \nDeferred membership fees | 2,462 |  |  | 2,337 | \nCurrent portion of long-term debt | 1,080 |  |  | 1,081 | \nOther current liabilities | 6,188 |  |  | 6,254 | \nTotal current liabilities | 36,768 |  |  | 33,583 | \nOTHER LIABILITIES |  |  | \nLong-term debt, excluding current portion | 5,866 |  |  | 5,377 | \nLong-term operating lease liabilities | 2,401 |  |  | 2,426 | \nOther long-term liabilities | 2,541 |  |  | 2,550 | \nTOTAL LIABILITIES | 47,576 |  |  | 43,936 | \nCOMMITMENTS AND CONTINGENCIES |  |  | \nEQUITY |  |  | \nPreferred stock $0.005par value;100,000,000shares authorized; no shares issued and outstanding | \u2014 |  |  | \u2014 | \nCommon stock $0.005par value;900,000,000shares authorized;443,787,000and442,793,000shares issued and outstanding | 2 |  |  | 2 | \nAdditional paid-in capital | 7,489 |  |  | 7,340 | \nAccumulated other comprehensive loss | (1,843) |  |  | (1,805) | \nRetained earnings | 20,499 |  |  | 19,521 | \n |  |  | \n |  |  | \nTOTAL EQUITY | 26,147 |  |  | 25,058 | \nTOTAL LIABILITIES AND EQUITY | $ | 73,723 |  |  | $ | 68,994 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended November 26, 2023\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveLoss |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE AT SEPTEMBER 3, 2023 | 442,793 |  |  | $ | 2 |  |  | $ | 7,340 |  |  | $ | (1,805) |  |  | $ | 19,521 |  |  | $ | 25,058 |  |  | $ | \u2014 |  |  | $ | 25,058 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1,589 |  |  | 1,589 |  |  | \u2014 |  |  | 1,589 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (38) |  |  | \u2014 |  |  | (38) |  |  | \u2014 |  |  | (38) | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 446 |  |  | \u2014 |  |  | \u2014 |  |  | 446 |  |  | \u2014 |  |  | 446 | \nRelease of vested restricted stock units (RSUs), including tax effects | 1,282 |  |  | \u2014 |  |  | (292) |  |  | \u2014 |  |  | \u2014 |  |  | (292) |  |  | \u2014 |  |  | (292) | \nRepurchases of common stock | (288) |  |  | \u2014 |  |  | (5) |  |  | \u2014 |  |  | (157) |  |  | (162) |  |  | \u2014 |  |  | (162) | \nCash dividend declared and other | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (454) |  |  | (454) |  |  | \u2014 |  |  | (454) | \nBALANCE AT NOVEMBER 26, 2023 | 443,787 |  |  | $ | 2 |  |  | $ | 7,489 |  |  | $ | (1,843) |  |  | $ | 20,499 |  |  | $ | 26,147 |  |  | $ | \u2014 |  |  | $ | 26,147 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended November 20, 2022\n | Common Stock |  | AdditionalPaid-inCapital |  | AccumulatedOtherComprehensiveLoss |  | RetainedEarnings |  | Total CostcoStockholders\u2019Equity |  | NoncontrollingInterests |  | TotalEquity\n | Shares (000s) |  | Amount | \nBALANCE ATAUGUST 28, 2022 | 442,664 |  |  | $ | 2 |  |  | $ | 6,884 |  |  | $ | (1,829) |  |  | $ | 15,585 |  |  | $ | 20,642 |  |  | $ | 5 |  |  | $ | 20,647 | \nNet income | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1,364 |  |  | 1,364 |  |  | \u2014 |  |  | 1,364 | \nForeign-currency translation adjustment and other, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (96) |  |  | \u2014 |  |  | (96) |  |  | \u2014 |  |  | (96) | \nStock-based compensation | \u2014 |  |  | \u2014 |  |  | 403 |  |  | \u2014 |  |  | \u2014 |  |  | 403 |  |  | \u2014 |  |  | 403 | \nRelease of vested RSUs, including tax effects | 1,462 |  |  | \u2014 |  |  | (301) |  |  | \u2014 |  |  | \u2014 |  |  | (301) |  |  | \u2014 |  |  | (301) | \nRepurchases of common stock | (285) |  |  | \u2014 |  |  | (4) |  |  | \u2014 |  |  | (137) |  |  | (141) |  |  | \u2014 |  |  | (141) | \nCash dividend declared | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (400) |  |  | (400) |  |  | \u2014 |  |  | (400) | \nBALANCE AT NOVEMBER 20, 2022 | 443,841 |  |  | $ | 2 |  |  | $ | 6,982 |  |  | $ | (1,925) |  |  | $ | 16,412 |  |  | $ | 21,471 |  |  | $ | 5 |  |  | $ | 21,476 |   |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | November 26,2023 |  | November 20,2022\nCASH FLOWS FROM OPERATING ACTIVITIES |  |  | \nNet income | $ | 1,589 |  |  | $ | 1,364 | \nAdjustments to reconcile net income to net cash provided by operating activities: |  |  | \nDepreciation and amortization | 501 |  |  | 447 | \nNon-cash lease expense | 74 |  |  | 111 | \nStock-based compensation | 444 |  |  | 402 | \nImpairment of assets and other non-cash operating activities, net | 43 |  |  | 121 | \nChanges in operating assets and liabilities: |  |  | \nMerchandise inventories | (1,384) |  |  | (737) | \nAccounts payable | 2,854 |  |  | 487 | \nOther operating assets and liabilities, net | 530 |  |  | 415 | \nNet cash provided by operating activities | 4,651 |  |  | 2,610 | \nCASH FLOWS FROM INVESTING ACTIVITIES |  |  | \nPurchases of short-term investments | (200) |  |  | (253) | \nMaturities of short-term investments | 878 |  |  | 274 | \nAdditions to property and equipment | (1,040) |  |  | (1,057) | \nOther investing activities, net | (4) |  |  | (21) | \nNet cash used in investing activities | (366) |  |  | (1,057) | \nCASH FLOWS FROM FINANCING ACTIVITIES |  |  | \nRepayments of short-term borrowings | (173) |  |  | (77) | \nProceeds from short-term borrowings | 144 |  |  | 29 | \nProceeds from issuance of long-term debt | 498 |  |  | \u2014 | \nTax withholdings on stock-based awards | (292) |  |  | (301) | \nRepurchases of common stock | (162) |  |  | (141) | \nCash dividend payments | (905) |  |  | (400) | \nFinancing lease payments | (82) |  |  | (60) | \nOther financing activities, net | (2) |  |  | 87 | \nNet cash used in financing activities | (974) |  |  | (863) | \nEFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | \u2014 |  |  | (37) | \nNet increase in cash and cash equivalents | 3,311 |  |  | 653 | \nCASH AND CASH EQUIVALENTS BEGINNING OF YEAR | 13,700 |  |  | 10,203 | \nCASH AND CASH EQUIVALENTS END OF PERIOD | $ | 17,011 |  |  | $ | 10,856 | \n |  |  | \nSUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: |  |  | \nCash paid during the first 12 weeks of the year for: |  |  | \nInterest | $ | 52 |  |  | $ | 52 | \nIncome taxes, net | $ | 210 |  |  | $ | 214 | \nSUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES: |  |  | \n |  |  | \nFinancing lease assets obtained in exchange for new or modified leases | $ | 29 |  |  | $ | 49 | \nOperating lease assets obtained in exchange for new or modified leases | $ | 18 |  |  | $ | 68 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNovember 26, 2023: | CostBasis |  | UnrealizedLosses, Net |  | RecordedBasis\nAvailable-for-sale: |  |  |  |  | \nGovernment and agency securities | $ | 665 |  |  | $ | (20) |  |  | $ | 645 | \n |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  | \nHeld-to-maturity: |  |  |  |  | \nCertificates of deposit | 208 |  |  | \u2014 |  |  | 208 | \n |  |  |  |  | \n |  |  |  |  | \nTotal short-term investments | $ | 873 |  |  | $ | (20) |  |  | $ | 853 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSeptember 3, 2023: | CostBasis |  | UnrealizedLosses, Net |  | RecordedBasis\nAvailable-for-sale: |  |  |  |  | \nGovernment and agency securities | $ | 650 |  |  | $ | (17) |  |  | $ | 633 | \nHeld-to-maturity: |  |  |  |  | \nCertificates of deposit | 901 |  |  | \u2014 |  |  | 901 | \nTotal short-term investments | $ | 1,551 |  |  | $ | (17) |  |  | $ | 1,534 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Available-For-Sale |  | Held-To-Maturity\n | Cost\u00a0Basis |  | Fair\u00a0Value | \nDue in one year or less | $ | 120 |  |  | $ | 118 |  |  | $ | 208 | \nDue after one year through five years | 362 |  |  | 354 |  |  | \u2014 | \nDue after five years | 183 |  |  | 173 |  |  | \u2014 | \nTotal | $ | 665 |  |  | $ | 645 |  |  | $ | 208 |   |  |  |  |  |  |  |  |  |  |  | \n | Level 2\n | November 26,2023 |  | September 3,2023\n |  |  | \nInvestment in government and agency securities | $ | 645 |  |  | $ | 633 | \n |  |  | \n |  |  | \n |  |  | \nForward foreign-exchange contracts, in asset position(1) | 7 |  |  | 18 | \nForward foreign-exchange contracts, in (liability) position(1) | (16) |  |  | (7) | \nTotal | $ | 636 |  |  | $ | 644 |   |  |  |  |  |  |  |  |  |  |  | \n | November 26,2023 |  | September 3,2023\n2.750% Senior Notes due May 2024 | $ | 1,000 |  |  | $ | 1,000 | \n3.000% Senior Notes due May 2027 | 1,000 |  |  | 1,000 | \n1.375% Senior Notes due June 2027 | 1,250 |  |  | 1,250 | \n1.600% Senior Notes due April 2030 | 1,750 |  |  | 1,750 | \n1.750% Senior Notes due April 2032 | 1,000 |  |  | 1,000 | \nOther long-term debt | 972 |  |  | 484 | \nTotal long-term debt | 6,972 |  |  | 6,484 | \nLess unamortized debt discounts and issuance costs | 26 |  |  | 26 | \nLess current portion(1) | 1,080 |  |  | 1,081 | \nLong-term debt, excluding current portion | $ | 5,866 |  |  | $ | 5,377 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Shares Repurchased (000s) |  | Average Price per Share |  | Total Cost\nFirst quarter of 2024 | 288 |  |  | $ | 564.06 |  |  | $ | 162 | \n |  |  |  |  | \n |  |  |  |  | \nFirst quarter of 2023 | 285 |  |  | $ | 495.94 |  |  | $ | 141 | \n |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | Number\u00a0ofUnits (in\u00a0000s) |  | Weighted-AverageGrant Date Fair Value\nOutstanding at September 3, 2023 | 3,045 |  |  | $ | 405.63 | \nGranted | 1,573 |  |  | 544.28 | \nVested and delivered | (1,810) |  |  | 430.49 | \nForfeited | (13) |  |  | 446.28 | \nOutstanding at November 26, 2023 | 2,795 |  |  | $ | 467.39 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 26,2023 |  | November 20,2022 |  |  |  | \nStock-based compensation expense | $ | 444 |  |  | $ | 402 |  |  |  |  | \nLess recognized income tax benefits | 95 |  |  | 89 |  |  |  |  | \nStock-based compensation expense, net | $ | 349 |  |  | $ | 313 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 26,2023 |  | November 20,2022 |  |  |  | \nNet income | $ | 1,589 |  |  | $ | 1,364 |  |  |  |  | \nWeighted average basic shares | 443,827 |  |  | 443,837 |  |  |  |  | \nRSUs | 576 |  |  | 694 |  |  |  |  | \nWeighted average diluted shares | 444,403 |  |  | 444,531 |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | United\u00a0States |  | Canada |  | OtherInternational |  | Total\n12 Weeks Ended November 26, 2023 |  |  |  |  |  |  | \nTotal revenue | $ | 41,833 |  |  | $ | 7,901 |  |  | $ | 8,065 |  |  | $ | 57,799 | \nOperating income | 1,358 |  |  | 325 |  |  | 301 |  |  | 1,984 | \n12 Weeks Ended November 20, 2022 |  |  |  |  |  |  | \nTotal revenue | $ | 40,145 |  |  | $ | 7,356 |  |  | $ | 6,936 |  |  | $ | 54,437 | \nOperating income | 1,236 |  |  | 288 |  |  | 227 |  |  | 1,751 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n53 Weeks Ended September 3, 2023 |  |  |  |  |  |  | \nTotal revenue | $ | 176,630 |  |  | $ | 33,056 |  |  | $ | 32,604 |  |  | $ | 242,290 | \nOperating income | 5,392 |  |  | 1,448 |  |  | 1,274 |  |  | 8,114 | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 26,2023 |  | November 20,2022 |  |  |  | \nFoods and Sundries | $ | 23,024 |  |  | $ | 21,448 |  |  |  |  | \nNon-Foods | 14,766 |  |  | 14,032 |  |  |  |  | \nFresh Foods | 7,328 |  |  | 6,717 |  |  |  |  | \nWarehouse Ancillary and Other Businesses | 11,599 |  |  | 11,240 |  |  |  |  | \nTotal net sales | $ | 56,717 |  |  | $ | 53,437 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 26,2023 |  | November 20,2022 |  |  |  | \nNet Sales | $ | 56,717 |  |  | $ | 53,437 |  |  |  |  | \nChanges in net sales: |  |  |  |  |  |  | \nU.S. | 4 | % |  | 11 | % |  |  |  | \nCanada | 7 | % |  | 3 | % |  |  |  | \nOther International | 16 | % |  | \u2014 | % |  |  |  | \nTotal Company | 6 | % |  | 8 | % |  |  |  | \nChanges in comparable sales: |  |  |  |  |  |  | \nU.S. | 2 | % |  | 9 | % |  |  |  | \nCanada | 6 | % |  | 2 | % |  |  |  | \nOther International | 11 | % |  | (3) | % |  |  |  | \nTotal Company | 4 | % |  | 7 | % |  |  |  | \nE-commerce | 6 | % |  | (4) | % |  |  |  | \nChanges in comparable sales excluding the impact of changes in foreign-currency and gasoline prices: |  |  |  |  |  |  | \nU.S. | 3 | % |  | 7 | % |  |  |  | \nCanada | 8 | % |  | 8 | % |  |  |  | \nOther International | 7 | % |  | 9 | % |  |  |  | \nTotal Company | 4 | % |  | 7 | % |  |  |  | \nE-commerce | 6 | % |  | (2) | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 26,2023 |  | November 20,2022 |  |  |  | \nMembership fees | $ | 1,082 |  |  | $ | 1,000 |  |  |  |  | \nMembership fees increase | 8 | % |  | 6 | % |  |  |  | \nTotal paid members (000s) | 72,000 |  |  | 66,900 |  |  |  |  | \nTotal cardholders (000s) | 129,500 |  |  | 120,900 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 26,2023 |  | November 20,2022 |  |  |  | \nNet sales | $ | 56,717 |  |  | $ | 53,437 |  |  |  |  | \nLess merchandise costs | 50,457 |  |  | 47,769 |  |  |  |  | \nGross margin | $ | 6,260 |  |  | $ | 5,668 |  |  |  |  | \nGross margin percentage | 11.04 | % |  | 10.61 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 26,2023 |  | November 20,2022 |  |  |  | \nSG&A expenses | $ | 5,358 |  |  | $ | 4,917 |  |  |  |  | \nSG&A expenses as a percentage of net sales | 9.45 | % |  | 9.20 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 26,2023 |  | November 20,2022 |  |  |  | \nInterest expense | $ | 38 |  |  | $ | 34 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 26,2023 |  | November 20,2022 |  |  |  | \nInterest income | $ | 154 |  |  | $ | 54 |  |  |  |  | \nForeign-currency transaction gains (losses), net | 3 |  |  | (9) |  |  |  |  | \nOther, net | 3 |  |  | 8 |  |  |  |  | \nInterest income and other, net | $ | 160 |  |  | $ | 53 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended |  | \n | November 26,2023 |  | November 20,2022 |  |  |  | \nProvision for income taxes | $ | 517 |  |  | $ | 406 |  |  |  |  | \nEffective tax rate | 24.5 | % |  | 23.0 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | 12 Weeks Ended\n | November 26,2023 |  | November 20,2022\nNet cash provided by operating activities | $ | 4,651 |  |  | $ | 2,610 | \nNet cash used in investing activities | (366) |  |  | (1,057) | \nNet cash used in financing activities | (974) |  |  | (863) | \n |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number of Shares Purchased |  | Average Price Paid Per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Programs(1) |  | Maximum Dollar Value of Shares that May Yet be Purchased Under the Programs(1)\nSeptember 4, 2023 \u2014 October 1, 2023 | 95,000 |  |  | $ | 558.12 |  |  | 95,000 |  |  | $ | 3,510 | \nOctober 2, 2023 \u2014 October 29, 2023 | 100,000 |  |  | 561.76 |  |  | 100,000 |  |  | 3,454 | \nOctober 30, 2023 \u2014 November 26, 2023 | 93,000 |  |  | 572.60 |  |  | 93,000 |  |  | 3,401 | \nTotal first quarter | 288,000 |  |  | $ | 564.06 |  |  | 288,000 |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  | Incorporated by Reference\nExhibitNumber |  | Exhibit\u00a0Description |  | FiledHerewith |  | Form |  | PeriodEnding |  | Filing\u00a0Date\n |  |  |  |  |  |  |  |  |  | \n3.1 |  | Articles of Incorporation as amended of Costco Wholesale Corporation |  |  |  | 10-K |  | 8/28/2022 |  | 10/5/2022\n |  |  |  |  |  |  |  |  |  | \n3.2 |  | Bylaws as amended of Costco Wholesale Corporation |  |  |  | 8-K |  |  |  | 8/10/2023\n |  |  |  |  |  |  |  |  |  | \n10.1* |  | Fiscal 2024 Executive Bonus Plan |  |  |  | 8-K |  |  |  | 11/24/2023\n |  |  |  |  |  |  |  |  |  | \n10.2* |  | Executive Employment Agreement effective January 1, 2024, between Ron Vachris and Costco Wholesale Corporation |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n31.1 |  | Rule 13(a) \u2013 14(a) Certifications |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n32.1 |  | Section 1350 Certifications |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.INS |  | Inline XBRL Instance Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.SCH |  | Inline XBRL Taxonomy Extension Schema Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  | x |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  | \n104 |  | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |  | x |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n |  |  | COSTCOWHOLESALECORPORATION(Registrant)\n |  | \nDecember 20, 2023 | By |  | /s/ W. CRAIGJELINEK\nDate |  |  | W. Craig JelinekChief Executive Officer and Director\n |  |  | \nDecember 20, 2023 | By |  | /s/ RICHARDA. GALANTI\nDate |  |  | Richard\u00a0A. GalantiExecutive Vice President, Chief Financial Officer and Director"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Eli Lilly, in 2022 Q1, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  |  |  |  | \nIndiana |  | 35-0470950\n(State or other jurisdiction of |  | (I.R.S. Employer\nincorporation or organization) |  | Identification No.)  |  |  |  |  |  |  |  | \nTitle of Each Class | Trading Symbols | Name of Each Exchange On Which Registered\nCommon Stock (no par value) | LLY | New York Stock Exchange\n7 1/8% Notes due 2025 | LLY25 | New York Stock Exchange\n1.625% Notes due 2026 | LLY26 | New York Stock Exchange\n2.125% Notes due 2030 | LLY30 | New York Stock Exchange\n0.625% Notes due 2031 | LLY31 | New York Stock Exchange\n0.500% Notes due 2033 | LLY33 | New York Stock Exchange\n6.77%\u00a0Notes due 2036 | LLY36 | New York Stock Exchange\n1.625% Notes due 2043 | LLY43 | New York Stock Exchange\n1.700% Notes due 2049 | LLY49A | New York Stock Exchange\n1.125% Notes due 2051 | LLY51 | New York Stock Exchange\n1.375% Notes due 2061 | LLY61 | New York Stock Exchange  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 |  |  |  |  | Accelerated\u00a0filer | \u2610\nNon-accelerated filer | \u2610 |  |  | Smaller reporting company | \u2610\n |  |  |  |  |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \nClass |  | Number of Shares Outstanding\nCommon |  | 950,159,559 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | Page\nPART I. Financial Information |  |  |  | 5\n |  |  |  | \nItem 1. |  | Financial Statements |  | 5\n |  | Consolidated Condensed Statements of Operations |  | 5\n |  | Consolidated Condensed Statements of Comprehensive Income |  | 6\n |  | Consolidated Condensed Balance Sheets |  | 7\n |  | Consolidated Condensed Statements of Equity |  | 8\n |  | Consolidated Condensed Statements of Cash Flows |  | 9\n |  | Notes to Consolidated Condensed Financial Statements |  | 10\nItem 2. |  | Management's Discussion and Analysis of Results of Operations and Financial Condition |  | 35\n |  | Executive Overview |  | 35\n |  | Revenue |  | 41\n |  | Gross Margin, Costs, and Expenses |  | 44\n |  | Financial Condition and Liquidity |  | 45\n |  |  |  | \n |  | Critical Accounting Estimates |  | 45\n |  | Available Information on our Website |  | 45\nItem 4. |  | Controls and Procedures |  | 46\n |  |  |  | \nPART II. Other Information |  |  |  | 47\n |  |  |  | \nItem 1. |  | Legal Proceedings |  | 47\nItem 1A. |  | Risk Factors |  | 47\nItem 2. |  | Unregistered Sales of Equity Securities and Use of Proceeds |  | 47\nItem 6. |  | Exhibits |  | 48\n |  |  |  | \nSignatures |  |  |  | 48  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2022 |  | 2021 |  |  |  | \nRevenue (Note 2) | $ | 7,810.0 |  |  | $ | 6,805.6 |  |  |  |  | \nCosts, expenses, and other: |  |  |  |  |  |  | \nCost of sales | 2,072.1 |  |  | 1,878.6 |  |  |  |  | \nResearch and development | 1,610.1 |  |  | 1,672.1 |  |  |  |  | \nMarketing, selling, and administrative | 1,557.9 |  |  | 1,576.0 |  |  |  |  | \nAcquired in-process research and development and development milestones (Note 3) | 165.6 |  |  | 312.0 |  |  |  |  | \nAsset impairment, restructuring, and other special charges (Note 5) | \u2014 |  |  | 211.6 |  |  |  |  | \nOther\u2013net, (income) expense (Note 11) | 350.7 |  |  | (321.1) |  |  |  |  | \n | 5,756.4 |  |  | 5,329.2 |  |  |  |  | \nIncome before income taxes | 2,053.6 |  |  | 1,476.4 |  |  |  |  | \nIncome taxes (Note 7) | 150.7 |  |  | 121.1 |  |  |  |  | \nNet income | $ | 1,902.9 |  |  | $ | 1,355.3 |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nEarnings per share: |  |  |  |  |  |  | \nBasic | $ | 2.11 |  |  | $ | 1.49 |  |  |  |  | \n |  |  |  |  |  |  | \nDiluted | $ | 2.10 |  |  | $ | 1.49 |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nShares used in calculation of earnings per share: |  |  |  |  |  |  | \nBasic | 903.7 |  | 908.8 |  |  |  | \nDiluted | 906.4 |  | 912.4 |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2022 |  | 2021 |  |  |  | \nNet income | $ | 1,902.9 |  |  | $ | 1,355.3 |  |  |  |  | \nOther comprehensive income, net of tax (Note 10) | 117.8 |  |  | 100.8 |  |  |  |  | \nComprehensive income | $ | 2,020.7 |  |  | $ | 1,456.1 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | March 31, 2022 |  | December 31, 2021\nAssets | (Unaudited) |  | \nCurrent Assets |  |  | \nCash and cash equivalents (Note 6) | $ | 2,459.2 |  |  | $ | 3,818.5 | \nShort-term investments (Note 6) | 109.1 |  |  | 90.1 | \nAccounts receivable, net of allowances of$22.0(2022)and $22.5(2021) | 6,322.5 |  |  | 6,672.8 | \nOther receivables | 1,483.2 |  |  | 1,454.4 | \nInventories | 3,893.0 |  |  | 3,886.0 | \nPrepaid expenses and other | 2,697.7 |  |  | 2,530.6 | \nTotal current assets | 16,964.7 |  |  | 18,452.4 | \nInvestments (Note 6) | 2,727.3 |  |  | 3,212.6 | \nGoodwill | 3,892.0 |  |  | 3,892.0 | \nOther intangibles, net | 7,482.4 |  |  | 7,691.9 | \nDeferred tax assets | 2,464.9 |  |  | 2,489.3 | \nProperty and equipment, net of accumulated depreciation of$10,138.3(2022)and $9,976.7(2021) | 9,102.7 |  |  | 8,985.1 | \nOther noncurrent assets | 4,285.3 |  |  | 4,082.7 | \nTotal assets | $ | 46,919.3 |  |  | $ | 48,806.0 | \nLiabilities and Equity |  |  | \nCurrent Liabilities |  |  | \nShort-term borrowings and current maturities of long-term debt | $ | 1,355.9 |  |  | $ | 1,538.3 | \nAccounts payable | 1,433.3 |  |  | 1,670.6 | \nEmployee compensation | 693.1 |  |  | 958.1 | \nSales rebates and discounts | 6,768.7 |  |  | 6,845.8 | \nDividends payable | \u2014 |  |  | 885.5 | \nIncome taxes payable | 598.3 |  |  | 126.9 | \nOther current liabilities | 2,536.7 |  |  | 3,027.5 | \nTotal current liabilities | 13,386.0 |  |  | 15,052.7 | \nOther Liabilities |  |  | \nLong-term debt | 15,152.9 |  |  | 15,346.4 | \nAccrued retirement benefits (Note 8) | 1,940.3 |  |  | 1,954.1 | \nLong-term income taxes payable | 3,978.1 |  |  | 3,920.0 | \nDeferred tax liabilities | 1,286.1 |  |  | 1,733.7 | \nOther noncurrent liabilities | 1,713.9 |  |  | 1,644.3 | \nTotal other liabilities | 24,071.3 |  |  | 24,598.5 | \nCommitments and Contingencies (Note 9) |  |  | \nEli Lilly and Company Shareholders' Equity |  |  | \nCommon stock | 594.1 |  |  | 596.3 | \nAdditional paid-in capital | 6,656.3 |  |  | 6,833.4 | \nRetained earnings | 9,369.4 |  |  | 8,958.5 | \nEmployee benefit trust | (3,013.2) |  |  | (3,013.2) | \nAccumulated other comprehensive loss (Note 10) | (4,225.3) |  |  | (4,343.1) | \nCost of common stock in treasury | (50.5) |  |  | (52.7) | \nTotal Eli Lilly and Company shareholders' equity | 9,330.8 |  |  | 8,979.2 | \nNoncontrolling interests | 131.2 |  |  | 175.6 | \nTotal equity | 9,462.0 |  |  | 9,154.8 | \nTotal liabilities and equity | $ | 46,919.3 |  |  | $ | 48,806.0 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Equity of Eli Lilly and Company Shareholders |  | \n(Dollars in millions and shares in thousands) | Common Stock |  | AdditionalPaid-inCapital |  | RetainedEarnings |  | Employee Benefit Trust |  | Accumulated Other Comprehensive Loss |  | Common Stock in Treasury(1) |  | Noncontrolling Interests\nShares |  | Amount | Shares |  | Amount\nBalance at January 1, 2021 | 957,077 |  |  | $ | 598.2 |  |  | $ | 6,778.5 |  |  | $ | 7,830.2 |  |  | $ | (3,013.2) |  |  | $ | (6,496.4) |  |  | 487 |  |  | $ | (55.7) |  |  | $ | 183.6 | \nNet income |  |  |  |  |  |  | 1,355.3 |  |  |  |  |  |  |  |  |  |  | 16.4 | \nOther comprehensive income, net of tax |  |  |  |  |  |  |  |  |  |  | 100.8 |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIssuance of stock under employee stock plans, net | 2,405 |  |  | 1.5 |  |  | (283.9) |  |  |  |  |  |  |  |  | (24) |  |  | 3.0 |  |  | \nStock-based compensation |  |  |  |  | 85.5 |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  | (0.9) |  |  | (4.2) |  |  |  |  |  |  |  |  |  |  | 0.6 | \nBalance at March 31, 2021 | 959,482 |  |  | $ | 599.7 |  |  | $ | 6,579.2 |  |  | $ | 9,181.3 |  |  | $ | (3,013.2) |  |  | $ | (6,395.6) |  |  | 463 |  |  | $ | (52.7) |  |  | $ | 200.6 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance at January 1, 2022 | 954,116 |  |  | $ | 596.3 |  |  | $ | 6,833.4 |  |  | $ | 8,958.5 |  |  | $ | (3,013.2) |  |  | $ | (4,343.1) |  |  | 463 |  |  | $ | (52.7) |  |  | $ | 175.6 | \nNet income (loss) |  |  |  |  |  |  | 1,902.9 |  |  |  |  |  |  |  |  |  |  | (36.6) | \nOther comprehensive income, net of tax |  |  |  |  |  |  |  |  |  |  | 117.8 |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nRetirement of treasury shares | (5,607) |  |  | (3.5) |  |  |  |  | (1,496.5) |  |  |  |  |  |  | (5,607) |  |  | 1,500.0 |  |  | \nPurchase of treasury shares |  |  |  |  |  |  |  |  |  |  |  |  | 5,607 |  |  | (1,500.0) |  |  | \nIssuance of stock under employee stock plans, net | 2,096 |  |  | 1.3 |  |  | (278.1) |  |  |  |  |  |  |  |  | (13) |  |  | 2.2 |  |  | \nStock-based compensation |  |  |  |  | 101.0 |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  | 4.5 |  |  |  |  |  |  |  |  |  |  | (7.8) | \nBalance at March 31, 2022 | 950,605 |  |  | $ | 594.1 |  |  | $ | 6,656.3 |  |  | $ | 9,369.4 |  |  | $ | (3,013.2) |  |  | $ | (4,225.3) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 131.2 |   |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31,\n | 2022 |  | 2021\nCash Flows from Operating Activities | \nNet income | $ | 1,902.9 |  |  | $ | 1,355.3 | \nAdjustments to Reconcile Net Income to Cash Flows from Operating Activities: |  |  | \n |  |  | \nDepreciation and amortization | 435.7 |  |  | 350.3 | \nChange in deferred income taxes | (506.6) |  |  | (119.1) | \n |  |  | \nStock-based compensation expense | 101.0 |  |  | 85.5 | \n |  |  | \nNet investment (gains) losses | 426.1 |  |  | (302.2) | \nAcquired in-process research and development | 153.0 |  |  | 299.3 | \nOther changes in operating assets and liabilities, net of acquisitions and divestitures | (45.5) |  |  | (102.8) | \nOther non-cash operating activities, net | 32.6 |  |  | 131.1 | \nNet Cash Provided by Operating Activities | 2,499.2 |  |  | 1,697.4 | \nCash Flows from Investing Activities |  |  | \nNet purchases of property and equipment | (365.4) |  |  | (300.3) | \nProceeds from sales and maturities of short-term investments | 26.7 |  |  | 4.0 | \nPurchases of short-term investments | (14.6) |  |  | (19.4) | \nProceeds from sales of noncurrent investments | 81.4 |  |  | 284.8 | \nPurchases of noncurrent investments | (116.7) |  |  | (291.5) | \nCash paid for acquisitions, net of cash acquired (Note 3) | \u2014 |  |  | (747.4) | \n |  |  | \nPurchases of in-process research and development | (491.8) |  |  | (191.8) | \nOther investing activities, net | (133.4) |  |  | (21.9) | \nNet Cash Used for Investing Activities | (1,013.8) |  |  | (1,283.5) | \nCash Flows from Financing Activities |  |  | \nDividends paid | (885.5) |  |  | (774.8) | \nNet change in short-term borrowings | 499.7 |  |  | (3.7) | \n |  |  | \nRepayments of long-term debt | (710.1) |  |  | \u2014 | \nPurchases of common stock | (1,500.0) |  |  | \u2014 | \n |  |  | \nOther financing activities, net | (282.4) |  |  | (279.9) | \nNet Cash Used for Financing Activities | (2,878.3) |  |  | (1,058.4) | \nEffect of exchange rate changes on cash and cash equivalents | 33.6 |  |  | (10.2) | \n |  |  | \nNet decrease in cash and cash equivalents | (1,359.3) |  |  | (654.7) | \nCash and cash equivalents at January\u00a01 | 3,818.5 |  |  | 3,657.1 | \nCash and Cash Equivalents at March 31 | $ | 2,459.2 |  |  | $ | 3,002.4 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2022 |  | 2021 |  |  |  | \nNet product revenue | $ | 7,132.9 |  |  | $ | 6,320.0 |  |  |  |  | \nCollaboration and other revenue(1) | 677.1 |  |  | 485.6 |  |  |  |  | \nRevenue | $ | 7,810.0 |  |  | $ | 6,805.6 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | March 31, 2022 |  | December 31, 2021\nContract liabilities | $ | 251.6 |  |  | $ | 262.6 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31,\n | 2022 |  | 2021\n | U.S. | Outside U.S. | Total |  | U.S. | Outside U.S. | Total\nRevenue\u2014to unaffiliated customers: |  |  |  |  |  |  | \nDiabetes: |  |  |  |  |  |  | \nTrulicity\u00ae | $ | 1,313.9 |  | $ | 427.4 |  | $ | 1,741.3 |  |  | $ | 1,116.8 |  | $ | 335.7 |  | $ | 1,452.4 | \nHumalog\u00ae (1) | 368.9 |  | 249.3 |  | 618.2 |  |  | 332.7 |  | 284.4 |  | 617.0 | \nJardiance(2) | 229.8 |  | 189.7 |  | 419.4 |  |  | 151.2 |  | 160.8 |  | 312.0 | \nHumulin\u00ae | 190.4 |  | 82.8 |  | 273.2 |  |  | 219.0 |  | 102.7 |  | 321.7 | \nBasaglar\u00ae | 119.3 |  | 72.2 |  | 191.5 |  |  | 175.2 |  | 71.4 |  | 246.6 | \nOther diabetes | 54.3 |  | 90.2 |  | 144.6 |  |  | 66.3 |  | 94.9 |  | 161.4 | \nTotal diabetes | 2,276.6 |  | 1,111.6 |  | 3,388.2 |  |  | 2,061.2 |  | 1,049.9 |  | 3,111.1 | \n |  |  |  |  |  |  | \nOncology: |  |  |  |  |  |  | \nVerzenio\u00ae | 301.5 |  | 167.9 |  | 469.4 |  |  | 172.8 |  | 96.2 |  | 269.0 | \nAlimta\u00ae | 254.3 |  | 89.7 |  | 343.9 |  |  | 261.1 |  | 297.8 |  | 559.0 | \nCyramza\u00ae | 79.2 |  | 151.1 |  | 230.3 |  |  | 80.2 |  | 160.3 |  | 240.5 | \nErbitux\u00ae | 109.7 |  | 13.0 |  | 122.7 |  |  | 107.9 |  | 14.4 |  | 122.4 | \nTyvyt\u00ae | \u2014 |  | 85.5 |  | 85.5 |  |  | \u2014 |  | 109.7 |  | 109.7 | \nOther oncology | 39.0 |  | 62.0 |  | 101.2 |  |  | 20.5 |  | 51.3 |  | 71.6 | \nTotal oncology | 783.7 |  | 569.2 |  | 1,353.0 |  |  | 642.5 |  | 729.7 |  | 1,372.2 | \n |  |  |  |  |  |  | \nImmunology: |  |  |  |  |  |  | \nTaltz\u00ae | 307.2 |  | 180.8 |  | 488.1 |  |  | 249.6 |  | 153.6 |  | 403.2 | \nOlumiant\u00ae (3) | 71.3 |  | 184.3 |  | 255.6 |  |  | 24.7 |  | 169.1 |  | 193.8 | \nOther immunology | \u2014 |  | 4.5 |  | 4.5 |  |  | 10.5 |  | 6.4 |  | 16.9 | \nTotal immunology | 378.5 |  | 369.6 |  | 748.1 |  |  | 284.8 |  | 329.1 |  | 613.9 | \n |  |  |  |  |  |  | \nNeuroscience: |  |  |  |  |  |  | \nEmgality\u00ae | 108.3 |  | 41.0 |  | 149.3 |  |  | 101.5 |  | 18.0 |  | 119.5 | \nZyprexa\u00ae | 9.6 |  | 83.5 |  | 93.1 |  |  | 6.9 |  | 88.9 |  | 95.8 | \nCymbalta\u00ae | 9.1 |  | 71.9 |  | 81.1 |  |  | 11.0 |  | 165.7 |  | 176.6 | \n |  |  |  |  |  |  | \nOther neuroscience | 26.4 |  | 48.0 |  | 74.2 |  |  | 22.3 |  | 51.1 |  | 73.5 | \nTotal neuroscience | 153.4 |  | 244.4 |  | 397.7 |  |  | 141.7 |  | 323.7 |  | 465.4 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nOther: |  |  |  |  |  |  | \nCOVID-19 antibodies(4) | 1,455.2 |  | 14.7 |  | 1,469.8 |  |  | 650.6 |  | 159.5 |  | 810.1 | \nCialis\u00ae | 6.9 |  | 210.8 |  | 217.7 |  |  | 8.6 |  | 118.1 |  | 126.8 | \nForteo\u00ae | 70.2 |  | 67.3 |  | 137.4 |  |  | 97.7 |  | 100.8 |  | 198.5 | \nOther | 50.1 |  | 47.8 |  | 98.1 |  |  | 54.2 |  | 53.4 |  | 107.5 | \nTotal other | 1,582.4 |  | 340.6 |  | 1,923.0 |  |  | 811.1 |  | 431.8 |  | 1,242.9 | \nRevenue | $ | 5,174.6 |  | $ | 2,635.4 |  | $ | 7,810.0 |  |  | $ | 3,941.3 |  | $ | 2,864.3 |  | $ | 6,805.6 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2022 |  | 2021 |  |  |  | \nRevenue\u2014to unaffiliated customers(1): |  |  |  |  |  |  | \nU.S. | $ | 5,174.6 |  |  | $ | 3,941.3 |  |  |  |  | \nEurope | 1,067.3 |  |  | 1,321.2 |  |  |  |  | \nJapan | 410.2 |  |  | 571.8 |  |  |  |  | \nChina | 406.5 |  |  | 362.2 |  |  |  |  | \nOther foreign countries | 751.5 |  |  | 609.1 |  |  |  |  | \nRevenue | $ | 7,810.0 |  |  | $ | 6,805.6 |  |  |  |  |   |  |  |  |  | \nEstimated Fair Value at January 22, 2021 | \nCash | $ | 90.5 | \nAcquired IPR&D(1) | 824.0\nGoodwill(2) | 126.8\nDeferred tax liabilities | (106.0) | \nOther assets and liabilities, net | (31.5) | \nAcquisition date fair value of consideration transferred | 903.8\nLess: | \nCash acquired | (90.5) | \nFair value of CVR liability(3) | (65.9) | \nCash paid, net of cash acquired | $ | 747.4 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCounterparty | Compound(s), Therapy or Asset | Acquisition Month |  | Phase of Development(1) |  | Acquired IPR&D Expense\nBioMarin Pharmaceutical Inc. | Priority Review Voucher | February 2022 |  | Not applicable |  | $ | 110.0 | \n |  |  |  |  |  | \nRigel Pharmaceuticals, Inc. | R552, a receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor, for the potential treatment of autoimmune and inflammatory diseases | March 2021 |  | Phase I |  | 125.0 | \nPrecision Biosciences, Inc. | Potential in vivo therapies for genetic disorders | January 2021 |  | Pre-clinical |  | 107.8 | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  |   |  |  |  |  |  |  |  | \n | Net Milestones Capitalized (Deferred)(1)as of:\n | March 31, 2022 | December 31, 2021\nJardiance | $ | 131.1 |  | $ | 136.1 | \nTrajenta | 82.0 |  | 88.5 | \nBasaglar | (144.6) |  | (149.3) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2022 |  | 2021 |  |  |  | \nJardiance | $ | 419.4 |  |  | $ | 312.0 |  |  |  |  | \nBasaglar | 191.5 |  |  | 246.6 |  |  |  |  | \nTrajenta | 92.0 |  |  | 94.6 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2022 |  | 2021 |  |  |  | \nOlumiant | $ | 255.6 |  |  | $ | 193.8 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2022 |  | 2021 |  |  |  | \nTyvyt | $ | 85.5 |  |  | $ | 109.7 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2022 |  | 2021 |  |  |  | \nSeverance | $ | \u2014 |  |  | $ | 11.5 |  |  |  |  | \nAsset impairment and other special charges | \u2014 |  |  | 200.1 |  |  |  |  | \nTotal asset impairment, restructuring, and other special charges | $ | \u2014 |  |  | $ | 211.6 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2022 |  | 2021 |  |  |  | \nFair value hedges: |  |  |  |  |  |  | \nEffect from hedged fixed-rate debt | $ | (94.6) |  |  | $ | (81.5) |  |  |  |  | \nEffect from interest rate contracts | 94.6 |  |  | 81.5 |  |  |  |  | \nCash flow hedges: |  |  |  |  |  |  | \nEffective portion of losses on interest rate contracts reclassified from accumulated other comprehensive loss | 4.1 |  |  | 4.1 |  |  |  |  | \nCross-currency interest rate swaps | 8.3 |  |  | 71.5 |  |  |  |  | \nNet (gains) losses on foreign currency exchange contracts not designated as hedging instruments | (6.1) |  |  | 133.0 |  |  |  |  | \nTotal | $ | 6.3 |  |  | $ | 208.6 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2022 |  | 2021 |  |  |  | \nNet investment hedges: |  |  |  |  |  |  | \nForeign currency-denominated notes | $ | 54.4 |  |  | $ | 207.7 |  |  |  |  | \nCross-currency interest rate swaps | 10.8 |  |  | 150.6 |  |  |  |  | \n |  |  |  |  |  |  | \nCash flow hedges: |  |  |  |  |  |  | \nForward-starting interest rate swaps | 122.5 |  |  | 295.1 |  |  |  |  | \nCross-currency interest rate swaps | 17.1 |  |  | 26.3 |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | Fair Value Measurements Using |  | \n | CarryingAmount |  | Cost(1) |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | Significant OtherObservable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue\nMarch 31, 2022 |  |  |  |  |  |  |  |  |  |  | \nCash equivalents | $ | 1,104.1 |  |  | $ | 1,104.1 |  |  | $ | 1,095.0 |  |  | $ | 9.1 |  |  | $ | \u2014 |  |  | $ | 1,104.1 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 45.1 |  |  | $ | 45.4 |  |  | $ | 45.1 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 45.1 | \nCorporate debt securities | 50.6 |  |  | 50.7 |  |  | \u2014 |  |  | 50.6 |  |  | \u2014 |  |  | 50.6 | \nMortgage-backed securities | 0.2 |  |  | 0.2 |  |  | \u2014 |  |  | 0.2 |  |  | \u2014 |  |  | 0.2 | \nAsset-backed securities | 2.9 |  |  | 3.0 |  |  | \u2014 |  |  | 2.9 |  |  | \u2014 |  |  | 2.9 | \nOther securities | 10.3 |  |  | 10.3 |  |  | \u2014 |  |  | \u2014 |  |  | 10.3 |  |  | 10.3 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments | $ | 109.1 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 116.2 |  |  | $ | 123.0 |  |  | $ | 116.2 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 116.2 | \n |  |  |  |  |  |  |  |  |  |  | \nCorporate debt securities | 212.3 |  |  | 224.3 |  |  | \u2014 |  |  | 224.3 |  |  | \u2014 |  |  | 224.3 | \nMortgage-backed securities | 105.1 |  |  | 109.0 |  |  | \u2014 |  |  | 105.1 |  |  | \u2014 |  |  | 105.1 | \nAsset-backed securities | 34.6 |  |  | 35.4 |  |  | \u2014 |  |  | 34.6 |  |  | \u2014 |  |  | 34.6 | \nOther securities | 112.5 |  |  | 15.3 |  |  | \u2014 |  |  | \u2014 |  |  | 112.5 |  |  | 112.5 | \nMarketable equity securities | 807.9 |  |  | 481.9 |  |  | 807.9 |  |  | \u2014 |  |  | \u2014 |  |  | 807.9 | \nEquity investments without readily determinable fair values(2) | 569.5 |  |  |  |  |  |  |  |  |  |  | \nEquity method investments(2) | 769.2 |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments | $ | 2,727.3 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDecember 31, 2021 |  |  |  |  |  |  |  |  |  |  | \nCash equivalents | $ | 2,379.5 |  |  | $ | 2,379.5 |  |  | $ | 2,361.0 |  |  | $ | 18.5 |  |  | $ | \u2014 |  |  | $ | 2,379.5 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 25.7 |  |  | $ | 25.6 |  |  | $ | 25.7 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 25.7 | \nCorporate debt securities | 43.7 |  |  | 43.7 |  |  | \u2014 |  |  | 43.7 |  |  | \u2014 |  |  | 43.7 | \nMortgage-backed securities | 0.2 |  |  | 0.2 |  |  | \u2014 |  |  | 0.2 |  |  | \u2014 |  |  | 0.2 | \nAsset-backed securities | 6.2 |  |  | 6.2 |  |  | \u2014 |  |  | 6.2 |  |  | \u2014 |  |  | 6.2 | \nOther securities | 14.3 |  |  | 14.3 |  |  | \u2014 |  |  | \u2014 |  |  | 14.3 |  |  | 14.3 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments | $ | 90.1 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 137.0 |  |  | $ | 136.8 |  |  | $ | 137.0 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 137.0 | \nCorporate debt securities | 235.3 |  |  | 232.7 |  |  | \u2014 |  |  | 235.3 |  |  | \u2014 |  |  | 235.3 | \nMortgage-backed securities | 109.8 |  |  | 108.1 |  |  | \u2014 |  |  | 109.8 |  |  | \u2014 |  |  | 109.8 | \nAsset-backed securities | 23.1 |  |  | 23.1 |  |  | \u2014 |  |  | 23.1 |  |  | \u2014 |  |  | 23.1 | \nOther securities | 108.1 |  |  | 22.2 |  |  | \u2014 |  |  | \u2014 |  |  | 108.1 |  |  | 108.1 | \nMarketable equity securities | 1,279.7 |  |  | 487.0 |  |  | 1,279.7 |  |  | \u2014 |  |  | \u2014 |  |  | 1,279.7 | \nEquity investments without readily determinable fair values(2) | 548.1 |  |  |  |  |  |  |  |  |  |  | \nEquity method investments(2) | 771.5 |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments | $ | 3,212.6 |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Fair Value Measurements Using |  | \n | CarryingAmount |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | SignificantOther Observable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue\nShort-term commercial paper borrowings |  |  |  |  |  |  |  |  | \nMarch 31, 2022 | $ | (499.7) |  |  | $ | \u2014 |  |  | $ | (499.7) |  |  | $ | \u2014 |  |  | $ | (499.7) | \nDecember 31, 2021 | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nLong-term debt, including current portion |  |  |  |  |  |  |  |  | \nMarch 31, 2022 | $ | (16,009.1) |  |  | $ | \u2014 |  |  | $ | (15,798.9) |  |  | $ | \u2014 |  |  | $ | (15,798.9) | \nDecember 31, 2021 | (16,884.7) |  |  | \u2014 |  |  | (18,157.7) |  |  | \u2014 |  |  | (18,157.7) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Fair Value Measurements Using |  |  |  | \n | CarryingAmount |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | SignificantOther Observable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue |  | \nMarch 31, 2022 |  |  |  |  |  |  |  |  |  |  | \nRisk-management instruments: |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | $ | 1.3 |  |  | $ | \u2014 |  |  | $ | 1.3 |  |  | $ | \u2014 |  |  | $ | 1.3 |  |  | \nOther noncurrent assets | 22.8 |  |  | \u2014 |  |  | 22.8 |  |  | \u2014 |  |  | 22.8 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent liabilities | (43.2) |  |  | \u2014 |  |  | (43.2) |  |  | \u2014 |  |  | (43.2) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 140.0 |  |  | \u2014 |  |  | 140.0 |  |  | \u2014 |  |  | 140.0 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 2.0 |  |  | \u2014 |  |  | 2.0 |  |  | \u2014 |  |  | 2.0 |  |  | \nOther noncurrent assets | 40.0 |  |  | \u2014 |  |  | 40.0 |  |  | \u2014 |  |  | 40.0 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 40.8 |  |  | \u2014 |  |  | 40.8 |  |  | \u2014 |  |  | 40.8 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nForeign exchange contracts not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 38.8 |  |  | \u2014 |  |  | 38.8 |  |  | \u2014 |  |  | 38.8 |  |  | \nOther current liabilities | (45.8) |  |  | \u2014 |  |  | (45.8) |  |  | \u2014 |  |  | (45.8) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nContingent consideration liability: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent liabilities | (70.0) |  |  | \u2014 |  |  | \u2014 |  |  | (70.0) |  |  | (70.0) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDecember 31, 2021 |  |  |  |  |  |  |  |  |  |  | \nRisk-management instruments: |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | $ | 4.8 |  |  | $ | \u2014 |  |  | $ | 4.8 |  |  | $ | \u2014 |  |  | $ | 4.8 |  |  | \nOther noncurrent assets | 78.3 |  |  | \u2014 |  |  | 78.3 |  |  | \u2014 |  |  | 78.3 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent liabilities | (7.6) |  |  | \u2014 |  |  | (7.6) |  |  | \u2014 |  |  | (7.6) |  |  | \nInterest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 49.2 |  |  | \u2014 |  |  | 49.2 |  |  | \u2014 |  |  | 49.2 |  |  | \nOther noncurrent liabilities | (31.7) |  |  | \u2014 |  |  | (31.7) |  |  | \u2014 |  |  | (31.7) |  |  | \nCross-currency interest rate contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 31.3 |  |  | \u2014 |  |  | 31.3 |  |  | \u2014 |  |  | 31.3 |  |  | \nOther current liabilities | (1.2) |  |  | \u2014 |  |  | (1.2) |  |  | \u2014 |  |  | (1.2) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 33.2 |  |  | \u2014 |  |  | 33.2 |  |  | \u2014 |  |  | 33.2 |  |  | \nOther noncurrent liabilities | (1.3) |  |  | \u2014 |  |  | (1.3) |  |  | \u2014 |  |  | (1.3) |  |  | \nForeign exchange contracts not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 9.9 |  |  | \u2014 |  |  | 9.9 |  |  | \u2014 |  |  | 9.9 |  |  | \nOther current liabilities | (35.3) |  |  | \u2014 |  |  | (35.3) |  |  | \u2014 |  |  | (35.3) |  |  | \nContingent consideration liabilities: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent liabilities | (70.5) |  |  | \u2014 |  |  | \u2014 |  |  | (70.5) |  |  | (70.5) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Maturities by Period\n | Total |  | Less\u00a0Than1 Year |  | 1-5Years |  | 6-10Years |  | More\u00a0Than10 Years\nFair value of debt securities | $ | 567.1 |  |  | $ | 98.9 |  |  | $ | 197.7 |  |  | $ | 110.7 |  |  | $ | 159.8 |   |  |  |  |  |  |  |  |  |  |  | \n | March 31, 2022 |  | December 31, 2021\nUnrealized gross gains | $ | 1.3 |  |  | $ | 9.7 | \nUnrealized gross losses | 25.2 |  |  | 5.2 | \nFair value of securities in an unrealized gain position | 89.5 |  |  | 250.7 | \nFair value of securities in an unrealized loss position | 440.6 |  |  | 290.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2022 |  | 2021 |  |  |  | \nProceeds from sales | $ | 35.2 |  |  | $ | 43.3 |  |  |  |  | \nRealized gross gains on sales | 0.1 |  |  | 1.1 |  |  |  |  | \nRealized gross losses on sales | 0.8 |  |  | 0.4 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Defined Benefit Pension Plans\n | Three Months Ended March 31, |  | \n | 2022 |  | 2021 |  |  |  | \nComponents of net periodic benefit cost: |  |  |  |  |  |  | \nService cost | $ | 89.1 |  |  | $ | 92.0 |  |  |  |  | \nInterest cost | 100.5 |  |  | 84.3 |  |  |  |  | \nExpected return on plan assets | (239.5) |  |  | (238.0) |  |  |  |  | \nAmortization of prior service cost | 0.7 |  |  | 1.1 |  |  |  |  | \nRecognized actuarial loss | 87.0 |  |  | 121.8 |  |  |  |  | \n |  |  |  |  |  |  | \nNet periodic benefit cost | $ | 37.8 |  |  | $ | 61.2 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Retiree Health Benefit Plans\n | Three Months Ended March 31, |  | \n | 2022 |  | 2021 |  |  |  | \nComponents of net periodic benefit income: |  |  |  |  |  |  | \nService cost | $ | 11.2 |  |  | $ | 11.7 |  |  |  |  | \nInterest cost | 9.4 |  |  | 8.1 |  |  |  |  | \nExpected return on plan assets | (37.9) |  |  | (36.6) |  |  |  |  | \nAmortization of prior service benefit | (13.7) |  |  | (14.9) |  |  |  |  | \nRecognized actuarial loss | 0.2 |  |  | 0.8 |  |  |  |  | \n |  |  |  |  |  |  | \nNet periodic benefit income | $ | (30.8) |  |  | $ | (30.9) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Unrealized Net Gains (Losses) on\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Effective Portion of Cash\u00a0Flow Hedges |  |  |  | Accumulated Other Comprehensive Loss\nBalance at January 1, 2022 | $ | (1,550.2) |  |  | $ | 3.7 |  |  | $ | (2,583.6) |  |  | $ | (213.0) |  |  |  |  | $ | (4,343.1) | \n |  |  |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (25.0) |  |  | (21.3) |  |  | (6.6) |  |  | 109.4 |  |  |  |  | 56.5 | \nNet amount reclassified from accumulated other comprehensive loss | \u2014 |  |  | (0.5) |  |  | 58.6 |  |  | 3.2 |  |  |  |  | 61.3 | \nNet other comprehensive income (loss) | (25.0) |  |  | (21.8) |  |  | 52.0 |  |  | 112.6 |  |  |  |  | 117.8 | \n |  |  |  |  |  |  |  |  |  |  | \nBalance at March 31, 2022 | $ | (1,575.2) |  |  | $ | (18.1) |  |  | $ | (2,531.6) |  |  | $ | (100.4) |  |  |  |  | $ | (4,225.3) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Unrealized Net Gains (Losses) on\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Effective Portion of Cash\u00a0Flow Hedges |  |  |  | Accumulated Other Comprehensive Loss\nBalance at January 1, 2021 | $ | (1,427.5) |  |  | $ | 14.8 |  |  | $ | (4,751.0) |  |  | $ | (332.7) |  |  |  |  | $ | (6,496.4) | \n |  |  |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (249.7) |  |  | (10.8) |  |  | 18.8 |  |  | 252.8 |  |  |  |  | 11.1 | \nNet amount reclassified from accumulated other comprehensive loss | \u2014 |  |  | 0.5 |  |  | 85.9 |  |  | 3.3 |  |  |  |  | 89.7 | \nNet other comprehensive income (loss) | (249.7) |  |  | (10.3) |  |  | 104.7 |  |  | 256.1 |  |  |  |  | 100.8 | \n |  |  |  |  |  |  |  |  |  |  | \nBalance at March 31, 2021 | $ | (1,677.2) |  |  | $ | 4.5 |  |  | $ | (4,646.3) |  |  | $ | (76.6) |  |  |  |  | $ | (6,395.6) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \nTax benefit (expense) | 2022 |  | 2021 |  |  |  | \nForeign currency translation gains/losses | $ | (13.7) |  |  | $ | (75.3) |  |  |  |  | \nUnrealized net gains/losses on securities | 6.7 |  |  | 4.4 |  |  |  |  | \nDefined benefit pension and retiree health benefit plans | (28.4) |  |  | (31.3) |  |  |  |  | \nEffective portion of cash flow hedges | (29.9) |  |  | (68.1) |  |  |  |  | \nBenefit (expense) for income taxes allocated to other comprehensive income (loss) items | $ | (65.3) |  |  | $ | (170.3) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nDetails about Accumulated Other Comprehensive Loss Components |  | Three Months Ended March 31, |  |  | Affected Line Item in the Consolidated Condensed Statements of Operations\n\n | 2022 |  | 2021 |  |  |  | \nAmortization of retirement benefit items: |  |  |  |  |  |  |  |  | \nPrior service benefits, net |  | $ | (13.0) |  |  | $ | (13.8) |  |  |  |  |  | Other\u2013net, (income) expense\nActuarial losses, net |  | 87.2 |  |  | 122.6 |  |  |  |  |  | Other\u2013net, (income) expense\nTotal before tax |  | 74.2 |  |  | 108.8 |  |  |  |  |  | \nTax benefit |  | (15.6) |  |  | (22.9) |  |  |  |  |  | Income taxes\nNet of tax |  | 58.6 |  |  | 85.9 |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \nOther, net of tax |  | 2.7 |  |  | 3.8 |  |  |  |  |  | Other\u2013net, (income) expense\n |  |  |  |  |  |  |  |  | \nTotal reclassifications, net of tax |  | $ | 61.3 |  |  | $ | 89.7 |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2022 |  | 2021 |  |  |  | \nInterest expense | $ | 84.9 |  |  | $ | 87.8 |  |  |  |  | \nInterest income | (7.0) |  |  | (5.5) |  |  |  |  | \nNet investment (gains) losses on equity securities (Note 6) | 425.4 |  |  | (301.5) |  |  |  |  | \nRetirement benefit plans | (93.3) |  |  | (73.4) |  |  |  |  | \n |  |  |  |  |  |  | \nOther (income) expense | (59.3) |  |  | (28.5) |  |  |  |  | \nOther\u2013net, (income) expense | $ | 350.7 |  |  | $ | (321.1) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  |  |  |  |  | \n | 2022 |  | 2021 |  | Percent Change |  |  |  |  |  | \nRevenue | $ | 7,810.0 |  |  | $ | 6,805.6 |  |  | 15 |  |  |  |  |  | \nGross margin | 5,737.9 |  |  | 4,927.0 |  |  | 16 |  |  |  |  |  | \nGross margin as a percent of revenue | 73.5 | % |  | 72.4 | % |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nResearch and development | $ | 1,610.1 |  |  | $ | 1,672.1 |  |  | (4) |  |  |  |  |  | \nMarketing, selling, and administrative | 1,557.9 |  |  | 1,576.0 |  |  | (1) |  |  |  |  |  | \nAcquired in-process research and development (IPR&D) and development milestones | 165.6 |  |  | 312.0 |  |  | (47) |  |  |  |  |  | \nAsset impairment, restructuring, and other special charges | \u2014 |  |  | 211.6 |  |  | NM |  |  |  |  |  | \nOther\u2013net, (income) expense | 350.7 |  |  | (321.1) |  |  | NM |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNet income | 1,902.9 |  |  | 1,355.3 |  |  | 40 |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nEPS - diluted | 2.10 |  |  | 1.49 |  |  | 41 |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication | Status | Developments | \nDiabetes | \nTirzepatide | Type 2 diabetes | Submitted | Submitted in the U.S. using a Priority Review Voucher and in Europe and Japan in 2021. | \nHeart failure with preserved ejection fraction | Phase III | Phase III trials are ongoing. | \nObesity | Phase III | Announced in April 2022 that the initial Phase III trial met co-primary and all key secondary endpoints. Phase III trials are ongoing. | \nNonalcoholic steatohepatitis | Phase II | Phase II trial is ongoing. | \nBasal Insulin-Fc | Type 1 and 2 diabetes | Phase III | Phase III trial initiated in the first quarter of 2022. | \nGGG Tri-Agonist | Obesity | Phase II | Phase II trials are ongoing. | \nType 2 diabetes | \nGLP-1R NPA | Obesity | Phase II | Phase II trials are ongoing. | \nType 2 diabetes | \nImmunology | \nMirikizumab | Ulcerative colitis | Submitted | Submitted in the U.S. in first quarter of 2022. | \nCrohn's Disease | Phase III | Phase III trials are ongoing. | \nLebrikizumab(1) | Atopic dermatitis | Phase III | Granted FDA Fast Track designation(2). Announced in 2021 that Phase III trials met primary and all key secondary endpoints. Phase III trials are ongoing. | \nCXCR1/2 Ligands Monoclonal Antibody | Hidradenitis suppurativa | Phase II | Phase II trial is ongoing. | \nIL-2 Conjugate | Systemic lupus erythematosus | Phase II | Phase II trial is ongoing. | \nUlcerative colitis | Discontinued | Announced in April 2022 that we have discontinued the Phase II trial due to lack of efficacy based on interim analysis. | \nPeresolimab (PD-1 MAB Agonist) | Rheumatoid arthritis | Phase II | Phase II trial is ongoing. |   |  |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication | Status | Developments | \nNeuroscience | \nDonanemab | Early Alzheimer's disease | Submission initiated | Granted FDA Breakthrough Therapy designation(3). Initiated a rolling submission in the U.S. for accelerated approval in 2021. Phase III trials are ongoing. | \nPreclinical Alzheimer's disease | Phase III | Phase III trial is ongoing. | \nSolanezumab | Preclinical Alzheimer's disease | Phase III | Phase III trial is ongoing. | \nGBA1 Gene Therapy (PR001) | Parkinson's disease | Phase II | Granted FDA Fast Track designation(2). Phase II trials are ongoing. | \nGRN Gene Therapy (PR006) | Frontotemporal dementia | Phase II | \nO-glc-NAcase | Alzheimer's disease | Phase II | Phase II trial is ongoing. | \nPACAP38 Antibody | Chronic pain | Phase II | Phase II trial is ongoing. | \nSSTR4 Agonist | Chronic pain | Phase II | Phase II trials are ongoing. | \nTRPA1 Antagonist | Pain | Phase II | Phase II trials are ongoing. | \nEpiregulin/TGF\u03b1 MAB | Chronic pain | Discontinued | Announced in April 2022 that we have discontinued the Phase II trial because it did not meet criteria for proceeding. | \nOncology | \nSelpercatinib (Retevmo\u00ae) | Lung cancer | Approved(4) | Phase III trials are ongoing. | \nThyroid cancer | \nPirtobrutinib (LOXO-305) | Mantle cell lymphoma | Submission initiated | Initiated a rolling submission in the U.S. for accelerated approval in 2021. Phase II and Phase III trials are ongoing. | \nChronic lymphocytic leukemia | Phase III | Phase III trials are ongoing. | \nB-cell malignancies | Phase II | Phase II trial is ongoing. | \nImlunestrant | ER+HER2- metastatic breast cancer | Phase III | Phase III trial is ongoing. | \nSintilimab injection(5) | Lung cancer | Not approved | In the first quarter of 2022 the FDA issued a complete response letter indicating that the FDA did not approve the application in its current form and recommended an additional multiregional clinical study be performed. In collaboration with Innovent, we are assessing next steps in the U.S. |   |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication | Status | Developments\nDiabetes\nEmpagliflozin (Jardiance\u00ae)(1) | Heart failure with preserved ejection fraction | Approved | Approved in the U.S. and Europe in the first quarter of 2022 and in Japan in April 2022.\nChronic kidney disease | Phase III | Granted FDA Fast Track designation(2). In the first quarter of 2022 the Independent Data Monitoring Committee recommended stopping the Phase III trial early due to clear positive efficacy.\nImmunology\nBaricitinib (Olumiant\u00ae) | COVID-19 | Emergency Use Authorization(3) | Submitted in the U.S. and the FDA granted priority review in the first quarter of 2022.\nAlopecia areata | Submitted | Granted FDA Breakthrough Therapy designation(4). Submitted in U.S., Europe, and Japan in 2021. In the first quarter of 2022 the FDA granted priority review in severe alopecia areata.\nOncology\nAbemaciclib (Verzenio\u00ae) | Prostate cancer | Phase III | Phase III trials are ongoing.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  |  |  |  | \n | 2022 |  | 2021 |  | Percent Change |  |  |  |  | \nU.S. | $ | 5,174.6 |  |  | $ | 3,941.3 |  |  | 31 |  |  |  |  | \nOutside U.S. | 2,635.4 |  |  | 2,864.3 |  |  | (8) |  |  |  |  | \nRevenue | $ | 7,810.0 |  |  | $ | 6,805.6 |  |  | 15 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2022 vs. 2021 |  | \n | U.S. | Outside U.S. | Consolidated |  |  |  | \nVolume | 32 | % | 4 | % | 20 | % |  |  |  | \nPrice | (1) |  | (7) |  | (3) |  |  |  |  | \nForeign exchange rates | \u2014 |  | (5) |  | (2) |  |  |  |  | \nPercent change | 31 | % | (8) | % | 15 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  |  | \n | 2022 |  | 2021 | \nProduct | U.S. |  | Outside U.S. |  | Total |  | Total | Percent Change | \nTrulicity | $ | 1,313.9 |  |  | $ | 427.4 |  |  | $ | 1,741.3 |  |  | $ | 1,452.4 |  |  | 20 | \nCOVID-19 antibodies(1) | 1,455.2 |  |  | 14.7 |  |  | 1,469.8 |  |  | 810.1 |  |  | 81 | \nHumalog(2) | 368.9 |  |  | 249.3 |  |  | 618.2 |  |  | 617.0 |  |  | \u2014 | \nTaltz | 307.2 |  |  | 180.8 |  |  | 488.1 |  |  | 403.2 |  |  | 21 | \nVerzenio | 301.5 |  |  | 167.9 |  |  | 469.4 |  |  | 269.0 |  |  | 74 | \nJardiance(3) | 229.8 |  |  | 189.7 |  |  | 419.4 |  |  | 312.0 |  |  | 34 | \nAlimta | 254.3 |  |  | 89.7 |  |  | 343.9 |  |  | 559.0 |  |  | (38) | \nHumulin\u00ae | 190.4 |  |  | 82.8 |  |  | 273.2 |  |  | 321.7 |  |  | (15) | \nOlumiant(4) | 71.3 |  |  | 184.3 |  |  | 255.6 |  |  | 193.8 |  |  | 32 | \nCyramza\u00ae | 79.2 |  |  | 151.1 |  |  | 230.3 |  |  | 240.5 |  |  | (4) | \nCialis | 6.9 |  |  | 210.8 |  |  | 217.7 |  |  | 126.8 |  |  | 72 | \nBasaglar\u00ae | 119.3 |  |  | 72.2 |  |  | 191.5 |  |  | 246.6 |  |  | (22) | \nEmgality\u00ae | 108.3 |  |  | 41.0 |  |  | 149.3 |  |  | 119.5 |  |  | 25 | \nForteo | 70.2 |  |  | 67.3 |  |  | 137.4 |  |  | 198.5 |  |  | (31) | \nErbitux\u00ae | 109.7 |  |  | 13.0 |  |  | 122.7 |  |  | 122.4 |  |  | \u2014 | \nZyprexa\u00ae | 9.6 |  |  | 83.5 |  |  | 93.1 |  |  | 95.8 |  |  | (3) | \nTyvyt | \u2014 |  |  | 85.5 |  |  | 85.5 |  |  | 109.7 |  |  | (22) | \nCymbalta | 9.1 |  |  | 71.9 |  |  | 81.1 |  |  | 176.6 |  |  | (54) | \nOther products | 169.8 |  |  | 252.5 |  |  | 422.5 |  |  | 431.0 |  |  | (2) | \nRevenue | $ | 5,174.6 |  |  | $ | 2,635.4 |  |  | $ | 7,810.0 |  |  | $ | 6,805.6 |  |  | 15 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number ofShares Purchased(in thousands) |  | Average\u00a0Price Paidper Share |  | Total\u00a0Number of SharesPurchased\u00a0as Part ofPublicly AnnouncedPlans or Programs(in thousands) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(in millions)\nJanuary 2022 | \u2014 |  |  | $ | \u2014 |  |  | \u2014 |  |  | $ | 4,750.0 | \nFebruary 2022 | 3,394 |  |  | 261.69 |  |  | 3,394 |  |  | 3,861.9 | \nMarch 2022 | 2,213 |  |  | 276.52 |  |  | 2,213 |  |  | 3,250.0 | \nTotal | 5,607 |  |  | 267.54 |  |  | 5,607 |  |  |   |  |  |  |  |  |  |  | \nExhibit |  | Description\nEXHIBIT 3.1 |  | Amended Articles of Incorporation are incorporated by reference to Exhibit 3.1 to the Company's Annual Report on Form 10-K for the year ended December 31, 2013\n |  | \nEXHIBIT 3.2 |  | Bylaws, as amended, are incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on December 16, 2021\n |  | \nEXHIBIT\u00a031.1 |  | Rule\u00a013a-14(a) Certification of David A. Ricks, Chair, President, and Chief Executive Officer\n |  | \nEXHIBIT 31.2 |  | Rule\u00a013a-14(a) Certification of Anat Ashkenazi, Senior Vice President and Chief Financial Officer\n | \nEXHIBIT 32. |  | Section 1350 Certification\n |  | \nEXHIBIT 101. |  | Interactive Data Files (embedded within the Inline XBRL document)\n |  | \nEXHIBIT 104. |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)  |  |  |  |  |  |  |  | \n |  | ELI LILLY AND COMPANY\n |  | (Registrant)\n |  | \nDate: | April 29, 2022 | /s/ Anat Ashkenazi\n |  | Anat Ashkenazi\n |  | Senior Vice President and Chief Financial Officer\nDate: | April 29, 2022 | /s/ Donald A. Zakrowski\n |  | Donald A. Zakrowski\n |  | Vice President, Finance, and Chief Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Eli Lilly, in 2022 Q2, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  |  |  |  | \nIndiana |  | 35-0470950\n(State or other jurisdiction of |  | (I.R.S. Employer\nincorporation or organization) |  | Identification No.)  |  |  |  |  |  |  |  | \nTitle of Each Class | Trading Symbols | Name of Each Exchange On Which Registered\nCommon Stock (no par value) | LLY | New York Stock Exchange\n7 1/8% Notes due 2025 | LLY25 | New York Stock Exchange\n1.625% Notes due 2026 | LLY26 | New York Stock Exchange\n2.125% Notes due 2030 | LLY30 | New York Stock Exchange\n0.625% Notes due 2031 | LLY31 | New York Stock Exchange\n0.500% Notes due 2033 | LLY33 | New York Stock Exchange\n6.77%\u00a0Notes due 2036 | LLY36 | New York Stock Exchange\n1.625% Notes due 2043 | LLY43 | New York Stock Exchange\n1.700% Notes due 2049 | LLY49A | New York Stock Exchange\n1.125% Notes due 2051 | LLY51 | New York Stock Exchange\n1.375% Notes due 2061 | LLY61 | New York Stock Exchange  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 |  |  |  |  | Accelerated\u00a0filer | \u2610\nNon-accelerated filer | \u2610 |  |  | Smaller reporting company | \u2610\n |  |  |  |  |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \nClass |  | Number of Shares Outstanding\nCommon |  | 950,174,817 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | Page\nPART I. Financial Information |  |  |  | 5\n |  |  |  | \nItem 1. |  | Financial Statements |  | 5\n |  | Consolidated Condensed Statements of Operations |  | 5\n |  | Consolidated Condensed Statements of Comprehensive Income |  | 6\n |  | Consolidated Condensed Balance Sheets |  | 7\n |  | Consolidated Condensed Statements of Equity |  | 8\n |  | Consolidated Condensed Statements of Cash Flows |  | 10\n |  | Notes to Consolidated Condensed Financial Statements |  | 11\nItem 2. |  | Management's Discussion and Analysis of Results of Operations and Financial Condition |  | 36\n |  | Executive Overview |  | 36\n |  | Revenue |  | 44\n |  | Gross Margin, Costs, and Expenses |  | 48\n |  | Financial Condition and Liquidity |  | 49\n |  |  |  | \n |  | Critical Accounting Estimates |  | 49\n |  | Available Information on our Website |  | 49\nItem 4. |  | Controls and Procedures |  | 50\n |  |  |  | \nPART II. Other Information |  |  |  | 51\n |  |  |  | \nItem 1. |  | Legal Proceedings |  | 51\nItem 1A. |  | Risk Factors |  | 51\nItem 2. |  | Unregistered Sales of Equity Securities and Use of Proceeds |  | 51\nItem 6. |  | Exhibits |  | 52\n |  |  |  | \nSignatures |  |  |  | 52  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nRevenue (Note 2) | $ | 6,488.0 |  |  | $ | 6,740.1 |  |  | $ | 14,298.0 |  |  | $ | 13,545.7 | \nCosts, expenses, and other: |  |  |  |  |  |  | \nCost of sales | 1,430.5 |  |  | 1,953.2 |  |  | 3,502.6 |  |  | 3,831.8 | \nResearch and development | 1,781.9 |  |  | 1,655.0 |  |  | 3,392.0 |  |  | 3,327.1 | \nMarketing, selling, and administrative | 1,625.1 |  |  | 1,685.7 |  |  | 3,183.0 |  |  | 3,261.7 | \nAcquired in-process research and development and development milestones (Note 3) | 440.4 |  |  | 42.8 |  |  | 606.0 |  |  | 354.8 | \nAsset impairment, restructuring, and other special charges (Note 5) | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 211.6 | \nOther\u2013net, (income) expense (Note 11) | 119.2 |  |  | (190.5) |  |  | 469.9 |  |  | (511.6) | \n | 5,397.1 |  |  | 5,146.2 |  |  | 11,153.5 |  |  | 10,475.4 | \nIncome before income taxes | 1,090.9 |  |  | 1,593.9 |  |  | 3,144.5 |  |  | 3,070.3 | \nIncome taxes (Note 7) | 138.4 |  |  | 203.7 |  |  | 289.1 |  |  | 324.8 | \nNet income | $ | 952.5 |  |  | $ | 1,390.2 |  |  | $ | 2,855.4 |  |  | $ | 2,745.5 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nEarnings per share: |  |  |  |  |  |  | \nBasic | $ | 1.06 |  |  | $ | 1.53 |  |  | $ | 3.17 |  |  | $ | 3.02 | \n |  |  |  |  |  |  | \nDiluted | $ | 1.05 |  |  | $ | 1.53 |  |  | $ | 3.16 |  |  | $ | 3.01 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nShares used in calculation of earnings per share: |  |  |  |  |  |  | \nBasic | 900.3 |  | 907.3 |  | 902.0 |  | 908.2\nDiluted | 902.9 |  | 910.4 |  | 904.4 |  | 911.6  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nNet income | $ | 952.5 |  |  | $ | 1,390.2 |  |  | $ | 2,855.4 |  |  | $ | 2,745.5 | \nOther comprehensive income (loss), net of tax (Note 10) | (62.4) |  |  | 108.5 |  |  | 55.4 |  |  | 209.3 | \nComprehensive income | $ | 890.1 |  |  | $ | 1,498.7 |  |  | $ | 2,910.8 |  |  | $ | 2,954.8 |   |  |  |  |  |  |  |  |  |  |  | \n | June 30, 2022 |  | December 31, 2021\nAssets | (Unaudited) |  | \nCurrent Assets |  |  | \nCash and cash equivalents (Note 6) | $ | 2,622.9 |  |  | $ | 3,818.5 | \nShort-term investments (Note 6) | 113.8 |  |  | 90.1 | \nAccounts receivable, net of allowances of$19.2(2022)and $22.5(2021) | 6,364.5 |  |  | 6,672.8 | \nOther receivables | 1,307.9 |  |  | 1,454.4 | \nInventories | 3,899.4 |  |  | 3,886.0 | \nPrepaid expenses and other | 2,806.7 |  |  | 2,530.6 | \nTotal current assets | 17,115.2 |  |  | 18,452.4 | \nInvestments (Note 6) | 2,587.2 |  |  | 3,212.6 | \nGoodwill | 3,891.8 |  |  | 3,892.0 | \nOther intangibles, net | 7,497.7 |  |  | 7,691.9 | \nDeferred tax assets | 2,371.9 |  |  | 2,489.3 | \nProperty and equipment, net of accumulated depreciation of$10,119.7(2022)and $9,976.7(2021) | 9,128.2 |  |  | 8,985.1 | \nOther noncurrent assets | 4,471.6 |  |  | 4,082.7 | \nTotal assets | $ | 47,063.6 |  |  | $ | 48,806.0 | \nLiabilities and Equity |  |  | \nCurrent Liabilities |  |  | \nShort-term borrowings and current maturities of long-term debt | $ | 2,121.8 |  |  | $ | 1,538.3 | \nAccounts payable | 1,659.3 |  |  | 1,670.6 | \nEmployee compensation | 835.8 |  |  | 958.1 | \nSales rebates and discounts | 7,991.4 |  |  | 6,845.8 | \nDividends payable | 882.2 |  |  | 885.5 | \nIncome taxes payable | 126.6 |  |  | 126.9 | \nOther current liabilities | 2,003.5 |  |  | 3,027.5 | \nTotal current liabilities | 15,620.6 |  |  | 15,052.7 | \nOther Liabilities |  |  | \nLong-term debt | 14,692.0 |  |  | 15,346.4 | \nAccrued retirement benefits (Note 8) | 1,888.6 |  |  | 1,954.1 | \nLong-term income taxes payable | 3,557.6 |  |  | 3,920.0 | \nDeferred tax liabilities | 862.5 |  |  | 1,733.7 | \nOther noncurrent liabilities | 1,783.1 |  |  | 1,644.3 | \nTotal other liabilities | 22,783.8 |  |  | 24,598.5 | \nCommitments and Contingencies (Note 9) |  |  | \nEli Lilly and Company Shareholders' Equity |  |  | \nCommon stock | 594.1 |  |  | 596.3 | \nAdditional paid-in capital | 6,746.0 |  |  | 6,833.4 | \nRetained earnings | 8,556.0 |  |  | 8,958.5 | \nEmployee benefit trust | (3,013.2) |  |  | (3,013.2) | \nAccumulated other comprehensive loss (Note 10) | (4,287.7) |  |  | (4,343.1) | \nCost of common stock in treasury | (50.5) |  |  | (52.7) | \nTotal Eli Lilly and Company shareholders' equity | 8,544.7 |  |  | 8,979.2 | \nNoncontrolling interests | 114.5 |  |  | 175.6 | \nTotal equity | 8,659.2 |  |  | 9,154.8 | \nTotal liabilities and equity | $ | 47,063.6 |  |  | $ | 48,806.0 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Equity of Eli Lilly and Company Shareholders |  | \n(Dollars in millions, except per-share data, and shares in thousands) | Common Stock |  | AdditionalPaid-inCapital |  | RetainedEarnings |  | Employee Benefit Trust |  | Accumulated Other Comprehensive Loss |  | Common Stock in Treasury(1) |  | Noncontrolling Interests\nShares |  | Amount | Shares |  | Amount\nBalance at April 1, 2021 | 959,482 |  |  | $ | 599.7 |  |  | $ | 6,579.2 |  |  | $ | 9,181.3 |  |  | $ | (3,013.2) |  |  | $ | (6,395.6) |  |  | 463 |  |  | $ | (52.7) |  |  | $ | 200.6 | \nNet income |  |  |  |  |  |  | 1,390.2 |  |  |  |  |  |  |  |  |  |  | 31.4 | \nOther comprehensive income, net of tax |  |  |  |  |  |  |  |  |  |  | 108.5 |  |  |  |  |  |  | \nCash dividends declared per share: $1.70 |  |  |  |  |  |  | (1,542.9) |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nRetirement of treasury shares | (2,467) |  |  | (1.6) |  |  |  |  | (498.5) |  |  |  |  |  |  | (2,467) |  |  | 500.0 |  |  | \nPurchase of treasury shares |  |  |  |  |  |  |  |  |  |  |  |  | 2,467 |  |  | (500.0) |  |  | \nIssuance of stock under employee stock plans, net | 23 |  |  |  |  | (1.9) |  |  |  |  |  |  |  |  |  |  |  |  | \nStock-based compensation |  |  |  |  | 91.9 |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (12.9) | \nBalance at June 30, 2021 | 957,038 |  |  | $ | 598.1 |  |  | $ | 6,669.2 |  |  | $ | 8,530.1 |  |  | $ | (3,013.2) |  |  | $ | (6,287.1) |  |  | 463 |  |  | $ | (52.7) |  |  | $ | 219.1 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance at April 1, 2022 | 950,605 |  |  | $ | 594.1 |  |  | $ | 6,656.3 |  |  | $ | 9,369.4 |  |  | $ | (3,013.2) |  |  | $ | (4,225.3) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 131.2 | \nNet income (loss) |  |  |  |  |  |  | 952.5 |  |  |  |  |  |  |  |  |  |  | (11.4) | \nOther comprehensive loss, net of tax |  |  |  |  |  |  |  |  |  |  | (62.4) |  |  |  |  |  |  | \nCash dividends declared per share: $1.96 |  |  |  |  |  |  | (1,765.9) |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIssuance of stock under employee stock plans, net | 14 |  |  |  |  | (2.4) |  |  |  |  |  |  |  |  |  |  |  |  | \nStock-based compensation |  |  |  |  | 92.1 |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (5.3) | \nBalance at June 30, 2022 | 950,619 |  |  | $ | 594.1 |  |  | $ | 6,746.0 |  |  | $ | 8,556.0 |  |  | $ | (3,013.2) |  |  | $ | (4,287.7) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 114.5 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Equity of Eli Lilly and Company Shareholders |  | \n(Dollars in millions, except per-share data, and shares in thousands) | Common Stock |  | AdditionalPaid-inCapital |  | RetainedEarnings |  | Employee Benefit Trust |  | Accumulated Other Comprehensive Loss |  | Common Stock in Treasury(1) |  | Noncontrolling Interests\nShares |  | Amount | Shares |  | Amount\nBalance at January 1, 2021 | 957,077 |  |  | $ | 598.2 |  |  | $ | 6,778.5 |  |  | $ | 7,830.2 |  |  | $ | (3,013.2) |  |  | $ | (6,496.4) |  |  | 487 |  |  | $ | (55.7) |  |  | $ | 183.6 | \nNet income |  |  |  |  |  |  | 2,745.5 |  |  |  |  |  |  |  |  |  |  | 47.8 | \nOther comprehensive income, net of tax |  |  |  |  |  |  |  |  |  |  | 209.3 |  |  |  |  |  |  | \nCash dividends declared per share: $1.70 |  |  |  |  |  |  | (1,542.9) |  |  |  |  |  |  |  |  |  |  | \nRetirement of treasury shares | (2,467) |  |  | (1.6) |  |  |  |  | (498.5) |  |  |  |  |  |  | (2,467) |  |  | 500.0 |  |  | \nPurchase of treasury shares |  |  |  |  |  |  |  |  |  |  |  |  | 2,467 |  |  | (500.0) |  |  | \nIssuance of stock under employee stock plans, net | 2,428 |  |  | 1.5 |  |  | (285.8) |  |  |  |  |  |  |  |  | (24) |  |  | 3.0 |  |  | \nStock-based compensation |  |  |  |  | 177.4 |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  | (0.9) |  |  | (4.2) |  |  |  |  |  |  |  |  |  |  | (12.3) | \nBalance at June 30, 2021 | 957,038 |  |  | $ | 598.1 |  |  | $ | 6,669.2 |  |  | $ | 8,530.1 |  |  | $ | (3,013.2) |  |  | $ | (6,287.1) |  |  | 463 |  |  | $ | (52.7) |  |  | $ | 219.1 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance at January 1, 2022 | 954,116 |  |  | $ | 596.3 |  |  | $ | 6,833.4 |  |  | $ | 8,958.5 |  |  | $ | (3,013.2) |  |  | $ | (4,343.1) |  |  | 463 |  |  | $ | (52.7) |  |  | $ | 175.6 | \nNet income (loss) |  |  |  |  |  |  | 2,855.4 |  |  |  |  |  |  |  |  |  |  | (48.0) | \nOther comprehensive income, net of tax |  |  |  |  |  |  |  |  |  |  | 55.4 |  |  |  |  |  |  | \nCash dividends declared per share: $1.96 |  |  |  |  |  |  | (1,765.9) |  |  |  |  |  |  |  |  |  |  | \nRetirement of treasury shares | (5,607) |  |  | (3.5) |  |  |  |  | (1,496.5) |  |  |  |  |  |  | (5,607) |  |  | 1,500.0 |  |  | \nPurchase of treasury shares |  |  |  |  |  |  |  |  |  |  |  |  | 5,607 |  |  | (1,500.0) |  |  | \nIssuance of stock under employee stock plans, net | 2,110 |  |  | 1.3 |  |  | (280.5) |  |  |  |  |  |  |  |  | (13) |  |  | 2.2 |  |  | \nStock-based compensation |  |  |  |  | 193.1 |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  | 4.5 |  |  |  |  |  |  |  |  |  |  | (13.1) | \nBalance at June 30, 2022 | 950,619 |  |  | $ | 594.1 |  |  | $ | 6,746.0 |  |  | $ | 8,556.0 |  |  | $ | (3,013.2) |  |  | $ | (4,287.7) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 114.5 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended June 30,\n | 2022 |  | 2021\nCash Flows from Operating Activities | \nNet income | $ | 2,855.4 |  |  | $ | 2,745.5 | \nAdjustments to Reconcile Net Income to Cash Flows from Operating Activities: |  |  | \n |  |  | \nDepreciation and amortization | 784.6 |  |  | 719.6 | \nChange in deferred income taxes | (1,125.0) |  |  | (413.8) | \n |  |  | \nStock-based compensation expense | 193.1 |  |  | 177.4 | \n |  |  | \nNet investment (gains) losses | 545.6 |  |  | (518.1) | \nAcquired in-process research and development | 233.0 |  |  | 324.3 | \nOther changes in operating assets and liabilities, net of acquisitions and divestitures | (117.6) |  |  | 118.4 | \nOther non-cash operating activities, net | (49.2) |  |  | 319.6 | \nNet Cash Provided by Operating Activities | 3,319.9 |  |  | 3,472.9 | \nCash Flows from Investing Activities |  |  | \nNet purchases of property and equipment | (736.4) |  |  | (681.6) | \nProceeds from sales and maturities of short-term investments | 57.6 |  |  | 21.3 | \nPurchases of short-term investments | (32.9) |  |  | (26.6) | \nProceeds from sales of noncurrent investments | 168.5 |  |  | 461.9 | \nPurchases of noncurrent investments | (251.4) |  |  | (503.1) | \nCash paid for acquisitions, net of cash acquired (Note 3) | \u2014 |  |  | (747.4) | \n |  |  | \nPurchases of in-process research and development | (571.8) |  |  | (341.8) | \nOther investing activities, net | (111.3) |  |  | 50.5 | \nNet Cash Used for Investing Activities | (1,477.7) |  |  | (1,766.8) | \nCash Flows from Financing Activities |  |  | \nDividends paid | (1,769.2) |  |  | (1,543.1) | \nNet change in short-term borrowings | 2,117.2 |  |  | 196.3 | \n |  |  | \nRepayments of long-term debt | (1,560.0) |  |  | \u2014 | \nPurchases of common stock | (1,500.0) |  |  | (500.0) | \n |  |  | \nOther financing activities, net | (290.0) |  |  | (294.8) | \nNet Cash Used for Financing Activities | (3,002.0) |  |  | (2,141.6) | \nEffect of exchange rate changes on cash and cash equivalents | (35.8) |  |  | (1.6) | \n |  |  | \nNet decrease in cash and cash equivalents | (1,195.6) |  |  | (437.1) | \nCash and cash equivalents at January\u00a01 | 3,818.5 |  |  | 3,657.1 | \nCash and Cash Equivalents at June 30 | $ | 2,622.9 |  |  | $ | 3,220.0 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nNet product revenue | $ | 5,870.9 |  |  | $ | 6,070.5 |  |  | $ | 13,003.8 |  |  | $ | 12,390.5 | \nCollaboration and other revenue(1) | 617.1 |  |  | 669.6 |  |  | 1,294.2 |  |  | 1,155.2 | \nRevenue | $ | 6,488.0 |  |  | $ | 6,740.1 |  |  | $ | 14,298.0 |  |  | $ | 13,545.7 |   |  |  |  |  |  |  |  |  |  |  | \n | June 30, 2022 |  | December 31, 2021\nContract liabilities | $ | 242.1 |  |  | $ | 262.6 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30,\n | 2022 |  | 2021\n | U.S. | Outside U.S. | Total |  | U.S. | Outside U.S. | Total\nRevenue\u2014to unaffiliated customers: |  |  |  |  |  |  | \nDiabetes: |  |  |  |  |  |  | \nTrulicity\u00ae | $ | 1,430.1 |  | $ | 481.7 |  | $ | 1,911.9 |  |  | $ | 1,147.6 |  | $ | 388.0 |  | $ | 1,535.6 | \nJardiance(1) | 250.7 |  | 210.3 |  | 461.0 |  |  | 194.4 |  | 162.1 |  | 356.5 | \nHumalog\u00ae (2) | 238.8 |  | 208.3 |  | 447.1 |  |  | 329.1 |  | 278.6 |  | 607.6 | \nHumulin\u00ae | 202.3 |  | 71.7 |  | 274.0 |  |  | 221.1 |  | 94.3 |  | 315.3 | \nBasaglar\u00ae | 95.8 |  | 78.4 |  | 174.2 |  |  | 133.4 |  | 77.3 |  | 210.7 | \nOther diabetes | 74.5 |  | 95.6 |  | 170.0 |  |  | 54.2 |  | 95.4 |  | 149.8 | \nTotal diabetes | 2,292.2 |  | 1,146.0 |  | 3,438.2 |  |  | 2,079.8 |  | 1,095.7 |  | 3,175.5 | \n |  |  |  |  |  |  | \nOncology: |  |  |  |  |  |  | \nVerzenio\u00ae | 384.3 |  | 204.2 |  | 588.5 |  |  | 209.7 |  | 131.6 |  | 341.3 | \nCyramza\u00ae | 92.6 |  | 138.6 |  | 231.3 |  |  | 101.4 |  | 167.3 |  | 268.7 | \nAlimta\u00ae | 171.7 |  | 56.1 |  | 227.7 |  |  | 353.5 |  | 257.1 |  | 610.6 | \nErbitux\u00ae | 125.1 |  | 15.7 |  | 140.8 |  |  | 135.8 |  | 11.2 |  | 147.0 | \nTyvyt\u00ae | \u2014 |  | 73.6 |  | 73.6 |  |  | \u2014 |  | 105.0 |  | 105.0 | \nOther oncology | 45.3 |  | 61.6 |  | 106.8 |  |  | 27.9 |  | 53.5 |  | 81.4 | \nTotal oncology | 819.0 |  | 549.8 |  | 1,368.7 |  |  | 828.3 |  | 725.7 |  | 1,554.0 | \n |  |  |  |  |  |  | \nImmunology: |  |  |  |  |  |  | \nTaltz\u00ae | 411.6 |  | 194.7 |  | 606.2 |  |  | 399.8 |  | 169.3 |  | 569.1 | \nOlumiant\u00ae (3) | 10.4 |  | 175.8 |  | 186.2 |  |  | 17.8 |  | 190.6 |  | 208.4 | \nOther immunology | \u2014 |  | 4.0 |  | 4.0 |  |  | 4.8 |  | 3.2 |  | 7.9 | \nTotal immunology | 422.0 |  | 374.5 |  | 796.5 |  |  | 422.4 |  | 363.1 |  | 785.4 | \n |  |  |  |  |  |  | \nNeuroscience: |  |  |  |  |  |  | \nEmgality\u00ae | 108.6 |  | 48.9 |  | 157.5 |  |  | 112.1 |  | 44.2 |  | 156.3 | \nZyprexa\u00ae | 8.7 |  | 78.6 |  | 87.3 |  |  | 8.4 |  | 86.9 |  | 95.4 | \nCymbalta\u00ae | 8.1 |  | 67.4 |  | 75.5 |  |  | 12.4 |  | 163.3 |  | 175.6 | \n |  |  |  |  |  |  | \nOther neuroscience | 19.4 |  | 50.3 |  | 69.6 |  |  | 33.8 |  | 51.1 |  | 84.9 | \nTotal neuroscience | 144.8 |  | 245.2 |  | 389.9 |  |  | 166.7 |  | 345.5 |  | 512.2 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nOther: |  |  |  |  |  |  | \nCialis\u00ae | 10.8 |  | 136.2 |  | 147.0 |  |  | (5.2) |  | 286.3 |  | 281.0 | \nForteo\u00ae | 78.5 |  | 60.0 |  | 138.5 |  |  | 122.8 |  | 95.6 |  | 218.4 | \nCOVID-19 antibodies(4) | 129.1 |  | \u2014 |  | 129.1 |  |  | 83.4 |  | 65.7 |  | 148.9 | \nOther | 38.5 |  | 41.7 |  | 80.1 |  |  | 6.0 |  | 58.4 |  | 64.6 | \nTotal other | 256.9 |  | 237.9 |  | 494.7 |  |  | 207.0 |  | 506.0 |  | 712.9 | \nRevenue | $ | 3,934.8 |  | $ | 2,553.3 |  | $ | 6,488.0 |  |  | $ | 3,704.2 |  | $ | 3,035.9 |  | $ | 6,740.1 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended June 30,\n | 2022 |  | 2021\n | U.S. | Outside U.S. | Total |  | U.S. | Outside U.S. | Total\nRevenue\u2014to unaffiliated customers: |  |  |  |  |  |  | \nDiabetes: |  |  |  |  |  |  | \nTrulicity | $ | 2,744.1 |  | $ | 909.1 |  | $ | 3,653.2 |  |  | $ | 2,264.3 |  | $ | 723.7 |  | $ | 2,988.1 | \nHumalog(1) | 607.7 |  | 457.6 |  | 1,065.3 |  |  | 661.7 |  | 562.9 |  | 1,224.6 | \nJardiance(2) | 480.4 |  | 400.0 |  | 880.4 |  |  | 345.6 |  | 322.9 |  | 668.5 | \nHumulin | 392.8 |  | 154.5 |  | 547.2 |  |  | 440.1 |  | 196.9 |  | 637.0 | \nBasaglar | 215.1 |  | 150.6 |  | 365.7 |  |  | 308.6 |  | 148.7 |  | 457.3 | \nOther diabetes | 128.6 |  | 185.8 |  | 314.5 |  |  | 120.7 |  | 190.4 |  | 311.1 | \nTotal diabetes | 4,568.7 |  | 2,257.6 |  | 6,826.3 |  |  | 4,141.0 |  | 2,145.5 |  | 6,286.6 | \n |  |  |  |  |  |  | \nOncology: |  |  |  |  |  |  | \nVerzenio | 685.7 |  | 372.1 |  | 1,057.9 |  |  | 382.5 |  | 227.8 |  | 610.3 | \nAlimta | 425.9 |  | 145.8 |  | 571.7 |  |  | 614.6 |  | 554.9 |  | 1,169.6 | \nCyramza | 171.8 |  | 289.7 |  | 461.5 |  |  | 181.5 |  | 327.7 |  | 509.2 | \nErbitux | 234.7 |  | 28.7 |  | 263.4 |  |  | 243.7 |  | 25.7 |  | 269.4 | \nTyvyt | \u2014 |  | 159.0 |  | 159.0 |  |  | \u2014 |  | 214.6 |  | 214.6 | \nOther oncology | 84.6 |  | 123.7 |  | 208.2 |  |  | 48.5 |  | 104.7 |  | 153.2 | \nTotal oncology | 1,602.7 |  | 1,119.0 |  | 2,721.7 |  |  | 1,470.8 |  | 1,455.4 |  | 2,926.3 | \n |  |  |  |  |  |  | \nImmunology: |  |  |  |  |  |  | \nTaltz | 718.8 |  | 375.5 |  | 1,094.3 |  |  | 649.4 |  | 322.9 |  | 972.4 | \nOlumiant(3) | 81.7 |  | 360.1 |  | 441.8 |  |  | 42.5 |  | 359.7 |  | 402.2 | \nOther immunology | \u2014 |  | 8.5 |  | 8.5 |  |  | 15.2 |  | 9.6 |  | 24.7 | \nTotal immunology | 800.5 |  | 744.1 |  | 1,544.6 |  |  | 707.1 |  | 692.2 |  | 1,399.3 | \n |  |  |  |  |  |  | \nNeuroscience: |  |  |  |  |  |  | \nEmgality | 216.9 |  | 89.8 |  | 306.7 |  |  | 213.6 |  | 62.2 |  | 275.7 | \nZyprexa | 18.3 |  | 162.1 |  | 180.4 |  |  | 15.3 |  | 175.8 |  | 191.1 | \nCymbalta | 17.2 |  | 139.4 |  | 156.6 |  |  | 23.3 |  | 328.9 |  | 352.3 | \n |  |  |  |  |  |  | \nOther neuroscience | 45.7 |  | 98.2 |  | 144.0 |  |  | 56.2 |  | 102.3 |  | 158.5 | \nTotal neuroscience | 298.1 |  | 489.5 |  | 787.7 |  |  | 308.4 |  | 669.2 |  | 977.6 | \n |  |  |  |  |  |  | \nOther: |  |  |  |  |  |  | \nCOVID-19 antibodies(4) | 1,584.3 |  | 14.7 |  | 1,598.9 |  |  | 734.0 |  | 225.1 |  | 959.1 | \nCialis | 17.7 |  | 347.0 |  | 364.7 |  |  | 3.4 |  | 404.4 |  | 407.8 | \nForteo | 148.7 |  | 127.2 |  | 275.9 |  |  | 220.5 |  | 196.4 |  | 416.9 | \nOther | 88.5 |  | 89.6 |  | 178.2 |  |  | 60.2 |  | 111.9 |  | 172.1 | \nTotal other | 1,839.2 |  | 578.5 |  | 2,417.7 |  |  | 1,018.1 |  | 937.8 |  | 1,955.9 | \nRevenue | $ | 9,109.4 |  | $ | 5,188.7 |  | $ | 14,298.0 |  |  | $ | 7,645.5 |  | $ | 5,900.2 |  | $ | 13,545.7 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nRevenue\u2014to unaffiliated customers(1): |  |  |  |  |  |  | \nU.S. | $ | 3,934.8 |  |  | $ | 3,704.2 |  |  | $ | 9,109.4 |  |  | $ | 7,645.5 | \nEurope | 1,101.1 |  |  | 1,209.8 |  |  | 2,168.4 |  |  | 2,531.0 | \nJapan | 454.4 |  |  | 665.4 |  |  | 864.6 |  |  | 1,237.2 | \nChina | 352.1 |  |  | 522.5 |  |  | 758.5 |  |  | 884.7 | \nOther foreign countries | 645.7 |  |  | 638.1 |  |  | 1,397.2 |  |  | 1,247.3 | \nRevenue | $ | 6,488.0 |  |  | $ | 6,740.1 |  |  | $ | 14,298.0 |  |  | $ | 13,545.7 |   |  |  |  |  | \nEstimated Fair Value at January 22, 2021 | \nCash | $ | 90.5 | \nAcquired IPR&D(1) | 824.0\nGoodwill(2) | 126.8\nDeferred tax liabilities | (106.0) | \nOther assets and liabilities, net | (31.5) | \nAcquisition date fair value of consideration transferred | 903.8\nLess: | \nCash acquired | (90.5) | \nFair value of CVR liability(3) | (65.9) | \nCash paid, net of cash acquired | $ | 747.4 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCounterparty | Compound(s), Therapy or Asset | Acquisition Month |  | Phase of Development(1) |  | Acquired IPR&D Expense\nBioMarin Pharmaceutical Inc. | Priority Review Voucher | February 2022 |  | Not applicable |  | $ | 110.0 | \n |  |  |  |  |  | \nRigel Pharmaceuticals, Inc. | R552, a receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor, for the potential treatment of autoimmune and inflammatory diseases | March 2021 |  | Phase I |  | 125.0 | \nPrecision Biosciences, Inc. | Potential in vivo therapies for genetic disorders | January 2021 |  | Pre-clinical |  | 107.8 | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  |   |  |  |  |  |  |  |  | \n | Net Milestones Capitalized (Deferred)(1)as of:\n | June 30, 2022 | December 31, 2021\nJardiance | $ | 126.1 |  | $ | 136.1 | \nTrajenta | 75.8 |  | 88.5 | \nBasaglar | (140.0) |  | (149.3) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nJardiance | $ | 461.0 |  |  | $ | 356.5 |  |  | $ | 880.4 |  |  | $ | 668.5 | \nBasaglar | 174.2 |  |  | 210.7 |  |  | 365.7 |  |  | 457.3 | \nTrajenta | 97.1 |  |  | 89.2 |  |  | 189.2 |  |  | 183.8 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nOlumiant | $ | 186.2 |  |  | $ | 208.4 |  |  | $ | 441.8 |  |  | $ | 402.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nTyvyt | $ | 73.6 |  |  | $ | 105.0 |  |  | $ | 159.0 |  |  | $ | 214.6 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Six Months Ended June 30,\n |  |  |  |  | 2022 |  | 2021\nSeverance |  |  |  |  | $ | \u2014 |  |  | $ | 11.5 | \nAsset impairment and other special charges |  |  |  |  | \u2014 |  |  | 200.1 | \nTotal asset impairment, restructuring, and other special charges |  |  |  |  | $ | \u2014 |  |  | $ | 211.6 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nFair value hedges: |  |  |  |  |  |  | \nEffect from hedged fixed-rate debt | $ | (58.2) |  |  | $ | 31.1 |  |  | $ | (152.8) |  |  | $ | (50.4) | \nEffect from interest rate contracts | 58.2 |  |  | (31.1) |  |  | 152.8 |  |  | 50.4 | \nCash flow hedges: |  |  |  |  |  |  | \nEffective portion of losses on interest rate contracts reclassified from accumulated other comprehensive loss | 4.1 |  |  | 4.2 |  |  | 8.2 |  |  | 8.3 | \nCross-currency interest rate swaps | 33.6 |  |  | (23.4) |  |  | 41.9 |  |  | 48.1 | \nNet (gains) losses on foreign currency exchange contracts not designated as hedging instruments | 151.1 |  |  | (73.2) |  |  | 145.0 |  |  | 59.8 | \nTotal | $ | 188.8 |  |  | $ | (92.4) |  |  | $ | 195.1 |  |  | $ | 116.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nNet investment hedges: |  |  |  |  |  |  | \nForeign currency-denominated notes | $ | 333.3 |  |  | $ | (57.8) |  |  | $ | 387.7 |  |  | $ | 149.9 | \nCross-currency interest rate swaps | 68.5 |  |  | (46.5) |  |  | 79.3 |  |  | 104.1 | \nForeign currency forward contracts | 13.6 |  |  | \u2014 |  |  | 13.6 |  |  | \u2014 | \nCash flow hedges: |  |  |  |  |  |  | \nForward-starting interest rate swaps | 157.7 |  |  | (165.2) |  |  | 280.2 |  |  | 129.9 | \nCross-currency interest rate swaps | 1.4 |  |  | (6.9) |  |  | 18.5 |  |  | 19.4 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | Fair Value Measurements Using |  | \n | CarryingAmount |  | Cost(1) |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | Significant OtherObservable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue\nJune 30, 2022 |  |  |  |  |  |  |  |  |  |  | \nCash equivalents | $ | 1,047.9 |  |  | $ | 1,047.9 |  |  | $ | 1,041.8 |  |  | $ | 6.1 |  |  | $ | \u2014 |  |  | $ | 1,047.9 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 45.6 |  |  | $ | 46.1 |  |  | $ | 45.6 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 45.6 | \nCorporate debt securities | 51.9 |  |  | 52.0 |  |  | \u2014 |  |  | 51.9 |  |  | \u2014 |  |  | 51.9 | \nMortgage-backed securities | 0.2 |  |  | 0.2 |  |  | \u2014 |  |  | 0.2 |  |  | \u2014 |  |  | 0.2 | \nAsset-backed securities | 4.4 |  |  | 4.5 |  |  | \u2014 |  |  | 4.4 |  |  | \u2014 |  |  | 4.4 | \nOther securities | 11.7 |  |  | 11.7 |  |  | \u2014 |  |  | \u2014 |  |  | 11.7 |  |  | 11.7 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments | $ | 113.8 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 109.5 |  |  | $ | 120.7 |  |  | $ | 109.5 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 109.5 | \n |  |  |  |  |  |  |  |  |  |  | \nCorporate debt securities | 202.4 |  |  | 226.2 |  |  | \u2014 |  |  | 202.4 |  |  | \u2014 |  |  | 202.4 | \nMortgage-backed securities | 97.7 |  |  | 105.5 |  |  | \u2014 |  |  | 97.7 |  |  | \u2014 |  |  | 97.7 | \nAsset-backed securities | 41.7 |  |  | 43.2 |  |  | \u2014 |  |  | 41.7 |  |  | \u2014 |  |  | 41.7 | \nOther securities | 171.2 |  |  | 81.2 |  |  | \u2014 |  |  | 47.9 |  |  | 123.3 |  |  | 171.2 | \nMarketable equity securities | 614.9 |  |  | 408.0 |  |  | 614.9 |  |  | \u2014 |  |  | \u2014 |  |  | 614.9 | \nEquity investments without readily determinable fair values(2) | 614.6 |  |  |  |  |  |  |  |  |  |  | \nEquity method investments(2) | 735.2 |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments | $ | 2,587.2 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDecember 31, 2021 |  |  |  |  |  |  |  |  |  |  | \nCash equivalents | $ | 2,379.5 |  |  | $ | 2,379.5 |  |  | $ | 2,361.0 |  |  | $ | 18.5 |  |  | $ | \u2014 |  |  | $ | 2,379.5 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 25.7 |  |  | $ | 25.6 |  |  | $ | 25.7 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 25.7 | \nCorporate debt securities | 43.7 |  |  | 43.7 |  |  | \u2014 |  |  | 43.7 |  |  | \u2014 |  |  | 43.7 | \nMortgage-backed securities | 0.2 |  |  | 0.2 |  |  | \u2014 |  |  | 0.2 |  |  | \u2014 |  |  | 0.2 | \nAsset-backed securities | 6.2 |  |  | 6.2 |  |  | \u2014 |  |  | 6.2 |  |  | \u2014 |  |  | 6.2 | \nOther securities | 14.3 |  |  | 14.3 |  |  | \u2014 |  |  | \u2014 |  |  | 14.3 |  |  | 14.3 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments | $ | 90.1 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 137.0 |  |  | $ | 136.8 |  |  | $ | 137.0 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 137.0 | \nCorporate debt securities | 235.3 |  |  | 232.7 |  |  | \u2014 |  |  | 235.3 |  |  | \u2014 |  |  | 235.3 | \nMortgage-backed securities | 109.8 |  |  | 108.1 |  |  | \u2014 |  |  | 109.8 |  |  | \u2014 |  |  | 109.8 | \nAsset-backed securities | 23.1 |  |  | 23.1 |  |  | \u2014 |  |  | 23.1 |  |  | \u2014 |  |  | 23.1 | \nOther securities | 108.1 |  |  | 22.2 |  |  | \u2014 |  |  | \u2014 |  |  | 108.1 |  |  | 108.1 | \nMarketable equity securities | 1,279.7 |  |  | 487.0 |  |  | 1,279.7 |  |  | \u2014 |  |  | \u2014 |  |  | 1,279.7 | \nEquity investments without readily determinable fair values(2) | 548.1 |  |  |  |  |  |  |  |  |  |  | \nEquity method investments(2) | 771.5 |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments | $ | 3,212.6 |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Fair Value Measurements Using |  | \n | CarryingAmount |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | SignificantOther Observable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue\nShort-term commercial paper borrowings |  |  |  |  |  |  |  |  | \nJune 30, 2022 | $ | (2,117.1) |  |  | $ | \u2014 |  |  | $ | (2,115.8) |  |  | $ | \u2014 |  |  | $ | (2,115.8) | \nDecember 31, 2021 | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nLong-term debt, including current portion |  |  |  |  |  |  |  |  | \nJune 30, 2022 | $ | (14,696.7) |  |  | $ | \u2014 |  |  | $ | (12,929.6) |  |  | $ | \u2014 |  |  | $ | (12,929.6) | \nDecember 31, 2021 | (16,884.7) |  |  | \u2014 |  |  | (18,157.7) |  |  | \u2014 |  |  | (18,157.7) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Fair Value Measurements Using |  |  |  | \n | CarryingAmount |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | SignificantOther Observable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue |  | \nJune 30, 2022 |  |  |  |  |  |  |  |  |  |  | \nRisk-management instruments: |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent liabilities | $ | (77.3) |  |  | $ | \u2014 |  |  | $ | (77.3) |  |  | $ | \u2014 |  |  | $ | (77.3) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 297.7 |  |  | \u2014 |  |  | 297.7 |  |  | \u2014 |  |  | 297.7 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 29.3 |  |  | \u2014 |  |  | 29.3 |  |  | \u2014 |  |  | 29.3 |  |  | \nOther noncurrent assets | 77.2 |  |  | \u2014 |  |  | 77.2 |  |  | \u2014 |  |  | 77.2 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 21.7 |  |  | \u2014 |  |  | 21.7 |  |  | \u2014 |  |  | 21.7 |  |  | \nOther noncurrent liabilities | (13.1) |  |  | \u2014 |  |  | (13.1) |  |  | \u2014 |  |  | (13.1) |  |  | \nForeign exchange contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 15.6 |  |  | \u2014 |  |  | 15.6 |  |  | \u2014 |  |  | 15.6 |  |  | \nForeign exchange contracts not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 19.1 |  |  | \u2014 |  |  | 19.1 |  |  | \u2014 |  |  | 19.1 |  |  | \nOther current liabilities | (17.0) |  |  | \u2014 |  |  | (17.0) |  |  | \u2014 |  |  | (17.0) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nContingent consideration liability: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent liabilities | (65.1) |  |  | \u2014 |  |  | \u2014 |  |  | (65.1) |  |  | (65.1) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDecember 31, 2021 |  |  |  |  |  |  |  |  |  |  | \nRisk-management instruments: |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | $ | 4.8 |  |  | $ | \u2014 |  |  | $ | 4.8 |  |  | $ | \u2014 |  |  | $ | 4.8 |  |  | \nOther noncurrent assets | 78.3 |  |  | \u2014 |  |  | 78.3 |  |  | \u2014 |  |  | 78.3 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent liabilities | (7.6) |  |  | \u2014 |  |  | (7.6) |  |  | \u2014 |  |  | (7.6) |  |  | \nInterest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 49.2 |  |  | \u2014 |  |  | 49.2 |  |  | \u2014 |  |  | 49.2 |  |  | \nOther noncurrent liabilities | (31.7) |  |  | \u2014 |  |  | (31.7) |  |  | \u2014 |  |  | (31.7) |  |  | \nCross-currency interest rate contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 31.3 |  |  | \u2014 |  |  | 31.3 |  |  | \u2014 |  |  | 31.3 |  |  | \nOther current liabilities | (1.2) |  |  | \u2014 |  |  | (1.2) |  |  | \u2014 |  |  | (1.2) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 33.2 |  |  | \u2014 |  |  | 33.2 |  |  | \u2014 |  |  | 33.2 |  |  | \nOther noncurrent liabilities | (1.3) |  |  | \u2014 |  |  | (1.3) |  |  | \u2014 |  |  | (1.3) |  |  | \nForeign exchange contracts not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 9.9 |  |  | \u2014 |  |  | 9.9 |  |  | \u2014 |  |  | 9.9 |  |  | \nOther current liabilities | (35.3) |  |  | \u2014 |  |  | (35.3) |  |  | \u2014 |  |  | (35.3) |  |  | \nContingent consideration liabilities: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent liabilities | (70.5) |  |  | \u2014 |  |  | \u2014 |  |  | (70.5) |  |  | (70.5) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Maturities by Period\n | Total |  | Less\u00a0Than1 Year |  | 1-5Years |  | 6-10Years |  | More\u00a0Than10 Years\nFair value of debt securities | $ | 553.4 |  |  | $ | 102.1 |  |  | $ | 170.4 |  |  | $ | 109.0 |  |  | $ | 171.9 |   |  |  |  |  |  |  |  |  |  |  | \n | June 30, 2022 |  | December 31, 2021\nUnrealized gross gains | $ | 0.2 |  |  | $ | 9.7 | \nUnrealized gross losses | 36.9 |  |  | 5.2 | \nFair value of securities in an unrealized gain position | 28.8 |  |  | 250.7 | \nFair value of securities in an unrealized loss position | 489.2 |  |  | 290.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nProceeds from sales | $ | 29.9 |  |  | $ | 44.4 |  |  | $ | 65.1 |  |  | $ | 87.7 | \nRealized gross gains on sales | 0.1 |  |  | 0.7 |  |  | 0.2 |  |  | 1.8 | \nRealized gross losses on sales | 0.7 |  |  | 0.4 |  |  | 1.5 |  |  | 0.8 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Defined Benefit Pension Plans\n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nComponents of net periodic benefit cost: |  |  |  |  |  |  | \nService cost | $ | 88.2 |  |  | $ | 93.3 |  |  | $ | 177.3 |  |  | $ | 185.3 | \nInterest cost | 99.6 |  |  | 84.8 |  |  | 200.1 |  |  | 169.1 | \nExpected return on plan assets | (237.0) |  |  | (237.2) |  |  | (476.5) |  |  | (475.2) | \nAmortization of prior service cost | 0.6 |  |  | 1.1 |  |  | 1.3 |  |  | 2.2 | \nRecognized actuarial loss | 84.5 |  |  | 122.6 |  |  | 171.5 |  |  | 244.4 | \n |  |  |  |  |  |  | \nNet periodic benefit cost | $ | 35.9 |  |  | $ | 64.6 |  |  | $ | 73.7 |  |  | $ | 125.8 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Retiree Health Benefit Plans\n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nComponents of net periodic benefit income: |  |  |  |  |  |  | \nService cost | $ | 12.1 |  |  | $ | 12.9 |  |  | $ | 23.3 |  |  | $ | 24.6 | \nInterest cost | 9.6 |  |  | 8.2 |  |  | 19.0 |  |  | 16.3 | \nExpected return on plan assets | (38.2) |  |  | (36.5) |  |  | (76.1) |  |  | (73.1) | \nAmortization of prior service benefit | (13.7) |  |  | (14.9) |  |  | (27.4) |  |  | (29.8) | \nRecognized actuarial loss | 0.3 |  |  | 0.8 |  |  | 0.5 |  |  | 1.6 | \n |  |  |  |  |  |  | \nNet periodic benefit income | $ | (29.9) |  |  | $ | (29.5) |  |  | $ | (60.7) |  |  | $ | (60.4) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Unrealized Net Gains (Losses) on\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Effective Portion of Cash\u00a0Flow Hedges |  |  |  | Accumulated Other Comprehensive Loss\nBalance at April 1, 2022 | $ | (1,575.2) |  |  | $ | (18.1) |  |  | $ | (2,531.6) |  |  | $ | (100.4) |  |  |  |  | $ | (4,225.3) | \n |  |  |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (269.6) |  |  | (9.3) |  |  | 31.7 |  |  | 124.8 |  |  |  |  | (122.4) | \nNet amount reclassified from accumulated other comprehensive loss | 0.6 |  |  | (0.5) |  |  | 56.7 |  |  | 3.2 |  |  |  |  | 60.0 | \nNet other comprehensive income (loss) | (269.0) |  |  | (9.8) |  |  | 88.4 |  |  | 128.0 |  |  |  |  | (62.4) | \n |  |  |  |  |  |  |  |  |  |  | \nBalance at June 30, 2022 | $ | (1,844.2) |  |  | $ | (27.9) |  |  | $ | (2,443.2) |  |  | $ | 27.6 |  |  |  |  | $ | (4,287.7) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Unrealized Net Gains (Losses) on\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Effective Portion of Cash\u00a0Flow Hedges |  |  |  | Accumulated Other Comprehensive Loss\nBalance at April 1, 2021 | $ | (1,677.2) |  |  | $ | 4.5 |  |  | $ | (4,646.3) |  |  | $ | (76.6) |  |  |  |  | $ | (6,395.6) | \n |  |  |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | 161.0 |  |  | 4.4 |  |  | (10.2) |  |  | (136.8) |  |  |  |  | 18.4 | \nNet amount reclassified from accumulated other comprehensive loss | \u2014 |  |  | 0.2 |  |  | 86.6 |  |  | 3.3 |  |  |  |  | 90.1 | \nNet other comprehensive income (loss) | 161.0 |  |  | 4.6 |  |  | 76.4 |  |  | (133.5) |  |  |  |  | 108.5 | \n |  |  |  |  |  |  |  |  |  |  | \nBalance at June 30, 2021 | $ | (1,516.2) |  |  | $ | 9.1 |  |  | $ | (4,569.9) |  |  | $ | (210.1) |  |  |  |  | $ | (6,287.1) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Unrealized Net Gains (Losses) on\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Effective Portion of Cash\u00a0Flow Hedges |  | Accumulated Other Comprehensive Loss\nBalance at January 1, 2022 | $ | (1,550.2) |  |  | $ | 3.7 |  |  | $ | (2,583.6) |  |  | $ | (213.0) |  |  | $ | (4,343.1) | \n |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (294.6) |  |  | (30.6) |  |  | 25.1 |  |  | 234.2 |  |  | (65.9) | \nNet amount reclassified from accumulated other comprehensive loss | 0.6 |  |  | (1.0) |  |  | 115.3 |  |  | 6.4 |  |  | 121.3 | \nNet other comprehensive income (loss) | (294.0) |  |  | (31.6) |  |  | 140.4 |  |  | 240.6 |  |  | 55.4 | \n |  |  |  |  |  |  |  |  | \nBalance at June 30, 2022 | $ | (1,844.2) |  |  | $ | (27.9) |  |  | $ | (2,443.2) |  |  | $ | 27.6 |  |  | $ | (4,287.7) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Unrealized Net Gains (Losses) on\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Effective Portion of Cash\u00a0Flow Hedges |  | Accumulated Other Comprehensive Loss\nBalance at January 1, 2021 | $ | (1,427.5) |  |  | $ | 14.8 |  |  | $ | (4,751.0) |  |  | $ | (332.7) |  |  | $ | (6,496.4) | \n |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (88.7) |  |  | (6.4) |  |  | 8.6 |  |  | 116.0 |  |  | 29.5 | \nNet amount reclassified from accumulated other comprehensive loss | \u2014 |  |  | 0.7 |  |  | 172.5 |  |  | 6.6 |  |  | 179.8 | \nNet other comprehensive income (loss) | (88.7) |  |  | (5.7) |  |  | 181.1 |  |  | 122.6 |  |  | 209.3 | \n |  |  |  |  |  |  |  |  | \nBalance at June 30, 2021 | $ | (1,516.2) |  |  | $ | 9.1 |  |  | $ | (4,569.9) |  |  | $ | (210.1) |  |  | $ | (6,287.1) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\nTax benefit (expense) | 2022 |  | 2021 |  | 2022 |  | 2021\nForeign currency translation gains/losses | $ | (87.2) |  |  | $ | (21.9) |  |  | $ | (100.9) |  |  | $ | (53.3) | \nUnrealized net gains/losses on securities | 3.0 |  |  | (1.3) |  |  | 9.7 |  |  | 3.1 | \nDefined benefit pension and retiree health benefit plans | (22.4) |  |  | (20.2) |  |  | (50.8) |  |  | (51.5) | \nEffective portion of cash flow hedges | (34.0) |  |  | 35.5 |  |  | (63.9) |  |  | (32.6) | \nBenefit (expense) for income taxes allocated to other comprehensive income (loss) items | $ | (140.6) |  |  | $ | (7.9) |  |  | $ | (205.9) |  |  | $ | (134.3) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nDetails about Accumulated Other Comprehensive Loss Components |  | Three Months Ended June 30, |  | Six Months Ended June 30, | Affected Line Item in the Consolidated Condensed Statements of Operations\n\n | 2022 |  | 2021 |  | 2022 |  | 2021\nAmortization of retirement benefit items: |  |  |  |  |  |  |  |  | \nPrior service benefits, net |  | $ | (13.1) |  |  | $ | (13.8) |  |  | $ | (26.1) |  |  | $ | (27.6) |  | Other\u2013net, (income) expense\nActuarial losses, net |  | 84.8 |  |  | 123.4 |  |  | 172.0 |  |  | 246.0 |  | Other\u2013net, (income) expense\nTotal before tax |  | 71.7 |  |  | 109.6 |  |  | 145.9 |  |  | 218.4 |  | \nTax benefit |  | (15.0) |  |  | (23.0) |  |  | (30.6) |  |  | (45.9) |  | Income taxes\nNet of tax |  | 56.7 |  |  | 86.6 |  |  | 115.3 |  |  | 172.5 |  | \n |  |  |  |  |  |  |  |  | \nOther, net of tax |  | 3.3 |  |  | 3.5 |  |  | 6.0 |  |  | 7.3 |  | Other\u2013net, (income) expense\n |  |  |  |  |  |  |  |  | \nTotal reclassifications, net of tax |  | $ | 60.0 |  |  | $ | 90.1 |  |  | $ | 121.3 |  |  | $ | 179.8 |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nInterest expense | $ | 81.2 |  |  | $ | 86.9 |  |  | $ | 166.1 |  |  | $ | 174.7 | \nInterest income | (10.2) |  |  | (5.4) |  |  | (17.2) |  |  | (10.9) | \nNet investment (gains) losses on equity securities (Note 6) | 118.9 |  |  | (215.4) |  |  | 544.3 |  |  | (517.0) | \nRetirement benefit plans | (94.3) |  |  | (71.1) |  |  | (187.6) |  |  | (144.5) | \n |  |  |  |  |  |  | \nOther (income) expense | 23.6 |  |  | 14.5 |  |  | (35.7) |  |  | (13.9) | \nOther\u2013net, (income) expense | $ | 119.2 |  |  | $ | (190.5) |  |  | $ | 469.9 |  |  | $ | (511.6) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  |  |  | Six Months Ended June 30, |  | \n | 2022 |  | 2021 |  | Percent Change |  | 2022 |  | 2021 |  | Percent Change\nRevenue | $ | 6,488.0 |  |  | $ | 6,740.1 |  |  | (4) |  | $ | 14,298.0 |  |  | $ | 13,545.7 |  |  | 6\nGross margin | 5,057.5 |  |  | 4,786.9 |  |  | 6 |  | 10,795.4 |  |  | 9,713.9 |  |  | 11\nGross margin as a percent of revenue | 78.0 | % |  | 71.0 | % |  |  |  | 75.5 | % |  | 71.7 | % |  | \n |  |  |  |  |  |  |  |  |  |  | \nResearch and development | $ | 1,781.9 |  |  | $ | 1,655.0 |  |  | 8 |  | $ | 3,392.0 |  |  | $ | 3,327.1 |  |  | 2\nMarketing, selling, and administrative | 1,625.1 |  |  | 1,685.7 |  |  | (4) |  | 3,183.0 |  |  | 3,261.7 |  |  | (2)\nAcquired in-process research and development (IPR&D) and development milestones | 440.4 |  |  | 42.8 |  |  | NM |  | 606.0 |  |  | 354.8 |  |  | 71\nAsset impairment, restructuring, and other special charges | \u2014 |  |  | \u2014 |  |  | \u2014 |  | \u2014 |  |  | 211.6 |  |  | NM\nOther\u2013net, (income) expense | 119.2 |  |  | (190.5) |  |  | NM |  | 469.9 |  |  | (511.6) |  |  | NM\n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNet income | 952.5 |  |  | 1,390.2 |  |  | (31) |  | 2,855.4 |  |  | 2,745.5 |  |  | 4\n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nEPS - diluted | 1.05 |  |  | 1.53 |  |  | (31) |  | 3.16 |  |  | 3.01 |  |  | 5  |  |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication | Status | Developments | \nDiabetes | \nTirzepatide (Mounjaro\u00ae) | Type 2 diabetes | Approved | Approved in the U.S. in the second quarter of 2022. Submitted in Europe and Japan in 2021. Received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use in July 2022. | \nHeart failure with preserved ejection fraction | Phase III | Phase III trials are ongoing. | \nObesity | Phase III | Announced in the second quarter of 2022 that the initial Phase III trial met co-primary and all key secondary endpoints. Phase III trials are ongoing. | \nObstructive sleep apnea | Phase III | Phase III trial initiated in July 2022. | \nNonalcoholic steatohepatitis | Phase II | Phase II trial is ongoing. | \nBasal Insulin-Fc | Type 1 and 2 diabetes | Phase III | Phase III trials initiated in the first and second quarters of 2022. | \nGLP-1R NPA | Obesity | Phase II | Phase II trials are ongoing. | \nType 2 diabetes | \nRetatrutide (GGG Tri-Agonist) | Obesity | Phase II | Phase II trials are ongoing. | \nType 2 diabetes | \nImmunology | \nMirikizumab | Ulcerative colitis | Submitted | Submitted in the U.S. in first quarter of 2022 and in Europe and Japan in the second quarter of 2022. | \nCrohn's Disease | Phase III | Phase III trials are ongoing. | \nLebrikizumab(1) | Atopic dermatitis | Phase III | Granted FDA Fast Track designation(2). Announced in 2021 and in the second quarter of 2022 that Phase III trials met primary and all key secondary endpoints. Phase III trials are ongoing. | \nBTLA MAB Agonist | Systemic lupus erythematosus | Phase II | Phase II trial initiated in the second quarter of 2022. | \nCXCR1/2 Ligands Monoclonal Antibody | Hidradenitis suppurativa | Phase II | Phase II trial is ongoing. | \nPeresolimab (PD-1 MAB Agonist) | Rheumatoid arthritis | Phase II | Phase II trial is ongoing. | \nRezpegaldesleukin (IL-2 Conjugate) | Systemic lupus erythematosus | Phase II | Phase II trial is ongoing. | \n |  |  |   |  |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication | Status | Developments | \nNeuroscience | \nDonanemab | Early Alzheimer's disease | Submitted | Granted FDA Breakthrough Therapy designation(3). Submitted in the U.S. in the second quarter of 2022. Received Priority Review designation under the accelerated approval pathway. Phase III trials are ongoing. | \nPreclinical Alzheimer's disease | Phase III | Phase III trial is ongoing. | \nSolanezumab | Preclinical Alzheimer's disease | Phase III | Phase III trial is ongoing. | \nGBA1 Gene Therapy (PR001) | Parkinson's disease | Phase II | Granted FDA Fast Track designation(2). Phase II trials are ongoing. | \nGRN Gene Therapy (PR006) | Frontotemporal dementia | Phase II | \nO-glc-NAcase | Alzheimer's disease | Phase II | Phase II trial is ongoing. | \nPACAP38 Antibody | Migraine | Phase II | Phase II trial is ongoing. | \nSSTR4 Agonist | Pain | Phase II | Phase II trials are ongoing. | \nTRPA1 Antagonist | Pain | Phase II | Phase II trials are ongoing. | \n |  |  |  | \nOncology | \nSelpercatinib (Retevmo\u00ae) | Lung cancer | Approved(4) | Phase III trials are ongoing. | \nThyroid cancer | \nPirtobrutinib (LOXO-305) | Mantle cell lymphoma | Submitted | Submitted in the U.S. in second quarter of 2022. Received Priority Review designation under the accelerated approval pathway. Phase II and Phase III trials are ongoing. | \nChronic lymphocytic leukemia | Phase III | Phase III trials are ongoing. | \nB-cell malignancies | Phase II | Phase II trial is ongoing. | \nImlunestrant | ER+HER2- metastatic breast cancer | Phase III | Phase III trial is ongoing. | \nSintilimab injection(5) | Lung cancer | Not pursuing submission | In the first quarter of 2022 the FDA issued a complete response letter indicating that the FDA did not approve the application in its current form and recommended an additional multiregional clinical study be performed. Lilly does not plan to further pursue submission. |   |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication | Status | Developments\nDiabetes\nEmpagliflozin (Jardiance\u00ae)(1) | Heart failure with preserved ejection fraction | Approved | Approved in the U.S. and Europe in the first quarter of 2022 and in Japan in the second quarter of 2022.\nChronic kidney disease | Phase III | Granted FDA Fast Track designation(2). In the first quarter of 2022 the Independent Data Monitoring Committee recommended stopping the Phase III trial early due to clear positive efficacy.\nImmunology\nBaricitinib (Olumiant\u00ae) | Alopecia areata | Approved | Approved in the U.S., Europe and Japan in the second quarter of 2022.\nCOVID-19 | Approved | Approved in the U.S. in the second quarter of 2022.\nOncology\nAbemaciclib (Verzenio\u00ae) | Prostate cancer | Phase III | Phase III trials are ongoing.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  |  | Six Months Ended June 30, |  | \n | 2022 |  | 2021 |  | Percent Change | 2022 |  | 2021 |  | Percent Change\nU.S. | $ | 3,934.8 |  |  | $ | 3,704.2 |  |  | 6 | $ | 9,109.4 |  |  | $ | 7,645.5 |  |  | 19\nOutside U.S. | 2,553.3 |  |  | 3,035.9 |  |  | (16) | 5,188.7 |  |  | 5,900.2 |  |  | (12)\nRevenue | $ | 6,488.0 |  |  | $ | 6,740.1 |  |  | (4) | $ | 14,298.0 |  |  | $ | 13,545.7 |  |  | 6  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 vs. 2021 |  | 2022 vs. 2021\n | U.S. | Outside U.S. | Consolidated |  | U.S. | Outside U.S. | Consolidated\nVolume | 14 | % | 5 | % | 10 | % |  | 23 | % | 5 | % | 15 | %\nPrice | (8) |  | (14) |  | (11) |  |  | (4) |  | (11) |  | (7) | \nForeign exchange rates | \u2014 |  | (6) |  | (3) |  |  | \u2014 |  | (6) |  | (3) | \nPercent change | 6 | % | (16) | % | (4) | % |  | 19 | % | (12) | % | 6 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  |  | \n | 2022 |  | 2021 | \nProduct | U.S. |  | Outside U.S. |  | Total |  | Total | Percent Change | \nTrulicity | $ | 1,430.1 |  |  | $ | 481.7 |  |  | $ | 1,911.9 |  |  | $ | 1,535.6 |  |  | 25 | \nTaltz | 411.6 |  |  | 194.7 |  |  | 606.2 |  |  | 569.1 |  |  | 7 | \nVerzenio | 384.3 |  |  | 204.2 |  |  | 588.5 |  |  | 341.3 |  |  | 72 | \nJardiance(1) | 250.7 |  |  | 210.3 |  |  | 461.0 |  |  | 356.5 |  |  | 29 | \nHumalog(2) | 238.8 |  |  | 208.3 |  |  | 447.1 |  |  | 607.6 |  |  | (26) | \nHumulin\u00ae | 202.3 |  |  | 71.7 |  |  | 274.0 |  |  | 315.3 |  |  | (13) | \nCyramza\u00ae | 92.6 |  |  | 138.6 |  |  | 231.3 |  |  | 268.7 |  |  | (14) | \nAlimta | 171.7 |  |  | 56.1 |  |  | 227.7 |  |  | 610.6 |  |  | (63) | \nOlumiant(3) | 10.4 |  |  | 175.8 |  |  | 186.2 |  |  | 208.4 |  |  | (11) | \nBasaglar | 95.8 |  |  | 78.4 |  |  | 174.2 |  |  | 210.7 |  |  | (17) | \nEmgality\u00ae | 108.6 |  |  | 48.9 |  |  | 157.5 |  |  | 156.3 |  |  | 1 | \nCialis | 10.8 |  |  | 136.2 |  |  | 147.0 |  |  | 281.0 |  |  | (48) | \nErbitux\u00ae | 125.1 |  |  | 15.7 |  |  | 140.8 |  |  | 147.0 |  |  | (4) | \nForteo | 78.5 |  |  | 60.0 |  |  | 138.5 |  |  | 218.4 |  |  | (37) | \nCOVID-19 antibodies(4) | 129.1 |  |  | \u2014 |  |  | 129.1 |  |  | 148.9 |  |  | (13) | \nZyprexa\u00ae | 8.7 |  |  | 78.6 |  |  | 87.3 |  |  | 95.4 |  |  | (8) | \nCymbalta | 8.1 |  |  | 67.4 |  |  | 75.5 |  |  | 175.6 |  |  | (57) | \nTyvyt | \u2014 |  |  | 73.6 |  |  | 73.6 |  |  | 105.0 |  |  | (30) | \nOther products | 177.6 |  |  | 253.1 |  |  | 430.6 |  |  | 388.7 |  |  | 11 | \nRevenue | $ | 3,934.8 |  |  | $ | 2,553.3 |  |  | $ | 6,488.0 |  |  | $ | 6,740.1 |  |  | (4) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended June 30, |  | \n | 2022 |  | 2021\nProduct | U.S. |  | Outside U.S. |  | Total |  | Total | Percent Change\nTrulicity | $ | 2,744.1 |  |  | $ | 909.1 |  |  | $ | 3,653.2 |  |  | $ | 2,988.1 |  |  | 22\nCOVID-19 antibodies(1) | 1,584.3 |  |  | 14.7 |  |  | 1,598.9 |  |  | 959.1 |  |  | 67\nTaltz | 718.8 |  |  | 375.5 |  |  | 1,094.3 |  |  | 972.4 |  |  | 13\nHumalog(2) | 607.7 |  |  | 457.6 |  |  | 1,065.3 |  |  | 1,224.6 |  |  | (13)\nVerzenio | 685.7 |  |  | 372.1 |  |  | 1,057.9 |  |  | 610.3 |  |  | 73\nJardiance(3) | 480.4 |  |  | 400.0 |  |  | 880.4 |  |  | 668.5 |  |  | 32\nAlimta | 425.9 |  |  | 145.8 |  |  | 571.7 |  |  | 1,169.6 |  |  | (51)\nHumulin | 392.8 |  |  | 154.5 |  |  | 547.2 |  |  | 637.0 |  |  | (14)\nCyramza | 171.8 |  |  | 289.7 |  |  | 461.5 |  |  | 509.2 |  |  | (9)\nOlumiant(4) | 81.7 |  |  | 360.1 |  |  | 441.8 |  |  | 402.2 |  |  | 10\nBasaglar | 215.1 |  |  | 150.6 |  |  | 365.7 |  |  | 457.3 |  |  | (20)\nCialis | 17.7 |  |  | 347.0 |  |  | 364.7 |  |  | 407.8 |  |  | (11)\nEmgality | 216.9 |  |  | 89.8 |  |  | 306.7 |  |  | 275.7 |  |  | 11\nForteo | 148.7 |  |  | 127.2 |  |  | 275.9 |  |  | 416.9 |  |  | (34)\nErbitux | 234.7 |  |  | 28.7 |  |  | 263.4 |  |  | 269.4 |  |  | (2)\nZyprexa | 18.3 |  |  | 162.1 |  |  | 180.4 |  |  | 191.1 |  |  | (6)\nTyvyt | \u2014 |  |  | 159.0 |  |  | 159.0 |  |  | 214.6 |  |  | (26)\nCymbalta | 17.2 |  |  | 139.4 |  |  | 156.6 |  |  | 352.3 |  |  | (56)\nOther products | 347.6 |  |  | 505.8 |  |  | 853.4 |  |  | 819.6 |  |  | 4\nRevenue | $ | 9,109.4 |  |  | $ | 5,188.7 |  |  | $ | 14,298.0 |  |  | $ | 13,545.7 |  |  | 6  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number ofShares Purchased(in thousands) |  | Average\u00a0Price Paidper Share |  | Total\u00a0Number of SharesPurchased\u00a0as Part ofPublicly AnnouncedPlans or Programs(in thousands) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(in millions)\nApril 2022 | \u2014 |  |  | $ | \u2014 |  |  | \u2014 |  |  | $ | 3,250.0 | \nMay 2022 | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3,250.0 | \nJune 2022 | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3,250.0 | \nTotal | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |   |  |  |  |  |  |  |  | \nExhibit |  | Description\nEXHIBIT 3.1 |  | Amended Articles of Incorporation are incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on May 4, 2022\n |  | \nEXHIBIT 3.2 |  | Bylaws, as amended, are incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed on May 4, 2022\n |  | \nEXHIBIT\u00a031.1 |  | Rule\u00a013a-14(a) Certification of David A. Ricks, Chair, President, and Chief Executive Officer\n |  | \nEXHIBIT 31.2 |  | Rule\u00a013a-14(a) Certification of Anat Ashkenazi, Senior Vice President and Chief Financial Officer\n | \nEXHIBIT 32. |  | Section 1350 Certification\n |  | \nEXHIBIT 101. |  | Interactive Data Files (embedded within the Inline XBRL document)\n |  | \nEXHIBIT 104. |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)  |  |  |  |  |  |  |  | \n |  | ELI LILLY AND COMPANY\n |  | (Registrant)\n |  | \nDate: | August 4, 2022 | /s/ Anat Ashkenazi\n |  | Anat Ashkenazi\n |  | Senior Vice President and Chief Financial Officer\nDate: | August 4, 2022 | /s/ Donald A. Zakrowski\n |  | Donald A. Zakrowski\n |  | Vice President, Finance, and Chief Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Eli Lilly, in 2022 Q3, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  |  |  |  | \nIndiana |  | 35-0470950\n(State or other jurisdiction of |  | (I.R.S. Employer\nincorporation or organization) |  | Identification No.)  |  |  |  |  |  |  |  | \nTitle of Each Class | Trading Symbols | Name of Each Exchange On Which Registered\nCommon Stock (no par value) | LLY | New York Stock Exchange\n7 1/8% Notes due 2025 | LLY25 | New York Stock Exchange\n1.625% Notes due 2026 | LLY26 | New York Stock Exchange\n2.125% Notes due 2030 | LLY30 | New York Stock Exchange\n0.625% Notes due 2031 | LLY31 | New York Stock Exchange\n0.500% Notes due 2033 | LLY33 | New York Stock Exchange\n6.77%\u00a0Notes due 2036 | LLY36 | New York Stock Exchange\n1.625% Notes due 2043 | LLY43 | New York Stock Exchange\n1.700% Notes due 2049 | LLY49A | New York Stock Exchange\n1.125% Notes due 2051 | LLY51 | New York Stock Exchange\n1.375% Notes due 2061 | LLY61 | New York Stock Exchange  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 |  |  |  |  | Accelerated\u00a0filer | \u2610\nNon-accelerated filer | \u2610 |  |  | Smaller reporting company | \u2610\n |  |  |  |  |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \nClass |  | Number of Shares Outstanding\nCommon |  | 950,177,900 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | Page\nPART I. Financial Information |  |  |  | 5\n |  |  |  | \nItem 1. |  | Financial Statements |  | 5\n |  | Consolidated Condensed Statements of Operations |  | 5\n |  | Consolidated Condensed Statements of Comprehensive Income |  | 6\n |  | Consolidated Condensed Balance Sheets |  | 7\n |  | Consolidated Condensed Statements of Equity |  | 8\n |  | Consolidated Condensed Statements of Cash Flows |  | 10\n |  | Notes to Consolidated Condensed Financial Statements |  | 11\nItem 2. |  | Management's Discussion and Analysis of Results of Operations and Financial Condition |  | 37\n |  | Executive Overview |  | 37\n |  | Revenue |  | 45\n |  | Gross Margin, Costs, and Expenses |  | 49\n |  | Financial Condition and Liquidity |  | 50\n |  |  |  | \n |  | Critical Accounting Estimates |  | 51\n |  | Available Information on our Website |  | 51\nItem 4. |  | Controls and Procedures |  | 52\n |  |  |  | \nPART II. Other Information |  |  |  | 53\n |  |  |  | \nItem 1. |  | Legal Proceedings |  | 53\nItem 1A. |  | Risk Factors |  | 53\nItem 2. |  | Unregistered Sales of Equity Securities and Use of Proceeds |  | 53\nItem 6. |  | Exhibits |  | 54\n |  |  |  | \nSignatures |  |  |  | 54  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nRevenue (Note 2) | $ | 6,941.6 |  |  | $ | 6,772.8 |  |  | $ | 21,239.6 |  |  | $ | 20,318.5 | \nCosts, expenses, and other: |  |  |  |  |  |  | \nCost of sales | 1,579.1 |  |  | 1,430.8 |  |  | 5,081.7 |  |  | 5,262.6 | \nResearch and development | 1,802.9 |  |  | 1,705.3 |  |  | 5,194.9 |  |  | 5,032.4 | \nMarketing, selling, and administrative | 1,614.2 |  |  | 1,577.9 |  |  | 4,797.2 |  |  | 4,839.6 | \nAcquired in-process research and development and development milestones (Note 3) | 62.4 |  |  | 177.6 |  |  | 668.4 |  |  | 532.4 | \nAsset impairment, restructuring, and other special charges (Note 5) | 206.5 |  |  | \u2014 |  |  | 206.5 |  |  | 211.6 | \nOther\u2013net, (income) expense (Note 11) | 111.0 |  |  | 635.9 |  |  | 580.9 |  |  | 124.3 | \n | 5,376.1 |  |  | 5,527.5 |  |  | 16,529.6 |  |  | 16,002.9 | \nIncome before income taxes | 1,565.5 |  |  | 1,245.3 |  |  | 4,710.0 |  |  | 4,315.6 | \nIncome taxes (Note 7) | 113.8 |  |  | 135.2 |  |  | 402.9 |  |  | 460.0 | \nNet income | $ | 1,451.7 |  |  | $ | 1,110.1 |  |  | $ | 4,307.1 |  |  | $ | 3,855.6 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nEarnings per share: |  |  |  |  |  |  | \nBasic | $ | 1.61 |  |  | $ | 1.22 |  |  | $ | 4.78 |  |  | $ | 4.25 | \n |  |  |  |  |  |  | \nDiluted | $ | 1.61 |  |  | $ | 1.22 |  |  | $ | 4.76 |  |  | $ | 4.23 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nShares used in calculation of earnings per share: |  |  |  |  |  |  | \nBasic | 900.7 |  | 906.7 |  | 901.8 |  | 907.7\nDiluted | 903.8 |  | 910.8 |  | 904.5 |  | 911.7  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nNet income | $ | 1,451.7 |  |  | $ | 1,110.1 |  |  | $ | 4,307.1 |  |  | $ | 3,855.6 | \nOther comprehensive income (loss), net of tax (Note 10) | (8.1) |  |  | 114.4 |  |  | 47.3 |  |  | 323.7 | \nComprehensive income | $ | 1,443.6 |  |  | $ | 1,224.5 |  |  | $ | 4,354.4 |  |  | $ | 4,179.3 |   |  |  |  |  |  |  |  |  |  |  | \n | September 30, 2022 |  | December 31, 2021\nAssets | (Unaudited) |  | \nCurrent Assets |  |  | \nCash and cash equivalents (Note 6) | $ | 2,617.4 |  |  | $ | 3,818.5 | \nShort-term investments (Note 6) | 124.7 |  |  | 90.1 | \nAccounts receivable, net of allowances of$17.7(2022)and $22.5(2021) | 6,715.3 |  |  | 6,672.8 | \nOther receivables | 1,609.5 |  |  | 1,454.4 | \nInventories | 3,831.1 |  |  | 3,886.0 | \nPrepaid expenses and other | 2,741.9 |  |  | 2,530.6 | \nTotal current assets | 17,639.9 |  |  | 18,452.4 | \nInvestments (Note 6) | 2,574.6 |  |  | 3,212.6 | \nGoodwill | 3,891.6 |  |  | 3,892.0 | \nOther intangibles, net | 7,124.1 |  |  | 7,691.9 | \nDeferred tax assets | 2,384.3 |  |  | 2,489.3 | \nProperty and equipment, net of accumulated depreciation of$10,074.0(2022)and $9,976.7(2021) | 9,311.3 |  |  | 8,985.1 | \nOther noncurrent assets | 4,535.7 |  |  | 4,082.7 | \nTotal assets | $ | 47,461.5 |  |  | $ | 48,806.0 | \nLiabilities and Equity |  |  | \nCurrent Liabilities |  |  | \nShort-term borrowings and current maturities of long-term debt | $ | 1,744.6 |  |  | $ | 1,538.3 | \nAccounts payable | 1,683.2 |  |  | 1,670.6 | \nEmployee compensation | 984.1 |  |  | 958.1 | \nSales rebates and discounts | 8,568.4 |  |  | 6,845.8 | \nDividends payable | \u2014 |  |  | 885.5 | \nIncome taxes payable | 685.6 |  |  | 126.9 | \nOther current liabilities | 1,986.9 |  |  | 3,027.5 | \nTotal current liabilities | 15,652.8 |  |  | 15,052.7 | \nOther Liabilities |  |  | \nLong-term debt | 14,143.8 |  |  | 15,346.4 | \nAccrued retirement benefits (Note 8) | 1,832.5 |  |  | 1,954.1 | \nLong-term income taxes payable | 3,641.7 |  |  | 3,920.0 | \nDeferred tax liabilities | 171.9 |  |  | 1,733.7 | \nOther noncurrent liabilities | 1,852.9 |  |  | 1,644.3 | \nTotal other liabilities | 21,642.8 |  |  | 24,598.5 | \nCommitments and Contingencies (Note 9) |  |  | \nEli Lilly and Company Shareholders' Equity |  |  | \nCommon stock | 594.1 |  |  | 596.3 | \nAdditional paid-in capital | 6,829.0 |  |  | 6,833.4 | \nRetained earnings | 10,006.5 |  |  | 8,958.5 | \nEmployee benefit trust | (3,013.2) |  |  | (3,013.2) | \nAccumulated other comprehensive loss (Note 10) | (4,295.8) |  |  | (4,343.1) | \nCost of common stock in treasury | (50.5) |  |  | (52.7) | \nTotal Eli Lilly and Company shareholders' equity | 10,070.1 |  |  | 8,979.2 | \nNoncontrolling interests | 95.8 |  |  | 175.6 | \nTotal equity | 10,165.9 |  |  | 9,154.8 | \nTotal liabilities and equity | $ | 47,461.5 |  |  | $ | 48,806.0 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Equity of Eli Lilly and Company Shareholders |  | \n(Dollars in millions, except per-share data, and shares in thousands) | Common Stock |  | AdditionalPaid-inCapital |  | RetainedEarnings |  | Employee Benefit Trust |  | Accumulated Other Comprehensive Loss |  | Common Stock in Treasury(1) |  | Noncontrolling Interests\nShares |  | Amount | Shares |  | Amount\nBalance at July 1, 2021 | 957,038 |  |  | $ | 598.1 |  |  | $ | 6,669.2 |  |  | $ | 8,530.1 |  |  | $ | (3,013.2) |  |  | $ | (6,287.1) |  |  | 463 |  |  | $ | (52.7) |  |  | $ | 219.1 | \nNet income (loss) |  |  |  |  |  |  | 1,110.1 |  |  |  |  |  |  |  |  |  |  | (22.6) | \nOther comprehensive income, net of tax |  |  |  |  |  |  |  |  |  |  | 114.4 |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIssuance of stock under employee stock plans, net | 14 |  |  | 0.1 |  |  | (1.3) |  |  |  |  |  |  |  |  |  |  |  |  | \nStock-based compensation |  |  |  |  | 90.1 |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  | (0.8) |  |  |  |  |  |  |  |  |  |  | 0.6 | \nBalance at September\u00a030, 2021 | 957,052 |  |  | $ | 598.2 |  |  | $ | 6,758.0 |  |  | $ | 9,639.4 |  |  | $ | (3,013.2) |  |  | $ | (6,172.7) |  |  | 463 |  |  | $ | (52.7) |  |  | $ | 197.1 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance at July 1, 2022 | 950,619 |  |  | $ | 594.1 |  |  | $ | 6,746.0 |  |  | $ | 8,556.0 |  |  | $ | (3,013.2) |  |  | $ | (4,287.7) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 114.5 | \nNet income (loss) |  |  |  |  |  |  | 1,451.7 |  |  |  |  |  |  |  |  |  |  | (15.7) | \nOther comprehensive loss, net of tax |  |  |  |  |  |  |  |  |  |  | (8.1) |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIssuance of stock under employee stock plans, net | 8 |  |  |  |  | (2.1) |  |  |  |  |  |  |  |  |  |  |  |  | \nStock-based compensation |  |  |  |  | 85.1 |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  | (1.2) |  |  |  |  |  |  |  |  |  |  | (3.0) | \nBalance at September\u00a030, 2022 | 950,627 |  |  | $ | 594.1 |  |  | $ | 6,829.0 |  |  | $ | 10,006.5 |  |  | $ | (3,013.2) |  |  | $ | (4,295.8) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 95.8 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Equity of Eli Lilly and Company Shareholders |  | \n(Dollars in millions, except per-share data, and shares in thousands) | Common Stock |  | AdditionalPaid-inCapital |  | RetainedEarnings |  | Employee Benefit Trust |  | Accumulated Other Comprehensive Loss |  | Common Stock in Treasury(1) |  | Noncontrolling Interests\nShares |  | Amount | Shares |  | Amount\nBalance at January 1, 2021 | 957,077 |  |  | $ | 598.2 |  |  | $ | 6,778.5 |  |  | $ | 7,830.2 |  |  | $ | (3,013.2) |  |  | $ | (6,496.4) |  |  | 487 |  |  | $ | (55.7) |  |  | $ | 183.6 | \nNet income |  |  |  |  |  |  | 3,855.6 |  |  |  |  |  |  |  |  |  |  | 25.2 | \nOther comprehensive income, net of tax |  |  |  |  |  |  |  |  |  |  | 323.7 |  |  |  |  |  |  | \nCash dividends declared per share: $1.70 |  |  |  |  |  |  | (1,542.9) |  |  |  |  |  |  |  |  |  |  | \nRetirement of treasury shares | (2,467) |  |  | (1.5) |  |  |  |  | (498.5) |  |  |  |  |  |  | (2,467) |  |  | 500.0 |  |  | \nPurchase of treasury shares |  |  |  |  |  |  |  |  |  |  |  |  | 2,467 |  |  | (500.0) |  |  | \nIssuance of stock under employee stock plans, net | 2,442 |  |  | 1.5 |  |  | (287.1) |  |  |  |  |  |  |  |  | (24) |  |  | 3.0 |  |  | \nStock-based compensation |  |  |  |  | 267.5 |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  | (0.9) |  |  | (5.0) |  |  |  |  |  |  |  |  |  |  | (11.7) | \nBalance at September\u00a030, 2021 | 957,052 |  |  | $ | 598.2 |  |  | $ | 6,758.0 |  |  | $ | 9,639.4 |  |  | $ | (3,013.2) |  |  | $ | (6,172.7) |  |  | 463 |  |  | $ | (52.7) |  |  | $ | 197.1 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance at January 1, 2022 | 954,116 |  |  | $ | 596.3 |  |  | $ | 6,833.4 |  |  | $ | 8,958.5 |  |  | $ | (3,013.2) |  |  | $ | (4,343.1) |  |  | 463 |  |  | $ | (52.7) |  |  | $ | 175.6 | \nNet income (loss) |  |  |  |  |  |  | 4,307.1 |  |  |  |  |  |  |  |  |  |  | (63.7) | \nOther comprehensive income, net of tax |  |  |  |  |  |  |  |  |  |  | 47.3 |  |  |  |  |  |  | \nCash dividends declared per share: $1.96 |  |  |  |  |  |  | (1,765.9) |  |  |  |  |  |  |  |  |  |  | \nRetirement of treasury shares | (5,607) |  |  | (3.5) |  |  |  |  | (1,496.5) |  |  |  |  |  |  | (5,607) |  |  | 1,500.0 |  |  | \nPurchase of treasury shares |  |  |  |  |  |  |  |  |  |  |  |  | 5,607 |  |  | (1,500.0) |  |  | \nIssuance of stock under employee stock plans, net | 2,118 |  |  | 1.3 |  |  | (282.6) |  |  |  |  |  |  |  |  | (13) |  |  | 2.2 |  |  | \nStock-based compensation |  |  |  |  | 278.2 |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  | 3.3 |  |  |  |  |  |  |  |  |  |  | (16.1) | \nBalance at September\u00a030, 2022 | 950,627 |  |  | $ | 594.1 |  |  | $ | 6,829.0 |  |  | $ | 10,006.5 |  |  | $ | (3,013.2) |  |  | $ | (4,295.8) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 95.8 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended September 30,\n | 2022 |  | 2021\nCash Flows from Operating Activities | \nNet income | $ | 4,307.1 |  |  | $ | 3,855.6 | \nAdjustments to Reconcile Net Income to Cash Flows from Operating Activities: |  |  | \n |  |  | \nDepreciation and amortization | 1,147.5 |  |  | 1,101.9 | \nChange in deferred income taxes | (2,195.6) |  |  | (709.8) | \nDebt extinguishment loss (Note 6) | \u2014 |  |  | 405.2 | \nStock-based compensation expense | 278.2 |  |  | 267.5 | \n |  |  | \nNet investment (gains) losses | 676.4 |  |  | (271.1) | \nAcquired in-process research and development | 252.0 |  |  | 498.3 | \nOther changes in operating assets and liabilities, net of acquisitions and divestitures | 821.5 |  |  | (548.1) | \nOther non-cash operating activities, net | 217.6 |  |  | 504.7 | \nNet Cash Provided by Operating Activities | 5,504.7 |  |  | 5,104.2 | \nCash Flows from Investing Activities |  |  | \nNet purchases of property and equipment | (1,353.6) |  |  | (1,018.4) | \nProceeds from sales and maturities of short-term investments | 83.1 |  |  | 46.6 | \nPurchases of short-term investments | (65.0) |  |  | (27.9) | \nProceeds from sales of noncurrent investments | 251.6 |  |  | 537.2 | \nPurchases of noncurrent investments | (474.1) |  |  | (710.1) | \nCash paid for acquisitions, net of cash acquired (Note 3) | \u2014 |  |  | (747.4) | \n |  |  | \nPurchases of in-process research and development | (574.8) |  |  | (460.6) | \nOther investing activities, net | (268.3) |  |  | (2.7) | \nNet Cash Used for Investing Activities | (2,401.1) |  |  | (2,383.3) | \nCash Flows from Financing Activities |  |  | \nDividends paid | (2,651.4) |  |  | (2,313.5) | \nNet change in short-term borrowings | 1,741.3 |  |  | (1.5) | \nProceeds from issuance of long-term debt | \u2014 |  |  | 2,410.8 | \nRepayments of long-term debt | (1,560.0) |  |  | (1,905.3) | \nPurchases of common stock | (1,500.0) |  |  | (500.0) | \n |  |  | \nOther financing activities, net | (295.2) |  |  | (295.3) | \nNet Cash Used for Financing Activities | (4,265.3) |  |  | (2,604.8) | \nEffect of exchange rate changes on cash and cash equivalents | (39.4) |  |  | 15.0 | \n |  |  | \nNet decrease in cash and cash equivalents | (1,201.1) |  |  | 131.1 | \nCash and cash equivalents at January\u00a01 | 3,818.5 |  |  | 3,657.1 | \nCash and Cash Equivalents at September 30 | $ | 2,617.4 |  |  | $ | 3,788.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nNet product revenue | $ | 6,119.2 |  |  | $ | 6,189.0 |  |  | $ | 19,123.0 |  |  | $ | 18,579.5 | \nCollaboration and other revenue(1) | 822.4 |  |  | 583.8 |  |  | 2,116.6 |  |  | 1,739.0 | \nRevenue | $ | 6,941.6 |  |  | $ | 6,772.8 |  |  | $ | 21,239.6 |  |  | $ | 20,318.5 |   |  |  |  |  |  |  |  |  |  |  | \n | September 30, 2022 |  | December 31, 2021\nContract liabilities | $ | 232.5 |  |  | $ | 262.6 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30,\n | 2022 |  | 2021\n | U.S. | Outside U.S. | Total |  | U.S. | Outside U.S. | Total\nRevenue\u2014to unaffiliated customers: |  |  |  |  |  |  | \nDiabetes: |  |  |  |  |  |  | \nTrulicity\u00ae | $ | 1,418.3 |  | $ | 432.0 |  | $ | 1,850.4 |  |  | $ | 1,201.4 |  | $ | 398.8 |  | $ | 1,600.1 | \nJardiance(1) | 350.9 |  | 222.4 |  | 573.3 |  |  | 221.2 |  | 169.2 |  | 390.4 | \nHumalog\u00ae (2) | 248.1 |  | 198.8 |  | 447.0 |  |  | 347.3 |  | 279.4 |  | 626.7 | \nHumulin\u00ae | 169.5 |  | 68.7 |  | 238.2 |  |  | 193.4 |  | 93.4 |  | 286.7 | \nBasaglar\u00ae | 124.8 |  | 68.1 |  | 193.0 |  |  | 114.7 |  | 78.1 |  | 192.8 | \nMounjaro\u00ae | 97.3 |  | 90.0 |  | 187.3 |  |  | \u2014 |  | \u2014 |  | \u2014 | \nOther diabetes | 79.7 |  | 94.0 |  | 173.4 |  |  | 65.0 |  | 112.2 |  | 177.4 | \nTotal diabetes | 2,488.6 |  | 1,174.0 |  | 3,662.6 |  |  | 2,143.0 |  | 1,131.1 |  | 3,274.1 | \n |  |  |  |  |  |  | \nOncology: |  |  |  |  |  |  | \nVerzenio\u00ae | 414.8 |  | 202.9 |  | 617.7 |  |  | 199.6 |  | 135.9 |  | 335.5 | \nCyramza\u00ae | 87.5 |  | 144.6 |  | 232.1 |  |  | 84.8 |  | 168.6 |  | 253.4 | \nErbitux\u00ae | 126.3 |  | 18.7 |  | 144.9 |  |  | 114.0 |  | 20.3 |  | 134.3 | \nAlimta\u00ae | 64.6 |  | 54.8 |  | 119.4 |  |  | 297.2 |  | 159.8 |  | 457.0 | \nTyvyt\u00ae | \u2014 |  | 76.8 |  | 76.8 |  |  | \u2014 |  | 125.6 |  | 125.6 | \nOther oncology | 39.5 |  | 62.8 |  | 102.4 |  |  | 35.3 |  | 65.1 |  | 100.3 | \nTotal oncology | 732.7 |  | 560.6 |  | 1,293.3 |  |  | 730.9 |  | 675.3 |  | 1,406.1 | \n |  |  |  |  |  |  | \nImmunology: |  |  |  |  |  |  | \nTaltz\u00ae | 493.8 |  | 186.1 |  | 679.9 |  |  | 422.2 |  | 170.9 |  | 593.1 | \nOlumiant\u00ae (3) | 22.9 |  | 160.0 |  | 182.9 |  |  | 194.0 |  | 212.9 |  | 406.9 | \nOther immunology | \u2014 |  | 3.6 |  | 3.6 |  |  | \u2014 |  | 4.9 |  | 4.9 | \nTotal immunology | 516.7 |  | 349.7 |  | 866.4 |  |  | 616.2 |  | 388.7 |  | 1,004.9 | \n |  |  |  |  |  |  | \nNeuroscience: |  |  |  |  |  |  | \nEmgality\u00ae | 114.0 |  | 54.6 |  | 168.5 |  |  | 99.9 |  | 40.1 |  | 140.0 | \nZyprexa\u00ae | 8.0 |  | 73.4 |  | 81.4 |  |  | 13.0 |  | 88.7 |  | 101.7 | \nCymbalta\u00ae | 7.8 |  | 54.9 |  | 62.7 |  |  | 7.0 |  | 125.1 |  | 132.0 | \n |  |  |  |  |  |  | \nOther neuroscience | 16.0 |  | 44.5 |  | 60.6 |  |  | 24.7 |  | 51.6 |  | 76.5 | \nTotal neuroscience | 145.8 |  | 227.4 |  | 373.2 |  |  | 144.6 |  | 305.5 |  | 450.2 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nOther: |  |  |  |  |  |  | \nCOVID-19 antibodies(4) | 386.6 |  | \u2014 |  | 386.6 |  |  | 215.5 |  | 1.6 |  | 217.1 | \nForteo\u00ae | 112.7 |  | 64.4 |  | 177.1 |  |  | 109.6 |  | 91.3 |  | 200.9 | \nCialis\u00ae | 8.1 |  | 107.7 |  | 115.7 |  |  | (6.5) |  | 137.4 |  | 130.9 | \nOther | 30.9 |  | 35.7 |  | 66.6 |  |  | 36.3 |  | 52.4 |  | 88.8 | \nTotal other | 538.3 |  | 207.8 |  | 746.0 |  |  | 354.9 |  | 282.7 |  | 637.7 | \nRevenue | $ | 4,422.1 |  | $ | 2,519.4 |  | $ | 6,941.6 |  |  | $ | 3,989.6 |  | $ | 2,783.3 |  | $ | 6,772.8 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended September 30,\n | 2022 |  | 2021\n | U.S. | Outside U.S. | Total |  | U.S. | Outside U.S. | Total\nRevenue\u2014to unaffiliated customers: |  |  |  |  |  |  | \nDiabetes: |  |  |  |  |  |  | \nTrulicity | $ | 4,162.4 |  | $ | 1,341.1 |  | $ | 5,503.5 |  |  | $ | 3,465.7 |  | $ | 1,122.5 |  | $ | 4,588.2 | \nHumalog(1) | 855.8 |  | 656.4 |  | 1,512.3 |  |  | 1,009.0 |  | 842.3 |  | 1,851.3 | \nJardiance(2) | 831.4 |  | 622.4 |  | 1,453.7 |  |  | 566.8 |  | 492.1 |  | 1,058.9 | \nHumulin | 562.3 |  | 223.1 |  | 785.4 |  |  | 633.5 |  | 290.3 |  | 923.8 | \nBasaglar | 339.9 |  | 218.8 |  | 558.7 |  |  | 423.3 |  | 226.8 |  | 650.1 | \nMounjaro | 109.9 |  | 93.3 |  | 203.2 |  |  | \u2014 |  | \u2014 |  | \u2014 | \nOther diabetes | 195.6 |  | 276.5 |  | 472.2 |  |  | 185.7 |  | 302.6 |  | 488.3 | \nTotal diabetes | 7,057.3 |  | 3,431.6 |  | 10,489.0 |  |  | 6,284.0 |  | 3,276.6 |  | 9,560.6 | \n |  |  |  |  |  |  | \nOncology: |  |  |  |  |  |  | \nVerzenio | 1,100.5 |  | 575.1 |  | 1,675.6 |  |  | 582.1 |  | 363.7 |  | 945.8 | \nCyramza | 259.3 |  | 434.3 |  | 693.6 |  |  | 266.3 |  | 496.3 |  | 762.5 | \nAlimta | 490.5 |  | 200.5 |  | 691.1 |  |  | 911.9 |  | 714.7 |  | 1,626.6 | \nErbitux | 361.0 |  | 47.4 |  | 408.3 |  |  | 357.7 |  | 45.9 |  | 403.7 | \nTyvyt | \u2014 |  | 235.8 |  | 235.8 |  |  | \u2014 |  | 340.2 |  | 340.2 | \nOther oncology | 124.1 |  | 186.5 |  | 310.6 |  |  | 83.7 |  | 169.9 |  | 253.6 | \nTotal oncology | 2,335.4 |  | 1,679.6 |  | 4,015.0 |  |  | 2,201.7 |  | 2,130.7 |  | 4,332.4 | \n |  |  |  |  |  |  | \nImmunology: |  |  |  |  |  |  | \nTaltz | 1,212.6 |  | 561.6 |  | 1,774.2 |  |  | 1,071.6 |  | 493.8 |  | 1,565.4 | \nOlumiant(3) | 104.6 |  | 520.1 |  | 624.7 |  |  | 236.5 |  | 572.6 |  | 809.1 | \nOther immunology | 0.1 |  | 12.1 |  | 12.1 |  |  | 15.2 |  | 14.5 |  | 29.7 | \nTotal immunology | 1,317.3 |  | 1,093.8 |  | 2,411.0 |  |  | 1,323.3 |  | 1,080.9 |  | 2,404.2 | \n |  |  |  |  |  |  | \nNeuroscience: |  |  |  |  |  |  | \nEmgality | 330.8 |  | 144.4 |  | 475.2 |  |  | 313.5 |  | 102.2 |  | 415.7 | \nZyprexa | 26.2 |  | 235.5 |  | 261.7 |  |  | 28.3 |  | 264.5 |  | 292.8 | \nCymbalta | 25.0 |  | 194.3 |  | 219.3 |  |  | 30.3 |  | 454.0 |  | 484.3 | \n |  |  |  |  |  |  | \nOther neuroscience | 62.0 |  | 142.7 |  | 204.7 |  |  | 81.0 |  | 154.0 |  | 235.0 | \nTotal neuroscience | 444.0 |  | 716.9 |  | 1,160.9 |  |  | 453.1 |  | 974.7 |  | 1,427.8 | \n |  |  |  |  |  |  | \nOther: |  |  |  |  |  |  | \nCOVID-19 antibodies(4) | 1,970.9 |  | 14.7 |  | 1,985.5 |  |  | 949.5 |  | 226.7 |  | 1,176.2 | \nCialis | 25.8 |  | 454.7 |  | 480.4 |  |  | (3.1) |  | 541.8 |  | 538.7 | \nForteo | 261.4 |  | 191.7 |  | 453.0 |  |  | 330.1 |  | 287.7 |  | 617.8 | \nOther | 119.4 |  | 125.1 |  | 244.8 |  |  | 96.5 |  | 164.3 |  | 260.8 | \nTotal other | 2,377.5 |  | 786.2 |  | 3,163.7 |  |  | 1,373.0 |  | 1,220.5 |  | 2,593.5 | \nRevenue | $ | 13,531.5 |  | $ | 7,708.1 |  | $ | 21,239.6 |  |  | $ | 11,635.1 |  | $ | 8,683.4 |  | $ | 20,318.5 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nRevenue\u2014to unaffiliated customers(1): |  |  |  |  |  |  | \nU.S. | $ | 4,422.1 |  |  | $ | 3,989.6 |  |  | $ | 13,531.5 |  |  | $ | 11,635.1 | \nEurope | 1,056.4 |  |  | 1,098.6 |  |  | 3,224.8 |  |  | 3,629.6 | \nJapan | 487.7 |  |  | 595.0 |  |  | 1,352.3 |  |  | 1,832.2 | \nChina | 343.4 |  |  | 400.3 |  |  | 1,102.0 |  |  | 1,285.0 | \nOther foreign countries | 632.0 |  |  | 689.4 |  |  | 2,029.1 |  |  | 1,936.7 | \nRevenue | $ | 6,941.6 |  |  | $ | 6,772.8 |  |  | $ | 21,239.6 |  |  | $ | 20,318.5 |   |  |  |  |  | \nEstimated Fair Value at January 22, 2021 | \nCash | $ | 90.5 | \nAcquired IPR&D(1) | 824.0\nGoodwill(2) | 126.8\nDeferred tax liabilities | (106.0) | \nOther assets and liabilities, net | (31.5) | \nAcquisition date fair value of consideration transferred | 903.8\nLess: | \nCash acquired | (90.5) | \nFair value of CVR liability(3) | (65.9) | \nCash paid, net of cash acquired | $ | 747.4 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCounterparty | Compound(s), Therapy or Asset | Acquisition Month |  | Phase of Development(1) |  | Acquired IPR&D Expense\nBioMarin Pharmaceutical Inc. | Priority Review Voucher | February 2022 |  | Not applicable |  | $ | 110.0 | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \nRigel Pharmaceuticals, Inc. | R552, a receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor, for the potential treatment of autoimmune and inflammatory diseases | March 2021 |  | Phase I |  | 125.0 | \nPrecision Biosciences, Inc. | Potential in vivo therapies for genetic disorders | January 2021 |  | Pre-clinical |  | 107.8 | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  |   |  |  |  |  |  |  |  | \n | Net Milestones Capitalized (Deferred)(1)\n | September 30, 2022 | December 31, 2021\nJardiance | $ | 121.2 |  | $ | 136.1 | \nTrajenta | 69.6 |  | 88.5 | \nBasaglar | (135.3) |  | (149.3) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nJardiance | $ | 573.3 |  |  | $ | 390.4 |  |  | $ | 1,453.7 |  |  | $ | 1,058.9 | \nBasaglar | 193.0 |  |  | 192.8 |  |  | 558.7 |  |  | 650.1 | \nTrajenta | 103.8 |  |  | 96.1 |  |  | 293.0 |  |  | 279.9 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nOlumiant | $ | 182.9 |  |  | $ | 406.9 |  |  | $ | 624.7 |  |  | $ | 809.1 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nTyvyt | $ | 76.8 |  |  | $ | 125.6 |  |  | $ | 235.8 |  |  | $ | 340.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nSeverance | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 11.5 | \nAsset impairment and other special charges | 206.5 |  |  | \u2014 |  |  | 206.5 |  |  | 200.1 | \nTotal asset impairment, restructuring, and other special charges | $ | 206.5 |  |  | $ | \u2014 |  |  | $ | 206.5 |  |  | $ | 211.6 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nFair value hedges: |  |  |  |  |  |  | \nEffect from hedged fixed-rate debt | $ | (62.9) |  |  | $ | (10.1) |  |  | $ | (215.7) |  |  | $ | (60.5) | \nEffect from interest rate contracts | 62.9 |  |  | 10.1 |  |  | 215.7 |  |  | 60.5 | \nCash flow hedges: |  |  |  |  |  |  | \nEffective portion of losses on interest rate contracts reclassified from accumulated other comprehensive loss | 4.1 |  |  | 4.2 |  |  | 12.3 |  |  | 12.5 | \nCross-currency interest rate swaps | 33.1 |  |  | 10.0 |  |  | 75.0 |  |  | 58.1 | \nNet (gains) losses on foreign currency exchange contracts not designated as hedging instruments | 129.6 |  |  | 50.8 |  |  | 280.7 |  |  | 110.6 | \nTotal | $ | 166.8 |  |  | $ | 65.0 |  |  | $ | 368.0 |  |  | $ | 181.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nNet investment hedges: |  |  |  |  |  |  | \nForeign currency-denominated notes | $ | 435.1 |  |  | $ | 119.0 |  |  | $ | 822.8 |  |  | $ | 268.8 | \nCross-currency interest rate swaps | 92.1 |  |  | 66.7 |  |  | 171.4 |  |  | 170.8 | \nForeign currency forward contracts | 107.8 |  |  | \u2014 |  |  | 121.4 |  |  | \u2014 | \nCash flow hedges: |  |  |  |  |  |  | \nForward-starting interest rate swaps | 57.5 |  |  | 19.4 |  |  | 337.7 |  |  | 149.3 | \nCross-currency interest rate swaps | 19.9 |  |  | 3.1 |  |  | 38.4 |  |  | 22.5 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | Fair Value Measurements Using |  | \n | CarryingAmount |  | Cost(1) |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | Significant OtherObservable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue\nSeptember 30, 2022 |  |  |  |  |  |  |  |  |  |  | \nCash equivalents | $ | 1,246.8 |  |  | $ | 1,246.8 |  |  | $ | 1,239.2 |  |  | $ | 7.6 |  |  | $ | \u2014 |  |  | $ | 1,246.8 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 43.0 |  |  | $ | 43.5 |  |  | $ | 43.0 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 43.0 | \nCorporate debt securities | 51.7 |  |  | 51.8 |  |  | \u2014 |  |  | 51.7 |  |  | \u2014 |  |  | 51.7 | \n |  |  |  |  |  |  |  |  |  |  | \nAsset-backed securities | 3.0 |  |  | 3.0 |  |  | \u2014 |  |  | 3.0 |  |  | \u2014 |  |  | 3.0 | \nOther securities | 27.0 |  |  | 27.0 |  |  | \u2014 |  |  | 14.8 |  |  | 12.2 |  |  | 27.0 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments | $ | 124.7 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 131.4 |  |  | $ | 148.3 |  |  | $ | 131.4 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 131.4 | \n |  |  |  |  |  |  |  |  |  |  | \nCorporate debt securities | 206.4 |  |  | 232.5 |  |  | \u2014 |  |  | 206.4 |  |  | \u2014 |  |  | 206.4 | \nMortgage-backed securities | 143.1 |  |  | 156.1 |  |  | \u2014 |  |  | 143.1 |  |  | \u2014 |  |  | 143.1 | \nAsset-backed securities | 43.6 |  |  | 45.5 |  |  | \u2014 |  |  | 43.6 |  |  | \u2014 |  |  | 43.6 | \nOther securities | 152.5 |  |  | 96.3 |  |  | \u2014 |  |  | 39.5 |  |  | 113.0 |  |  | 152.5 | \nMarketable equity securities | 549.1 |  |  | 416.1 |  |  | 549.1 |  |  | \u2014 |  |  | \u2014 |  |  | 549.1 | \nEquity investments without readily determinable fair values(2) | 583.7 |  |  |  |  |  |  |  |  |  |  | \nEquity method investments(2) | 764.8 |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments | $ | 2,574.6 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDecember 31, 2021 |  |  |  |  |  |  |  |  |  |  | \nCash equivalents | $ | 2,379.5 |  |  | $ | 2,379.5 |  |  | $ | 2,361.0 |  |  | $ | 18.5 |  |  | $ | \u2014 |  |  | $ | 2,379.5 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 25.7 |  |  | $ | 25.6 |  |  | $ | 25.7 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 25.7 | \nCorporate debt securities | 43.7 |  |  | 43.7 |  |  | \u2014 |  |  | 43.7 |  |  | \u2014 |  |  | 43.7 | \nMortgage-backed securities | 0.2 |  |  | 0.2 |  |  | \u2014 |  |  | 0.2 |  |  | \u2014 |  |  | 0.2 | \nAsset-backed securities | 6.2 |  |  | 6.2 |  |  | \u2014 |  |  | 6.2 |  |  | \u2014 |  |  | 6.2 | \nOther securities | 14.3 |  |  | 14.3 |  |  | \u2014 |  |  | \u2014 |  |  | 14.3 |  |  | 14.3 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments | $ | 90.1 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 137.0 |  |  | $ | 136.8 |  |  | $ | 137.0 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 137.0 | \nCorporate debt securities | 235.3 |  |  | 232.7 |  |  | \u2014 |  |  | 235.3 |  |  | \u2014 |  |  | 235.3 | \nMortgage-backed securities | 109.8 |  |  | 108.1 |  |  | \u2014 |  |  | 109.8 |  |  | \u2014 |  |  | 109.8 | \nAsset-backed securities | 23.1 |  |  | 23.1 |  |  | \u2014 |  |  | 23.1 |  |  | \u2014 |  |  | 23.1 | \nOther securities | 108.1 |  |  | 22.2 |  |  | \u2014 |  |  | \u2014 |  |  | 108.1 |  |  | 108.1 | \nMarketable equity securities | 1,279.7 |  |  | 487.0 |  |  | 1,279.7 |  |  | \u2014 |  |  | \u2014 |  |  | 1,279.7 | \nEquity investments without readily determinable fair values(2) | 548.1 |  |  |  |  |  |  |  |  |  |  | \nEquity method investments(2) | 771.5 |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments | $ | 3,212.6 |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Fair Value Measurements Using |  | \n | CarryingAmount |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | SignificantOther Observable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue\nShort-term commercial paper borrowings |  |  |  |  |  |  |  |  | \nSeptember 30, 2022 | $ | (1,741.3) |  |  | $ | \u2014 |  |  | $ | (1,738.0) |  |  | $ | \u2014 |  |  | $ | (1,738.0) | \nDecember 31, 2021 | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nLong-term debt, including current portion |  |  |  |  |  |  |  |  | \nSeptember 30, 2022 | $ | (14,147.1) |  |  | $ | \u2014 |  |  | $ | (11,848.6) |  |  | $ | \u2014 |  |  | $ | (11,848.6) | \nDecember 31, 2021 | (16,884.7) |  |  | \u2014 |  |  | (18,157.7) |  |  | \u2014 |  |  | (18,157.7) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Fair Value Measurements Using |  |  |  | \n | CarryingAmount |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | SignificantOther Observable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue |  | \nSeptember 30, 2022 |  |  |  |  |  |  |  |  |  |  | \nRisk-management instruments: |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent liabilities | $ | (140.2) |  |  | $ | \u2014 |  |  | $ | (140.2) |  |  | $ | \u2014 |  |  | $ | (140.2) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 355.2 |  |  | \u2014 |  |  | 355.2 |  |  | \u2014 |  |  | 355.2 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 81.6 |  |  | \u2014 |  |  | 81.6 |  |  | \u2014 |  |  | 81.6 |  |  | \nOther noncurrent assets | 116.9 |  |  | \u2014 |  |  | 116.9 |  |  | \u2014 |  |  | 116.9 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 8.3 |  |  | \u2014 |  |  | 8.3 |  |  | \u2014 |  |  | 8.3 |  |  | \nOther noncurrent liabilities | (12.9) |  |  | \u2014 |  |  | (12.9) |  |  | \u2014 |  |  | (12.9) |  |  | \nForeign exchange contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 108.2 |  |  | \u2014 |  |  | 108.2 |  |  | \u2014 |  |  | 108.2 |  |  | \nOther current liabilities | (2.9) |  |  | \u2014 |  |  | (2.9) |  |  | \u2014 |  |  | (2.9) |  |  | \nForeign exchange contracts not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 48.1 |  |  | \u2014 |  |  | 48.1 |  |  | \u2014 |  |  | 48.1 |  |  | \nOther current liabilities | (93.5) |  |  | \u2014 |  |  | (93.5) |  |  | \u2014 |  |  | (93.5) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nContingent consideration liability: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent liabilities | (42.1) |  |  | \u2014 |  |  | \u2014 |  |  | (42.1) |  |  | (42.1) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDecember 31, 2021 |  |  |  |  |  |  |  |  |  |  | \nRisk-management instruments: |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | $ | 4.8 |  |  | $ | \u2014 |  |  | $ | 4.8 |  |  | $ | \u2014 |  |  | $ | 4.8 |  |  | \nOther noncurrent assets | 78.3 |  |  | \u2014 |  |  | 78.3 |  |  | \u2014 |  |  | 78.3 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent liabilities | (7.6) |  |  | \u2014 |  |  | (7.6) |  |  | \u2014 |  |  | (7.6) |  |  | \nInterest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 49.2 |  |  | \u2014 |  |  | 49.2 |  |  | \u2014 |  |  | 49.2 |  |  | \nOther noncurrent liabilities | (31.7) |  |  | \u2014 |  |  | (31.7) |  |  | \u2014 |  |  | (31.7) |  |  | \nCross-currency interest rate contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 31.3 |  |  | \u2014 |  |  | 31.3 |  |  | \u2014 |  |  | 31.3 |  |  | \nOther current liabilities | (1.2) |  |  | \u2014 |  |  | (1.2) |  |  | \u2014 |  |  | (1.2) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 33.2 |  |  | \u2014 |  |  | 33.2 |  |  | \u2014 |  |  | 33.2 |  |  | \nOther noncurrent liabilities | (1.3) |  |  | \u2014 |  |  | (1.3) |  |  | \u2014 |  |  | (1.3) |  |  | \nForeign exchange contracts not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 9.9 |  |  | \u2014 |  |  | 9.9 |  |  | \u2014 |  |  | 9.9 |  |  | \nOther current liabilities | (35.3) |  |  | \u2014 |  |  | (35.3) |  |  | \u2014 |  |  | (35.3) |  |  | \nContingent consideration liabilities: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent liabilities | (70.5) |  |  | \u2014 |  |  | \u2014 |  |  | (70.5) |  |  | (70.5) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Maturities by Period\n | Total |  | Less\u00a0Than1 Year |  | 1-5Years |  | 6-10Years |  | More\u00a0Than10 Years\nFair value of debt securities | $ | 622.2 |  |  | $ | 97.7 |  |  | $ | 197.8 |  |  | $ | 121.0 |  |  | $ | 205.7 |   |  |  |  |  |  |  |  |  |  |  | \n | September 30, 2022 |  | December 31, 2021\nUnrealized gross gains | $ | 0.1 |  |  | $ | 9.7 | \nUnrealized gross losses | 51.6 |  |  | 5.2 | \nFair value of securities in an unrealized gain position | 13.8 |  |  | 250.7 | \nFair value of securities in an unrealized loss position | 578.8 |  |  | 290.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nProceeds from sales | $ | 50.5 |  |  | $ | 49.6 |  |  | $ | 115.6 |  |  | $ | 137.3 | \nRealized gross gains on sales | \u2014 |  |  | 0.4 |  |  | 0.2 |  |  | 2.2 | \nRealized gross losses on sales | 7.5 |  |  | 0.3 |  |  | 9.0 |  |  | 1.1 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Defined Benefit Pension Plans\n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nComponents of net periodic benefit cost: |  |  |  |  |  |  | \nService cost | $ | 87.1 |  |  | $ | 92.5 |  |  | $ | 264.4 |  |  | $ | 277.8 | \nInterest cost | 98.9 |  |  | 84.5 |  |  | 299.0 |  |  | 253.6 | \nExpected return on plan assets | (235.1) |  |  | (237.5) |  |  | (711.6) |  |  | (712.7) | \nAmortization of prior service cost | 0.6 |  |  | 1.0 |  |  | 1.9 |  |  | 3.2 | \nRecognized actuarial loss | 85.3 |  |  | 121.9 |  |  | 256.8 |  |  | 366.3 | \n |  |  |  |  |  |  | \nNet periodic benefit cost | $ | 36.8 |  |  | $ | 62.4 |  |  | $ | 110.5 |  |  | $ | 188.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Retiree Health Benefit Plans\n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nComponents of net periodic benefit income: |  |  |  |  |  |  | \nService cost | $ | 11.7 |  |  | $ | 12.4 |  |  | $ | 35.0 |  |  | $ | 37.0 | \nInterest cost | 9.4 |  |  | 8.1 |  |  | 28.4 |  |  | 24.4 | \nExpected return on plan assets | (38.0) |  |  | (36.5) |  |  | (114.1) |  |  | (109.6) | \nAmortization of prior service benefit | (13.7) |  |  | (14.9) |  |  | (41.1) |  |  | (44.7) | \nRecognized actuarial loss | 0.2 |  |  | 0.8 |  |  | 0.7 |  |  | 2.4 | \n |  |  |  |  |  |  | \nNet periodic benefit income | $ | (30.4) |  |  | $ | (30.1) |  |  | $ | (91.1) |  |  | $ | (90.5) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Unrealized Net Gains (Losses) on\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Effective Portion of Cash\u00a0Flow Hedges |  |  |  | Accumulated Other Comprehensive Loss\nBalance at July 1, 2022 | $ | (1,844.2) |  |  | $ | (27.9) |  |  | $ | (2,443.2) |  |  | $ | 27.6 |  |  |  |  | $ | (4,287.7) | \n |  |  |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (165.1) |  |  | (24.9) |  |  | 47.8 |  |  | 63.0 |  |  |  |  | (79.2) | \nNet amount reclassified from accumulated other comprehensive loss | \u2014 |  |  | 13.5 |  |  | 57.2 |  |  | 0.4 |  |  |  |  | 71.1 | \nNet other comprehensive income (loss) | (165.1) |  |  | (11.4) |  |  | 105.0 |  |  | 63.4 |  |  |  |  | (8.1) | \n |  |  |  |  |  |  |  |  |  |  | \nBalance at September\u00a030, 2022 | $ | (2,009.3) |  |  | $ | (39.3) |  |  | $ | (2,338.2) |  |  | $ | 91.0 |  |  |  |  | $ | (4,295.8) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Unrealized Net Gains (Losses) on\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Effective Portion of Cash\u00a0Flow Hedges |  |  |  | Accumulated Other Comprehensive Loss\nBalance at July 1, 2021 | $ | (1,516.2) |  |  | $ | 9.1 |  |  | $ | (4,569.9) |  |  | $ | (210.1) |  |  |  |  | $ | (6,287.1) | \n |  |  |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (8.0) |  |  | (2.4) |  |  | 18.6 |  |  | 16.8 |  |  |  |  | 25.0 | \nNet amount reclassified from accumulated other comprehensive loss | \u2014 |  |  | 0.1 |  |  | 86.0 |  |  | 3.3 |  |  |  |  | 89.4 | \nNet other comprehensive income (loss) | (8.0) |  |  | (2.3) |  |  | 104.6 |  |  | 20.1 |  |  |  |  | 114.4 | \n |  |  |  |  |  |  |  |  |  |  | \nBalance at September\u00a030, 2021 | $ | (1,524.2) |  |  | $ | 6.8 |  |  | $ | (4,465.3) |  |  | $ | (190.0) |  |  |  |  | $ | (6,172.7) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Unrealized Net Gains (Losses) on\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Effective Portion of Cash\u00a0Flow Hedges |  | Accumulated Other Comprehensive Loss\nBalance at January 1, 2022 | $ | (1,550.2) |  |  | $ | 3.7 |  |  | $ | (2,583.6) |  |  | $ | (213.0) |  |  | $ | (4,343.1) | \n |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (459.7) |  |  | (55.5) |  |  | 72.9 |  |  | 297.2 |  |  | (145.1) | \nNet amount reclassified from accumulated other comprehensive loss | 0.6 |  |  | 12.5 |  |  | 172.5 |  |  | 6.8 |  |  | 192.4 | \nNet other comprehensive income (loss) | (459.1) |  |  | (43.0) |  |  | 245.4 |  |  | 304.0 |  |  | 47.3 | \n |  |  |  |  |  |  |  |  | \nBalance at September\u00a030, 2022 | $ | (2,009.3) |  |  | $ | (39.3) |  |  | $ | (2,338.2) |  |  | $ | 91.0 |  |  | $ | (4,295.8) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Unrealized Net Gains (Losses) on\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Effective Portion of Cash\u00a0Flow Hedges |  | Accumulated Other Comprehensive Loss\nBalance at January 1, 2021 | $ | (1,427.5) |  |  | $ | 14.8 |  |  | $ | (4,751.0) |  |  | $ | (332.7) |  |  | $ | (6,496.4) | \n |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (96.7) |  |  | (8.8) |  |  | 27.2 |  |  | 132.8 |  |  | 54.5 | \nNet amount reclassified from accumulated other comprehensive loss | \u2014 |  |  | 0.8 |  |  | 258.5 |  |  | 9.9 |  |  | 269.2 | \nNet other comprehensive income (loss) | (96.7) |  |  | (8.0) |  |  | 285.7 |  |  | 142.7 |  |  | 323.7 | \n |  |  |  |  |  |  |  |  | \nBalance at September\u00a030, 2021 | $ | (1,524.2) |  |  | $ | 6.8 |  |  | $ | (4,465.3) |  |  | $ | (190.0) |  |  | $ | (6,172.7) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\nTax benefit (expense) | 2022 |  | 2021 |  | 2022 |  | 2021\nForeign currency translation gains/losses | $ | (133.3) |  |  | $ | (39.0) |  |  | $ | (234.2) |  |  | $ | (92.3) | \nUnrealized net gains/losses on securities | 3.4 |  |  | 0.8 |  |  | 13.1 |  |  | 3.8 | \nDefined benefit pension and retiree health benefit plans | (22.4) |  |  | (28.2) |  |  | (73.2) |  |  | (79.7) | \nEffective portion of cash flow hedges | (16.9) |  |  | (5.4) |  |  | (80.8) |  |  | (37.9) | \nBenefit (expense) for income taxes allocated to other comprehensive income (loss) items | $ | (169.2) |  |  | $ | (71.8) |  |  | $ | (375.1) |  |  | $ | (206.1) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nDetails about Accumulated Other Comprehensive Loss Components |  | Three Months Ended September 30, |  | Nine Months Ended September 30, | Affected Line Item in the Consolidated Condensed Statements of Operations\n\n | 2022 |  | 2021 |  | 2022 |  | 2021\nAmortization of retirement benefit items: |  |  |  |  |  |  |  |  | \nPrior service benefits, net |  | $ | (13.1) |  |  | $ | (13.9) |  |  | $ | (39.2) |  |  | $ | (41.5) |  | Other\u2013net, (income) expense\nActuarial losses, net |  | 85.5 |  |  | 122.7 |  |  | 257.5 |  |  | 368.7 |  | Other\u2013net, (income) expense\nTotal before tax |  | 72.4 |  |  | 108.8 |  |  | 218.3 |  |  | 327.2 |  | \nTax benefit |  | (15.2) |  |  | (22.8) |  |  | (45.8) |  |  | (68.7) |  | Income taxes\nNet of tax |  | 57.2 |  |  | 86.0 |  |  | 172.5 |  |  | 258.5 |  | \n |  |  |  |  |  |  |  |  | \nOther, net of tax |  | 13.9 |  |  | 3.4 |  |  | 19.9 |  |  | 10.7 |  | Other\u2013net, (income) expense\n |  |  |  |  |  |  |  |  | \nTotal reclassifications, net of tax |  | $ | 71.1 |  |  | $ | 89.4 |  |  | $ | 192.4 |  |  | $ | 269.2 |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nInterest expense | $ | 81.5 |  |  | $ | 83.6 |  |  | $ | 247.6 |  |  | $ | 258.4 | \nInterest income | (20.1) |  |  | (7.0) |  |  | (37.3) |  |  | (18.0) | \nNet investment (gains) losses on equity securities (Note 6) | 123.3 |  |  | 246.8 |  |  | 667.6 |  |  | (270.1) | \nRetirement benefit plans | (92.4) |  |  | (72.6) |  |  | (280.0) |  |  | (217.1) | \nDebt extinguishment loss (Note 6) | \u2014 |  |  | 405.2 |  |  | \u2014 |  |  | 405.2 | \nOther (income) expense | 18.7 |  |  | (20.1) |  |  | (17.0) |  |  | (34.1) | \nOther\u2013net, (income) expense | $ | 111.0 |  |  | $ | 635.9 |  |  | $ | 580.9 |  |  | $ | 124.3 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  |  |  | Nine Months EndedSeptember 30, |  | \n | 2022 |  | 2021 |  | Percent Change |  | 2022 |  | 2021 |  | Percent Change\nRevenue | $ | 6,941.6 |  |  | $ | 6,772.8 |  |  | 2 |  | $ | 21,239.6 |  |  | $ | 20,318.5 |  |  | 5\nGross margin | 5,362.5 |  |  | 5,342.0 |  |  | \u2014 |  | 16,157.9 |  |  | 15,055.9 |  |  | 7\nGross margin as a percent of revenue | 77.3 | % |  | 78.9 | % |  |  |  | 76.1 | % |  | 74.1 | % |  | \n |  |  |  |  |  |  |  |  |  |  | \nResearch and development | $ | 1,802.9 |  |  | $ | 1,705.3 |  |  | 6 |  | $ | 5,194.9 |  |  | $ | 5,032.4 |  |  | 3\nMarketing, selling, and administrative | 1,614.2 |  |  | 1,577.9 |  |  | 2 |  | 4,797.2 |  |  | 4,839.6 |  |  | (1)\nAcquired in-process research and development (IPR&D) and development milestones | 62.4 |  |  | 177.6 |  |  | (65) |  | 668.4 |  |  | 532.4 |  |  | 26\nAsset impairment, restructuring, and other special charges | 206.5 |  |  | \u2014 |  |  | NM |  | 206.5 |  |  | 211.6 |  |  | (2)\nOther\u2013net, (income) expense | 111.0 |  |  | 635.9 |  |  | (83) |  | 580.9 |  |  | 124.3 |  |  | NM\n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNet income | 1,451.7 |  |  | 1,110.1 |  |  | 31 |  | 4,307.1 |  |  | 3,855.6 |  |  | 12\n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nEPS - diluted | 1.61 |  |  | 1.22 |  |  | 32 |  | 4.76 |  |  | 4.23 |  |  | 13  |  |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication | Status | Developments | \nDiabetes | \nTirzepatide (Mounjaro) | Type 2 diabetes | Approved | Approved in the U.S. in the second quarter of 2022 and in Europe and Japan in the third quarter of 2022. | \nHeart failure with preserved ejection fraction | Phase III | Phase III trials are ongoing. | \nObesity | Phase III | Granted FDA Fast Track designation(1)in October 2022. Announced in the second quarter of 2022 that the initial Phase III trial met co-primary and all key secondary endpoints. Phase III trials are ongoing. | \nObstructive sleep apnea | Phase III | Phase III trial initiated in the third quarter of 2022. | \nNonalcoholic steatohepatitis | Phase II | Phase II trial is ongoing. | \nBasal Insulin-Fc | Type 1 and 2 diabetes | Phase III | Phase III trials initiated in the first, second, and third quarters of 2022. | \nOrforglipron (GLP-1R NPA) | Obesity | Phase II | Phase II trials are ongoing. | \nType 2 diabetes | \nRetatrutide (GGG Tri-Agonist) | Obesity | Phase II | Phase II trials are ongoing. | \nType 2 diabetes | \nImmunology | \nLebrikizumab(2) | Atopic dermatitis | Submitted | Granted FDA Fast Track designation(1). Submitted in the U.S. in the third quarter of 2022 and in Europe in October 2022. Phase III trials are ongoing. | \nMirikizumab | Ulcerative colitis | Submitted | Submitted in the U.S. in first quarter of 2022 and in Europe and Japan in the second quarter of 2022. | \nCrohn's Disease | Phase III | Phase III trials are ongoing. | \nANGPTL3 siRNA | Cardiovascular disease | Phase II | Phase II trial initiated in the third quarter of 2022. | \nBTLA MAB Agonist | Systemic lupus erythematosus | Phase II | Phase II trial initiated in the second quarter of 2022. | \nCXCR1/2 Ligands Monoclonal Antibody | Hidradenitis suppurativa | Phase II | Phase II trial is ongoing. | \nPeresolimab (PD-1 MAB Agonist) | Rheumatoid arthritis | Phase II | Phase II trial is ongoing. | \nRezpegaldesleukin (IL-2 Conjugate) | Systemic lupus erythematosus | Phase II | Phase II trial is ongoing. | \n |  |  |   |  |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication | Status | Developments | \nNeuroscience | \nDonanemab | Early Alzheimer's disease | Submitted | Granted FDA Breakthrough Therapy designation(3). Submitted in the U.S. in the second quarter of 2022. Received Priority Review designation under the accelerated approval pathway. Phase III trials are ongoing. | \nPreclinical Alzheimer's disease | Phase III | Phase III trial is ongoing. | \nRemternetug | Early Alzheimer's disease | Phase III | Phase III trial initiated in the third quarter of 2022. | \nSolanezumab | Preclinical Alzheimer's disease | Phase III | Phase III trial is ongoing. | \nGBA1 Gene Therapy (PR001) | Parkinson's disease | Phase II | Granted FDA Fast Track designation(1). Phase II trial is ongoing. | \nGRN Gene Therapy (PR006) | Frontotemporal dementia | Phase II | Granted FDA Fast Track designation(1). Phase II trial is ongoing. | \nO-GlcNAcase Inh | Alzheimer's disease | Phase II | Phase II trial is ongoing. | \nSSTR4 Agonist | Pain | Phase II | Phase II trials are ongoing. | \nTRPA1 Antagonist | Pain | Phase II | Phase II trials are ongoing. | \nPACAP38 Antibody | Migraine | Discontinued | In the third quarter of 2022 based on the results of the Phase II trial, we discontinued development. | \nOncology | \nSelpercatinib (Retevmo\u00ae) | Lung cancer | Approved(4) | Phase III trials are ongoing. In the third quarter of 2022, the FDA granted accelerated approval in tumor-agnostic RET fusion-positive advanced or metastatic solid tumors and traditional approval in locally advanced or metastatic RET fusion-positive non-small cell lung cancer. | \nThyroid cancer | Approved(4) | Phase III trial is ongoing. | \nPirtobrutinib (LOXO-305) | Mantle cell lymphoma | Submitted | Submitted in the U.S. in second quarter of 2022. Received Priority Review designation under the accelerated approval pathway. Phase III trial is ongoing. | \nChronic lymphocytic leukemia | Phase III | Phase III trials are ongoing. | \nB-cell malignancies | Phase II | Phase II trial is ongoing. | \nImlunestrant | ER+HER2- metastatic breast cancer | Phase III | Phase III trial is ongoing. |   |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication | Status | Developments\nDiabetes\nEmpagliflozin (Jardiance\u00ae)(1) | Heart failure with preserved ejection fraction | Approved | Approved in the U.S. and Europe in the first quarter of 2022 and in Japan in the second quarter of 2022.\nChronic kidney disease | Phase III | Granted FDA Fast Track designation(2). In the first quarter of 2022 the Independent Data Monitoring Committee recommended stopping the Phase III trial early due to clear positive efficacy.\nImmunology\nBaricitinib (Olumiant\u00ae) | Alopecia areata | Approved | Approved in the U.S., Europe, and Japan in the second quarter of 2022.\nCOVID-19 | Approved | Approved in the U.S. in the second quarter of 2022.\nOncology\nAbemaciclib (Verzenio\u00ae) | Prostate cancer | Phase III | Phase III trials are ongoing.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |  | \n | 2022 |  | 2021 |  | Percent Change | 2022 |  | 2021 |  | Percent Change\nU.S. | $ | 4,422.1 |  |  | $ | 3,989.6 |  |  | 11 | $ | 13,531.5 |  |  | $ | 11,635.1 |  |  | 16\nOutside U.S. | 2,519.4 |  |  | 2,783.3 |  |  | (9) | 7,708.1 |  |  | 8,683.4 |  |  | (11)\nRevenue | $ | 6,941.6 |  |  | $ | 6,772.8 |  |  | 2 | $ | 21,239.6 |  |  | $ | 20,318.5 |  |  | 5  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 vs. 2021 |  | 2022 vs. 2021\n | U.S. | Outside U.S. | Consolidated |  | U.S. | Outside U.S. | Consolidated\nVolume | 15 | % | 13 | % | 14 | % |  | 20 | % | 7 | % | 15 | %\nPrice | (4) |  | (12) |  | (7) |  |  | (4) |  | (11) |  | (7) | \nForeign exchange rates | \u2014 |  | (11) |  | (4) |  |  | \u2014 |  | (7) |  | (3) | \nPercent change | 11 | % | (9) | % | 2 | % |  | 16 | % | (11) | % | 5 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  |  | \n | 2022 |  | 2021 | \nProduct | U.S. |  | Outside U.S. |  | Total |  | Total | Percent Change | \nTrulicity | $ | 1,418.3 |  |  | $ | 432.0 |  |  | $ | 1,850.4 |  |  | $ | 1,600.1 |  |  | 16 | \nTaltz | 493.8 |  |  | 186.1 |  |  | 679.9 |  |  | 593.1 |  |  | 15 | \nVerzenio | 414.8 |  |  | 202.9 |  |  | 617.7 |  |  | 335.5 |  |  | 84 | \nJardiance(1) | 350.9 |  |  | 222.4 |  |  | 573.3 |  |  | 390.4 |  |  | 47 | \nHumalog(2) | 248.1 |  |  | 198.8 |  |  | 447.0 |  |  | 626.7 |  |  | (29) | \nCOVID-19 antibodies(3) | 386.6 |  |  | \u2014 |  |  | 386.6 |  |  | 217.1 |  |  | 78 | \nHumulin\u00ae | 169.5 |  |  | 68.7 |  |  | 238.2 |  |  | 286.7 |  |  | (17) | \nCyramza\u00ae | 87.5 |  |  | 144.6 |  |  | 232.1 |  |  | 253.4 |  |  | (8) | \nBasaglar\u00ae | 124.8 |  |  | 68.1 |  |  | 193.0 |  |  | 192.8 |  |  | \u2014 | \nMounjaro | 97.3 |  |  | 90.0 |  |  | 187.3 |  |  | \u2014 |  |  | NM | \nOlumiant(4) | 22.9 |  |  | 160.0 |  |  | 182.9 |  |  | 406.9 |  |  | (55) | \nForteo | 112.7 |  |  | 64.4 |  |  | 177.1 |  |  | 200.9 |  |  | (12) | \nEmgality\u00ae | 114.0 |  |  | 54.6 |  |  | 168.5 |  |  | 140.0 |  |  | 20 | \nErbitux\u00ae | 126.3 |  |  | 18.7 |  |  | 144.9 |  |  | 134.3 |  |  | 8 | \nAlimta | 64.6 |  |  | 54.8 |  |  | 119.4 |  |  | 457.0 |  |  | (74) | \nCialis | 8.1 |  |  | 107.7 |  |  | 115.7 |  |  | 130.9 |  |  | (12) | \nZyprexa\u00ae | 8.0 |  |  | 73.4 |  |  | 81.4 |  |  | 101.7 |  |  | (20) | \nTyvyt | \u2014 |  |  | 76.8 |  |  | 76.8 |  |  | 125.6 |  |  | (39) | \nCymbalta | 7.8 |  |  | 54.9 |  |  | 62.7 |  |  | 132.0 |  |  | (53) | \nOther products | 166.1 |  |  | 240.5 |  |  | 406.7 |  |  | 447.7 |  |  | (9) | \nRevenue | $ | 4,422.1 |  |  | $ | 2,519.4 |  |  | $ | 6,941.6 |  |  | $ | 6,772.8 |  |  | 2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended September 30, |  | \n | 2022 |  | 2021\nProduct | U.S. |  | Outside U.S. |  | Total |  | Total | Percent Change\nTrulicity | $ | 4,162.4 |  |  | $ | 1,341.1 |  |  | $ | 5,503.5 |  |  | $ | 4,588.2 |  |  | 20\nCOVID-19 antibodies(1) | 1,970.9 |  |  | 14.7 |  |  | 1,985.5 |  |  | 1,176.2 |  |  | 69\nTaltz | 1,212.6 |  |  | 561.6 |  |  | 1,774.2 |  |  | 1,565.4 |  |  | 13\nVerzenio | 1,100.5 |  |  | 575.1 |  |  | 1,675.6 |  |  | 945.8 |  |  | 77\nHumalog(2) | 855.8 |  |  | 656.4 |  |  | 1,512.3 |  |  | 1,851.3 |  |  | (18)\nJardiance(3) | 831.4 |  |  | 622.4 |  |  | 1,453.7 |  |  | 1,058.9 |  |  | 37\nHumulin | 562.3 |  |  | 223.1 |  |  | 785.4 |  |  | 923.8 |  |  | (15)\nCyramza | 259.3 |  |  | 434.3 |  |  | 693.6 |  |  | 762.5 |  |  | (9)\nAlimta | 490.5 |  |  | 200.5 |  |  | 691.1 |  |  | 1,626.6 |  |  | (58)\nOlumiant(4) | 104.6 |  |  | 520.1 |  |  | 624.7 |  |  | 809.1 |  |  | (23)\nBasaglar | 339.9 |  |  | 218.8 |  |  | 558.7 |  |  | 650.1 |  |  | (14)\nCialis | 25.8 |  |  | 454.7 |  |  | 480.4 |  |  | 538.7 |  |  | (11)\nEmgality | 330.8 |  |  | 144.4 |  |  | 475.2 |  |  | 415.7 |  |  | 14\nForteo | 261.4 |  |  | 191.7 |  |  | 453.0 |  |  | 617.8 |  |  | (27)\nErbitux | 361.0 |  |  | 47.4 |  |  | 408.3 |  |  | 403.7 |  |  | 1\nZyprexa | 26.2 |  |  | 235.5 |  |  | 261.7 |  |  | 292.8 |  |  | (11)\nTyvyt | \u2014 |  |  | 235.8 |  |  | 235.8 |  |  | 340.2 |  |  | (31)\nCymbalta | 25.0 |  |  | 194.3 |  |  | 219.3 |  |  | 484.3 |  |  | (55)\nMounjaro | 109.9 |  |  | 93.3 |  |  | 203.2 |  |  | \u2014 |  |  | NM\nOther products | 501.1 |  |  | 743.0 |  |  | 1,244.2 |  |  | 1,267.3 |  |  | (2)\nRevenue | $ | 13,531.5 |  |  | $ | 7,708.1 |  |  | $ | 21,239.6 |  |  | $ | 20,318.5 |  |  | 5  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number ofShares Purchased(in thousands) |  | Average\u00a0Price Paidper Share |  | Total\u00a0Number of SharesPurchased\u00a0as Part ofPublicly AnnouncedPlans or Programs(in thousands) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(in millions)\nJuly 2022 | \u2014 |  |  | $ | \u2014 |  |  | \u2014 |  |  | $ | 3,250.0 | \nAugust 2022 | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3,250.0 | \nSeptember 2022 | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 3,250.0 | \nTotal | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |   |  |  |  |  |  |  |  | \nExhibit |  | Description\nEXHIBIT 3.1 |  | Amended Articles of Incorporation are incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on May 4, 2022\n |  | \nEXHIBIT 3.2 |  | Bylaws, as amended, are incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed on May 4, 2022\n |  | \nEXHIBIT 10.1 |  | Form of Performance Award under the 2002 Lilly Stock Plan (with non-compete)(1)\n |  | \nEXHIBIT 10.2 |  | Form of Shareholder Value Award under the 2002 Lilly Stock Plan (with non-compete)(1)\n |  | \nEXHIBIT 10.3 |  | Form of Relative Value Award under the 2002 Lilly Stock Plan (with non-compete)(1)\n |  | \nEXHIBIT\u00a031.1 |  | Rule\u00a013a-14(a) Certification of David A. Ricks, Chair, President, and Chief Executive Officer\n |  | \nEXHIBIT 31.2 |  | Rule\u00a013a-14(a) Certification of Anat Ashkenazi,ExecutiveVice President and Chief Financial Officer\n | \nEXHIBIT 32. |  | Section 1350 Certification\n |  | \nEXHIBIT 101. |  | Interactive Data Files (embedded within the Inline XBRL document)\n |  | \nEXHIBIT 104. |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)  |  |  |  |  |  |  |  | \n |  | ELI LILLY AND COMPANY\n |  | (Registrant)\n |  | \nDate: | November 1, 2022 | /s/ Anat Ashkenazi\n |  | Anat Ashkenazi\n |  | Executive Vice President and Chief Financial Officer\nDate: | November 1, 2022 | /s/ Donald A. Zakrowski\n |  | Donald A. Zakrowski\n |  | Senior Vice President, Finance, and Chief Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Eli Lilly, in 2023 Q1, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  |  |  |  | \nIndiana |  | 35-0470950\n(State or other jurisdiction of |  | (I.R.S. Employer\nincorporation or organization) |  | Identification No.)  |  |  |  |  |  |  |  | \nTitle of Each Class | Trading Symbols | Name of Each Exchange On Which Registered\nCommon Stock (no par value) | LLY | New York Stock Exchange\n7 1/8% Notes due 2025 | LLY25 | New York Stock Exchange\n1.625% Notes due 2026 | LLY26 | New York Stock Exchange\n2.125% Notes due 2030 | LLY30 | New York Stock Exchange\n0.625% Notes due 2031 | LLY31 | New York Stock Exchange\n0.500% Notes due 2033 | LLY33 | New York Stock Exchange\n6.77%\u00a0Notes due 2036 | LLY36 | New York Stock Exchange\n1.625% Notes due 2043 | LLY43 | New York Stock Exchange\n1.700% Notes due 2049 | LLY49A | New York Stock Exchange\n1.125% Notes due 2051 | LLY51 | New York Stock Exchange\n1.375% Notes due 2061 | LLY61 | New York Stock Exchange  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 |  |  |  |  | Accelerated\u00a0filer | \u2610\nNon-accelerated filer | \u2610 |  |  | Smaller reporting company | \u2610\n |  |  |  |  |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \nClass |  | Number of Shares Outstanding\nCommon |  | 949,272,933 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | Page\nPART I. Financial Information |  |  |  | 5\n |  |  |  | \nItem 1. |  | Financial Statements |  | 5\n |  | Consolidated Condensed Statements of Operations |  | 5\n |  | Consolidated Condensed Statements of Comprehensive Income |  | 6\n |  | Consolidated Condensed Balance Sheets |  | 7\n |  | Consolidated Condensed Statements of Equity |  | 8\n |  | Consolidated Condensed Statements of Cash Flows |  | 9\n |  | Notes to Consolidated Condensed Financial Statements |  | 10\nItem 2. |  | Management's Discussion and Analysis of Results of Operations and Financial Condition |  | 32\n |  | Executive Overview |  | 32\n |  | Results of Operations |  | 38\n |  | Financial Condition and Liquidity |  | 41\n |  |  |  | \n |  | Critical Accounting Estimates |  | 41\n |  | Available Information on our Website |  | 42\nItem 3. |  | Quantitative and Qualitative Disclosures About Market Risk |  | 43\nItem 4. |  | Controls and Procedures |  | 43\n |  |  |  | \nPART II. Other Information |  |  |  | 44\n |  |  |  | \nItem 1. |  | Legal Proceedings |  | 44\nItem 1A. |  | Risk Factors |  | 44\nItem 2. |  | Unregistered Sales of Equity Securities and Use of Proceeds |  | 44\nItem 6. |  | Exhibits |  | 45\n |  |  |  | \nSignatures |  |  |  | 45  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2023 |  | 2022 |  |  |  | \nRevenue (Note 2) | $ | 6,960.0 |  |  | $ | 7,810.0 |  |  |  |  | \nCosts, expenses, and other: |  |  |  |  |  |  | \nCost of sales | 1,626.7 |  |  | 2,072.1 |  |  |  |  | \nResearch and development | 1,985.1 |  |  | 1,610.1 |  |  |  |  | \nMarketing, selling, and administrative | 1,749.2 |  |  | 1,557.9 |  |  |  |  | \nAcquired in-process research and development (Note 3) | 105.0 |  |  | 165.6 |  |  |  |  | \n |  |  |  |  |  |  | \nOther\u2013net, (income) expense (Note 10) | (35.7) |  |  | 350.7 |  |  |  |  | \n | 5,430.3 |  |  | 5,756.4 |  |  |  |  | \nIncome before income taxes | 1,529.7 |  |  | 2,053.6 |  |  |  |  | \nIncome taxes (Note 6) | 184.8 |  |  | 150.7 |  |  |  |  | \nNet income | $ | 1,344.9 |  |  | $ | 1,902.9 |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nEarnings per share: |  |  |  |  |  |  | \nBasic | $ | 1.49 |  |  | $ | 2.11 |  |  |  |  | \n |  |  |  |  |  |  | \nDiluted | $ | 1.49 |  |  | $ | 2.10 |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nShares used in calculation of earnings per share: |  |  |  |  |  |  | \nBasic | 901.0 |  | 903.7 |  |  |  | \nDiluted | 903.3 |  | 906.4 |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2023 |  | 2022 |  |  |  | \nNet income | $ | 1,344.9 |  |  | $ | 1,902.9 |  |  |  |  | \nOther comprehensive income, net of tax (Note 9) | 67.3 |  |  | 117.8 |  |  |  |  | \nComprehensive income | $ | 1,412.2 |  |  | $ | 2,020.7 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | March 31, 2023 |  | December 31, 2022\nAssets | (Unaudited) |  | \nCurrent Assets |  |  | \nCash and cash equivalents (Note 5) | $ | 3,545.9 |  |  | $ | 2,067.0 | \nShort-term investments (Note 5) | 123.4 |  |  | 144.8 | \nAccounts receivable, net of allowances of$14.0(2023)and $16.0(2022) | 7,526.2 |  |  | 6,896.0 | \nOther receivables | 1,495.9 |  |  | 1,662.9 | \nInventories | 4,544.8 |  |  | 4,309.7 | \nPrepaid expenses and other current assets | 3,575.2 |  |  | 2,954.1 | \nTotal current assets | 20,811.4 |  |  | 18,034.5 | \nInvestments (Note 5) | 2,750.4 |  |  | 2,901.8 | \nGoodwill | 4,073.1 |  |  | 4,073.0 | \nOther intangibles, net | 7,087.1 |  |  | 7,206.6 | \nDeferred tax assets | 3,406.7 |  |  | 2,792.9 | \nProperty and equipment, net of accumulated depreciation of$10,486.0(2023)and $10,233.4(2022) | 10,546.2 |  |  | 10,144.0 | \nOther noncurrent assets | 4,488.1 |  |  | 4,337.0 | \nTotal assets | $ | 53,163.0 |  |  | $ | 49,489.8 | \nLiabilities and Equity |  |  | \nCurrent Liabilities |  |  | \nShort-term borrowings and current maturities of long-term debt | $ | 3.1 |  |  | $ | 1,501.1 | \nAccounts payable | 2,015.9 |  |  | 1,930.6 | \nEmployee compensation | 739.7 |  |  | 1,059.8 | \nSales rebates and discounts | 9,529.5 |  |  | 8,784.1 | \nDividends payable | \u2014 |  |  | 1,017.2 | \nIncome taxes payable | 1,528.3 |  |  | 475.1 | \nOther current liabilities | 2,193.5 |  |  | 2,370.3 | \nTotal current liabilities | 16,010.0 |  |  | 17,138.2 | \nOther Liabilities |  |  | \nLong-term debt | 18,880.5 |  |  | 14,737.5 | \nAccrued retirement benefits (Note 7) | 1,313.0 |  |  | 1,305.1 | \nLong-term income taxes payable | 3,842.1 |  |  | 3,709.6 | \nOther noncurrent liabilities | 1,822.5 |  |  | 1,824.0 | \nTotal other liabilities | 25,858.1 |  |  | 21,576.2 | \nCommitments and Contingencies (Note 8) |  |  | \nEli Lilly and Company Shareholders' Equity |  |  | \nCommon stock | 593.5 |  |  | 594.1 | \nAdditional paid-in capital | 6,793.1 |  |  | 6,921.4 | \nRetained earnings | 10,639.3 |  |  | 10,042.6 | \nEmployee benefit trust | (3,013.2) |  |  | (3,013.2) | \nAccumulated other comprehensive loss (Note 9) | (3,777.3) |  |  | (3,844.6) | \nCost of common stock in treasury | (45.0) |  |  | (50.5) | \nTotal Eli Lilly and Company shareholders' equity | 11,190.4 |  |  | 10,649.8 | \nNoncontrolling interests | 104.5 |  |  | 125.6 | \nTotal equity | 11,294.9 |  |  | 10,775.4 | \nTotal liabilities and equity | $ | 53,163.0 |  |  | $ | 49,489.8 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Equity of Eli Lilly and Company Shareholders |  | \n(Dollars in millions, except per-share data, and shares in thousands) | Common Stock |  | AdditionalPaid-inCapital |  | RetainedEarnings |  | Employee Benefit Trust |  | Accumulated Other Comprehensive Loss |  | Common Stock in Treasury(1) |  | Noncontrolling Interests\nShares |  | Amount | Shares |  | Amount\nBalance at January\u00a01, 2022 | 954,116 |  |  | $ | 596.3 |  |  | $ | 6,833.4 |  |  | $ | 8,958.5 |  |  | $ | (3,013.2) |  |  | $ | (4,343.1) |  |  | 463 |  |  | $ | (52.7) |  |  | $ | 175.6 | \nNet income (loss) |  |  |  |  |  |  | 1,902.9 |  |  |  |  |  |  |  |  |  |  | (36.6) | \nOther comprehensive income, net of tax |  |  |  |  |  |  |  |  |  |  | 117.8 |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nRetirement of treasury shares | (5,607) |  |  | (3.5) |  |  |  |  | (1,496.5) |  |  |  |  |  |  | (5,607) |  |  | 1,500.0 |  |  | \nPurchase of treasury shares |  |  |  |  |  |  |  |  |  |  |  |  | 5,607 |  |  | (1,500.0) |  |  | \nIssuance of stock under employee stock plans, net | 2,096 |  |  | 1.3 |  |  | (278.1) |  |  |  |  |  |  |  |  | (13) |  |  | 2.2 |  |  | \nStock-based compensation |  |  |  |  | 101.0 |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  | 4.5 |  |  |  |  |  |  |  |  |  |  | (7.8) | \nBalance at March\u00a031, 2022 | 950,605 |  |  | $ | 594.1 |  |  | $ | 6,656.3 |  |  | $ | 9,369.4 |  |  | $ | (3,013.2) |  |  | $ | (4,225.3) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 131.2 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance at January\u00a01, 2023 | 950,632 |  |  | $ | 594.1 |  |  | $ | 6,921.4 |  |  | $ | 10,042.6 |  |  | $ | (3,013.2) |  |  | $ | (3,844.6) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 125.6 | \nNet income |  |  |  |  |  |  | 1,344.9 |  |  |  |  |  |  |  |  |  |  | 10.0 | \nOther comprehensive income, net of tax |  |  |  |  |  |  |  |  |  |  | 67.3 |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nRetirement of treasury shares | (2,299) |  |  | (1.4) |  |  |  |  | (748.6) |  |  |  |  |  |  | (2,299) |  |  | 750.0 |  |  | \nPurchase of treasury shares |  |  |  |  |  |  |  |  |  |  |  |  | 2,299 |  |  | (750.0) |  |  | \nIssuance of stock under employee stock plans, net | 1,336 |  |  | 0.8 |  |  | (259.5) |  |  |  |  |  |  |  |  | (48) |  |  | 8.8 |  |  | \nStock-based compensation |  |  |  |  | 131.2 |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  | 0.4 |  |  |  |  |  |  |  |  | (3.3) |  |  | (31.1) | \nBalance at March\u00a031, 2023 | 949,669 |  |  | $ | 593.5 |  |  | $ | 6,793.1 |  |  | $ | 10,639.3 |  |  | $ | (3,013.2) |  |  | $ | (3,777.3) |  |  | 402 |  |  | $ | (45.0) |  |  | $ | 104.5 |   |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31,\n | 2023 |  | 2022\nCash Flows from Operating Activities | \nNet income | $ | 1,344.9 |  |  | $ | 1,902.9 | \nAdjustments to Reconcile Net Income to Cash Flows from Operating Activities: |  |  | \n |  |  | \nDepreciation and amortization | 362.3 |  |  | 435.7 | \nChange in deferred income taxes | (559.4) |  |  | (506.6) | \n |  |  | \nStock-based compensation expense | 131.2 |  |  | 101.0 | \n |  |  | \nNet investment losses | 14.2 |  |  | 426.1 | \nAcquired in-process research and development | 105.0 |  |  | 165.6 | \nOther changes in operating assets and liabilities, net of acquisitions and divestitures | 164.1 |  |  | (34.3) | \nOther operating activities, net | 168.3 |  |  | 32.6 | \nNet Cash Provided by Operating Activities | 1,730.6 |  |  | 2,523.0 | \nCash Flows from Investing Activities |  |  | \nPurchases of property and equipment | (668.5) |  |  | (365.4) | \nProceeds from sales and maturities of short-term investments | 61.5 |  |  | 26.7 | \nPurchases of short-term investments | (23.0) |  |  | (14.6) | \nProceeds from sales of and distributions from noncurrent investments | 281.9 |  |  | 81.4 | \nPurchases of noncurrent investments | (146.0) |  |  | (116.7) | \n |  |  | \n |  |  | \nPurchases of in-process research and development | (235.0) |  |  | (515.6) | \nOther investing activities, net | 40.3 |  |  | (133.4) | \nNet Cash Used for Investing Activities | (688.8) |  |  | (1,037.6) | \nCash Flows from Financing Activities |  |  | \nDividends paid | (1,017.2) |  |  | (885.5) | \nNet change in short-term borrowings | (1,498.0) |  |  | 499.7 | \nProceeds from issuance of long-term debt | 3,958.5 |  |  | \u2014 | \nRepayments of long-term debt | \u2014 |  |  | (710.1) | \nPurchases of common stock | (750.0) |  |  | (1,500.0) | \n |  |  | \nOther financing activities, net | (281.0) |  |  | (282.4) | \nNet Cash Provided by (Used for) Financing Activities | 412.3 |  |  | (2,878.3) | \nEffect of exchange rate changes on cash and cash equivalents | 24.8 |  |  | 33.6 | \n |  |  | \nNet increase (decrease) in cash and cash equivalents | 1,478.9 |  |  | (1,359.3) | \nCash and cash equivalents at January\u00a01 | 2,067.0 |  |  | 3,818.5 | \nCash and Cash Equivalents at March 31 | $ | 3,545.9 |  |  | $ | 2,459.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2023 |  | 2022 |  |  |  | \nNet product revenue | $ | 6,238.2 |  |  | $ | 7,132.9 |  |  |  |  | \nCollaboration and other revenue(1) | 721.8 |  |  | 677.1 |  |  |  |  | \nRevenue | $ | 6,960.0 |  |  | $ | 7,810.0 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | March 31, 2023 |  | December 31, 2022\nContract liabilities | $ | 220.3 |  |  | $ | 219.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31,\n | 2023 |  | 2022\n | U.S. | Outside U.S. | Total |  | U.S. | Outside U.S. | Total\nRevenue\u2014to unaffiliated customers: |  |  |  |  |  |  | \nDiabetes: |  |  |  |  |  |  | \nTrulicity\u00ae | $ | 1,547.4 |  | $ | 429.7 |  | $ | 1,977.1 |  |  | $ | 1,313.9 |  | $ | 427.4 |  | $ | 1,741.3 | \nJardiance(1) | 329.4 |  | 248.1 |  | 577.5 |  |  | 229.8 |  | 189.7 |  | 419.4 | \nMounjaro\u00ae | 536.4 |  | 32.0 |  | 568.5 |  |  | \u2014 |  | \u2014 |  | \u2014 | \nHumalog\u00ae (2) | 271.6 |  | 189.3 |  | 460.9 |  |  | 368.9 |  | 249.3 |  | 618.2 | \nHumulin\u00ae | 198.8 |  | 53.2 |  | 252.0 |  |  | 190.4 |  | 82.8 |  | 273.2 | \nBasaglar\u00ae | 135.4 |  | 73.9 |  | 209.3 |  |  | 119.3 |  | 72.2 |  | 191.5 | \nOther diabetes | 56.0 |  | 89.2 |  | 145.1 |  |  | 54.3 |  | 90.2 |  | 144.6 | \nTotal diabetes | 3,075.0 |  | 1,115.4 |  | 4,190.4 |  |  | 2,276.6 |  | 1,111.6 |  | 3,388.2 | \n |  |  |  |  |  |  | \nOncology: |  |  |  |  |  |  | \nVerzenio\u00ae | 461.1 |  | 289.8 |  | 750.9 |  |  | 301.5 |  | 167.9 |  | 469.4 | \nCyramza\u00ae | 100.6 |  | 136.1 |  | 236.8 |  |  | 79.2 |  | 151.1 |  | 230.3 | \nErbitux\u00ae | 118.8 |  | 11.1 |  | 129.9 |  |  | 109.7 |  | 13.0 |  | 122.7 | \nAlimta\u00ae | 20.1 |  | 38.1 |  | 58.2 |  |  | 254.3 |  | 89.7 |  | 343.9 | \nOther oncology | 52.8 |  | 127.5 |  | 180.2 |  |  | 39.0 |  | 147.5 |  | 186.7 | \nTotal oncology | 753.4 |  | 602.6 |  | 1,356.0 |  |  | 783.7 |  | 569.2 |  | 1,353.0 | \n |  |  |  |  |  |  | \nImmunology: |  |  |  |  |  |  | \nTaltz\u00ae | 312.2 |  | 214.8 |  | 527.0 |  |  | 307.2 |  | 180.8 |  | 488.1 | \nOlumiant\u00ae (3) | 42.3 |  | 186.5 |  | 228.9 |  |  | 71.3 |  | 184.3 |  | 255.6 | \nOther immunology | \u2014 |  | 22.0 |  | 22.0 |  |  | \u2014 |  | 4.5 |  | 4.5 | \nTotal immunology | 354.5 |  | 423.3 |  | 777.8 |  |  | 378.5 |  | 369.6 |  | 748.1 | \n |  |  |  |  |  |  | \nNeuroscience: |  |  |  |  |  |  | \nEmgality\u00ae | 108.7 |  | 45.6 |  | 154.3 |  |  | 108.3 |  | 41.0 |  | 149.3 | \n |  |  |  |  |  |  | \nOther neuroscience | 35.8 |  | 170.4 |  | 206.2 |  |  | 45.1 |  | 203.4 |  | 248.4 | \nTotal neuroscience | 144.5 |  | 216.0 |  | 360.5 |  |  | 153.4 |  | 244.4 |  | 397.7 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nOther: |  |  |  |  |  |  | \nForteo\u00ae | 70.7 |  | 51.7 |  | 122.3 |  |  | 70.2 |  | 67.3 |  | 137.4 | \nCialis\u00ae | 7.6 |  | 92.7 |  | 100.3 |  |  | 6.9 |  | 210.8 |  | 217.7 | \nCOVID-19 antibodies(4) | \u2014 |  | \u2014 |  | \u2014 |  |  | 1,455.2 |  | 14.7 |  | 1,469.8 | \nOther | 30.5 |  | 22.2 |  | 52.8 |  |  | 50.1 |  | 47.8 |  | 98.1 | \nTotal other | 108.7 |  | 166.6 |  | 275.3 |  |  | 1,582.4 |  | 340.6 |  | 1,923.0 | \nRevenue | $ | 4,436.2 |  | $ | 2,523.9 |  | $ | 6,960.0 |  |  | $ | 5,174.6 |  | $ | 2,635.4 |  | $ | 7,810.0 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2023 |  | 2022 |  |  |  | \nRevenue\u2014to unaffiliated customers(1): |  |  |  |  |  |  | \nU.S. | $ | 4,436.2 |  |  | $ | 5,174.6 |  |  |  |  | \nEurope | 1,090.9 |  |  | 1,067.3 |  |  |  |  | \nJapan | 387.2 |  |  | 410.2 |  |  |  |  | \nChina | 372.7 |  |  | 406.5 |  |  |  |  | \nOther foreign countries | 673.1 |  |  | 751.5 |  |  |  |  | \nRevenue | $ | 6,960.0 |  |  | $ | 7,810.0 |  |  |  |  |   |  |  |  |  | \nEstimated Fair Value at December 1, 2022 | \nCash | $ | 153.2 | \nAcquired IPR&D(1) | 184.0\nGoodwill(2) | 181.2\n | \nOther assets and liabilities, net | 28.9 | \nAcquisition date fair value of consideration transferred | 547.3\nLess: | \nCash acquired | (153.2) | \nFair value of CVR liability(3) | (66.9) | \nCash paid, net of cash acquired | $ | 327.2 |   |  |  |  |  |  |  |  | \n | Net Milestones Capitalized (Deferred)(1)\n | March 31, 2023 | December 31, 2022\nJardiance | $ | 111.2 |  | $ | 116.2 | \nTrajenta | 57.3 |  | 63.5 | \nBasaglar | (126.0) |  | (130.6) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2023 |  | 2022 |  |  |  | \nJardiance | $ | 577.5 |  |  | $ | 419.4 |  |  |  |  | \nBasaglar | 209.3 |  |  | 191.5 |  |  |  |  | \nTrajenta | 85.8 |  |  | 92.0 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2023 |  | 2022 |  |  |  | \nOlumiant | $ | 228.9 |  |  | $ | 255.6 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Maturities by Period\n | Total |  | Less\u00a0Than1 Year |  | 1-5Years |  | 6-10Years |  | More\u00a0Than10 Years\nFair value of debt securities | $ | 648.1 |  |  | $ | 76.0 |  |  | $ | 219.4 |  |  | $ | 115.5 |  |  | $ | 237.2 |   |  |  |  |  |  |  |  |  |  |  | \n | March 31, 2023 |  | December 31, 2022\nUnrealized gross gains | $ | 1.8 |  |  | $ | 0.6 | \nUnrealized gross losses | 39.0 |  |  | 49.2 | \nFair value of securities in an unrealized gain position | 120.5 |  |  | 46.8 | \nFair value of securities in an unrealized loss position | 512.4 |  |  | 568.7 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2023 |  | 2022 |  |  |  | \nProceeds from sales | $ | 27.6 |  |  | $ | 35.2 |  |  |  |  | \nRealized gross gains on sales | 0.2 |  |  | 0.1 |  |  |  |  | \nRealized gross losses on sales | 0.7 |  |  | 0.8 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | Fair Value Measurements Using |  | \n | CarryingAmount |  | Cost(1) |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | Significant OtherObservable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue\nMarch 31, 2023 |  |  |  |  |  |  |  |  |  |  | \nCash equivalents(2) | $ | 2,343.1 |  |  | $ | 2,343.1 |  |  | $ | 2,330.2 |  |  | $ | 12.9 |  |  | $ | \u2014 |  |  | $ | 2,343.1 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 23.1 |  |  | $ | 23.5 |  |  | $ | 23.1 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 23.1 | \nCorporate debt securities | 50.1 |  |  | 50.2 |  |  | \u2014 |  |  | 50.1 |  |  | \u2014 |  |  | 50.1 | \n |  |  |  |  |  |  |  |  |  |  | \nAsset-backed securities | 2.8 |  |  | 2.8 |  |  | \u2014 |  |  | 2.8 |  |  | \u2014 |  |  | 2.8 | \nOther securities | 47.4 |  |  | 47.4 |  |  | \u2014 |  |  | 28.0 |  |  | 19.4 |  |  | 47.4 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments | $ | 123.4 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 145.2 |  |  | $ | 157.5 |  |  | $ | 145.2 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 145.2 | \n |  |  |  |  |  |  |  |  |  |  | \nCorporate debt securities | 214.8 |  |  | 232.5 |  |  | \u2014 |  |  | 214.8 |  |  | \u2014 |  |  | 214.8 | \nMortgage-backed securities | 155.3 |  |  | 165.2 |  |  | \u2014 |  |  | 155.3 |  |  | \u2014 |  |  | 155.3 | \nAsset-backed securities | 56.8 |  |  | 58.2 |  |  | \u2014 |  |  | 56.8 |  |  | \u2014 |  |  | 56.8 | \nOther securities | 204.0 |  |  | 22.7 |  |  | \u2014 |  |  | 113.8 |  |  | 90.2 |  |  | 204.0 | \nMarketable equity securities | 624.0 |  |  | 475.6 |  |  | 624.0 |  |  | \u2014 |  |  | \u2014 |  |  | 624.0 | \nEquity investments without readily determinable fair values(3) | 516.6 |  |  |  |  |  |  |  |  |  |  | \nEquity method investments(3) | 833.7 |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments | $ | 2,750.4 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDecember 31, 2022 |  |  |  |  |  |  |  |  |  |  | \nCash equivalents(2) | $ | 657.4 |  |  | $ | 657.4 |  |  | $ | 650.4 |  |  | $ | 7.0 |  |  | $ | \u2014 |  |  | $ | 657.4 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 30.8 |  |  | $ | 31.1 |  |  | $ | 30.8 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 30.8 | \nCorporate debt securities | 53.4 |  |  | 53.5 |  |  | \u2014 |  |  | 53.4 |  |  | \u2014 |  |  | 53.4 | \n |  |  |  |  |  |  |  |  |  |  | \nAsset-backed securities | 2.0 |  |  | 2.0 |  |  | \u2014 |  |  | 2.0 |  |  | \u2014 |  |  | 2.0 | \nOther securities | 58.6 |  |  | 58.6 |  |  | \u2014 |  |  | 39.1 |  |  | 19.5 |  |  | 58.6 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments | $ | 144.8 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 146.4 |  |  | $ | 163.2 |  |  | $ | 146.4 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 146.4 | \nCorporate debt securities | 213.9 |  |  | 235.8 |  |  | \u2014 |  |  | 213.9 |  |  | \u2014 |  |  | 213.9 | \nMortgage-backed securities | 149.2 |  |  | 161.5 |  |  | \u2014 |  |  | 149.2 |  |  | \u2014 |  |  | 149.2 | \nAsset-backed securities | 50.6 |  |  | 52.5 |  |  | \u2014 |  |  | 50.6 |  |  | \u2014 |  |  | 50.6 | \nOther securities | 398.6 |  |  | 34.5 |  |  | \u2014 |  |  | 311.0 |  |  | 87.6 |  |  | 398.6 | \nMarketable equity securities | 683.6 |  |  | 484.7 |  |  | 683.6 |  |  | \u2014 |  |  | \u2014 |  |  | 683.6 | \nEquity investments without readily determinable fair values(3) | 478.4 |  |  |  |  |  |  |  |  |  |  | \nEquity method investments(3) | 781.1 |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments | $ | 2,901.8 |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Fair Value Measurements Using |  | \n | CarryingAmount |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | SignificantOther Observable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue\nShort-term commercial paper borrowings |  |  |  |  |  |  |  |  | \nMarch 31, 2023 | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 | \nDecember 31, 2022 | (1,498.0) |  |  | \u2014 |  |  | (1,492.0) |  |  | \u2014 |  |  | (1,492.0) | \nLong-term debt, including current portion |  |  |  |  |  |  |  |  | \nMarch 31, 2023 | $ | (18,883.6) |  |  | $ | \u2014 |  |  | $ | (16,654.6) |  |  | $ | \u2014 |  |  | $ | (16,654.6) | \nDecember 31, 2022 | (14,740.6) |  |  | \u2014 |  |  | (12,329.3) |  |  | \u2014 |  |  | (12,329.3) |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMarch 31, 2023\nPurchase |  | Sell\nCurrency | Amount(in millions) |  | Currency | Amount(in millions)\nU.S. dollars | 2,410.5 |  | Euro | 2,231.4\nEuro | 3,667.4 |  | U.S. dollars | 3,948.6\nU.S. dollars | 229.8 |  | Chinese yuan | 1,574.7\n |  |  |  | \n |  |  |  | \nBritish pounds | 216.7 |  | U.S. dollars | 265.8\n |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2023 |  | 2022 |  |  |  | \nFair value hedges: |  |  |  |  |  |  | \nEffect from hedged fixed-rate debt | $ | 35.3 |  |  | $ | (94.6) |  |  |  |  | \nEffect from interest rate contracts | (35.3) |  |  | 94.6 |  |  |  |  | \nCash flow hedges: |  |  |  |  |  |  | \nEffective portion of losses on interest rate contracts reclassified from accumulated other comprehensive loss | 3.8 |  |  | 4.1 |  |  |  |  | \nCross-currency interest rate swaps | (12.9) |  |  | 8.3 |  |  |  |  | \nNet gains on foreign currency exchange contracts not designated as hedging instruments | (52.8) |  |  | (6.1) |  |  |  |  | \nTotal | $ | (61.9) |  |  | $ | 6.3 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2023 |  | 2022 |  |  |  | \nNet investment hedges: |  |  |  |  |  |  | \nForeign currency-denominated notes | $ | (131.8) |  |  | $ | 54.4 |  |  |  |  | \nCross-currency interest rate swaps | (11.8) |  |  | 10.8 |  |  |  |  | \nForeign currency forward contracts | (46.1) |  |  | \u2014 |  |  |  |  | \nCash flow hedges: |  |  |  |  |  |  | \nForward-starting interest rate swaps | 23.8 |  |  | 122.5 |  |  |  |  | \nCross-currency interest rate swaps | (7.8) |  |  | 17.1 |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Fair Value Measurements Using |  |  |  | \n | CarryingAmount |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | SignificantOther Observable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue |  | \nMarch 31, 2023 |  |  |  |  |  |  |  |  |  |  | \nRisk-management instruments: |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | $ | 2.7 |  |  | $ | \u2014 |  |  | $ | 2.7 |  |  | $ | \u2014 |  |  | $ | 2.7 |  |  | \nOther current liabilities | (9.9) |  |  | \u2014 |  |  | (9.9) |  |  | \u2014 |  |  | (9.9) |  |  | \nOther noncurrent liabilities | (91.8) |  |  | \u2014 |  |  | (91.8) |  |  | \u2014 |  |  | (91.8) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 228.6 |  |  | \u2014 |  |  | 228.6 |  |  | \u2014 |  |  | 228.6 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 55.6 |  |  | \u2014 |  |  | 55.6 |  |  | \u2014 |  |  | 55.6 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 58.2 |  |  | \u2014 |  |  | 58.2 |  |  | \u2014 |  |  | 58.2 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nForeign exchange contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 0.9 |  |  | \u2014 |  |  | 0.9 |  |  | \u2014 |  |  | 0.9 |  |  | \nOther current liabilities | (13.1) |  |  | \u2014 |  |  | (13.1) |  |  | \u2014 |  |  | (13.1) |  |  | \nForeign exchange contracts not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 63.7 |  |  | \u2014 |  |  | 63.7 |  |  | \u2014 |  |  | 63.7 |  |  | \nOther current liabilities | (32.0) |  |  | \u2014 |  |  | (32.0) |  |  | \u2014 |  |  | (32.0) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nContingent consideration liabilities: |  |  |  |  |  |  |  |  |  |  | \nOther current liabilities | (40.1) |  |  | \u2014 |  |  | \u2014 |  |  | (40.1) |  |  | (40.1) |  |  | \nOther noncurrent liabilities | (71.8) |  |  | \u2014 |  |  | \u2014 |  |  | (71.8) |  |  | (71.8) |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Fair Value Measurements Using |  |  |  | \n | CarryingAmount |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | SignificantOther Observable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue |  | \nDecember 31, 2022 |  |  |  |  |  |  |  |  |  |  | \nRisk-management instruments: |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent liabilities | $ | (134.3) |  |  | $ | \u2014 |  |  | $ | (134.3) |  |  | $ | \u2014 |  |  | $ | (134.3) |  |  | \nInterest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 162.9 |  |  | \u2014 |  |  | 162.9 |  |  | \u2014 |  |  | 162.9 |  |  | \nOther noncurrent assets | 246.0 |  |  | \u2014 |  |  | 246.0 |  |  | \u2014 |  |  | 246.0 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 67.6 |  |  | \u2014 |  |  | 67.6 |  |  | \u2014 |  |  | 67.6 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 53.1 |  |  | \u2014 |  |  | 53.1 |  |  | \u2014 |  |  | 53.1 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nForeign exchange contracts designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  | \nOther current liabilities | (38.3) |  |  | \u2014 |  |  | (38.3) |  |  | \u2014 |  |  | (38.3) |  |  | \nForeign exchange contracts not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 26.6 |  |  | \u2014 |  |  | 26.6 |  |  | \u2014 |  |  | 26.6 |  |  | \nOther current liabilities | (21.5) |  |  | \u2014 |  |  | (21.5) |  |  | \u2014 |  |  | (21.5) |  |  | \nContingent consideration liabilities: |  |  |  |  |  |  |  |  |  |  | \nOther current liabilities | (39.5) |  |  | \u2014 |  |  | \u2014 |  |  | (39.5) |  |  | (39.5) |  |  | \nOther noncurrent liabilities | (70.6) |  |  | \u2014 |  |  | \u2014 |  |  | (70.6) |  |  | (70.6) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Defined Benefit Pension Plans\n | Three Months Ended March 31, |  | \n | 2023 |  | 2022 |  |  |  | \nComponents of net periodic (benefit) cost: |  |  |  |  |  |  | \nService cost | $ | 70.4 |  |  | $ | 89.1 |  |  |  |  | \nInterest cost | 161.1 |  |  | 100.5 |  |  |  |  | \nExpected return on plan assets | (263.3) |  |  | (239.5) |  |  |  |  | \nAmortization of prior service cost | 0.6 |  |  | 0.7 |  |  |  |  | \nRecognized actuarial loss | 30.0 |  |  | 87.0 |  |  |  |  | \n |  |  |  |  |  |  | \nNet periodic (benefit) cost | $ | (1.2) |  |  | $ | 37.8 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Retiree Health Benefit Plans\n | Three Months Ended March 31, |  | \n | 2023 |  | 2022 |  |  |  | \nComponents of net periodic benefit: |  |  |  |  |  |  | \nService cost | $ | 7.7 |  |  | $ | 11.2 |  |  |  |  | \nInterest cost | 15.4 |  |  | 9.4 |  |  |  |  | \nExpected return on plan assets | (45.5) |  |  | (37.9) |  |  |  |  | \nAmortization of prior service benefit | (13.2) |  |  | (13.7) |  |  |  |  | \nRecognized actuarial (gain) loss | (0.9) |  |  | 0.2 |  |  |  |  | \n |  |  |  |  |  |  | \nNet periodic benefit | $ | (36.5) |  |  | $ | (30.8) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Net Unrealized Gains (Losses) on Available-For-Sale\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Net Unrealized Gains (Losses) on Cash\u00a0Flow Hedges |  |  |  | Accumulated Other Comprehensive Loss\nBalance at January\u00a01, 2023 | $ | (1,874.2) |  |  | $ | (37.1) |  |  | $ | (2,062.3) |  |  | $ | 129.0 |  |  |  |  | $ | (3,844.6) | \n |  |  |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | 72.8 |  |  | 8.1 |  |  | (16.8) |  |  | 12.7 |  |  |  |  | 76.8 | \nNet amount reclassified from accumulated other comprehensive loss | (25.2) |  |  | 0.7 |  |  | 13.0 |  |  | 2.0 |  |  |  |  | (9.5) | \nNet other comprehensive income (loss) | 47.6 |  |  | 8.8 |  |  | (3.8) |  |  | 14.7 |  |  |  |  | 67.3 | \n |  |  |  |  |  |  |  |  |  |  | \nBalance at March\u00a031, 2023 | $ | (1,826.6) |  |  | $ | (28.3) |  |  | $ | (2,066.1) |  |  | $ | 143.7 |  |  |  |  | $ | (3,777.3) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Net Unrealized Gains (Losses) on Available-For-Sale\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Net Unrealized Gains (Losses) on Cash\u00a0Flow Hedges |  |  |  | Accumulated Other Comprehensive Loss\nBalance at January\u00a01, 2022 | $ | (1,550.2) |  |  | $ | 3.7 |  |  | $ | (2,583.6) |  |  | $ | (213.0) |  |  |  |  | $ | (4,343.1) | \n |  |  |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (25.0) |  |  | (21.3) |  |  | (6.6) |  |  | 109.4 |  |  |  |  | 56.5 | \nNet amount reclassified from accumulated other comprehensive loss | \u2014 |  |  | (0.5) |  |  | 58.6 |  |  | 3.2 |  |  |  |  | 61.3 | \nNet other comprehensive income (loss) | (25.0) |  |  | (21.8) |  |  | 52.0 |  |  | 112.6 |  |  |  |  | 117.8 | \n |  |  |  |  |  |  |  |  |  |  | \nBalance at March\u00a031, 2022 | $ | (1,575.2) |  |  | $ | (18.1) |  |  | $ | (2,531.6) |  |  | $ | (100.4) |  |  |  |  | $ | (4,225.3) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \nTax benefit (expense) | 2023 |  | 2022 |  |  |  | \nForeign currency translation gains/losses | $ | 46.5 |  |  | $ | (13.7) |  |  |  |  | \nNet unrealized gains/losses on available-for-sale securities | (2.6) |  |  | 6.7 |  |  |  |  | \nDefined benefit pension and retiree health benefit plans | (4.0) |  |  | (28.4) |  |  |  |  | \nNet unrealized gains/losses on cash flow hedges | (3.9) |  |  | (29.9) |  |  |  |  | \nBenefit (expense) for income taxes allocated to other comprehensive income (loss) items | $ | 36.0 |  |  | $ | (65.3) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nDetails about Accumulated Other Comprehensive Loss Components |  | Three Months Ended March 31, |  |  | Affected Line Item in the Consolidated Condensed Statements of Operations\n\n | 2023 |  | 2022 |  |  |  | \nAmortization of retirement benefit items: |  |  |  |  |  |  |  |  | \nPrior service benefits, net |  | $ | (12.6) |  |  | $ | (13.0) |  |  |  |  |  | Other\u2013net, (income) expense\nActuarial losses, net |  | 29.1 |  |  | 87.2 |  |  |  |  |  | Other\u2013net, (income) expense\nTotal before tax |  | 16.5 |  |  | 74.2 |  |  |  |  |  | \nTax benefit |  | (3.5) |  |  | (15.6) |  |  |  |  |  | Income taxes\nNet of tax |  | 13.0 |  |  | 58.6 |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \nOther, net of tax |  | (22.5) |  |  | 2.7 |  |  |  |  |  | Other\u2013net, (income) expense\n |  |  |  |  |  |  |  |  | \nTotal reclassifications, net of tax |  | $ | (9.5) |  |  | $ | 61.3 |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2023 |  | 2022 |  |  |  | \nInterest expense | $ | 102.8 |  |  | $ | 84.9 |  |  |  |  | \nInterest income | (34.2) |  |  | (7.0) |  |  |  |  | \nNet investment losses on equity securities (Note 5) | 13.7 |  |  | 425.4 |  |  |  |  | \nRetirement benefit plans | (115.8) |  |  | (93.3) |  |  |  |  | \n |  |  |  |  |  |  | \nOther (income) expense | (2.2) |  |  | (59.3) |  |  |  |  | \nOther\u2013net, (income) expense | $ | (35.7) |  |  | $ | 350.7 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  |  |  |  |  | \n | 2023 |  | 2022 |  | Percent Change |  |  |  |  |  | \nRevenue | $ | 6,960.0 |  |  | $ | 7,810.0 |  |  | (11) |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNet income | 1,344.9 |  |  | 1,902.9 |  |  | (29) |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nEarnings per share - diluted | 1.49 |  |  | 2.10 |  |  | (29) |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication | Status | Developments | \nDiabetes and Obesity | \n |  |  |  | \nEmpagliflozin (Jardiance\u00ae)(1) | Chronic kidney disease | Submitted | Granted U.S. Food and Drug Administration (FDA) Fast Track designation(2). Submitted in Japan in 2022 and in the U.S. and Europe in the first quarter of 2023. | \nTirzepatide (Mounjaro) | Obesity | Submitted | Submitted in Europe in the first quarter of 2023. Granted FDA Fast Track designation(2). Initiated a rolling submission in the U.S. in 2022. Announced in April 2023 that a Phase III trial met co-primary and all key secondary endpoints. Phase III trials are ongoing. | \nHeart failure with preserved ejection fraction | Phase III | Phase III trials are ongoing. | \nObstructive sleep apnea | Phase III | Granted FDA Fast Track designation(2). Phase III trial is ongoing. | \nNonalcoholic steatohepatitis | Phase II | Phase II trial is ongoing. | \nInsulin Efsitora Alfa(Basal Insulin-Fc) | Type 1 and 2 diabetes | Phase III | Phase III trials are ongoing. | \nLP(a) siRNA | Cardiovascular disease | Phase II | Phase II trial is ongoing. | \nMuvalaplin(LP(a) Inhibitor) | Cardiovascular disease | Phase II | Phase II trial is ongoing. | \nOrforglipron | Obesity | Phase II | Phase II trials were completed. | \nType 2 diabetes | \nRelaxin-LA | Heart failure | Phase II | Phase II trial initiated in the first quarter of 2023. | \nRetatrutide | Obesity | Phase II | Phase II trials were completed. | \nType 2 diabetes | \nSolbinsiran(ANGPTL3 siRNA) | Cardiovascular disease | Phase II | Phase II trial is ongoing. |   |  |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication | Status | Developments | \nImmunology | \nMirikizumab(Omvoh\u00ae) | Ulcerative colitis | Approved | Approved in Japan in the first quarter of 2023. Submitted in the U.S. and Europe in 2022. Received a complete response letter from the FDA in April 2023. Received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in Europe in the first quarter of 2023. | \nCrohn's Disease | Phase III | Phase III trials are ongoing. | \nLebrikizumab(3) | Atopic dermatitis | Submitted | Submitted in the U.S. and Europe in 2022 and in Japan in the first quarter of 2023. Phase III trials are ongoing. | \nBTLA MAB Agonist | Systemic lupus erythematosus | Phase II | Phase II trial is ongoing. | \nEltrekibart(CXCR1/2 Ligands Monoclonal Antibody) | Hidradenitis suppurativa | Phase II | Phase II trial is ongoing. | \nPeresolimab | Rheumatoid arthritis | Phase II | Phase II trial is ongoing. | \nRezpegaldesleukin | Systemic lupus erythematosus | Discontinued | Phase II trial failed to meet primary endpoint in the first quarter of 2023. | \n |  |  | \nNeuroscience | \nDonanemab | Early Alzheimer's disease | Complete Response Letter | Granted FDA Breakthrough Therapy designation(4). Submitted in the U.S. in 2022 under the accelerated approval pathway. Received a complete response letter from the FDA in the first quarter of 2023 for the accelerated approval submission. Phase III trials are ongoing. | \nPreclinical Alzheimer's disease | Phase III | Phase III trial is ongoing. | \nRemternetug | Early Alzheimer's disease | Phase III | Phase III trial is ongoing. | \nGBA1 Gene Therapy (PR001) | Gaucher disease Type 1 | Phase II | Phase II trial initiated in April 2023. | \nParkinson's disease | Phase II | Granted FDA Fast Track designation(2). Phase II trial is ongoing. | \nGRN Gene Therapy (PR006) | Frontotemporal dementia | Phase II | Granted FDA Fast Track designation(2). Phase II trial is ongoing. | \nO-GlcNAcase Inh | Alzheimer's disease | Phase II | Phase II trial is ongoing. | \nP2X7 Inhibitor | Pain | Phase II | Phase II trials are ongoing. | \nSSTR4 Agonist | Pain | Phase II | Phase II trials are ongoing. | \nSolanezumab | Preclinical Alzheimer's disease | Discontinued | Phase III trial failed to meet primary and secondary endpoints in the first quarter of 2023. | \nTRPA1 Antagonist | Pain | Discontinued | Phase II trials discontinued in the first quarter of 2023. |   |  |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication | Status | Developments | \nOncology | \nPirtobrutinib(Jaypirca\u00ae) | Mantle cell lymphoma | Approved(5) | FDA granted accelerated approval(5)in the U.S. in the first quarter of 2023. Submitted in Europe in 2022. Received a positive opinion from the CHMP in Europe in April 2023. Phase III trial is ongoing. | \nChronic lymphocytic leukemia | Phase III | Phase III trials are ongoing. | \nB-cell malignancies | Phase II | Phase II trial is ongoing. | \nSelpercatinib (Retevmo\u00ae) | Lung cancer | Approved(5) | Phase III trials are ongoing. | \nThyroid cancer | Approved(5) | Phase III trial is ongoing. | \nAbemaciclib (Verzenio\u00ae) | Prostate cancer | Phase III | Phase III trials are ongoing. | \nImlunestrant | Adjuvant breast cancer | Phase III | Phase III trial is ongoing. | \nER+HER2- metastatic breast cancer | Phase III | Phase III trial is ongoing. |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  |  |  |  | \n | 2023 |  | 2022 |  | Percent Change |  |  |  |  | \nU.S. | $ | 4,436.2 |  |  | $ | 5,174.6 |  |  | (14) |  |  |  |  | \nOutside U.S. | 2,523.9 |  |  | 2,635.4 |  |  | (4) |  |  |  |  | \nRevenue | $ | 6,960.0 |  |  | $ | 7,810.0 |  |  | (11) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | 2023 vs. 2022 |  | \n | U.S. | Outside U.S. | Consolidated |  |  |  | \nVolume | (10) | % | 7 | % | (4) | % |  |  |  | \nPrice | (5) |  | (5) |  | (5) |  |  |  |  | \nForeign exchange rates | \u2014 |  | (6) |  | (2) |  |  |  |  | \nPercent change | (14) | % | (4) | % | (11) | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | Percent Change | \n | 2023 |  | 2022 | \nProduct | U.S. |  | Outside U.S. |  | Total |  | Total | \nTrulicity | $ | 1,547.4 |  |  | $ | 429.7 |  |  | $ | 1,977.1 |  |  | $ | 1,741.3 |  |  | 14 | \nVerzenio | 461.1 |  |  | 289.8 |  |  | 750.9 |  |  | 469.4 |  |  | 60 | \nJardiance(1) | 329.4 |  |  | 248.1 |  |  | 577.5 |  |  | 419.4 |  |  | 38 | \nMounjaro | 536.4 |  |  | 32.0 |  |  | 568.5 |  |  | \u2014 |  |  | NM | \nTaltz | 312.2 |  |  | 214.8 |  |  | 527.0 |  |  | 488.1 |  |  | 8 | \nHumalog(2) | 271.6 |  |  | 189.3 |  |  | 460.9 |  |  | 618.2 |  |  | (25) | \nHumulin\u00ae | 198.8 |  |  | 53.2 |  |  | 252.0 |  |  | 273.2 |  |  | (8) | \nCyramza\u00ae | 100.6 |  |  | 136.1 |  |  | 236.8 |  |  | 230.3 |  |  | 3 | \nOlumiant\u00ae (3) | 42.3 |  |  | 186.5 |  |  | 228.9 |  |  | 255.6 |  |  | (10) | \nBasaglar\u00ae | 135.4 |  |  | 73.9 |  |  | 209.3 |  |  | 191.5 |  |  | 9 | \nEmgality\u00ae | 108.7 |  |  | 45.6 |  |  | 154.3 |  |  | 149.3 |  |  | 3 | \nErbitux\u00ae | 118.8 |  |  | 11.1 |  |  | 129.9 |  |  | 122.7 |  |  | 6 | \nForteo\u00ae | 70.7 |  |  | 51.7 |  |  | 122.3 |  |  | 137.4 |  |  | (11) | \nCialis | 7.6 |  |  | 92.7 |  |  | 100.3 |  |  | 217.7 |  |  | (54) | \nAlimta | 20.1 |  |  | 38.1 |  |  | 58.2 |  |  | 343.9 |  |  | (83) | \nCOVID-19 antibodies(4) | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1,469.8 |  |  | (100) | \nOther products | 175.1 |  |  | 431.3 |  |  | 606.1 |  |  | 682.2 |  |  | (11) | \nRevenue | $ | 4,436.2 |  |  | $ | 2,523.9 |  |  | $ | 6,960.0 |  |  | $ | 7,810.0 |  |  | (11) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, |  |  |  |  |  | \n | 2023 |  | 2022 |  | Percent Change |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nGross margin | $ | 5,333.3 |  |  | $ | 5,737.9 |  |  | (7) |  |  |  |  |  | \nGross margin as a percent of revenue | 76.6 | % |  | 73.5 | % |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nResearch and development | $ | 1,985.1 |  |  | $ | 1,610.1 |  |  | 23 |  |  |  |  |  | \nMarketing, selling, and administrative | 1,749.2 |  |  | 1,557.9 |  |  | 12 |  |  |  |  |  | \nAcquired in-process research and development (IPR&D) | 105.0 |  |  | 165.6 |  |  | (37) |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther\u2013net, (income) expense | (35.7) |  |  | 350.7 |  |  | NM |  |  |  |  |  | \nIncome taxes | 184.8 |  |  | 150.7 |  |  | 23 |  |  |  |  |  | \nEffective tax rate | 12.1 | % |  | 7.3 | % |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number ofShares Purchased(in thousands) |  | Average\u00a0Price Paidper Share |  | Total\u00a0Number of SharesPurchased\u00a0as Part ofPublicly AnnouncedPlans or Programs(in thousands) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(in millions)\nJanuary 2023 | \u2014 |  |  | $ | \u2014 |  |  | \u2014 |  |  | $ | 3,250.0 | \nFebruary 2023 | 1,210 |  |  | 326.24 |  |  | 1,210 |  |  | 2,855.4 | \nMarch 2023 | 1,089 |  |  | 326.34 |  |  | 1,089 |  |  | 2,500.0 | \nTotal | 2,299 |  |  | 326.29 |  |  | 2,299 |  |  |   |  |  |  |  |  |  |  | \nExhibit |  | Description\n3.1 |  | Amended Articles of Incorporation,incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on May 4, 2022\n |  | \n3.2 |  | Bylaws, as amended,incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed on May 4, 2022\n |  | \n31.1 |  | Rule\u00a013a-14(a) Certification of David Ricks, Chair, President, and Chief Executive Officer*\n |  | \n31.2 |  | Rule\u00a013a-14(a) Certification of Anat Ashkenazi, Executive Vice President and Chief Financial Officer*\n | \n32 |  | Section 1350 Certification*\n |  | \n101 |  | Interactive Data Files (embedded within the Inline XBRL document)*\n |  | \n104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*\n\n* Filed herewith.  |  |  |  |  |  |  |  | \n |  | ELI LILLY AND COMPANY\n |  | (Registrant)\n |  | \nDate: | April 27, 2023 | /s/ Anat Ashkenazi\n |  | Anat Ashkenazi\n |  | Executive Vice President and Chief Financial Officer\nDate: | April 27, 2023 | /s/ Donald Zakrowski\n |  | Donald Zakrowski\n |  | Senior Vice President, Finance, and Chief Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Eli Lilly, in 2023 Q2, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  |  |  |  | \nIndiana |  | 35-0470950\n(State or other jurisdiction of |  | (I.R.S. Employer\nincorporation or organization) |  | Identification No.)  |  |  |  |  |  |  |  | \nTitle of Each Class | Trading Symbols | Name of Each Exchange On Which Registered\nCommon Stock (no par value) | LLY | New York Stock Exchange\n7 1/8% Notes due 2025 | LLY25 | New York Stock Exchange\n1.625% Notes due 2026 | LLY26 | New York Stock Exchange\n2.125% Notes due 2030 | LLY30 | New York Stock Exchange\n0.625% Notes due 2031 | LLY31 | New York Stock Exchange\n0.500% Notes due 2033 | LLY33 | New York Stock Exchange\n6.77%\u00a0Notes due 2036 | LLY36 | New York Stock Exchange\n1.625% Notes due 2043 | LLY43 | New York Stock Exchange\n1.700% Notes due 2049 | LLY49A | New York Stock Exchange\n1.125% Notes due 2051 | LLY51 | New York Stock Exchange\n1.375% Notes due 2061 | LLY61 | New York Stock Exchange  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 |  |  |  |  | Accelerated\u00a0filer | \u2610\nNon-accelerated filer | \u2610 |  |  | Smaller reporting company | \u2610\n |  |  |  |  |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \nClass |  | Number of Shares Outstanding\nCommon |  | 949,295,173 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | Page\nPART I. Financial Information |  |  |  | 5\n |  |  |  | \nItem 1. |  | Financial Statements |  | 5\n |  | Consolidated Condensed Statements of Operations |  | 5\n |  | Consolidated Condensed Statements of Comprehensive Income |  | 6\n |  | Consolidated Condensed Balance Sheets |  | 7\n |  | Consolidated Condensed Statements of Equity |  | 8\n |  | Consolidated Condensed Statements of Cash Flows |  | 10\n |  | Notes to Consolidated Condensed Financial Statements |  | 11\nItem 2. |  | Management's Discussion and Analysis of Results of Operations and Financial Condition |  | 36\n |  | Executive Overview |  | 36\n |  | Results of Operations |  | 42\n |  | Financial Condition and Liquidity |  | 46\n |  |  |  | \n |  | Critical Accounting Estimates |  | 47\n |  | Available Information on our Website |  | 47\nItem 3. |  | Quantitative and Qualitative Disclosures About Market Risk |  | 48\nItem 4. |  | Controls and Procedures |  | 48\n |  |  |  | \nPART II. Other Information |  |  |  | 49\n |  |  |  | \nItem 1. |  | Legal Proceedings |  | 49\nItem 1A. |  | Risk Factors |  | 49\nItem 2. |  | Unregistered Sales of Equity Securities and Use of Proceeds |  | 49\nItem 5. |  | Other Information |  | 49\nItem 6. |  | Exhibits |  | 50\n |  |  |  | \nSignatures |  |  |  | 50  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nRevenue (Note 2) | $ | 8,312.1 |  |  | $ | 6,488.0 |  |  | $ | 15,272.1 |  |  | $ | 14,298.0 | \nCosts, expenses, and other: |  |  |  |  |  |  | \nCost of sales | 1,807.4 |  |  | 1,430.5 |  |  | 3,434.1 |  |  | 3,502.6 | \nResearch and development | 2,356.5 |  |  | 1,781.9 |  |  | 4,341.6 |  |  | 3,392.0 | \nMarketing, selling, and administrative | 1,925.4 |  |  | 1,625.1 |  |  | 3,674.6 |  |  | 3,183.0 | \nAcquired in-process research and development (Note 3) | 97.1 |  |  | 440.4 |  |  | 202.1 |  |  | 606.0 | \n |  |  |  |  |  |  | \nOther\u2013net, (income) expense (Note 10) | 36.8 |  |  | 119.2 |  |  | 1.1 |  |  | 469.9 | \n | 6,223.2 |  |  | 5,397.1 |  |  | 11,653.5 |  |  | 11,153.5 | \nIncome before income taxes | 2,088.9 |  |  | 1,090.9 |  |  | 3,618.6 |  |  | 3,144.5 | \nIncome taxes (Note 6) | 325.7 |  |  | 138.4 |  |  | 510.5 |  |  | 289.1 | \nNet income | $ | 1,763.2 |  |  | $ | 952.5 |  |  | $ | 3,108.1 |  |  | $ | 2,855.4 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nEarnings per share: |  |  |  |  |  |  | \nBasic | $ | 1.96 |  |  | $ | 1.06 |  |  | $ | 3.45 |  |  | $ | 3.17 | \n |  |  |  |  |  |  | \nDiluted | $ | 1.95 |  |  | $ | 1.05 |  |  | $ | 3.44 |  |  | $ | 3.16 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nShares used in calculation of earnings per share: |  |  |  |  |  |  | \nBasic | 899.7 |  | 900.3 |  | 900.3 |  | 902.0\nDiluted | 902.7 |  | 902.9 |  | 903.0 |  | 904.4  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nNet income | $ | 1,763.2 |  |  | $ | 952.5 |  |  | $ | 3,108.1 |  |  | $ | 2,855.4 | \nOther comprehensive income (loss), net of tax (Note 9) | (11.4) |  |  | (62.4) |  |  | 55.9 |  |  | 55.4 | \nComprehensive income | $ | 1,751.8 |  |  | $ | 890.1 |  |  | $ | 3,164.0 |  |  | $ | 2,910.8 |   |  |  |  |  |  |  |  |  |  |  | \n | June 30, 2023 |  | December 31, 2022\nAssets | (Unaudited) |  | \nCurrent Assets |  |  | \nCash and cash equivalents (Note 5) | $ | 2,694.5 |  |  | $ | 2,067.0 | \nShort-term investments (Note 5) | 134.6 |  |  | 144.8 | \nAccounts receivable, net of allowances of$13.8(2023)and $16.0(2022) | 7,516.1 |  |  | 6,896.0 | \nOther receivables | 1,655.3 |  |  | 1,662.9 | \nInventories | 4,798.7 |  |  | 4,309.7 | \nPrepaid expenses and other current assets | 4,532.4 |  |  | 2,954.1 | \nTotal current assets | 21,331.6 |  |  | 18,034.5 | \nInvestments (Note 5) | 2,745.1 |  |  | 2,901.8 | \nGoodwill | 4,078.9 |  |  | 4,073.0 | \nOther intangibles, net | 6,903.5 |  |  | 7,206.6 | \nDeferred tax assets | 3,805.9 |  |  | 2,792.9 | \nProperty and equipment, net of accumulated depreciation of$10,631.6(2023)and $10,233.4(2022) | 11,277.4 |  |  | 10,144.0 | \nOther noncurrent assets | 4,671.6 |  |  | 4,337.0 | \nTotal assets | $ | 54,814.0 |  |  | $ | 49,489.8 | \nLiabilities and Equity |  |  | \nCurrent Liabilities |  |  | \nShort-term borrowings and current maturities of long-term debt | $ | 661.6 |  |  | $ | 1,501.1 | \nAccounts payable | 2,474.2 |  |  | 1,930.6 | \nEmployee compensation | 867.7 |  |  | 1,059.8 | \nSales rebates and discounts | 10,389.9 |  |  | 8,784.1 | \nDividends payable | 1,016.2 |  |  | 1,017.2 | \nIncome taxes payable | 1,233.8 |  |  | 475.1 | \nOther current liabilities | 2,271.6 |  |  | 2,370.3 | \nTotal current liabilities | 18,915.0 |  |  | 17,138.2 | \nOther Liabilities |  |  | \nLong-term debt | 18,158.4 |  |  | 14,737.5 | \nAccrued retirement benefits (Note 7) | 1,308.8 |  |  | 1,305.1 | \nLong-term income taxes payable | 3,330.7 |  |  | 3,709.6 | \nOther noncurrent liabilities | 1,951.8 |  |  | 1,824.0 | \nTotal other liabilities | 24,749.7 |  |  | 21,576.2 | \nCommitments and Contingencies (Note 8) |  |  | \nEli Lilly and Company Shareholders' Equity |  |  | \nCommon stock | 593.6 |  |  | 594.1 | \nAdditional paid-in capital | 6,948.6 |  |  | 6,921.4 | \nRetained earnings | 10,368.5 |  |  | 10,042.6 | \nEmployee benefit trust | (3,013.2) |  |  | (3,013.2) | \nAccumulated other comprehensive loss (Note 9) | (3,788.7) |  |  | (3,844.6) | \nCost of common stock in treasury | (45.0) |  |  | (50.5) | \nTotal Eli Lilly and Company shareholders' equity | 11,063.8 |  |  | 10,649.8 | \nNoncontrolling interests | 85.5 |  |  | 125.6 | \nTotal equity | 11,149.3 |  |  | 10,775.4 | \nTotal liabilities and equity | $ | 54,814.0 |  |  | $ | 49,489.8 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Equity of Eli Lilly and Company Shareholders |  | \n(Dollars in millions, except per-share data, and shares in thousands) | Common Stock |  | AdditionalPaid-inCapital |  | RetainedEarnings |  | Employee Benefit Trust |  | Accumulated Other Comprehensive Loss |  | Common Stock in Treasury(1) |  | Noncontrolling Interests\nShares |  | Amount | Shares |  | Amount\nBalance at April\u00a01, 2022 | 950,605 |  |  | $ | 594.1 |  |  | $ | 6,656.3 |  |  | $ | 9,369.4 |  |  | $ | (3,013.2) |  |  | $ | (4,225.3) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 131.2 | \nNet income (loss) |  |  |  |  |  |  | 952.5 |  |  |  |  |  |  |  |  |  |  | (11.4) | \nOther comprehensive loss, net of tax |  |  |  |  |  |  |  |  |  |  | (62.4) |  |  |  |  |  |  | \nCash dividends declared per share: $1.96 |  |  |  |  |  |  | (1,765.9) |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIssuance of stock under employee stock plans, net | 14 |  |  |  |  | (2.4) |  |  |  |  |  |  |  |  |  |  |  |  | \nStock-based compensation |  |  |  |  | 92.1 |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (5.3) | \nBalance at June\u00a030, 2022 | 950,619 |  |  | $ | 594.1 |  |  | $ | 6,746.0 |  |  | $ | 8,556.0 |  |  | $ | (3,013.2) |  |  | $ | (4,287.7) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 114.5 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance at April\u00a01, 2023 | 949,669 |  |  | $ | 593.5 |  |  | $ | 6,793.1 |  |  | $ | 10,639.3 |  |  | $ | (3,013.2) |  |  | $ | (3,777.3) |  |  | 402 |  |  | $ | (45.0) |  |  | $ | 104.5 | \nNet income (loss) |  |  |  |  |  |  | 1,763.2 |  |  |  |  |  |  |  |  |  |  | (9.5) | \nOther comprehensive loss, net of tax |  |  |  |  |  |  |  |  |  |  | (11.4) |  |  |  |  |  |  | \nCash dividends declared per share: $2.26 |  |  |  |  |  |  | (2,034.0) |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIssuance of stock under employee stock plans, net | 19 |  |  | 0.1 |  |  | (6.0) |  |  |  |  |  |  |  |  |  |  |  |  | \nStock-based compensation |  |  |  |  | 161.5 |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (9.5) | \nBalance at June\u00a030, 2023 | 949,688 |  |  | $ | 593.6 |  |  | $ | 6,948.6 |  |  | $ | 10,368.5 |  |  | $ | (3,013.2) |  |  | $ | (3,788.7) |  |  | 402 |  |  | $ | (45.0) |  |  | $ | 85.5 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Equity of Eli Lilly and Company Shareholders |  | \n(Dollars in millions, except per-share data, and shares in thousands) | Common Stock |  | AdditionalPaid-inCapital |  | RetainedEarnings |  | Employee Benefit Trust |  | Accumulated Other Comprehensive Loss |  | Common Stock in Treasury(1) |  | Noncontrolling Interests\nShares |  | Amount | Shares |  | Amount\nBalance at January\u00a01, 2022 | 954,116 |  |  | $ | 596.3 |  |  | $ | 6,833.4 |  |  | $ | 8,958.5 |  |  | $ | (3,013.2) |  |  | $ | (4,343.1) |  |  | 463 |  |  | $ | (52.7) |  |  | $ | 175.6 | \nNet income (loss) |  |  |  |  |  |  | 2,855.4 |  |  |  |  |  |  |  |  |  |  | (48.0) | \nOther comprehensive income, net of tax |  |  |  |  |  |  |  |  |  |  | 55.4 |  |  |  |  |  |  | \nCash dividends declared per share: $1.96 |  |  |  |  |  |  | (1,765.9) |  |  |  |  |  |  |  |  |  |  | \nRetirement of treasury shares | (5,607) |  |  | (3.5) |  |  |  |  | (1,496.5) |  |  |  |  |  |  | (5,607) |  |  | 1,500.0 |  |  | \nPurchase of treasury shares |  |  |  |  |  |  |  |  |  |  |  |  | 5,607 |  |  | (1,500.0) |  |  | \nIssuance of stock under employee stock plans, net | 2,110 |  |  | 1.3 |  |  | (280.5) |  |  |  |  |  |  |  |  | (13) |  |  | 2.2 |  |  | \nStock-based compensation |  |  |  |  | 193.1 |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  | 4.5 |  |  |  |  |  |  |  |  |  |  | (13.1) | \nBalance at June\u00a030, 2022 | 950,619 |  |  | $ | 594.1 |  |  | $ | 6,746.0 |  |  | $ | 8,556.0 |  |  | $ | (3,013.2) |  |  | $ | (4,287.7) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 114.5 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance at January\u00a01, 2023 | 950,632 |  |  | $ | 594.1 |  |  | $ | 6,921.4 |  |  | $ | 10,042.6 |  |  | $ | (3,013.2) |  |  | $ | (3,844.6) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 125.6 | \nNet income |  |  |  |  |  |  | 3,108.1 |  |  |  |  |  |  |  |  |  |  | 0.5 | \nOther comprehensive income, net of tax |  |  |  |  |  |  |  |  |  |  | 55.9 |  |  |  |  |  |  | \nCash dividends declared per share: $2.26 |  |  |  |  |  |  | (2,034.0) |  |  |  |  |  |  |  |  |  |  | \nRetirement of treasury shares | (2,299) |  |  | (1.4) |  |  |  |  | (748.6) |  |  |  |  |  |  | (2,299) |  |  | 750.0 |  |  | \nPurchase of treasury shares |  |  |  |  |  |  |  |  |  |  |  |  | 2,299 |  |  | (750.0) |  |  | \nIssuance of stock under employee stock plans, net | 1,355 |  |  | 0.9 |  |  | (265.5) |  |  |  |  |  |  |  |  | (48) |  |  | 8.8 |  |  | \nStock-based compensation |  |  |  |  | 292.7 |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  | 0.4 |  |  |  |  |  |  |  |  | (3.3) |  |  | (40.6) | \nBalance at June\u00a030, 2023 | 949,688 |  |  | $ | 593.6 |  |  | $ | 6,948.6 |  |  | $ | 10,368.5 |  |  | $ | (3,013.2) |  |  | $ | (3,788.7) |  |  | 402 |  |  | $ | (45.0) |  |  | $ | 85.5 |   |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended June 30,\n | 2023 |  | 2022\nCash Flows from Operating Activities | \nNet income | $ | 3,108.1 |  |  | $ | 2,855.4 | \nAdjustments to Reconcile Net Income to Cash Flows from Operating Activities: |  |  | \n |  |  | \nDepreciation and amortization | 728.6 |  |  | 784.6 | \nChange in deferred income taxes | (990.5) |  |  | (1,125.0) | \n |  |  | \nStock-based compensation expense | 292.7 |  |  | 193.1 | \n |  |  | \nNet investment losses | 80.0 |  |  | 545.6 | \nAcquired in-process research and development | 202.1 |  |  | 606.0 | \nOther changes in operating assets and liabilities, net of acquisitions and divestitures | (676.1) |  |  | (104.2) | \nOther operating activities, net | (382.4) |  |  | (49.2) | \nNet Cash Provided by Operating Activities | 2,362.5 |  |  | 3,706.3 | \nCash Flows from Investing Activities |  |  | \nPurchases of property and equipment | (1,406.7) |  |  | (736.4) | \nProceeds from sales and maturities of short-term investments | 109.6 |  |  | 57.6 | \nPurchases of short-term investments | (59.8) |  |  | (32.9) | \nProceeds from sales of and distributions from noncurrent investments | 388.4 |  |  | 168.5 | \nPurchases of noncurrent investments | (343.4) |  |  | (251.4) | \n |  |  | \n |  |  | \nPurchases of in-process research and development | (333.1) |  |  | (958.2) | \nOther investing activities, net | 497.1 |  |  | (111.3) | \nNet Cash Used for Investing Activities | (1,147.9) |  |  | (1,864.1) | \nCash Flows from Financing Activities |  |  | \nDividends paid | (2,035.0) |  |  | (1,769.2) | \nNet change in short-term borrowings | (1,498.0) |  |  | 2,117.2 | \nProceeds from issuance of long-term debt | 3,958.5 |  |  | \u2014 | \nRepayments of long-term debt | \u2014 |  |  | (1,560.0) | \nPurchases of common stock | (750.0) |  |  | (1,500.0) | \n |  |  | \nOther financing activities, net | (296.6) |  |  | (290.0) | \nNet Cash Used for Financing Activities | (621.1) |  |  | (3,002.0) | \nEffect of exchange rate changes on cash and cash equivalents | 34.0 |  |  | (35.8) | \n |  |  | \nNet increase (decrease) in cash and cash equivalents | 627.5 |  |  | (1,195.6) | \nCash and cash equivalents at January\u00a01 | 2,067.0 |  |  | 3,818.5 | \nCash and Cash Equivalents at June 30 | $ | 2,694.5 |  |  | $ | 2,622.9 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nNet product revenue | $ | 6,979.8 |  |  | $ | 5,870.9 |  |  | $ | 13,218.0 |  |  | $ | 13,003.8 | \nCollaboration and other revenue(1) | 1,332.3 |  |  | 617.1 |  |  | 2,054.1 |  |  | 1,294.2 | \nRevenue | $ | 8,312.1 |  |  | $ | 6,488.0 |  |  | $ | 15,272.1 |  |  | $ | 14,298.0 |   |  |  |  |  |  |  |  |  |  |  | \n | June 30, 2023 |  | December 31, 2022\nContract liabilities | $ | 211.1 |  |  | $ | 219.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30,\n | 2023 |  | 2022\n | U.S. | Outside U.S. | Total |  | U.S. | Outside U.S. | Total\n |  |  |  |  |  |  | \nDiabetes: |  |  |  |  |  |  | \nTrulicity\u00ae | $ | 1,371.3 |  | $ | 441.2 |  | $ | 1,812.5 |  |  | $ | 1,430.1 |  | $ | 481.7 |  | $ | 1,911.9 | \nMounjaro\u00ae | 915.7 |  | 64.0 |  | 979.7 |  |  | 12.6 |  | 3.4 |  | 16.0 | \nJardiance(1) | 386.1 |  | 282.2 |  | 668.3 |  |  | 250.7 |  | 210.3 |  | 461.0 | \nBaqsimi | 606.2 |  | 7.7 |  | 613.9 |  |  | 21.8 |  | 7.2 |  | 29.0 | \nHumalog\u00ae (2) | 229.8 |  | 210.6 |  | 440.4 |  |  | 238.8 |  | 208.3 |  | 447.1 | \nHumulin\u00ae | 144.3 |  | 61.0 |  | 205.3 |  |  | 202.3 |  | 71.7 |  | 274.0 | \nBasaglar\u00ae (3) | 83.0 |  | 71.2 |  | 154.2 |  |  | 95.8 |  | 78.4 |  | 174.2 | \nOther diabetes | 45.0 |  | 91.6 |  | 136.6 |  |  | 40.1 |  | 85.0 |  | 125.0 | \nTotal diabetes | 3,781.4 |  | 1,229.5 |  | 5,010.9 |  |  | 2,292.2 |  | 1,146.0 |  | 3,438.2 | \n |  |  |  |  |  |  | \nOncology: |  |  |  |  |  |  | \nVerzenio\u00ae | 588.6 |  | 338.2 |  | 926.8 |  |  | 384.3 |  | 204.2 |  | 588.5 | \nCyramza\u00ae | 115.0 |  | 145.3 |  | 260.3 |  |  | 92.6 |  | 138.6 |  | 231.3 | \nErbitux\u00ae | 145.5 |  | 17.0 |  | 162.5 |  |  | 125.1 |  | 15.7 |  | 140.8 | \nAlimta\u00ae | 17.9 |  | 43.1 |  | 60.9 |  |  | 171.7 |  | 56.1 |  | 227.7 | \nOther oncology | 68.0 |  | 192.4 |  | 260.5 |  |  | 45.3 |  | 135.2 |  | 180.4 | \nTotal oncology | 935.0 |  | 736.0 |  | 1,671.0 |  |  | 819.0 |  | 549.8 |  | 1,368.7 | \n |  |  |  |  |  |  | \nImmunology: |  |  |  |  |  |  | \nTaltz\u00ae | 472.3 |  | 231.6 |  | 703.9 |  |  | 411.6 |  | 194.7 |  | 606.2 | \nOlumiant\u00ae (4) | 50.8 |  | 168.1 |  | 218.9 |  |  | 10.4 |  | 175.8 |  | 186.2 | \nOther immunology | \u2014 |  | 5.7 |  | 5.7 |  |  | \u2014 |  | 4.0 |  | 4.0 | \nTotal immunology | 523.1 |  | 405.4 |  | 928.5 |  |  | 422.0 |  | 374.5 |  | 796.5 | \n |  |  |  |  |  |  | \nNeuroscience: |  |  |  |  |  |  | \nEmgality\u00ae | 118.8 |  | 50.5 |  | 169.3 |  |  | 108.6 |  | 48.9 |  | 157.5 | \n |  |  |  |  |  |  | \nOther neuroscience | 42.1 |  | 175.8 |  | 217.9 |  |  | 36.2 |  | 196.3 |  | 232.4 | \nTotal neuroscience | 160.9 |  | 226.3 |  | 387.2 |  |  | 144.8 |  | 245.2 |  | 389.9 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nOther: |  |  |  |  |  |  | \nForteo\u00ae | 97.4 |  | 50.6 |  | 148.0 |  |  | 78.5 |  | 60.0 |  | 138.5 | \nCialis\u00ae | 9.2 |  | 106.4 |  | 115.6 |  |  | 10.8 |  | 136.2 |  | 147.0 | \nCOVID-19 antibodies(5) | \u2014 |  | \u2014 |  | \u2014 |  |  | 129.1 |  | \u2014 |  | 129.1 | \nOther | 24.4 |  | 26.5 |  | 51.0 |  |  | 38.5 |  | 41.7 |  | 80.1 | \nTotal other | 131.0 |  | 183.5 |  | 314.6 |  |  | 256.9 |  | 237.9 |  | 494.7 | \nRevenue | $ | 5,531.4 |  | $ | 2,780.7 |  | $ | 8,312.1 |  |  | $ | 3,934.8 |  | $ | 2,553.3 |  | $ | 6,488.0 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended June 30,\n | 2023 |  | 2022\n | U.S. | Outside U.S. | Total |  | U.S. | Outside U.S. | Total\n |  |  |  |  |  |  | \nDiabetes: |  |  |  |  |  |  | \nTrulicity | $ | 2,918.7 |  | $ | 871.0 |  | $ | 3,789.6 |  |  | $ | 2,744.1 |  | $ | 909.1 |  | $ | 3,653.2 | \nMounjaro | 1,452.2 |  | 96.0 |  | 1,548.2 |  |  | 12.6 |  | 3.4 |  | 16.0 | \nJardiance(1) | 715.6 |  | 530.2 |  | 1,245.8 |  |  | 480.4 |  | 400.0 |  | 880.4 | \nHumalog(2) | 501.4 |  | 400.0 |  | 901.4 |  |  | 607.7 |  | 457.6 |  | 1,065.3 | \nBaqsimi | 629.3 |  | 16.1 |  | 645.4 |  |  | 44.3 |  | 13.9 |  | 58.2 | \nHumulin | 343.1 |  | 114.2 |  | 457.3 |  |  | 392.8 |  | 154.5 |  | 547.2 | \nBasaglar(3) | 218.4 |  | 145.2 |  | 363.5 |  |  | 215.1 |  | 150.6 |  | 365.7 | \nOther diabetes | 77.7 |  | 172.2 |  | 250.1 |  |  | 71.7 |  | 168.5 |  | 240.3 | \nTotal diabetes | 6,856.4 |  | 2,344.9 |  | 9,201.3 |  |  | 4,568.7 |  | 2,257.6 |  | 6,826.3 | \n |  |  |  |  |  |  | \nOncology: |  |  |  |  |  |  | \nVerzenio | 1,049.6 |  | 628.0 |  | 1,677.7 |  |  | 685.7 |  | 372.1 |  | 1,057.9 | \nCyramza | 215.6 |  | 281.4 |  | 497.0 |  |  | 171.8 |  | 289.7 |  | 461.5 | \nErbitux | 264.2 |  | 28.1 |  | 292.4 |  |  | 234.7 |  | 28.7 |  | 263.4 | \nAlimta | 38.0 |  | 81.2 |  | 119.1 |  |  | 425.9 |  | 145.8 |  | 571.7 | \nOther oncology | 121.0 |  | 319.9 |  | 440.8 |  |  | 84.6 |  | 282.7 |  | 367.2 | \nTotal oncology | 1,688.4 |  | 1,338.6 |  | 3,027.0 |  |  | 1,602.7 |  | 1,119.0 |  | 2,721.7 | \n |  |  |  |  |  |  | \nImmunology: |  |  |  |  |  |  | \nTaltz | 784.5 |  | 446.3 |  | 1,230.8 |  |  | 718.8 |  | 375.5 |  | 1,094.3 | \nOlumiant(4) | 93.1 |  | 354.6 |  | 447.8 |  |  | 81.7 |  | 360.1 |  | 441.8 | \nOther immunology | \u2014 |  | 27.7 |  | 27.7 |  |  | \u2014 |  | 8.5 |  | 8.5 | \nTotal immunology | 877.6 |  | 828.6 |  | 1,706.3 |  |  | 800.5 |  | 744.1 |  | 1,544.6 | \n |  |  |  |  |  |  | \nNeuroscience: |  |  |  |  |  |  | \nEmgality | 227.5 |  | 96.1 |  | 323.6 |  |  | 216.9 |  | 89.8 |  | 306.7 | \n |  |  |  |  |  |  | \nOther neuroscience | 77.9 |  | 346.2 |  | 424.1 |  |  | 81.2 |  | 399.7 |  | 481.0 | \nTotal neuroscience | 305.4 |  | 442.3 |  | 747.7 |  |  | 298.1 |  | 489.5 |  | 787.7 | \n |  |  |  |  |  |  | \nOther: |  |  |  |  |  |  | \nForteo | 168.0 |  | 102.3 |  | 270.3 |  |  | 148.7 |  | 127.2 |  | 275.9 | \nCialis | 16.8 |  | 199.1 |  | 215.9 |  |  | 17.7 |  | 347.0 |  | 364.7 | \nCOVID-19 antibodies(5) | \u2014 |  | \u2014 |  | \u2014 |  |  | 1,584.3 |  | 14.7 |  | 1,598.9 | \nOther | 55.0 |  | 48.7 |  | 103.7 |  |  | 88.5 |  | 89.6 |  | 178.2 | \nTotal other | 239.8 |  | 350.1 |  | 589.9 |  |  | 1,839.2 |  | 578.5 |  | 2,417.7 | \nRevenue | $ | 9,967.6 |  | $ | 5,304.6 |  | $ | 15,272.1 |  |  | $ | 9,109.4 |  | $ | 5,188.7 |  | $ | 14,298.0 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nRevenue(1): |  |  |  |  |  |  | \nU.S. | $ | 5,531.4 |  |  | $ | 3,934.8 |  |  | $ | 9,967.6 |  |  | $ | 9,109.4 | \nEurope | 1,177.6 |  |  | 1,101.1 |  |  | 2,268.5 |  |  | 2,168.4 | \nJapan | 455.6 |  |  | 454.4 |  |  | 842.8 |  |  | 864.6 | \nChina | 399.0 |  |  | 352.1 |  |  | 771.7 |  |  | 758.5 | \nOther foreign countries | 748.5 |  |  | 645.7 |  |  | 1,421.5 |  |  | 1,397.2 | \nRevenue | $ | 8,312.1 |  |  | $ | 6,488.0 |  |  | $ | 15,272.1 |  |  | $ | 14,298.0 |   |  |  |  |  | \nEstimated Fair Value at December 1, 2022 | \nCash | $ | 153.2 | \nAcquired IPR&D(1) | 184.0\nGoodwill(2) | 187.1\n | \nOther assets and liabilities, net | 23.0 | \nAcquisition date fair value of consideration transferred | 547.3\nLess: | \nCash acquired | (153.2) | \nFair value of CVR liability(3) | (66.9) | \nCash paid, net of cash acquired | $ | 327.2 |   |  |  |  |  |  |  |  | \n | Net Milestones Capitalized (Deferred)(1)\n | June 30, 2023 | December 31, 2022\nJardiance | $ | 106.3 |  | $ | 116.2 | \nTrajenta | 51.2 |  | 63.5 | \nBasaglar | (121.3) |  | (130.6) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nJardiance | $ | 668.3 |  |  | $ | 461.0 |  |  | $ | 1,245.8 |  |  | $ | 880.4 | \nBasaglar | 154.2 |  |  | 174.2 |  |  | 363.5 |  |  | 365.7 | \nTrajenta | 103.6 |  |  | 97.1 |  |  | 189.5 |  |  | 189.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nOlumiant | $ | 218.9 |  |  | $ | 186.2 |  |  | $ | 447.8 |  |  | $ | 441.8 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Maturities by Period\n | Total |  | Less\u00a0Than1 Year |  | 1-5Years |  | 6-10Years |  | More\u00a0Than10 Years\nFair value of debt securities | $ | 663.6 |  |  | $ | 86.1 |  |  | $ | 213.2 |  |  | $ | 117.0 |  |  | $ | 247.3 |   |  |  |  |  |  |  |  |  |  |  | \n | June 30, 2023 |  | December 31, 2022\nUnrealized gross gains | $ | 0.6 |  |  | $ | 0.6 | \nUnrealized gross losses | 44.6 |  |  | 49.2 | \nFair value of securities in an unrealized gain position | 54.6 |  |  | 46.8 | \nFair value of securities in an unrealized loss position | 570.6 |  |  | 568.7 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nProceeds from sales | $ | 34.2 |  |  | $ | 29.9 |  |  | $ | 61.8 |  |  | $ | 65.1 | \nRealized gross gains on sales | 0.1 |  |  | 0.1 |  |  | 0.3 |  |  | 0.2 | \nRealized gross losses on sales | 1.0 |  |  | 0.7 |  |  | 1.7 |  |  | 1.5 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | Fair Value Measurements Using |  | \n | CarryingAmount |  | Cost(1) |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | Significant OtherObservable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue\nJune 30, 2023 |  |  |  |  |  |  |  |  |  |  | \nCash equivalents(2) | $ | 1,340.9 |  |  | $ | 1,340.9 |  |  | $ | 1,333.7 |  |  | $ | 7.2 |  |  | $ | \u2014 |  |  | $ | 1,340.9 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 19.5 |  |  | $ | 19.9 |  |  | $ | 19.5 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 19.5 | \nCorporate debt securities | 65.3 |  |  | 65.6 |  |  | \u2014 |  |  | 65.3 |  |  | \u2014 |  |  | 65.3 | \n |  |  |  |  |  |  |  |  |  |  | \nAsset-backed securities | 1.3 |  |  | 1.3 |  |  | \u2014 |  |  | 1.3 |  |  | \u2014 |  |  | 1.3 | \nOther securities | 48.5 |  |  | 48.5 |  |  | \u2014 |  |  | 23.5 |  |  | 25.0 |  |  | 48.5 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments | $ | 134.6 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 150.2 |  |  | $ | 164.7 |  |  | $ | 150.2 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 150.2 | \n |  |  |  |  |  |  |  |  |  |  | \nCorporate debt securities | 211.5 |  |  | 230.7 |  |  | \u2014 |  |  | 211.5 |  |  | \u2014 |  |  | 211.5 | \nMortgage-backed securities | 158.3 |  |  | 170.8 |  |  | \u2014 |  |  | 158.3 |  |  | \u2014 |  |  | 158.3 | \nAsset-backed securities | 57.5 |  |  | 59.2 |  |  | \u2014 |  |  | 57.5 |  |  | \u2014 |  |  | 57.5 | \nOther securities | 166.2 |  |  | 69.5 |  |  | \u2014 |  |  | 6.2 |  |  | 160.0 |  |  | 166.2 | \nMarketable equity securities | 577.6 |  |  | 460.6 |  |  | 577.6 |  |  | \u2014 |  |  | \u2014 |  |  | 577.6 | \nEquity investments without readily determinable fair values(3) | 535.4 |  |  |  |  |  |  |  |  |  |  | \nEquity method investments(3) | 888.4 |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments | $ | 2,745.1 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDecember 31, 2022 |  |  |  |  |  |  |  |  |  |  | \nCash equivalents(2) | $ | 657.4 |  |  | $ | 657.4 |  |  | $ | 650.4 |  |  | $ | 7.0 |  |  | $ | \u2014 |  |  | $ | 657.4 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 30.8 |  |  | $ | 31.1 |  |  | $ | 30.8 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 30.8 | \nCorporate debt securities | 53.4 |  |  | 53.5 |  |  | \u2014 |  |  | 53.4 |  |  | \u2014 |  |  | 53.4 | \n |  |  |  |  |  |  |  |  |  |  | \nAsset-backed securities | 2.0 |  |  | 2.0 |  |  | \u2014 |  |  | 2.0 |  |  | \u2014 |  |  | 2.0 | \nOther securities | 58.6 |  |  | 58.6 |  |  | \u2014 |  |  | 39.1 |  |  | 19.5 |  |  | 58.6 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments | $ | 144.8 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 146.4 |  |  | $ | 163.2 |  |  | $ | 146.4 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 146.4 | \nCorporate debt securities | 213.9 |  |  | 235.8 |  |  | \u2014 |  |  | 213.9 |  |  | \u2014 |  |  | 213.9 | \nMortgage-backed securities | 149.2 |  |  | 161.5 |  |  | \u2014 |  |  | 149.2 |  |  | \u2014 |  |  | 149.2 | \nAsset-backed securities | 50.6 |  |  | 52.5 |  |  | \u2014 |  |  | 50.6 |  |  | \u2014 |  |  | 50.6 | \nOther securities | 398.6 |  |  | 34.5 |  |  | \u2014 |  |  | 311.0 |  |  | 87.6 |  |  | 398.6 | \nMarketable equity securities | 683.6 |  |  | 484.7 |  |  | 683.6 |  |  | \u2014 |  |  | \u2014 |  |  | 683.6 | \nEquity investments without readily determinable fair values(3) | 478.4 |  |  |  |  |  |  |  |  |  |  | \nEquity method investments(3) | 781.1 |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments | $ | 2,901.8 |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Fair Value Measurements Using |  | \n | CarryingAmount |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | SignificantOther Observable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue\nShort-term commercial paper borrowings |  |  |  |  |  |  |  |  | \nJune 30, 2023 | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 | \nDecember 31, 2022 | (1,498.0) |  |  | \u2014 |  |  | (1,492.0) |  |  | \u2014 |  |  | (1,492.0) | \nLong-term debt, including current portion |  |  |  |  |  |  |  |  | \nJune 30, 2023 | $ | (18,820.0) |  |  | $ | \u2014 |  |  | $ | (16,589.9) |  |  | $ | \u2014 |  |  | $ | (16,589.9) | \nDecember 31, 2022 | (14,740.6) |  |  | \u2014 |  |  | (12,329.3) |  |  | \u2014 |  |  | (12,329.3) |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nJune 30, 2023\nPurchase |  | Sell\nCurrency | Amount(in millions) |  | Currency | Amount(in millions)\nEuro | 3,373.9 |  | U.S. dollars | 3,683.6\nU.S. dollars | 2,617.8 |  | Euro | 2,394.7\nBritish pounds | 182.9 |  | U.S. dollars | 234.4\n |  |  |  | \n |  |  |  | \n |  |  |  | \nU.S. dollars | 151.4 |  | Chinese yuan | 1,084.8\n |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nFair value hedges: |  |  |  |  |  |  | \nEffect from hedged fixed-rate debt | $ | (34.4) |  |  | $ | (58.2) |  |  | $ | 0.9 |  |  | $ | (152.8) | \nEffect from interest rate contracts | 34.4 |  |  | 58.2 |  |  | (0.9) |  |  | 152.8 | \nCash flow hedges: |  |  |  |  |  |  | \nEffective portion of losses on interest rate contracts reclassified from accumulated other comprehensive loss | 3.3 |  |  | 4.1 |  |  | 7.1 |  |  | 8.2 | \nCross-currency interest rate swaps | (17.1) |  |  | 33.6 |  |  | (30.0) |  |  | 41.9 | \nNet (gains) losses on foreign currency exchange contracts not designated as hedging instruments | 29.6 |  |  | 151.1 |  |  | (23.2) |  |  | 145.0 | \nTotal | $ | 15.8 |  |  | $ | 188.8 |  |  | $ | (46.1) |  |  | $ | 195.1 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nNet investment hedges: |  |  |  |  |  |  | \nForeign currency-denominated notes | $ | 10.6 |  |  | $ | 333.3 |  |  | $ | (121.2) |  |  | $ | 387.7 | \nCross-currency interest rate swaps | (7.8) |  |  | 68.5 |  |  | (19.6) |  |  | 79.3 | \nForeign currency forward contracts | 27.7 |  |  | 13.6 |  |  | (18.4) |  |  | 13.6 | \nCash flow hedges: |  |  |  |  |  |  | \nForward-starting interest rate swaps | 33.3 |  |  | 157.7 |  |  | 57.1 |  |  | 280.2 | \nCross-currency interest rate swaps | 21.9 |  |  | 1.4 |  |  | 14.1 |  |  | 18.5 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Fair Value Measurements Using |  |  |  | \n | CarryingAmount |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | SignificantOther Observable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue |  | \nJune 30, 2023 |  |  |  |  |  |  |  |  |  |  | \nRisk-management instruments: |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther current liabilities | $ | (8.7) |  |  | $ | \u2014 |  |  | $ | (8.7) |  |  | $ | \u2014 |  |  | $ | (8.7) |  |  | \nOther noncurrent liabilities | (124.8) |  |  | \u2014 |  |  | (124.8) |  |  | \u2014 |  |  | (124.8) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 261.9 |  |  | \u2014 |  |  | 261.9 |  |  | \u2014 |  |  | 261.9 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 42.7 |  |  | \u2014 |  |  | 42.7 |  |  | \u2014 |  |  | 42.7 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 69.5 |  |  | \u2014 |  |  | 69.5 |  |  | \u2014 |  |  | 69.5 |  |  | \nOther noncurrent assets | 27.6 |  |  | \u2014 |  |  | 27.6 |  |  | \u2014 |  |  | 27.6 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nForeign exchange contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 17.3 |  |  | \u2014 |  |  | 17.3 |  |  | \u2014 |  |  | 17.3 |  |  | \nOther current liabilities | (15.2) |  |  | \u2014 |  |  | (15.2) |  |  | \u2014 |  |  | (15.2) |  |  | \nForeign exchange contracts not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 15.3 |  |  | \u2014 |  |  | 15.3 |  |  | \u2014 |  |  | 15.3 |  |  | \nOther current liabilities | (17.8) |  |  | \u2014 |  |  | (17.8) |  |  | \u2014 |  |  | (17.8) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nContingent consideration liabilities: |  |  |  |  |  |  |  |  |  |  | \nOther current liabilities | (38.9) |  |  | \u2014 |  |  | \u2014 |  |  | (38.9) |  |  | (38.9) |  |  | \nOther noncurrent liabilities | (72.3) |  |  | \u2014 |  |  | \u2014 |  |  | (72.3) |  |  | (72.3) |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Fair Value Measurements Using |  |  |  | \n | CarryingAmount |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | SignificantOther Observable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue |  | \nDecember 31, 2022 |  |  |  |  |  |  |  |  |  |  | \nRisk-management instruments: |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent liabilities | $ | (134.3) |  |  | $ | \u2014 |  |  | $ | (134.3) |  |  | $ | \u2014 |  |  | $ | (134.3) |  |  | \nInterest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 162.9 |  |  | \u2014 |  |  | 162.9 |  |  | \u2014 |  |  | 162.9 |  |  | \nOther noncurrent assets | 246.0 |  |  | \u2014 |  |  | 246.0 |  |  | \u2014 |  |  | 246.0 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 67.6 |  |  | \u2014 |  |  | 67.6 |  |  | \u2014 |  |  | 67.6 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 53.1 |  |  | \u2014 |  |  | 53.1 |  |  | \u2014 |  |  | 53.1 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nForeign exchange contracts designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  | \nOther current liabilities | (38.3) |  |  | \u2014 |  |  | (38.3) |  |  | \u2014 |  |  | (38.3) |  |  | \nForeign exchange contracts not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 26.6 |  |  | \u2014 |  |  | 26.6 |  |  | \u2014 |  |  | 26.6 |  |  | \nOther current liabilities | (21.5) |  |  | \u2014 |  |  | (21.5) |  |  | \u2014 |  |  | (21.5) |  |  | \nContingent consideration liabilities: |  |  |  |  |  |  |  |  |  |  | \nOther current liabilities | (39.5) |  |  | \u2014 |  |  | \u2014 |  |  | (39.5) |  |  | (39.5) |  |  | \nOther noncurrent liabilities | (70.6) |  |  | \u2014 |  |  | \u2014 |  |  | (70.6) |  |  | (70.6) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Defined Benefit Pension Plans\n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nComponents of net periodic cost: |  |  |  |  |  |  | \nService cost | $ | 74.9 |  |  | $ | 88.2 |  |  | $ | 145.3 |  |  | $ | 177.3 | \nInterest cost | 162.6 |  |  | 99.6 |  |  | 323.7 |  |  | 200.1 | \nExpected return on plan assets | (264.2) |  |  | (237.0) |  |  | (527.5) |  |  | (476.5) | \nAmortization of prior service cost | 0.6 |  |  | 0.6 |  |  | 1.2 |  |  | 1.3 | \nRecognized actuarial loss | 30.9 |  |  | 84.5 |  |  | 60.9 |  |  | 171.5 | \n |  |  |  |  |  |  | \nNet periodic cost | $ | 4.8 |  |  | $ | 35.9 |  |  | $ | 3.6 |  |  | $ | 73.7 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Retiree Health Benefit Plans\n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nComponents of net periodic benefit: |  |  |  |  |  |  | \nService cost | $ | 8.2 |  |  | $ | 12.1 |  |  | $ | 15.9 |  |  | $ | 23.3 | \nInterest cost | 15.3 |  |  | 9.6 |  |  | 30.7 |  |  | 19.0 | \nExpected return on plan assets | (45.6) |  |  | (38.2) |  |  | (91.1) |  |  | (76.1) | \nAmortization of prior service benefit | (13.2) |  |  | (13.7) |  |  | (26.4) |  |  | (27.4) | \nRecognized actuarial (gain) loss | (2.0) |  |  | 0.3 |  |  | (2.9) |  |  | 0.5 | \n |  |  |  |  |  |  | \nNet periodic benefit | $ | (37.3) |  |  | $ | (29.9) |  |  | $ | (73.8) |  |  | $ | (60.7) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Net Unrealized Gains (Losses) on Available-For-Sale\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Net Unrealized Gains (Losses) on Cash\u00a0Flow Hedges |  |  |  | Accumulated Other Comprehensive Loss\nBalance at April\u00a01, 2023 | $ | (1,826.6) |  |  | $ | (28.3) |  |  | $ | (2,066.1) |  |  | $ | 143.7 |  |  |  |  | $ | (3,777.3) | \n |  |  |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (58.7) |  |  | (5.9) |  |  | (5.6) |  |  | 43.5 |  |  |  |  | (26.7) | \nNet amount reclassified from accumulated other comprehensive loss | \u2014 |  |  | 0.7 |  |  | 12.9 |  |  | 1.7 |  |  |  |  | 15.3 | \nNet other comprehensive income (loss) | (58.7) |  |  | (5.2) |  |  | 7.3 |  |  | 45.2 |  |  |  |  | (11.4) | \n |  |  |  |  |  |  |  |  |  |  | \nBalance at June\u00a030, 2023 | $ | (1,885.3) |  |  | $ | (33.5) |  |  | $ | (2,058.8) |  |  | $ | 188.9 |  |  |  |  | $ | (3,788.7) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Net Unrealized Gains (Losses) on Available-For-Sale\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Net Unrealized Gains (Losses) on Cash\u00a0Flow Hedges |  |  |  | Accumulated Other Comprehensive Loss\nBalance at April\u00a01, 2022 | $ | (1,575.2) |  |  | $ | (18.1) |  |  | $ | (2,531.6) |  |  | $ | (100.4) |  |  |  |  | $ | (4,225.3) | \n |  |  |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (269.6) |  |  | (9.3) |  |  | 31.7 |  |  | 124.8 |  |  |  |  | (122.4) | \nNet amount reclassified from accumulated other comprehensive loss | 0.6 |  |  | (0.5) |  |  | 56.7 |  |  | 3.2 |  |  |  |  | 60.0 | \nNet other comprehensive income (loss) | (269.0) |  |  | (9.8) |  |  | 88.4 |  |  | 128.0 |  |  |  |  | (62.4) | \n |  |  |  |  |  |  |  |  |  |  | \nBalance at June\u00a030, 2022 | $ | (1,844.2) |  |  | $ | (27.9) |  |  | $ | (2,443.2) |  |  | $ | 27.6 |  |  |  |  | $ | (4,287.7) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Net Unrealized Gains (Losses) on Available-For-Sale\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Net Unrealized Gains (Losses) on Cash\u00a0Flow Hedges |  | Accumulated Other Comprehensive Loss\nBalance at January\u00a01, 2023 | $ | (1,874.2) |  |  | $ | (37.1) |  |  | $ | (2,062.3) |  |  | $ | 129.0 |  |  | $ | (3,844.6) | \n |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | 14.1 |  |  | 2.2 |  |  | (22.4) |  |  | 56.2 |  |  | 50.1 | \nNet amount reclassified from accumulated other comprehensive loss | (25.2) |  |  | 1.4 |  |  | 25.9 |  |  | 3.7 |  |  | 5.8 | \nNet other comprehensive income (loss) | (11.1) |  |  | 3.6 |  |  | 3.5 |  |  | 59.9 |  |  | 55.9 | \n |  |  |  |  |  |  |  |  | \nBalance at June\u00a030, 2023 | $ | (1,885.3) |  |  | $ | (33.5) |  |  | $ | (2,058.8) |  |  | $ | 188.9 |  |  | $ | (3,788.7) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Net Unrealized Gains (Losses) on Available-For-Sale\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Net Unrealized Gains (Losses) on Cash\u00a0Flow Hedges |  | Accumulated Other Comprehensive Loss\nBalance at January\u00a01, 2022 | $ | (1,550.2) |  |  | $ | 3.7 |  |  | $ | (2,583.6) |  |  | $ | (213.0) |  |  | $ | (4,343.1) | \n |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (294.6) |  |  | (30.6) |  |  | 25.1 |  |  | 234.2 |  |  | (65.9) | \nNet amount reclassified from accumulated other comprehensive loss | 0.6 |  |  | (1.0) |  |  | 115.3 |  |  | 6.4 |  |  | 121.3 | \nNet other comprehensive income (loss) | (294.0) |  |  | (31.6) |  |  | 140.4 |  |  | 240.6 |  |  | 55.4 | \n |  |  |  |  |  |  |  |  | \nBalance at June\u00a030, 2022 | $ | (1,844.2) |  |  | $ | (27.9) |  |  | $ | (2,443.2) |  |  | $ | 27.6 |  |  | $ | (4,287.7) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\nTax benefit (expense) | 2023 |  | 2022 |  | 2023 |  | 2022\nForeign currency translation gains/losses | $ | (6.4) |  |  | $ | (87.2) |  |  | $ | 40.1 |  |  | $ | (100.9) | \nNet unrealized gains/losses on available-for-sale securities | 1.6 |  |  | 3.0 |  |  | (1.0) |  |  | 9.7 | \nDefined benefit pension and retiree health benefit plans | (3.0) |  |  | (22.4) |  |  | (7.0) |  |  | (50.8) | \nNet unrealized gains/losses on cash flow hedges | (12.0) |  |  | (34.0) |  |  | (15.9) |  |  | (63.9) | \nBenefit (expense) for income taxes allocated to other comprehensive income (loss) items | $ | (19.8) |  |  | $ | (140.6) |  |  | $ | 16.2 |  |  | $ | (205.9) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nDetails about Accumulated Other Comprehensive Loss Components | Three Months Ended June 30, |  | Six Months Ended June 30, | Affected Line Item in the Consolidated Condensed Statements of Operations\n\n2023 |  | 2022 |  | 2023 |  | 2022\nAmortization of retirement benefit items: |  |  |  |  |  |  |  | \nPrior service benefits, net | $ | (12.6) |  |  | $ | (13.1) |  |  | $ | (25.2) |  |  | $ | (26.1) |  | Other\u2013net, (income) expense\nActuarial losses, net | 28.9 |  |  | 84.8 |  |  | 58.0 |  |  | 172.0 |  | Other\u2013net, (income) expense\nTotal before tax | 16.3 |  |  | 71.7 |  |  | 32.8 |  |  | 145.9 |  | \nTax benefit | (3.4) |  |  | (15.0) |  |  | (6.9) |  |  | (30.6) |  | Income taxes\nNet of tax | 12.9 |  |  | 56.7 |  |  | 25.9 |  |  | 115.3 |  | \n |  |  |  |  |  |  |  | \nOther, net of tax | 2.4 |  |  | 3.3 |  |  | (20.1) |  |  | 6.0 |  | Other\u2013net, (income) expense\n |  |  |  |  |  |  |  | \nTotal reclassifications, net of tax | $ | 15.3 |  |  | $ | 60.0 |  |  | $ | 5.8 |  |  | $ | 121.3 |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nInterest expense | $ | 120.3 |  |  | $ | 81.2 |  |  | $ | 223.1 |  |  | $ | 166.1 | \nInterest income | (46.0) |  |  | (10.2) |  |  | (80.2) |  |  | (17.2) | \nNet investment losses on equity securities (Note 5) | 64.9 |  |  | 118.9 |  |  | 78.6 |  |  | 544.3 | \nRetirement benefit plans | (115.6) |  |  | (94.3) |  |  | (231.4) |  |  | (187.6) | \n |  |  |  |  |  |  | \nOther (income) expense | 13.2 |  |  | 23.6 |  |  | 11.0 |  |  | (35.7) | \nOther\u2013net, (income) expense | $ | 36.8 |  |  | $ | 119.2 |  |  | $ | 1.1 |  |  | $ | 469.9 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Percent Change |  | Six Months Ended June 30, |  | Percent Change\n | 2023 |  | 2022 |  |  | 2023 |  | 2022 | \nRevenue | $ | 8,312.1 |  |  | $ | 6,488.0 |  |  | 28 |  | $ | 15,272.1 |  |  | $ | 14,298.0 |  |  | 7\n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNet income | 1,763.2 |  |  | 952.5 |  |  | 85 |  | 3,108.1 |  |  | 2,855.4 |  |  | 9\nEarnings per share - diluted | 1.95 |  |  | 1.05 |  |  | 86 |  | 3.44 |  |  | 3.16 |  |  | 9  |  |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication | Status | Developments | \nDiabetes and Obesity | \n |  |  |  | \nEmpagliflozin (Jardiance)(1) | Chronic kidney disease | Approved | Approved in Europe in July 2023. Submitted in Japan in 2022 and in the U.S. in the first quarter of 2023. Granted U.S. Food and Drug Administration (FDA) Fast Track designation(2). | \nTirzepatide (Mounjaro) | Obesity | Submitted | Submitted in Europe in the first quarter of 2023 and in the U.S. in the second quarter of 2023. Received Priority Review designation from the FDA. Announced in the second quarter of 2023 and in July 2023 that Phase III trials met all primary and key secondary endpoints. Phase III trials are ongoing. | \nHeart failure with preserved ejection fraction | Phase III | Phase III trials are ongoing. | \nObstructive sleep apnea | Phase III | Granted FDA Fast Track designation(2). Phase III trial is ongoing. | \nNonalcoholic steatohepatitis | Phase II | Phase II trial is ongoing. | \nInsulin Efsitora Alfa | Type 1 and 2 diabetes | Phase III | Phase III trials are ongoing. | \nOrforglipron | Obesity | Phase III | Phase III trials initiated in the second quarter of 2023. | \nType 2 diabetes | Phase III | Phase III trial initiated in the second quarter of 2023. | \nRetatrutide | Obesity | Phase III | Phase III trials initiated in the second quarter of 2023. | \nType 2 diabetes | Phase II | Phase II trial was completed. | \nLepodisiran(LP(a) siRNA) | Cardiovascular disease | Phase II | Phase II trial is ongoing. | \nMuvalaplin | Cardiovascular disease | Phase II | Phase II trial is ongoing. | \nRelaxin-LA | Heart failure | Phase II | Phase II trial initiated in the first quarter of 2023. | \nSolbinsiran | Cardiovascular disease | Phase II | Phase II trial is ongoing. |   |  |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication | Status | Developments | \nImmunology | \nMirikizumab(Omvoh\u00ae) | Ulcerative colitis | Approved | Approved in Japan in the first quarter of 2023 and in Europe in the second quarter of 2023. Following the receipt of a complete response letter from the FDA, re-submitted in the U.S. in the second quarter of 2023. | \nCrohn's Disease | Phase III | Phase III trials are ongoing. | \nLebrikizumab(3) | Atopic dermatitis | Submitted | Submitted in the U.S. and Europe in 2022 and in Japan in the first quarter of 2023. Phase III trials are ongoing. | \nBTLA MAB Agonist | Systemic lupus erythematosus | Phase II | Phase II trial is ongoing. | \nEltrekibart | Hidradenitis suppurativa | Phase II | Phase II trial is ongoing. | \nPeresolimab | Rheumatoid arthritis | Phase II | Phase II trial is ongoing. | \nNeuroscience | \nDonanemab | Early Alzheimer's disease | Submitted | Submitted for traditional approval in the U.S. in the second quarter of 2023 and in Europe in July 2023. Granted FDA Breakthrough Therapy designation(4). Announced in the second quarter of 2023 that a Phase III trial met primary and all secondary endpoints. Phase III trials are ongoing. | \nPreclinical Alzheimer's disease | Phase III | Phase III trial is ongoing. | \nRemternetug | Early Alzheimer's disease | Phase III | Phase III trial is ongoing. | \nGBA1 Gene Therapy (PR001) | Gaucher disease Type 1 | Phase II | Phase II trial initiated in the second quarter of 2023. | \nParkinson's disease | Phase II | Granted FDA Fast Track designation(2). Phase II trial is ongoing. | \nGRN Gene Therapy (PR006) | Frontotemporal dementia | Phase II | Granted FDA Fast Track designation(2). Phase II trial is ongoing. | \nO-GlcNAcase Inh | Alzheimer's disease | Phase II | Phase II trial is ongoing. | \nP2X7 Inhibitor | Pain | Phase II | Phase II trials are ongoing. | \nSSTR4 Agonist | Pain | Phase II | Phase II trials are ongoing. |   |  |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication | Status | Developments | \nOncology | \nPirtobrutinib(Jaypirca\u00ae) | Mantle cell lymphoma | Approved(5) | FDA granted accelerated approval(5)in the U.S. in the first quarter of 2023. Submitted in Europe in 2022 and in Japan in the second quarter of 2023. Received a positive opinion from the Committee for Medicinal Products for Human Use in Europe in the second quarter of 2023. Phase III trial is ongoing. | \nChronic lymphocytic leukemia | Submitted | Submitted in the U.S. in August 2023 under the accelerated approval pathway. Phase III trials are ongoing. | \nB-cell malignancies | Phase II | Phase II trial is ongoing. | \nSelpercatinib (Retevmo\u00ae) | Lung cancer | Approved(5) | Phase III trials are ongoing. | \nThyroid cancer | Approved(5) | Phase III trial is ongoing. | \nAbemaciclib (Verzenio) | Prostate cancer | Phase III | Phase III trials are ongoing. | \nImlunestrant | Adjuvant breast cancer | Phase III | Phase III trial is ongoing. | \nER+HER2- metastatic breast cancer | Phase III | Phase III trial is ongoing. |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Percent Change | Six Months Ended June 30, |  | Percent Change\n | 2023 |  | 2022 |  | 2023 |  | 2022 | \nU.S. | $ | 5,531.4 |  |  | $ | 3,934.8 |  |  | 41 | $ | 9,967.6 |  |  | $ | 9,109.4 |  |  | 9\nOutside U.S. | 2,780.7 |  |  | 2,553.3 |  |  | 9 | 5,304.6 |  |  | 5,188.7 |  |  | 2\nRevenue | $ | 8,312.1 |  |  | $ | 6,488.0 |  |  | 28 | $ | 15,272.1 |  |  | $ | 14,298.0 |  |  | 7  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2023 vs. 2022 |  | 2023 vs. 2022\n | U.S. | Outside U.S. | Consolidated |  | U.S. | Outside U.S. | Consolidated\nVolume | 39 | % | 14 | % | 29 | % |  | 11 | % | 10 | % | 11 | %\nPrice | 2 |  | (3) |  | \u2014 |  |  | (2) |  | (4) |  | (3) | \nForeign exchange rates | \u2014 |  | (3) |  | (1) |  |  | \u2014 |  | (4) |  | (2) | \nPercent change | 41 | % | 9 | % | 28 | % |  | 9 | % | 2 | % | 7 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Percent Change | \n | 2023 |  | 2022 | \nProduct | U.S. |  | Outside U.S. |  | Total |  | Total | \nTrulicity | $ | 1,371.3 |  |  | $ | 441.2 |  |  | $ | 1,812.5 |  |  | $ | 1,911.9 |  |  | (5) | \nMounjaro | 915.7 |  |  | 64.0 |  |  | 979.7 |  |  | 16.0 |  |  | NM | \nVerzenio | 588.6 |  |  | 338.2 |  |  | 926.8 |  |  | 588.5 |  |  | 57 | \nTaltz | 472.3 |  |  | 231.6 |  |  | 703.9 |  |  | 606.2 |  |  | 16 | \nJardiance(1) | 386.1 |  |  | 282.2 |  |  | 668.3 |  |  | 461.0 |  |  | 45 | \nBaqsimi | 606.2 |  |  | 7.7 |  |  | 613.9 |  |  | 29.0 |  |  | NM | \nHumalog(2) | 229.8 |  |  | 210.6 |  |  | 440.4 |  |  | 447.1 |  |  | (1) | \nCyramza\u00ae | 115.0 |  |  | 145.3 |  |  | 260.3 |  |  | 231.3 |  |  | 13 | \nOlumiant(3) | 50.8 |  |  | 168.1 |  |  | 218.9 |  |  | 186.2 |  |  | 18 | \nHumulin\u00ae | 144.3 |  |  | 61.0 |  |  | 205.3 |  |  | 274.0 |  |  | (25) | \nEmgality\u00ae | 118.8 |  |  | 50.5 |  |  | 169.3 |  |  | 157.5 |  |  | 8 | \nErbitux\u00ae | 145.5 |  |  | 17.0 |  |  | 162.5 |  |  | 140.8 |  |  | 15 | \nBasaglar\u00ae (4) | 83.0 |  |  | 71.2 |  |  | 154.2 |  |  | 174.2 |  |  | (11) | \nForteo\u00ae | 97.4 |  |  | 50.6 |  |  | 148.0 |  |  | 138.5 |  |  | 7 | \nCialis | 9.2 |  |  | 106.4 |  |  | 115.6 |  |  | 147.0 |  |  | (21) | \nAlimta | 17.9 |  |  | 43.1 |  |  | 60.9 |  |  | 227.7 |  |  | (73) | \nCOVID-19 antibodies(5) | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 129.1 |  |  | (100) | \nOther products | 179.5 |  |  | 492.0 |  |  | 671.6 |  |  | 622.0 |  |  | 8 | \nRevenue | $ | 5,531.4 |  |  | $ | 2,780.7 |  |  | $ | 8,312.1 |  |  | $ | 6,488.0 |  |  | 28 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended June 30, |  | \n | 2023 |  | 2022\nProduct | U.S. |  | Outside U.S. |  | Total |  | Total | Percent Change\nTrulicity | $ | 2,918.7 |  |  | $ | 871.0 |  |  | $ | 3,789.6 |  |  | $ | 3,653.2 |  |  | 4\nVerzenio | 1,049.6 |  |  | 628.0 |  |  | 1,677.7 |  |  | 1,057.9 |  |  | 59\nMounjaro | 1,452.2 |  |  | 96.0 |  |  | 1,548.2 |  |  | 16.0 |  |  | NM\nJardiance(1) | 715.6 |  |  | 530.2 |  |  | 1,245.8 |  |  | 880.4 |  |  | 42\nTaltz | 784.5 |  |  | 446.3 |  |  | 1,230.8 |  |  | 1,094.3 |  |  | 12\nHumalog(2) | 501.4 |  |  | 400.0 |  |  | 901.4 |  |  | 1,065.3 |  |  | (15)\nBaqsimi | 629.3 |  |  | 16.1 |  |  | 645.4 |  |  | 58.2 |  |  | NM\nCyramza | 215.6 |  |  | 281.4 |  |  | 497.0 |  |  | 461.5 |  |  | 8\nHumulin | 343.1 |  |  | 114.2 |  |  | 457.3 |  |  | 547.2 |  |  | (16)\nOlumiant(3) | 93.1 |  |  | 354.6 |  |  | 447.8 |  |  | 441.8 |  |  | 1\nBasaglar(4) | 218.4 |  |  | 145.2 |  |  | 363.5 |  |  | 365.7 |  |  | (1)\nEmgality | 227.5 |  |  | 96.1 |  |  | 323.6 |  |  | 306.7 |  |  | 6\nErbitux | 264.2 |  |  | 28.1 |  |  | 292.4 |  |  | 263.4 |  |  | 11\nForteo | 168.0 |  |  | 102.3 |  |  | 270.3 |  |  | 275.9 |  |  | (2)\nCialis | 16.8 |  |  | 199.1 |  |  | 215.9 |  |  | 364.7 |  |  | (41)\nAlimta | 38.0 |  |  | 81.2 |  |  | 119.1 |  |  | 571.7 |  |  | (79)\nCOVID-19 antibodies(5) | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1,598.9 |  |  | (100)\nOther products | 331.6 |  |  | 914.8 |  |  | 1,246.3 |  |  | 1,275.2 |  |  | 71\nRevenue | $ | 9,967.6 |  |  | $ | 5,304.6 |  |  | $ | 15,272.1 |  |  | $ | 14,298.0 |  |  | 7  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Percent Change |  | Six Months Ended June 30, |  | Percent Change\n | 2023 |  | 2022 |  |  | 2023 |  | 2022 | \n |  |  |  |  |  |  |  |  |  |  | \nGross margin | $ | 6,504.7 |  |  | $ | 5,057.5 |  |  | 29 |  | $ | 11,838.0 |  |  | $ | 10,795.4 |  |  | 10\nGross margin as a percent of revenue | 78.3 | % |  | 78.0 | % |  |  |  | 77.5 | % |  | 75.5 | % |  | \n |  |  |  |  |  |  |  |  |  |  | \nResearch and development | $ | 2,356.5 |  |  | $ | 1,781.9 |  |  | 32 |  | $ | 4,341.6 |  |  | $ | 3,392.0 |  |  | 28\nMarketing, selling, and administrative | 1,925.4 |  |  | 1,625.1 |  |  | 18 |  | 3,674.6 |  |  | 3,183.0 |  |  | 15\nAcquired IPR&D | 97.1 |  |  | 440.4 |  |  | (78) |  | 202.1 |  |  | 606.0 |  |  | (67)\n |  |  |  |  |  |  |  |  |  |  | \nOther\u2013net, (income) expense | 36.8 |  |  | 119.2 |  |  | (69) |  | 1.1 |  |  | 469.9 |  |  | (100)\nIncome taxes | 325.7 |  |  | 138.4 |  |  | NM |  | 510.5 |  |  | 289.1 |  |  | 77\nEffective tax rate | 15.6 | % |  | 12.7 | % |  |  |  | 14.1 | % |  | 9.2 | % |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number ofShares Purchased(in thousands) |  | Average\u00a0Price Paidper Share |  | Total\u00a0Number of SharesPurchased\u00a0as Part ofPublicly AnnouncedPlans or Programs(in thousands) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(in millions)\nApril 2023 | \u2014 |  |  | $ | \u2014 |  |  | \u2014 |  |  | $ | 2,500.0 | \nMay 2023 | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 2,500.0 | \nJune 2023 | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 2,500.0 | \nTotal | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |   |  |  |  |  |  |  |  | \nExhibit |  | Description\n3.1 |  | Amended Articles of Incorporation, incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on May 4, 2022\n |  | \n3.2 |  | Bylaws, as amended, incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed on May 4, 2022\n |  | \n31.1 |  | Rule\u00a013a-14(a) Certification of David Ricks, Chair, President, and Chief Executive Officer*\n |  | \n31.2 |  | Rule\u00a013a-14(a) Certification of Anat Ashkenazi, Executive Vice President and Chief Financial Officer*\n | \n32 |  | Section 1350 Certification*\n |  | \n101 |  | Interactive Data Files (embedded within the Inline XBRL document)*\n |  | \n104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*\n\n* Filed herewith.  |  |  |  |  |  |  |  | \n |  | ELI LILLY AND COMPANY\n |  | (Registrant)\n |  | \nDate: | August 8, 2023 | /s/ Anat Ashkenazi\n |  | Anat Ashkenazi\n |  | Executive Vice President and Chief Financial Officer\nDate: | August 8, 2023 | /s/ Donald Zakrowski\n |  | Donald Zakrowski\n |  | Senior Vice President, Finance, and Chief Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Eli Lilly, in 2023 Q3, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  |  |  |  | \nIndiana |  | 35-0470950\n(State or other jurisdiction of |  | (I.R.S. Employer\nincorporation or organization) |  | Identification No.)  |  |  |  |  |  |  |  | \nTitle of Each Class | Trading Symbols | Name of Each Exchange On Which Registered\nCommon Stock (no par value) | LLY | New York Stock Exchange\n7 1/8% Notes due 2025 | LLY25 | New York Stock Exchange\n1.625% Notes due 2026 | LLY26 | New York Stock Exchange\n2.125% Notes due 2030 | LLY30 | New York Stock Exchange\n0.625% Notes due 2031 | LLY31 | New York Stock Exchange\n0.500% Notes due 2033 | LLY33 | New York Stock Exchange\n6.77%\u00a0Notes due 2036 | LLY36 | New York Stock Exchange\n1.625% Notes due 2043 | LLY43 | New York Stock Exchange\n1.700% Notes due 2049 | LLY49A | New York Stock Exchange\n1.125% Notes due 2051 | LLY51 | New York Stock Exchange\n1.375% Notes due 2061 | LLY61 | New York Stock Exchange  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 |  |  |  |  | Accelerated\u00a0filer | \u2610\nNon-accelerated filer | \u2610 |  |  | Smaller reporting company | \u2610\n |  |  |  |  |  | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \nClass |  | Number of Shares Outstanding\nCommon |  | 949,307,237 |   |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | Page\nPART I. Financial Information |  |  |  | 5\n |  |  |  | \nItem 1. |  | Financial Statements |  | 5\n |  | Consolidated Condensed Statements of Operations |  | 5\n |  | Consolidated Condensed Statements of Comprehensive Income (Loss) |  | 6\n |  | Consolidated Condensed Balance Sheets |  | 7\n |  | Consolidated Condensed Statements of Equity |  | 8\n |  | Consolidated Condensed Statements of Cash Flows |  | 10\n |  | Notes to Consolidated Condensed Financial Statements |  | 11\nItem 2. |  | Management's Discussion and Analysis of Results of Operations and Financial Condition |  | 35\n |  | Executive Overview |  | 35\n |  | Results of Operations |  | 41\n |  | Financial Condition and Liquidity |  | 45\n |  |  |  | \n |  | Critical Accounting Estimates |  | 46\n |  | Available Information on our Website |  | 46\nItem 3. |  | Quantitative and Qualitative Disclosures About Market Risk |  | 47\nItem 4. |  | Controls and Procedures |  | 47\n |  |  |  | \nPART II. Other Information |  |  |  | 48\n |  |  |  | \nItem 1. |  | Legal Proceedings |  | 48\nItem 1A. |  | Risk Factors |  | 48\nItem 2. |  | Unregistered Sales of Equity Securities and Use of Proceeds |  | 48\nItem 5. |  | Other Information |  | 48\nItem 6. |  | Exhibits |  | 49\n |  |  |  | \nSignatures |  |  |  | 49  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nRevenue (Note 2) | $ | 9,498.6 |  |  | $ | 6,941.6 |  |  | $ | 24,770.7 |  |  | $ | 21,239.6 | \nCosts, expenses, and other: |  |  |  |  |  |  | \nCost of sales | 1,860.1 |  |  | 1,579.1 |  |  | 5,294.2 |  |  | 5,081.7 | \nResearch and development | 2,409.1 |  |  | 1,802.9 |  |  | 6,750.7 |  |  | 5,194.9 | \nMarketing, selling, and administrative | 1,803.9 |  |  | 1,614.2 |  |  | 5,478.5 |  |  | 4,797.2 | \nAcquired in-process research and development (Note 3) | 2,975.1 |  |  | 62.4 |  |  | 3,177.2 |  |  | 668.4 | \nAsset impairment, restructuring, and other special charges (Note 5) | \u2014 |  |  | 206.5 |  |  | \u2014 |  |  | 206.5 | \nOther\u2013net, (income) expense (Note 11) | 23.2 |  |  | 111.0 |  |  | 24.3 |  |  | 580.9 | \n | 9,071.4 |  |  | 5,376.1 |  |  | 20,724.9 |  |  | 16,529.6 | \nIncome before income taxes | 427.2 |  |  | 1,565.5 |  |  | 4,045.8 |  |  | 4,710.0 | \nIncome taxes (Note 7) | 484.6 |  |  | 113.8 |  |  | 995.1 |  |  | 402.9 | \nNet income (loss) | $ | (57.4) |  |  | $ | 1,451.7 |  |  | $ | 3,050.7 |  |  | $ | 4,307.1 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nEarnings (loss) per share: |  |  |  |  |  |  | \nBasic | $ | (0.06) |  |  | $ | 1.61 |  |  | $ | 3.39 |  |  | $ | 4.78 | \n |  |  |  |  |  |  | \nDiluted | $ | (0.06) |  |  | $ | 1.61 |  |  | $ | 3.38 |  |  | $ | 4.76 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nShares used in calculation of earnings (loss) per share: |  |  |  |  |  |  | \nBasic | 899.8 |  | 900.7 |  | 900.2 |  | 901.8\nDiluted | 899.8 |  | 903.8 |  | 903.1 |  | 904.5  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nNet income (loss) | $ | (57.4) |  |  | $ | 1,451.7 |  |  | $ | 3,050.7 |  |  | $ | 4,307.1 | \nOther comprehensive income (loss), net of tax (Note 10) | 3.8 |  |  | (8.1) |  |  | 59.7 |  |  | 47.3 | \nComprehensive income (loss) | $ | (53.6) |  |  | $ | 1,443.6 |  |  | $ | 3,110.4 |  |  | $ | 4,354.4 |   |  |  |  |  |  |  |  |  |  |  | \n | September 30, 2023 |  | December 31, 2022\nAssets | (Unaudited) |  | \nCurrent Assets |  |  | \nCash and cash equivalents (Note 6) | $ | 2,380.8 |  |  | $ | 2,067.0 | \nShort-term investments (Note 6) | 113.1 |  |  | 144.8 | \nAccounts receivable, net of allowances of$13.4(2023)and $16.0(2022) | 8,167.1 |  |  | 6,896.0 | \nOther receivables | 2,196.7 |  |  | 1,662.9 | \nInventories | 4,901.4 |  |  | 4,309.7 | \nPrepaid expenses and other current assets | 5,247.9 |  |  | 2,954.1 | \nTotal current assets | 23,007.0 |  |  | 18,034.5 | \nInvestments (Note 6) | 2,691.7 |  |  | 2,901.8 | \nGoodwill | 4,085.2 |  |  | 4,073.0 | \nOther intangibles, net | 6,781.7 |  |  | 7,206.6 | \nDeferred tax assets | 4,574.8 |  |  | 2,792.9 | \nProperty and equipment, net of accumulated depreciation of$10,767.8(2023)and $10,233.4(2022) | 11,863.2 |  |  | 10,144.0 | \nOther noncurrent assets | 4,911.9 |  |  | 4,337.0 | \nTotal assets | $ | 57,915.5 |  |  | $ | 49,489.8 | \nLiabilities and Equity |  |  | \nCurrent Liabilities |  |  | \nShort-term borrowings and current maturities of long-term debt | $ | 2,244.7 |  |  | $ | 1,501.1 | \nAccounts payable | 2,435.1 |  |  | 1,930.6 | \nEmployee compensation | 1,233.2 |  |  | 1,059.8 | \nSales rebates and discounts | 11,522.3 |  |  | 8,784.1 | \nDividends payable | \u2014 |  |  | 1,017.2 | \nIncome taxes payable | 1,977.5 |  |  | 475.1 | \nOther current liabilities | 2,585.4 |  |  | 2,370.3 | \nTotal current liabilities | 21,998.2 |  |  | 17,138.2 | \nOther Liabilities |  |  | \nLong-term debt | 17,923.6 |  |  | 14,737.5 | \nAccrued retirement benefits (Note 8) | 1,311.9 |  |  | 1,305.1 | \nLong-term income taxes payable | 3,468.3 |  |  | 3,709.6 | \nOther noncurrent liabilities | 1,906.1 |  |  | 1,824.0 | \nTotal other liabilities | 24,609.9 |  |  | 21,576.2 | \nCommitments and Contingencies (Note 9) |  |  | \nEli Lilly and Company Shareholders' Equity |  |  | \nCommon stock | 593.6 |  |  | 594.1 | \nAdditional paid-in capital | 7,160.0 |  |  | 6,921.4 | \nRetained earnings | 10,309.9 |  |  | 10,042.6 | \nEmployee benefit trust | (3,013.2) |  |  | (3,013.2) | \nAccumulated other comprehensive loss (Note 10) | (3,784.9) |  |  | (3,844.6) | \nCost of common stock in treasury | (45.0) |  |  | (50.5) | \nTotal Eli Lilly and Company shareholders' equity | 11,220.4 |  |  | 10,649.8 | \nNoncontrolling interests | 87.0 |  |  | 125.6 | \nTotal equity | 11,307.4 |  |  | 10,775.4 | \nTotal liabilities and equity | $ | 57,915.5 |  |  | $ | 49,489.8 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Equity of Eli Lilly and Company Shareholders |  | \n(Dollars in millions, except per-share data, and shares in thousands) | Common Stock |  | AdditionalPaid-inCapital |  | RetainedEarnings |  | Employee Benefit Trust |  | Accumulated Other Comprehensive Loss |  | Common Stock in Treasury(1) |  | Noncontrolling Interests\nShares |  | Amount | Shares |  | Amount\nBalance at July\u00a01, 2022 | 950,619 |  |  | $ | 594.1 |  |  | $ | 6,746.0 |  |  | $ | 8,556.0 |  |  | $ | (3,013.2) |  |  | $ | (4,287.7) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 114.5 | \nNet income (loss) |  |  |  |  |  |  | 1,451.7 |  |  |  |  |  |  |  |  |  |  | (15.7) | \nOther comprehensive loss, net of tax |  |  |  |  |  |  |  |  |  |  | (8.1) |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIssuance of stock under employee stock plans, net | 8 |  |  |  |  | (2.1) |  |  |  |  |  |  |  |  |  |  |  |  | \nStock-based compensation |  |  |  |  | 85.1 |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  | (1.2) |  |  |  |  |  |  |  |  |  |  | (3.0) | \nBalance at September\u00a030, 2022 | 950,627 |  |  | $ | 594.1 |  |  | $ | 6,829.0 |  |  | $ | 10,006.5 |  |  | $ | (3,013.2) |  |  | $ | (4,295.8) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 95.8 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance at July\u00a01, 2023 | 949,688 |  |  | $ | 593.6 |  |  | $ | 6,948.6 |  |  | $ | 10,368.5 |  |  | $ | (3,013.2) |  |  | $ | (3,788.7) |  |  | 402 |  |  | $ | (45.0) |  |  | $ | 85.5 | \nNet income (loss) |  |  |  |  |  |  | (57.4) |  |  |  |  |  |  |  |  |  |  | 4.1 | \nOther comprehensive income, net of tax |  |  |  |  |  |  |  |  |  |  | 3.8 |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIssuance of stock under employee stock plans, net | 17 |  |  |  |  | (4.2) |  |  |  |  |  |  |  |  |  |  |  |  | \nStock-based compensation |  |  |  |  | 215.6 |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  | (1.2) |  |  |  |  |  |  |  |  |  |  | (2.6) | \nBalance at September\u00a030, 2023 | 949,705 |  |  | $ | 593.6 |  |  | $ | 7,160.0 |  |  | $ | 10,309.9 |  |  | $ | (3,013.2) |  |  | $ | (3,784.9) |  |  | 402 |  |  | $ | (45.0) |  |  | $ | 87.0 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Equity of Eli Lilly and Company Shareholders |  | \n(Dollars in millions, except per-share data, and shares in thousands) | Common Stock |  | AdditionalPaid-inCapital |  | RetainedEarnings |  | Employee Benefit Trust |  | Accumulated Other Comprehensive Loss |  | Common Stock in Treasury(1) |  | Noncontrolling Interests\nShares |  | Amount | Shares |  | Amount\nBalance at January\u00a01, 2022 | 954,116 |  |  | $ | 596.3 |  |  | $ | 6,833.4 |  |  | $ | 8,958.5 |  |  | $ | (3,013.2) |  |  | $ | (4,343.1) |  |  | 463 |  |  | $ | (52.7) |  |  | $ | 175.6 | \nNet income (loss) |  |  |  |  |  |  | 4,307.1 |  |  |  |  |  |  |  |  |  |  | (63.7) | \nOther comprehensive income, net of tax |  |  |  |  |  |  |  |  |  |  | 47.3 |  |  |  |  |  |  | \nCash dividends declared per share: $1.96 |  |  |  |  |  |  | (1,765.9) |  |  |  |  |  |  |  |  |  |  | \nRetirement of treasury shares | (5,607) |  |  | (3.5) |  |  |  |  | (1,496.5) |  |  |  |  |  |  | (5,607) |  |  | 1,500.0 |  |  | \nPurchase of treasury shares |  |  |  |  |  |  |  |  |  |  |  |  | 5,607 |  |  | (1,500.0) |  |  | \nIssuance of stock under employee stock plans, net | 2,118 |  |  | 1.3 |  |  | (282.6) |  |  |  |  |  |  |  |  | (13) |  |  | 2.2 |  |  | \nStock-based compensation |  |  |  |  | 278.2 |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  | 3.3 |  |  |  |  |  |  |  |  |  |  | (16.1) | \nBalance at September\u00a030, 2022 | 950,627 |  |  | $ | 594.1 |  |  | $ | 6,829.0 |  |  | $ | 10,006.5 |  |  | $ | (3,013.2) |  |  | $ | (4,295.8) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 95.8 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance at January\u00a01, 2023 | 950,632 |  |  | $ | 594.1 |  |  | $ | 6,921.4 |  |  | $ | 10,042.6 |  |  | $ | (3,013.2) |  |  | $ | (3,844.6) |  |  | 450 |  |  | $ | (50.5) |  |  | $ | 125.6 | \nNet income |  |  |  |  |  |  | 3,050.7 |  |  |  |  |  |  |  |  |  |  | 4.6 | \nOther comprehensive income, net of tax |  |  |  |  |  |  |  |  |  |  | 59.7 |  |  |  |  |  |  | \nCash dividends declared per share: $2.26 |  |  |  |  |  |  | (2,034.0) |  |  |  |  |  |  |  |  |  |  | \nRetirement of treasury shares | (2,299) |  |  | (1.4) |  |  |  |  | (748.6) |  |  |  |  |  |  | (2,299) |  |  | 750.0 |  |  | \nPurchase of treasury shares |  |  |  |  |  |  |  |  |  |  |  |  | 2,299 |  |  | (750.0) |  |  | \nIssuance of stock under employee stock plans, net | 1,372 |  |  | 0.9 |  |  | (269.7) |  |  |  |  |  |  |  |  | (48) |  |  | 8.8 |  |  | \nStock-based compensation |  |  |  |  | 508.3 |  |  |  |  |  |  |  |  |  |  |  |  | \nOther |  |  |  |  |  |  | (0.8) |  |  |  |  |  |  |  |  | (3.3) |  |  | (43.2) | \nBalance at September\u00a030, 2023 | 949,705 |  |  | $ | 593.6 |  |  | $ | 7,160.0 |  |  | $ | 10,309.9 |  |  | $ | (3,013.2) |  |  | $ | (3,784.9) |  |  | 402 |  |  | $ | (45.0) |  |  | $ | 87.0 |   |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended September 30,\n | 2023 |  | 2022\nCash Flows from Operating Activities | \nNet income | $ | 3,050.7 |  |  | $ | 4,307.1 | \nAdjustments to Reconcile Net Income to Cash Flows from Operating Activities: |  |  | \n |  |  | \nDepreciation and amortization | 1,139.6 |  |  | 1,147.5 | \nChange in deferred income taxes | (1,834.8) |  |  | (2,195.6) | \n |  |  | \nStock-based compensation expense | 508.3 |  |  | 278.2 | \n |  |  | \nNet investment losses | 144.5 |  |  | 676.4 | \nGains on sale of product rights | (1,853.9) |  |  | (94.5) | \nAcquired in-process research and development | 3,177.2 |  |  | 668.4 | \nOther changes in operating assets and liabilities, net of acquisitions and divestitures | 117.2 |  |  | 823.4 | \nOther operating activities, net | 103.2 |  |  | 312.1 | \nNet Cash Provided by Operating Activities | 4,552.0 |  |  | 5,923.0 | \nCash Flows from Investing Activities |  |  | \nPurchases of property and equipment | (2,377.0) |  |  | (1,353.6) | \nProceeds from sales and maturities of short-term investments | 155.2 |  |  | 83.1 | \nPurchases of short-term investments | (79.2) |  |  | (65.0) | \nProceeds from sales of and distributions from noncurrent investments | 476.2 |  |  | 251.6 | \nPurchases of noncurrent investments | (474.8) |  |  | (474.1) | \n |  |  | \nProceeds from sale of product rights | 1,604.3 |  |  | 65.8 | \nPurchases of in-process research and development | (3,364.0) |  |  | (993.1) | \nOther investing activities, net | (169.1) |  |  | (334.1) | \nNet Cash Used for Investing Activities | (4,228.4) |  |  | (2,819.4) | \nCash Flows from Financing Activities |  |  | \nDividends paid | (3,051.2) |  |  | (2,651.4) | \nNet change in short-term borrowings | 97.0 |  |  | 1,741.3 | \nProceeds from issuance of long-term debt | 3,958.5 |  |  | \u2014 | \nRepayments of long-term debt | \u2014 |  |  | (1,560.0) | \nPurchases of common stock | (750.0) |  |  | (1,500.0) | \n |  |  | \nOther financing activities, net | (303.4) |  |  | (295.2) | \nNet Cash Used for Financing Activities | (49.1) |  |  | (4,265.3) | \nEffect of exchange rate changes on cash and cash equivalents | 39.3 |  |  | (39.4) | \n |  |  | \nNet increase (decrease) in cash and cash equivalents | 313.8 |  |  | (1,201.1) | \nCash and cash equivalents at January\u00a01 | 2,067.0 |  |  | 3,818.5 | \nCash and Cash Equivalents at September 30 | $ | 2,380.8 |  |  | $ | 2,617.4 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nNet product revenue | $ | 7,306.2 |  |  | $ | 6,119.2 |  |  | $ | 20,524.2 |  |  | $ | 19,123.0 | \nCollaboration and other revenue(1) | 2,192.4 |  |  | 822.4 |  |  | 4,246.5 |  |  | 2,116.6 | \nRevenue | $ | 9,498.6 |  |  | $ | 6,941.6 |  |  | $ | 24,770.7 |  |  | $ | 21,239.6 |   |  |  |  |  |  |  |  |  |  |  | \n | September 30, 2023 |  | December 31, 2022\nContract liabilities | $ | 200.7 |  |  | $ | 219.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30,\n | 2023 |  | 2022\n | U.S. | Outside U.S. | Total |  | U.S. | Outside U.S. | Total\n |  |  |  |  |  |  | \nDiabetes: |  |  |  |  |  |  | \nTrulicity\u00ae | $ | 1,259.0 |  | $ | 414.6 |  | $ | 1,673.6 |  |  | $ | 1,418.3 |  | $ | 432.0 |  | $ | 1,850.4 | \nMounjaro\u00ae | 1,277.0 |  | 132.4 |  | 1,409.3 |  |  | 97.3 |  | 90.0 |  | 187.3 | \nJardiance(1) | 415.9 |  | 284.8 |  | 700.8 |  |  | 350.9 |  | 222.4 |  | 573.3 | \nHumalog\u00ae (2) | 194.2 |  | 201.2 |  | 395.4 |  |  | 248.1 |  | 198.8 |  | 447.0 | \nHumulin\u00ae | 145.5 |  | 61.2 |  | 206.7 |  |  | 169.5 |  | 68.7 |  | 238.2 | \nBasaglar\u00ae (3) | 111.4 |  | 68.2 |  | 179.6 |  |  | 124.8 |  | 68.1 |  | 193.0 | \nBaqsimi | 3.8 |  | 9.3 |  | 13.1 |  |  | 35.2 |  | 7.8 |  | 43.0 | \nOther diabetes | 53.2 |  | 88.6 |  | 141.9 |  |  | 44.5 |  | 86.2 |  | 130.4 | \nTotal diabetes | 3,460.0 |  | 1,260.3 |  | 4,720.4 |  |  | 2,488.6 |  | 1,174.0 |  | 3,662.6 | \n |  |  |  |  |  |  | \nOncology: |  |  |  |  |  |  | \nVerzenio\u00ae | 684.6 |  | 355.7 |  | 1,040.2 |  |  | 414.8 |  | 202.9 |  | 617.7 | \nCyramza\u00ae | 88.0 |  | 136.1 |  | 224.1 |  |  | 87.5 |  | 144.6 |  | 232.1 | \nErbitux\u00ae | 134.0 |  | 19.9 |  | 153.9 |  |  | 126.3 |  | 18.7 |  | 144.9 | \nAlimta\u00ae | 21.2 |  | 32.3 |  | 53.5 |  |  | 64.6 |  | 54.8 |  | 119.4 | \nOther oncology | 73.8 |  | 201.5 |  | 275.4 |  |  | 39.5 |  | 139.6 |  | 179.2 | \nTotal oncology | 1,001.6 |  | 745.5 |  | 1,747.1 |  |  | 732.7 |  | 560.6 |  | 1,293.3 | \n |  |  |  |  |  |  | \nImmunology: |  |  |  |  |  |  | \nTaltz\u00ae | 509.3 |  | 234.9 |  | 744.2 |  |  | 493.8 |  | 186.1 |  | 679.9 | \nOlumiant\u00ae (4) | 65.7 |  | 165.7 |  | 231.4 |  |  | 22.9 |  | 160.0 |  | 182.9 | \nOther immunology | \u2014 |  | 11.4 |  | 11.4 |  |  | \u2014 |  | 3.6 |  | 3.6 | \nTotal immunology | 575.0 |  | 412.0 |  | 986.9 |  |  | 516.7 |  | 349.7 |  | 866.4 | \n |  |  |  |  |  |  | \nNeuroscience: |  |  |  |  |  |  | \nZyprexa(5) | 49.9 |  | 1,431.5 |  | 1,481.4 |  |  | 8.0 |  | 73.4 |  | 81.4 | \nEmgality\u00ae | 126.5 |  | 42.1 |  | 168.5 |  |  | 114.0 |  | 54.6 |  | 168.5 | \nOther neuroscience | 31.0 |  | 87.0 |  | 118.2 |  |  | 23.8 |  | 99.4 |  | 123.3 | \nTotal neuroscience | 207.4 |  | 1,560.6 |  | 1,768.1 |  |  | 145.8 |  | 227.4 |  | 373.2 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nOther: |  |  |  |  |  |  | \nForteo\u00ae | 101.2 |  | 45.2 |  | 146.4 |  |  | 112.7 |  | 64.4 |  | 177.1 | \nCialis\u00ae | 4.9 |  | 82.0 |  | 86.8 |  |  | 8.1 |  | 107.7 |  | 115.7 | \nCOVID-19 antibodies(6) | \u2014 |  | \u2014 |  | \u2014 |  |  | 386.6 |  | \u2014 |  | 386.6 | \nOther | 18.0 |  | 24.8 |  | 42.9 |  |  | 30.9 |  | 35.7 |  | 66.6 | \nTotal other | 124.1 |  | 152.0 |  | 276.1 |  |  | 538.3 |  | 207.8 |  | 746.0 | \nRevenue | $ | 5,368.1 |  | $ | 4,130.5 |  | $ | 9,498.6 |  |  | $ | 4,422.1 |  | $ | 2,519.4 |  | $ | 6,941.6 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended September 30,\n | 2023 |  | 2022\n | U.S. | Outside U.S. | Total |  | U.S. | Outside U.S. | Total\n |  |  |  |  |  |  | \nDiabetes: |  |  |  |  |  |  | \nTrulicity | $ | 4,177.7 |  | $ | 1,285.6 |  | $ | 5,463.2 |  |  | $ | 4,162.4 |  | $ | 1,341.1 |  | $ | 5,503.5 | \nMounjaro | 2,729.1 |  | 228.4 |  | 2,957.5 |  |  | 109.9 |  | 93.3 |  | 203.2 | \nJardiance(1) | 1,131.5 |  | 815.1 |  | 1,946.6 |  |  | 831.4 |  | 622.4 |  | 1,453.7 | \nHumalog(2) | 695.6 |  | 601.2 |  | 1,296.8 |  |  | 855.8 |  | 656.4 |  | 1,512.3 | \nHumulin | 488.6 |  | 175.4 |  | 664.0 |  |  | 562.3 |  | 223.1 |  | 785.4 | \nBaqsimi | 633.1 |  | 25.4 |  | 658.4 |  |  | 79.5 |  | 21.7 |  | 101.2 | \nBasaglar(3) | 329.7 |  | 213.4 |  | 543.1 |  |  | 339.9 |  | 218.8 |  | 558.7 | \nOther diabetes | 131.1 |  | 260.7 |  | 392.0 |  |  | 116.1 |  | 254.8 |  | 371.0 | \nTotal diabetes | 10,316.4 |  | 3,605.2 |  | 13,921.6 |  |  | 7,057.3 |  | 3,431.6 |  | 10,489.0 | \n |  |  |  |  |  |  | \nOncology: |  |  |  |  |  |  | \nVerzenio | 1,734.2 |  | 983.7 |  | 2,717.9 |  |  | 1,100.5 |  | 575.1 |  | 1,675.6 | \nCyramza | 303.6 |  | 417.5 |  | 721.1 |  |  | 259.3 |  | 434.3 |  | 693.6 | \nErbitux | 398.3 |  | 48.0 |  | 446.3 |  |  | 361.0 |  | 47.4 |  | 408.3 | \nAlimta | 59.2 |  | 113.5 |  | 172.6 |  |  | 490.5 |  | 200.5 |  | 691.1 | \nOther oncology | 194.7 |  | 521.4 |  | 716.2 |  |  | 124.1 |  | 422.3 |  | 546.4 | \nTotal oncology | 2,690.0 |  | 2,084.1 |  | 4,774.1 |  |  | 2,335.4 |  | 1,679.6 |  | 4,015.0 | \n |  |  |  |  |  |  | \nImmunology: |  |  |  |  |  |  | \nTaltz | 1,293.8 |  | 681.2 |  | 1,975.0 |  |  | 1,212.6 |  | 561.6 |  | 1,774.2 | \nOlumiant(4) | 158.8 |  | 520.4 |  | 679.2 |  |  | 104.6 |  | 520.1 |  | 624.7 | \nOther immunology | \u2014 |  | 39.0 |  | 39.0 |  |  | 0.1 |  | 12.1 |  | 12.1 | \nTotal immunology | 1,452.6 |  | 1,240.6 |  | 2,693.2 |  |  | 1,317.3 |  | 1,093.8 |  | 2,411.0 | \n |  |  |  |  |  |  | \nNeuroscience: |  |  |  |  |  |  | \nZyprexa(5) | 69.1 |  | 1,581.9 |  | 1,651.0 |  |  | 26.2 |  | 235.5 |  | 261.7 | \nEmgality | 354.0 |  | 138.2 |  | 492.2 |  |  | 330.8 |  | 144.4 |  | 475.2 | \nOther neuroscience | 89.7 |  | 282.9 |  | 372.6 |  |  | 87.0 |  | 337.0 |  | 424.0 | \nTotal neuroscience | 512.8 |  | 2,003.0 |  | 2,515.8 |  |  | 444.0 |  | 716.9 |  | 1,160.9 | \n |  |  |  |  |  |  | \nOther: |  |  |  |  |  |  | \nForteo | 269.2 |  | 147.6 |  | 416.8 |  |  | 261.4 |  | 191.7 |  | 453.0 | \nCialis | 21.6 |  | 281.1 |  | 302.7 |  |  | 25.8 |  | 454.7 |  | 480.4 | \nCOVID-19 antibodies(6) | \u2014 |  | \u2014 |  | \u2014 |  |  | 1,970.9 |  | 14.7 |  | 1,985.5 | \nOther | 73.0 |  | 73.4 |  | 146.5 |  |  | 119.4 |  | 125.1 |  | 244.8 | \nTotal other | 363.8 |  | 502.1 |  | 866.0 |  |  | 2,377.5 |  | 786.2 |  | 3,163.7 | \nRevenue | $ | 15,335.6 |  | $ | 9,435.0 |  | $ | 24,770.7 |  |  | $ | 13,531.5 |  | $ | 7,708.1 |  | $ | 21,239.6 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nRevenue(1): |  |  |  |  |  |  | \nU.S. | $ | 5,368.1 |  |  | $ | 4,422.1 |  |  | $ | 15,335.6 |  |  | $ | 13,531.5 | \nEurope | 2,568.6 |  |  | 1,056.4 |  |  | 4,837.1 |  |  | 3,224.8 | \nJapan | 390.8 |  |  | 487.7 |  |  | 1,233.6 |  |  | 1,352.3 | \nChina | 390.8 |  |  | 343.4 |  |  | 1,162.6 |  |  | 1,102.0 | \nOther foreign countries | 780.3 |  |  | 632.0 |  |  | 2,201.8 |  |  | 2,029.1 | \nRevenue | $ | 9,498.6 |  |  | $ | 6,941.6 |  |  | $ | 24,770.7 |  |  | $ | 21,239.6 |   |  |  |  |  | \nEstimated Fair Value at December 1, 2022 | \nCash | $ | 153.2 | \nAcquired IPR&D(1) | 184.0\nGoodwill(2) | 187.1\n | \nOther assets and liabilities, net | 23.0 | \nAcquisition date fair value of consideration transferred | 547.3\nLess: | \nCash acquired | (153.2) | \nFair value of CVR liability(3) | (66.9) | \nCash paid, net of cash acquired | $ | 327.2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCounterparty | Compound(s), Therapy or Asset | Acquisition Month |  | Phase of Development(1) |  | Acquired IPR&D Expense\nDICE Therapeutics, Inc. | DC-806, an oral IL-17 inhibitor for the treatment of chronic diseases in immunology | August 2023 |  | Phase II |  | $ | 1,915.5 | \nVersanis Bio, Inc. | Bimagrumab, a monoclonal antibody for the treatment of people living with obesity and obesity-related complications | August 2023 |  | Phase II |  | 604.1 | \nEmergence Therapeutics AG | ETx-22, a Nectin-4 antibody-drug conjugate for the treatment of urothelial cancer | August 2023 |  | Pre-clinical |  | 406.5 | \n |  |  |  |  |  | \nBioMarin Pharmaceutical Inc. | Priority Review Voucher | February 2022 |  | Not applicable |  | 110.0 |   |  |  |  |  |  |  |  | \n | Net Milestones Capitalized (Deferred)(1)\n | September 30, 2023 | December 31, 2022\nJardiance | $ | 101.3 |  | $ | 116.2 | \nTrajenta | 45.0 |  | 63.5 | \nBasaglar | (116.6) |  | (130.6) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nJardiance | $ | 700.8 |  |  | $ | 573.3 |  |  | $ | 1,946.6 |  |  | $ | 1,453.7 | \nBasaglar | 179.6 |  |  | 193.0 |  |  | 543.1 |  |  | 558.7 | \nTrajenta | 95.2 |  |  | 103.8 |  |  | 284.7 |  |  | 293.0 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nOlumiant | $ | 231.4 |  |  | $ | 182.9 |  |  | $ | 679.2 |  |  | $ | 624.7 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Maturities by Period\n | Total |  | Less\u00a0Than1 Year |  | 1-5Years |  | 6-10Years |  | More\u00a0Than10 Years\nFair value of debt securities | $ | 628.3 |  |  | $ | 88.2 |  |  | $ | 201.6 |  |  | $ | 109.4 |  |  | $ | 229.1 |   |  |  |  |  |  |  |  |  |  |  | \n | September 30, 2023 |  | December 31, 2022\nUnrealized gross gains | $ | 0.1 |  |  | $ | 0.6 | \nUnrealized gross losses | 59.7 |  |  | 49.2 | \nFair value of securities in an unrealized gain position | 30.4 |  |  | 46.8 | \nFair value of securities in an unrealized loss position | 559.6 |  |  | 568.7 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nProceeds from sales | $ | 60.0 |  |  | $ | 50.5 |  |  | $ | 121.8 |  |  | $ | 115.6 | \nRealized gross gains on sales | 0.3 |  |  | \u2014 |  |  | 0.6 |  |  | 0.2 | \nRealized gross losses on sales | 1.9 |  |  | 7.5 |  |  | 3.6 |  |  | 9.0 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | Fair Value Measurements Using |  | \n | CarryingAmount |  | Cost(1) |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | Significant OtherObservable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue\nSeptember 30, 2023 |  |  |  |  |  |  |  |  |  |  | \nCash equivalents(2) | $ | 1,201.4 |  |  | $ | 1,201.4 |  |  | $ | 1,196.5 |  |  | $ | 4.9 |  |  | $ | \u2014 |  |  | $ | 1,201.4 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 30.2 |  |  | $ | 30.6 |  |  | $ | 30.2 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 30.2 | \nCorporate debt securities | 57.4 |  |  | 57.7 |  |  | \u2014 |  |  | 57.4 |  |  | \u2014 |  |  | 57.4 | \n |  |  |  |  |  |  |  |  |  |  | \nAsset-backed securities | 0.6 |  |  | 0.6 |  |  | \u2014 |  |  | 0.6 |  |  | \u2014 |  |  | 0.6 | \nOther securities | 24.9 |  |  | 24.9 |  |  | \u2014 |  |  | 11.0 |  |  | 13.9 |  |  | 24.9 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments | $ | 113.1 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 139.3 |  |  | $ | 160.0 |  |  | $ | 139.3 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 139.3 | \n |  |  |  |  |  |  |  |  |  |  | \nCorporate debt securities | 198.6 |  |  | 222.3 |  |  | \u2014 |  |  | 198.6 |  |  | \u2014 |  |  | 198.6 | \nMortgage-backed securities | 144.9 |  |  | 161.9 |  |  | \u2014 |  |  | 144.9 |  |  | \u2014 |  |  | 144.9 | \nAsset-backed securities | 57.2 |  |  | 59.5 |  |  | \u2014 |  |  | 57.2 |  |  | \u2014 |  |  | 57.2 | \nOther securities | 171.1 |  |  | 77.0 |  |  | \u2014 |  |  | 6.2 |  |  | 164.9 |  |  | 171.1 | \nMarketable equity securities | 532.0 |  |  | 443.2 |  |  | 532.0 |  |  | \u2014 |  |  | \u2014 |  |  | 532.0 | \nEquity investments without readily determinable fair values(3) | 531.4 |  |  |  |  |  |  |  |  |  |  | \nEquity method investments(3) | 917.2 |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments | $ | 2,691.7 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDecember 31, 2022 |  |  |  |  |  |  |  |  |  |  | \nCash equivalents(2) | $ | 657.4 |  |  | $ | 657.4 |  |  | $ | 650.4 |  |  | $ | 7.0 |  |  | $ | \u2014 |  |  | $ | 657.4 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 30.8 |  |  | $ | 31.1 |  |  | $ | 30.8 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 30.8 | \nCorporate debt securities | 53.4 |  |  | 53.5 |  |  | \u2014 |  |  | 53.4 |  |  | \u2014 |  |  | 53.4 | \n |  |  |  |  |  |  |  |  |  |  | \nAsset-backed securities | 2.0 |  |  | 2.0 |  |  | \u2014 |  |  | 2.0 |  |  | \u2014 |  |  | 2.0 | \nOther securities | 58.6 |  |  | 58.6 |  |  | \u2014 |  |  | 39.1 |  |  | 19.5 |  |  | 58.6 | \n |  |  |  |  |  |  |  |  |  |  | \nShort-term investments | $ | 144.8 |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments: |  |  |  |  |  |  |  |  |  |  | \nU.S. government and agency securities | $ | 146.4 |  |  | $ | 163.2 |  |  | $ | 146.4 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 146.4 | \nCorporate debt securities | 213.9 |  |  | 235.8 |  |  | \u2014 |  |  | 213.9 |  |  | \u2014 |  |  | 213.9 | \nMortgage-backed securities | 149.2 |  |  | 161.5 |  |  | \u2014 |  |  | 149.2 |  |  | \u2014 |  |  | 149.2 | \nAsset-backed securities | 50.6 |  |  | 52.5 |  |  | \u2014 |  |  | 50.6 |  |  | \u2014 |  |  | 50.6 | \nOther securities | 398.6 |  |  | 34.5 |  |  | \u2014 |  |  | 311.0 |  |  | 87.6 |  |  | 398.6 | \nMarketable equity securities | 683.6 |  |  | 484.7 |  |  | 683.6 |  |  | \u2014 |  |  | \u2014 |  |  | 683.6 | \nEquity investments without readily determinable fair values(3) | 478.4 |  |  |  |  |  |  |  |  |  |  | \nEquity method investments(3) | 781.1 |  |  |  |  |  |  |  |  |  |  | \nNoncurrent investments | $ | 2,901.8 |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Fair Value Measurements Using |  | \n | CarryingAmount |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | SignificantOther Observable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue\nShort-term commercial paper borrowings |  |  |  |  |  |  |  |  | \nSeptember 30, 2023 | $ | (1,594.9) |  |  | $ | \u2014 |  |  | $ | (1,592.5) |  |  | $ | \u2014 |  |  | $ | (1,592.5) | \nDecember 31, 2022 | (1,498.0) |  |  | \u2014 |  |  | (1,492.0) |  |  | \u2014 |  |  | (1,492.0) | \nLong-term debt, including current portion |  |  |  |  |  |  |  |  | \nSeptember 30, 2023 | $ | (18,573.4) |  |  | $ | \u2014 |  |  | $ | (15,412.6) |  |  | $ | \u2014 |  |  | $ | (15,412.6) | \nDecember 31, 2022 | (14,740.6) |  |  | \u2014 |  |  | (12,329.3) |  |  | \u2014 |  |  | (12,329.3) |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSeptember 30, 2023\nPurchase |  | Sell\nCurrency | Amount(in millions) |  | Currency | Amount(in millions)\nEuro | 5,774.2 |  | U.S. dollars | 6,170.9\nU.S. dollars | 3,420.4 |  | Euro | 3,224.2\nU.S. dollars | 240.0 |  | Chinese yuan | 1,736.5\n |  |  |  | \nBritish pounds | 185.7 |  | U.S. dollars | 229.7\nU.S. dollars | 200.2 |  | Japanese yen | 29,626.8\n |  |  |  | \n |  |  |  | \n |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nFair value hedges: |  |  |  |  |  |  | \nEffect from hedged fixed-rate debt | $ | (29.9) |  |  | $ | (62.9) |  |  | $ | (29.0) |  |  | $ | (215.7) | \nEffect from interest rate contracts | 29.9 |  |  | 62.9 |  |  | 29.0 |  |  | 215.7 | \nCash flow hedges: |  |  |  |  |  |  | \nEffective portion of losses on interest rate contracts reclassified from accumulated other comprehensive loss | 3.2 |  |  | 4.1 |  |  | 10.3 |  |  | 12.3 | \nCross-currency interest rate swaps | 24.7 |  |  | 33.1 |  |  | (5.3) |  |  | 75.0 | \nNet losses on foreign currency exchange contracts not designated as hedging instruments | 201.0 |  |  | 129.6 |  |  | 177.8 |  |  | 280.7 | \nTotal | $ | 228.9 |  |  | $ | 166.8 |  |  | $ | 182.8 |  |  | $ | 368.0 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nNet investment hedges: |  |  |  |  |  |  | \nForeign currency-denominated notes | $ | 183.5 |  |  | $ | 435.1 |  |  | $ | 62.3 |  |  | $ | 822.8 | \nCross-currency interest rate swaps | 28.6 |  |  | 92.1 |  |  | 9.0 |  |  | 171.4 | \nForeign currency forward contracts | 217.7 |  |  | 107.8 |  |  | 199.3 |  |  | 121.4 | \nCash flow hedges: |  |  |  |  |  |  | \nForward-starting interest rate swaps | 84.3 |  |  | 57.5 |  |  | 141.4 |  |  | 337.7 | \nCross-currency interest rate swaps | 16.4 |  |  | 19.9 |  |  | 30.5 |  |  | 38.4 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Fair Value Measurements Using |  |  |  | \n | CarryingAmount |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | SignificantOther Observable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue |  | \nSeptember 30, 2023 |  |  |  |  |  |  |  |  |  |  | \nRisk-management instruments: |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther current liabilities | $ | (5.6) |  |  | $ | \u2014 |  |  | $ | (5.6) |  |  | $ | \u2014 |  |  | $ | (5.6) |  |  | \nOther noncurrent liabilities | (157.7) |  |  | \u2014 |  |  | (157.7) |  |  | \u2014 |  |  | (157.7) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 346.2 |  |  | \u2014 |  |  | 346.2 |  |  | \u2014 |  |  | 346.2 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 71.3 |  |  | \u2014 |  |  | 71.3 |  |  | \u2014 |  |  | 71.3 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 58.3 |  |  | \u2014 |  |  | 58.3 |  |  | \u2014 |  |  | 58.3 |  |  | \nOther noncurrent assets | 30.7 |  |  | \u2014 |  |  | 30.7 |  |  | \u2014 |  |  | 30.7 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nForeign exchange contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 106.0 |  |  | \u2014 |  |  | 106.0 |  |  | \u2014 |  |  | 106.0 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nForeign exchange contracts not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 32.9 |  |  | \u2014 |  |  | 32.9 |  |  | \u2014 |  |  | 32.9 |  |  | \nOther current liabilities | (100.5) |  |  | \u2014 |  |  | (100.5) |  |  | \u2014 |  |  | (100.5) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nContingent consideration liabilities: |  |  |  |  |  |  |  |  |  |  | \nOther current liabilities | (39.0) |  |  | \u2014 |  |  | \u2014 |  |  | (39.0) |  |  | (39.0) |  |  | \nOther noncurrent liabilities | (63.9) |  |  | \u2014 |  |  | \u2014 |  |  | (63.9) |  |  | (63.9) |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Fair Value Measurements Using |  |  |  | \n | CarryingAmount |  | Quoted Prices in Active Markets for Identical Assets(Level 1) |  | SignificantOther Observable Inputs(Level 2) |  | SignificantUnobservableInputs(Level 3) |  | FairValue |  | \nDecember 31, 2022 |  |  |  |  |  |  |  |  |  |  | \nRisk-management instruments: |  |  |  |  |  |  |  |  |  |  | \nInterest rate contracts designated as fair value hedges: |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent liabilities | $ | (134.3) |  |  | $ | \u2014 |  |  | $ | (134.3) |  |  | $ | \u2014 |  |  | $ | (134.3) |  |  | \nInterest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 162.9 |  |  | \u2014 |  |  | 162.9 |  |  | \u2014 |  |  | 162.9 |  |  | \nOther noncurrent assets | 246.0 |  |  | \u2014 |  |  | 246.0 |  |  | \u2014 |  |  | 246.0 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as net investment hedges: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 67.6 |  |  | \u2014 |  |  | 67.6 |  |  | \u2014 |  |  | 67.6 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nCross-currency interest rate contracts designated as cash flow hedges: |  |  |  |  |  |  |  |  |  |  | \nOther noncurrent assets | 53.1 |  |  | \u2014 |  |  | 53.1 |  |  | \u2014 |  |  | 53.1 |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nForeign exchange contracts designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  | \nOther current liabilities | (38.3) |  |  | \u2014 |  |  | (38.3) |  |  | \u2014 |  |  | (38.3) |  |  | \nForeign exchange contracts not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |  | \nOther receivables | 26.6 |  |  | \u2014 |  |  | 26.6 |  |  | \u2014 |  |  | 26.6 |  |  | \nOther current liabilities | (21.5) |  |  | \u2014 |  |  | (21.5) |  |  | \u2014 |  |  | (21.5) |  |  | \nContingent consideration liabilities: |  |  |  |  |  |  |  |  |  |  | \nOther current liabilities | (39.5) |  |  | \u2014 |  |  | \u2014 |  |  | (39.5) |  |  | (39.5) |  |  | \nOther noncurrent liabilities | (70.6) |  |  | \u2014 |  |  | \u2014 |  |  | (70.6) |  |  | (70.6) |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Defined Benefit Pension Plans\n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nComponents of net periodic cost: |  |  |  |  |  |  | \nService cost | $ | 72.5 |  |  | $ | 87.1 |  |  | $ | 217.8 |  |  | $ | 264.4 | \nInterest cost | 162.3 |  |  | 98.9 |  |  | 486.0 |  |  | 299.0 | \nExpected return on plan assets | (264.0) |  |  | (235.1) |  |  | (791.5) |  |  | (711.6) | \nAmortization of prior service cost | 0.6 |  |  | 0.6 |  |  | 1.8 |  |  | 1.9 | \nRecognized actuarial loss | 30.6 |  |  | 85.3 |  |  | 91.5 |  |  | 256.8 | \n |  |  |  |  |  |  | \nNet periodic cost | $ | 2.0 |  |  | $ | 36.8 |  |  | $ | 5.6 |  |  | $ | 110.5 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Retiree Health Benefit Plans\n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nComponents of net periodic benefit: |  |  |  |  |  |  | \nService cost | $ | 7.9 |  |  | $ | 11.7 |  |  | $ | 23.8 |  |  | $ | 35.0 | \nInterest cost | 15.3 |  |  | 9.4 |  |  | 46.0 |  |  | 28.4 | \nExpected return on plan assets | (45.5) |  |  | (38.0) |  |  | (136.6) |  |  | (114.1) | \nAmortization of prior service benefit | (13.3) |  |  | (13.7) |  |  | (39.7) |  |  | (41.1) | \nRecognized actuarial (gain) loss | (1.5) |  |  | 0.2 |  |  | (4.4) |  |  | 0.7 | \n |  |  |  |  |  |  | \nNet periodic benefit | $ | (37.1) |  |  | $ | (30.4) |  |  | $ | (110.9) |  |  | $ | (91.1) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Net Unrealized Gains (Losses) on Available-For-Sale\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Net Unrealized Gains (Losses) on Cash\u00a0Flow Hedges |  |  |  | Accumulated Other Comprehensive Loss\nBalance at July\u00a01, 2023 | $ | (1,885.3) |  |  | $ | (33.5) |  |  | $ | (2,058.8) |  |  | $ | 188.9 |  |  |  |  | $ | (3,788.7) | \n |  |  |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (88.7) |  |  | (13.5) |  |  | 10.5 |  |  | 79.6 |  |  |  |  | (12.1) | \nNet amount reclassified from accumulated other comprehensive loss | \u2014 |  |  | 1.4 |  |  | 13.0 |  |  | 1.5 |  |  |  |  | 15.9 | \nNet other comprehensive income (loss) | (88.7) |  |  | (12.1) |  |  | 23.5 |  |  | 81.1 |  |  |  |  | 3.8 | \n |  |  |  |  |  |  |  |  |  |  | \nBalance at September\u00a030, 2023 | $ | (1,974.0) |  |  | $ | (45.6) |  |  | $ | (2,035.3) |  |  | $ | 270.0 |  |  |  |  | $ | (3,784.9) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Net Unrealized Gains (Losses) on Available-For-Sale\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Net Unrealized Gains (Losses) on Cash\u00a0Flow Hedges |  |  |  | Accumulated Other Comprehensive Loss\nBalance at July\u00a01, 2022 | $ | (1,844.2) |  |  | $ | (27.9) |  |  | $ | (2,443.2) |  |  | $ | 27.6 |  |  |  |  | $ | (4,287.7) | \n |  |  |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (165.1) |  |  | (24.9) |  |  | 47.8 |  |  | 63.0 |  |  |  |  | (79.2) | \nNet amount reclassified from accumulated other comprehensive loss | \u2014 |  |  | 13.5 |  |  | 57.2 |  |  | 0.4 |  |  |  |  | 71.1 | \nNet other comprehensive income (loss) | (165.1) |  |  | (11.4) |  |  | 105.0 |  |  | 63.4 |  |  |  |  | (8.1) | \n |  |  |  |  |  |  |  |  |  |  | \nBalance at September\u00a030, 2022 | $ | (2,009.3) |  |  | $ | (39.3) |  |  | $ | (2,338.2) |  |  | $ | 91.0 |  |  |  |  | $ | (4,295.8) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Net Unrealized Gains (Losses) on Available-For-Sale\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Net Unrealized Gains (Losses) on Cash\u00a0Flow Hedges |  | Accumulated Other Comprehensive Loss\nBalance at January\u00a01, 2023 | $ | (1,874.2) |  |  | $ | (37.1) |  |  | $ | (2,062.3) |  |  | $ | 129.0 |  |  | $ | (3,844.6) | \n |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (74.6) |  |  | (11.3) |  |  | (11.9) |  |  | 135.8 |  |  | 38.0 | \nNet amount reclassified from accumulated other comprehensive loss | (25.2) |  |  | 2.8 |  |  | 38.9 |  |  | 5.2 |  |  | 21.7 | \nNet other comprehensive income (loss) | (99.8) |  |  | (8.5) |  |  | 27.0 |  |  | 141.0 |  |  | 59.7 | \n |  |  |  |  |  |  |  |  | \nBalance at September\u00a030, 2023 | $ | (1,974.0) |  |  | $ | (45.6) |  |  | $ | (2,035.3) |  |  | $ | 270.0 |  |  | $ | (3,784.9) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(Amounts presented net of taxes) | Foreign Currency Translation Gains\u00a0(Losses) |  | Net Unrealized Gains (Losses) on Available-For-Sale\u00a0Securities |  | Defined Benefit Pension and Retiree\u00a0Health Benefit Plans |  | Net Unrealized Gains (Losses) on Cash\u00a0Flow Hedges |  | Accumulated Other Comprehensive Loss\nBalance at January\u00a01, 2022 | $ | (1,550.2) |  |  | $ | 3.7 |  |  | $ | (2,583.6) |  |  | $ | (213.0) |  |  | $ | (4,343.1) | \n |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) before reclassifications | (459.7) |  |  | (55.5) |  |  | 72.9 |  |  | 297.2 |  |  | (145.1) | \nNet amount reclassified from accumulated other comprehensive loss | 0.6 |  |  | 12.5 |  |  | 172.5 |  |  | 6.8 |  |  | 192.4 | \nNet other comprehensive income (loss) | (459.1) |  |  | (43.0) |  |  | 245.4 |  |  | 304.0 |  |  | 47.3 | \n |  |  |  |  |  |  |  |  | \nBalance at September\u00a030, 2022 | $ | (2,009.3) |  |  | $ | (39.3) |  |  | $ | (2,338.2) |  |  | $ | 91.0 |  |  | $ | (4,295.8) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\nTax benefit (expense) | 2023 |  | 2022 |  | 2023 |  | 2022\nForeign currency translation gains/losses | $ | (90.3) |  |  | $ | (133.3) |  |  | $ | (50.2) |  |  | $ | (234.2) | \nNet unrealized gains/losses on available-for-sale securities | 3.5 |  |  | 3.4 |  |  | 2.5 |  |  | 13.1 | \nDefined benefit pension and retiree health benefit plans | (6.9) |  |  | (22.4) |  |  | (13.9) |  |  | (73.2) | \nNet unrealized gains/losses on cash flow hedges | (21.6) |  |  | (16.9) |  |  | (37.5) |  |  | (80.8) | \nBenefit (expense) for income taxes allocated to other comprehensive income (loss) items | $ | (115.3) |  |  | $ | (169.2) |  |  | $ | (99.1) |  |  | $ | (375.1) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nDetails about Accumulated Other Comprehensive Loss Components | Three Months Ended September 30, |  | Nine Months Ended September 30, | Affected Line Item in the Consolidated Condensed Statements of Operations\n\n2023 |  | 2022 |  | 2023 |  | 2022\nAmortization of retirement benefit items: |  |  |  |  |  |  |  | \nPrior service benefits, net | $ | (12.7) |  |  | $ | (13.1) |  |  | $ | (37.9) |  |  | $ | (39.2) |  | Other\u2013net, (income) expense\nActuarial losses, net | 29.1 |  |  | 85.5 |  |  | 87.1 |  |  | 257.5 |  | Other\u2013net, (income) expense\nTotal before tax | 16.4 |  |  | 72.4 |  |  | 49.2 |  |  | 218.3 |  | \nTax benefit | (3.4) |  |  | (15.2) |  |  | (10.3) |  |  | (45.8) |  | Income taxes\nNet of tax | 13.0 |  |  | 57.2 |  |  | 38.9 |  |  | 172.5 |  | \n |  |  |  |  |  |  |  | \nOther, net of tax | 2.9 |  |  | 13.9 |  |  | (17.2) |  |  | 19.9 |  | Other\u2013net, (income) expense\n |  |  |  |  |  |  |  | \nTotal reclassifications, net of tax | $ | 15.9 |  |  | $ | 71.1 |  |  | $ | 21.7 |  |  | $ | 192.4 |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nInterest expense | $ | 124.6 |  |  | $ | 81.5 |  |  | $ | 347.7 |  |  | $ | 247.6 | \nInterest income | (48.9) |  |  | (20.1) |  |  | (129.1) |  |  | (37.3) | \nNet investment losses on equity securities (Note 6) | 62.9 |  |  | 123.3 |  |  | 141.5 |  |  | 667.6 | \nRetirement benefit plans | (115.5) |  |  | (92.4) |  |  | (346.9) |  |  | (280.0) | \n |  |  |  |  |  |  | \nOther (income) expense | 0.1 |  |  | 18.7 |  |  | 11.1 |  |  | (17.0) | \nOther\u2013net, (income) expense | $ | 23.2 |  |  | $ | 111.0 |  |  | $ | 24.3 |  |  | $ | 580.9 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Percent Change |  | Nine Months Ended September 30, |  | Percent Change\n | 2023 |  | 2022 |  |  | 2023 |  | 2022 | \nRevenue | $ | 9,498.6 |  |  | $ | 6,941.6 |  |  | 37 |  | $ | 24,770.7 |  |  | $ | 21,239.6 |  |  | 17\nNet income (loss) | (57.4) |  |  | 1,451.7 |  |  | NM |  | 3,050.7 |  |  | 4,307.1 |  |  | (29)\nEarnings (loss) per share - diluted | (0.06) |  |  | 1.61 |  |  | NM |  | 3.38 |  |  | 4.76 |  |  | (29)  |  |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication/Study | Status | Developments | \nDiabetes and Obesity | \n |  |  |  | \nEmpagliflozin (Jardiance\u00ae)(1) | Chronic kidney disease | Approved | Approved in the U.S. and in the EU in the third quarter of 2023. Submitted in Japan in 2022. | \nTirzepatide | Obesity | Submitted | Submitted in the EU in the first quarter of 2023 and in the U.S. in the second quarter of 2023. Received Priority Review designation from the U.S. Food and Drug Administration (FDA). Announced in the second and third quarters of 2023 that Phase III trials met all primary and key secondary endpoints. Phase III trials are ongoing. | \nCardiovascular outcomes in type 2 diabetes | Phase III | Phase III trial is ongoing. | \nHeart failure with preserved ejection fraction | Phase III | Phase III trials are ongoing. | \nMorbidity and mortality in obesity | Phase III | Phase III trial is ongoing. | \nObstructive sleep apnea (OSA) | Phase III | Granted FDA Fast Track designation(2). Phase III trial is ongoing. | \nHigher doses | Phase II | Phase II trial initiated in the third quarter of 2023. | \nNonalcoholic steatohepatitis | Phase II | Phase II trial is ongoing. | \nInsulin Efsitora Alfa | Type 1 and 2 diabetes | Phase III | Phase III trials are ongoing. | \nOrforglipron | Obesity | Phase III | Phase III trials initiated in the second quarter of 2023. | \nType 2 diabetes | Phase III | Phase III trials initiated in the second and third quarters of 2023. | \nRetatrutide | Obesity, osteoarthritis, OSA | Phase III | Phase III trials initiated in the second and third quarters of 2023. | \nType 2 diabetes | Phase II | Phase II trial was completed. | \nBimagrumab | Obesity | Phase II | Acquired in the acquisition of Versanis Bio, Inc. (Versanis) in the third quarter of 2023. Phase II trial is ongoing. | \nLepodisiran | Cardiovascular disease | Phase II | Phase II trial is ongoing. | \nMuvalaplin | Cardiovascular disease | Phase II | Phase II trial is ongoing. | \nSolbinsiran | Cardiovascular disease | Phase II | Phase II trial is ongoing. | \nVolenrelaxin (Relaxin-LA) | Heart failure | Phase II | Phase II trial initiated in the first quarter of 2023. |   |  |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication/Study | Status | Developments | \nImmunology | \nMirikizumab(OmvohTM) | Ulcerative colitis | Approved | Approved in Japan in the first quarter of 2023, in the EU in the second quarter of 2023, and in the U.S. in October 2023. | \nCrohn's Disease | Phase III | Announced in October 2023 that a Phase III trial met the co-primary and all major secondary endpoints versus placebo. Phase III trials are ongoing. | \nLebrikizumab(3) | Atopic dermatitis | Submitted | Submitted in the U.S. and the EU in 2022 and in Japan in the first quarter of 2023. Announced in October 2023 we received a complete response letter from the FDA based on inspection findings at a third-party manufacturer with no stated concerns about the clinical data package, safety, or label. Phase III trials are ongoing. | \nDC-806 | Psoriasis | Phase II | Acquired in the acquisition of DICE Therapeutics, Inc. (DICE) in the third quarter of 2023. Phase II trial is ongoing. | \nEltrekibart | Hidradenitis suppurativa | Phase II | Phase II trial is ongoing. | \nPeresolimab | Rheumatoid arthritis | Phase II | Phase II trial is ongoing. | \nRIPK1 inhibitor | Rheumatoid arthritis | Phase II | Phase II trial initiated in the second quarter of 2023. | \nUcenprubart | Atopic dermatitis | Phase II | Phase II trial initiated in the second quarter of 2023. | \nBTLA MAB Agonist | Systemic lupus erythematosus | Discontinued | Phase II trial failed to demonstrate efficacy in the third quarter of 2023. | \nNeuroscience | \nDonanemab | Early Alzheimer's disease | Submitted | Submitted for traditional approval in the U.S. in the second quarter of 2023 and in the EU and Japan in the third quarter of 2023. Granted FDA Breakthrough Therapy designation(4). Announced in the second quarter of 2023 that a Phase III trial met primary and all secondary endpoints. Phase III trials are ongoing. | \nPreclinical Alzheimer's disease | Phase III | Phase III trial is ongoing. | \nRemternetug | Early Alzheimer's disease | Phase III | Phase III trial is ongoing. | \nGBA1 Gene Therapy | Gaucher disease Type 1 | Phase II | Phase II trial initiated in the second quarter of 2023. | \nParkinson's disease | Phase II | Granted FDA Fast Track designation(2). Phase II trial is ongoing. | \nGRN Gene Therapy | Frontotemporal dementia | Phase II | Granted FDA Fast Track designation(2). Phase II trial is ongoing. | \nO-GlcNAcase Inh | Alzheimer's disease | Phase II | Phase II trial is ongoing. | \nP2X7 Inhibitor | Pain | Phase II | Phase II trials were recently completed. | \nSSTR4 Agonist | Pain | Phase II | Phase II trials are ongoing. |   |  |  |  |  |  |  |  |  |  |  |  | \nCompound | Indication/Study | Status | Developments | \nOncology | \nPirtobrutinib(Jaypirca\u00ae) | Mantle cell lymphoma | Approved(5) | FDA granted accelerated approval(5)in the U.S. in the first quarter of 2023. Submitted in the EU in 2022 and in Japan in the second quarter of 2023. Received a positive opinion from the Committee for Medicinal Products for Human Use in the EU in the second quarter of 2023. Phase III trial is ongoing. | \nChronic lymphocytic leukemia | Submitted | Submitted in the U.S. in the third quarter of 2023 under the accelerated approval pathway. Phase III trials are ongoing. | \nSelpercatinib (Retevmo\u00ae) | Lung cancer | Approved | Announced in the third quarter of 2023 that a Phase III trial met its primary endpoint. Phase III trial is ongoing. | \nThyroid cancer | Approved | Announced in the third quarter of 2023 that a Phase III trial met its primary endpoint. | \nAbemaciclib | Prostate cancer | Phase III | Phase III trials are ongoing. | \nImlunestrant | Adjuvant breast cancer | Phase III | Phase III trial is ongoing. | \nER+HER2- metastatic breast cancer | Phase III | Phase III trial is ongoing. |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Percent Change | Nine Months Ended September 30, |  | Percent Change\n | 2023 |  | 2022 |  | 2023 |  | 2022 | \nU.S. | $ | 5,368.1 |  |  | $ | 4,422.1 |  |  | 21 | $ | 15,335.6 |  |  | $ | 13,531.5 |  |  | 13\nOutside U.S. | 4,130.5 |  |  | 2,519.4 |  |  | 64 | 9,435.0 |  |  | 7,708.1 |  |  | 22\nRevenue | $ | 9,498.6 |  |  | $ | 6,941.6 |  |  | 37 | $ | 24,770.7 |  |  | $ | 21,239.6 |  |  | 17  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2023 vs. 2022 |  | 2023 vs. 2022\n | U.S. | Outside U.S. | Consolidated |  | U.S. | Outside U.S. | Consolidated\nVolume | 9 | % | 69 | % | 31 | % |  | 10 | % | 30 | % | 17 | %\nPrice | 13 |  | (7) |  | 6 |  |  | 3 |  | (5) |  | \u2014 | \nForeign exchange rates | \u2014 |  | 2 |  | 1 |  |  | \u2014 |  | (2) |  | (1) | \nPercent change | 21 | % | 64 | % | 37 | % |  | 13 | % | 22 | % | 17 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Percent Change | \n | 2023 |  | 2022 | \nProduct | U.S. |  | Outside U.S. |  | Total |  | Total | \nTrulicity | $ | 1,259.0 |  |  | $ | 414.6 |  |  | $ | 1,673.6 |  |  | $ | 1,850.4 |  |  | (10) | \nZyprexa(1) | 49.9 |  |  | 1,431.5 |  |  | 1,481.4 |  |  | 81.4 |  |  | NM | \nMounjaro | 1,277.0 |  |  | 132.4 |  |  | 1,409.3 |  |  | 187.3 |  |  | NM | \nVerzenio | 684.6 |  |  | 355.7 |  |  | 1,040.2 |  |  | 617.7 |  |  | 68 | \nTaltz | 509.3 |  |  | 234.9 |  |  | 744.2 |  |  | 679.9 |  |  | 9 | \nJardiance(2) | 415.9 |  |  | 284.8 |  |  | 700.8 |  |  | 573.3 |  |  | 22 | \nHumalog(3) | 194.2 |  |  | 201.2 |  |  | 395.4 |  |  | 447.0 |  |  | (12) | \nOlumiant\u00ae(4) | 65.7 |  |  | 165.7 |  |  | 231.4 |  |  | 182.9 |  |  | 27 | \nCyramza\u00ae | 88.0 |  |  | 136.1 |  |  | 224.1 |  |  | 232.1 |  |  | (3) | \nHumulin\u00ae | 145.5 |  |  | 61.2 |  |  | 206.7 |  |  | 238.2 |  |  | (13) | \nBasaglar\u00ae (5) | 111.4 |  |  | 68.2 |  |  | 179.6 |  |  | 193.0 |  |  | (7) | \nEmgality\u00ae | 126.5 |  |  | 42.1 |  |  | 168.5 |  |  | 168.5 |  |  | \u2014 | \nErbitux\u00ae | 134.0 |  |  | 19.9 |  |  | 153.9 |  |  | 144.9 |  |  | 6 | \nForteo\u00ae | 101.2 |  |  | 45.2 |  |  | 146.4 |  |  | 177.1 |  |  | (17) | \nCialis\u00ae | 4.9 |  |  | 82.0 |  |  | 86.8 |  |  | 115.7 |  |  | (25) | \nAlimta | 21.2 |  |  | 32.3 |  |  | 53.5 |  |  | 119.4 |  |  | (55) | \nBaqsimi | 3.8 |  |  | 9.3 |  |  | 13.1 |  |  | 43.0 |  |  | (70) | \nCOVID-19 antibodies(6) | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 386.6 |  |  | (100) | \nOther products | 176.0 |  |  | 413.4 |  |  | 589.7 |  |  | 503.2 |  |  | 17 | \nRevenue | $ | 5,368.1 |  |  | $ | 4,130.5 |  |  | $ | 9,498.6 |  |  | $ | 6,941.6 |  |  | 37 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended September 30, |  | \n | 2023 |  | 2022\nProduct | U.S. |  | Outside U.S. |  | Total |  | Total | Percent Change\nTrulicity | $ | 4,177.7 |  |  | $ | 1,285.6 |  |  | $ | 5,463.2 |  |  | $ | 5,503.5 |  |  | (1)\nMounjaro | 2,729.1 |  |  | 228.4 |  |  | 2,957.5 |  |  | 203.2 |  |  | NM\nVerzenio | 1,734.2 |  |  | 983.7 |  |  | 2,717.9 |  |  | 1,675.6 |  |  | 62\nTaltz | 1,293.8 |  |  | 681.2 |  |  | 1,975.0 |  |  | 1,774.2 |  |  | 11\nJardiance(1) | 1,131.5 |  |  | 815.1 |  |  | 1,946.6 |  |  | 1,453.7 |  |  | 34\nZyprexa(2) | 69.1 |  |  | 1,581.9 |  |  | 1,651.0 |  |  | 261.7 |  |  | NM\nHumalog(3) | 695.6 |  |  | 601.2 |  |  | 1,296.8 |  |  | 1,512.3 |  |  | (14)\nCyramza | 303.6 |  |  | 417.5 |  |  | 721.1 |  |  | 693.6 |  |  | 4\nOlumiant(4) | 158.8 |  |  | 520.4 |  |  | 679.2 |  |  | 624.7 |  |  | 9\nHumulin | 488.6 |  |  | 175.4 |  |  | 664.0 |  |  | 785.4 |  |  | (15)\nBaqsimi | 633.1 |  |  | 25.4 |  |  | 658.4 |  |  | 101.2 |  |  | NM\nBasaglar(5) | 329.7 |  |  | 213.4 |  |  | 543.1 |  |  | 558.7 |  |  | (3)\nEmgality | 354.0 |  |  | 138.2 |  |  | 492.2 |  |  | 475.2 |  |  | 4\nErbitux | 398.3 |  |  | 48.0 |  |  | 446.3 |  |  | 408.3 |  |  | 9\nForteo | 269.2 |  |  | 147.6 |  |  | 416.8 |  |  | 453.0 |  |  | (8)\nCialis | 21.6 |  |  | 281.1 |  |  | 302.7 |  |  | 480.4 |  |  | (37)\nAlimta | 59.2 |  |  | 113.5 |  |  | 172.6 |  |  | 691.1 |  |  | (75)\nCOVID-19 antibodies(6) | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1,985.5 |  |  | (100)\nOther products | 488.5 |  |  | 1,177.4 |  |  | 1,666.3 |  |  | 1,598.3 |  |  | 49\nRevenue | $ | 15,335.6 |  |  | $ | 9,435.0 |  |  | $ | 24,770.7 |  |  | $ | 21,239.6 |  |  | 17  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Percent Change |  | Nine Months Ended September 30, |  | Percent Change\n | 2023 |  | 2022 |  |  | 2023 |  | 2022 | \n |  |  |  |  |  |  |  |  |  |  | \nGross margin | $ | 7,638.5 |  |  | $ | 5,362.5 |  |  | 42 |  | $ | 19,476.5 |  |  | $ | 16,157.9 |  |  | 21\nGross margin as a percent of revenue | 80.4 | % |  | 77.3 | % |  |  |  | 78.6 | % |  | 76.1 | % |  | \n |  |  |  |  |  |  |  |  |  |  | \nResearch and development | $ | 2,409.1 |  |  | $ | 1,802.9 |  |  | 34 |  | $ | 6,750.7 |  |  | $ | 5,194.9 |  |  | 30\nMarketing, selling, and administrative | 1,803.9 |  |  | 1,614.2 |  |  | 12 |  | 5,478.5 |  |  | 4,797.2 |  |  | 14\nAcquired IPR&D | 2,975.1 |  |  | 62.4 |  |  | NM |  | 3,177.2 |  |  | 668.4 |  |  | NM\nAsset impairment, restructuring, and other special charges | \u2014 |  |  | 206.5 |  |  | (100) |  | \u2014 |  |  | 206.5 |  |  | (100)\nOther\u2013net, (income) expense | 23.2 |  |  | 111.0 |  |  | (79) |  | 24.3 |  |  | 580.9 |  |  | (96)\nIncome taxes | 484.6 |  |  | 113.8 |  |  | NM |  | 995.1 |  |  | 402.9 |  |  | NM\nEffective tax rate | 113.4 | % |  | 7.3 | % |  |  |  | 24.6 | % |  | 8.6 | % |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod | Total Number ofShares Purchased(in thousands) |  | Average\u00a0Price Paidper Share |  | Total\u00a0Number of SharesPurchased\u00a0as Part ofPublicly AnnouncedPlans or Programs(in thousands) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(in millions)\nJuly 2023 | \u2014 |  |  | $ | \u2014 |  |  | \u2014 |  |  | $ | 2,500.0 | \nAugust 2023 | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 2,500.0 | \nSeptember 2023 | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 2,500.0 | \nTotal | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |   |  |  |  |  |  |  |  | \nExhibit |  | Description\n3.1 |  | Amended Articles of Incorporation, incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on May 4, 2022\n |  | \n3.2 |  | Bylaws, as amended, incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed on May 4, 2022\n |  | \n31.1 |  | Rule\u00a013a-14(a) Certification of David Ricks, Chair, President, and Chief Executive Officer*\n |  | \n31.2 |  | Rule\u00a013a-14(a) Certification of Anat Ashkenazi, Executive Vice President and Chief Financial Officer*\n | \n32 |  | Section 1350 Certification*\n |  | \n101 |  | Interactive Data Files (embedded within the Inline XBRL document)*\n |  | \n104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*\n\n* Filed herewith.  |  |  |  |  |  |  |  | \n |  | ELI LILLY AND COMPANY\n |  | (Registrant)\n |  | \nDate: | November 2, 2023 | /s/ Anat Ashkenazi\n |  | Anat Ashkenazi\n |  | Executive Vice President and Chief Financial Officer\nDate: | November 2, 2023 | /s/ Donald Zakrowski\n |  | Donald Zakrowski\n |  | Senior Vice President, Finance, and Chief Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Exxon Mobil, in 2022 Q1, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  |  |  |  | \nNew Jersey |  | 13-5409005\n(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification Number)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of Each Class |  | Trading Symbol |  | Name of Each Exchangeon Which Registered\nCommon Stock, without par value |  | XOM |  | New York Stock Exchange\n0.142% Notes due 2024 |  | XOM24B |  | New York Stock Exchange\n0.524% Notes due 2028 |  | XOM28 |  | New York Stock Exchange\n0.835% Notes due 2032 |  | XOM32 |  | New York Stock Exchange\n1.408% Notes due 2039 |  | XOM39A |  | New York Stock Exchange  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2611 | Accelerated filer | \u2610\n |  |  | \nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n\n | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \nClass |  | Outstanding as of March\u00a031, 2022\nCommon stock, without par value |  | 4,212,543,236  |  |  |  |  | \nPART I. FINANCIAL INFORMATION\n | \nItem 1. Financial Statements | \n | \nCondensed Consolidated Statement of IncomeThree months ended March\u00a031, 2022 and 2021 | 3 | \n | \nCondensed Consolidated Statement of Comprehensive IncomeThree months ended March\u00a031, 2022 and 2021 | 4 | \n | \nCondensed Consolidated Balance SheetAs of March\u00a031, 2022 and December\u00a031, 2021 | 5 | \n | \nCondensed Consolidated Statement of Cash FlowsThree months ended March\u00a031, 2022 and 2021 | 6 | \n | \nCondensed Consolidated Statement of Changes in EquityThree months ended March\u00a031, 2022 and 2021 | 7 | \n | \n | \n | \n | \n | \nNotes to Condensed Consolidated Financial Statements | 8 | \n | \nItem 2. Management's Discussion and Analysis of Financial Condition and Results of Operations | 16 | \n | \nItem 3. Quantitative and Qualitative Disclosures About Market Risk | 26 | \n | \nItem 4. Controls and Procedures | 26 | \n | \n | \nPART II. OTHER INFORMATION\n | \nItem 1. Legal Proceedings | 27 | \n | \n | \n | \nItem 2. Unregistered Sales of Equity Securities and Use of Proceeds | 27 | \n | \nItem 6. Exhibits | 27 | \n | \nIndex to Exhibits | 28 | \n | \nSignature | 29 | \n |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEXXON MOBIL CORPORATION\nCONDENSED CONSOLIDATED STATEMENT OF INCOME\n(millions of dollars)\n |  |  |  | Three Months EndedMarch 31,\n |  |  |  |  |  | 2022 |  | 2021\nRevenues and other income |  |  |  |  |  |  |  | \nSales and other operating revenue |  |  |  |  |  | 87,734 |  |  | 57,552 | \nIncome from equity affiliates |  |  |  |  |  | 2,538 |  |  | 1,473 | \nOther income |  |  |  |  |  | 228 |  |  | 122 | \nTotal revenues and other income |  |  |  |  |  | 90,500 |  |  | 59,147 | \nCosts and other deductions |  |  |  |  |  |  |  | \nCrude oil and product purchases |  |  |  |  |  | 52,388 |  |  | 32,601 | \nProduction and manufacturing expenses |  |  |  |  |  | 10,241 |  |  | 8,062 | \nSelling, general and administrative expenses |  |  |  |  |  | 2,409 |  |  | 2,428 | \nDepreciation and depletion (including impairments) |  |  |  |  |  | 8,883 |  |  | 5,004 | \nExploration expenses, including dry holes |  |  |  |  |  | 173 |  |  | 164 | \nNon-service pension and postretirement benefit expense |  |  |  |  |  | 108 |  |  | 378 | \nInterest expense |  |  |  |  |  | 188 |  |  | 258 | \nOther taxes and duties |  |  |  |  |  | 7,554 |  |  | 6,660 | \nTotal costs and other deductions |  |  |  |  |  | 81,944 |  |  | 55,555 | \nIncome (loss) before income taxes |  |  |  |  |  | 8,556 |  |  | 3,592 | \nIncome taxes |  |  |  |  |  | 2,806 |  |  | 796 | \nNet income (loss) including noncontrolling interests |  |  |  |  |  | 5,750 |  |  | 2,796 | \nNet income (loss) attributable to noncontrolling interests |  |  |  |  |  | 270 |  |  | 66 | \nNet income (loss) attributable to ExxonMobil |  |  |  |  |  | 5,480 |  |  | 2,730 | \n |  |  |  |  |  |  |  | \nEarnings (loss) per common share(dollars) |  |  |  |  |  | 1.28 |  |  | 0.64 | \n |  |  |  |  |  |  |  | \nEarnings (loss) per common share - assuming dilution(dollars) |  |  |  |  |  | 1.28 |  |  | 0.64 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEXXON MOBIL CORPORATION\nCONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME\n(millions of dollars)\n |  |  |  |  |  | \n |  |  |  | Three Months EndedMarch 31,\n |  |  |  |  |  | 2022 |  | 2021\nNet income (loss) including noncontrolling interests |  |  |  |  |  | 5,750 |  |  | 2,796 | \nOther comprehensive income (loss) (net of income taxes) |  |  |  |  |  |  |  | \nForeign exchange translation adjustment |  |  |  |  |  | 741 |  |  | 149 | \n |  |  |  |  |  |  |  | \nPostretirement benefits reserves adjustment (excluding amortization) |  |  |  |  |  | 105 |  |  | 168 | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  |  |  |  |  | 93 |  |  | 378 | \nTotal other comprehensive income (loss) |  |  |  |  |  | 939 |  |  | 695 | \nComprehensive income (loss) including noncontrolling interests |  |  |  |  |  | 6,689 |  |  | 3,491 | \nComprehensive income (loss) attributable to noncontrolling interests |  |  |  |  |  | 359 |  |  | 146 | \nComprehensive income (loss) attributable to ExxonMobil |  |  |  |  |  | 6,330 |  |  | 3,345 |   |  |  |  |  |  |  |  |  |  |  | \nEXXON MOBIL CORPORATION\nCONDENSED CONSOLIDATED BALANCE SHEET\n(millions of dollars)\n | March 31,2022 |  | December 31,2021\nAssets |  |  | \nCurrent assets |  |  | \nCash and cash equivalents | 11,074 |  |  | 6,802 | \nNotes and accounts receivable \u2013 net | 42,142 |  |  | 32,383 | \nInventories |  |  | \nCrude oil, products and merchandise | 18,074 |  |  | 14,519 | \nMaterials and supplies | 4,103 |  |  | 4,261 | \nOther current assets | 1,862 |  |  | 1,189 | \nTotal current assets | 77,255 |  |  | 59,154 | \nInvestments, advances and long-term receivables | 46,329 |  |  | 45,195 | \nProperty, plant and equipment \u2013 net | 212,773 |  |  | 216,552 | \nOther assets, including intangibles \u2013 net | 18,414 |  |  | 18,022 | \nTotal Assets | 354,771 |  |  | 338,923 | \n |  |  | \nLiabilities |  |  | \nCurrent liabilities |  |  | \nNotes and loans payable | 4,886 |  |  | 4,276 | \nAccounts payable and accrued liabilities | 63,501 |  |  | 50,766 | \nIncome taxes payable | 3,672 |  |  | 1,601 | \nTotal current liabilities | 72,059 |  |  | 56,643 | \nLong-term debt | 42,651 |  |  | 43,428 | \nPostretirement benefits reserves | 18,255 |  |  | 18,430 | \nDeferred income tax liabilities | 19,533 |  |  | 20,165 | \nLong-term obligations to equity companies | 2,875 |  |  | 2,857 | \nOther long-term obligations | 22,872 |  |  | 21,717 | \nTotal Liabilities | 178,245 |  |  | 163,240 | \n |  |  | \nCommitments and contingencies (Note 3) |  |  | \n |  |  | \nEquity |  |  | \nCommon stock without par value |  |  | \n(9,000million shares authorized,8,019million shares issued) | 15,879 |  |  | 15,746 | \nEarnings reinvested | 393,779 |  |  | 392,059 | \nAccumulated other comprehensive income | (12,914) |  |  | (13,764) | \nCommon stock held in treasury |  |  | \n(3,806million shares at March\u00a031, 2022 and3,780million shares at December\u00a031, 2021) | (227,529) |  |  | (225,464) | \nExxonMobil share of equity | 169,215 |  |  | 168,577 | \nNoncontrolling interests | 7,311 |  |  | 7,106 | \nTotal Equity | 176,526 |  |  | 175,683 | \nTotal Liabilities and Equity | 354,771 |  |  | 338,923 |   |  |  |  |  |  |  |  |  |  |  | \nEXXON MOBIL CORPORATION\nCONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS\n(millions of dollars)\n | Three Months EndedMarch 31,\n | 2022 |  | 2021\nCash flows from operating activities |  |  | \nNet income (loss) including noncontrolling interests | 5,750 |  |  | 2,796 | \nDepreciation and depletion (including impairments) | 8,883 |  |  | 5,004 | \n |  |  | \nChanges in operational working capital, excluding cash and debt | 1,086 |  |  | 1,953 | \nAll other items \u2013 net | (931) |  |  | (489) | \nNet cash provided by operating activities | 14,788 |  |  | 9,264 | \n |  |  | \nCash flows from investing activities |  |  | \nAdditions to property, plant and equipment | (3,911) |  |  | (2,400) | \nProceeds from asset sales and returns of investments | 293 |  |  | 307 | \nAdditional investments and advances | (417) |  |  | (349) | \nOther investing activities including collection of advances | 90 |  |  | 87 | \nNet cash used in investing activities | (3,945) |  |  | (2,355) | \n |  |  | \nCash flows from financing activities |  |  | \n |  |  | \n |  |  | \nAdditions to short-term debt | \u2014 |  |  | 5,781 | \nReductions in short-term debt | (2,098) |  |  | (10,849) | \nAdditions/(reductions) in debt with three months or less maturity | 1,366 |  |  | 1,003 | \n |  |  | \nCash dividends to ExxonMobil shareholders | (3,760) |  |  | (3,720) | \nCash dividends to noncontrolling interests | (60) |  |  | (52) | \nChanges in noncontrolling interests | (94) |  |  | 53 | \nCommon stock acquired | (2,067) |  |  | (1) | \nNet cash used in financing activities | (6,713) |  |  | (7,785) | \nEffects of exchange rate changes on cash | 142 |  |  | 27 | \nIncrease/(decrease) in cash and cash equivalents | 4,272 |  |  | (849) | \nCash and cash equivalents at beginning of period | 6,802 |  |  | 4,364 | \nCash and cash equivalents at end of period | 11,074 |  |  | 3,515 | \n |  |  | \nSupplemental Disclosures |  |  | \nIncome taxes paid | 1,798 |  |  | 855 | \nCash interest paid |  |  | \nIncluded in cash flows from operating activities | 319 |  |  | 405 | \nCapitalized, included in cash flows from investing activities | 187 |  |  | 151 | \nTotal cash interest paid | 506 |  |  | 556 | \n |  |  | \nNoncash right of use assets recorded in exchange for lease liabilities |  |  | \nOperating leases | 240 |  |  | 265 | \nFinance leases | 656 |  |  | \u2014 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEXXON MOBIL CORPORATION\nCONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY\n(millions of dollars)\n | ExxonMobil Share of Equity |  |  |  | \n | Common Stock |  | Earnings Reinvested |  | Accumulated Other Comprehensive Income |  | Common Stock Held in Treasury |  | ExxonMobil Share of Equity |  | Non-controlling Interests |  | Total Equity\nBalance as of December 31, 2020 | 15,688 |  |  | 383,943 |  |  | (16,705) |  |  | (225,776) |  |  | 157,150 |  |  | 6,980 |  |  | 164,130 | \nAmortization of stock-based awards | 202 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 202 |  |  | \u2014 |  |  | 202 | \nOther | (6) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (6) |  |  | 53 |  |  | 47 | \nNet income (loss) for the period | \u2014 |  |  | 2,730 |  |  | \u2014 |  |  | \u2014 |  |  | 2,730 |  |  | 66 |  |  | 2,796 | \nDividends - common shares | \u2014 |  |  | (3,720) |  |  | \u2014 |  |  | \u2014 |  |  | (3,720) |  |  | (52) |  |  | (3,772) | \n |  |  |  |  |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) | \u2014 |  |  | \u2014 |  |  | 615 |  |  | \u2014 |  |  | 615 |  |  | 80 |  |  | 695 | \nAcquisitions, at cost | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (1) |  |  | (1) |  |  | \u2014 |  |  | (1) | \nDispositions | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 4 |  |  | 4 |  |  | \u2014 |  |  | 4 | \nBalance as of March 31, 2021 | 15,884 |  |  | 382,953 |  |  | (16,090) |  |  | (225,773) |  |  | 156,974 |  |  | 7,127 |  |  | 164,101 | \n |  |  |  |  |  |  |  |  |  |  |  |  | \nBalance as of December 31, 2021 | 15,746 |  |  | 392,059 |  |  | (13,764) |  |  | (225,464) |  |  | 168,577 |  |  | 7,106 |  |  | 175,683 | \nAmortization of stock-based awards | 138 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 138 |  |  | \u2014 |  |  | 138 | \nOther | (5) |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (5) |  |  | 14 |  |  | 9 | \nNet income (loss) for the period | \u2014 |  |  | 5,480 |  |  | \u2014 |  |  | \u2014 |  |  | 5,480 |  |  | 270 |  |  | 5,750 | \nDividends - common shares | \u2014 |  |  | (3,760) |  |  | \u2014 |  |  | \u2014 |  |  | (3,760) |  |  | (60) |  |  | (3,820) | \n |  |  |  |  |  |  |  |  |  |  |  |  | \nOther comprehensive income (loss) | \u2014 |  |  | \u2014 |  |  | 850 |  |  | \u2014 |  |  | 850 |  |  | 89 |  |  | 939 | \nAcquisitions, at cost | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (2,067) |  |  | (2,067) |  |  | (108) |  |  | (2,175) | \nDispositions | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 2 |  |  | 2 |  |  | \u2014 |  |  | 2 | \nBalance as of March 31, 2022 | 15,879 |  |  | 393,779 |  |  | (12,914) |  |  | (227,529) |  |  | 169,215 |  |  | 7,311 |  |  | 176,526 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, 2022 |  |  |  | Three Months Ended March 31, 2021\nCommon Stock Share Activity | Issued |  | Held in Treasury |  | Outstanding |  |  |  | Issued |  | Held in Treasury |  | Outstanding\n | (millions of shares) |  |  |  | (millions of shares)\nBalance as of December 31 | 8,019 |  |  | (3,780) |  |  | 4,239 |  |  |  |  | 8,019 |  |  | (3,786) |  |  | 4,233 | \nAcquisitions | \u2014 |  |  | (26) |  |  | (26) |  |  |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nDispositions | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  |  |  | \u2014 |  |  | 1 |  |  | 1 | \nBalance as of March 31 | 8,019 |  |  | (3,806) |  |  | 4,213 |  |  |  |  | 8,019 |  |  | (3,785) |  |  | 4,234 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | March 31, 2022\n |  |  | Equity CompanyObligations(1) |  | Other Third-Party Obligations |  | Total\n |  |  | (millions of dollars)\nGuarantees |  |  |  |  | \n |  | Debt-related | 1,152 |  |  | 145 |  |  | 1,297 | \n |  | Other | 830 |  |  | 6,379 |  |  | 7,209 | \n |  | Total | 1,982 |  |  | 6,524 |  |  | 8,506 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nExxonMobil Share of Accumulated OtherComprehensive Income | Cumulative Foreign Exchange Translation Adjustment |  | Postretirement BenefitsReserves Adjustment |  | Total\n | (millions of dollars)\n |  |  |  |  | \nBalance as of December 31, 2020 | (10,614) |  |  | (6,091) |  |  | (16,705) | \nCurrent period change excluding amounts reclassifiedfrom accumulated other comprehensive income(1) | 88 |  |  | 158 |  |  | 246 | \nAmounts reclassified from accumulated othercomprehensive income | \u2014 |  |  | 369 |  |  | 369 | \nTotal change in accumulated other comprehensive income | 88 |  |  | 527 |  |  | 615 | \nBalance as of March 31, 2021 | (10,526) |  |  | (5,564) |  |  | (16,090) | \n |  |  |  |  | \nBalance as of December 31, 2021 | (11,499) |  |  | (2,265) |  |  | (13,764) | \nCurrent period change excluding amounts reclassifiedfrom accumulated other comprehensive income(1) | 661 |  |  | 102 |  |  | 763 | \nAmounts reclassified from accumulated othercomprehensive income | \u2014 |  |  | 87 |  |  | 87 | \nTotal change in accumulated other comprehensive income | 661 |  |  | 189 |  |  | 850 | \nBalance as of March 31, 2022 | (10,838) |  |  | (2,076) |  |  | (12,914) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAmounts Reclassified Out of Accumulated OtherComprehensive Income - Before-tax Income/(Expense) |  |  |  | Three Months EndedMarch 31,\n |  |  |  |  | 2022 |  | 2021\n |  |  |  | (millions of dollars)\n |  |  |  |  |  |  |  | \nAmortization and settlement of postretirement benefits reservesadjustment included in net periodic benefit costs |  |  |  |  |  |  |  | \n(Statement of Income line: Non-service pension and postretirement benefit expense) |  |  |  |  |  | (120) |  |  | (484) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIncome Tax (Expense)/Credit ForComponents of Other Comprehensive Income |  |  |  | Three Months EndedMarch 31,\n |  |  |  |  | 2022 |  | 2021\n |  |  |  | (millions of dollars)\nForeign exchange translation adjustment |  |  |  |  |  | (22) |  |  | (53) | \nPostretirement benefits reserves adjustment (excludingamortization) |  |  |  |  |  | (40) |  |  | (58) | \nAmortization and settlement of postretirement benefits reservesadjustment included in net periodic benefit costs |  |  |  |  |  | (27) |  |  | (106) | \nTotal |  |  |  |  |  | (89) |  |  | (217) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | Three Months EndedMarch 31,\n |  |  |  |  |  | 2022 |  | 2021\nEarnings per common share |  |  |  |  |  |  |  | \nNet income (loss) attributable to ExxonMobil(millions of dollars) |  |  |  |  |  | 5,480 |  |  | 2,730 | \nWeighted average number of common shares outstanding(millions of shares) |  |  |  |  |  | 4,266 |  |  | 4,272 | \nEarnings (loss) per common share(dollars)(1) |  |  |  |  |  | 1.28 |  |  | 0.64 | \nDividends paid per common share(dollars) |  |  |  |  |  | 0.88 |  |  | 0.87 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | Three Months EndedMarch 31,\n |  |  |  |  |  | 2022 |  | 2021\n |  |  |  | (millions of dollars)\nComponents of net benefit cost |  |  |  |  |  |  |  | \nPension Benefits - U.S. |  |  |  |  |  |  |  | \nService cost |  |  |  |  |  | 179 |  |  | 225 | \nInterest cost |  |  |  |  |  | 129 |  |  | 139 | \nExpected return on plan assets |  |  |  |  |  | (140) |  |  | (180) | \nAmortization of actuarial loss/(gain) |  |  |  |  |  | 39 |  |  | 61 | \nAmortization of prior service cost |  |  |  |  |  | (7) |  |  | (6) | \nNet pension enhancement and curtailment/settlement cost |  |  |  |  |  | 37 |  |  | 298 | \nNet benefit cost |  |  |  |  |  | 237 |  |  | 537 | \n |  |  |  |  |  |  |  | \nPension Benefits - Non-U.S. |  |  |  |  |  |  |  | \nService cost |  |  |  |  |  | 150 |  |  | 195 | \nInterest cost |  |  |  |  |  | 160 |  |  | 130 | \nExpected return on plan assets |  |  |  |  |  | (213) |  |  | (258) | \nAmortization of actuarial loss/(gain) |  |  |  |  |  | 47 |  |  | 108 | \nAmortization of prior service cost |  |  |  |  |  | 12 |  |  | 15 | \nNet pension enhancement and curtailment/settlement cost |  |  |  |  |  | \u2014 |  |  | 12 | \nNet benefit cost |  |  |  |  |  | 156 |  |  | 202 | \n |  |  |  |  |  |  |  | \nOther Postretirement Benefits |  |  |  |  |  |  |  | \nService cost |  |  |  |  |  | 40 |  |  | 49 | \nInterest cost |  |  |  |  |  | 55 |  |  | 56 | \nExpected return on plan assets |  |  |  |  |  | (3) |  |  | (5) | \nAmortization of actuarial loss/(gain) |  |  |  |  |  | 3 |  |  | 19 | \nAmortization of prior service cost |  |  |  |  |  | (11) |  |  | (11) | \nNet benefit cost |  |  |  |  |  | 84 |  |  | 108 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | March 31, 2022\n |  | (millions of dollars)\n |  | Fair Value |  |  |  |  |  |  |  | \n |  | Level 1 |  | Level 2 |  | Level 3 |  | Total Gross Assets& Liabilities |  | Effect ofCounterparty Netting |  | Effect ofCollateralNetting |  | Differencein CarryingValue andFair Value |  | NetCarryingValue\nAssets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Derivative assets(1) | 6,886 |  |  | 2,890 |  |  | \u2014 |  |  | 9,776 |  |  | (7,888) |  |  | (60) |  |  | \u2014 |  |  | 1,828 | \n | Advances to/receivables |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | from equity companies(2)(6) | \u2014 |  |  | 2,631 |  |  | 5,491 |  |  | 8,122 |  |  | \u2014 |  |  | \u2014 |  |  | 435 |  |  | 8,557 | \n | Other long-term |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | financial assets(3) | 1,152 |  |  | \u2014 |  |  | 1,049 |  |  | 2,201 |  |  | \u2014 |  |  | \u2014 |  |  | 165 |  |  | 2,366 | \nLiabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Derivative liabilities(4) | 7,459 |  |  | 3,940 |  |  | \u2014 |  |  | 11,399 |  |  | (7,888) |  |  | (632) |  |  | \u2014 |  |  | 2,879 | \n | Long-term debt(5) | 40,367 |  |  | 76 |  |  | 2 |  |  | 40,445 |  |  | \u2014 |  |  | \u2014 |  |  | (140) |  |  | 40,305 | \n | Long-term obligations |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | to equity companies(6) | \u2014 |  |  | \u2014 |  |  | 2,969 |  |  | 2,969 |  |  | \u2014 |  |  | \u2014 |  |  | (94) |  |  | 2,875 | \n | Other long-term |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | financial liabilities(7) | \u2014 |  |  | \u2014 |  |  | 886 |  |  | 886 |  |  | \u2014 |  |  | \u2014 |  |  | 53 |  |  | 939 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | December 31, 2021\n |  | (millions of dollars)\n |  | Fair Value |  |  |  |  |  |  |  | \n |  | Level 1 |  | Level 2 |  | Level 3 |  | Total Gross Assets& Liabilities |  | Effect ofCounterparty Netting |  | Effect ofCollateralNetting |  | Differencein CarryingValue andFair Value |  | NetCarryingValue\nAssets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Derivative assets(1) | 1,422 |  |  | 1,523 |  |  | \u2014 |  |  | 2,945 |  |  | (1,930) |  |  | (28) |  |  | \u2014 |  |  | 987 | \n | Advances to/receivables |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | from equity companies(2)(6) | \u2014 |  |  | 3,076 |  |  | 5,373 |  |  | 8,449 |  |  | \u2014 |  |  | \u2014 |  |  | (123) |  |  | 8,326 | \n | Other long-term |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | financial assets(3) | 1,134 |  |  | \u2014 |  |  | 1,058 |  |  | 2,192 |  |  | \u2014 |  |  | \u2014 |  |  | 181 |  |  | 2,373 | \nLiabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Derivative liabilities(4) | 1,701 |  |  | 2,594 |  |  | \u2014 |  |  | 4,295 |  |  | (1,930) |  |  | (306) |  |  | \u2014 |  |  | 2,059 | \n | Long-term debt(5) | 44,454 |  |  | 88 |  |  | 3 |  |  | 44,545 |  |  | \u2014 |  |  | \u2014 |  |  | (2,878) |  |  | 41,667 | \n | Long-term obligations |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | to equity companies(6) | \u2014 |  |  | \u2014 |  |  | 3,084 |  |  | 3,084 |  |  | \u2014 |  |  | \u2014 |  |  | (227) |  |  | 2,857 | \n | Other long-term |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | financial liabilities(7) | \u2014 |  |  | \u2014 |  |  | 902 |  |  | 902 |  |  | \u2014 |  |  | \u2014 |  |  | 58 |  |  | 960 |   |  |  |  |  |  |  |  |  |  |  | \n | March 31, |  | December 31,\n | 2022 |  | 2021\n | (millions)\nCrude oil (barrels) | 91 |  |  | 82 | \nPetroleum products (barrels) | (37) |  |  | (48) | \nNatural gas (MMBTUs) | (101) |  |  | (115) | \n |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  | Three Months EndedMarch 31,\n |  |  |  |  |  | 2022 |  | 2021\n |  |  |  | (millions of dollars)\nSales and other operating revenue |  |  |  |  |  | (2,535) |  |  | (512) | \nCrude oil and product purchases |  |  |  |  |  | (26) |  |  | 1 | \nTotal |  |  |  |  |  | (2,561) |  |  | (511) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months EndedMarch 31, |  | \n |  | 2022 |  | 2021 |  |  |  | \nEarnings (Loss) After Income Tax |  | (millions of dollars) |  | \nUpstream |  |  |  |  |  |  |  | \nUnited States |  | 2,376 |  |  | 363 |  |  |  |  | \nNon-U.S.(1) |  | 2,112 |  |  | 2,191 |  |  |  |  | \nDownstream |  |  |  |  |  |  |  | \nUnited States |  | 685 |  |  | (113) |  |  |  |  | \nNon-U.S. |  | (353) |  |  | (277) |  |  |  |  | \nChemical |  |  |  |  |  |  |  | \nUnited States |  | 819 |  |  | 715 |  |  |  |  | \nNon-U.S. |  | 535 |  |  | 700 |  |  |  |  | \nCorporate and Financing(1) |  | (694) |  |  | (849) |  |  |  |  | \nCorporate total |  | 5,480 |  |  | 2,730 |  |  |  |  | \n |  |  |  |  |  |  |  | \n(1)Results for 2022 include charges of  $3.3billion in non-U.S. Upstream and $0.1billion in Corporate and Financing associated with the Corporation's interest in Sakhalin-1. (See Note 2 to Condensed Consolidated Financial Statements) |  |  |  | \n |  |  | \n |  |  |  |  |  |  |  | \nSales and Other Operating Revenue |  |  |  |  |  |  |  | \nUpstream |  |  |  |  |  |  |  | \nUnited States |  | 2,656 |  |  | 1,885 |  |  |  |  | \nNon-U.S. |  | 6,343 |  |  | 3,094 |  |  |  |  | \nDownstream |  |  |  |  |  |  |  | \nUnited States |  | 25,356 |  |  | 16,078 |  |  |  |  | \nNon-U.S. |  | 43,609 |  |  | 28,613 |  |  |  |  | \nChemical |  |  |  |  |  |  |  | \nUnited States |  | 3,982 |  |  | 3,091 |  |  |  |  | \nNon-U.S. |  | 5,781 |  |  | 4,887 |  |  |  |  | \nCorporate and Financing |  | 7 |  |  | (96) |  |  |  |  | \nCorporate total |  | 87,734 |  |  | 57,552 |  |  |  |  | \n |  |  |  |  |  |  |  | \nIntersegment Revenue |  |  |  |  |  |  |  | \nUpstream |  |  |  |  |  |  |  | \nUnited States |  | 6,191 |  |  | 3,323 |  |  |  |  | \nNon-U.S. |  | 10,835 |  |  | 6,817 |  |  |  |  | \nDownstream |  |  |  |  |  |  |  | \nUnited States |  | 8,261 |  |  | 3,953 |  |  |  |  | \nNon-U.S. |  | 9,503 |  |  | 5,381 |  |  |  |  | \nChemical |  |  |  |  |  |  |  | \nUnited States |  | 2,863 |  |  | 1,950 |  |  |  |  | \nNon-U.S. |  | 2,213 |  |  | 1,231 |  |  |  |  | \nCorporate and Financing |  | 57 |  |  | 57 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nGeographic |  |  |  |  |  |  |  | \n |  |  |  | Three Months EndedMarch 31,\nSales and Other Operating Revenue |  |  |  |  |  | 2022 |  | 2021\n |  |  |  | (millions of dollars)\nUnited States |  |  |  |  |  | 31,994 |  |  | 21,054 | \nNon-U.S. |  |  |  |  |  | 55,740 |  |  | 36,498 | \nTotal |  |  |  |  |  | 87,734 |  |  | 57,552 | \n |  |  |  |  |  |  |  | \nSignificant Non-U.S. revenue sources include:(1) |  |  |  |  |  |  |  | \nUnited Kingdom |  |  |  |  |  | 7,548 |  |  | 2,943 | \nCanada |  |  |  |  |  | 6,995 |  |  | 4,258 | \nFrance |  |  |  |  |  | 4,356 |  |  | 2,782 | \nSingapore |  |  |  |  |  | 4,322 |  |  | 3,435 | \nBelgium |  |  |  |  |  | 2,836 |  |  | 1,989 | \nItaly |  |  |  |  |  | 2,836 |  |  | 1,865 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months EndedMarch 31, 2022 | Upstream |  | Downstream |  | Chemical |  | Corporate  and Financing |  | Total\nU.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | \n | (millions of dollars)\nEarnings (loss) (U.S. GAAP) | 2,376 | 2,112 |  | 685 | (353) |  | 819 | 535 |  | (694) |  | 5,480\nIdentified Items |  |  |  |  |  |  |  |  |  |  |  | \nImpairments | \u2014 | (2,877) |  | \u2014 | \u2014 |  | \u2014 | \u2014 |  | (98) |  | (2,975)\nOther - Russia impacts | \u2014 | (378) |  | \u2014 | \u2014 |  | \u2014 | \u2014 |  | \u2014 |  | (378)\nEarnings (loss) excluding Identified Items | 2,376 | 5,367 |  | 685 | (353) |  | 819 | 535 |  | (596) |  | 8,833  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months EndedMarch 31, 2021 | Upstream |  | Downstream |  | Chemical |  | Corporate and Financing |  | Total\nU.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | \n | (millions of dollars)\nEarnings (loss) (U.S. GAAP) | 363 | 2,191 |  | (113) | (277) |  | 715 | 700 |  | (849) |  | 2,730\nIdentified Items |  |  |  |  |  |  |  |  |  |  |  | \nSeverance charges | \u2014 | \u2014 |  | \u2014 | \u2014 |  | \u2014 | \u2014 |  | (31) |  | (31)\nEarnings (loss) excluding Identified Items | 363 | 2,191 |  | (113) | (277) |  | 715 | 700 |  | (818) |  | 2,761  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months EndedMarch 31, |  | \n |  | 2022 |  | 2021 |  |  |  | \nEarnings (loss) (U.S. GAAP) |  | (millions of dollars) |  |  |  | \nUnited States |  | 2,376 |  |  | 363 |  |  |  |  | \nNon-U.S. |  | 2,112 |  |  | 2,191 |  |  |  |  | \nTotal |  | 4,488 |  |  | 2,554 |  |  |  |  | \nIdentified Items(1) |  |  |  |  |  |  |  | \nUnited States |  | \u2014 |  |  | \u2014 |  |  |  |  | \nNon-U.S. |  | (3,255) |  |  | \u2014 |  |  |  |  | \nTotal |  | (3,255) |  |  | \u2014 |  |  |  |  | \nEarnings (loss) excluding Identified Items(1) |  |  |  |  |  |  |  | \nUnited States |  | 2,376 |  |  | 363 |  |  |  |  | \nNon-U.S. |  | 5,367 |  |  | 2,191 |  |  |  |  | \nTotal |  | 7,743 |  |  | 2,554 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months EndedMarch 31, |  |  |  | \n |  | 2022 |  | 2021 |  |  |  | \nProduction of crude oil, natural gas liquids, bitumen and synthetic oil |  |  |  |  |  |  |  | \nNet production |  | (thousands of barrels daily)\nUnited States |  | 753 |  |  | 665 |  |  |  |  | \nCanada/Other Americas |  | 474 |  |  | 575 |  |  |  |  | \nEurope |  | 4 |  |  | 35 |  |  |  |  | \nAfrica |  | 257 |  |  | 253 |  |  |  |  | \nAsia |  | 738 |  |  | 691 |  |  |  |  | \nAustralia/Oceania |  | 40 |  |  | 39 |  |  |  |  | \nWorldwide |  | 2,266 |  |  | 2,258 |  |  |  |  | \n |  |  |  |  |  |  |  | \nNatural gas production available for sale |  |  |  |  |  |  |  | \nNet production |  | (millions of cubic feet daily)\nUnited States |  | 2,777 |  |  | 2,767 |  |  |  |  | \nCanada/Other Americas |  | 182 |  |  | 216 |  |  |  |  | \nEurope |  | 770 |  |  | 1,403 |  |  |  |  | \nAfrica |  | 58 |  |  | 24 |  |  |  |  | \nAsia |  | 3,340 |  |  | 3,599 |  |  |  |  | \nAustralia/Oceania |  | 1,325 |  |  | 1,164 |  |  |  |  | \nWorldwide |  | 8,452 |  |  | 9,173 |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  | (thousands of oil-equivalent barrels daily)\nOil-equivalent production(1) |  | 3,675 |  |  | 3,787 |  |  |  |  | \n |  |  |  |  |  |  |  | \n(1)Natural gas is converted to an oil-equivalent basis at six million cubic feet per one thousand barrels. |  |  |  |   |  |  |  |  |  |  |  |  |  | \n |  |  |  | Three Months EndedMarch 31\n |  |  |  | (thousands of barrels daily)\nVolumes reconciliation(Oil-equivalent production)(1) |  |  |  | \n2021 |  |  |  | 3,787\nEntitlements - Net Interest |  |  |  | (30)\nEntitlements - Price / Spend / Other |  |  |  | (44)\nGovernment Mandates |  |  |  | 113\nDivestments |  |  |  | (62)\nOther |  |  |  | (89)\n2022 |  |  |  | 3,675  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months EndedMarch 31, |  | \n |  | 2022 |  | 2021 |  |  |  | \nEarnings (loss) (U.S. GAAP) |  | (millions of dollars) |  |  |  | \nUnited States |  | 685 |  |  | (113) |  |  |  |  | \nNon-U.S. |  | (353) |  |  | (277) |  |  |  |  | \nTotal |  | 332 |  |  | (390) |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1) |  |  |  |  |  |  |  | \nUnited States |  | 685 |  |  | (113) |  |  |  |  | \nNon-U.S. |  | (353) |  |  | (277) |  |  |  |  | \nTotal |  | 332 |  |  | (390) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months EndedMarch 31, |  |  |  | \n |  | 2022 |  | 2021 |  |  |  | \nRefinery throughput |  | (thousands of barrels daily)\nUnited States |  | 1,685 |  |  | 1,532 |  |  |  |  | \nCanada |  | 399 |  |  | 364 |  |  |  |  | \nEurope |  | 1,193 |  |  | 1,153 |  |  |  |  | \nAsia Pacific |  | 537 |  |  | 545 |  |  |  |  | \nOther |  | 169 |  |  | 157 |  |  |  |  | \nWorldwide |  | 3,983 |  |  | 3,751 |  |  |  |  | \n |  |  |  |  |  |  |  | \nPetroleum product sales(1) |  |  |  |  |  |  |  | \nUnited States |  | 2,256 |  |  | 2,077 |  |  |  |  | \nCanada |  | 442 |  |  | 409 |  |  |  |  | \nEurope |  | 1,345 |  |  | 1,272 |  |  |  |  | \nAsia Pacific |  | 644 |  |  | 665 |  |  |  |  | \nOther |  | 471 |  |  | 458 |  |  |  |  | \nWorldwide |  | 5,158 |  |  | 4,881 |  |  |  |  | \nGasoline, naphthas |  | 2,114 |  |  | 1,996 |  |  |  |  | \nHeating oils, kerosene, diesel oils |  | 1,722 |  |  | 1,692 |  |  |  |  | \nAviation fuels |  | 289 |  |  | 183 |  |  |  |  | \nHeavy fuels |  | 249 |  |  | 257 |  |  |  |  | \nSpecialty petroleum products |  | 784 |  |  | 753 |  |  |  |  | \nWorldwide |  | 5,158 |  |  | 4,881 |  |  |  |  | \n |  |  |  |  |  |  |  | \n(1)Data reported net of purchases/sales contracts with the same counterparty. |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months EndedMarch 31, |  | \n |  | 2022 |  | 2021 |  |  |  | \nEarnings (loss) (U.S. GAAP) |  | (millions of dollars) |  |  |  | \nUnited States |  | 819 |  | 715 |  |  |  |  | \nNon-U.S. |  | 535 |  | 700 |  |  |  |  | \nTotal |  | 1,354 |  |  | 1,415 |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(2) |  |  |  |  |  |  |  | \nUnited States |  | 819 |  |  | 715 |  |  |  |  | \nNon-U.S. |  | 535 |  |  | 700 |  |  |  |  | \nTotal |  | 1,354 |  |  | 1,415 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months EndedMarch 31, |  |  |  | \n |  | 2022 |  | 2021 |  |  |  | \nChemical prime product sales(1) |  | (thousands of metric tons)\nUnited States |  | 2,704 |  |  | 2,190 |  |  |  |  | \nNon-U.S. |  | 4,033 |  |  | 4,256 |  |  |  |  | \nWorldwide |  | 6,737 |  |  | 6,446 |  |  |  |  | \n |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months EndedMarch 31, |  | \n |  | 2022 |  | 2021 |  |  |  | \n |  | (millions of dollars) |  | \nEarnings (loss) (U.S. GAAP) |  | (694) |  |  | (849) |  |  |  |  | \nIdentified Items(1) |  | (98) |  |  | (31) |  |  |  |  | \nEarnings (loss) excluding Identified Items(1) |  | (596) |  |  | (818) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | Three Months EndedMarch 31,\n |  |  |  |  |  | 2022 |  | 2021\n |  |  |  | (millions of dollars)\nNet cash provided by/(used in) |  |  |  |  |  |  |  | \nOperating activities |  |  |  |  |  | 14,788 |  |  | 9,264 | \nInvesting activities |  |  |  |  |  | (3,945) |  |  | (2,355) | \nFinancing activities |  |  |  |  |  | (6,713) |  |  | (7,785) | \nEffect of exchange rate changes |  |  |  |  |  | 142 |  |  | 27 | \nIncrease/(decrease) in cash and cash equivalents |  |  |  |  |  | 4,272 |  |  | (849) | \n |  |  |  |  |  |  |  | \nCash and cash equivalents (at end of period) |  |  |  |  |  | 11,074 |  |  | 3,515 | \n |  |  |  |  |  |  |  | \nCash flow from operations and asset sales |  |  |  |  |  |  |  | \nNet cash provided by operating activities (U.S. GAAP) |  |  |  |  |  | 14,788 |  |  | 9,264 | \nProceeds associated with sales of subsidiaries, property, plant & equipment, and sales and returns of investments |  |  |  |  |  | 293 |  |  | 307 | \nCash flow from operations and asset sales |  |  |  |  |  | 15,081 |  |  | 9,571 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | Three Months EndedMarch 31,\n |  |  |  |  |  | 2022 |  | 2021\n |  |  |  | (millions of dollars)\nIncome taxes |  |  |  |  |  | 2,806 |  |  | 796 | \nEffective income tax rate |  |  |  |  |  | 40 | % |  | 33 | %\nTotal other taxes and duties(1) |  |  |  |  |  | 8,449 |  |  | 7,283 | \nTotal |  |  |  |  |  | 11,255 |  |  | 8,079 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | Three Months EndedMarch 31,\n |  |  |  |  |  | 2022 |  | 2021\n |  |  |  | (millions of dollars)\nUpstream (including exploration expenses) |  |  |  |  |  | 3,879 |  |  | 2,357 | \nDownstream |  |  |  |  |  | 577 |  |  | 470 | \nChemical |  |  |  |  |  | 448 |  |  | 306 | \nOther |  |  |  |  |  | \u2014 |  |  | \u2014 | \nTotal |  |  |  |  |  | 4,904 |  |  | 3,133 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIssuer Purchase of Equity Securities for Quarter Ended March\u00a031, 2022\nPeriod |  | Total Numberof SharesPurchased(1) |  | AveragePrice Paidper Share |  | Total Number ofShares Purchasedas Part of PubliclyAnnounced Plansor Programs(2) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program(Billions of dollars)\nJanuary 2022 |  | 5,764,362 |  | $70.75 |  | 5,639,871 |  | $29.6\nFebruary 2022 |  | 8,320,607 |  | $78.69 |  | 8,320,607 |  | $28.9\nMarch 2022 |  | 12,197,886 |  | $82.32 |  | 12,197,886 |  | $27.9\nTotal |  | 26,282,855 |  | $78.63 |  | 26,158,364 |  |   |  |  |  |  |  |  |  | \nExhibit |  | Description\n |  | \n |  | \n |  | \n |  | \n |  | \n |  | \n31.1 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Chief Executive Officer.\n31.2 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Chief Financial Officer.\n31.3 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Principal Accounting Officer.\n32.1 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Chief Executive Officer.\n32.2 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Chief Financial Officer.\n32.3 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Principal Accounting Officer.\n101 |  | Interactive Data Files (formatted as Inline XBRL).\n104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).  |  |  |  |  |  |  |  | \n | EXXON MOBIL CORPORATION\nDate: May\u00a04, 2022 | By: | /s/ LEN M. FOX\n |  | Len M. Fox\n |  | Vice President, Controller and\n |  | Principal Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Exxon Mobil, in 2022 Q2, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  |  |  |  | \nNew Jersey |  | 13-5409005\n(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification Number)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of Each Class |  | Trading Symbol |  | Name of Each Exchange on Which Registered\nCommon Stock, without par value |  | XOM |  | New York Stock Exchange\n0.142% Notes due 2024 |  | XOM24B |  | New York Stock Exchange\n0.524% Notes due 2028 |  | XOM28 |  | New York Stock Exchange\n0.835% Notes due 2032 |  | XOM32 |  | New York Stock Exchange\n1.408% Notes due 2039 |  | XOM39A |  | New York Stock Exchange  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2611 | Accelerated filer | \u2610\n |  |  | \nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n\n | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \nClass |  | Outstanding as of June\u00a030, 2022\nCommon stock, without par value |  | 4,167,636,295  |  |  |  |  | \nPART I. FINANCIAL INFORMATION\n | \nItem 1. Financial Statements | \n | \nCondensed Consolidated Statement of Income - Three and six months ended June\u00a030, 2022 and 2021 | 3 | \n | \nCondensed Consolidated Statement of Comprehensive Income - Three and six months ended June\u00a030, 2022 and 2021 | 4 | \n | \nCondensed Consolidated Balance Sheet - As of June\u00a030, 2022 and December\u00a031, 2021 | 5 | \n | \nCondensed Consolidated Statement of Cash Flows - Six months ended June\u00a030, 2022 and 2021 | 6 | \n | \nCondensed Consolidated Statement of Changes in Equity - Three months ended June\u00a030, 2022 and 2021 | 7 | \n | \nCondensed Consolidated Statement of Changes in Equity - Six months ended June\u00a030, 2022 and 2021 | 8 | \n | \n | \n | \nNotes to Condensed Consolidated Financial Statements | 9 | \n | \nItem 2. Management's Discussion and Analysis of Financial Condition and Results of Operations | 18 | \n | \nItem 3. Quantitative and Qualitative Disclosures About Market Risk | 33 | \n | \nItem 4. Controls and Procedures | 33 | \n | \n | \nPART II. OTHER INFORMATION\n | \nItem 1. Legal Proceedings | 34 | \n | \n | \n | \nItem 2. Unregistered Sales of Equity Securities and Use of Proceeds | 34 | \n | \nItem 6. Exhibits | 34 | \n | \nIndex to Exhibits | 35 | \n | \nSignature | 36 | \n |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nITEM 1. FINANCIAL STATEMENTS |  |   |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF INCOME  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | Three Months Ended June 30, |  |  | Six Months Ended June 30,\n | 2022 | 2021 |  |  | 2022 | 2021\nRevenues and other income |  |  |  |  |  |  | \nSales and other operating revenue |  | 111,265 |  | 65,943 |  |  |  | 198,999 |  | 123,495 | \nIncome from equity affiliates |  | 3,688 |  | 1,436 |  |  |  | 6,226 |  | 2,909 | \nOther income |  | 728 |  | 363 |  |  |  | 956 |  | 485 | \nTotal revenues and other income |  | 115,681 |  | 67,742 |  |  |  | 206,181 |  | 126,889 | \nCosts and other deductions |  |  |  |  |  |  | \nCrude oil and product purchases |  | 65,613 |  | 37,329 |  |  |  | 118,001 |  | 69,930 | \nProduction and manufacturing expenses |  | 10,686 |  | 8,471 |  |  |  | 20,927 |  | 16,533 | \nSelling, general and administrative expenses |  | 2,530 |  | 2,345 |  |  |  | 4,939 |  | 4,773 | \nDepreciation and depletion (including impairments) |  | 4,451 |  | 4,952 |  |  |  | 13,334 |  | 9,956 | \nExploration expenses, including dry holes |  | 286 |  | 176 |  |  |  | 459 |  | 340 | \nNon-service pension and postretirement benefit expense |  | 120 |  | 162 |  |  |  | 228 |  | 540 | \nInterest expense |  | 194 |  | 254 |  |  |  | 382 |  | 512 | \nOther taxes and duties |  | 6,868 |  | 7,746 |  |  |  | 14,422 |  | 14,406 | \nTotal costs and other deductions |  | 90,748 |  | 61,435 |  |  |  | 172,692 |  | 116,990 | \nIncome (loss) before income taxes |  | 24,933 |  | 6,307 |  |  |  | 33,489 |  | 9,899 | \nIncome taxes |  | 6,359 |  | 1,526 |  |  |  | 9,165 |  | 2,322 | \nNet income (loss) including noncontrolling interests |  | 18,574 |  | 4,781 |  |  |  | 24,324 |  | 7,577 | \nNet income (loss) attributable to noncontrolling interests |  | 724 |  | 91 |  |  |  | 994 |  | 157 | \nNet income (loss) attributable to ExxonMobil |  | 17,850 |  | 4,690 |  |  |  | 23,330 |  | 7,420 | \n |  |  |  |  |  |  | \nEarnings (loss) per common share(dollars) |  | 4.21 |  | 1.10 |  |  |  | 5.49 |  | 1.74 | \n |  |  |  |  |  |  | \nEarnings (loss) per common share - assuming dilution(dollars) |  | 4.21 |  | 1.10 |  |  |  | 5.49 |  | 1.74 | \n |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nNet income (loss) including noncontrolling interests |  | 18,574 |  |  | 4,781 |  |  | 24,324 |  |  | 7,577 | \n |  |  |  |  |  |  |  | \nOther comprehensive income (loss) (net of income taxes) |  |  |  |  |  |  |  | \nForeign exchange translation adjustment |  | (2,537) |  |  | 423 |  |  | (1,796) |  |  | 572 | \n |  |  |  |  |  |  |  | \nPostretirement benefits reserves adjustment (excluding amortization) |  | 155 |  |  | (47) |  |  | 260 |  |  | 121 | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  | 102 |  |  | 215 |  |  | 195 |  |  | 593 | \nTotal other comprehensive income (loss) |  | (2,280) |  |  | 591 |  |  | (1,341) |  |  | 1,286 | \nComprehensive income (loss) including noncontrolling interests |  | 16,294 |  |  | 5,372 |  |  | 22,983 |  |  | 8,863 | \nComprehensive income (loss) attributable to noncontrolling interests |  | 547 |  |  | 178 |  |  | 906 |  |  | 324 | \nComprehensive income (loss) attributable to ExxonMobil |  | 15,747 |  |  | 5,194 |  |  | 22,077 |  |  | 8,539 | \n |  |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED BALANCE SHEET  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | June 30, 2022 | December 31, 2021 |  |  | \n |  |  |  |  |  | \nASSETS |  |  |  |  |  | \nCurrent assets |  |  |  |  |  | \nCash and cash equivalents |  | 18,861 |  | 6,802 |  |  |  | \nNotes and accounts receivable \u2013 net |  | 48,063 |  | 32,383 |  |  |  | \nInventories |  |  |  |  |  | \nCrude oil, products and merchandise |  | 19,580 |  | 14,519 |  |  |  | \nMaterials and supplies |  | 4,005 |  | 4,261 |  |  |  | \nOther current assets |  | 2,654 |  | 1,189 |  |  |  | \nTotal current assets |  | 93,163 |  | 59,154 |  |  |  | \nInvestments, advances and long-term receivables |  | 46,820 |  | 45,195 |  |  |  | \nProperty, plant and equipment \u2013 net |  | 209,159 |  | 216,552 |  |  |  | \nOther assets, including intangibles \u2013 net |  | 18,632 |  | 18,022 |  |  |  | \nTotal Assets |  | 367,774 |  | 338,923 |  |  |  | \n |  |  |  |  |  | \nLIABILITIES |  |  |  |  |  | \nCurrent liabilities |  |  |  |  |  | \nNotes and loans payable |  | 7,367 |  | 4,276 |  |  |  | \nAccounts payable and accrued liabilities |  | 67,958 |  | 50,766 |  |  |  | \nIncome taxes payable |  | 4,785 |  | 1,601 |  |  |  | \nTotal current liabilities |  | 80,110 |  | 56,643 |  |  |  | \nLong-term debt |  | 39,516 |  | 43,428 |  |  |  | \nPostretirement benefits reserves |  | 17,408 |  | 18,430 |  |  |  | \nDeferred income tax liabilities |  | 20,807 |  | 20,165 |  |  |  | \nLong-term obligations to equity companies |  | 2,617 |  | 2,857 |  |  |  | \nOther long-term obligations |  | 22,808 |  | 21,717 |  |  |  | \nTotal Liabilities |  | 183,266 |  | 163,240 |  |  |  | \n |  |  |  |  |  | \nCommitments and contingencies (Note 3) |  |  |  |  |  | \n |  |  |  |  |  | \nEQUITY |  |  |  |  |  | \nCommon stock without par value |  |  |  |  |  | \n(9,000million shares authorized,8,019million shares issued) |  | 16,018 |  | 15,746 |  |  |  | \nEarnings reinvested |  | 407,902 |  | 392,059 |  |  |  | \nAccumulated other comprehensive income |  | (15,017) |  | (13,764) |  |  |  | \nCommon stock held in treasury |  |  |  |  |  | \n(3,851million shares at June\u00a030, 2022 and3,780million shares at December\u00a031, 2021) |  | (231,587) |  | (225,464) |  |  |  | \nExxonMobil share of equity |  | 177,316 |  | 168,577 |  |  |  | \nNoncontrolling interests |  | 7,192 |  | 7,106 |  |  |  | \nTotal Equity |  | 184,508 |  | 175,683 |  |  |  | \nTotal Liabilities and Equity |  | 367,774 |  | 338,923 |  |  |  | \n |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements. |  |  |   |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF CASH FLOW  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Six Months Ended June 30,\n | 2022 | 2021\n |  |  | \nCASH FLOW FROM OPERATING ACTIVITIES |  |  | \nNet income (loss) including noncontrolling interests |  | 24,324 |  | 7,577 | \nDepreciation and depletion (including impairments) |  | 13,334 |  | 9,956 | \n |  |  | \nChanges in operational working capital, excluding cash and debt |  | (1,661) |  | 1,573 | \nAll other items \u2013 net |  | (1,246) |  | (192) | \nNet cash provided by operating activities |  | 34,751 |  | 18,914 | \n |  |  | \nCASH FLOW FROM INVESTING ACTIVITIES |  |  | \nAdditions to property, plant and equipment |  | (7,748) |  | (5,147) | \nProceeds from asset sales and returns of investments |  | 1,232 |  | 557 | \nAdditional investments and advances |  | (643) |  | (613) | \nOther investing activities including collection of advances |  | 150 |  | 132 | \nNet cash used in investing activities |  | (7,009) |  | (5,071) | \n |  |  | \nCASH FLOW FROM FINANCING ACTIVITIES |  |  | \n |  |  | \n |  |  | \nAdditions to short-term debt |  | \u2014 |  | 9,662 | \nReductions in short-term debt |  | (2,336) |  | (18,000) | \nAdditions/(reductions) in debt with three months or less maturity |  | 1,303 |  | 1,320 | \nContingent consideration payments |  | (58) |  | (28) | \nCash dividends to ExxonMobil shareholders |  | (7,487) |  | (7,441) | \nCash dividends to noncontrolling interests |  | (123) |  | (112) | \nChanges in noncontrolling interests |  | (697) |  | (207) | \nCommon stock acquired |  | (5,986) |  | (1) | \nNet cash used in financing activities |  | (15,384) |  | (14,807) | \n |  |  | \nEffects of exchange rate changes on cash |  | (299) |  | 65 | \nIncrease/(decrease) in cash and cash equivalents |  | 12,059 |  | (899) | \nCash and cash equivalents at beginning of period |  | 6,802 |  | 4,364 | \nCash and cash equivalents at end of period |  | 18,861 |  | 3,465 | \n |  |  | \nSUPPLEMENTAL DISCLOSURES |  |  | \nIncome taxes paid |  | 5,545 |  | 2,079 | \nCash interest paid |  |  | \nIncluded in cash flows from operating activities |  | 352 |  | 466 | \nCapitalized, included in cash flows from investing activities |  | 388 |  | 313 | \nTotal cash interest paid |  | 740 |  | 779 | \n |  |  | \n |  |  | \nNoncash right of use assets recorded in exchange for lease liabilities |  |  | \nOperating leases |  | 1,039 |  | 511 | \nFinance leases |  | 656 |  | 55 | \n |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF CHANGE IN EQUITY  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | ExxonMobil Share of Equity |  | \n |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | Common Stock | Earnings Reinvested | Accumulated Other Comprehensive Income | Common Stock Held in Treasury | ExxonMobil Share of Equity | Non-controlling Interests | Total Equity\n |  |  |  |  |  |  |  | \nBalance as of March 31, 2021 |  | 15,884 |  | 382,953 |  | (16,090) |  | (225,773) |  | 156,974 |  | 7,127 |  | 164,101 | \nAmortization of stock-based awards |  | 126 |  | \u2014 |  | \u2014 |  | \u2014 |  | 126 |  | \u2014 |  | 126 | \nOther |  | (4) |  | \u2014 |  | \u2014 |  | \u2014 |  | (4) |  | 33 |  | 29 | \nNet income (loss) for the period |  | \u2014 |  | 4,690 |  | \u2014 |  | \u2014 |  | 4,690 |  | 91 |  | 4,781 | \nDividends - common shares |  | \u2014 |  | (3,721) |  | \u2014 |  | \u2014 |  | (3,721) |  | (60) |  | (3,781) | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | 504 |  | \u2014 |  | 504 |  | 87 |  | 591 | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  | (293) |  | (293) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 2 |  | 2 |  | \u2014 |  | 2 | \nBalance as of June 30, 2021 |  | 16,006 |  | 383,922 |  | (15,586) |  | (225,771) |  | 158,571 |  | 6,985 |  | 165,556 | \n |  |  |  |  |  |  |  | \nBalance as of March 31, 2022 |  | 15,879 |  | 393,779 |  | (12,914) |  | (227,529) |  | 169,215 |  | 7,311 |  | 176,526 | \nAmortization of stock-based awards |  | 143 |  | \u2014 |  | \u2014 |  | \u2014 |  | 143 |  | \u2014 |  | 143 | \nOther |  | (4) |  | \u2014 |  | \u2014 |  | \u2014 |  | (4) |  | (15) |  | (19) | \nNet income (loss) for the period |  | \u2014 |  | 17,850 |  | \u2014 |  | \u2014 |  | 17,850 |  | 724 |  | 18,574 | \nDividends - common shares |  | \u2014 |  | (3,727) |  | \u2014 |  | \u2014 |  | (3,727) |  | (63) |  | (3,790) | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | (2,103) |  | \u2014 |  | (2,103) |  | (177) |  | (2,280) | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (4,059) |  | (4,059) |  | (588) |  | (4,647) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 1 |  | 1 |  | \u2014 |  | 1 | \nBalance as of June 30, 2022 |  | 16,018 |  | 407,902 |  | (15,017) |  | (231,587) |  | 177,316 |  | 7,192 |  | 184,508 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended June 30, 2022 |  | Three Months Ended June 30, 2021\n |  |  |  |  |  |  |  | \nCommon Stock Share Activity(millions of shares) |  | Issued | Held in Treasury | Outstanding |  | Issued | Held in Treasury | Outstanding\nBalance as of March 31 |  | 8,019 |  | (3,806) |  | 4,213 |  |  | 8,019 |  | (3,785) |  | 4,234 | \nAcquisitions |  | \u2014 |  | (45) |  | (45) |  |  | \u2014 |  | \u2014 |  | \u2014 | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 | \nBalance as of June 30 |  | 8,019 |  | (3,851) |  | 4,168 |  |  | 8,019 |  | (3,785) |  | 4,234 | \n |  |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF CHANGE IN EQUITY  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | ExxonMobil Share of Equity |  | \n |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | Common Stock | Earnings Reinvested | Accumulated Other Comprehensive Income | Common Stock Held in Treasury | ExxonMobil Share of Equity | Non-controlling Interests | Total Equity\n |  |  |  |  |  |  |  | \nBalance as of December 31, 2020 |  | 15,688 |  | 383,943 |  | (16,705) |  | (225,776) |  | 157,150 |  | 6,980 |  | 164,130 | \nAmortization of stock-based awards |  | 328 |  | \u2014 |  | \u2014 |  | \u2014 |  | 328 |  | \u2014 |  | 328 | \nOther |  | (10) |  | \u2014 |  | \u2014 |  | \u2014 |  | (10) |  | 86 |  | 76 | \nNet income (loss) for the period |  | \u2014 |  | 7,420 |  | \u2014 |  | \u2014 |  | 7,420 |  | 157 |  | 7,577 | \nDividends - common shares |  | \u2014 |  | (7,441) |  | \u2014 |  | \u2014 |  | (7,441) |  | (112) |  | (7,553) | \n |  |  |  |  |  |  |  | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | 1,119 |  | \u2014 |  | 1,119 |  | 167 |  | 1,286 | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (1) |  | (1) |  | (293) |  | (294) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 6 |  | 6 |  | \u2014 |  | 6 | \nBalance as of June 30, 2021 |  | 16,006 |  | 383,922 |  | (15,586) |  | (225,771) |  | 158,571 |  | 6,985 |  | 165,556 | \n |  |  |  |  |  |  |  | \nBalance as of December 31, 2021 |  | 15,746 |  | 392,059 |  | (13,764) |  | (225,464) |  | 168,577 |  | 7,106 |  | 175,683 | \nAmortization of stock-based awards |  | 281 |  | \u2014 |  | \u2014 |  | \u2014 |  | 281 |  | \u2014 |  | 281 | \nOther |  | (9) |  | \u2014 |  | \u2014 |  | \u2014 |  | (9) |  | (1) |  | (10) | \nNet income (loss) for the period |  | \u2014 |  | 23,330 |  | \u2014 |  | \u2014 |  | 23,330 |  | 994 |  | 24,324 | \nDividends - common shares |  | \u2014 |  | (7,487) |  | \u2014 |  | \u2014 |  | (7,487) |  | (123) |  | (7,610) | \n |  |  |  |  |  |  |  | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | (1,253) |  | \u2014 |  | (1,253) |  | (88) |  | (1,341) | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (6,126) |  | (6,126) |  | (696) |  | (6,822) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 3 |  | 3 |  | \u2014 |  | 3 | \nBalance as of June 30, 2022 |  | 16,018 |  | 407,902 |  | (15,017) |  | (231,587) |  | 177,316 |  | 7,192 |  | 184,508 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Six Months Ended June 30, 2022 |  | Six Months Ended June 30, 2021\n |  |  |  |  |  |  |  | \nCommon Stock Share Activity(millions of shares) |  | Issued | Held in Treasury | Outstanding |  | Issued | Held in Treasury | Outstanding\nBalance as of December 31 |  | 8,019 |  | (3,780) |  | 4,239 |  |  | 8,019 |  | (3,786) |  | 4,233 | \nAcquisitions |  | \u2014 |  | (71) |  | (71) |  |  | \u2014 |  | \u2014 |  | \u2014 | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  |  | \u2014 |  | 1 |  | 1 | \nBalance as of June 30 |  | 8,019 |  | (3,851) |  | 4,168 |  |  | 8,019 |  | (3,785) |  | 4,234 | \n |  |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  |  |  |  |  |  |  |  |  |  |  | \n | June 30, 2022\n |  |  | \n(millions of dollars) | Equity CompanyObligations(1) | Other Third-Party Obligations | Total\nGuarantees |  |  | \nDebt-related | 1,138 |  | 144 |  | 1,282 | \nOther | 757 |  | 5,903 |  | 6,660 | \nTotal | 1,895 |  | 6,047 |  | 7,942 | \n |  |  | \n(1) ExxonMobil share |  |  |   |  |  |  |  |  |  |  |  |  |  | \nExxonMobil Share of Accumulated OtherComprehensive Income(millions of dollars) | Cumulative Foreign Exchange Translation Adjustment | Postretirement BenefitsReserves Adjustment | Total\nBalance as of December 31, 2020 | (10,614) |  | (6,091) |  | (16,705) | \nCurrent period change excluding amounts reclassified from accumulated other comprehensive income(1) | 425 |  | 119 |  | 544 | \nAmounts reclassified from accumulated other comprehensive income | \u2014 |  | 575 |  | 575 | \nTotal change in accumulated other comprehensive income | 425 |  | 694 |  | 1,119 | \nBalance as of June 30, 2021 | (10,189) |  | (5,397) |  | (15,586) | \n |  |  | \nBalance as of December 31, 2021 | (11,499) |  | (2,265) |  | (13,764) | \nCurrent period change excluding amounts reclassified from accumulated other comprehensive income(1) | (1,682) |  | 245 |  | (1,437) | \nAmounts reclassified from accumulated other comprehensive income | \u2014 |  | 184 |  | 184 | \nTotal change in accumulated other comprehensive income | (1,682) |  | 429 |  | (1,253) | \nBalance as of June 30, 2022 | (13,181) |  | (1,836) |  | (15,017) | \n |  |  | \n(1) Cumulative Foreign Exchange Translation Adjustment includes net investment hedge gain/(loss) net of taxes of $327million and $135million in 2022 and 2021, respectively.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAmounts Reclassified Out of Accumulated OtherComprehensive Income - Before-tax Income/(Expense)(millions of dollars) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 | 2021 |  | 2022 |  | 2021\n |  |  |  |  |  |  | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  |  |  |  |  |  | \n(Statement of Income line: Non-service pension and postretirement benefit expense) |  | (132) |  | (280) |  |  | (252) |  |  | (764) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIncome Tax (Expense)/Credit ForComponents of Other Comprehensive Income(millions of dollars) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n2022 | 2021 |  | 2022 |  | 2021\n |  |  |  | \nForeign exchange translation adjustment |  | (68) |  | 19 |  |  | (90) |  |  | (34) | \nPostretirement benefits reserves adjustment (excluding amortization) |  | (83) |  | 25 |  |  | (123) |  |  | (33) | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  | (30) |  | (65) |  |  | (57) |  |  | (171) | \nTotal |  | (181) |  | (21) |  |  | (270) |  |  | (238) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n2022 | 2021 |  | 2022 |  | 2021\nEarnings per common share |  |  |  |  |  |  | \nNet income (loss) attributable to ExxonMobil(millions of dollars) |  | 17,850 |  | 4,690 |  |  | 23,330 |  |  | 7,420 | \nWeighted average number of common shares outstanding(millions of shares) |  | 4,233 |  | 4,276 |  |  | 4,248 |  |  | 4,274 | \nEarnings (loss) per common share(dollars)(1) |  | 4.21 |  | 1.10 |  |  | 5.49 |  |  | 1.74 | \nDividends paid per common share(dollars) |  | 0.88 |  | 0.87 |  |  | 1.76 |  |  | 1.74 | \n |  |  |  |  |  |  | \n(1) The calculation of earnings (loss) per common share and earnings (loss) per common share \u2013 assuming dilution are the same in each period shown.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n2022 | 2021 |  | 2022 |  | 2021\nComponents of net benefit cost |  |  |  |  |  |  | \nPension Benefits - U.S. |  |  |  |  |  |  | \nService cost |  | 177 |  | 208 |  |  | 356 |  |  | 433 | \nInterest cost |  | 129 |  | 140 |  |  | 258 |  |  | 279 | \nExpected return on plan assets |  | (140) |  | (181) |  |  | (280) |  |  | (361) | \nAmortization of actuarial loss/(gain) |  | 39 |  | 61 |  |  | 78 |  |  | 122 | \nAmortization of prior service cost |  | (7) |  | (6) |  |  | (14) |  |  | (12) | \nNet pension enhancement and curtailment/settlement cost |  | 53 |  | 95 |  |  | 90 |  |  | 393 | \nNet benefit cost |  | 251 |  | 317 |  |  | 488 |  |  | 854 | \n |  |  |  |  |  |  | \nPension Benefits - Non-U.S. |  |  |  |  |  |  | \nService cost |  | 145 |  | 198 |  |  | 295 |  |  | 393 | \nInterest cost |  | 157 |  | 135 |  |  | 317 |  |  | 265 | \nExpected return on plan assets |  | (207) |  | (263) |  |  | (420) |  |  | (521) | \nAmortization of actuarial loss/(gain) |  | 47 |  | 107 |  |  | 94 |  |  | 215 | \nAmortization of prior service cost |  | 11 |  | 14 |  |  | 23 |  |  | 29 | \nNet pension enhancement and curtailment/settlement cost |  | (1) |  | \u2014 |  |  | (1) |  |  | 12 | \nNet benefit cost |  | 152 |  | 191 |  |  | 308 |  |  | 393 | \n |  |  |  |  |  |  | \nOther Postretirement Benefits |  |  |  |  |  |  | \nService cost |  | 38 |  | 46 |  |  | 78 |  |  | 95 | \nInterest cost |  | 53 |  | 55 |  |  | 108 |  |  | 111 | \nExpected return on plan assets |  | (4) |  | (4) |  |  | (7) |  |  | (9) | \nAmortization of actuarial loss/(gain) |  | \u2014 |  | 19 |  |  | 3 |  |  | 38 | \nAmortization of prior service cost |  | (10) |  | (10) |  |  | (21) |  |  | (21) | \nNet benefit cost |  | 77 |  | 106 |  |  | 161 |  |  | 214 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | June 30, 2022\n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n | Fair Value |  |  |  | \n(millions of dollars) | Level 1 | Level 2 | Level 3 | Total Gross Assets& Liabilities | Effect ofCounterparty Netting | Effect ofCollateralNetting | Difference in Carrying Value and Fair Value | NetCarryingValue\nAssets |  |  |  |  |  |  |  | \nDerivative assets(1) | 6,269 |  | 2,935 |  | \u2014 |  | 9,204 |  | (7,954) |  | (209) |  | \u2014 |  | 1,041 | \n |  |  |  |  |  |  |  | \nAdvances to/receivables from equity companies(2)(6) | \u2014 |  | 2,511 |  | 5,017 |  | 7,528 |  | \u2014 |  | \u2014 |  | 666 |  | 8,194 | \n |  |  |  |  |  |  |  | \nOther long-term financial assets(3) | 1,166 |  | \u2014 |  | 1,017 |  | 2,183 |  | \u2014 |  | \u2014 |  | 188 |  | 2,371 | \n |  |  |  |  |  |  |  | \nLiabilities |  |  |  |  |  |  |  | \nDerivative liabilities(4) | 6,278 |  | 3,921 |  | \u2014 |  | 10,199 |  | (7,954) |  | (218) |  | \u2014 |  | 2,027 | \nLong-term debt(5) | 34,229 |  | 61 |  | 5 |  | 34,295 |  | \u2014 |  | \u2014 |  | 2,935 |  | 37,230 | \n |  |  |  |  |  |  |  | \nLong-term obligations to equity companies(6) | \u2014 |  | \u2014 |  | 2,635 |  | 2,635 |  | \u2014 |  | \u2014 |  | (18) |  | 2,617 | \n |  |  |  |  |  |  |  | \nOther long-term financial liabilities(7) | \u2014 |  | \u2014 |  | 742 |  | 742 |  | \u2014 |  | \u2014 |  | 51 |  | 793 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | December 31, 2021\n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n |  | Fair Value |  |  |  | \n(millions of dollars) |  | Level 1 | Level 2 | Level 3 | Total Gross Assets& Liabilities | Effect ofCounterparty Netting | Effect ofCollateralNetting | Difference in Carrying Value and Fair Value | NetCarryingValue\nAssets |  |  |  |  |  |  |  |  | \nDerivative assets(1) |  | 1,422 |  | 1,523 |  | \u2014 |  | 2,945 |  | (1,930) |  | (28) |  | \u2014 |  | 987 | \n |  |  |  |  |  |  |  |  | \nAdvances to/receivables from equity companies(2)(6) |  | \u2014 |  | 3,076 |  | 5,373 |  | 8,449 |  | \u2014 |  | \u2014 |  | (123) |  | 8,326 | \n |  |  |  |  |  |  |  |  | \nOther long-term financial assets(3) |  | 1,134 |  | \u2014 |  | 1,058 |  | 2,192 |  | \u2014 |  | \u2014 |  | 181 |  | 2,373 | \n |  |  |  |  |  |  |  |  | \nLiabilities |  |  |  |  |  |  |  |  | \nDerivative liabilities(4) |  | 1,701 |  | 2,594 |  | \u2014 |  | 4,295 |  | (1,930) |  | (306) |  | \u2014 |  | 2,059 | \nLong-term debt(5) |  | 44,454 |  | 88 |  | 3 |  | 44,545 |  | \u2014 |  | \u2014 |  | (2,878) |  | 41,667 | \n |  |  |  |  |  |  |  |  | \nLong-term obligations to equity companies(6) |  | \u2014 |  | \u2014 |  | 3,084 |  | 3,084 |  | \u2014 |  | \u2014 |  | (227) |  | 2,857 | \n |  |  |  |  |  |  |  |  | \nOther long-term financial liabilities(7) |  | \u2014 |  | \u2014 |  | 902 |  | 902 |  | \u2014 |  | \u2014 |  | 58 |  | 960 |   |  |  |  |  | \n(1) | Included in the Balance Sheet lines: Notes and accounts receivable - net and Other assets, including intangibles - net\n(2) | Included in the Balance Sheet line: Investments, advances and long-term receivables\n(3) | Included in the Balance Sheet lines: Investments, advances and long-term receivables and Other assets, including intangibles - net\n(4) | Included in the Balance Sheet lines: Accounts payable and accrued liabilities and Other long-term obligations\n(5) | Excluding finance lease obligations\n(6) | Advances to/receivables from equity companies and long-term obligations to equity companies are mainly designated as hierarchy level 3 inputs. The fair value is calculated by discounting the remaining obligations by a rate consistent with the credit quality and industry of the company.\n(7) | Included in the Balance Sheet line: Other long-term obligations. Includes contingent consideration related to a prior year acquisition where fair value is based on expected drilling activities and discount rates.  |  |  |  |  |  |  |  | \n\n |  | \n(millions) | June 30, 2022 | December 31, 2021\nCrude oil (barrels) | 47 |  | 82 | \nPetroleum products (barrels) | (39) |  | (48) | \nNatural gas (MMBTUs) | (115) |  | (115) | \n |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n\n |  |  |  |  |  | \n(millions of dollars) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 | 2021 |  | 2022 | 2021\nSales and other operating revenue |  | (1,413) |  | (1,088) |  |  | (3,948) |  | (1,600) | \nCrude oil and product purchases |  | \u2014 |  | (20) |  |  | (26) |  | (19) | \nTotal |  | (1,413) |  | (1,108) |  |  | (3,974) |  | (1,619) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 | 2021 |  | 2022 | 2021\nEarnings (Loss) After Income Tax |  |  |  |  |  | \nUpstream |  |  |  |  |  | \nUnited States |  | 3,749 |  | 663 |  |  | 6,125 |  | 1,026 | \nNon-U.S. |  | 7,622 |  | 2,522 |  |  | 9,734 |  | 4,713 | \nEnergy Products |  |  |  |  |  | \nUnited States |  | 2,655 |  | (278) |  |  | 3,144 |  | (510) | \nNon-U.S. |  | 2,617 |  | (578) |  |  | 1,933 |  | (1,267) | \nChemical Products |  |  |  |  |  | \nUnited States |  | 625 |  | 1,149 |  |  | 1,395 |  | 1,803 | \nNon-U.S. |  | 450 |  | 1,051 |  |  | 1,086 |  | 1,788 | \nSpecialty Products |  |  |  |  |  | \nUnited States |  | 232 |  | 262 |  |  | 478 |  | 442 | \nNon-U.S. |  | 185 |  | 487 |  |  | 415 |  | 862 | \nCorporate and Financing |  | (286) |  | (588) |  |  | (980) |  | (1,437) | \nCorporate total |  | 17,850 |  | 4,690 |  |  | 23,330 |  | 7,420 | \n |  |  |  |  |  | \nSales and Other Operating Revenue |  |  |  |  |  | \nUpstream |  |  |  |  |  | \nUnited States |  | 3,958 |  | 1,726 |  |  | 6,614 |  | 3,611 | \nNon-U.S. |  | 7,101 |  | 3,792 |  |  | 13,444 |  | 6,886 | \nEnergy Products |  |  |  |  |  | \nUnited States |  | 34,473 |  | 18,770 |  |  | 59,326 |  | 34,304 | \nNon-U.S. |  | 52,804 |  | 29,925 |  |  | 94,519 |  | 56,815 | \nChemical Products |  |  |  |  |  | \nUnited States |  | 3,180 |  | 3,035 |  |  | 6,274 |  | 5,533 | \nNon-U.S. |  | 4,497 |  | 4,244 |  |  | 8,994 |  | 7,985 | \nSpecialty Products |  |  |  |  |  | \nUnited States |  | 1,653 |  | 1,242 |  |  | 3,044 |  | 2,379 | \nNon-U.S. |  | 3,591 |  | 3,204 |  |  | 6,769 |  | 6,073 | \nCorporate and Financing |  | 8 |  | 5 |  |  | 15 |  | (91) | \nCorporate total(1) |  | 111,265 |  | 65,943 |  |  | 198,999 |  | 123,495 | \n |  |  |  |  |  | \nIntersegment Revenue |  |  |  |  |  | \nUpstream |  |  |  |  |  | \nUnited States |  | 7,180 |  | 3,827 |  |  | 13,371 |  | 7,150 | \nNon-U.S. |  | 13,533 |  | 7,747 |  |  | 24,368 |  | 14,564 | \nEnergy Products |  |  |  |  |  | \nUnited States |  | 8,348 |  | 4,102 |  |  | 15,197 |  | 7,263 | \nNon-U.S. |  | 10,848 |  | 5,186 |  |  | 19,610 |  | 10,085 | \nChemical Products |  |  |  |  |  | \nUnited States |  | 2,558 |  | 1,461 |  |  | 4,325 |  | 2,806 | \nNon-U.S. |  | 1,600 |  | 929 |  |  | 3,107 |  | 1,751 | \nSpecialty Products |  |  |  |  |  | \nUnited States |  | 713 |  | 584 |  |  | 1,272 |  | 1,080 | \nNon-U.S. |  | 195 |  | 160 |  |  | 419 |  | 320 | \nCorporate and Financing |  | 59 |  | 52 |  |  | 116 |  | 109 | \n |  |  |  |  |  | \n(1)See footnote on the next page  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nGeographic Sales and Other Operating Revenue |  |  |  |  |  | \n(millions of dollars) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 | 2021 |  | 2022 | 2021\nUnited States |  | 43,264 |  | 24,773 |  |  | 75,258 |  | 45,827 | \nNon-U.S. |  | 68,001 |  | 41,170 |  |  | 123,741 |  | 77,668 | \nTotal(1) |  | 111,265 |  | 65,943 |  |  | 198,999 |  | 123,495 | \n |  |  |  |  |  | \nSignificant Non-U.S. revenue sources include:(2) |  |  |  |  |  | \nCanada |  | 9,642 |  | 5,282 |  |  | 16,638 |  | 9,541 | \nUnited Kingdom |  | 8,306 |  | 3,815 |  |  | 15,854 |  | 6,758 | \nFrance |  | 5,265 |  | 3,247 |  |  | 9,622 |  | 6,029 | \nSingapore |  | 4,774 |  | 3,515 |  |  | 9,096 |  | 6,950 | \nItaly |  | 3,063 |  | 2,466 |  |  | 5,898 |  | 4,331 | \nBelgium |  | 3,041 |  | 2,192 |  |  | 5,877 |  | 4,181 | \nAustralia |  | 3,205 |  | 2,019 |  |  | 5,661 |  | 3,748 | \n |  |  |  |  |  | \n(1)Includes approximately23% and15% related to revenue outside the scope of ASC 606 \"Revenue from Contracts with Customers\" for the three months ended June\u00a030, 2022 and June\u00a030, 2021, respectively, and22% and16% for the six months ended June\u00a030, 2022 and June\u00a030, 2021, respectively. Trade receivables in Notes and accounts receivable \u2013 net reported on the Balance Sheet include both receivables within the scope of ASC 606 and those outside the scope of ASC 606. Revenue and receivables outside the scope of ASC 606 primarily relate to physically settled commodity contracts accounted for as derivatives. Credit quality and type of customer are generally similar between those revenues and receivables within the scope of ASC 606 and those outside it.\n(2)Revenue is determined by primary country of operations. Excludes certain sales and other operating revenues in Non-U.S. operations where attribution to a specific country is not practicable.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months EndedJune 30, 2022 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss) (U.S. GAAP) | 3,749 | 7,622 |  | 2,655 | 2,617 |  | 625 | 450 | 232 | 185 |  |  | (286) |  | 17,850\nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nGain/(loss) on sale of assets | 299 | \u2014 |  | \u2014 | \u2014 |  | \u2014 | \u2014 | \u2014 | \u2014 |  |  | \u2014 |  | 299\n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items | 3,450 | 7,622 |  | 2,655 | 2,617 |  | 625 | 450 | 232 | 185 |  |  | (286) |  | 17,551  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months EndedJune 30, 2021 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss) (U.S. GAAP) | 663 |  | 2,522 |  |  | (278) |  | (578) |  |  | 1,149 |  | 1,051 |  | 262 | 487 |  |  | (588) |  |  | 4,690\nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSeverance charges | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 | \u2014 |  |  | (12) |  |  | (12)\n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items | 663 |  | 2,522 |  |  | (278) |  | (578) |  |  | 1,149 |  | 1,051 |  | 262 | 487 |  |  | (576) |  |  | 4,702  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSix Months EndedJune 30, 2022 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss) (U.S. GAAP) | 6,125 | 9,734 |  | 3,144 | 1,933 |  | 1,395 | 1,086 | 478 | 415 |  |  | (980) |  | 23,330\nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nImpairments | \u2014 | (2,877) |  | \u2014 | \u2014 |  | \u2014 | \u2014 | \u2014 | \u2014 |  |  | (98) |  | (2,975)\nGain/(loss) on sale of assets | 299 | \u2014 |  | \u2014 | \u2014 |  | \u2014 | \u2014 | \u2014 | \u2014 |  |  | \u2014 |  | 299\n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther - Russia impacts | \u2014 | (378) |  | \u2014 | \u2014 |  | \u2014 | \u2014 | \u2014 | \u2014 |  |  | \u2014 |  | (378)\n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items | 5,826 | 12,989 |  | 3,144 | 1,933 |  | 1,395 | 1,086 | 478 | 415 |  |  | (882) |  | 26,384  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSix Months EndedJune 30, 2021 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss) (U.S. GAAP) | 1,026 |  | 4,713 |  |  | (510) |  | (1,267) |  |  | 1,803 |  | 1,788 |  | 442 | 862 |  |  | (1,437) |  |  | 7,420\nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSeverance charges | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 | \u2014 |  |  | (43) |  |  | (43)\n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items | 1,026 |  | 4,713 |  |  | (510) |  | (1,267) |  |  | 1,803 |  | 1,788 |  | 442 | 862 |  |  | (1,394) |  |  | 7,463\n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Financial Results |  |  |  |  |  | \n |  |  |  |  |  | \n(millions of dollars) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 | 2021 |  | 2022 | 2021\nEarnings (loss) (U.S. GAAP) |  |  |  |  |  | \nUnited States |  | 3,749 |  | 663 |  |  | 6,125 |  | 1,026 | \nNon-U.S. |  | 7,622 |  | 2,522 |  |  | 9,734 |  | 4,713 | \nTotal |  | 11,371 |  | 3,185 |  |  | 15,859 |  | 5,739 | \n |  |  |  |  |  | \nIdentified Items(1) |  |  |  |  |  | \nUnited States |  | 299 |  | \u2014 |  |  | 299 |  | \u2014 | \nNon-U.S. |  | \u2014 |  | \u2014 |  |  | (3,255) |  | \u2014 | \nTotal |  | 299 |  | \u2014 |  |  | (2,956) |  | \u2014 | \n |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1) |  |  |  |  |  | \nUnited States |  | 3,450 |  | 663 |  |  | 5,826 |  | 1,026 | \nNon-U.S. |  | 7,622 |  | 2,522 |  |  | 12,989 |  | 4,713 | \nTotal |  | 11,072 |  | 3,185 |  |  | 18,815 |  | 5,739 |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Second Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Operational Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n |  | 2022 |  | 2021 |  | 2022 |  | 2021\nNet production of crude oil, natural gas liquids, bitumen and synthetic oil(thousands of barrels daily) |  |  |  |  |  |  |  | \nUnited States |  | 777 |  |  | 687 |  |  | 765 |  |  | 676 | \nCanada/Other Americas |  | 556 |  |  | 529 |  |  | 516 |  |  | 552 | \nEurope |  | 4 |  |  | 16 |  |  | 4 |  |  | 25 | \nAfrica |  | 224 |  |  | 254 |  |  | 240 |  |  | 254 | \nAsia |  | 691 |  |  | 669 |  |  | 714 |  |  | 680 | \nAustralia/Oceania |  | 46 |  |  | 45 |  |  | 43 |  |  | 42 | \nWorldwide |  | 2,298 |  |  | 2,200 |  |  | 2,282 |  |  | 2,229 | \n |  |  |  |  |  |  |  | \nNet natural gas production available for sale(millions of cubic feet daily) |  |  |  |  |  |  |  | \nUnited States |  | 2,699 |  |  | 2,804 |  |  | 2,738 |  |  | 2,786 | \nCanada/Other Americas |  | 180 |  |  | 189 |  |  | 180 |  |  | 203 | \nEurope |  | 825 |  |  | 654 |  |  | 798 |  |  | 1,026 | \nAfrica |  | 67 |  |  | 46 |  |  | 63 |  |  | 35 | \nAsia |  | 3,320 |  |  | 3,433 |  |  | 3,330 |  |  | 3,515 | \nAustralia/Oceania |  | 1,515 |  |  | 1,168 |  |  | 1,421 |  |  | 1,166 | \nWorldwide |  | 8,606 |  |  | 8,294 |  |  | 8,530 |  |  | 8,731 | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nOil-equivalent production(1)(thousands of oil-equivalent barrels daily) |  | 3,732 |  |  | 3,582 |  |  | 3,704 |  | 3,684\n |  |  |  |  |  |  |  | \n(1) Natural gas is converted to an oil-equivalent basis at six million cubic feet per one thousand barrels.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Additional Information |  |  |  |  |  | \n |  |  |  |  |  | \n(thousands of barrels daily) |  |  | Three  Months Ended June 30 |  |  | Six Months Ended June 30\nVolumes reconciliation (Oil-equivalent production)(1) |  |  |  |  |  | \n2021 |  |  | 3,582 |  |  | 3,684\nEntitlements - Net Interest |  |  | (27) |  |  | (29)\nEntitlements - Price / Spend / Other |  |  | (57) |  |  | (48)\nGovernment Mandates |  |  | 90 |  |  | 101\nDivestments |  |  | (28) |  |  | (46)\nOther |  |  | 172 |  |  | 42\n2022 |  |  | 3,732 |  |  | 3,704\n |  |  |  |  |  | \n(1)Natural gas is converted to an oil-equivalent basis at six million cubic feet per one thousand barrels.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nEarnings (loss) (U.S. GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 2,655 |  |  | (278) |  |  | 3,144 |  |  | (510) | \nNon-U.S. |  | 2,617 |  |  | (578) |  |  | 1,933 |  |  | (1,267) | \nTotal |  | 5,273 |  |  | (856) |  |  | 5,077 |  |  | (1,777) | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1) |  |  |  |  |  |  |  | \nUnited States |  | 2,655 |  |  | (278) |  |  | 3,144 |  |  | (510) | \nNon-U.S. |  | 2,617 |  |  | (578) |  |  | 1,933 |  |  | (1,267) | \nTotal |  | 5,273 |  |  | (856) |  |  | 5,077 |  |  | (1,777) | \n |  |  |  |  |  |  |  | \n(1) Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Second Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Operational Results |  |  |  |  |  | \n |  |  |  |  |  | \n(thousands of barrels daily) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 | 2021 |  | 2022 | 2021\nRefinery throughput |  |  |  |  |  | \nUnited States |  | 1,686 |  | 1,532 |  |  | 1,686 |  | 1,532 | \nCanada |  | 413 |  | 332 |  |  | 406 |  | 348 | \nEurope |  | 1,164 |  | 1,223 |  |  | 1,179 |  | 1,188 | \nAsia Pacific |  | 532 |  | 607 |  |  | 534 |  | 576 | \nOther |  | 193 |  | 164 |  |  | 180 |  | 161 | \nWorldwide |  | 3,988 |  | 3,858 |  |  | 3,985 |  | 3,805 | \n |  |  |  |  |  | \nEnergy Products sales(1) |  |  |  |  |  | \nUnited States |  | 2,452 |  | 2,230 |  |  | 2,358 |  | 2,153 | \nNon-U.S. |  | 2,858 |  | 2,776 |  |  | 2,853 |  | 2,766 | \nWorldwide |  | 5,310 |  | 5,006 |  |  | 5,211 |  | 4,920 | \n |  |  |  |  |  | \nGasoline, naphthas |  | 2,208 |  | 2,117 |  |  | 2,161 |  | 2,057 | \nHeating oils, kerosene, diesel oils |  | 1,755 |  | 1,704 |  |  | 1,739 |  | 1,698 | \nAviation fuels |  | 350 |  | 201 |  |  | 319 |  | 192 | \nHeavy fuels |  | 228 |  | 275 |  |  | 238 |  | 266 | \nOther energy products |  | 769 |  | 709 |  |  | 753 |  | 707 | \n |  |  |  |  |  | \n(1) Data reported net of purchases/sales contracts with the same counterparty. |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nEarnings (loss) (U.S. GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 625 |  | 1,149 |  |  | 1,395 |  |  | 1,803 | \nNon-U.S. |  | 450 |  | 1,051 |  |  | 1,086 |  |  | 1,788 | \nTotal |  | 1,076 |  |  | 2,200 |  |  | 2,481 |  |  | 3,591 | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1) |  |  |  |  |  |  |  | \nUnited States |  | 625 |  |  | 1,149 |  |  | 1,395 |  |  | 1,803 | \nNon-U.S. |  | 450 |  |  | 1,051 |  |  | 1,086 |  |  | 1,788 | \nTotal |  | 1,076 |  |  | 2,200 |  |  | 2,481 |  |  | 3,591 | \n |  |  |  |  |  |  |  | \n(1) Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Second Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Operational Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(thousands of metric tons) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nChemical Products sales(1) |  |  |  |  |  |  |  | \nUnited States |  | 1,998 |  |  | 1,782 |  |  | 4,030 |  |  | 3,403 | \nNon-U.S. |  | 2,812 |  |  | 2,949 |  |  | 5,798 |  |  | 6,093 | \nWorldwide |  | 4,811 |  |  | 4,731 |  |  | 9,829 |  |  | 9,496 | \n |  |  |  |  |  |  |  | \n(1) Data reported net of purchases/sales contracts with the same counterparty.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nEarnings (loss) (U.S. GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 232 |  |  | 262 |  |  | 478 |  |  | 442 | \nNon-U.S. |  | 185 |  |  | 487 |  |  | 415 |  |  | 862 | \nTotal |  | 417 |  |  | 750 |  |  | 893 |  |  | 1,304 | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1) |  |  |  |  |  |  |  | \nUnited States |  | 232 |  |  | 262 |  |  | 478 |  |  | 442 | \nNon-U.S. |  | 185 |  |  | 487 |  |  | 415 |  |  | 862 | \nTotal |  | 417 |  |  | 750 |  |  | 893 |  |  | 1,304 | \n |  |  |  |  |  |  |  | \n(1) Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Second Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Operational Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(thousands of metric tons) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nSpecialty Products sales(1) |  |  |  |  |  |  |  | \nUnited States |  | 590 |  |  | 495 |  |  | 1,111 |  |  | 1,005 | \nNon-U.S. |  | 1,511 |  |  | 1,447 |  |  | 2,995 |  |  | 2,932 | \nWorldwide |  | 2,100 |  |  | 1,942 |  |  | 4,107 |  |  | 3,936 | \n |  |  |  |  |  |  |  | \n(1) Data reported net of purchases/sales contracts with the same counterparty. |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCorporate and Financing Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\n |  |  |  |  |  |  |  | \nEarnings (loss) (U.S. GAAP) |  | (286) |  |  | (588) |  |  | (980) |  |  | (1,437) | \nIdentified Items(1) |  | \u2014 |  |  | (12) |  |  | (98) |  |  | (43) | \nEarnings (loss) excluding Identified Items(1) |  | (286) |  |  | (576) |  |  | (882) |  |  | (1,394) | \n |  |  |  |  |  |  |  | \n(1) Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nNet cash provided by/(used in) |  |  |  |  |  |  |  | \nOperating activities |  |  |  |  |  | 34,751 |  |  | 18,914 | \nInvesting activities |  |  |  |  |  | (7,009) |  |  | (5,071) | \nFinancing activities |  |  |  |  |  | (15,384) |  |  | (14,807) | \nEffect of exchange rate changes |  |  |  |  |  | (299) |  |  | 65 | \nIncrease/(decrease) in cash and cash equivalents |  |  |  |  |  | 12,059 |  |  | (899) | \n |  |  |  |  |  |  |  | \nCash and cash equivalents (at end of period) |  |  |  |  |  | 18,861 |  |  | 3,465 | \n |  |  |  |  |  |  |  | \nCash flow from operations and asset sales |  |  |  |  |  |  |  | \nNet cash provided by operating activities (U.S. GAAP) |  | 19,963 |  |  | 9,650 |  |  | 34,751 |  |  | 18,914 | \nProceeds associated with sales of subsidiaries, property, plant & equipment, and sales and returns of investments |  | 939 |  |  | 250 |  |  | 1,232 |  |  | 557 | \nCash flow from operations and asset sales |  | 20,902 |  |  | 9,900 |  |  | 35,983 |  |  | 19,471 | \n |  |  |  |  |  |  |  | \nBecause of the ongoing nature of our asset management and divestment program, we believe it is useful for investors to consider proceeds associated with asset sales together with cash provided by operating activities when evaluating cash available for investment in the business and financing activities, including shareholder distributions.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nIncome taxes |  | 6,359 |  |  | 1,526 |  |  | 9,165 |  |  | 2,322 | \nEffective income tax rate |  | 31 | % |  | 30 | % |  | 34 | % |  | 31 | %\nTotal other taxes and duties(1) |  | 7,779 |  |  | 8,441 |  |  | 16,228 |  |  | 15,724 | \nTotal |  | 14,138 |  |  | 9,967 |  |  | 25,393 |  |  | 18,046 | \n |  |  |  |  |  |  |  | \n(1)Includes \u201cOther taxes and duties\u201d plus taxes that are included in \u201cProduction and manufacturing expenses\u201d and \u201cSelling, general and administrative expenses\u201d.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nUpstream (including exploration expenses) |  | 3,627 |  |  | 2,817 |  |  | 7,506 |  |  | 5,174 | \nEnergy Products |  | 506 |  |  | 429 |  |  | 1,072 |  |  | 878 | \nChemical Products |  | 419 |  |  | 512 |  |  | 855 |  |  | 811 | \nSpecialty Products |  | 56 |  |  | 44 |  |  | 79 |  |  | 72 | \nOther |  | 1 |  |  | 1 |  |  | 1 |  |  | 1 | \nTotal |  | 4,609 |  |  | 3,803 |  |  | 9,513 |  |  | 6,936 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIssuer Purchase of Equity Securities for Quarter Ended June\u00a030, 2022\n |  |  |  |  |  |  |  | \nPeriod |  | Total Numberof SharesPurchased(1) |  | AveragePrice Paidper Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(3) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program(Billions of dollars)\nApril 2022 |  | 13,118,849 |  | $85.39 |  | 13,118,849 |  | $26.8\nMay 2022 |  | 16,117,414 |  | $90.83 |  | 16,113,008 |  | $25.4\nJune 2022 |  | 15,691,398 |  | $94.02 |  | 15,691,302 |  | $23.9\nTotal |  | 44,927,661 |  | $90.36 |  | 44,923,159 |  | \n |  |  |  |  |  |  |  | \n(1) Includes shares withheld from participants in the company's incentive program for personal income taxes.\n(2) In the first quarter, the average price paid per share was $78.63, which brings the full-year average price paid per share to $86.03.\n(3) In its earnings release dated April 29, 2022, the Corporation stated that the company increased its share repurchase program from up to $10 billion to a total of up to $30 billion through 2023. Purchases in the second quarter of 2022 were made under terms intended to qualify for exemption under Rules 10b-18 and 10b5-1.  |  |  |  |  |  |  |  | \nExhibit |  | Description\n |  | \n |  | \n |  | \n |  | \n |  | \n |  | \n31.1 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Chief Executive Officer.\n31.2 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Chief Financial Officer.\n31.3 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Principal Accounting Officer.\n32.1 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Chief Executive Officer.\n32.2 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Chief Financial Officer.\n32.3 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Principal Accounting Officer.\n101 |  | Interactive Data Files (formatted as Inline XBRL).\n104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).  |  |  |  |  |  |  |  | \n | EXXON MOBIL CORPORATION\nDate: August\u00a03, 2022 | By: | /s/ LEN M. FOX\n |  | Len M. Fox\n |  | Vice President, Controller and\n |  | Principal Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Exxon Mobil, in 2022 Q3, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  |  |  |  | \nNew Jersey |  | 13-5409005\n(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification Number)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of Each Class |  | Trading Symbol |  | Name of Each Exchange on Which Registered\nCommon Stock, without par value |  | XOM |  | New York Stock Exchange\n0.142% Notes due 2024 |  | XOM24B |  | New York Stock Exchange\n0.524% Notes due 2028 |  | XOM28 |  | New York Stock Exchange\n0.835% Notes due 2032 |  | XOM32 |  | New York Stock Exchange\n1.408% Notes due 2039 |  | XOM39A |  | New York Stock Exchange  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2611 | Accelerated filer | \u2610\n |  |  | \nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n\n | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \nClass |  | Outstanding as of September\u00a030, 2022\nCommon stock, without par value |  | 4,118,293,421  |  |  |  |  | \nPART I. FINANCIAL INFORMATION\n | \nItem 1. Financial Statements | \n | \nCondensed Consolidated Statement of Income - Three and nine months ended September\u00a030, 2022 and 2021 | 3 | \n | \nCondensed Consolidated Statement of Comprehensive Income - Three and nine months ended September\u00a030, 2022 and 2021 | 4 | \n | \nCondensed Consolidated Balance Sheet - As of September\u00a030, 2022 and December\u00a031, 2021 | 5 | \n | \nCondensed Consolidated Statement of Cash Flows - Nine months ended September\u00a030, 2022 and 2021 | 6 | \n | \nCondensed Consolidated Statement of Changes in Equity - Three months ended September\u00a030, 2022 and 2021 | 7 | \n | \nCondensed Consolidated Statement of Changes in Equity - Nine months ended September\u00a030, 2022 and 2021 | 8 | \n | \n | \n | \nNotes to Condensed Consolidated Financial Statements | 9 | \n | \nItem 2. Management's Discussion and Analysis of Financial Condition and Results of Operations | 18 | \n | \nItem 3. Quantitative and Qualitative Disclosures About Market Risk | 34 | \n | \nItem 4. Controls and Procedures | 34 | \n | \n | \nPART II. OTHER INFORMATION\n | \nItem 1. Legal Proceedings | 35 | \n | \n | \n | \nItem 2. Unregistered Sales of Equity Securities and Use of Proceeds | 36 | \n | \nItem 6. Exhibits | 36 | \n | \nIndex to Exhibits | 37 | \n | \nSignature | 38 | \n |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nITEM 1. FINANCIAL STATEMENTS |  |   |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF INCOME  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | Three Months EndedSeptember 30, |  |  | Nine Months EndedSeptember 30,\n | 2022 | 2021 |  |  | 2022 | 2021\nRevenues and other income |  |  |  |  |  |  | \nSales and other operating revenue |  | 106,512 |  | 71,892 |  |  |  | 305,511 |  | 195,387 | \nIncome from equity affiliates |  | 4,632 |  | 1,670 |  |  |  | 10,858 |  | 4,579 | \nOther income |  | 926 |  | 224 |  |  |  | 1,882 |  | 709 | \nTotal revenues and other income |  | 112,070 |  | 73,786 |  |  |  | 318,251 |  | 200,675 | \nCosts and other deductions |  |  |  |  |  |  | \nCrude oil and product purchases |  | 60,197 |  | 39,745 |  |  |  | 178,198 |  | 109,675 | \nProduction and manufacturing expenses |  | 11,317 |  | 8,719 |  |  |  | 32,244 |  | 25,252 | \nSelling, general and administrative expenses |  | 2,324 |  | 2,287 |  |  |  | 7,263 |  | 7,060 | \nDepreciation and depletion (including impairments) |  | 5,642 |  | 4,990 |  |  |  | 18,976 |  | 14,946 | \nExploration expenses, including dry holes(1) |  | 218 |  | 190 |  |  |  | 677 |  | 530 | \nNon-service pension and postretirement benefit expense |  | 154 |  | 146 |  |  |  | 382 |  | 686 | \nInterest expense |  | 209 |  | 214 |  |  |  | 591 |  | 726 | \nOther taxes and duties |  | 6,587 |  | 7,889 |  |  |  | 21,009 |  | 22,295 | \nTotal costs and other deductions |  | 86,648 |  | 64,180 |  |  |  | 259,340 |  | 181,170 | \nIncome (loss) before income taxes |  | 25,422 |  | 9,606 |  |  |  | 58,911 |  | 19,505 | \nIncome taxes |  | 5,224 |  | 2,664 |  |  |  | 14,389 |  | 4,986 | \nNet income (loss) including noncontrolling interests |  | 20,198 |  | 6,942 |  |  |  | 44,522 |  | 14,519 | \nNet income (loss) attributable to noncontrolling interests |  | 538 |  | 192 |  |  |  | 1,532 |  | 349 | \nNet income (loss) attributable to ExxonMobil |  | 19,660 |  | 6,750 |  |  |  | 42,990 |  | 14,170 | \n |  |  |  |  |  |  | \nEarnings (loss) per common share(dollars) |  | 4.68 |  | 1.57 |  |  |  | 10.17 |  | 3.31 | \n |  |  |  |  |  |  | \nEarnings (loss) per common share - assuming dilution(dollars) |  | 4.68 |  | 1.57 |  |  |  | 10.17 |  | 3.31 | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(1) | Includes $74million related to the write-off of exploratory well costs in 2022 that were previously capitalized for greater than one year at December 31, 2021.\n |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nNet income (loss) including noncontrolling interests |  | 20,198 |  |  | 6,942 |  |  | 44,522 |  |  | 14,519 | \n |  |  |  |  |  |  |  | \nOther comprehensive income (loss) (net of income taxes) |  |  |  |  |  |  |  | \nForeign exchange translation adjustment |  | (3,361) |  |  | (1,625) |  |  | (5,157) |  |  | (1,053) | \n |  |  |  |  |  |  |  | \nPostretirement benefits reserves adjustment (excluding amortization) |  | 108 |  |  | 184 |  |  | 368 |  |  | 305 | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  | 128 |  |  | 196 |  |  | 323 |  |  | 789 | \nTotal other comprehensive income (loss) |  | (3,125) |  |  | (1,245) |  |  | (4,466) |  |  | 41 | \nComprehensive income (loss) including noncontrolling interests |  | 17,073 |  |  | 5,697 |  |  | 40,056 |  |  | 14,560 | \nComprehensive income (loss) attributable to noncontrolling interests |  | 199 |  |  | 57 |  |  | 1,105 |  |  | 381 | \nComprehensive income (loss) attributable to ExxonMobil |  | 16,874 |  |  | 5,640 |  |  | 38,951 |  |  | 14,179 | \n |  |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED BALANCE SHEET  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | September 30, 2022 | December 31, 2021 |  |  | \n |  |  |  |  |  | \nASSETS |  |  |  |  |  | \nCurrent assets |  |  |  |  |  | \nCash and cash equivalents |  | 30,407 |  | 6,802 |  |  |  | \nCash and cash equivalents \u2013 restricted |  | 57 |  | \u2014 |  |  |  | \nNotes and accounts receivable \u2013 net |  | 42,411 |  | 32,383 |  |  |  | \nInventories |  |  |  |  |  | \nCrude oil, products and merchandise |  | 20,078 |  | 14,519 |  |  |  | \nMaterials and supplies |  | 4,018 |  | 4,261 |  |  |  | \nOther current assets |  | 2,318 |  | 1,189 |  |  |  | \nTotal current assets |  | 99,289 |  | 59,154 |  |  |  | \nInvestments, advances and long-term receivables |  | 50,235 |  | 45,195 |  |  |  | \nProperty, plant and equipment \u2013 net |  | 203,102 |  | 216,552 |  |  |  | \nOther assets, including intangibles \u2013 net |  | 17,526 |  | 18,022 |  |  |  | \nTotal Assets |  | 370,152 |  | 338,923 |  |  |  | \n |  |  |  |  |  | \nLIABILITIES |  |  |  |  |  | \nCurrent liabilities |  |  |  |  |  | \nNotes and loans payable |  | 6,182 |  | 4,276 |  |  |  | \nAccounts payable and accrued liabilities |  | 62,550 |  | 50,766 |  |  |  | \nIncome taxes payable |  | 5,325 |  | 1,601 |  |  |  | \nTotal current liabilities |  | 74,057 |  | 56,643 |  |  |  | \nLong-term debt |  | 39,246 |  | 43,428 |  |  |  | \nPostretirement benefits reserves |  | 16,799 |  | 18,430 |  |  |  | \nDeferred income tax liabilities |  | 21,274 |  | 20,165 |  |  |  | \nLong-term obligations to equity companies |  | 2,647 |  | 2,857 |  |  |  | \nOther long-term obligations |  | 23,086 |  | 21,717 |  |  |  | \nTotal Liabilities |  | 177,109 |  | 163,240 |  |  |  | \n |  |  |  |  |  | \nCommitments and contingencies (Note 3) |  |  |  |  |  | \n |  |  |  |  |  | \nEQUITY |  |  |  |  |  | \nCommon stock without par value |  |  |  |  |  | \n(9,000million shares authorized,8,019million shares issued) |  | 16,106 |  | 15,746 |  |  |  | \nEarnings reinvested |  | 423,877 |  | 392,059 |  |  |  | \nAccumulated other comprehensive income |  | (17,803) |  | (13,764) |  |  |  | \nCommon stock held in treasury |  |  |  |  |  | \n(3,901million shares at September\u00a030, 2022 and3,780million shares at December\u00a031, 2021) |  | (236,080) |  | (225,464) |  |  |  | \nExxonMobil share of equity |  | 186,100 |  | 168,577 |  |  |  | \nNoncontrolling interests |  | 6,943 |  | 7,106 |  |  |  | \nTotal Equity |  | 193,043 |  | 175,683 |  |  |  | \nTotal Liabilities and Equity |  | 370,152 |  | 338,923 |  |  |  | \n |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements. |  |  |   |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF CASH FLOW  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Nine Months Ended September 30,\n | 2022 | 2021\n |  |  | \nCASH FLOW FROM OPERATING ACTIVITIES |  |  | \nNet income (loss) including noncontrolling interests |  | 44,522 |  | 14,519 | \nDepreciation and depletion (including impairments) |  | 18,976 |  | 14,946 | \n |  |  | \nChanges in operational working capital, excluding cash and debt |  | 6 |  | 2,232 | \nAll other items \u2013 net |  | (4,328) |  | (692) | \nNet cash provided by operating activities |  | 59,176 |  | 31,005 | \n |  |  | \nCASH FLOW FROM INVESTING ACTIVITIES |  |  | \nAdditions to property, plant and equipment |  | (12,624) |  | (7,987) | \nProceeds from asset sales and returns of investments |  | 3,914 |  | 575 | \nAdditional investments and advances |  | (915) |  | (1,055) | \nOther investing activities including collection of advances |  | 238 |  | 342 | \nNet cash used in investing activities |  | (9,387) |  | (8,125) | \n |  |  | \nCASH FLOW FROM FINANCING ACTIVITIES |  |  | \nAdditions to long-term debt |  | 55 |  | 46 | \nReductions in long-term debt |  | \u2014 |  | (4) | \nAdditions to short-term debt |  | \u2014 |  | 12,197 | \nReductions in short-term debt |  | (3,895) |  | (24,066) | \nAdditions/(reductions) in debt with three months or less maturity |  | 1,638 |  | 997 | \nContingent consideration payments |  | (58) |  | (28) | \nCash dividends to ExxonMobil shareholders |  | (11,172) |  | (11,161) | \nCash dividends to noncontrolling interests |  | (191) |  | (166) | \nChanges in noncontrolling interests |  | (1,074) |  | (278) | \nCommon stock acquired |  | (10,480) |  | (1) | \nNet cash used in financing activities |  | (25,177) |  | (22,464) | \n |  |  | \nEffects of exchange rate changes on cash |  | (950) |  | (12) | \nIncrease/(decrease) in cash and cash equivalents |  | 23,662 |  | 404 | \nCash and cash equivalents at beginning of period |  | 6,802 |  | 4,364 | \nCash and cash equivalents at end of period |  | 30,464 |  | 4,768 | \n |  |  | \nSUPPLEMENTAL DISCLOSURES |  |  | \nIncome taxes paid |  | 10,172 |  | 3,516 | \nCash interest paid |  |  | \nIncluded in cash flows from operating activities |  | 660 |  | 818 | \nCapitalized, included in cash flows from investing activities |  | 605 |  | 478 | \nTotal cash interest paid |  | 1,265 |  | 1,296 | \n |  |  | \n |  |  | \nNoncash right of use assets recorded in exchange for lease liabilities |  |  | \nOperating leases |  | 1,648 |  | 804 | \nFinance leases |  | 730 |  | 168 | \n |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF CHANGE IN EQUITY  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | ExxonMobil Share of Equity |  | \n |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | Common Stock | Earnings Reinvested | Accumulated Other Comprehensive Income | Common Stock Held in Treasury | ExxonMobil Share of Equity | Non-controlling Interests | Total Equity\n |  |  |  |  |  |  |  | \nBalance as of June 30, 2021 |  | 16,006 |  | 383,922 |  | (15,586) |  | (225,771) |  | 158,571 |  | 6,985 |  | 165,556 | \nAmortization of stock-based awards |  | 99 |  | \u2014 |  | \u2014 |  | \u2014 |  | 99 |  | \u2014 |  | 99 | \nOther |  | (1) |  | \u2014 |  | \u2014 |  | \u2014 |  | (1) |  | 4 |  | 3 | \nNet income (loss) for the period |  | \u2014 |  | 6,750 |  | \u2014 |  | \u2014 |  | 6,750 |  | 192 |  | 6,942 | \nDividends - common shares |  | \u2014 |  | (3,720) |  | \u2014 |  | \u2014 |  | (3,720) |  | (54) |  | (3,774) | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | (1,110) |  | \u2014 |  | (1,110) |  | (135) |  | (1,245) | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  | (75) |  | (75) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 | \nBalance as of September 30, 2021 |  | 16,104 |  | 386,952 |  | (16,696) |  | (225,771) |  | 160,589 |  | 6,917 |  | 167,506 | \n |  |  |  |  |  |  |  | \nBalance as of June 30, 2022 |  | 16,018 |  | 407,902 |  | (15,017) |  | (231,587) |  | 177,316 |  | 7,192 |  | 184,508 | \nAmortization of stock-based awards |  | 91 |  | \u2014 |  | \u2014 |  | \u2014 |  | 91 |  | \u2014 |  | 91 | \nOther |  | (3) |  | \u2014 |  | \u2014 |  | \u2014 |  | (3) |  | (29) |  | (32) | \nNet income (loss) for the period |  | \u2014 |  | 19,660 |  | \u2014 |  | \u2014 |  | 19,660 |  | 538 |  | 20,198 | \nDividends - common shares |  | \u2014 |  | (3,685) |  | \u2014 |  | \u2014 |  | (3,685) |  | (68) |  | (3,753) | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | (2,786) |  | \u2014 |  | (2,786) |  | (339) |  | (3,125) | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (4,494) |  | (4,494) |  | (351) |  | (4,845) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 1 |  | 1 |  | \u2014 |  | 1 | \nBalance as of September 30, 2022 |  | 16,106 |  | 423,877 |  | (17,803) |  | (236,080) |  | 186,100 |  | 6,943 |  | 193,043 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended September 30, 2022 |  | Three Months Ended September 30, 2021\n |  |  |  |  |  |  |  | \nCommon Stock Share Activity(millions of shares) |  | Issued | Held in Treasury | Outstanding |  | Issued | Held in Treasury | Outstanding\nBalance as of June 30 |  | 8,019 |  | (3,851) |  | 4,168 |  |  | 8,019 |  | (3,785) |  | 4,234 | \nAcquisitions |  | \u2014 |  | (50) |  | (50) |  |  | \u2014 |  | \u2014 |  | \u2014 | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 | \nBalance as of September 30 |  | 8,019 |  | (3,901) |  | 4,118 |  |  | 8,019 |  | (3,785) |  | 4,234 | \n |  |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF CHANGE IN EQUITY  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | ExxonMobil Share of Equity |  | \n |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | Common Stock | Earnings Reinvested | Accumulated Other Comprehensive Income | Common Stock Held in Treasury | ExxonMobil Share of Equity | Non-controlling Interests | Total Equity\n |  |  |  |  |  |  |  | \nBalance as of December 31, 2020 |  | 15,688 |  | 383,943 |  | (16,705) |  | (225,776) |  | 157,150 |  | 6,980 |  | 164,130 | \nAmortization of stock-based awards |  | 427 |  | \u2014 |  | \u2014 |  | \u2014 |  | 427 |  | \u2014 |  | 427 | \nOther |  | (11) |  | \u2014 |  | \u2014 |  | \u2014 |  | (11) |  | 90 |  | 79 | \nNet income (loss) for the period |  | \u2014 |  | 14,170 |  | \u2014 |  | \u2014 |  | 14,170 |  | 349 |  | 14,519 | \nDividends - common shares |  | \u2014 |  | (11,161) |  | \u2014 |  | \u2014 |  | (11,161) |  | (166) |  | (11,327) | \n |  |  |  |  |  |  |  | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | 9 |  | \u2014 |  | 9 |  | 32 |  | 41 | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (1) |  | (1) |  | (368) |  | (369) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 6 |  | 6 |  | \u2014 |  | 6 | \nBalance as of September 30, 2021 |  | 16,104 |  | 386,952 |  | (16,696) |  | (225,771) |  | 160,589 |  | 6,917 |  | 167,506 | \n |  |  |  |  |  |  |  | \nBalance as of December 31, 2021 |  | 15,746 |  | 392,059 |  | (13,764) |  | (225,464) |  | 168,577 |  | 7,106 |  | 175,683 | \nAmortization of stock-based awards |  | 372 |  | \u2014 |  | \u2014 |  | \u2014 |  | 372 |  | \u2014 |  | 372 | \nOther |  | (12) |  | \u2014 |  | \u2014 |  | \u2014 |  | (12) |  | (30) |  | (42) | \nNet income (loss) for the period |  | \u2014 |  | 42,990 |  | \u2014 |  | \u2014 |  | 42,990 |  | 1,532 |  | 44,522 | \nDividends - common shares |  | \u2014 |  | (11,172) |  | \u2014 |  | \u2014 |  | (11,172) |  | (191) |  | (11,363) | \n |  |  |  |  |  |  |  | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | (4,039) |  | \u2014 |  | (4,039) |  | (427) |  | (4,466) | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (10,620) |  | (10,620) |  | (1,047) |  | (11,667) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 4 |  | 4 |  | \u2014 |  | 4 | \nBalance as of September 30, 2022 |  | 16,106 |  | 423,877 |  | (17,803) |  | (236,080) |  | 186,100 |  | 6,943 |  | 193,043 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Nine Months Ended September 30, 2022 |  | Nine Months Ended September 30, 2021\n |  |  |  |  |  |  |  | \nCommon Stock Share Activity(millions of shares) |  | Issued | Held in Treasury | Outstanding |  | Issued | Held in Treasury | Outstanding\nBalance as of December 31 |  | 8,019 |  | (3,780) |  | 4,239 |  |  | 8,019 |  | (3,786) |  | 4,233 | \nAcquisitions |  | \u2014 |  | (121) |  | (121) |  |  | \u2014 |  | \u2014 |  | \u2014 | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  |  | \u2014 |  | 1 |  | 1 | \nBalance as of September 30 |  | 8,019 |  | (3,901) |  | 4,118 |  |  | 8,019 |  | (3,785) |  | 4,234 | \n |  |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  |  |  |  |  |  |  |  |  |  |  | \n | September 30, 2022\n |  |  | \n(millions of dollars) | Equity CompanyObligations(1) | Other Third-Party Obligations | Total\nGuarantees |  |  | \nDebt-related | 1,239 |  | 154 |  | 1,393 | \nOther | 727 |  | 5,032 |  | 5,759 | \nTotal | 1,966 |  | 5,186 |  | 7,152 | \n |  |  | \n(1) ExxonMobil share |  |  |   |  |  |  |  |  |  |  |  |  |  | \nExxonMobil Share of Accumulated OtherComprehensive Income(millions of dollars) | Cumulative Foreign Exchange Translation Adjustment | Postretirement BenefitsReserves Adjustment | Total\nBalance as of December 31, 2020 | (10,614) |  | (6,091) |  | (16,705) | \nCurrent period change excluding amounts reclassified from accumulated other comprehensive income(1) | (1,041) |  | 289 |  | (752) | \nAmounts reclassified from accumulated other comprehensive income | \u2014 |  | 761 |  | 761 | \nTotal change in accumulated other comprehensive income | (1,041) |  | 1,050 |  | 9 | \nBalance as of September 30, 2021 | (11,655) |  | (5,041) |  | (16,696) | \n |  |  | \nBalance as of December 31, 2021 | (11,499) |  | (2,265) |  | (13,764) | \nCurrent period change excluding amounts reclassified from accumulated other comprehensive income(1) | (4,680) |  | 335 |  | (4,345) | \nAmounts reclassified from accumulated other comprehensive income | \u2014 |  | 306 |  | 306 | \nTotal change in accumulated other comprehensive income | (4,680) |  | 641 |  | (4,039) | \nBalance as of September 30, 2022 | (16,179) |  | (1,624) |  | (17,803) | \n |  |  | \n(1) Cumulative Foreign Exchange Translation Adjustment includes net investment hedge gain/(loss) net of taxes of $551million and $240million in 2022 and 2021, respectively.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAmounts Reclassified Out of Accumulated OtherComprehensive Income - Before-tax Income/(Expense)(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 | 2021 |  | 2022 |  | 2021\n |  |  |  |  |  |  | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  |  |  |  |  |  | \n(Statement of Income line: Non-service pension and postretirement benefit expense) |  | (163) |  | (256) |  |  | (415) |  |  | (1,020) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIncome Tax (Expense)/Credit ForComponents of Other Comprehensive Income(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n2022 | 2021 |  | 2022 |  | 2021\n |  |  |  | \nForeign exchange translation adjustment |  | (61) |  | (26) |  |  | (151) |  |  | (60) | \nPostretirement benefits reserves adjustment (excluding amortization) |  | (82) |  | (76) |  |  | (205) |  |  | (109) | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  | (35) |  | (60) |  |  | (92) |  |  | (231) | \nTotal |  | (178) |  | (162) |  |  | (448) |  |  | (400) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n2022 | 2021 |  | 2022 |  | 2021\nEarnings per common share |  |  |  |  |  |  | \nNet income (loss) attributable to ExxonMobil(millions of dollars) |  | 19,660 |  | 6,750 |  |  | 42,990 |  |  | 14,170 | \nWeighted average number of common shares outstanding(millions of shares) |  | 4,185 |  | 4,276 |  |  | 4,227 |  |  | 4,275 | \nEarnings (loss) per common share(dollars)(1) |  | 4.68 |  | 1.57 |  |  | 10.17 |  |  | 3.31 | \nDividends paid per common share(dollars) |  | 0.88 |  | 0.87 |  |  | 2.64 |  |  | 2.61 | \n |  |  |  |  |  |  | \n(1) The calculation of earnings (loss) per common share and earnings (loss) per common share \u2013 assuming dilution are the same in each period shown.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n2022 | 2021 |  | 2022 |  | 2021\nComponents of net benefit cost |  |  |  |  |  |  | \nPension Benefits - U.S. |  |  |  |  |  |  | \nService cost |  | 173 |  | 228 |  |  | 529 |  |  | 661 | \nInterest cost |  | 130 |  | 139 |  |  | 388 |  |  | 418 | \nExpected return on plan assets |  | (140) |  | (181) |  |  | (420) |  |  | (542) | \nAmortization of actuarial loss/(gain) |  | 39 |  | 62 |  |  | 117 |  |  | 184 | \nAmortization of prior service cost |  | (8) |  | (5) |  |  | (22) |  |  | (17) | \nNet pension enhancement and curtailment/settlement cost |  | 87 |  | 75 |  |  | 177 |  |  | 468 | \nNet benefit cost |  | 281 |  | 318 |  |  | 769 |  |  | 1,172 | \n |  |  |  |  |  |  | \nPension Benefits - Non-U.S. |  |  |  |  |  |  | \nService cost |  | 138 |  | 194 |  |  | 433 |  |  | 587 | \nInterest cost |  | 149 |  | 131 |  |  | 466 |  |  | 396 | \nExpected return on plan assets |  | (198) |  | (256) |  |  | (618) |  |  | (777) | \nAmortization of actuarial loss/(gain) |  | 44 |  | 104 |  |  | 138 |  |  | 319 | \nAmortization of prior service cost |  | 10 |  | 14 |  |  | 33 |  |  | 43 | \nNet pension enhancement and curtailment/settlement cost |  | \u2014 |  | 4 |  |  | (1) |  |  | 16 | \nNet benefit cost |  | 143 |  | 191 |  |  | 451 |  |  | 584 | \n |  |  |  |  |  |  | \nOther Postretirement Benefits |  |  |  |  |  |  | \nService cost |  | 30 |  | 44 |  |  | 108 |  |  | 139 | \nInterest cost |  | 54 |  | 55 |  |  | 162 |  |  | 166 | \nExpected return on plan assets |  | (4) |  | (5) |  |  | (11) |  |  | (14) | \nAmortization of actuarial loss/(gain) |  | 1 |  | 19 |  |  | 4 |  |  | 57 | \nAmortization of prior service cost |  | (10) |  | (10) |  |  | (31) |  |  | (31) | \nNet benefit cost |  | 71 |  | 103 |  |  | 232 |  |  | 317 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | September 30, 2022\n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n | Fair Value |  |  |  | \n(millions of dollars) | Level 1 | Level 2 | Level 3 | Total Gross Assets& Liabilities | Effect ofCounterparty Netting | Effect ofCollateralNetting | Difference in Carrying Value and Fair Value | NetCarryingValue\nAssets |  |  |  |  |  |  |  | \nDerivative assets(1) | 5,972 |  | 4,379 |  | \u2014 |  | 10,351 |  | (8,398) |  | (519) |  | \u2014 |  | 1,434 | \n |  |  |  |  |  |  |  | \nAdvances to/receivables from equity companies(2)(6) | \u2014 |  | 2,374 |  | 5,325 |  | 7,699 |  | \u2014 |  | \u2014 |  | 734 |  | 8,433 | \n |  |  |  |  |  |  |  | \nOther long-term financial assets(3) | 1,185 |  | \u2014 |  | 1,329 |  | 2,514 |  | \u2014 |  | \u2014 |  | 313 |  | 2,827 | \n |  |  |  |  |  |  |  | \nLiabilities |  |  |  |  |  |  |  | \nDerivative liabilities(4) | 5,638 |  | 5,112 |  | \u2014 |  | 10,750 |  | (8,398) |  | (185) |  | \u2014 |  | 2,167 | \nLong-term debt(5) | 32,236 |  | 90 |  | 6 |  | 32,332 |  | \u2014 |  | \u2014 |  | 4,638 |  | 36,970 | \n |  |  |  |  |  |  |  | \nLong-term obligations to equity companies(6) | \u2014 |  | \u2014 |  | 2,711 |  | 2,711 |  | \u2014 |  | \u2014 |  | (64) |  | 2,647 | \n |  |  |  |  |  |  |  | \nOther long-term financial liabilities(7) | \u2014 |  | \u2014 |  | 773 |  | 773 |  | \u2014 |  | \u2014 |  | 56 |  | 829 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | December 31, 2021\n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n |  | Fair Value |  |  |  | \n(millions of dollars) |  | Level 1 | Level 2 | Level 3 | Total Gross Assets& Liabilities | Effect ofCounterparty Netting | Effect ofCollateralNetting | Difference in Carrying Value and Fair Value | NetCarryingValue\nAssets |  |  |  |  |  |  |  |  | \nDerivative assets(1) |  | 1,422 |  | 1,523 |  | \u2014 |  | 2,945 |  | (1,930) |  | (28) |  | \u2014 |  | 987 | \n |  |  |  |  |  |  |  |  | \nAdvances to/receivables from equity companies(2)(6) |  | \u2014 |  | 3,076 |  | 5,373 |  | 8,449 |  | \u2014 |  | \u2014 |  | (123) |  | 8,326 | \n |  |  |  |  |  |  |  |  | \nOther long-term financial assets(3) |  | 1,134 |  | \u2014 |  | 1,058 |  | 2,192 |  | \u2014 |  | \u2014 |  | 181 |  | 2,373 | \n |  |  |  |  |  |  |  |  | \nLiabilities |  |  |  |  |  |  |  |  | \nDerivative liabilities(4) |  | 1,701 |  | 2,594 |  | \u2014 |  | 4,295 |  | (1,930) |  | (306) |  | \u2014 |  | 2,059 | \nLong-term debt(5) |  | 44,454 |  | 88 |  | 3 |  | 44,545 |  | \u2014 |  | \u2014 |  | (2,878) |  | 41,667 | \n |  |  |  |  |  |  |  |  | \nLong-term obligations to equity companies(6) |  | \u2014 |  | \u2014 |  | 3,084 |  | 3,084 |  | \u2014 |  | \u2014 |  | (227) |  | 2,857 | \n |  |  |  |  |  |  |  |  | \nOther long-term financial liabilities(7) |  | \u2014 |  | \u2014 |  | 902 |  | 902 |  | \u2014 |  | \u2014 |  | 58 |  | 960 |   |  |  |  |  | \n(1) | Included in the Balance Sheet lines: Notes and accounts receivable - net and Other assets, including intangibles - net\n(2) | Included in the Balance Sheet line: Investments, advances and long-term receivables\n(3) | Included in the Balance Sheet lines: Investments, advances and long-term receivables and Other assets, including intangibles - net\n(4) | Included in the Balance Sheet lines: Accounts payable and accrued liabilities and Other long-term obligations\n(5) | Excluding finance lease obligations\n(6) | Advances to/receivables from equity companies and long-term obligations to equity companies are mainly designated as hierarchy level 3 inputs. The fair value is calculated by discounting the remaining obligations by a rate consistent with the credit quality and industry of the company.\n(7) | Included in the Balance Sheet line: Other long-term obligations. Includes contingent consideration related to a prior year acquisition where fair value is based on expected drilling activities and discount rates.  |  |  |  |  |  |  |  | \n\n |  | \n(millions) | September 30, 2022 | December 31, 2021\nCrude oil (barrels) | (15) |  | 82 | \nPetroleum products (barrels) | (22) |  | (48) | \nNatural gas (MMBTUs) | (120) |  | (115) | \n |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n\n |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 | 2021 |  | 2022 | 2021\nSales and other operating revenue |  | 945 |  | (1,596) |  |  | (3,003) |  | (3,196) | \nCrude oil and product purchases |  | (56) |  | (34) |  |  | (82) |  | (53) | \nTotal |  | 889 |  | (1,630) |  |  | (3,085) |  | (3,249) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 | 2021 |  | 2022 | 2021\nEarnings (Loss) After Income Tax |  |  |  |  |  | \nUpstream |  |  |  |  |  | \nUnited States |  | 3,110 |  | 869 |  |  | 9,235 |  | 1,895 | \nNon-U.S. |  | 9,309 |  | 3,082 |  |  | 19,043 |  | 7,795 | \nEnergy Products |  |  |  |  |  | \nUnited States |  | 3,008 |  | 479 |  |  | 6,152 |  | (31) | \nNon-U.S. |  | 2,811 |  | 50 |  |  | 4,744 |  | (1,217) | \nChemical Products |  |  |  |  |  | \nUnited States |  | 635 |  | 1,121 |  |  | 2,030 |  | 2,923 | \nNon-U.S. |  | 177 |  | 907 |  |  | 1,263 |  | 2,695 | \nSpecialty Products |  |  |  |  |  | \nUnited States |  | 306 |  | 247 |  |  | 784 |  | 689 | \nNon-U.S. |  | 456 |  | 592 |  |  | 871 |  | 1,454 | \nCorporate and Financing |  | (152) |  | (596) |  |  | (1,132) |  | (2,033) | \nCorporate total |  | 19,660 |  | 6,750 |  |  | 42,990 |  | 14,170 | \n |  |  |  |  |  | \nSales and Other Operating Revenue |  |  |  |  |  | \nUpstream |  |  |  |  |  | \nUnited States |  | 4,163 |  | 2,072 |  |  | 10,777 |  | 5,683 | \nNon-U.S. |  | 8,770 |  | 2,295 |  |  | 22,214 |  | 9,181 | \nEnergy Products |  |  |  |  |  | \nUnited States |  | 31,324 |  | 20,988 |  |  | 90,650 |  | 55,292 | \nNon-U.S. |  | 50,215 |  | 34,305 |  |  | 144,734 |  | 91,120 | \nChemical Products |  |  |  |  |  | \nUnited States |  | 2,499 |  | 3,474 |  |  | 8,773 |  | 9,007 | \nNon-U.S. |  | 4,213 |  | 4,215 |  |  | 13,207 |  | 12,200 | \nSpecialty Products |  |  |  |  |  | \nUnited States |  | 1,615 |  | 1,227 |  |  | 4,659 |  | 3,606 | \nNon-U.S. |  | 3,709 |  | 3,309 |  |  | 10,478 |  | 9,382 | \nCorporate and Financing |  | 4 |  | 7 |  |  | 19 |  | (84) | \nCorporate total(1) |  | 106,512 |  | 71,892 |  |  | 305,511 |  | 195,387 | \n |  |  |  |  |  | \nIntersegment Revenue |  |  |  |  |  | \nUpstream |  |  |  |  |  | \nUnited States |  | 6,536 |  | 4,374 |  |  | 19,907 |  | 11,524 | \nNon-U.S. |  | 11,723 |  | 9,371 |  |  | 36,091 |  | 23,935 | \nEnergy Products |  |  |  |  |  | \nUnited States |  | 7,580 |  | 4,132 |  |  | 22,777 |  | 11,395 | \nNon-U.S. |  | 9,551 |  | 6,787 |  |  | 29,161 |  | 16,872 | \nChemical Products |  |  |  |  |  | \nUnited States |  | 2,579 |  | 1,479 |  |  | 6,904 |  | 4,285 | \nNon-U.S. |  | 1,252 |  | 1,098 |  |  | 4,359 |  | 2,849 | \nSpecialty Products |  |  |  |  |  | \nUnited States |  | 662 |  | 578 |  |  | 1,934 |  | 1,658 | \nNon-U.S. |  | 246 |  | 212 |  |  | 665 |  | 532 | \nCorporate and Financing |  | 59 |  | 57 |  |  | 175 |  | 166 | \n |  |  |  |  |  | \n(1)See footnote on the next page.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nGeographic Sales and Other Operating Revenue |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 | 2021 |  | 2022 | 2021\nUnited States |  | 39,601 |  | 27,761 |  |  | 114,859 |  | 73,588 | \nNon-U.S. |  | 66,911 |  | 44,131 |  |  | 190,652 |  | 121,799 | \nTotal(1) |  | 106,512 |  | 71,892 |  |  | 305,511 |  | 195,387 | \n |  |  |  |  |  | \nSignificant Non-U.S. revenue sources include:(2) |  |  |  |  |  | \nCanada |  | 8,468 |  | 5,837 |  |  | 25,105 |  | 15,378 | \nUnited Kingdom |  | 8,845 |  | 3,379 |  |  | 24,699 |  | 10,137 | \nSingapore |  | 5,262 |  | 3,678 |  |  | 14,358 |  | 10,628 | \nFrance |  | 4,449 |  | 3,513 |  |  | 14,071 |  | 9,541 | \nItaly |  | 2,990 |  | 2,808 |  |  | 8,888 |  | 7,139 | \nBelgium |  | 2,755 |  | 2,409 |  |  | 8,632 |  | 6,590 | \nAustralia |  | 2,936 |  | 1,751 |  |  | 8,597 |  | 5,499 | \n |  |  |  |  |  | \n(1)Includes approximately25% and16% related to revenue outside the scope of ASC 606 \"Revenue from Contracts with Customers\" for the three months ended September\u00a030, 2022 and September\u00a030, 2021, respectively, and23% and16% for the nine months ended September\u00a030, 2022 and September\u00a030, 2021, respectively. Trade receivables in Notes and accounts receivable \u2013 net reported on the Balance Sheet include both receivables within the scope of ASC 606 and those outside the scope of ASC 606. Revenue and receivables outside the scope of ASC 606 primarily relate to physically settled commodity contracts accounted for as derivatives. Credit quality and type of customer are generally similar between those revenues and receivables within the scope of ASC 606 and those outside it.\n(2)Revenue is determined by primary country of operations. Excludes certain sales and other operating revenues in Non-U.S. operations where attribution to a specific country is not practicable.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months EndedSeptember 30, 2022 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss) (U.S. GAAP) | 3,110 |  | 9,309 |  |  | 3,008 |  | 2,811 |  |  | 635 |  | 177 |  | 306 |  | 456 |  |  |  | (152) |  |  | 19,660 | \nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nImpairments | \u2014 |  | (697) |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | \u2014 |  |  | (697) | \nGain/(loss) on sale of assets | \u2014 |  | 587 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | \u2014 |  |  | 587 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTax-related items | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | 324 |  |  | 324 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther | \u2014 |  | 688 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | 76 |  |  | 764 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items | 3,110 |  | 8,731 |  |  | 3,008 |  | 2,811 |  |  | 635 |  | 177 |  | 306 |  | 456 |  |  |  | (552) |  |  | 18,682 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months EndedSeptember 30, 2021 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss) (U.S. GAAP) | 869 |  | 3,082 |  |  | 479 |  | 50 |  |  | 1,121 |  | 907 |  | 247 |  | 592 |  |  |  | (596) |  |  | 6,750 | \nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSeverance charges | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | (5) |  |  | (5) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items | 869 |  | 3,082 |  |  | 479 |  | 50 |  |  | 1,121 |  | 907 |  | 247 |  | 592 |  |  |  | (591) |  |  | 6,755 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNine Months EndedSeptember 30, 2022 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss) (U.S. GAAP) | 9,235 |  | 19,043 |  |  | 6,152 |  | 4,744 |  |  | 2,030 |  | 1,263 |  | 784 |  | 871 |  |  |  | (1,132) |  |  | 42,990 | \nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nImpairments | \u2014 |  | (3,574) |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | (98) |  |  | (3,672) | \nGain/(loss) on sale of assets | 299 |  | 587 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | \u2014 |  |  | 886 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTax-related items | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | 324 |  |  | 324 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther | \u2014 |  | 310 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | 76 |  |  | 386 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items | 8,936 |  | 21,720 |  |  | 6,152 |  | 4,744 |  |  | 2,030 |  | 1,263 |  | 784 |  | 871 |  |  |  | (1,434) |  |  | 45,066 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNine Months EndedSeptember 30, 2021 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss) (U.S. GAAP) | 1,895 |  | 7,795 |  |  | (31) |  | (1,217) |  |  | 2,923 |  | 2,695 |  | 689 |  | 1,454 |  |  |  | (2,033) |  |  | 14,170 | \nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSeverance charges | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | (48) |  |  | (48) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items | 1,895 |  | 7,795 |  |  | (31) |  | (1,217) |  |  | 2,923 |  | 2,695 |  | 689 |  | 1,454 |  |  |  | (1,985) |  |  | 14,218 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Financial Results |  |  |  |  |  | \n |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 | 2021 |  | 2022 | 2021\nEarnings (loss) (U.S. GAAP) |  |  |  |  |  | \nUnited States |  | 3,110 |  | 869 |  |  | 9,235 |  | 1,895 | \nNon-U.S. |  | 9,309 |  | 3,082 |  |  | 19,043 |  | 7,795 | \nTotal |  | 12,419 |  | 3,951 |  |  | 28,278 |  | 9,690 | \n |  |  |  |  |  | \nIdentified Items(1) |  |  |  |  |  | \nUnited States |  | \u2014 |  | \u2014 |  |  | 299 |  | \u2014 | \nNon-U.S. |  | 578 |  | \u2014 |  |  | (2,677) |  | \u2014 | \nTotal |  | 578 |  | \u2014 |  |  | (2,378) |  | \u2014 | \n |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1) |  |  |  |  |  | \nUnited States |  | 3,110 |  | 869 |  |  | 8,936 |  | 1,895 | \nNon-U.S. |  | 8,731 |  | 3,082 |  |  | 21,720 |  | 7,795 | \nTotal |  | 11,841 |  | 3,951 |  |  | 30,656 |  | 9,690 |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Third Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Operational Results |  |  |  |  |  | \n |  |  |  |  |  | \n(thousands of barrels daily) |  |  | Three Months EndedSeptember 30, 2022 |  |  | Nine Months EndedSeptember 30, 2022\nVolumes reconciliation (Oil-equivalent production)(1) |  |  |  |  |  | \n2021 |  |  | 3,665 |  |  | 3,677\nEntitlements - Net Interest |  |  | (27) |  |  | (28)\nEntitlements - Price / Spend / Other |  |  | (52) |  |  | (53)\nGovernment Mandates |  |  | 85 |  |  | 97\nDivestments |  |  | (75) |  |  | (58)\nGrowth / Demand / Other |  |  | 120 |  |  | 73\n2022 |  |  | 3,716 |  |  | 3,708\n |  |  |  |  |  | \n(1)Natural gas is converted to an oil-equivalent basis at six million cubic feet per one thousand barrels.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n |  | 2022 |  | 2021 |  | 2022 |  | 2021\nNet production of crude oil, natural gas liquids, bitumen and synthetic oil(thousands of barrels daily) |  |  |  |  |  |  |  | \nUnited States |  | 783 |  |  | 758 |  |  | 771 |  |  | 704 | \nCanada/Other Americas |  | 641 |  |  | 569 |  |  | 558 |  |  | 557 | \nEurope |  | 4 |  |  | 21 |  |  | 4 |  |  | 24 | \nAfrica |  | 249 |  |  | 248 |  |  | 243 |  |  | 252 | \nAsia |  | 666 |  |  | 668 |  |  | 698 |  |  | 676 | \nAustralia/Oceania |  | 46 |  |  | 49 |  |  | 44 |  |  | 44 | \nWorldwide |  | 2,389 |  |  | 2,313 |  |  | 2,318 |  |  | 2,257 | \n |  |  |  |  |  |  |  | \nNet natural gas production available for sale(millions of cubic feet daily) |  |  |  |  |  |  |  | \nUnited States |  | 2,351 |  |  | 2,701 |  |  | 2,607 |  |  | 2,757 | \nCanada/Other Americas |  | 158 |  |  | 184 |  |  | 175 |  |  | 197 | \nEurope |  | 541 |  |  | 343 |  |  | 711 |  |  | 796 | \nAfrica |  | 70 |  |  | 53 |  |  | 65 |  |  | 41 | \nAsia |  | 3,304 |  |  | 3,365 |  |  | 3,321 |  |  | 3,465 | \nAustralia/Oceania |  | 1,539 |  |  | 1,464 |  |  | 1,460 |  |  | 1,266 | \nWorldwide |  | 7,963 |  |  | 8,110 |  |  | 8,339 |  |  | 8,522 | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nOil-equivalent production(1)(thousands of oil-equivalent barrels daily) |  | 3,716 |  |  | 3,665 |  |  | 3,708 |  |  | 3,677 | \n |  |  |  |  |  |  |  | \n(1) Natural gas is converted to an oil-equivalent basis at six million cubic feet per one thousand barrels.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nEarnings (loss) (U.S. GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 3,008 |  |  | 479 |  |  | 6,152 |  |  | (31) | \nNon-U.S. |  | 2,811 |  |  | 50 |  |  | 4,744 |  |  | (1,217) | \nTotal |  | 5,819 |  |  | 529 |  |  | 10,896 |  |  | (1,248) | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1) |  |  |  |  |  |  |  | \nUnited States |  | 3,008 |  |  | 479 |  |  | 6,152 |  |  | (31) | \nNon-U.S. |  | 2,811 |  |  | 50 |  |  | 4,744 |  |  | (1,217) | \nTotal |  | 5,819 |  |  | 529 |  |  | 10,896 |  |  | (1,248) | \n |  |  |  |  |  |  |  | \n(1) Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Third Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Operational Results |  |  |  |  |  | \n |  |  |  |  |  | \n(thousands of barrels daily) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 | 2021 |  | 2022 | 2021\nRefinery throughput |  |  |  |  |  | \nUnited States |  | 1,742 |  | 1,684 |  |  | 1,705 |  | 1,583 | \nCanada |  | 426 |  | 404 |  |  | 413 |  | 367 | \nEurope |  | 1,253 |  | 1,215 |  |  | 1,204 |  | 1,197 | \nAsia Pacific |  | 557 |  | 585 |  |  | 542 |  | 579 | \nOther |  | 187 |  | 163 |  |  | 182 |  | 162 | \nWorldwide |  | 4,165 |  | 4,051 |  |  | 4,046 |  | 3,888 | \n |  |  |  |  |  | \nEnergy Products sales(1) |  |  |  |  |  | \nUnited States |  | 2,479 |  | 2,361 |  |  | 2,399 |  | 2,223 | \nNon-U.S. |  | 3,058 |  | 2,941 |  |  | 2,922 |  | 2,825 | \nWorldwide |  | 5,537 |  | 5,302 |  |  | 5,321 |  | 5,049 | \n |  |  |  |  |  | \nGasoline, naphthas |  | 2,335 |  | 2,191 |  |  | 2,220 |  | 2,102 | \nHeating oils, kerosene, diesel |  | 1,818 |  | 1,796 |  |  | 1,766 |  | 1,731 | \nAviation fuels |  | 365 |  | 228 |  |  | 335 |  | 204 | \nHeavy fuels |  | 252 |  | 276 |  |  | 243 |  | 269 | \nOther energy products |  | 767 |  | 811 |  |  | 758 |  | 742 | \n |  |  |  |  |  | \n(1) Data reported net of purchases/sales contracts with the same counterparty. |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nEarnings (loss) (U.S. GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 635 |  |  | 1,121 |  |  | 2,030 |  |  | 2,923 | \nNon-U.S. |  | 177 |  |  | 907 |  |  | 1,263 |  |  | 2,695 | \nTotal |  | 812 |  |  | 2,027 |  |  | 3,293 |  |  | 5,618 | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1) |  |  |  |  |  |  |  | \nUnited States |  | 635 |  |  | 1,121 |  |  | 2,030 |  |  | 2,923 | \nNon-U.S. |  | 177 |  |  | 907 |  |  | 1,263 |  |  | 2,695 | \nTotal |  | 812 |  |  | 2,027 |  |  | 3,293 |  |  | 5,618 | \n |  |  |  |  |  |  |  | \n(1) Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Third Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Operational Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(thousands of metric tons) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nChemical Products sales(1) |  |  |  |  |  |  |  | \nUnited States |  | 1,658 |  |  | 1,807 |  |  | 5,688 |  |  | 5,210 | \nNon-U.S. |  | 3,023 |  |  | 3,007 |  |  | 8,821 |  |  | 9,100 | \nWorldwide |  | 4,680 |  |  | 4,814 |  |  | 14,509 |  |  | 14,309 | \n |  |  |  |  |  |  |  | \n(1) Data reported net of purchases/sales contracts with the same counterparty.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nEarnings (loss) (U.S. GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 306 |  |  | 247 |  |  | 784 |  |  | 689 | \nNon-U.S. |  | 456 |  |  | 592 |  |  | 871 |  |  | 1,454 | \nTotal |  | 762 |  |  | 839 |  |  | 1,655 |  |  | 2,143 | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1) |  |  |  |  |  |  |  | \nUnited States |  | 306 |  |  | 247 |  |  | 784 |  |  | 689 | \nNon-U.S. |  | 456 |  |  | 592 |  |  | 871 |  |  | 1,454 | \nTotal |  | 762 |  |  | 839 |  |  | 1,655 |  |  | 2,143 | \n |  |  |  |  |  |  |  | \n(1) Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Third Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Operational Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(thousands of metric tons) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nSpecialty Products sales(1) |  |  |  |  |  |  |  | \nUnited States |  | 483 |  |  | 471 |  |  | 1,594 |  |  | 1,476 | \nNon-U.S. |  | 1,434 |  |  | 1,424 |  |  | 4,430 |  |  | 4,356 | \nWorldwide |  | 1,917 |  |  | 1,896 |  |  | 6,024 |  |  | 5,832 | \n |  |  |  |  |  |  |  | \n(1) Data reported net of purchases/sales contracts with the same counterparty. |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCorporate and Financing Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\n |  |  |  |  |  |  |  | \nEarnings (loss) (U.S. GAAP) |  | (152) |  |  | (596) |  |  | (1,132) |  |  | (2,033) | \nIdentified Items(1) |  | 400 |  |  | (5) |  |  | 302 |  |  | (48) | \nEarnings (loss) excluding Identified Items(1) |  | (552) |  |  | (591) |  |  | (1,434) |  |  | (1,985) | \n |  |  |  |  |  |  |  | \n(1) Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nNet cash provided by/(used in) |  |  |  |  |  |  |  | \nOperating activities |  |  |  |  |  | 59,176 |  |  | 31,005 | \nInvesting activities |  |  |  |  |  | (9,387) |  |  | (8,125) | \nFinancing activities |  |  |  |  |  | (25,177) |  |  | (22,464) | \nEffect of exchange rate changes |  |  |  |  |  | (950) |  |  | (12) | \nIncrease/(decrease) in cash and cash equivalents |  |  |  |  |  | 23,662 |  |  | 404 | \n |  |  |  |  |  |  |  | \nCash and cash equivalents (at end of period) |  |  |  |  |  | 30,464 |  |  | 4,768 | \n |  |  |  |  |  |  |  | \nCash flow from operations and asset sales |  |  |  |  |  |  |  | \nNet cash provided by operating activities (U.S. GAAP) |  | 24,425 |  |  | 12,091 |  |  | 59,176 |  |  | 31,005 | \nProceeds associated with sales of subsidiaries, property, plant & equipment, and sales and returns of investments |  | 2,682 |  |  | 18 |  |  | 3,914 |  |  | 575 | \nCash flow from operations and asset sales |  | 27,107 |  |  | 12,109 |  |  | 63,090 |  |  | 31,580 | \n |  |  |  |  |  |  |  | \nBecause of the ongoing nature of our asset management and divestment program, we believe it is useful for investors to consider proceeds associated with asset sales together with cash provided by operating activities when evaluating cash available for investment in the business and financing activities, including shareholder distributions.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nIncome taxes |  | 5,224 |  |  | 2,664 |  |  | 14,389 |  |  | 4,986 | \nEffective income tax rate |  | 29 | % |  | 33 | % |  | 31 | % |  | 32 | %\nTotal other taxes and duties(1) |  | 7,473 |  |  | 8,572 |  |  | 23,701 |  |  | 24,296 | \nTotal |  | 12,697 |  |  | 11,236 |  |  | 38,090 |  |  | 29,282 | \n |  |  |  |  |  |  |  | \n(1)Includes \u201cOther taxes and duties\u201d plus taxes that are included in \u201cProduction and manufacturing expenses\u201d and \u201cSelling, general and administrative expenses\u201d.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2022 |  | 2021 |  | 2022 |  | 2021\nUpstream (including exploration expenses) |  | 4,081 |  |  | 2,839 |  |  | 11,587 |  |  | 8,013 | \nEnergy Products |  | 590 |  |  | 434 |  |  | 1,662 |  |  | 1,312 | \nChemical Products |  | 954 |  |  | 534 |  |  | 1,809 |  |  | 1,345 | \nSpecialty Products |  | 87 |  |  | 43 |  |  | 166 |  |  | 115 | \nOther |  | 16 |  |  | 1 |  |  | 17 |  |  | 2 | \nTotal |  | 5,728 |  |  | 3,851 |  |  | 15,241 |  |  | 10,787 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIssuer Purchase of Equity Securities for Quarter Ended September\u00a030, 2022\n |  |  |  |  |  |  |  | \nPeriod |  | Total Numberof SharesPurchased(1) |  | AveragePrice Paidper Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(3) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program(Billions of dollars)\nJuly 2022 |  | 16,157,299 |  | $86.97 |  | 16,157,219 |  | $22.5\nAugust 2022 |  | 17,193,196 |  | $93.80 |  | 17,193,188 |  | $20.9\nSeptember 2022 |  | 16,006,749 |  | $92.18 |  | 16,006,703 |  | $19.4\nTotal |  | 49,357,244 |  | $91.04 |  | 49,357,110 |  | \n |  |  |  |  |  |  |  | \n(1) Includes shares withheld from participants in the company's incentive program for personal income taxes.\n(2) The full-year average price paid per share is $88.08.\n(3) In its earnings release dated April 29, 2022, the Corporation stated that the company increased its share repurchase program from up to $10 billion to a total of up to $30 billion through 2023. Purchases in the third quarter of 2022 were made under terms intended to qualify for exemption under Rules 10b-18 and 10b5-1.  |  |  |  |  |  |  |  | \nExhibit |  | Description\n |  | \n3(ii) |  | By-Laws, as amended effective October 25, 2022 (incorporated by reference to Exhibit 3(ii) to the Registrant\u2019s Report on Form 8-K of October 31, 2022).\n |  | \n |  | \n |  | \n |  | \n31.1 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Chief Executive Officer.\n31.2 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Chief Financial Officer.\n31.3 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Principal Accounting Officer.\n32.1 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Chief Executive Officer.\n32.2 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Chief Financial Officer.\n32.3 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Principal Accounting Officer.\n101 |  | Interactive Data Files (formatted as Inline XBRL).\n104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).  |  |  |  |  |  |  |  | \n | EXXON MOBIL CORPORATION\nDate: November\u00a02, 2022 | By: | /s/ LEN M. FOX\n |  | Len M. Fox\n |  | Vice President, Controller and\n |  | Principal Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Exxon Mobil, in 2023 Q1, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  |  |  |  | \nNew Jersey |  | 13-5409005\n(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification Number)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of Each Class |  | Trading Symbol |  | Name of Each Exchange on Which Registered\nCommon Stock, without par value |  | XOM |  | New York Stock Exchange\n0.142% Notes due 2024 |  | XOM24B |  | New York Stock Exchange\n0.524% Notes due 2028 |  | XOM28 |  | New York Stock Exchange\n0.835% Notes due 2032 |  | XOM32 |  | New York Stock Exchange\n1.408% Notes due 2039 |  | XOM39A |  | New York Stock Exchange  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2611 | Accelerated filer | \u2610\n |  |  | \nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n\n | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \nClass |  | Outstanding as of March\u00a031, 2023\nCommon stock, without par value |  | 4,042,984,946  |  |  |  |  | \nPART I. FINANCIAL INFORMATION\n | \nItem 1. Financial Statements | \n | \nCondensed Consolidated Statement of Income - Three months ended March\u00a031, 2023 and 2022 | 3\n | \nCondensed Consolidated Statement of Comprehensive Income - Three months ended March\u00a031, 2023 and 2022 | 4\n | \nCondensed Consolidated Balance Sheet - As of March\u00a031, 2023 and December\u00a031, 2022 | 5\n | \nCondensed Consolidated Statement of Cash Flows - Three months ended March\u00a031, 2023 and 2022 | 6\n | \n | \n | \nCondensed Consolidated Statement of Changes in Equity - Three months ended March\u00a031, 2023 and 2022 | 7\n | \n | \n | \nNotes to Condensed Consolidated Financial Statements | 8\n | \nItem 2. Management's Discussion and Analysis of Financial Condition and Results of Operations | 17\n | \nItem 3. Quantitative and Qualitative Disclosures About Market Risk | 29\n | \nItem 4. Controls and Procedures | 29\n | \n | \nPART II. OTHER INFORMATION\n | \nItem 1. Legal Proceedings | 30\n | \n | \n | \nItem 2. Unregistered Sales of Equity Securities and Use of Proceeds | 30\n | \nItem 6. Exhibits | 30\n | \nIndex to Exhibits | 31\n | \nSignature | 32\n |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nITEM 1. FINANCIAL STATEMENTS |  |   |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF INCOME  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | Three Months EndedMarch 31, |  | \n | 2023 | 2022 |  |  | \nRevenues and other income |  |  |  |  |  | \nSales and other operating revenue |  | 83,644 |  | 87,734 |  |  |  | \nIncome from equity affiliates |  | 2,381 |  | 2,538 |  |  |  | \nOther income |  | 539 |  | 228 |  |  |  | \nTotal revenues and other income |  | 86,564 |  | 90,500 |  |  |  | \nCosts and other deductions |  |  |  |  |  | \nCrude oil and product purchases |  | 46,003 |  | 52,388 |  |  |  | \nProduction and manufacturing expenses |  | 9,436 |  | 10,241 |  |  |  | \nSelling, general and administrative expenses |  | 2,390 |  | 2,409 |  |  |  | \nDepreciation and depletion (includes impairments) |  | 4,244 |  | 8,883 |  |  |  | \nExploration expenses, including dry holes |  | 141 |  | 173 |  |  |  | \nNon-service pension and postretirement benefit expense |  | 167 |  | 108 |  |  |  | \nInterest expense |  | 159 |  | 188 |  |  |  | \nOther taxes and duties |  | 7,221 |  | 7,554 |  |  |  | \nTotal costs and other deductions |  | 69,761 |  | 81,944 |  |  |  | \nIncome (loss) before income taxes |  | 16,803 |  | 8,556 |  |  |  | \nIncome tax expense (benefit) |  | 4,960 |  | 2,806 |  |  |  | \nNet income (loss) including noncontrolling interests |  | 11,843 |  | 5,750 |  |  |  | \nNet income (loss) attributable to noncontrolling interests |  | 413 |  | 270 |  |  |  | \nNet income (loss) attributable to ExxonMobil |  | 11,430 |  | 5,480 |  |  |  | \n |  |  |  |  |  | \nEarnings (loss) per common share(dollars) |  | 2.79 |  | 1.28 |  |  |  | \n |  |  |  |  |  | \nEarnings (loss) per common share - assuming dilution(dollars) |  | 2.79 |  | 1.28 |  |  |  | \n |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements. |  |  |   |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedMarch 31, |  | \n | 2023 |  | 2022 |  |  |  | \nNet income (loss) including noncontrolling interests |  | 11,843 |  |  | 5,750 |  |  |  |  | \n |  |  |  |  |  |  |  | \nOther comprehensive income (loss) (net of income taxes) |  |  |  |  |  |  |  | \nForeign exchange translation adjustment |  | 173 |  |  | 741 |  |  |  |  | \n |  |  |  |  |  |  |  | \nPostretirement benefits reserves adjustment (excluding amortization) |  | 19 |  |  | 105 |  |  |  |  | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  | 6 |  |  | 93 |  |  |  |  | \nTotal other comprehensive income (loss) |  | 198 |  |  | 939 |  |  |  |  | \nComprehensive income (loss) including noncontrolling interests |  | 12,041 |  |  | 6,689 |  |  |  |  | \nComprehensive income (loss) attributable to noncontrolling interests |  | 436 |  |  | 359 |  |  |  |  | \nComprehensive income (loss) attributable to ExxonMobil |  | 11,605 |  |  | 6,330 |  |  |  |  | \n |  |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED BALANCE SHEET  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | March 31, 2023 |  | December 31, 2022 |  |  | \n |  |  |  |  |  |  | \nASSETS |  |  |  |  |  |  | \nCurrent assets |  |  |  |  |  |  | \nCash and cash equivalents |  | 32,651 |  |  | 29,640 |  |  |  | \nCash and cash equivalents \u2013 restricted |  | 25 |  |  | 25 |  |  |  | \nNotes and accounts receivable \u2013 net |  | 38,808 |  |  | 41,749 |  |  |  | \nInventories |  |  |  |  |  |  | \nCrude oil, products and merchandise |  | 19,458 |  |  | 20,434 |  |  |  | \nMaterials and supplies |  | 4,184 |  |  | 4,001 |  |  |  | \nOther current assets |  | 2,098 |  |  | 1,782 |  |  |  | \nTotal current assets |  | 97,224 |  |  | 97,631 |  |  |  | \nInvestments, advances and long-term receivables |  | 49,044 |  |  | 49,793 |  |  |  | \nProperty, plant and equipment \u2013 net |  | 206,023 |  |  | 204,692 |  |  |  | \nOther assets, including intangibles \u2013 net |  | 17,080 |  |  | 16,951 |  |  |  | \nTotal Assets |  | 369,371 |  |  | 369,067 |  |  |  | \n |  |  |  |  |  |  | \nLIABILITIES |  |  |  |  |  |  | \nCurrent liabilities |  |  |  |  |  |  | \nNotes and loans payable |  | 2,296 |  |  | 634 |  |  |  | \nAccounts payable and accrued liabilities |  | 59,935 |  |  | 63,197 |  |  |  | \nIncome taxes payable |  | 4,435 |  |  | 5,214 |  |  |  | \nTotal current liabilities |  | 66,666 |  |  | 69,045 |  |  |  | \nLong-term debt |  | 39,150 |  |  | 40,559 |  |  |  | \nPostretirement benefits reserves |  | 10,183 |  |  | 10,045 |  |  |  | \nDeferred income tax liabilities |  | 23,195 |  |  | 22,874 |  |  |  | \nLong-term obligations to equity companies |  | 2,376 |  |  | 2,338 |  |  |  | \nOther long-term obligations |  | 21,387 |  |  | 21,733 |  |  |  | \nTotal Liabilities |  | 162,957 |  |  | 166,594 |  |  |  | \n |  |  |  |  |  |  | \nCommitments and contingencies (Note 3) |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nEQUITY |  |  |  |  |  |  | \nCommon stock without par value(9,000million shares authorized,8,019million shares issued) |  | 15,904 |  |  | 15,752 |  |  |  | \nEarnings reinvested |  | 440,552 |  |  | 432,860 |  |  |  | \nAccumulated other comprehensive income |  | (13,095) |  |  | (13,270) |  |  |  | \nCommon stock held in treasury(3,976million shares at March\u00a031, 2023 and3,937million shares at December\u00a031, 2022) |  | (244,676) |  |  | (240,293) |  |  |  | \nExxonMobil share of equity |  | 198,685 |  |  | 195,049 |  |  |  | \nNoncontrolling interests |  | 7,729 |  |  | 7,424 |  |  |  | \nTotal Equity |  | 206,414 |  |  | 202,473 |  |  |  | \nTotal Liabilities and Equity |  | 369,371 |  |  | 369,067 |  |  |  | \n |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements. |  |  |   |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedMarch 31,\n | 2023 | 2022\n |  |  | \nCASH FLOWS FROM OPERATING ACTIVITIES |  |  | \nNet income (loss) including noncontrolling interests |  | 11,843 |  | 5,750 | \nDepreciation and depletion (includes impairments) |  | 4,244 |  | 8,883 | \n |  |  | \nChanges in operational working capital, excluding cash and debt |  | (302) |  | 1,086 | \nAll other items \u2013 net |  | 556 |  | (931) | \nNet cash provided by operating activities |  | 16,341 |  | 14,788 | \n |  |  | \nCASH FLOWS FROM INVESTING ACTIVITIES |  |  | \nAdditions to property, plant and equipment |  | (5,412) |  | (3,911) | \nProceeds from asset sales and returns of investments |  | 854 |  | 293 | \nAdditional investments and advances |  | (445) |  | (417) | \nOther investing activities including collection of advances |  | 78 |  | 90 | \nNet cash used in investing activities |  | (4,925) |  | (3,945) | \n |  |  | \nCASH FLOWS FROM FINANCING ACTIVITIES |  |  | \nAdditions to long-term debt |  | 20 |  | \u2014 | \n |  |  | \n |  |  | \nReductions in short-term debt |  | (126) |  | (2,098) | \nAdditions/(reductions) in debt with three months or less maturity |  | (192) |  | 1,366 | \n |  |  | \nCash dividends to ExxonMobil shareholders |  | (3,738) |  | (3,760) | \nCash dividends to noncontrolling interests |  | (115) |  | (60) | \nChanges in noncontrolling interests |  | (16) |  | (94) | \nCommon stock acquired |  | (4,340) |  | (2,067) | \nNet cash used in financing activities |  | (8,507) |  | (6,713) | \n |  |  | \nEffects of exchange rate changes on cash |  | 102 |  | 142 | \nIncrease/(decrease) in cash and cash equivalents |  | 3,011 |  | 4,272 | \nCash and cash equivalents at beginning of period |  | 29,665 |  | 6,802 | \nCash and cash equivalents at end of period |  | 32,676 |  | 11,074 | \n |  |  | \nSUPPLEMENTAL DISCLOSURES |  |  | \nIncome taxes paid |  | 4,404 |  | 1,798 | \nCash interest paid |  |  | \nIncluded in cash flows from operating activities |  | 256 |  | 319 | \nCapitalized, included in cash flows from investing activities |  | 291 |  | 187 | \nTotal cash interest paid |  | 547 |  | 506 | \n |  |  | \n |  |  | \nNoncash right of use assets recorded in exchange for lease liabilities |  |  | \nOperating leases |  | 393 |  | 240 | \nFinance leases |  | 438 |  | 656 | \n |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF CHANGE IN EQUITY  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | ExxonMobil Share of Equity |  | \n |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | Common Stock | Earnings Reinvested | Accumulated Other Comprehensive Income | Common Stock Held in Treasury | ExxonMobil Share of Equity | Non-controlling Interests | Total Equity\n |  |  |  |  |  |  |  | \nBalance as of December 31, 2021 |  | 15,746 |  | 392,059 |  | (13,764) |  | (225,464) |  | 168,577 |  | 7,106 |  | 175,683 | \nAmortization of stock-based awards |  | 138 |  | \u2014 |  | \u2014 |  | \u2014 |  | 138 |  | \u2014 |  | 138 | \nOther |  | (5) |  | \u2014 |  | \u2014 |  | \u2014 |  | (5) |  | 14 |  | 9 | \nNet income (loss) for the period |  | \u2014 |  | 5,480 |  | \u2014 |  | \u2014 |  | 5,480 |  | 270 |  | 5,750 | \nDividends - common shares |  | \u2014 |  | (3,760) |  | \u2014 |  | \u2014 |  | (3,760) |  | (60) |  | (3,820) | \n |  |  |  |  |  |  |  | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | 850 |  | \u2014 |  | 850 |  | 89 |  | 939 | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (2,067) |  | (2,067) |  | (108) |  | (2,175) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 2 |  | 2 |  | \u2014 |  | 2 | \nBalance as of March 31, 2022 |  | 15,879 |  | 393,779 |  | (12,914) |  | (227,529) |  | 169,215 |  | 7,311 |  | 176,526 | \n |  |  |  |  |  |  |  | \nBalance as of December 31, 2022 |  | 15,752 |  | 432,860 |  | (13,270) |  | (240,293) |  | 195,049 |  | 7,424 |  | 202,473 | \nAmortization of stock-based awards |  | 158 |  | \u2014 |  | \u2014 |  | \u2014 |  | 158 |  | \u2014 |  | 158 | \nOther |  | (6) |  | \u2014 |  | \u2014 |  | \u2014 |  | (6) |  | (16) |  | (22) | \nNet income (loss) for the period |  | \u2014 |  | 11,430 |  | \u2014 |  | \u2014 |  | 11,430 |  | 413 |  | 11,843 | \nDividends - common shares |  | \u2014 |  | (3,738) |  | \u2014 |  | \u2014 |  | (3,738) |  | (115) |  | (3,853) | \n |  |  |  |  |  |  |  | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | 175 |  | \u2014 |  | 175 |  | 23 |  | 198 | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (4,385) |  | (4,385) |  | \u2014 |  | (4,385) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 2 |  | 2 |  | \u2014 |  | 2 | \nBalance as of March 31, 2023 |  | 15,904 |  | 440,552 |  | (13,095) |  | (244,676) |  | 198,685 |  | 7,729 |  | 206,414 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended March 31, 2023 |  | Three Months Ended March 31, 2022\n |  |  |  |  |  |  |  | \nCommon Stock Share Activity(millions of shares) |  | Issued | Held in Treasury | Outstanding |  | Issued | Held in Treasury | Outstanding\nBalance as of December 31 |  | 8,019 |  | (3,937) |  | 4,082 |  |  | 8,019 |  | (3,780) |  | 4,239 | \nAcquisitions |  | \u2014 |  | (39) |  | (39) |  |  | \u2014 |  | (26) |  | (26) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 | \nBalance as of March 31 |  | 8,019 |  | (3,976) |  | 4,043 |  |  | 8,019 |  | (3,806) |  | 4,213 | \n |  |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  |  |  |  |  |  |  |  |  |  |  | \n | March 31, 2023\n |  |  | \n(millions of dollars) | Equity CompanyObligations(1) | Other Third-Party Obligations | Total\nGuarantees |  |  | \nDebt-related | 1,229 |  | 155 |  | 1,384 | \nOther | 739 |  | 5,385 |  | 6,124 | \nTotal | 1,968 |  | 5,540 |  | 7,508 | \n |  |  | \n(1)ExxonMobil share |  |  |   |  |  |  |  |  |  |  |  |  |  | \nExxonMobil Share of Accumulated OtherComprehensive Income(millions of dollars) | Cumulative Foreign Exchange Translation Adjustment | Postretirement Benefits Reserves Adjustment | Total\nBalance as of December 31, 2021 | (11,499) |  | (2,265) |  | (13,764) | \nCurrent period change excluding amounts reclassified from accumulated other comprehensive income(1) | 661 |  | 102 |  | 763 | \nAmounts reclassified from accumulated other comprehensive income | \u2014 |  | 87 |  | 87 | \nTotal change in accumulated other comprehensive income | 661 |  | 189 |  | 850 | \nBalance as of March 31, 2022 | (10,838) |  | (2,076) |  | (12,914) | \n |  |  | \nBalance as of December 31, 2022 | (14,591) |  | 1,321 |  | (13,270) | \nCurrent period change excluding amounts reclassified from accumulated other comprehensive income(1) | 157 |  | 14 |  | 171 | \nAmounts reclassified from accumulated other comprehensive income | \u2014 |  | 4 |  | 4 | \nTotal change in accumulated other comprehensive income | 157 |  | 18 |  | 175 | \nBalance as of March 31, 2023 | (14,434) |  | 1,339 |  | (13,095) | \n |  |  | \n(1)Cumulative Foreign Exchange Translation Adjustment includes net investment hedge gain/(loss) net of taxes of $(74) million and $79million in 2023 and 2022, respectively.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAmounts Reclassified Out of Accumulated OtherComprehensive Income - Before-tax Income/(Expense)(millions of dollars) |  |  |  | Three Months EndedMarch 31,\n |  |  |  | 2023 |  | 2022\n |  |  |  |  |  |  | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  |  |  |  |  |  | \n(Statement of Income line: Non-service pension and postretirement benefit expense) |  |  |  |  | (8) |  |  | (120) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIncome Tax (Expense)/Credit ForComponents of Other Comprehensive Income(millions of dollars) |  |  |  | Three Months EndedMarch 31,\n |  |  | 2023 |  | 2022\n |  |  |  | \nForeign exchange translation adjustment |  |  |  |  | 48 |  |  | (22) | \nPostretirement benefits reserves adjustment (excluding amortization) |  |  |  |  | 11 |  |  | (40) | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  |  |  |  | (2) |  |  | (27) | \nTotal |  |  |  |  | 57 |  |  | (89) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings per common share |  | Three Months EndedMarch 31, |  | \n2023 | 2022 |  |  |  | \nNet income (loss) attributable to ExxonMobil(millions of dollars) |  | 11,430 |  | 5,480 |  |  |  |  | \nWeighted-average number of common shares outstanding(millions of shares) |  | 4,102 |  | 4,266 |  |  |  |  | \nEarnings (loss) per common share(dollars)(1) |  | 2.79 |  | 1.28 |  |  |  |  | \nDividends paid per common share(dollars) |  | 0.91 |  | 0.88 |  |  |  |  | \n |  |  |  |  |  |  | \n(1)The calculation of earnings (loss) per common share and earnings (loss) per common share \u2013 assuming dilution are the same in eachperiod shown.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedMarch 31, |  | \n2023 | 2022 |  |  |  | \nComponents of net benefit cost |  |  |  |  |  |  | \nPension Benefits - U.S. |  |  |  |  |  |  | \nService cost |  | 120 |  | 179 |  |  |  |  | \nInterest cost |  | 166 |  | 129 |  |  |  |  | \nExpected return on plan assets |  | (133) |  | (140) |  |  |  |  | \nAmortization of actuarial loss/(gain) |  | 21 |  | 39 |  |  |  |  | \nAmortization of prior service cost |  | (7) |  | (7) |  |  |  |  | \nNet pension enhancement and curtailment/settlement cost |  | 8 |  | 37 |  |  |  |  | \nNet benefit cost |  | 175 |  | 237 |  |  |  |  | \n |  |  |  |  |  |  | \nPension Benefits - Non-U.S. |  |  |  |  |  |  | \nService cost |  | 82 |  | 150 |  |  |  |  | \nInterest cost |  | 234 |  | 160 |  |  |  |  | \nExpected return on plan assets |  | (174) |  | (213) |  |  |  |  | \nAmortization of actuarial loss/(gain) |  | 14 |  | 47 |  |  |  |  | \nAmortization of prior service cost |  | 12 |  | 12 |  |  |  |  | \n |  |  |  |  |  |  | \nNet benefit cost |  | 168 |  | 156 |  |  |  |  | \n |  |  |  |  |  |  | \nOther Postretirement Benefits |  |  |  |  |  |  | \nService cost |  | 20 |  | 40 |  |  |  |  | \nInterest cost |  | 70 |  | 55 |  |  |  |  | \nExpected return on plan assets |  | (4) |  | (3) |  |  |  |  | \nAmortization of actuarial loss/(gain) |  | (30) |  | 3 |  |  |  |  | \nAmortization of prior service cost |  | (10) |  | (11) |  |  |  |  | \nNet benefit cost |  | 46 |  | 84 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | March 31, 2023\n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n | Fair Value |  |  |  | \n(millions of dollars) | Level 1 | Level 2 | Level 3 | Total Gross Assets& Liabilities | Effect ofCounterparty Netting | Effect ofCollateralNetting | Difference in Carrying Value and Fair Value | NetCarryingValue\nAssets |  |  |  |  |  |  |  | \nDerivative assets(1) | 5,122 |  | 2,372 |  | \u2014 |  | 7,494 |  | (5,761) |  | (943) |  | \u2014 |  | 790 | \n |  |  |  |  |  |  |  | \nAdvances to/receivables from equity companies(2)(6) | \u2014 |  | 2,440 |  | 5,165 |  | 7,605 |  | \u2014 |  | \u2014 |  | 614 |  | 8,219 | \n |  |  |  |  |  |  |  | \nOther long-term financial assets(3) | 1,243 |  | \u2014 |  | 1,506 |  | 2,749 |  | \u2014 |  | \u2014 |  | 313 |  | 3,062 | \n |  |  |  |  |  |  |  | \nLiabilities |  |  |  |  |  |  |  | \nDerivative liabilities(4) | 4,233 |  | 2,720 |  | \u2014 |  | 6,953 |  | (5,761) |  | (60) |  | \u2014 |  | 1,132 | \nLong-term debt(5) | 32,905 |  | 1,036 |  | 6 |  | 33,947 |  | \u2014 |  | \u2014 |  | 3,415 |  | 37,362 | \n |  |  |  |  |  |  |  | \nLong-term obligations to equity companies(6) | \u2014 |  | \u2014 |  | 2,502 |  | 2,502 |  | \u2014 |  | \u2014 |  | (126) |  | 2,376 | \n |  |  |  |  |  |  |  | \nOther long-term financial liabilities(7) | \u2014 |  | \u2014 |  | 713 |  | 713 |  | \u2014 |  | \u2014 |  | 40 |  | 753 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | December 31, 2022\n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n |  | Fair Value |  |  |  | \n(millions of dollars) |  | Level 1 | Level 2 | Level 3 | Total Gross Assets& Liabilities | Effect ofCounterparty Netting | Effect ofCollateralNetting | Difference in Carrying Value and Fair Value | NetCarryingValue\nAssets |  |  |  |  |  |  |  |  | \nDerivative assets(1) |  | 4,309 |  | 3,455 |  | \u2014 |  | 7,764 |  | (5,778) |  | (969) |  | \u2014 |  | 1,017 | \n |  |  |  |  |  |  |  |  | \nAdvances to/receivables from equity companies(2)(6) |  | \u2014 |  | 2,406 |  | 4,958 |  | 7,364 |  | \u2014 |  | \u2014 |  | 685 |  | 8,049 | \n |  |  |  |  |  |  |  |  | \nOther long-term financial assets(3) |  | 1,208 |  | \u2014 |  | 1,413 |  | 2,621 |  | \u2014 |  | \u2014 |  | 346 |  | 2,967 | \n |  |  |  |  |  |  |  |  | \nLiabilities |  |  |  |  |  |  |  |  | \nDerivative liabilities(4) |  | 3,417 |  | 3,264 |  | \u2014 |  | 6,681 |  | (5,778) |  | (79) |  | \u2014 |  | 824 | \nLong-term debt(5) |  | 33,112 |  | 1,880 |  | 6 |  | 34,998 |  | \u2014 |  | \u2014 |  | 4,173 |  | 39,171 | \n |  |  |  |  |  |  |  |  | \nLong-term obligations to equity companies(6) |  | \u2014 |  | \u2014 |  | 2,467 |  | 2,467 |  | \u2014 |  | \u2014 |  | (129) |  | 2,338 | \n |  |  |  |  |  |  |  |  | \nOther long-term financial liabilities(7) |  | \u2014 |  | \u2014 |  | 679 |  | 679 |  | \u2014 |  | \u2014 |  | 38 |  | 717 |   |  | \n(1)Included in the Balance Sheet lines: Notes and accounts receivable - net and Other assets, including intangibles - net\n(2)Included in the Balance Sheet line: Investments, advances and long-term receivables\n(3)Included in the Balance Sheet lines: Investments, advances and long-term receivables and Other assets, including intangibles - net\n(4)Included in the Balance Sheet lines: Accounts payable and accrued liabilities and Other long-term obligations\n(5)Excluding finance lease obligations\n(6)Advances to/receivables from equity companies and long-term obligations to equity companies are mainly designated as hierarchy level 3 inputs. The fair value is calculated by discounting the remaining obligations by a rate consistent with the credit quality and industry of the company.\n(7)Included in the Balance Sheet line: Other long-term obligations. Includes contingent consideration related to a prior year acquisition where fair value is based on expected drilling activities and discount rates.  |  |  |  |  |  |  |  | \n\n |  | \n(millions) | March 31, 2023 | December 31, 2022\nCrude oil (barrels) | 15 |  | 4 | \nPetroleum products (barrels) | (48) |  | (52) | \nNatural gas (MMBTUs) | (29) |  | (64) | \n |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n\n |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedMarch 31, |  | \n | 2023 | 2022 |  |  | \nSales and other operating revenue |  | 651 |  | (2,535) |  |  |  | \nCrude oil and product purchases |  | (25) |  | (26) |  |  |  | \nTotal |  | 626 |  | (2,561) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedMarch 31, |  | \n | 2023 | 2022 |  |  | \nEarnings (Loss) After Income Tax |  |  |  |  |  | \nUpstream |  |  |  |  |  | \nUnited States |  | 1,632 |  | 2,376 |  |  |  | \nNon-U.S.(1) |  | 4,825 |  | 2,112 |  |  |  | \nEnergy Products |  |  |  |  |  | \nUnited States |  | 1,910 |  | 489 |  |  |  | \nNon-U.S. |  | 2,273 |  | (684) |  |  |  | \nChemical Products |  |  |  |  |  | \nUnited States |  | 324 |  | 770 |  |  |  | \nNon-U.S. |  | 47 |  | 636 |  |  |  | \nSpecialty Products |  |  |  |  |  | \nUnited States |  | 451 |  | 246 |  |  |  | \nNon-U.S. |  | 323 |  | 230 |  |  |  | \nCorporate and Financing(1) |  | (355) |  | (694) |  |  |  | \nCorporate total |  | 11,430 |  | 5,480 |  |  |  | \n |  |  |  |  |  | \nSales and Other Operating Revenue |  |  |  |  |  | \nUpstream |  |  |  |  |  | \nUnited States |  | 2,770 |  | 2,656 |  |  |  | \nNon-U.S. |  | 5,387 |  | 6,343 |  |  |  | \nEnergy Products |  |  |  |  |  | \nUnited States |  | 24,924 |  | 24,853 |  |  |  | \nNon-U.S. |  | 39,976 |  | 41,715 |  |  |  | \nChemical Products |  |  |  |  |  | \nUnited States |  | 2,029 |  | 3,094 |  |  |  | \nNon-U.S. |  | 3,692 |  | 4,497 |  |  |  | \nSpecialty Products |  |  |  |  |  | \nUnited States |  | 1,568 |  | 1,391 |  |  |  | \nNon-U.S. |  | 3,289 |  | 3,178 |  |  |  | \nCorporate and Financing |  | 9 |  | 7 |  |  |  | \nCorporate total |  | 83,644 |  | 87,734 |  |  |  | \n |  |  |  |  |  | \nIntersegment Revenue |  |  |  |  |  | \nUpstream |  |  |  |  |  | \nUnited States |  | 4,956 |  | 6,191 |  |  |  | \nNon-U.S. |  | 9,399 |  | 10,835 |  |  |  | \nEnergy Products |  |  |  |  |  | \nUnited States |  | 5,451 |  | 6,849 |  |  |  | \nNon-U.S. |  | 6,969 |  | 8,762 |  |  |  | \nChemical Products |  |  |  |  |  | \nUnited States |  | 1,788 |  | 1,767 |  |  |  | \nNon-U.S. |  | 777 |  | 1,507 |  |  |  | \nSpecialty Products |  |  |  |  |  | \nUnited States |  | 680 |  | 559 |  |  |  | \nNon-U.S. |  | 99 |  | 224 |  |  |  | \nCorporate and Financing |  | 64 |  | 57 |  |  |  | \n |  |  |  |  |  | \n(1)Results for 2022 include charges of $3.3billion in non-U.S. Upstream and $0.1billion in Corporate and Financing associated with the expropriation of the Corporation's interest in Sakhalin-1. |  |  | \n |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nGeographic Sales and Other Operating Revenue |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedMarch 31, |  | \n | 2023 | 2022 |  |  | \nUnited States |  | 31,291 |  | 31,994 |  |  |  | \nNon-U.S. |  | 52,353 |  | 55,740 |  |  |  | \nTotal |  | 83,644 |  | 87,734 |  |  |  | \n |  |  |  |  |  | \nSignificant Non-U.S. revenue sources include:(1) |  |  |  |  |  | \nUnited Kingdom |  | 7,011 |  | 7,548 |  |  |  | \nCanada |  | 6,721 |  | 6,995 |  |  |  | \nSingapore |  | 3,731 |  | 4,322 |  |  |  | \nFrance |  | 3,484 |  | 4,356 |  |  |  | \nBelgium |  | 2,649 |  | 2,836 |  |  |  | \nItaly |  | 2,536 |  | 2,836 |  |  |  | \nAustralia |  | 2,428 |  | 2,456 |  |  |  | \n |  |  |  |  |  | \n(1)Revenue is determined by primary country of operations. Excludes certain sales and other operating revenues in non-U.S. operations where attribution to a specific country is not practicable.  |  |  |  |  |  |  |  |  |  |  |  | \nSales and other operating revenue(millions of dollars) | Three Months EndedMarch 31, |  | \n2023 | 2022 |  |  |  | \n |  |  |  |  |  | \nRevenue from contracts with customers | 64,304 |  | 68,816 |  |  |  |  | \nRevenue outside the scope of ASC 606 | 19,340 |  | 18,918 |  |  |  |  | \nTotal | 83,644 |  | 87,734 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months EndedMarch 31, 2023 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss)(U.S. GAAP) | 1,632 |  | 4,825 |  |  | 1,910 |  | 2,273 |  |  | 324 |  | 47 |  | 451 |  | 323 |  |  |  | (355) |  |  | 11,430 | \nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTax-related items | \u2014 |  | (158) |  |  | \u2014 |  | (30) |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | \u2014 |  |  | (188) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(Non-GAAP) | 1,632 |  | 4,983 |  |  | 1,910 |  | 2,303 |  |  | 324 |  | 47 |  | 451 |  | 323 |  |  |  | (355) |  |  | 11,618 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months EndedMarch 31, 2022 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss)(U.S. GAAP) | 2,376 |  | 2,112 |  |  | 489 |  | (684) |  |  | 770 |  | 636 |  | 246 |  | 230 |  |  |  | (694) |  |  | 5,480 | \nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nImpairments | \u2014 |  | (2,877) |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | (98) |  |  | (2,975) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther | \u2014 |  | (378) |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | \u2014 |  |  | (378) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(Non-GAAP) | 2,376 |  | 5,367 |  |  | 489 |  | (684) |  |  | 770 |  | 636 |  | 246 |  | 230 |  |  |  | (596) |  |  | 8,833 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Financial Results |  |  |  |  |  | \n |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedMarch 31, |  | \n | 2023 | 2022 |  |  | \nEarnings (loss)(U.S. GAAP) |  |  |  |  |  | \nUnited States |  | 1,632 |  | 2,376 |  |  |  | \nNon-U.S. |  | 4,825 |  | 2,112 |  |  |  | \nTotal |  | 6,457 |  | 4,488 |  |  |  | \n |  |  |  |  |  | \nIdentified Items(1) |  |  |  |  |  | \nUnited States |  | \u2014 |  | \u2014 |  |  |  | \nNon-U.S. |  | (158) |  | (3,255) |  |  |  | \nTotal |  | (158) |  | (3,255) |  |  |  | \n |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1)(Non-GAAP) |  |  |  |  |  | \nUnited States |  | 1,632 |  | 2,376 |  |  |  | \nNon-U.S. |  | 4,983 |  | 5,367 |  |  |  | \nTotal |  | 6,615 |  | 7,743 |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream First Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Operational Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  | Three Months EndedMarch 31, |  | \n |  | 2023 |  | 2022 |  |  |  | \nNet production of crude oil, natural gas liquids, bitumen and synthetic oil(thousands of barrels daily) |  |  |  |  |  |  |  | \nUnited States |  | 820 |  |  | 753 |  |  |  |  | \nCanada/Other Americas |  | 670 |  |  | 474 |  |  |  |  | \nEurope |  | 4 |  |  | 4 |  |  |  |  | \nAfrica |  | 220 |  |  | 257 |  |  |  |  | \nAsia |  | 749 |  |  | 738 |  |  |  |  | \nAustralia/Oceania |  | 32 |  |  | 40 |  |  |  |  | \nWorldwide |  | 2,495 |  |  | 2,266 |  |  |  |  | \n |  |  |  |  |  |  |  | \nNet natural gas production available for sale(millions of cubic feet daily) |  |  |  |  |  |  |  | \nUnited States |  | 2,367 |  |  | 2,777 |  |  |  |  | \nCanada/Other Americas |  | 94 |  |  | 182 |  |  |  |  | \nEurope |  | 548 |  |  | 770 |  |  |  |  | \nAfrica |  | 134 |  |  | 58 |  |  |  |  | \nAsia |  | 3,597 |  |  | 3,340 |  |  |  |  | \nAustralia/Oceania |  | 1,276 |  |  | 1,325 |  |  |  |  | \nWorldwide |  | 8,016 |  |  | 8,452 |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nOil-equivalent production(1)(thousands of oil-equivalent barrels daily) |  | 3,831 |  |  | 3,675 |  |  |  |  | \n |  |  |  |  |  |  |  | \n(1)Natural gas is converted to an oil-equivalent basis at six million cubic feet per one thousand barrels.  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Additional Information |  |  |  |  |  | \n |  |  |  |  |  | \n(thousands of barrels daily) |  |  | Three Months EndedMarch 31, 2023 |  |  | \nVolumes reconciliation (Oil-equivalent production)(1) |  |  |  |  |  | \n2022 |  |  | 3,675 |  |  | \nEntitlements - Net Interest |  |  | (65) |  |  | \nEntitlements - Price / Spend / Other |  |  | 55 |  |  | \nGovernment Mandates |  |  | 4 |  |  | \nDivestments |  |  | (133) |  |  | \nGrowth / Other |  |  | 295 |  |  | \n2023 |  |  | 3,831 |  |  | \n |  |  |  |  |  | \n(1)Natural gas is converted to an oil-equivalent basis at six million cubic feet per one thousand barrels.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n1Q 2023versus1Q 2022 | 3.8 million oil-equivalent barrels per day in 1Q 2023 increased 156 thousand oil-equivalent barrels per day from 1Q 2022. Growth in Guyana and the Permian more than offset the impacts from divestments and the Russia expropriation. 1Q 2023 production also benefited from lower downtime and higher entitlements due to lower prices.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedMarch 31, |  | \n | 2023 |  | 2022 |  |  |  | \nEarnings (loss)(U.S. GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 1,910 |  |  | 489 |  |  |  |  | \nNon-U.S. |  | 2,273 |  |  | (684) |  |  |  |  | \nTotal |  | 4,183 |  |  | (196) |  |  |  |  | \n |  |  |  |  |  |  |  | \nIdentified Items(1) |  |  |  |  |  |  |  | \nUnited States |  | \u2014 |  |  | \u2014 |  |  |  |  | \nNon-U.S. |  | (30) |  |  | \u2014 |  |  |  |  | \nTotal |  | (30) |  |  | \u2014 |  |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1)(Non-GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 1,910 |  |  | 489 |  |  |  |  | \nNon-U.S. |  | 2,303 |  |  | (684) |  |  |  |  | \nTotal |  | 4,213 |  |  | (196) |  |  |  |  | \nDue to rounding, numbers presented may not add up precisely to the totals indicated. |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products First Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Operational Results |  |  |  |  |  | \n |  |  |  |  |  | \n(thousands of barrels daily) |  | Three Months EndedMarch 31, |  | \n | 2023 | 2022 |  |  | \nRefinery throughput |  |  |  |  |  | \nUnited States |  | 1,643 |  | 1,685 |  |  |  | \nCanada |  | 417 |  | 399 |  |  |  | \nEurope |  | 1,189 |  | 1,193 |  |  |  | \nAsia Pacific |  | 565 |  | 537 |  |  |  | \nOther |  | 184 |  | 169 |  |  |  | \nWorldwide |  | 3,998 |  | 3,983 |  |  |  | \n |  |  |  |  |  | \nEnergy Products sales(1) |  |  |  |  |  | \nUnited States |  | 2,459 |  | 2,262 |  |  |  | \nNon-U.S. |  | 2,818 |  | 2,849 |  |  |  | \nWorldwide |  | 5,277 |  | 5,111 |  |  |  | \n |  |  |  |  |  | \nGasoline, naphthas |  | 2,177 |  | 2,114 |  |  |  | \nHeating oils, kerosene, diesel |  | 1,770 |  | 1,722 |  |  |  | \nAviation fuels |  | 312 |  | 289 |  |  |  | \nHeavy fuels |  | 215 |  | 249 |  |  |  | \nOther energy products |  | 803 |  | 737 |  |  |  | \n |  |  |  |  |  | \n(1)Data reported net of purchases/sales contracts with the same counterparty. | \nDue to rounding, numbers presented may not add up precisely to the totals indicated. |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedMarch 31, |  | \n | 2023 |  | 2022 |  |  |  | \nEarnings (loss)(U.S. GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 324 |  |  | 770 |  |  |  |  | \nNon-U.S. |  | 47 |  |  | 636 |  |  |  |  | \nTotal |  | 371 |  |  | 1,405 |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1)(Non-GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 324 |  |  | 770 |  |  |  |  | \nNon-U.S. |  | 47 |  |  | 636 |  |  |  |  | \nTotal |  | 371 |  |  | 1,405 |  |  |  |  | \n |  |  |  |  |  |  |  | \n(1)Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.\nDue to rounding, numbers presented may not add up precisely to the totals indicated. |  |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products First Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Operational Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(thousands of metric tons) |  | Three Months EndedMarch 31, |  | \n | 2023 |  | 2022 |  |  |  | \nChemical Products sales(1) |  |  |  |  |  |  |  | \nUnited States |  | 1,561 |  |  | 2,032 |  |  |  |  | \nNon-U.S. |  | 3,088 |  |  | 2,986 |  |  |  |  | \nWorldwide |  | 4,649 |  |  | 5,018 |  |  |  |  | \n |  |  |  |  |  |  |  | \n(1)Data reported net of purchases/sales contracts with the same counterparty.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedMarch 31, |  | \n | 2023 |  | 2022 |  |  |  | \nEarnings (loss)(U.S. GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 451 |  |  | 246 |  |  |  |  | \nNon-U.S. |  | 323 |  |  | 230 |  |  |  |  | \nTotal |  | 774 |  |  | 476 |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1)(Non-GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 451 |  |  | 246 |  |  |  |  | \nNon-U.S. |  | 323 |  |  | 230 |  |  |  |  | \nTotal |  | 774 |  |  | 476 |  |  |  |  | \n |  |  |  |  |  |  |  | \n(1)Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products First Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Operational Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(thousands of metric tons) |  | Three Months EndedMarch 31, |  | \n | 2023 |  | 2022 |  |  |  | \nSpecialty Products sales(1) |  |  |  |  |  |  |  | \nUnited States |  | 476 |  |  | 522 |  |  |  |  | \nNon-U.S. |  | 1,464 |  |  | 1,484 |  |  |  |  | \nWorldwide |  | 1,940 |  |  | 2,006 |  |  |  |  | \n |  |  |  |  |  |  |  | \n(1)Data reported net of purchases/sales contracts with the same counterparty. |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCorporate and Financing Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedMarch 31, |  | \n | 2023 |  | 2022 |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) (U.S. GAAP) |  | (355) |  |  | (694) |  |  |  |  | \nIdentified Items(1) |  | \u2014 |  |  | (98) |  |  |  |  | \nEarnings (loss) excluding Identified Items(1)(Non-GAAP) |  | (355) |  |  | (596) |  |  |  |  | \n |  |  |  |  |  |  |  | \n(1)Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  |  |  |  | Three Months EndedMarch 31,\n |  |  |  |  |  | 2023 |  | 2022\nNet cash provided by/(used in) |  |  |  |  |  |  |  |  | \nOperating activities |  |  |  |  |  |  | 16,341 |  |  | 14,788 | \nInvesting activities |  |  |  |  |  |  | (4,925) |  |  | (3,945) | \nFinancing activities |  |  |  |  |  |  | (8,507) |  |  | (6,713) | \nEffect of exchange rate changes |  |  |  |  |  |  | 102 |  |  | 142 | \nIncrease/(decrease) in cash and cash equivalents |  |  |  |  |  |  | 3,011 |  |  | 4,272 | \n |  |  |  |  |  |  |  |  | \nCash and cash equivalents (at end of period) |  |  |  |  |  |  | 32,676 |  |  | 11,074 | \n |  |  |  |  |  |  |  |  | \nCash flow from operations and asset sales |  |  |  |  |  |  |  |  | \nNet cash provided by operating activities (U.S. GAAP) |  |  |  |  |  |  | 16,341 |  |  | 14,788 | \nProceeds associated with sales of subsidiaries, property, plant & equipment, and sales and returns of investments |  |  |  |  |  |  | 854 |  |  | 293 | \nCash flow from operations and asset sales(Non-GAAP) |  |  |  |  |  |  | 17,195 |  |  | 15,081 | \n |  |  |  |  |  |  |  |  | \nBecause of the ongoing nature of our asset management and divestment program, we believe it is useful for investors to consider proceeds associated with asset sales together with cash provided by operating activities when evaluating cash available for investment in the business and financing activities, including shareholder distributions.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n(millions of dollars) |  |  | Three Months EndedMarch 31, |  | \n |  | 2023 |  | 2022 |  |  |  | \nIncome taxes |  |  | 4,960 |  |  | 2,806 |  |  |  |  | \nEffective income tax rate |  |  | 34 | % |  | 40 | % |  |  |  | \nTotal other taxes and duties(1) |  |  | 8,095 |  |  | 8,449 |  |  |  |  | \nTotal |  |  | 13,055 |  |  | 11,255 |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n(1)Includes \u201cOther taxes and duties\u201d plus taxes that are included in \u201cProduction and manufacturing expenses\u201d and \u201cSelling, general and administrative expenses\u201d.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedMarch 31, |  | \n | 2023 |  | 2022 |  |  |  | \nUpstream (including exploration expenses) |  | 4,581 |  |  | 3,879 |  |  |  |  | \nEnergy Products |  | 685 |  |  | 566 |  |  |  |  | \nChemical Products |  | 831 |  |  | 436 |  |  |  |  | \nSpecialty Products |  | 91 |  |  | 23 |  |  |  |  | \nOther |  | 192 |  |  | \u2014 |  |  |  |  | \nTotal |  | 6,380 |  |  | 4,904 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIssuer Purchases of Equity Securities for Quarter Ended March\u00a031, 2023\n |  |  |  |  |  |  |  | \n |  | Total Numberof SharesPurchased(1) |  | AveragePrice Paidper Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(3) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program(Billions of dollars)\nJanuary 2023 |  | 12,526,472 |  | $111.81 |  | 12,517,807 |  | $33.6\nFebruary 2023 |  | 11,737,763 |  | $113.24 |  | 11,737,763 |  | $32.3\nMarch 2023 |  | 15,039,938 |  | $107.07 |  | 15,039,938 |  | $30.7\nTotal |  | 39,304,173 |  | $110.42 |  | 39,295,508 |  | \n |  |  |  |  |  |  |  | \n(1)Includes shares withheld from participants in the company's incentive program for personal income taxes.\n(2)Excludes 1% excise tax on stock repurchases of $45M.\n(3)In its 2022 Corporate Plan Update released December 8, 2022, the Corporation stated that the company expanded its sharerepurchase program to up to $50 billion through 2024.\n  |  |  |  |  |  |  |  | \nExhibit |  | Description\n |  | \n |  | \n |  | \n |  | \n |  | \n |  | \n31.1 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Chief Executive Officer.\n31.2 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Chief Financial Officer.\n31.3 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Principal Accounting Officer.\n32.1 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Chief Executive Officer.\n32.2 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Chief Financial Officer.\n32.3 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Principal Accounting Officer.\n101 |  | Interactive Data Files (formatted as Inline XBRL).\n104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).  |  |  |  |  |  |  |  | \n | EXXON MOBIL CORPORATION\nDate: May\u00a02, 2023 | By: | /s/ LEN M. FOX\n |  | Len M. Fox\n |  | Vice President, Controller and\n |  | Principal Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Exxon Mobil, in 2023 Q2, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  |  |  |  | \nNew Jersey |  | 13-5409005\n(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification Number)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of Each Class |  | Trading Symbol |  | Name of Each Exchange on Which Registered\nCommon Stock, without par value |  | XOM |  | New York Stock Exchange\n0.142% Notes due 2024 |  | XOM24B |  | New York Stock Exchange\n0.524% Notes due 2028 |  | XOM28 |  | New York Stock Exchange\n0.835% Notes due 2032 |  | XOM32 |  | New York Stock Exchange\n1.408% Notes due 2039 |  | XOM39A |  | New York Stock Exchange  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2611 | Accelerated filer | \u2610\n |  |  | \nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n\n | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \nClass |  | Outstanding as of June\u00a030, 2023\nCommon stock, without par value |  | 4,003,192,787  |  |  |  |  | \nPART I. FINANCIAL INFORMATION\n | \nItem 1. Financial Statements | \n | \nCondensed Consolidated Statement of Income - Three and six months ended June\u00a030, 2023 and 2022 | 3\n | \nCondensed Consolidated Statement of Comprehensive Income - Three and six months ended June\u00a030, 2023 and 2022 | 4\n | \nCondensed Consolidated Balance Sheet - As of June\u00a030, 2023 and December\u00a031, 2022 | 5\n | \nCondensed Consolidated Statement of Cash Flows - Six months ended June\u00a030, 2023 and 2022 | 6\n | \nCondensed Consolidated Statement of Changes in Equity - Three months ended June\u00a030, 2023 and 2022 | 7\n | \nCondensed Consolidated Statement of Changes in Equity - Six months ended June\u00a030, 2023 and 2022 | 8\n | \n | \n | \nNotes to Condensed Consolidated Financial Statements | 9\n | \nItem 2. Management's Discussion and Analysis of Financial Condition and Results of Operations | 18\n | \nItem 3. Quantitative and Qualitative Disclosures About Market Risk | 34\n | \nItem 4. Controls and Procedures | 34\n | \n | \nPART II. OTHER INFORMATION\n | \nItem 1. Legal Proceedings | 35\n | \n | \n | \nItem 2. Unregistered Sales of Equity Securities and Use of Proceeds | 35\n | \nItem 5. Other Information | 35\n | \nItem 6. Exhibits | 35\n | \nIndex to Exhibits | 36\n | \nSignature | 37\n |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nITEM 1. FINANCIAL STATEMENTS |  |   |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF INCOME  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 | 2022 |  | 2023 | 2022\nRevenues and other income |  |  |  |  |  | \nSales and other operating revenue |  | 80,795 |  | 111,265 |  |  | 164,439 |  | 198,999 | \nIncome from equity affiliates |  | 1,382 |  | 3,688 |  |  | 3,763 |  | 6,226 | \nOther income |  | 737 |  | 728 |  |  | 1,276 |  | 956 | \nTotal revenues and other income |  | 82,914 |  | 115,681 |  |  | 169,478 |  | 206,181 | \nCosts and other deductions |  |  |  |  |  | \nCrude oil and product purchases |  | 47,598 |  | 65,613 |  |  | 93,601 |  | 118,001 | \nProduction and manufacturing expenses |  | 8,860 |  | 10,686 |  |  | 18,296 |  | 20,927 | \nSelling, general and administrative expenses |  | 2,449 |  | 2,530 |  |  | 4,839 |  | 4,939 | \nDepreciation and depletion (includes impairments) |  | 4,242 |  | 4,451 |  |  | 8,486 |  | 13,334 | \nExploration expenses, including dry holes |  | 133 |  | 286 |  |  | 274 |  | 459 | \nNon-service pension and postretirement benefit expense |  | 164 |  | 120 |  |  | 331 |  | 228 | \nInterest expense |  | 249 |  | 194 |  |  | 408 |  | 382 | \nOther taxes and duties |  | 7,563 |  | 6,868 |  |  | 14,784 |  | 14,422 | \nTotal costs and other deductions |  | 71,258 |  | 90,748 |  |  | 141,019 |  | 172,692 | \nIncome (loss) before income taxes |  | 11,656 |  | 24,933 |  |  | 28,459 |  | 33,489 | \nIncome tax expense (benefit) |  | 3,503 |  | 6,359 |  |  | 8,463 |  | 9,165 | \nNet income (loss) including noncontrolling interests |  | 8,153 |  | 18,574 |  |  | 19,996 |  | 24,324 | \nNet income (loss) attributable to noncontrolling interests |  | 273 |  | 724 |  |  | 686 |  | 994 | \nNet income (loss) attributable to ExxonMobil |  | 7,880 |  | 17,850 |  |  | 19,310 |  | 23,330 | \n |  |  |  |  |  | \nEarnings (loss) per common share(dollars) |  | 1.94 |  | 4.21 |  |  | 4.73 |  | 5.49 | \n |  |  |  |  |  | \nEarnings (loss) per common share - assuming dilution(dollars) |  | 1.94 |  | 4.21 |  |  | 4.73 |  | 5.49 | \n |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nNet income (loss) including noncontrolling interests |  | 8,153 |  |  | 18,574 |  |  | 19,996 |  |  | 24,324 | \n |  |  |  |  |  |  |  | \nOther comprehensive income (loss) (net of income taxes) |  |  |  |  |  |  |  | \nForeign exchange translation adjustment |  | 514 |  |  | (2,537) |  |  | 687 |  |  | (1,796) | \n |  |  |  |  |  |  |  | \nPostretirement benefits reserves adjustment (excluding amortization) |  | 17 |  |  | 155 |  |  | 36 |  |  | 260 | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  | 7 |  |  | 102 |  |  | 13 |  |  | 195 | \nTotal other comprehensive income (loss) |  | 538 |  |  | (2,280) |  |  | 736 |  |  | (1,341) | \nComprehensive income (loss) including noncontrolling interests |  | 8,691 |  |  | 16,294 |  |  | 20,732 |  |  | 22,983 | \nComprehensive income (loss) attributable to noncontrolling interests |  | 373 |  |  | 547 |  |  | 809 |  |  | 906 | \nComprehensive income (loss) attributable to ExxonMobil |  | 8,318 |  |  | 15,747 |  |  | 19,923 |  |  | 22,077 | \n |  |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED BALANCE SHEET  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | June 30, 2023 |  | December 31, 2022 |  |  | \n |  |  |  |  |  |  | \nASSETS |  |  |  |  |  |  | \nCurrent assets |  |  |  |  |  |  | \nCash and cash equivalents |  | 29,528 |  |  | 29,640 |  |  |  | \nCash and cash equivalents \u2013 restricted |  | 29 |  |  | 25 |  |  |  | \nNotes and accounts receivable \u2013 net |  | 35,915 |  |  | 41,749 |  |  |  | \nInventories |  |  |  |  |  |  | \nCrude oil, products and merchandise |  | 20,006 |  |  | 20,434 |  |  |  | \nMaterials and supplies |  | 4,243 |  |  | 4,001 |  |  |  | \nOther current assets |  | 2,039 |  |  | 1,782 |  |  |  | \nTotal current assets |  | 91,760 |  |  | 97,631 |  |  |  | \nInvestments, advances and long-term receivables |  | 47,273 |  |  | 49,793 |  |  |  | \nProperty, plant and equipment \u2013 net |  | 206,736 |  |  | 204,692 |  |  |  | \nOther assets, including intangibles \u2013 net |  | 17,479 |  |  | 16,951 |  |  |  | \nTotal Assets |  | 363,248 |  |  | 369,067 |  |  |  | \n |  |  |  |  |  |  | \nLIABILITIES |  |  |  |  |  |  | \nCurrent liabilities |  |  |  |  |  |  | \nNotes and loans payable |  | 3,929 |  |  | 634 |  |  |  | \nAccounts payable and accrued liabilities |  | 54,404 |  |  | 63,197 |  |  |  | \nIncome taxes payable |  | 3,482 |  |  | 5,214 |  |  |  | \nTotal current liabilities |  | 61,815 |  |  | 69,045 |  |  |  | \nLong-term debt |  | 37,567 |  |  | 40,559 |  |  |  | \nPostretirement benefits reserves |  | 10,278 |  |  | 10,045 |  |  |  | \nDeferred income tax liabilities |  | 23,460 |  |  | 22,874 |  |  |  | \nLong-term obligations to equity companies |  | 2,036 |  |  | 2,338 |  |  |  | \nOther long-term obligations |  | 21,095 |  |  | 21,733 |  |  |  | \nTotal Liabilities |  | 156,251 |  |  | 166,594 |  |  |  | \n |  |  |  |  |  |  | \nCommitments and contingencies (Note 3) |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nEQUITY |  |  |  |  |  |  | \nCommon stock without par value(9,000million shares authorized,8,019million shares issued) |  | 16,029 |  |  | 15,752 |  |  |  | \nEarnings reinvested |  | 444,731 |  |  | 432,860 |  |  |  | \nAccumulated other comprehensive income |  | (12,657) |  |  | (13,270) |  |  |  | \nCommon stock held in treasury(4,016million shares at June\u00a030, 2023 and3,937million shares at December\u00a031, 2022) |  | (249,057) |  |  | (240,293) |  |  |  | \nExxonMobil share of equity |  | 199,046 |  |  | 195,049 |  |  |  | \nNoncontrolling interests |  | 7,951 |  |  | 7,424 |  |  |  | \nTotal Equity |  | 206,997 |  |  | 202,473 |  |  |  | \nTotal Liabilities and Equity |  | 363,248 |  |  | 369,067 |  |  |  | \n |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements. |  |  |   |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Six Months EndedJune 30,\n | 2023 | 2022\n |  |  | \nCASH FLOWS FROM OPERATING ACTIVITIES |  |  | \nNet income (loss) including noncontrolling interests |  | 19,996 |  | 24,324 | \nDepreciation and depletion (includes impairments) |  | 8,486 |  | 13,334 | \n |  |  | \nChanges in operational working capital, excluding cash and debt |  | (3,885) |  | (1,661) | \nAll other items \u2013 net |  | 1,127 |  | (1,246) | \nNet cash provided by operating activities |  | 25,724 |  | 34,751 | \n |  |  | \nCASH FLOWS FROM INVESTING ACTIVITIES |  |  | \nAdditions to property, plant and equipment |  | (10,771) |  | (7,748) | \nProceeds from asset sales and returns of investments |  | 2,141 |  | 1,232 | \nAdditional investments and advances |  | (834) |  | (643) | \nOther investing activities including collection of advances |  | 183 |  | 150 | \nNet cash used in investing activities |  | (9,281) |  | (7,009) | \n |  |  | \nCASH FLOWS FROM FINANCING ACTIVITIES |  |  | \nAdditions to long-term debt |  | 136 |  | \u2014 | \nReductions in long-term debt |  | (6) |  | \u2014 | \n |  |  | \nReductions in short-term debt |  | (172) |  | (2,336) | \nAdditions/(reductions) in debt with three months or less maturity |  | (172) |  | 1,303 | \nContingent consideration payments |  | (68) |  | (58) | \nCash dividends to ExxonMobil shareholders |  | (7,439) |  | (7,487) | \nCash dividends to noncontrolling interests |  | (293) |  | (123) | \nChanges in noncontrolling interests |  | 11 |  | (697) | \nCommon stock acquired |  | (8,680) |  | (5,986) | \nNet cash used in financing activities |  | (16,683) |  | (15,384) | \n |  |  | \nEffects of exchange rate changes on cash |  | 132 |  | (299) | \nIncrease/(decrease) in cash and cash equivalents |  | (108) |  | 12,059 | \nCash and cash equivalents at beginning of period |  | 29,665 |  | 6,802 | \nCash and cash equivalents at end of period |  | 29,557 |  | 18,861 | \n |  |  | \nSUPPLEMENTAL DISCLOSURES |  |  | \nIncome taxes paid |  | 8,841 |  | 5,545 | \nCash interest paid |  |  | \nIncluded in cash flows from operating activities |  | 295 |  | 352 | \nCapitalized, included in cash flows from investing activities |  | 561 |  | 388 | \nTotal cash interest paid |  | 856 |  | 740 | \n |  |  | \n |  |  | \nNoncash right of use assets recorded in exchange for lease liabilities |  |  | \nOperating leases |  | 1,036 |  | 1,039 | \nFinance leases |  | 438 |  | 656 | \n |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF CHANGE IN EQUITY  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | ExxonMobil Share of Equity |  | \n |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | Common Stock | Earnings Reinvested | Accumulated Other Comprehensive Income | Common Stock Held in Treasury | ExxonMobil Share of Equity | Non-controlling Interests | Total Equity\n |  |  |  |  |  |  |  | \nBalance as of March 31, 2022 |  | 15,879 |  | 393,779 |  | (12,914) |  | (227,529) |  | 169,215 |  | 7,311 |  | 176,526 | \nAmortization of stock-based awards |  | 143 |  | \u2014 |  | \u2014 |  | \u2014 |  | 143 |  | \u2014 |  | 143 | \nOther |  | (4) |  | \u2014 |  | \u2014 |  | \u2014 |  | (4) |  | (15) |  | (19) | \nNet income (loss) for the period |  | \u2014 |  | 17,850 |  | \u2014 |  | \u2014 |  | 17,850 |  | 724 |  | 18,574 | \nDividends - common shares |  | \u2014 |  | (3,727) |  | \u2014 |  | \u2014 |  | (3,727) |  | (63) |  | (3,790) | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | (2,103) |  | \u2014 |  | (2,103) |  | (177) |  | (2,280) | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (4,059) |  | (4,059) |  | (588) |  | (4,647) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 1 |  | 1 |  | \u2014 |  | 1 | \nBalance as of June 30, 2022 |  | 16,018 |  | 407,902 |  | (15,017) |  | (231,587) |  | 177,316 |  | 7,192 |  | 184,508 | \n |  |  |  |  |  |  |  | \nBalance as of March 31, 2023 |  | 15,904 |  | 440,552 |  | (13,095) |  | (244,676) |  | 198,685 |  | 7,729 |  | 206,414 | \nAmortization of stock-based awards |  | 130 |  | \u2014 |  | \u2014 |  | \u2014 |  | 130 |  | \u2014 |  | 130 | \nOther |  | (5) |  | \u2014 |  | \u2014 |  | \u2014 |  | (5) |  | 27 |  | 22 | \nNet income (loss) for the period |  | \u2014 |  | 7,880 |  | \u2014 |  | \u2014 |  | 7,880 |  | 273 |  | 8,153 | \nDividends - common shares |  | \u2014 |  | (3,701) |  | \u2014 |  | \u2014 |  | (3,701) |  | (178) |  | (3,879) | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | 438 |  | \u2014 |  | 438 |  | 100 |  | 538 | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (4,383) |  | (4,383) |  | \u2014 |  | (4,383) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 2 |  | 2 |  | \u2014 |  | 2 | \nBalance as of June 30, 2023 |  | 16,029 |  | 444,731 |  | (12,657) |  | (249,057) |  | 199,046 |  | 7,951 |  | 206,997 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended June 30, 2023 |  | Three Months Ended June 30, 2022\n |  |  |  |  |  |  |  | \nCommon Stock Share Activity(millions of shares) |  | Issued | Held in Treasury | Outstanding |  | Issued | Held in Treasury | Outstanding\nBalance as of March 31 |  | 8,019 |  | (3,976) |  | 4,043 |  |  | 8,019 |  | (3,806) |  | 4,213 | \nAcquisitions |  | \u2014 |  | (40) |  | (40) |  |  | \u2014 |  | (45) |  | (45) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 | \nBalance as of June 30 |  | 8,019 |  | (4,016) |  | 4,003 |  |  | 8,019 |  | (3,851) |  | 4,168 | \n |  |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF CHANGE IN EQUITY  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | ExxonMobil Share of Equity |  | \n |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | Common Stock | Earnings Reinvested | Accumulated Other Comprehensive Income | Common Stock Held in Treasury | ExxonMobil Share of Equity | Non-controlling Interests | Total Equity\n |  |  |  |  |  |  |  | \nBalance as of December 31, 2021 |  | 15,746 |  | 392,059 |  | (13,764) |  | (225,464) |  | 168,577 |  | 7,106 |  | 175,683 | \nAmortization of stock-based awards |  | 281 |  | \u2014 |  | \u2014 |  | \u2014 |  | 281 |  | \u2014 |  | 281 | \nOther |  | (9) |  | \u2014 |  | \u2014 |  | \u2014 |  | (9) |  | (1) |  | (10) | \nNet income (loss) for the period |  | \u2014 |  | 23,330 |  | \u2014 |  | \u2014 |  | 23,330 |  | 994 |  | 24,324 | \nDividends - common shares |  | \u2014 |  | (7,487) |  | \u2014 |  | \u2014 |  | (7,487) |  | (123) |  | (7,610) | \n |  |  |  |  |  |  |  | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | (1,253) |  | \u2014 |  | (1,253) |  | (88) |  | (1,341) | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (6,126) |  | (6,126) |  | (696) |  | (6,822) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 3 |  | 3 |  | \u2014 |  | 3 | \nBalance as of June 30, 2022 |  | 16,018 |  | 407,902 |  | (15,017) |  | (231,587) |  | 177,316 |  | 7,192 |  | 184,508 | \n |  |  |  |  |  |  |  | \nBalance as of December 31, 2022 |  | 15,752 |  | 432,860 |  | (13,270) |  | (240,293) |  | 195,049 |  | 7,424 |  | 202,473 | \nAmortization of stock-based awards |  | 288 |  | \u2014 |  | \u2014 |  | \u2014 |  | 288 |  | \u2014 |  | 288 | \nOther |  | (11) |  | \u2014 |  | \u2014 |  | \u2014 |  | (11) |  | 11 |  | \u2014 | \nNet income (loss) for the period |  | \u2014 |  | 19,310 |  | \u2014 |  | \u2014 |  | 19,310 |  | 686 |  | 19,996 | \nDividends - common shares |  | \u2014 |  | (7,439) |  | \u2014 |  | \u2014 |  | (7,439) |  | (293) |  | (7,732) | \n |  |  |  |  |  |  |  | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | 613 |  | \u2014 |  | 613 |  | 123 |  | 736 | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (8,768) |  | (8,768) |  | \u2014 |  | (8,768) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 4 |  | 4 |  | \u2014 |  | 4 | \nBalance as of June 30, 2023 |  | 16,029 |  | 444,731 |  | (12,657) |  | (249,057) |  | 199,046 |  | 7,951 |  | 206,997 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Six Months Ended June 30, 2023 |  | Six Months Ended June 30, 2022\n |  |  |  |  |  |  |  | \nCommon Stock Share Activity(millions of shares) |  | Issued | Held in Treasury | Outstanding |  | Issued | Held in Treasury | Outstanding\nBalance as of December 31 |  | 8,019 |  | (3,937) |  | 4,082 |  |  | 8,019 |  | (3,780) |  | 4,239 | \nAcquisitions |  | \u2014 |  | (79) |  | (79) |  |  | \u2014 |  | (71) |  | (71) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 | \nBalance as of June 30 |  | 8,019 |  | (4,016) |  | 4,003 |  |  | 8,019 |  | (3,851) |  | 4,168 | \n |  |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  |  |  |  |  |  |  |  |  |  |  | \n | June 30, 2023\n |  |  | \n(millions of dollars) | Equity CompanyObligations(1) | Other Third-Party Obligations | Total\nGuarantees |  |  | \nDebt-related | 1,164 |  | 150 |  | 1,314 | \nOther | 716 |  | 5,725 |  | 6,441 | \nTotal | 1,880 |  | 5,875 |  | 7,755 | \n |  |  | \n(1)ExxonMobil share |  |  |   |  |  |  |  |  |  |  |  |  |  | \nExxonMobil Share of Accumulated OtherComprehensive Income(millions of dollars) | Cumulative Foreign Exchange Translation Adjustment | Postretirement Benefits Reserves Adjustment | Total\nBalance as of December 31, 2021 | (11,499) |  | (2,265) |  | (13,764) | \nCurrent period change excluding amounts reclassified from accumulated other comprehensive income(1) | (1,682) |  | 245 |  | (1,437) | \nAmounts reclassified from accumulated other comprehensive income | \u2014 |  | 184 |  | 184 | \nTotal change in accumulated other comprehensive income | (1,682) |  | 429 |  | (1,253) | \nBalance as of June 30, 2022 | (13,181) |  | (1,836) |  | (15,017) | \n |  |  | \nBalance as of December 31, 2022 | (14,591) |  | 1,321 |  | (13,270) | \nCurrent period change excluding amounts reclassified from accumulated other comprehensive income(1) | 570 |  | 35 |  | 605 | \nAmounts reclassified from accumulated other comprehensive income | \u2014 |  | 8 |  | 8 | \nTotal change in accumulated other comprehensive income | 570 |  | 43 |  | 613 | \nBalance as of June 30, 2023 | (14,021) |  | 1,364 |  | (12,657) | \n |  |  | \n(1)Cumulative Foreign Exchange Translation Adjustment includes net investment hedge gain/(loss) net of taxes of $(70) million and $327million in 2023 and 2022, respectively.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAmounts Reclassified Out of Accumulated OtherComprehensive Income - Before-tax Income/(Expense)(millions of dollars) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 | 2022 |  | 2023 |  | 2022\n |  |  |  |  |  |  | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  |  |  |  |  |  | \n(Statement of Income line: Non-service pension and postretirement benefit expense) |  | (6) |  | (132) |  |  | (14) |  |  | (252) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIncome Tax (Expense)/Credit ForComponents of Other Comprehensive Income(millions of dollars) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n2023 | 2022 |  | 2023 |  | 2022\n |  |  |  | \nForeign exchange translation adjustment |  | 85 |  | (68) |  |  | 133 |  |  | (90) | \nPostretirement benefits reserves adjustment (excluding amortization) |  | 20 |  | (83) |  |  | 31 |  |  | (123) | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  | 1 |  | (30) |  |  | (1) |  |  | (57) | \nTotal |  | 106 |  | (181) |  |  | 163 |  |  | (270) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings per common share |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n2023 | 2022 |  | 2023 | 2022\nNet income (loss) attributable to ExxonMobil(millions of dollars) |  | 7,880 |  | 17,850 |  |  | 19,310 |  | 23,330 | \nWeighted-average number of common shares outstanding(millions of shares)(1) |  | 4,066 |  | 4,233 |  |  | 4,084 |  | 4,248 | \nEarnings (loss) per common share(dollars)(2) |  | 1.94 |  | 4.21 |  |  | 4.73 |  | 5.49 | \nDividends paid per common share(dollars) |  | 0.91 |  | 0.88 |  |  | 1.82 |  | 1.76 | \n |  |  |  |  |  | \n(1)Includes restricted shares not vested.\n(2)Earnings (loss) per common share and earnings (loss) per common share \u2013 assuming dilution are the same in each period shown.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n2023 | 2022 |  | 2023 | 2022\nComponents of net benefit cost |  |  |  |  |  | \nPension Benefits - U.S. |  |  |  |  |  | \nService cost |  | 122 |  | 177 |  |  | 242 |  | 356 | \nInterest cost |  | 165 |  | 129 |  |  | 331 |  | 258 | \nExpected return on plan assets |  | (133) |  | (140) |  |  | (266) |  | (280) | \nAmortization of actuarial loss/(gain) |  | 21 |  | 39 |  |  | 42 |  | 78 | \nAmortization of prior service cost |  | (7) |  | (7) |  |  | (14) |  | (14) | \nNet pension enhancement and curtailment/settlement cost |  | 7 |  | 53 |  |  | 15 |  | 90 | \nNet benefit cost |  | 175 |  | 251 |  |  | 350 |  | 488 | \n |  |  |  |  |  | \nPension Benefits - Non-U.S. |  |  |  |  |  | \nService cost |  | 81 |  | 145 |  |  | 163 |  | 295 | \nInterest cost |  | 232 |  | 157 |  |  | 466 |  | 317 | \nExpected return on plan assets |  | (172) |  | (207) |  |  | (346) |  | (420) | \nAmortization of actuarial loss/(gain) |  | 14 |  | 47 |  |  | 28 |  | 94 | \nAmortization of prior service cost |  | 13 |  | 11 |  |  | 25 |  | 23 | \nNet pension enhancement and curtailment/settlement cost |  | \u2014 |  | (1) |  |  | \u2014 |  | (1) | \nNet benefit cost |  | 168 |  | 152 |  |  | 336 |  | 308 | \n |  |  |  |  |  | \nOther Postretirement Benefits |  |  |  |  |  | \nService cost |  | 20 |  | 38 |  |  | 40 |  | 78 | \nInterest cost |  | 69 |  | 53 |  |  | 139 |  | 108 | \nExpected return on plan assets |  | (3) |  | (4) |  |  | (7) |  | (7) | \nAmortization of actuarial loss/(gain) |  | (31) |  | \u2014 |  |  | (61) |  | 3 | \nAmortization of prior service cost |  | (11) |  | (10) |  |  | (21) |  | (21) | \nNet benefit cost |  | 44 |  | 77 |  |  | 90 |  | 161 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | June 30, 2023\n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n | Fair Value |  |  |  | \n(millions of dollars) | Level 1 | Level 2 | Level 3 | Total Gross Assets& Liabilities | Effect ofCounterparty Netting | Effect ofCollateralNetting | Difference in Carrying Value and Fair Value | NetCarryingValue\nAssets |  |  |  |  |  |  |  | \nDerivative assets(1) | 4,768 |  | 1,980 |  | \u2014 |  | 6,748 |  | (5,477) |  | (807) |  | \u2014 |  | 464 | \n |  |  |  |  |  |  |  | \nAdvances to/receivables from equity companies(2)(6) | \u2014 |  | 2,472 |  | 4,645 |  | 7,117 |  | \u2014 |  | \u2014 |  | 592 |  | 7,709 | \n |  |  |  |  |  |  |  | \nOther long-term financial assets(3) | 1,255 |  | \u2014 |  | 864 |  | 2,119 |  | \u2014 |  | \u2014 |  | 283 |  | 2,402 | \n |  |  |  |  |  |  |  | \nLiabilities |  |  |  |  |  |  |  | \nDerivative liabilities(4) | 4,031 |  | 2,136 |  | \u2014 |  | 6,167 |  | (5,477) |  | (72) |  | \u2014 |  | 618 | \nLong-term debt(5) | 30,891 |  | 1,099 |  | 9 |  | 31,999 |  | \u2014 |  | \u2014 |  | 3,790 |  | 35,789 | \n |  |  |  |  |  |  |  | \nLong-term obligations to equity companies(6) | \u2014 |  | \u2014 |  | 2,161 |  | 2,161 |  | \u2014 |  | \u2014 |  | (125) |  | 2,036 | \n |  |  |  |  |  |  |  | \nOther long-term financial liabilities(7) | \u2014 |  | \u2014 |  | 631 |  | 631 |  | \u2014 |  | \u2014 |  | 44 |  | 675 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | December 31, 2022\n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n |  | Fair Value |  |  |  | \n(millions of dollars) |  | Level 1 | Level 2 | Level 3 | Total Gross Assets& Liabilities | Effect ofCounterparty Netting | Effect ofCollateralNetting | Difference in Carrying Value and Fair Value | NetCarryingValue\nAssets |  |  |  |  |  |  |  |  | \nDerivative assets(1) |  | 4,309 |  | 3,455 |  | \u2014 |  | 7,764 |  | (5,778) |  | (969) |  | \u2014 |  | 1,017 | \n |  |  |  |  |  |  |  |  | \nAdvances to/receivables from equity companies(2)(6) |  | \u2014 |  | 2,406 |  | 4,958 |  | 7,364 |  | \u2014 |  | \u2014 |  | 685 |  | 8,049 | \n |  |  |  |  |  |  |  |  | \nOther long-term financial assets(3) |  | 1,208 |  | \u2014 |  | 1,413 |  | 2,621 |  | \u2014 |  | \u2014 |  | 346 |  | 2,967 | \n |  |  |  |  |  |  |  |  | \nLiabilities |  |  |  |  |  |  |  |  | \nDerivative liabilities(4) |  | 3,417 |  | 3,264 |  | \u2014 |  | 6,681 |  | (5,778) |  | (79) |  | \u2014 |  | 824 | \nLong-term debt(5) |  | 33,112 |  | 1,880 |  | 6 |  | 34,998 |  | \u2014 |  | \u2014 |  | 4,173 |  | 39,171 | \n |  |  |  |  |  |  |  |  | \nLong-term obligations to equity companies(6) |  | \u2014 |  | \u2014 |  | 2,467 |  | 2,467 |  | \u2014 |  | \u2014 |  | (129) |  | 2,338 | \n |  |  |  |  |  |  |  |  | \nOther long-term financial liabilities(7) |  | \u2014 |  | \u2014 |  | 679 |  | 679 |  | \u2014 |  | \u2014 |  | 38 |  | 717 |   |  | \n(1)Included in the Balance Sheet lines: Notes and accounts receivable - net and Other assets, including intangibles - net\n(2)Included in the Balance Sheet line: Investments, advances and long-term receivables\n(3)Included in the Balance Sheet lines: Investments, advances and long-term receivables and Other assets, including intangibles - net\n(4)Included in the Balance Sheet lines: Accounts payable and accrued liabilities and Other long-term obligations\n(5)Excluding finance lease obligations\n(6)Advances to/receivables from equity companies and long-term obligations to equity companies are mainly designated as hierarchy level 3 inputs. The fair value is calculated by discounting the remaining obligations by a rate consistent with the credit quality and industry of the company.\n(7)Included in the Balance Sheet line: Other long-term obligations. Includes contingent consideration related to a prior year acquisition where fair value is based on expected drilling activities and discount rates.  |  |  |  |  |  |  |  | \n\n |  | \n(millions) | June 30, 2023 | December 31, 2022\nCrude oil (barrels) | 34 |  | 4 | \nPetroleum products (barrels) | (69) |  | (52) | \nNatural gas (MMBTUs) | (75) |  | (64) | \n |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n\n |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 | 2022 |  | 2023 | 2022\nSales and other operating revenue |  | 332 |  | (1,413) |  |  | 983 |  | (3,948) | \nCrude oil and product purchases |  | 5 |  | \u2014 |  |  | (20) |  | (26) | \nTotal |  | 337 |  | (1,413) |  |  | 963 |  | (3,974) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 | 2022 |  | 2023 | 2022\nEarnings (Loss) After Income Tax |  |  |  |  |  | \nUpstream |  |  |  |  |  | \nUnited States |  | 920 |  | 3,749 |  |  | 2,552 |  | 6,125 | \nNon-U.S.(1) |  | 3,657 |  | 7,622 |  |  | 8,482 |  | 9,734 | \nEnergy Products |  |  |  |  |  | \nUnited States |  | 1,528 |  | 2,655 |  |  | 3,438 |  | 3,144 | \nNon-U.S. |  | 782 |  | 2,617 |  |  | 3,055 |  | 1,933 | \nChemical Products |  |  |  |  |  | \nUnited States |  | 486 |  | 625 |  |  | 810 |  | 1,395 | \nNon-U.S. |  | 342 |  | 450 |  |  | 389 |  | 1,086 | \nSpecialty Products |  |  |  |  |  | \nUnited States |  | 373 |  | 232 |  |  | 824 |  | 478 | \nNon-U.S. |  | 298 |  | 185 |  |  | 621 |  | 415 | \nCorporate and Financing(1) |  | (506) |  | (286) |  |  | (861) |  | (980) | \nCorporate total |  | 7,880 |  | 17,850 |  |  | 19,310 |  | 23,330 | \n |  |  |  |  |  | \nSales and Other Operating Revenue |  |  |  |  |  | \nUpstream |  |  |  |  |  | \nUnited States |  | 1,673 |  | 3,958 |  |  | 4,443 |  | 6,614 | \nNon-U.S. |  | 3,739 |  | 7,101 |  |  | 9,126 |  | 13,444 | \nEnergy Products |  |  |  |  |  | \nUnited States |  | 26,128 |  | 34,473 |  |  | 51,052 |  | 59,326 | \nNon-U.S. |  | 38,945 |  | 52,804 |  |  | 78,921 |  | 94,519 | \nChemical Products |  |  |  |  |  | \nUnited States |  | 1,992 |  | 3,180 |  |  | 4,021 |  | 6,274 | \nNon-U.S. |  | 3,678 |  | 4,497 |  |  | 7,370 |  | 8,994 | \nSpecialty Products |  |  |  |  |  | \nUnited States |  | 1,542 |  | 1,653 |  |  | 3,110 |  | 3,044 | \nNon-U.S. |  | 3,095 |  | 3,591 |  |  | 6,384 |  | 6,769 | \nCorporate and Financing |  | 3 |  | 8 |  |  | 12 |  | 15 | \nCorporate total |  | 80,795 |  | 111,265 |  |  | 164,439 |  | 198,999 | \n |  |  |  |  |  | \nIntersegment Revenue |  |  |  |  |  | \nUpstream |  |  |  |  |  | \nUnited States |  | 5,044 |  | 7,180 |  |  | 10,000 |  | 13,371 | \nNon-U.S. |  | 8,412 |  | 13,533 |  |  | 17,811 |  | 24,368 | \nEnergy Products |  |  |  |  |  | \nUnited States |  | 5,074 |  | 8,348 |  |  | 10,525 |  | 15,197 | \nNon-U.S. |  | 6,988 |  | 10,848 |  |  | 13,957 |  | 19,610 | \nChemical Products |  |  |  |  |  | \nUnited States |  | 2,084 |  | 2,558 |  |  | 3,872 |  | 4,325 | \nNon-U.S. |  | 977 |  | 1,600 |  |  | 1,754 |  | 3,107 | \nSpecialty Products |  |  |  |  |  | \nUnited States |  | 684 |  | 713 |  |  | 1,364 |  | 1,272 | \nNon-U.S. |  | 169 |  | 195 |  |  | 268 |  | 419 | \nCorporate and Financing |  | 64 |  | 59 |  |  | 128 |  | 116 | \n |  |  |  |  |  | \n(1)Results for first quarter 2022 include charges of $3.3billion in non-U.S. Upstream and $0.1billion in Corporate and Financing associated with the expropriation of the Corporation's interest in Sakhalin-1.\n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nGeographic Sales and Other Operating Revenue |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 | 2022 |  | 2023 | 2022\nUnited States |  | 31,335 |  | 43,264 |  |  | 62,626 |  | 75,258 | \nNon-U.S. |  | 49,460 |  | 68,001 |  |  | 101,813 |  | 123,741 | \nTotal |  | 80,795 |  | 111,265 |  |  | 164,439 |  | 198,999 | \n |  |  |  |  |  | \nSignificant Non-U.S. revenue sources include:(1) |  |  |  |  |  | \nCanada |  | 6,825 |  | 9,642 |  |  | 13,546 |  | 16,638 | \nUnited Kingdom |  | 5,242 |  | 8,306 |  |  | 12,253 |  | 15,854 | \nSingapore |  | 3,758 |  | 4,774 |  |  | 7,489 |  | 9,096 | \nFrance |  | 3,494 |  | 5,265 |  |  | 6,978 |  | 9,622 | \nItaly |  | 2,527 |  | 3,063 |  |  | 5,063 |  | 5,898 | \nBelgium |  | 2,410 |  | 3,041 |  |  | 5,059 |  | 5,877 | \nAustralia |  | 2,392 |  | 3,205 |  |  | 4,820 |  | 5,661 | \n |  |  |  |  |  | \n(1)Revenue is determined by primary country of operations. Excludes certain sales and other operating revenues in non-U.S. operations where attribution to a specific country is not practicable.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSales and other operating revenue(millions of dollars) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 | 2022 |  | 2023 |  | 2022\n |  |  |  |  |  |  | \nRevenue from contracts with customers |  | 63,322 |  | 85,851 |  |  | 127,626 |  |  | 154,667 | \nRevenue outside the scope of ASC 606 |  | 17,473 |  | 25,414 |  |  | 36,813 |  |  | 44,332 | \nTotal |  | 80,795 |  | 111,265 |  |  | 164,439 |  |  | 198,999 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months EndedJune 30, 2023 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss)(U.S. GAAP) | 920 |  | 3,657 |  |  | 1,528 |  | 782 |  |  | 486 |  | 342 |  | 373 |  | 298 |  |  |  | (506) |  |  | 7,880 | \nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTax-related items | \u2014 |  | (12) |  |  | \u2014 |  | 18 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | \u2014 |  |  | 6 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(Non-GAAP) | 920 |  | 3,669 |  |  | 1,528 |  | 764 |  |  | 486 |  | 342 |  | 373 |  | 298 |  |  |  | (506) |  |  | 7,874 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months EndedJune 30, 2022 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss)(U.S. GAAP) | 3,749 |  | 7,622 |  |  | 2,655 |  | 2,617 |  |  | 625 |  | 450 |  | 232 |  | 185 |  |  |  | (286) |  |  | 17,850 | \nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nGain/(loss) on sale of assets | 299 |  | \u2014 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | \u2014 |  |  | 299 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(Non-GAAP) | 3,450 |  | 7,622 |  |  | 2,655 |  | 2,617 |  |  | 625 |  | 450 |  | 232 |  | 185 |  |  |  | (286) |  |  | 17,551 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSix Months EndedJune 30, 2023 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss)(U.S. GAAP) | 2,552 |  | 8,482 |  |  | 3,438 |  | 3,055 |  |  | 810 |  | 389 |  | 824 |  | 621 |  |  |  | (861) |  |  | 19,310 | \nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTax-related items | \u2014 |  | (170) |  |  | \u2014 |  | (12) |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | \u2014 |  |  | (182) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(Non-GAAP) | 2,552 |  | 8,652 |  |  | 3,438 |  | 3,067 |  |  | 810 |  | 389 |  | 824 |  | 621 |  |  |  | (861) |  |  | 19,492 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSix Months EndedJune 30, 2022 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss)(U.S. GAAP) | 6,125 |  | 9,734 |  |  | 3,144 |  | 1,933 |  |  | 1,395 |  | 1,086 |  | 478 |  | 415 |  |  |  | (980) |  |  | 23,330 | \nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nImpairments | \u2014 |  | (2,877) |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | (98) |  |  | (2,975) | \nGain/(loss) on sale of assets | 299 |  | \u2014 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | \u2014 |  |  | 299 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther | \u2014 |  | (378) |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | \u2014 |  |  | (378) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(Non-GAAP) | 5,826 |  | 12,989 |  |  | 3,144 |  | 1,933 |  |  | 1,395 |  | 1,086 |  | 478 |  | 415 |  |  |  | (882) |  |  | 26,384 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Financial Results |  |  |  |  |  | \n |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 | 2022 |  | 2023 | 2022\nEarnings (loss)(U.S. GAAP) |  |  |  |  |  | \nUnited States |  | 920 |  | 3,749 |  |  | 2,552 |  | 6,125 | \nNon-U.S. |  | 3,657 |  | 7,622 |  |  | 8,482 |  | 9,734 | \nTotal |  | 4,577 |  | 11,371 |  |  | 11,034 |  | 15,859 | \n |  |  |  |  |  | \nIdentified Items(1) |  |  |  |  |  | \nUnited States |  | \u2014 |  | 299 |  |  | \u2014 |  | 299 | \nNon-U.S. |  | (12) |  | \u2014 |  |  | (170) |  | (3,255) | \nTotal |  | (12) |  | 299 |  |  | (170) |  | (2,956) | \n |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1)(Non-GAAP) |  |  |  |  |  | \nUnited States |  | 920 |  | 3,450 |  |  | 2,552 |  | 5,826 | \nNon-U.S. |  | 3,669 |  | 7,622 |  |  | 8,652 |  | 12,989 | \nTotal |  | 4,589 |  | 11,072 |  |  | 11,204 |  | 18,815 |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Second Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Operational Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n |  | 2023 |  | 2022 |  | 2023 |  | 2022\nNet production of crude oil, natural gas liquids, bitumen and synthetic oil(thousands of barrels daily) |  |  |  |  |  |  |  | \nUnited States |  | 785 |  |  | 777 |  |  | 802 |  |  | 765 | \nCanada/Other Americas |  | 618 |  |  | 556 |  |  | 645 |  |  | 516 | \nEurope |  | 4 |  |  | 4 |  |  | 4 |  |  | 4 | \nAfrica |  | 206 |  |  | 224 |  |  | 213 |  |  | 240 | \nAsia |  | 702 |  |  | 691 |  |  | 725 |  |  | 714 | \nAustralia/Oceania |  | 38 |  |  | 46 |  |  | 35 |  |  | 43 | \nWorldwide |  | 2,353 |  |  | 2,298 |  |  | 2,424 |  |  | 2,282 | \n |  |  |  |  |  |  |  | \nNet natural gas production available for sale(millions of cubic feet daily) |  |  |  |  |  |  |  | \nUnited States |  | 2,346 |  |  | 2,699 |  |  | 2,357 |  |  | 2,738 | \nCanada/Other Americas |  | 97 |  |  | 180 |  |  | 94 |  |  | 180 | \nEurope |  | 375 |  |  | 825 |  |  | 461 |  |  | 798 | \nAfrica |  | 86 |  |  | 67 |  |  | 110 |  |  | 63 | \nAsia |  | 3,350 |  |  | 3,320 |  |  | 3,473 |  |  | 3,330 | \nAustralia/Oceania |  | 1,275 |  |  | 1,515 |  |  | 1,276 |  |  | 1,421 | \nWorldwide |  | 7,529 |  |  | 8,606 |  |  | 7,771 |  |  | 8,530 | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nOil-equivalent production(1)(thousands of oil-equivalent barrels daily) |  | 3,608 |  |  | 3,732 |  |  | 3,719 |  |  | 3,704 | \n |  |  |  |  |  |  |  | \n(1)Natural gas is converted to an oil-equivalent basis at six million cubic feet per one thousand barrels.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Additional Information |  |  |  |  |  | \n |  |  |  |  |  | \n(thousands of barrels daily) |  |  | Three Months EndedJune 30 |  |  | Six Months EndedJune 30\nVolumes reconciliation (Oil-equivalent production)(1) |  |  |  |  |  | \n2022 |  |  | 3,732 |  |  | 3,704\nEntitlements - Net Interest |  |  | (26) |  |  | (46)\nEntitlements - Price / Spend / Other |  |  | 77 |  |  | 64\nGovernment Mandates |  |  | (47) |  |  | (25)\nDivestments |  |  | (152) |  |  | (141)\nGrowth / Other |  |  | 24 |  |  | 163\n2023 |  |  | 3,608 |  |  | 3,719\n |  |  |  |  |  | \n(1)Natural gas is converted to an oil-equivalent basis at six million cubic feet per one thousand barrels.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n2Q 2023versus2Q 2022 | 3.6 million oil-equivalent barrels per day in 2Q 2023 decreased 124 thousand oil-equivalent barrels per day from 2Q 2022. Net production increased 24 thousand oil-equivalent barrels per day, excluding the impacts from entitlements, divestments, the Russia expropriation, and higher government-mandated curtailments.\nYTD 2023versusYTD 2022 | 3.7 million oil-equivalent barrels per day in 2023 increased 15 thousand oil-equivalent barrels per day from 2022. Net production increased 163 thousand oil-equivalent barrels per day driven by growth in Guyana and Permian, excluding the impacts from entitlements, divestments, the Russia expropriation, and higher government-mandated curtailments.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nEarnings (loss)(U.S. GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 1,528 |  |  | 2,655 |  |  | 3,438 |  |  | 3,144 | \nNon-U.S. |  | 782 |  |  | 2,617 |  |  | 3,055 |  |  | 1,933 | \nTotal |  | 2,310 |  |  | 5,273 |  |  | 6,493 |  |  | 5,077 | \n |  |  |  |  |  |  |  | \nIdentified Items(1) |  |  |  |  |  |  |  | \nUnited States |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nNon-U.S. |  | 18 |  |  | \u2014 |  |  | (12) |  |  | \u2014 | \nTotal |  | 18 |  |  | \u2014 |  |  | (12) |  |  | \u2014 | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1)(Non-GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 1,528 |  |  | 2,655 |  |  | 3,438 |  |  | 3,144 | \nNon-U.S. |  | 764 |  |  | 2,617 |  |  | 3,067 |  |  | 1,933 | \nTotal |  | 2,292 |  |  | 5,273 |  |  | 6,505 |  |  | 5,077 | \n |  |  |  |  |  |  |  | \nDue to rounding, numbers presented may not add up precisely to the totals indicated. |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Second Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Operational Results |  |  |  |  |  | \n |  |  |  |  |  | \n(thousands of barrels daily) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 | 2022 |  | 2023 | 2022\nRefinery throughput |  |  |  |  |  | \nUnited States |  | 1,944 |  | 1,686 |  |  | 1,794 |  | 1,686 | \nCanada |  | 388 |  | 413 |  |  | 403 |  | 406 | \nEurope |  | 1,209 |  | 1,164 |  |  | 1,199 |  | 1,179 | \nAsia Pacific |  | 463 |  | 532 |  |  | 514 |  | 534 | \nOther |  | 169 |  | 193 |  |  | 176 |  | 180 | \nWorldwide |  | 4,173 |  | 3,988 |  |  | 4,086 |  | 3,985 | \n |  |  |  |  |  | \nEnergy Products sales(2) |  |  |  |  |  | \nUnited States |  | 2,743 |  | 2,452 |  |  | 2,601 |  | 2,358 | \nNon-U.S. |  | 2,916 |  | 2,858 |  |  | 2,867 |  | 2,853 | \nWorldwide |  | 5,658 |  | 5,310 |  |  | 5,469 |  | 5,211 | \n |  |  |  |  |  | \nGasoline, naphthas |  | 2,401 |  | 2,208 |  |  | 2,290 |  | 2,161 | \nHeating oils, kerosene, diesel |  | 1,842 |  | 1,755 |  |  | 1,806 |  | 1,739 | \nAviation fuels |  | 344 |  | 350 |  |  | 328 |  | 319 | \nHeavy fuels |  | 228 |  | 228 |  |  | 221 |  | 238 | \nOther energy products |  | 844 |  | 769 |  |  | 823 |  | 753 | \n |  |  |  |  |  | \n(2)Data reported net of purchases/sales contracts with the same counterparty.\nDue to rounding, numbers presented may not add up precisely to the totals indicated.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nEarnings (loss)(U.S. GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 486 |  |  | 625 |  |  | 810 |  |  | 1,395 | \nNon-U.S. |  | 342 |  |  | 450 |  |  | 389 |  |  | 1,086 | \nTotal |  | 828 |  |  | 1,076 |  |  | 1,199 |  |  | 2,481 | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1)(Non-GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 486 |  |  | 625 |  |  | 810 |  |  | 1,395 | \nNon-U.S. |  | 342 |  |  | 450 |  |  | 389 |  |  | 1,086 | \nTotal |  | 828 |  |  | 1,076 |  |  | 1,199 |  |  | 2,481 | \n |  |  |  |  |  |  |  | \n(1)Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.\nDue to rounding, numbers presented may not add up precisely to the totals indicated.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Second Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Operational Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(thousands of metric tons) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nChemical Products sales(1) |  |  |  |  |  |  |  | \nUnited States |  | 1,725 |  |  | 1,998 |  |  | 3,286 |  |  | 4,030 | \nNon-U.S. |  | 3,124 |  |  | 2,812 |  |  | 6,212 |  |  | 5,798 | \nWorldwide |  | 4,849 |  |  | 4,811 |  |  | 9,498 |  |  | 9,829 | \n |  |  |  |  |  |  |  | \n(1)Data reported net of purchases/sales contracts with the same counterparty.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nEarnings (loss)(U.S. GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 373 |  |  | 232 |  |  | 824 |  |  | 478 | \nNon-U.S. |  | 298 |  |  | 185 |  |  | 621 |  |  | 415 | \nTotal |  | 671 |  |  | 417 |  |  | 1,445 |  |  | 893 | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1)(Non-GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 373 |  |  | 232 |  |  | 824 |  |  | 478 | \nNon-U.S. |  | 298 |  |  | 185 |  |  | 621 |  |  | 415 | \nTotal |  | 671 |  |  | 417 |  |  | 1,445 |  |  | 893 | \n |  |  |  |  |  |  |  | \n(1)Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Second Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Operational Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(thousands of metric tons) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nSpecialty Products sales(1) |  |  |  |  |  |  |  | \nUnited States |  | 514 |  |  | 590 |  |  | 991 |  |  | 1,111 | \nNon-U.S. |  | 1,391 |  |  | 1,511 |  |  | 2,855 |  |  | 2,995 | \nWorldwide |  | 1,905 |  |  | 2,100 |  |  | 3,845 |  |  | 4,107 | \n |  |  |  |  |  |  |  | \n(1)Data reported net of purchases/sales contracts with the same counterparty. |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCorporate and Financing Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\n |  |  |  |  |  |  |  | \nEarnings (loss) (U.S. GAAP) |  | (506) |  |  | (286) |  |  | (861) |  |  | (980) | \nIdentified Items(2) |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | (98) | \nEarnings (loss) excluding Identified Items(2)(Non-GAAP) |  | (506) |  |  | (286) |  |  | (861) |  |  | (882) | \n |  |  |  |  |  |  |  | \n(2)Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n |  | 2023 |  | 2022 |  | 2023 |  | 2022\nNet cash provided by/(used in) |  |  |  |  |  |  |  |  | \nOperating activities |  |  |  |  |  |  | 25,724 |  |  | 34,751 | \nInvesting activities |  |  |  |  |  |  | (9,281) |  |  | (7,009) | \nFinancing activities |  |  |  |  |  |  | (16,683) |  |  | (15,384) | \nEffect of exchange rate changes |  |  |  |  |  |  | 132 |  |  | (299) | \nIncrease/(decrease) in cash and cash equivalents |  |  |  |  |  |  | (108) |  |  | 12,059 | \n |  |  |  |  |  |  |  |  | \nCash and cash equivalents (at end of period) |  |  |  |  |  |  | 29,557 |  |  | 18,861 | \n |  |  |  |  |  |  |  |  | \nCash flow from operations and asset sales |  |  |  |  |  |  |  |  | \nNet cash provided by operating activities (U.S. GAAP) |  |  | 9,383 |  |  | 19,963 |  |  | 25,724 |  |  | 34,751 | \nProceeds associated with sales of subsidiaries, property, plant & equipment, and sales and returns of investments |  |  | 1,287 |  |  | 939 |  |  | 2,141 |  |  | 1,232 | \nCash flow from operations and asset sales(Non-GAAP) |  |  | 10,670 |  |  | 20,902 |  |  | 27,865 |  |  | 35,983 | \n |  |  |  |  |  |  |  |  | \nBecause of the ongoing nature of our asset management and divestment program, we believe it is useful for investors to consider proceeds associated with asset sales together with cash provided by operating activities when evaluating cash available for investment in the business and financing activities, including shareholder distributions.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n(millions of dollars) |  |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n |  | 2023 |  | 2022 |  | 2023 |  | 2022\nIncome taxes |  |  | 3,503 |  |  | 6,359 |  |  | 8,463 |  |  | 9,165 | \nEffective income tax rate |  |  | 33 | % |  | 31 | % |  | 34 | % |  | 34 | %\nTotal other taxes and duties(1) |  |  | 8,328 |  |  | 7,779 |  |  | 16,423 |  |  | 16,228 | \nTotal |  |  | 11,831 |  |  | 14,138 |  |  | 24,886 |  |  | 25,393 | \n |  |  |  |  |  |  |  |  | \n(1)Includes \u201cOther taxes and duties\u201d plus taxes that are included in \u201cProduction and manufacturing expenses\u201d and \u201cSelling, general and administrative expenses\u201d.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedJune 30, |  | Six Months EndedJune 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nUpstream (including exploration expenses) |  | 4,609 |  |  | 3,627 |  |  | 9,190 |  |  | 7,506 | \nEnergy Products |  | 731 |  |  | 506 |  |  | 1,416 |  |  | 1,072 | \nChemical Products |  | 659 |  |  | 419 |  |  | 1,490 |  |  | 855 | \nSpecialty Products |  | 103 |  |  | 56 |  |  | 194 |  |  | 79 | \nOther |  | 64 |  |  | 1 |  |  | 256 |  |  | 1 | \nTotal |  | 6,166 |  |  | 4,609 |  |  | 12,546 |  |  | 9,513 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIssuer Purchases of Equity Securities for Quarter Ended June\u00a030, 2023\n |  |  |  |  |  |  |  | \n |  | Total Numberof SharesPurchased(1) |  | AveragePrice Paidper Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(3) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program(Billions of dollars)\nApril 2023 |  | 11,468,654 |  | $115.97 |  | 11,467,390 |  | $29.3\nMay 2023 |  | 14,417,519 |  | $106.81 |  | 14,416,979 |  | $27.8\nJune 2023 |  | 13,945,206 |  | $105.42 |  | 13,945,174 |  | $26.3\nTotal |  | 39,831,379 |  | $108.96 |  | 39,829,543 |  | \n |  |  |  |  |  |  |  | \n(1)Includes shares withheld from participants in the company's incentive program for personal income taxes.\n(2)Excludes 1% excise tax on stock repurchases of $43M.\n(3)In its 2022 Corporate Plan Update released December 8, 2022, the Corporation stated that the company expanded its share repurchase program to up to $50 billion through 2024, including $15 billion of repurchases in 2022. Purchases were made under terms intended to qualify for exemption under Rules 10b-18 and 10b5-1. The Corporation will temporarily pause repurchases due to trading restrictions during the proxy solicitation period for the Denbury acquisition, which we expect to occur during the second half of 2023.\n  |  |  |  |  |  |  |  | \nExhibit |  | Description\n |  | \n |  | \n |  | \n |  | \n |  | \n |  | \n31.1 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Chief Executive Officer.\n31.2 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Chief Financial Officer.\n31.3 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Principal Accounting Officer.\n32.1 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Chief Executive Officer.\n32.2 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Chief Financial Officer.\n32.3 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Principal Accounting Officer.\n101 |  | Interactive Data Files (formatted as Inline XBRL).\n104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).  |  |  |  |  |  |  |  | \n | EXXON MOBIL CORPORATION\nDate: August\u00a01, 2023 | By: | /s/ LEN M. FOX\n |  | Len M. Fox\n |  | Vice President, Controller and\n |  | Principal Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Exxon Mobil, in 2023 Q3, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  |  |  |  |  |  |  | \nNew Jersey |  | 13-5409005\n(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification Number)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTitle of Each Class |  | Trading Symbol |  | Name of Each Exchange on Which Registered\nCommon Stock, without par value |  | XOM |  | New York Stock Exchange\n0.142% Notes due 2024 |  | XOM24B |  | New York Stock Exchange\n0.524% Notes due 2028 |  | XOM28 |  | New York Stock Exchange\n0.835% Notes due 2032 |  | XOM32 |  | New York Stock Exchange\n1.408% Notes due 2039 |  | XOM39A |  | New York Stock Exchange  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2611 | Accelerated filer | \u2610\n |  |  | \nNon-accelerated filer | \u2610 | Smaller reporting company | \u2610\n\n | Emerging growth company | \u2610  |  |  |  |  |  |  |  | \nClass |  | Outstanding as of September\u00a030, 2023\nCommon stock, without par value |  | 3,962,917,886  |  |  |  |  | \nPART I. FINANCIAL INFORMATION\n | \nItem 1. Financial Statements | \n | \nCondensed Consolidated Statement of Income - Three and nine months ended September\u00a030, 2023 and 2022 | 3\n | \nCondensed Consolidated Statement of Comprehensive Income - Three and nine months ended September\u00a030, 2023 and 2022 | 4\n | \nCondensed Consolidated Balance Sheet - As of September\u00a030, 2023 and December\u00a031, 2022 | 5\n | \nCondensed Consolidated Statement of Cash Flows - Nine months ended September\u00a030, 2023 and 2022 | 6\n | \nCondensed Consolidated Statement of Changes in Equity - Three months ended September\u00a030, 2023 and 2022 | 7\n | \nCondensed Consolidated Statement of Changes in Equity - Nine months ended September\u00a030, 2023 and 2022 | 8\n | \n | \n | \nNotes to Condensed Consolidated Financial Statements | 9\n | \nItem 2. Management's Discussion and Analysis of Financial Condition and Results of Operations | 18\n | \nItem 3. Quantitative and Qualitative Disclosures About Market Risk | 34\n | \nItem 4. Controls and Procedures | 34\n | \n | \nPART II. OTHER INFORMATION\n | \nItem 1. Legal Proceedings | 35\n | \n | \n | \nItem 2. Unregistered Sales of Equity Securities and Use of Proceeds | 35\n | \nItem 5. Other Information | 35\n | \nItem 6. Exhibits | 35\n | \nIndex to Exhibits | 36\n | \nSignature | 37\n |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nITEM 1. FINANCIAL STATEMENTS |  |   |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF INCOME  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 | 2022 |  | 2023 | 2022\nRevenues and other income |  |  |  |  |  | \nSales and other operating revenue |  | 88,570 |  | 106,512 |  |  | 253,009 |  | 305,511 | \nIncome from equity affiliates |  | 1,457 |  | 4,632 |  |  | 5,220 |  | 10,858 | \nOther income |  | 733 |  | 926 |  |  | 2,009 |  | 1,882 | \nTotal revenues and other income |  | 90,760 |  | 112,070 |  |  | 260,238 |  | 318,251 | \nCosts and other deductions |  |  |  |  |  | \nCrude oil and product purchases |  | 53,076 |  | 60,197 |  |  | 146,677 |  | 178,198 | \nProduction and manufacturing expenses |  | 8,696 |  | 11,317 |  |  | 26,992 |  | 32,244 | \nSelling, general and administrative expenses |  | 2,489 |  | 2,324 |  |  | 7,328 |  | 7,263 | \nDepreciation and depletion (includes impairments) |  | 4,415 |  | 5,642 |  |  | 12,901 |  | 18,976 | \nExploration expenses, including dry holes |  | 338 |  | 218 |  |  | 612 |  | 677 | \nNon-service pension and postretirement benefit expense |  | 166 |  | 154 |  |  | 497 |  | 382 | \nInterest expense |  | 169 |  | 209 |  |  | 577 |  | 591 | \nOther taxes and duties |  | 7,712 |  | 6,587 |  |  | 22,496 |  | 21,009 | \nTotal costs and other deductions |  | 77,061 |  | 86,648 |  |  | 218,080 |  | 259,340 | \nIncome (loss) before income taxes |  | 13,699 |  | 25,422 |  |  | 42,158 |  | 58,911 | \nIncome tax expense (benefit) |  | 4,353 |  | 5,224 |  |  | 12,816 |  | 14,389 | \nNet income (loss) including noncontrolling interests |  | 9,346 |  | 20,198 |  |  | 29,342 |  | 44,522 | \nNet income (loss) attributable to noncontrolling interests |  | 276 |  | 538 |  |  | 962 |  | 1,532 | \nNet income (loss) attributable to ExxonMobil |  | 9,070 |  | 19,660 |  |  | 28,380 |  | 42,990 | \n |  |  |  |  |  | \nEarnings (loss) per common share(dollars) |  | 2.25 |  | 4.68 |  |  | 6.98 |  | 10.17 | \n |  |  |  |  |  | \nEarnings (loss) per common share - assuming dilution(dollars) |  | 2.25 |  | 4.68 |  |  | 6.98 |  | 10.17 | \n |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nNet income (loss) including noncontrolling interests |  | 9,346 |  |  | 20,198 |  |  | 29,342 |  |  | 44,522 | \n |  |  |  |  |  |  |  | \nOther comprehensive income (net of income taxes) |  |  |  |  |  |  |  | \nForeign exchange translation adjustment |  | (933) |  |  | (3,361) |  |  | (246) |  |  | (5,157) | \nAdjustment for foreign exchange translation (gain)/lossincluded in net income |  | 549 |  |  | \u2014 |  |  | 549 |  |  | \u2014 | \nPostretirement benefits reserves adjustment (excluding amortization) |  | 11 |  |  | 108 |  |  | 47 |  |  | 368 | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  | 6 |  |  | 128 |  |  | 19 |  |  | 323 | \nTotal other comprehensive income (loss) |  | (367) |  |  | (3,125) |  |  | 369 |  |  | (4,466) | \nComprehensive income (loss) including noncontrolling interests |  | 8,979 |  |  | 17,073 |  |  | 29,711 |  |  | 40,056 | \nComprehensive income (loss) attributable to noncontrolling interests |  | 340 |  |  | 199 |  |  | 1,149 |  |  | 1,105 | \nComprehensive income (loss) attributable to ExxonMobil |  | 8,639 |  |  | 16,874 |  |  | 28,562 |  |  | 38,951 | \n |  |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED BALANCE SHEET  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | September 30, 2023 |  | December 31, 2022 |  |  | \n |  |  |  |  |  |  | \nASSETS |  |  |  |  |  |  | \nCurrent assets |  |  |  |  |  |  | \nCash and cash equivalents |  | 32,944 |  |  | 29,640 |  |  |  | \nCash and cash equivalents \u2013 restricted |  | 29 |  |  | 25 |  |  |  | \nNotes and accounts receivable \u2013 net |  | 41,814 |  |  | 41,749 |  |  |  | \nInventories |  |  |  |  |  |  | \nCrude oil, products and merchandise |  | 20,052 |  |  | 20,434 |  |  |  | \nMaterials and supplies |  | 4,398 |  |  | 4,001 |  |  |  | \nOther current assets |  | 1,905 |  |  | 1,782 |  |  |  | \nTotal current assets |  | 101,142 |  |  | 97,631 |  |  |  | \nInvestments, advances and long-term receivables |  | 48,066 |  |  | 49,793 |  |  |  | \nProperty, plant and equipment \u2013 net |  | 205,862 |  |  | 204,692 |  |  |  | \nOther assets, including intangibles \u2013 net |  | 17,189 |  |  | 16,951 |  |  |  | \nTotal Assets |  | 372,259 |  |  | 369,067 |  |  |  | \n |  |  |  |  |  |  | \nLIABILITIES |  |  |  |  |  |  | \nCurrent liabilities |  |  |  |  |  |  | \nNotes and loans payable |  | 4,743 |  |  | 634 |  |  |  | \nAccounts payable and accrued liabilities |  | 62,257 |  |  | 63,197 |  |  |  | \nIncome taxes payable |  | 4,186 |  |  | 5,214 |  |  |  | \nTotal current liabilities |  | 71,186 |  |  | 69,045 |  |  |  | \nLong-term debt |  | 36,510 |  |  | 40,559 |  |  |  | \nPostretirement benefits reserves |  | 10,174 |  |  | 10,045 |  |  |  | \nDeferred income tax liabilities |  | 23,912 |  |  | 22,874 |  |  |  | \nLong-term obligations to equity companies |  | 2,076 |  |  | 2,338 |  |  |  | \nOther long-term obligations |  | 20,868 |  |  | 21,733 |  |  |  | \nTotal Liabilities |  | 164,726 |  |  | 166,594 |  |  |  | \n |  |  |  |  |  |  | \nCommitments and contingencies (Note 3) |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nEQUITY |  |  |  |  |  |  | \nCommon stock without par value(9,000million shares authorized,8,019million shares issued) |  | 16,165 |  |  | 15,752 |  |  |  | \nEarnings reinvested |  | 450,138 |  |  | 432,860 |  |  |  | \nAccumulated other comprehensive income |  | (13,088) |  |  | (13,270) |  |  |  | \nCommon stock held in treasury(4,056million shares at September\u00a030, 2023 and3,937million shares at December\u00a031, 2022) |  | (253,512) |  |  | (240,293) |  |  |  | \nExxonMobil share of equity |  | 199,703 |  |  | 195,049 |  |  |  | \nNoncontrolling interests |  | 7,830 |  |  | 7,424 |  |  |  | \nTotal Equity |  | 207,533 |  |  | 202,473 |  |  |  | \nTotal Liabilities and Equity |  | 372,259 |  |  | 369,067 |  |  |  | \n |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements. |  |  |   |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Nine Months EndedSeptember 30,\n | 2023 | 2022\n |  |  | \nCASH FLOWS FROM OPERATING ACTIVITIES |  |  | \nNet income (loss) including noncontrolling interests |  | 29,342 |  | 44,522 | \nDepreciation and depletion (includes impairments) |  | 12,901 |  | 18,976 | \n |  |  | \nChanges in operational working capital, excluding cash and debt |  | (2,064) |  | 6 | \nAll other items \u2013 net |  | 1,508 |  | (4,328) | \nNet cash provided by operating activities |  | 41,687 |  | 59,176 | \n |  |  | \nCASH FLOWS FROM INVESTING ACTIVITIES |  |  | \nAdditions to property, plant and equipment |  | (15,691) |  | (12,624) | \nProceeds from asset sales and returns of investments |  | 3,058 |  | 3,914 | \nAdditional investments and advances |  | (1,141) |  | (915) | \nOther investing activities including collection of advances |  | 214 |  | 238 | \nNet cash used in investing activities |  | (13,560) |  | (9,387) | \n |  |  | \nCASH FLOWS FROM FINANCING ACTIVITIES |  |  | \nAdditions to long-term debt(1) |  | 805 |  | 55 | \nReductions in long-term debt |  | (11) |  | \u2014 | \n |  |  | \nReductions in short-term debt |  | (222) |  | (3,895) | \nAdditions/(reductions) in debt with three months or less maturity |  | (283) |  | 1,638 | \nContingent consideration payments |  | (68) |  | (58) | \nCash dividends to ExxonMobil shareholders |  | (11,102) |  | (11,172) | \nCash dividends to noncontrolling interests |  | (511) |  | (191) | \nChanges in noncontrolling interests |  | (258) |  | (1,074) | \nCommon stock acquired |  | (13,092) |  | (10,480) | \nNet cash used in financing activities |  | (24,742) |  | (25,177) | \n |  |  | \nEffects of exchange rate changes on cash |  | (77) |  | (950) | \nIncrease/(decrease) in cash and cash equivalents |  | 3,308 |  | 23,662 | \nCash and cash equivalents at beginning of period |  | 29,665 |  | 6,802 | \nCash and cash equivalents at end of period |  | 32,973 |  | 30,464 | \n |  |  | \nSUPPLEMENTAL DISCLOSURES |  |  | \nIncome taxes paid |  | 11,627 |  | 10,172 | \nCash interest paid |  |  | \nIncluded in cash flows from operating activities |  | 578 |  | 660 | \nCapitalized, included in cash flows from investing activities |  | 862 |  | 605 | \nTotal cash interest paid |  | 1,440 |  | 1,265 | \n |  |  | \n |  |  | \nNoncash right of use assets recorded in exchange for lease liabilities |  |  | \nOperating leases |  | 1,421 |  | 1,648 | \nFinance leases |  | 438 |  | 730 | \n |  |  | \n\n |  |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(1) | Includes $568million issued to facilitate the sale of an entity where the buyer assumed the debt upon closing; no longer on the Condensed Consolidated Balance Sheet at the end of the third quarter 2023.\n |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF CHANGE IN EQUITY  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | ExxonMobil Share of Equity |  | \n |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | Common Stock | Earnings Reinvested | Accumulated Other Comprehensive Income | Common Stock Held in Treasury | ExxonMobil Share of Equity | Non-controlling Interests | Total Equity\n |  |  |  |  |  |  |  | \nBalance as of June 30, 2022 |  | 16,018 |  | 407,902 |  | (15,017) |  | (231,587) |  | 177,316 |  | 7,192 |  | 184,508 | \nAmortization of stock-based awards |  | 91 |  | \u2014 |  | \u2014 |  | \u2014 |  | 91 |  | \u2014 |  | 91 | \nOther |  | (3) |  | \u2014 |  | \u2014 |  | \u2014 |  | (3) |  | (29) |  | (32) | \nNet income (loss) for the period |  | \u2014 |  | 19,660 |  | \u2014 |  | \u2014 |  | 19,660 |  | 538 |  | 20,198 | \nDividends - common shares |  | \u2014 |  | (3,685) |  | \u2014 |  | \u2014 |  | (3,685) |  | (68) |  | (3,753) | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | (2,786) |  | \u2014 |  | (2,786) |  | (339) |  | (3,125) | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (4,494) |  | (4,494) |  | (351) |  | (4,845) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 1 |  | 1 |  | \u2014 |  | 1 | \nBalance as of September 30, 2022 |  | 16,106 |  | 423,877 |  | (17,803) |  | (236,080) |  | 186,100 |  | 6,943 |  | 193,043 | \n |  |  |  |  |  |  |  | \nBalance as of June 30, 2023 |  | 16,029 |  | 444,731 |  | (12,657) |  | (249,057) |  | 199,046 |  | 7,951 |  | 206,997 | \nAmortization of stock-based awards |  | 138 |  | \u2014 |  | \u2014 |  | \u2014 |  | 138 |  | \u2014 |  | 138 | \nOther |  | (2) |  | \u2014 |  | \u2014 |  | \u2014 |  | (2) |  | 59 |  | 57 | \nNet income (loss) for the period |  | \u2014 |  | 9,070 |  | \u2014 |  | \u2014 |  | 9,070 |  | 276 |  | 9,346 | \nDividends - common shares |  | \u2014 |  | (3,663) |  | \u2014 |  | \u2014 |  | (3,663) |  | (218) |  | (3,881) | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | (431) |  | \u2014 |  | (431) |  | 64 |  | (367) | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (4,456) |  | (4,456) |  | (302) |  | (4,758) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 1 |  | 1 |  | \u2014 |  | 1 | \nBalance as of September 30, 2023 |  | 16,165 |  | 450,138 |  | (13,088) |  | (253,512) |  | 199,703 |  | 7,830 |  | 207,533 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended September 30, 2023 |  | Three Months Ended September 30, 2022\n |  |  |  |  |  |  |  | \nCommon Stock Share Activity(millions of shares) |  | Issued | Held in Treasury | Outstanding |  | Issued | Held in Treasury | Outstanding\nBalance as of June 30 |  | 8,019 |  | (4,016) |  | 4,003 |  |  | 8,019 |  | (3,851) |  | 4,168 | \nAcquisitions |  | \u2014 |  | (40) |  | (40) |  |  | \u2014 |  | (50) |  | (50) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 | \nBalance as of September 30 |  | 8,019 |  | (4,056) |  | 3,963 |  |  | 8,019 |  | (3,901) |  | 4,118 | \n |  |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nCONDENSED CONSOLIDATED STATEMENT OF CHANGE IN EQUITY  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | ExxonMobil Share of Equity |  | \n |  |  |  |  |  |  |  | \n(millions of dollars, unless noted) |  | Common Stock | Earnings Reinvested | Accumulated Other Comprehensive Income | Common Stock Held in Treasury | ExxonMobil Share of Equity | Non-controlling Interests | Total Equity\n |  |  |  |  |  |  |  | \nBalance as of December 31, 2021 |  | 15,746 |  | 392,059 |  | (13,764) |  | (225,464) |  | 168,577 |  | 7,106 |  | 175,683 | \nAmortization of stock-based awards |  | 372 |  | \u2014 |  | \u2014 |  | \u2014 |  | 372 |  | \u2014 |  | 372 | \nOther |  | (12) |  | \u2014 |  | \u2014 |  | \u2014 |  | (12) |  | (30) |  | (42) | \nNet income (loss) for the period |  | \u2014 |  | 42,990 |  | \u2014 |  | \u2014 |  | 42,990 |  | 1,532 |  | 44,522 | \nDividends - common shares |  | \u2014 |  | (11,172) |  | \u2014 |  | \u2014 |  | (11,172) |  | (191) |  | (11,363) | \n |  |  |  |  |  |  |  | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | (4,039) |  | \u2014 |  | (4,039) |  | (427) |  | (4,466) | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (10,620) |  | (10,620) |  | (1,047) |  | (11,667) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 4 |  | 4 |  | \u2014 |  | 4 | \nBalance as of September 30, 2022 |  | 16,106 |  | 423,877 |  | (17,803) |  | (236,080) |  | 186,100 |  | 6,943 |  | 193,043 | \n |  |  |  |  |  |  |  | \nBalance as of December 31, 2022 |  | 15,752 |  | 432,860 |  | (13,270) |  | (240,293) |  | 195,049 |  | 7,424 |  | 202,473 | \nAmortization of stock-based awards |  | 426 |  | \u2014 |  | \u2014 |  | \u2014 |  | 426 |  | \u2014 |  | 426 | \nOther |  | (13) |  | \u2014 |  | \u2014 |  | \u2014 |  | (13) |  | 70 |  | 57 | \nNet income (loss) for the period |  | \u2014 |  | 28,380 |  | \u2014 |  | \u2014 |  | 28,380 |  | 962 |  | 29,342 | \nDividends - common shares |  | \u2014 |  | (11,102) |  | \u2014 |  | \u2014 |  | (11,102) |  | (511) |  | (11,613) | \n |  |  |  |  |  |  |  | \nOther comprehensive income (loss) |  | \u2014 |  | \u2014 |  | 182 |  | \u2014 |  | 182 |  | 187 |  | 369 | \nAcquisitions, at cost |  | \u2014 |  | \u2014 |  | \u2014 |  | (13,224) |  | (13,224) |  | (302) |  | (13,526) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  | 5 |  | 5 |  | \u2014 |  | 5 | \nBalance as of September 30, 2023 |  | 16,165 |  | 450,138 |  | (13,088) |  | (253,512) |  | 199,703 |  | 7,830 |  | 207,533 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Nine Months Ended September 30, 2023 |  | Nine Months Ended September 30, 2022\n |  |  |  |  |  |  |  | \nCommon Stock Share Activity(millions of shares) |  | Issued | Held in Treasury | Outstanding |  | Issued | Held in Treasury | Outstanding\nBalance as of December 31 |  | 8,019 |  | (3,937) |  | 4,082 |  |  | 8,019 |  | (3,780) |  | 4,239 | \nAcquisitions |  | \u2014 |  | (119) |  | (119) |  |  | \u2014 |  | (121) |  | (121) | \nDispositions |  | \u2014 |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 | \nBalance as of September 30 |  | 8,019 |  | (4,056) |  | 3,963 |  |  | 8,019 |  | (3,901) |  | 4,118 | \n |  |  |  |  |  |  |  | \nThe information in the Notes to Condensed Consolidated Financial Statements is an integral part of these statements.  |  |  |  |  | \n | \nNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  |  |  |  |  |  |  |  |  |  |  | \n | September 30, 2023\n |  |  | \n(millions of dollars) | Equity CompanyObligations(1) | Other Third-Party Obligations | Total\nGuarantees |  |  | \nDebt-related | 1,188 |  | 152 |  | 1,340 | \nOther | 706 |  | 5,664 |  | 6,370 | \nTotal | 1,894 |  | 5,816 |  | 7,710 | \n |  |  | \n(1)ExxonMobil share |  |  |   |  |  |  |  |  |  |  |  |  |  | \nExxonMobil Share of Accumulated OtherComprehensive Income(millions of dollars) | Cumulative Foreign Exchange Translation Adjustment | Postretirement Benefits Reserves Adjustment | Total\nBalance as of December 31, 2021 | (11,499) |  | (2,265) |  | (13,764) | \nCurrent period change excluding amounts reclassified from accumulated other comprehensive income(1) | (4,680) |  | 335 |  | (4,345) | \nAmounts reclassified from accumulated other comprehensive income | \u2014 |  | 306 |  | 306 | \nTotal change in accumulated other comprehensive income | (4,680) |  | 641 |  | (4,039) | \nBalance as of September 30, 2022 | (16,179) |  | (1,624) |  | (17,803) | \n |  |  | \nBalance as of December 31, 2022 | (14,591) |  | 1,321 |  | (13,270) | \nCurrent period change excluding amounts reclassified from accumulated other comprehensive income(1) | (241) |  | 44 |  | (197) | \nAmounts reclassified from accumulated other comprehensive income | 367 |  | 12 |  | 379 | \nTotal change in accumulated other comprehensive income | 126 |  | 56 |  | 182 | \nBalance as of September 30, 2023 | (14,465) |  | 1,377 |  | (13,088) | \n |  |  | \n(1)Cumulative Foreign Exchange Translation Adjustment includes net investment hedge gain/(loss) net of taxes of $25million and $551million in 2023 and 2022, respectively.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nAmounts Reclassified Out of Accumulated OtherComprehensive Income - Before-tax Income/(Expense)(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 | 2022 |  | 2023 |  | 2022\nForeign exchange translation gain/(loss) included in net income(Statement of Income line: Other income) |  | (549) |  | \u2014 |  |  | (549) |  |  | \u2014 | \n |  |  |  |  |  |  | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  |  |  |  |  |  | \n(Statement of Income line: Non-service pension and postretirement benefit expense) |  | (8) |  | (163) |  |  | (22) |  |  | (415) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIncome Tax (Expense)/Credit ForComponents of Other Comprehensive Income(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n2023 | 2022 |  | 2023 |  | 2022\n |  |  |  | \nForeign exchange translation adjustment |  | 83 |  | (61) |  |  | 216 |  |  | (151) | \nPostretirement benefits reserves adjustment (excluding amortization) |  | (15) |  | (82) |  |  | 16 |  |  | (205) | \nAmortization and settlement of postretirement benefits reserves adjustment included in net periodic benefit costs |  | (2) |  | (35) |  |  | (3) |  |  | (92) | \nTotal |  | 66 |  | (178) |  |  | 229 |  |  | (448) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings per common share |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n2023 | 2022 |  | 2023 | 2022\nNet income (loss) attributable to ExxonMobil(millions of dollars) |  | 9,070 |  | 19,660 |  |  | 28,380 |  | 42,990 | \nWeighted-average number of common shares outstanding(millions of shares)(1) |  | 4,025 |  | 4,185 |  |  | 4,064 |  | 4,227 | \nEarnings (loss) per common share(dollars)(2) |  | 2.25 |  | 4.68 |  |  | 6.98 |  | 10.17 | \nDividends paid per common share(dollars) |  | 0.91 |  | 0.88 |  |  | 2.73 |  | 2.64 | \n |  |  |  |  |  | \n(1)Includes restricted shares not vested.\n(2)Earnings (loss) per common share and earnings (loss) per common share \u2013 assuming dilution are the same in each period shown.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n2023 | 2022 |  | 2023 | 2022\nComponents of net benefit cost |  |  |  |  |  | \nPension Benefits - U.S. |  |  |  |  |  | \nService cost |  | 111 |  | 173 |  |  | 353 |  | 529 | \nInterest cost |  | 169 |  | 130 |  |  | 500 |  | 388 | \nExpected return on plan assets |  | (133) |  | (140) |  |  | (399) |  | (420) | \nAmortization of actuarial loss/(gain) |  | 21 |  | 39 |  |  | 63 |  | 117 | \nAmortization of prior service cost |  | (8) |  | (8) |  |  | (22) |  | (22) | \nNet pension enhancement and curtailment/settlement cost |  | 8 |  | 87 |  |  | 23 |  | 177 | \nNet benefit cost |  | 168 |  | 281 |  |  | 518 |  | 769 | \n |  |  |  |  |  | \nPension Benefits - Non-U.S. |  |  |  |  |  | \nService cost |  | 81 |  | 138 |  |  | 244 |  | 433 | \nInterest cost |  | 231 |  | 149 |  |  | 697 |  | 466 | \nExpected return on plan assets |  | (172) |  | (198) |  |  | (518) |  | (618) | \nAmortization of actuarial loss/(gain) |  | 15 |  | 44 |  |  | 43 |  | 138 | \nAmortization of prior service cost |  | 13 |  | 10 |  |  | 38 |  | 33 | \nNet pension enhancement and curtailment/settlement cost |  | \u2014 |  | \u2014 |  |  | \u2014 |  | (1) | \nNet benefit cost |  | 168 |  | 143 |  |  | 504 |  | 451 | \n |  |  |  |  |  | \nOther Postretirement Benefits |  |  |  |  |  | \nService cost |  | 20 |  | 30 |  |  | 60 |  | 108 | \nInterest cost |  | 67 |  | 54 |  |  | 206 |  | 162 | \nExpected return on plan assets |  | (4) |  | (4) |  |  | (11) |  | (11) | \nAmortization of actuarial loss/(gain) |  | (30) |  | 1 |  |  | (91) |  | 4 | \nAmortization of prior service cost |  | (11) |  | (10) |  |  | (32) |  | (31) | \nNet benefit cost |  | 42 |  | 71 |  |  | 132 |  | 232 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | September 30, 2023\n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n | Fair Value |  |  |  | \n(millions of dollars) | Level 1 | Level 2 | Level 3 | Total Gross Assets& Liabilities | Effect ofCounterparty Netting | Effect ofCollateralNetting | Difference in Carrying Value and Fair Value | NetCarryingValue\nAssets |  |  |  |  |  |  |  | \nDerivative assets(1) | 7,459 |  | 1,485 |  | \u2014 |  | 8,944 |  | (8,279) |  | (238) |  | \u2014 |  | 427 | \n |  |  |  |  |  |  |  | \nAdvances to/receivables from equity companies(2)(6) | \u2014 |  | 2,456 |  | 4,927 |  | 7,383 |  | \u2014 |  | \u2014 |  | 621 |  | 8,004 | \n |  |  |  |  |  |  |  | \nOther long-term financial assets(3) | 1,294 |  | \u2014 |  | 854 |  | 2,148 |  | \u2014 |  | \u2014 |  | 264 |  | 2,412 | \n |  |  |  |  |  |  |  | \nLiabilities |  |  |  |  |  |  |  | \nDerivative liabilities(4) | 7,354 |  | 1,624 |  | \u2014 |  | 8,978 |  | (8,279) |  | (132) |  | \u2014 |  | 567 | \nLong-term debt(5) | 28,555 |  | 1,164 |  | 4 |  | 29,723 |  | \u2014 |  | \u2014 |  | 5,045 |  | 34,768 | \n |  |  |  |  |  |  |  | \nLong-term obligations to equity companies(6) | \u2014 |  | \u2014 |  | 2,163 |  | 2,163 |  | \u2014 |  | \u2014 |  | (87) |  | 2,076 | \n |  |  |  |  |  |  |  | \nOther long-term financial liabilities(7) | \u2014 |  | \u2014 |  | 665 |  | 665 |  | \u2014 |  | \u2014 |  | 50 |  | 715 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | December 31, 2022\n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n |  | Fair Value |  |  |  | \n(millions of dollars) |  | Level 1 | Level 2 | Level 3 | Total Gross Assets& Liabilities | Effect ofCounterparty Netting | Effect ofCollateralNetting | Difference in Carrying Value and Fair Value | NetCarryingValue\nAssets |  |  |  |  |  |  |  |  | \nDerivative assets(1) |  | 4,309 |  | 3,455 |  | \u2014 |  | 7,764 |  | (5,778) |  | (969) |  | \u2014 |  | 1,017 | \n |  |  |  |  |  |  |  |  | \nAdvances to/receivables from equity companies(2)(6) |  | \u2014 |  | 2,406 |  | 4,958 |  | 7,364 |  | \u2014 |  | \u2014 |  | 685 |  | 8,049 | \n |  |  |  |  |  |  |  |  | \nOther long-term financial assets(3) |  | 1,208 |  | \u2014 |  | 1,413 |  | 2,621 |  | \u2014 |  | \u2014 |  | 346 |  | 2,967 | \n |  |  |  |  |  |  |  |  | \nLiabilities |  |  |  |  |  |  |  |  | \nDerivative liabilities(4) |  | 3,417 |  | 3,264 |  | \u2014 |  | 6,681 |  | (5,778) |  | (79) |  | \u2014 |  | 824 | \nLong-term debt(5) |  | 33,112 |  | 1,880 |  | 6 |  | 34,998 |  | \u2014 |  | \u2014 |  | 4,173 |  | 39,171 | \n |  |  |  |  |  |  |  |  | \nLong-term obligations to equity companies(6) |  | \u2014 |  | \u2014 |  | 2,467 |  | 2,467 |  | \u2014 |  | \u2014 |  | (129) |  | 2,338 | \n |  |  |  |  |  |  |  |  | \nOther long-term financial liabilities(7) |  | \u2014 |  | \u2014 |  | 679 |  | 679 |  | \u2014 |  | \u2014 |  | 38 |  | 717 |   |  | \n(1)Included in the Balance Sheet lines: Notes and accounts receivable - net and Other assets, including intangibles - net.\n(2)Included in the Balance Sheet line: Investments, advances and long-term receivables.\n(3)Included in the Balance Sheet lines: Investments, advances and long-term receivables and Other assets, including intangibles - net.\n(4)Included in the Balance Sheet lines: Accounts payable and accrued liabilities and Other long-term obligations.\n(5)Excluding finance lease obligations.\n(6)Advances to/receivables from equity companies and long-term obligations to equity companies are mainly designated as hierarchy level 3 inputs. The fair value is calculated by discounting the remaining obligations by a rate consistent with the credit quality and industry of the company.\n(7)Included in the Balance Sheet line: Other long-term obligations. Includes contingent consideration related to a prior year acquisition where fair value is based on expected drilling activities and discount rates.  |  |  |  |  |  |  |  | \n\n |  | \n(millions) | September 30, 2023 | December 31, 2022\nCrude oil (barrels) | 14 |  | 4 | \nPetroleum products (barrels) | (95) |  | (52) | \nNatural gas (MMBTUs) | (151) |  | (64) | \n |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | \n\n |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 | 2022 |  | 2023 | 2022\nSales and other operating revenue |  | (1,049) |  | 945 |  |  | (66) |  | (3,003) | \nCrude oil and product purchases |  | 34 |  | (56) |  |  | 14 |  | (82) | \nTotal |  | (1,015) |  | 889 |  |  | (52) |  | (3,085) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 | 2022 |  | 2023 | 2022\nEarnings (Loss) After Income Tax |  |  |  |  |  | \nUpstream |  |  |  |  |  | \nUnited States |  | 1,566 |  | 3,110 |  |  | 4,118 |  | 9,235 | \nNon-U.S.(1) |  | 4,559 |  | 9,309 |  |  | 13,041 |  | 19,043 | \nEnergy Products |  |  |  |  |  | \nUnited States |  | 1,356 |  | 3,008 |  |  | 4,794 |  | 6,152 | \nNon-U.S. |  | 1,086 |  | 2,811 |  |  | 4,141 |  | 4,744 | \nChemical Products |  |  |  |  |  | \nUnited States |  | 338 |  | 635 |  |  | 1,148 |  | 2,030 | \nNon-U.S. |  | (89) |  | 177 |  |  | 300 |  | 1,263 | \nSpecialty Products |  |  |  |  |  | \nUnited States |  | 326 |  | 306 |  |  | 1,150 |  | 784 | \nNon-U.S. |  | 293 |  | 456 |  |  | 914 |  | 871 | \nCorporate and Financing(1) |  | (365) |  | (152) |  |  | (1,226) |  | (1,132) | \nCorporate total |  | 9,070 |  | 19,660 |  |  | 28,380 |  | 42,990 | \n |  |  |  |  |  | \nSales and Other Operating Revenue |  |  |  |  |  | \nUpstream |  |  |  |  |  | \nUnited States |  | 2,587 |  | 4,163 |  |  | 7,030 |  | 10,777 | \nNon-U.S. |  | 3,424 |  | 8,770 |  |  | 12,550 |  | 22,214 | \nEnergy Products |  |  |  |  |  | \nUnited States |  | 27,251 |  | 31,324 |  |  | 78,303 |  | 90,650 | \nNon-U.S. |  | 45,295 |  | 50,215 |  |  | 124,216 |  | 144,734 | \nChemical Products |  |  |  |  |  | \nUnited States |  | 1,924 |  | 2,499 |  |  | 5,945 |  | 8,773 | \nNon-U.S. |  | 3,557 |  | 4,213 |  |  | 10,927 |  | 13,207 | \nSpecialty Products |  |  |  |  |  | \nUnited States |  | 1,503 |  | 1,615 |  |  | 4,613 |  | 4,659 | \nNon-U.S. |  | 2,998 |  | 3,709 |  |  | 9,382 |  | 10,478 | \nCorporate and Financing |  | 31 |  | 4 |  |  | 43 |  | 19 | \nCorporate total |  | 88,570 |  | 106,512 |  |  | 253,009 |  | 305,511 | \n |  |  |  |  |  | \nIntersegment Revenue |  |  |  |  |  | \nUpstream |  |  |  |  |  | \nUnited States |  | 5,091 |  | 6,536 |  |  | 15,091 |  | 19,907 | \nNon-U.S. |  | 10,532 |  | 11,723 |  |  | 28,343 |  | 36,091 | \nEnergy Products |  |  |  |  |  | \nUnited States |  | 6,724 |  | 7,580 |  |  | 17,249 |  | 22,777 | \nNon-U.S. |  | 7,286 |  | 9,551 |  |  | 21,243 |  | 29,161 | \nChemical Products |  |  |  |  |  | \nUnited States |  | 2,231 |  | 2,579 |  |  | 6,103 |  | 6,904 | \nNon-U.S. |  | 976 |  | 1,252 |  |  | 2,730 |  | 4,359 | \nSpecialty Products |  |  |  |  |  | \nUnited States |  | 594 |  | 662 |  |  | 1,958 |  | 1,934 | \nNon-U.S. |  | 142 |  | 246 |  |  | 410 |  | 665 | \nCorporate and Financing |  | 39 |  | 59 |  |  | 167 |  | 175 | \n |  |  |  |  |  | \n(1)Results for first quarter 2022 include charges of $3.3billion in non-U.S. Upstream and $0.1billion in Corporate and Financing associated with the expropriation of the Corporation's interest in Sakhalin-1.\n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nGeographic Sales and Other Operating Revenue |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 | 2022 |  | 2023 | 2022\nUnited States |  | 33,265 |  | 39,601 |  |  | 95,891 |  | 114,859 | \nNon-U.S. |  | 55,305 |  | 66,911 |  |  | 157,118 |  | 190,652 | \nTotal |  | 88,570 |  | 106,512 |  |  | 253,009 |  | 305,511 | \n |  |  |  |  |  | \nSignificant Non-U.S. revenue sources include:(1) |  |  |  |  |  | \nCanada |  | 8,314 |  | 8,468 |  |  | 21,860 |  | 25,105 | \nUnited Kingdom |  | 5,509 |  | 8,845 |  |  | 17,762 |  | 24,699 | \nSingapore |  | 3,880 |  | 5,262 |  |  | 11,369 |  | 14,358 | \nFrance |  | 4,017 |  | 4,449 |  |  | 10,995 |  | 14,071 | \nItaly |  | 2,923 |  | 2,990 |  |  | 7,986 |  | 8,888 | \nBelgium |  | 2,407 |  | 2,755 |  |  | 7,467 |  | 8,632 | \nAustralia |  | 2,448 |  | 2,936 |  |  | 7,269 |  | 8,597 | \n |  |  |  |  |  | \n(1)Revenue is determined by primary country of operations. Excludes certain sales and other operating revenues in non-U.S. operations where attribution to a specific country is not practicable.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSales and other operating revenue(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 | 2022 |  | 2023 |  | 2022\n |  |  |  |  |  |  | \nRevenue from contracts with customers |  | 68,533 |  | 79,358 |  |  | 196,159 |  |  | 234,025 | \nRevenue outside the scope of ASC 606 |  | 20,037 |  | 27,154 |  |  | 56,850 |  |  | 71,486 | \nTotal |  | 88,570 |  | 106,512 |  |  | 253,009 |  |  | 305,511 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months EndedSeptember 30, 2023 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss)(U.S. GAAP) | 1,566 |  | 4,559 |  |  | 1,356 |  | 1,086 |  |  | 338 |  | (89) |  | 326 |  | 293 |  |  |  | (365) |  |  | 9,070 | \nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTax-related items | \u2014 |  | (14) |  |  | \u2014 |  | (33) |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | \u2014 |  |  | (47) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(Non-GAAP) | 1,566 |  | 4,573 |  |  | 1,356 |  | 1,119 |  |  | 338 |  | (89) |  | 326 |  | 293 |  |  |  | (365) |  |  | 9,117 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nThree Months EndedSeptember 30, 2022 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss)(U.S. GAAP) | 3,110 |  | 9,309 |  |  | 3,008 |  | 2,811 |  |  | 635 |  | 177 |  | 306 |  | 456 |  |  |  | (152) |  |  | 19,660 | \nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nImpairments | \u2014 |  | (697) |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | \u2014 |  |  | (697) | \nGain/(loss) on sale of assets | \u2014 |  | 587 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | \u2014 |  |  | 587 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTax-related items | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | 324 |  |  | 324 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther | \u2014 |  | 688 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | 76 |  |  | 764 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(Non-GAAP) | 3,110 |  | 8,731 |  |  | 3,008 |  | 2,811 |  |  | 635 |  | 177 |  | 306 |  | 456 |  |  |  | (552) |  |  | 18,682 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNine Months EndedSeptember 30, 2023 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss)(U.S. GAAP) | 4,118 |  | 13,041 |  |  | 4,794 |  | 4,141 |  |  | 1,148 |  | 300 |  | 1,150 |  | 914 |  |  |  | (1,226) |  |  | 28,380 | \nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTax-related items | \u2014 |  | (184) |  |  | \u2014 |  | (45) |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | \u2014 |  |  | (229) | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(Non-GAAP) | 4,118 |  | 13,225 |  |  | 4,794 |  | 4,186 |  |  | 1,148 |  | 300 |  | 1,150 |  | 914 |  |  |  | (1,226) |  |  | 28,609 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nNine Months EndedSeptember 30, 2022 | Upstream |  | Energy Products |  | Chemical Products | Specialty Products |  |  | Corporate  and Financing |  | Total\n(millions of dollars) | U.S. | Non-U.S. |  | U.S. | Non-U.S. |  | U.S. | Non-U.S. | U.S. | Non-U.S. |  |  | \nEarnings (loss)(U.S. GAAP) | 9,235 |  | 19,043 |  |  | 6,152 |  | 4,744 |  |  | 2,030 |  | 1,263 |  | 784 |  | 871 |  |  |  | (1,132) |  |  | 42,990 | \nIdentified Items |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nImpairments | \u2014 |  | (3,574) |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | (98) |  |  | (3,672) | \nGain/(loss) on sale of assets | 299 |  | 587 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | \u2014 |  |  | 886 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTax-related items | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | 324 |  |  | 324 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nOther | \u2014 |  | 310 |  |  | \u2014 |  | \u2014 |  |  | \u2014 |  | \u2014 |  | \u2014 |  | \u2014 |  |  |  | 76 |  |  | 386 | \n |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(Non-GAAP) | 8,936 |  | 21,720 |  |  | 6,152 |  | 4,744 |  |  | 2,030 |  | 1,263 |  | 784 |  | 871 |  |  |  | (1,434) |  |  | 45,066 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Financial Results |  |  |  |  |  | \n |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 | 2022 |  | 2023 | 2022\nEarnings (loss)(U.S. GAAP) |  |  |  |  |  | \nUnited States |  | 1,566 |  | 3,110 |  |  | 4,118 |  | 9,235 | \nNon-U.S. |  | 4,559 |  | 9,309 |  |  | 13,041 |  | 19,043 | \nTotal |  | 6,125 |  | 12,419 |  |  | 17,159 |  | 28,278 | \n |  |  |  |  |  | \nIdentified Items(1) |  |  |  |  |  | \nUnited States |  | \u2014 |  | \u2014 |  |  | \u2014 |  | 299 | \nNon-U.S. |  | (14) |  | 578 |  |  | (184) |  | (2,677) | \nTotal |  | (14) |  | 578 |  |  | (184) |  | (2,378) | \n |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1)(Non-GAAP) |  |  |  |  |  | \nUnited States |  | 1,566 |  | 3,110 |  |  | 4,118 |  | 8,936 | \nNon-U.S. |  | 4,573 |  | 8,731 |  |  | 13,225 |  | 21,720 | \nTotal |  | 6,139 |  | 11,841 |  |  | 17,343 |  | 30,656 |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Third Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Operational Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n |  | 2023 |  | 2022 |  | 2023 |  | 2022\nNet production of crude oil, natural gas liquids, bitumen and synthetic oil(thousands of barrels daily) |  |  |  |  |  |  |  | \nUnited States |  | 756 |  |  | 783 |  |  | 787 |  |  | 771 | \nCanada/Other Americas |  | 655 |  |  | 641 |  |  | 648 |  |  | 558 | \nEurope |  | 4 |  |  | 4 |  |  | 4 |  |  | 4 | \nAfrica |  | 229 |  |  | 249 |  |  | 218 |  |  | 243 | \nAsia |  | 713 |  |  | 666 |  |  | 721 |  |  | 698 | \nAustralia/Oceania |  | 40 |  |  | 46 |  |  | 37 |  |  | 44 | \nWorldwide |  | 2,397 |  |  | 2,389 |  |  | 2,415 |  |  | 2,318 | \n |  |  |  |  |  |  |  | \nNet natural gas production available for sale(millions of cubic feet daily) |  |  |  |  |  |  |  | \nUnited States |  | 2,271 |  |  | 2,351 |  |  | 2,328 |  |  | 2,607 | \nCanada/Other Americas |  | 94 |  |  | 158 |  |  | 96 |  |  | 175 | \nEurope |  | 368 |  |  | 541 |  |  | 429 |  |  | 711 | \nAfrica |  | 129 |  |  | 70 |  |  | 116 |  |  | 65 | \nAsia |  | 3,528 |  |  | 3,304 |  |  | 3,491 |  |  | 3,321 | \nAustralia/Oceania |  | 1,358 |  |  | 1,539 |  |  | 1,303 |  |  | 1,460 | \nWorldwide |  | 7,748 |  |  | 7,963 |  |  | 7,763 |  |  | 8,339 | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nOil-equivalent production(1)(thousands of oil-equivalent barrels daily) |  | 3,688 |  |  | 3,716 |  |  | 3,709 |  |  | 3,708 | \n |  |  |  |  |  |  |  | \n(1)Natural gas is converted to an oil-equivalent basis at six million cubic feet per one thousand barrels.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nUpstream Additional Information |  |  |  |  |  | \n |  |  |  |  |  | \n(thousands of barrels daily) |  |  | Three Months EndedSeptember 30 |  |  | Nine Months EndedSeptember 30\nVolumes reconciliation (Oil-equivalent production)(1) |  |  |  |  |  | \n2022 |  |  | 3,716 |  |  | 3,708\nEntitlements - Net Interest |  |  | (6) |  |  | (32)\nEntitlements - Price / Spend / Other |  |  | 44 |  |  | 66\nGovernment Mandates |  |  | (36) |  |  | (28)\nDivestments |  |  | (109) |  |  | (130)\nGrowth / Other |  |  | 79 |  |  | 125\n2023 |  |  | 3,688 |  |  | 3,709\n |  |  |  |  |  | \n(1)Natural gas is converted to an oil-equivalent basis at six million cubic feet per one thousand barrels.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n3Q 2023versus3Q 2022 | 3.7 million oil-equivalent barrels per day in 3Q 2023 decreased 28 thousand oil-equivalent barrels per day from 3Q 2022. Excluding the impacts from entitlements, divestments, and higher government-mandated curtailments, net production grew by 79 thousand oil-equivalent barrels per day driven by Permian and Guyana.\nYTD 2023versusYTD 2022 | 3.7 million oil-equivalent barrels per day in 2023 increased 1 thousand oil-equivalent barrels per day from 2022. Excluding the impacts from entitlements, Russia expropriation, divestments, and higher government-mandated curtailments, net production grew by 125 thousand oil-equivalent barrels per day driven by Permian and Guyana.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nEarnings (loss)(U.S. GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 1,356 |  |  | 3,008 |  |  | 4,794 |  |  | 6,152 | \nNon-U.S. |  | 1,086 |  |  | 2,811 |  |  | 4,141 |  |  | 4,744 | \nTotal |  | 2,442 |  |  | 5,819 |  |  | 8,935 |  |  | 10,896 | \n |  |  |  |  |  |  |  | \nIdentified Items(1) |  |  |  |  |  |  |  | \nUnited States |  | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nNon-U.S. |  | (33) |  |  | \u2014 |  |  | (45) |  |  | \u2014 | \nTotal |  | (33) |  |  | \u2014 |  |  | (45) |  |  | \u2014 | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1)(Non-GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 1,356 |  |  | 3,008 |  |  | 4,794 |  |  | 6,152 | \nNon-U.S. |  | 1,119 |  |  | 2,811 |  |  | 4,186 |  |  | 4,744 | \nTotal |  | 2,475 |  |  | 5,819 |  |  | 8,980 |  |  | 10,896 | \n |  |  |  |  |  |  |  | \nDue to rounding, numbers presented may not add up precisely to the totals indicated. |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Third Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nEnergy Products Operational Results |  |  |  |  |  | \n |  |  |  |  |  | \n(thousands of barrels daily) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 | 2022 |  | 2023 | 2022\nRefinery throughput |  |  |  |  |  | \nUnited States |  | 1,868 |  | 1,742 |  |  | 1,819 |  | 1,705 | \nCanada |  | 415 |  | 426 |  |  | 407 |  | 413 | \nEurope |  | 1,251 |  | 1,253 |  |  | 1,217 |  | 1,204 | \nAsia Pacific |  | 517 |  | 557 |  |  | 515 |  | 542 | \nOther |  | 164 |  | 187 |  |  | 171 |  | 182 | \nWorldwide |  | 4,215 |  | 4,165 |  |  | 4,129 |  | 4,046 | \n |  |  |  |  |  | \nEnergy Products sales(2) |  |  |  |  |  | \nUnited States |  | 2,626 |  | 2,479 |  |  | 2,610 |  | 2,399 | \nNon-U.S. |  | 2,925 |  | 3,058 |  |  | 2,887 |  | 2,922 | \nWorldwide |  | 5,551 |  | 5,537 |  |  | 5,496 |  | 5,321 | \n |  |  |  |  |  | \nGasoline, naphthas |  | 2,316 |  | 2,335 |  |  | 2,299 |  | 2,220 | \nHeating oils, kerosene, diesel |  | 1,834 |  | 1,818 |  |  | 1,815 |  | 1,766 | \nAviation fuels |  | 358 |  | 365 |  |  | 338 |  | 335 | \nHeavy fuels |  | 229 |  | 252 |  |  | 224 |  | 243 | \nOther energy products |  | 814 |  | 767 |  |  | 820 |  | 758 | \n |  |  |  |  |  | \n(2)Data reported net of purchases/sales contracts with the same counterparty.\nDue to rounding, numbers presented may not add up precisely to the totals indicated.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nEarnings (loss)(U.S. GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 338 |  |  | 635 |  |  | 1,148 |  |  | 2,030 | \nNon-U.S. |  | (89) |  |  | 177 |  |  | 300 |  |  | 1,263 | \nTotal |  | 249 |  |  | 812 |  |  | 1,448 |  |  | 3,293 | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1)(Non-GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 338 |  |  | 635 |  |  | 1,148 |  |  | 2,030 | \nNon-U.S. |  | (89) |  |  | 177 |  |  | 300 |  |  | 1,263 | \nTotal |  | 249 |  |  | 812 |  |  | 1,448 |  |  | 3,293 | \n |  |  |  |  |  |  |  | \n(1)Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.\nDue to rounding, numbers presented may not add up precisely to the totals indicated.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Third Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nChemical Products Operational Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(thousands of metric tons) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nChemical Products sales(1) |  |  |  |  |  |  |  | \nUnited States |  | 1,750 |  |  | 1,658 |  |  | 5,036 |  |  | 5,688 | \nNon-U.S. |  | 3,358 |  |  | 3,023 |  |  | 9,570 |  |  | 8,821 | \nWorldwide |  | 5,108 |  |  | 4,680 |  |  | 14,606 |  |  | 14,509 | \n |  |  |  |  |  |  |  | \n(1)Data reported net of purchases/sales contracts with the same counterparty.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nEarnings (loss)(U.S. GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 326 |  |  | 306 |  |  | 1,150 |  |  | 784 | \nNon-U.S. |  | 293 |  |  | 456 |  |  | 914 |  |  | 871 | \nTotal |  | 619 |  |  | 762 |  |  | 2,064 |  |  | 1,655 | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \nEarnings (loss) excluding Identified Items(1)(Non-GAAP) |  |  |  |  |  |  |  | \nUnited States |  | 326 |  |  | 306 |  |  | 1,150 |  |  | 784 | \nNon-U.S. |  | 293 |  |  | 456 |  |  | 914 |  |  | 871 | \nTotal |  | 619 |  |  | 762 |  |  | 2,064 |  |  | 1,655 | \n |  |  |  |  |  |  |  | \n(1)Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Third Quarter Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Year-to-Date Earnings Factor Analysis |  | \n(millions of dollars) |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSpecialty Products Operational Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(thousands of metric tons) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nSpecialty Products sales(1) |  |  |  |  |  |  |  | \nUnited States |  | 498 |  |  | 483 |  |  | 1,489 |  |  | 1,594 | \nNon-U.S. |  | 1,414 |  |  | 1,434 |  |  | 4,268 |  |  | 4,430 | \nWorldwide |  | 1,912 |  |  | 1,917 |  |  | 5,758 |  |  | 6,024 | \n |  |  |  |  |  |  |  | \n(1)Data reported net of purchases/sales contracts with the same counterparty. |  | \nDue to rounding, numbers presented may not add up precisely to the totals indicated.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nCorporate and Financing Financial Results |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\n |  |  |  |  |  |  |  | \nEarnings (loss) (U.S. GAAP) |  | (365) |  |  | (152) |  |  | (1,226) |  |  | (1,132) | \nIdentified Items(2) |  | \u2014 |  |  | 400 |  |  | \u2014 |  |  | 302 | \nEarnings (loss) excluding Identified Items(2)(Non-GAAP) |  | (365) |  |  | (552) |  |  | (1,226) |  |  | (1,434) | \n |  |  |  |  |  |  |  | \n(2)Refer to Functional Earnings Summary for definition of Identified Items and earnings (loss) excluding Identified Items.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n(millions of dollars) |  |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n |  | 2023 |  | 2022 |  | 2023 |  | 2022\nNet cash provided by/(used in) |  |  |  |  |  |  |  |  | \nOperating activities |  |  |  |  |  |  | 41,687 |  |  | 59,176 | \nInvesting activities |  |  |  |  |  |  | (13,560) |  |  | (9,387) | \nFinancing activities |  |  |  |  |  |  | (24,742) |  |  | (25,177) | \nEffect of exchange rate changes |  |  |  |  |  |  | (77) |  |  | (950) | \nIncrease/(decrease) in cash and cash equivalents |  |  |  |  |  |  | 3,308 |  |  | 23,662 | \n |  |  |  |  |  |  |  |  | \nCash and cash equivalents (at end of period) |  |  |  |  |  |  | 32,973 |  |  | 30,464 | \n |  |  |  |  |  |  |  |  | \nCash flow from operations and asset sales |  |  |  |  |  |  |  |  | \nNet cash provided by operating activities (U.S. GAAP) |  |  | 15,963 |  |  | 24,425 |  |  | 41,687 |  |  | 59,176 | \nProceeds associated with sales of subsidiaries, property, plant & equipment, and sales and returns of investments |  |  | 917 |  |  | 2,682 |  |  | 3,058 |  |  | 3,914 | \nCash flow from operations and asset sales(Non-GAAP) |  |  | 16,880 |  |  | 27,107 |  |  | 44,745 |  |  | 63,090 | \n |  |  |  |  |  |  |  |  | \nBecause of the ongoing nature of our asset management and divestment program, we believe it is useful for investors to consider proceeds associated with asset sales together with cash provided by operating activities when evaluating cash available for investment in the business and financing activities, including shareholder distributions.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  | \n(millions of dollars) |  |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n |  | 2023 |  | 2022 |  | 2023 |  | 2022\nIncome taxes |  |  | 4,353 |  |  | 5,224 |  |  | 12,816 |  |  | 14,389 | \nEffective income tax rate |  |  | 34 | % |  | 29 | % |  | 34 | % |  | 31 | %\nTotal other taxes and duties(1) |  |  | 8,460 |  |  | 7,473 |  |  | 24,883 |  |  | 23,701 | \nTotal |  |  | 12,813 |  |  | 12,697 |  |  | 37,699 |  |  | 38,090 | \n |  |  |  |  |  |  |  |  | \n(1)Includes \u201cOther taxes and duties\u201d plus taxes that are included in \u201cProduction and manufacturing expenses\u201d and \u201cSelling, general and administrative expenses\u201d.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | \n(millions of dollars) |  | Three Months EndedSeptember 30, |  | Nine Months EndedSeptember 30,\n | 2023 |  | 2022 |  | 2023 |  | 2022\nUpstream (including exploration expenses) |  | 4,801 |  |  | 4,081 |  |  | 13,991 |  |  | 11,587 | \nEnergy Products |  | 647 |  |  | 590 |  |  | 2,063 |  |  | 1,662 | \nChemical Products |  | 371 |  |  | 954 |  |  | 1,861 |  |  | 1,809 | \nSpecialty Products |  | 111 |  |  | 87 |  |  | 305 |  |  | 166 | \nOther |  | 92 |  |  | 16 |  |  | 348 |  |  | 17 | \nTotal |  | 6,022 |  |  | 5,728 |  |  | 18,568 |  |  | 15,241 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nIssuer Purchases of Equity Securities for Quarter Ended September\u00a030, 2023\n |  |  |  |  |  |  |  | \n |  | Total Numberof SharesPurchased(1) |  | AveragePrice Paidper Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(3) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program(Billions of dollars)\nJuly 2023 |  | 13,412,202 |  | $104.37 |  | 13,412,138 |  | $24.9\nAugust 2023 |  | 14,830,204 |  | $108.63 |  | 14,830,192 |  | $23.3\nSeptember 2023 |  | 12,033,445 |  | $116.41 |  | 12,033,445 |  | $21.9\nTotal |  | 40,275,851 |  |  |  | 40,275,775 |  | \n |  |  |  |  |  |  |  | \n(1)Includes shares withheld from participants in the company's incentive program for personal income taxes.\n(2)Excludes 1% excise tax on stock repurchases of $44M.\n(3)In its 2022 Corporate Plan Update released December 8, 2022, the Corporation stated that the company expanded its share repurchase program to up to $50 billion through 2024, including $15 billion of repurchases in 2022. Purchases were made under terms intended to qualify for exemption under Rules 10b-18 and 10b5-1. As required by securities law restrictions, no repurchases will take place during proxy solicitation and voting periods for transactions involving the issuance of ExxonMobil shares. For the Denbury transaction this period took place during October 2023. For the Pioneer transaction, the Corporation expects this period to occur sometime during the first half of 2024.\n  |  |  |  |  |  |  |  | \nExhibit |  | Description\n |  | \n2.1* |  | Agreement and Plan of Merger, dated as of October 10, 2023 among Exxon Mobil Corporation, SPQR, LLC and Pioneer Natural Resources Company (incorporated by reference to Exhibit 2.1 to the Registrant\u2019s Report on Form 8-K of October 11, 2023).\n10(iii)(g) |  | Aircraft Time Share Agreement dated as of August 29, 2023, between Exxon Mobil Corporation and Darren W. Woods.\n31.1 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Chief Executive Officer.\n31.2 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Chief Financial Officer.\n31.3 |  | Certification (pursuant to Securities Exchange Act Rule 13a-14(a)) by Principal Accounting Officer.\n32.1 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Chief Executive Officer.\n32.2 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Chief Financial Officer.\n32.3 |  | Section 1350 Certification (pursuant to Sarbanes-Oxley Section 906) by Principal Accounting Officer.\n101 |  | Interactive Data Files (formatted as Inline XBRL).\n104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).\n |  | \n* Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule or exhibit will be furnished supplementally to the SEC upon request.  |  |  |  |  |  |  |  | \n | EXXON MOBIL CORPORATION\nDate: October\u00a031, 2023 | By: | /s/ LEN M. FOX\n |  | Len M. Fox\n |  | Vice President, Controller and\n |  | Principal Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Google, in 2022 Q1, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION\u00a013 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \nDelaware | 61-1767919\n(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number)  |  |  |  |  |  |  |  | \nSecurities registered pursuant to Section\u00a012(b) of the Act:\nTitle of each class | Trading Symbol(s) | Name of each exchange on which registered\nClass\u00a0A Common Stock, $0.001 par value | GOOGL | Nasdaq Stock Market LLC\n |  | (Nasdaq Global Select Market)\nClass C Capital Stock, $0.001 par value | GOOG | Nasdaq Stock Market LLC\n |  | (Nasdaq Global Select Market)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 |  | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 |  | Smaller reporting company | \u2610\nEmerging growth company | \u2610 |  |  |   |  | \n  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  | \n |  | Page\u00a0No.\nNote About Forward-Looking Statements | 3\n\nPART I. FINANCIAL INFORMATION\nItem\u00a01 | Financial Statements | 5\n | Consolidated Balance Sheets- December\u00a031, 2021 and March\u00a031, 2022 | 5\n | Consolidated Statements of Income -Three Months Ended March 31,2021and2022 | 6\n | Consolidated Statements of Comprehensive Income -Three Months Ended March 31,2021and2022 | 7\n | Consolidated Statements of Stockholders' Equity -Three Months Ended March 31,2021and2022 | 8\n | Consolidated Statements of Cash Flows -Three Months Ended March 31,2021and2022 | 9\n | Notes to Consolidated Financial Statements | 10\nItem\u00a02 | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 30\nItem\u00a03 | Quantitative and Qualitative Disclosures About Market Risk | 42\nItem\u00a04 | Controls and Procedures | 42\n |  | \nPART II. OTHER INFORMATION\nItem\u00a01 | Legal Proceedings | 43\nItem\u00a01A | Risk Factors | 43\nItem 2 | Unregistered Sales of Equity Securities and Use of Proceeds | 43\n |  | \n |  | \nItem\u00a06 | Exhibits | 44\nSignature | 45  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2021 |  | As ofMarch 31, 2022\n |  |  | (unaudited)\nAssets |  |  | \nCurrent assets: |  |  | \nCash and cash equivalents | $ | 20,945 |  |  | $ | 20,886 | \nMarketable securities | 118,704 |  |  | 113,084 | \nTotal cash, cash equivalents, and marketable securities | 139,649 |  |  | 133,970 | \nAccounts receivable, net | 39,304 |  |  | 34,703 | \nIncome taxes receivable, net | 966 |  |  | 919 | \nInventory | 1,170 |  |  | 1,369 | \nOther current assets | 7,054 |  |  | 6,892 | \nTotal current assets | 188,143 |  |  | 177,853 | \nNon-marketable securities | 29,549 |  |  | 30,544 | \nDeferred income taxes | 1,284 |  |  | 1,388 | \nProperty and equipment, net | 97,599 |  |  | 104,218 | \nOperating lease assets | 12,959 |  |  | 12,992 | \nIntangible assets, net | 1,417 |  |  | 1,313 | \nGoodwill | 22,956 |  |  | 23,010 | \nOther non-current assets | 5,361 |  |  | 5,778 | \nTotal assets | $ | 359,268 |  |  | $ | 357,096 | \nLiabilities and Stockholders\u2019 Equity |  |  | \nCurrent liabilities: |  |  | \nAccounts payable | $ | 6,037 |  |  | $ | 3,436 | \n |  |  | \nAccrued compensation and benefits | 13,889 |  |  | 9,803 | \nAccrued expenses and other current liabilities | 31,236 |  |  | 33,051 | \nAccrued revenue share | 8,996 |  |  | 8,116 | \nDeferred revenue | 3,288 |  |  | 3,198 | \nIncome taxes payable, net | 808 |  |  | 4,344 | \nTotal current liabilities | 64,254 |  |  | 61,948 | \nLong-term debt | 14,817 |  |  | 14,791 | \nDeferred revenue, non-current | 535 |  |  | 499 | \nIncome taxes payable, non-current | 9,176 |  |  | 9,406 | \nDeferred income taxes | 5,257 |  |  | 2,843 | \nOperating lease liabilities | 11,389 |  |  | 11,363 | \nOther long-term liabilities | 2,205 |  |  | 2,242 | \nTotal liabilities | 107,633 |  |  | 103,092 | \nContingencies (Note 9) |  |  | \nStockholders\u2019 equity: |  |  | \nPreferred stock, $0.001par value per share,100,000shares authorized;noshares issued and outstanding | 0 |  |  | 0 | \nClass\u00a0A, Class B, and Class C stock and additional paid-in capital, $0.001par value per share:15,000,000shares authorized\u00a0(Class\u00a0A9,000,000, Class B3,000,000, Class C3,000,000);662,121(Class\u00a0A300,737, Class B44,665, Class C316,719) and658,763(Class\u00a0A300,763, Class B44,404, Class C313,596) shares issued and outstanding | 61,774 |  |  | 62,832 | \nAccumulated other comprehensive income (loss) | (1,623) |  |  | (4,049) | \nRetained earnings | 191,484 |  |  | 195,221 | \nTotal stockholders\u2019 equity | 251,635 |  |  | 254,004 | \nTotal liabilities and stockholders\u2019 equity | $ | 359,268 |  |  | $ | 357,096 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\n |  |  | March 31,\n |  |  |  |  | 2021 |  | 2022\nRevenues |  |  |  |  | $ | 55,314 |  |  | $ | 68,011 | \nCosts and expenses: |  |  |  |  |  |  | \nCost of revenues |  |  |  |  | 24,103 |  |  | 29,599 | \nResearch and development |  |  |  |  | 7,485 |  |  | 9,119 | \nSales and marketing |  |  |  |  | 4,516 |  |  | 5,825 | \nGeneral and administrative |  |  |  |  | 2,773 |  |  | 3,374 | \nTotal costs and expenses |  |  |  |  | 38,877 |  |  | 47,917 | \nIncome from operations |  |  |  |  | 16,437 |  |  | 20,094 | \nOther income (expense), net |  |  |  |  | 4,846 |  |  | (1,160) | \nIncome before income taxes |  |  |  |  | 21,283 |  |  | 18,934 | \nProvision for income taxes |  |  |  |  | 3,353 |  |  | 2,498 | \nNet income |  |  |  |  | $ | 17,930 |  |  | $ | 16,436 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income per share of Class A, Class B, and Class C stock |  |  |  |  | $ | 26.63 |  |  | $ | 24.90 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nDiluted net income per share of Class A, Class B, and Class C stock |  |  |  |  | $ | 26.29 |  |  | $ | 24.62 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\n |  |  | March 31,\n |  |  |  |  | 2021 |  | 2022\nNet income |  |  |  |  | $ | 17,930 |  |  | $ | 16,436 | \nOther comprehensive loss: |  |  |  |  |  |  | \nChange in foreign currency translation adjustment |  |  |  |  | (423) |  |  | 39 | \nAvailable-for-sale investments: |  |  |  |  |  |  | \nChange in net unrealized gains (losses) |  |  |  |  | (488) |  |  | (2,478) | \nLess: reclassification adjustment for net (gains) losses included in net income |  |  |  |  | 11 |  |  | 148 | \nNet change, net of income tax benefit (expense) of $135and $633 |  |  |  |  | (477) |  |  | (2,330) | \nCash flow hedges: |  |  |  |  |  |  | \nChange in net unrealized gains (losses) |  |  |  |  | 179 |  |  | 114 | \nLess: reclassification adjustment for net (gains) losses included in net income |  |  |  |  | 85 |  |  | (249) | \nNet change, net of income tax benefit (expense) of $(50) and $44 |  |  |  |  | 264 |  |  | (135) | \nOther comprehensive loss |  |  |  |  | (636) |  |  | (2,426) | \nComprehensive income |  |  |  |  | $ | 17,294 |  |  | $ | 14,010 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, 2021\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of December 31, 2020 | 675,222 |  |  | $ | 58,510 |  |  | $ | 633 |  |  | $ | 163,401 |  |  | $ | 222,544 | \nStock issued | 1,569 |  |  | 6 |  |  | 0 |  |  | 0 |  |  | 6 | \nStock-based compensation expense | 0 |  |  | 3,788 |  |  | 0 |  |  | 0 |  |  | 3,788 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (2,234) |  |  | 0 |  |  | 0 |  |  | (2,234) | \nRepurchases of stock | (5,697) |  |  | (644) |  |  | 0 |  |  | (10,751) |  |  | (11,395) | \nSale of interest in consolidated entities | 0 |  |  | 10 |  |  | 0 |  |  | 0 |  |  | 10 | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 17,930 |  |  | 17,930 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | (636) |  |  | 0 |  |  | (636) | \nBalance as of March 31, 2021 | 671,094 |  |  | $ | 59,436 |  |  | $ | (3) |  |  | $ | 170,580 |  |  | $ | 230,013 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, 2022\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of December 31, 2021 | 662,121 |  |  | $ | 61,774 |  |  | $ | (1,623) |  |  | $ | 191,484 |  |  | $ | 251,635 | \nStock issued | 1,555 |  |  | 7 |  |  | 0 |  |  | 0 |  |  | 7 | \nStock-based compensation expense | 0 |  |  | 4,547 |  |  | 0 |  |  | 0 |  |  | 4,547 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (2,895) |  |  | 0 |  |  | 0 |  |  | (2,895) | \nRepurchases of stock | (4,913) |  |  | (601) |  |  | 0 |  |  | (12,699) |  |  | (13,300) | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 16,436 |  |  | 16,436 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | (2,426) |  |  | 0 |  |  | (2,426) | \nBalance as of March 31, 2022 | 658,763 |  |  | $ | 62,832 |  |  | $ | (4,049) |  |  | $ | 195,221 |  |  | $ | 254,004 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended\n | March 31,\n | 2021 |  | 2022\nOperating activities |  |  | \nNet income | $ | 17,930 |  |  | $ | 16,436 | \nAdjustments: |  |  | \nDepreciation and impairment of property and equipment | 2,525 |  |  | 3,591 | \nAmortization and impairment of intangible assets | 228 |  |  | 191 | \nStock-based compensation expense | 3,745 |  |  | 4,504 | \nDeferred income taxes | 1,100 |  |  | (2,090) | \n(Gain) loss on debt and equity securities, net | (4,751) |  |  | 1,437 | \nOther | (255) |  |  | 140 | \nChanges in assets and liabilities, net of effects of acquisitions: |  |  | \nAccounts receivable | 2,794 |  |  | 4,364 | \nIncome taxes, net | 785 |  |  | 3,820 | \nOther assets | 7 |  |  | (776) | \nAccounts payable | (982) |  |  | (2,373) | \nAccrued expenses and other liabilities | (3,530) |  |  | (3,216) | \nAccrued revenue share | (444) |  |  | (828) | \nDeferred revenue | 137 |  |  | (94) | \nNet cash provided by operating activities | 19,289 |  |  | 25,106 | \nInvesting activities |  |  | \nPurchases of property and equipment | (5,942) |  |  | (9,786) | \nPurchases of marketable securities | (36,426) |  |  | (28,462) | \nMaturities and sales of marketable securities | 39,248 |  |  | 29,779 | \nPurchases of non-marketable securities | (646) |  |  | (776) | \nMaturities and sales of non-marketable securities | 19 |  |  | 12 | \n |  |  | \n |  |  | \nAcquisitions, net of cash acquired, and purchases of intangible assets | (1,666) |  |  | (173) | \nOther investing activities | 30 |  |  | 355 | \n |  |  | \nNet cash used in investing activities | (5,383) |  |  | (9,051) | \nFinancing activities |  |  | \nNet payments related to stock-based award activities | (2,184) |  |  | (2,916) | \n |  |  | \nRepurchases of stock | (11,395) |  |  | (13,300) | \nProceeds from issuance of debt, net of costs | 900 |  |  | 16,422 | \nRepayments of debt | (937) |  |  | (16,420) | \nProceeds from sale of interest in consolidated entities, net | 10 |  |  | 0 | \nNet cash used in financing activities | (13,606) |  |  | (16,214) | \nEffect of exchange rate changes on cash and cash equivalents | (143) |  |  | 100 | \nNet increase (decrease) in cash and cash equivalents | 157 |  |  | (59) | \nCash and cash equivalents at beginning of period | 26,465 |  |  | 20,945 | \nCash and cash equivalents at end of period | $ | 26,622 |  |  | $ | 20,886 | \n |  |  | \n |  |  | \n |  |  | \n |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\n |  |  | March 31,\n |  |  |  |  | 2021 |  | 2022\nGoogle Search & other |  |  |  |  | $ | 31,879 |  |  | $ | 39,618 | \nYouTube ads |  |  |  |  | 6,005 |  |  | 6,869 | \nGoogle Network |  |  |  |  | 6,800 |  |  | 8,174 | \nGoogle advertising |  |  |  |  | 44,684 |  |  | 54,661 | \nGoogle other |  |  |  |  | 6,494 |  |  | 6,811 | \nGoogle Services total |  |  |  |  | 51,178 |  |  | 61,472 | \nGoogle Cloud |  |  |  |  | 4,047 |  |  | 5,821 | \nOther Bets |  |  |  |  | 198 |  |  | 440 | \nHedging gains (losses) |  |  |  |  | (109) |  |  | 278 | \nTotal revenues |  |  |  |  | $ | 55,314 |  |  | $ | 68,011 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\n |  |  | March 31,\n |  |  |  |  | 2021 |  | 2022\nUnited States |  |  |  |  |  |  |  |  | $ | 25,032 |  |  | 45 | % |  | $ | 31,733 |  |  | 47 | %\nEMEA(1) |  |  |  |  |  |  |  |  | 17,031 |  |  | 31 |  |  | 20,317 |  |  | 30 | \nAPAC(1) |  |  |  |  |  |  |  |  | 10,455 |  |  | 19 |  |  | 11,841 |  |  | 17 | \nOther Americas(1) |  |  |  |  |  |  |  |  | 2,905 |  |  | 5 |  |  | 3,842 |  |  | 6 | \nHedging gains (losses) |  |  |  |  |  |  |  |  | (109) |  |  | 0 |  |  | 278 |  |  | 0 | \nTotal revenues |  |  |  |  |  |  |  |  | $ | 55,314 |  |  | 100 | % |  | $ | 68,011 |  |  | 100 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n | AdjustedCost |  | GrossUnrealizedGains |  | GrossUnrealizedLosses |  | FairValue |  | Cash and CashEquivalents |  | MarketableSecurities\nLevel 2: |  |  |  |  |  |  |  |  |  |  | \nTime deposits(1) | $ | 5,133 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 5,133 |  |  | $ | 5,133 |  |  | $ | 0 | \nGovernment bonds | 53,288 |  |  | 258 |  |  | (238) |  |  | 53,308 |  |  | 5 |  |  | 53,303 | \nCorporate debt securities | 35,605 |  |  | 194 |  |  | (223) |  |  | 35,576 |  |  | 12 |  |  | 35,564 | \nMortgage-backed and asset-backed securities | 18,829 |  |  | 96 |  |  | (112) |  |  | 18,813 |  |  | 0 |  |  | 18,813 | \nTotal | $ | 112,855 |  |  | $ | 548 |  |  | $ | (573) |  |  | $ | 112,830 |  |  | $ | 5,150 |  |  | $ | 107,680 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of March 31, 2022\n | AdjustedCost |  | GrossUnrealizedGains |  | GrossUnrealizedLosses |  | FairValue |  | Cash and CashEquivalents |  | MarketableSecurities\nLevel 2: |  |  |  |  |  |  |  |  |  |  | \nTime deposits(1) | $ | 4,690 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 4,690 |  |  | $ | 4,690 |  |  | $ | 0 | \nGovernment bonds | 50,485 |  |  | 58 |  |  | (1,365) |  |  | 49,178 |  |  | 0 |  |  | 49,178 | \nCorporate debt securities | 36,621 |  |  | 30 |  |  | (1,043) |  |  | 35,608 |  |  | 10 |  |  | 35,598 | \nMortgage-backed and asset-backed securities | 18,852 |  |  | 6 |  |  | (594) |  |  | 18,264 |  |  | 0 |  |  | 18,264 | \nTotal | $ | 110,648 |  |  | $ | 94 |  |  | $ | (3,002) |  |  | $ | 107,740 |  |  | $ | 4,700 |  |  | $ | 103,040 |   |  |  |  |  | \n | As ofMarch 31, 2022\nDue in 1 year or less | $ | 15,516 | \nDue in 1 year through 5 years | 75,938 | \nDue in 5 years through 10 years | 4,755 | \nDue after 10 years | 12,245 | \nTotal | $ | 108,454 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n | Less\u00a0than\u00a012 Months |  | 12 Months or Greater |  | Total\n | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss\nGovernment bonds | $ | 32,843 |  |  | $ | (236) |  |  | $ | 71 |  |  | $ | (2) |  |  | $ | 32,914 |  |  | $ | (238) | \nCorporate debt securities | 22,737 |  |  | (152) |  |  | 303 |  |  | (5) |  |  | 23,040 |  |  | (157) | \nMortgage-backed and asset-backed securities | 11,502 |  |  | (106) |  |  | 248 |  |  | (6) |  |  | 11,750 |  |  | (112) | \nTotal | $ | 67,082 |  |  | $ | (494) |  |  | $ | 622 |  |  | $ | (13) |  |  | $ | 67,704 |  |  | $ | (507) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of March 31, 2022\n | Less\u00a0than\u00a012 Months |  | 12 Months or Greater |  | Total\n | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss\nGovernment bonds | $ | 37,948 |  |  | $ | (1,203) |  |  | $ | 3,909 |  |  | $ | (162) |  |  | $ | 41,857 |  |  | $ | (1,365) | \nCorporate debt securities | 27,403 |  |  | (879) |  |  | 2,572 |  |  | (164) |  |  | 29,975 |  |  | (1,043) | \nMortgage-backed and asset-backed securities | 15,415 |  |  | (532) |  |  | 1,101 |  |  | (62) |  |  | 16,516 |  |  | (594) | \nTotal | $ | 80,766 |  |  | $ | (2,614) |  |  | $ | 7,582 |  |  | $ | (388) |  |  | $ | 88,348 |  |  | $ | (3,002) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\n |  |  | March 31,\n |  |  |  |  | 2021 |  | 2022\nNet gain (loss) on equity securities sold during the period |  |  |  |  | $ | 201 |  |  | $ | (74) | \nNet unrealized gain (loss) on equity securities held as of the end of the period |  |  |  |  | 4,636 |  |  | (996) | \nTotal gain (loss) recognized in other income (expense), net |  |  |  |  | $ | 4,837 |  |  | $ | (1,070) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | Equity Securities Sold\n |  |  | Three Months Ended\n |  |  | March 31,\n |  |  |  |  | 2021 |  | 2022\nTotal sale price |  |  |  |  | $ | 725 |  |  | $ | 364 | \nTotal initial cost |  |  |  |  | 357 |  |  | 260 | \nCumulative net gains |  |  |  |  | $ | 368 |  |  | $ | 104 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n | Marketable Securities |  | Non-Marketable Securities |  | Total\nTotal initial cost | $ | 4,211 |  |  | $ | 15,135 |  |  | $ | 19,346 | \nCumulative net gain (loss)(1) | 3,587 |  |  | 12,436 |  |  | 16,023 | \nCarrying value(2) | $ | 7,798 |  |  | $ | 27,571 |  |  | $ | 35,369 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of March 31, 2022\n | Marketable Securities |  | Non-Marketable Securities |  | Total\nTotal initial cost | $ | 4,549 |  |  | $ | 15,770 |  |  | $ | 20,319 | \nCumulative net gain (loss)(1) | 1,586 |  |  | 12,882 |  |  | 14,468 | \nCarrying value(2) | $ | 6,135 |  |  | $ | 28,652 |  |  | $ | 34,787 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021 |  | As of March 31, 2022\n | Cash and Cash Equivalents |  | MarketableSecurities |  | Cash and Cash Equivalents |  | MarketableSecurities\nLevel 1: |  |  |  |  | \nMoney market funds | $ | 7,499 |  |  | $ | 0 |  |  | $ | 7,820 |  |  | $ | 0 | \nMarketable equity securities(1)(2) | 0 |  |  | 7,447 |  |  | 0 |  |  | 5,877 | \n | 7,499 |  |  | 7,447 |  |  | 7,820 |  |  | 5,877 | \nLevel 2: |  |  |  |  |  |  | \nMutual funds | 0 |  |  | 351 |  |  | 0 |  |  | 258 | \nTotal | $ | 7,499 |  |  | $ | 7,798 |  |  | $ | 7,820 |  |  | $ | 6,135 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\n |  |  | March 31,\n |  |  |  |  | 2021 |  | 2022\nUnrealized gains on non-marketable equity securities |  |  |  |  | $ | 4,678 |  |  | $ | 838 | \nUnrealized losses on non-marketable equity securities (including impairment) |  |  |  |  | (2) |  |  | (378) | \nTotal unrealized gain (loss) recognized on non-marketable equity securities |  |  |  |  | $ | 4,676 |  |  | $ | 460 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021 |  | As of March 31, 2022\nDerivatives Designated as Hedging Instruments: |  | \nForeign exchange contracts |  |  | \nCash flow hedges | $ | 16,362 |  |  | $ | 17,817 | \nFair value hedges | $ | 2,556 |  |  | $ | 2,438 | \nNet investment hedges | $ | 10,159 |  |  | $ | 9,933 | \nDerivatives Not Designated as Hedging Instruments: |  | \nForeign exchange contracts | $ | 41,031 |  |  | $ | 42,338 | \nOther contracts | $ | 4,275 |  |  | $ | 6,052 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | As of December 31, 2021\n | Balance\u00a0Sheet\u00a0Location |  | Fair\u00a0Value\u00a0ofDerivativesDesignated\u00a0asHedging\u00a0Instruments |  | Fair\u00a0Value\u00a0ofDerivatives\u00a0NotDesignated asHedging\u00a0Instruments |  | Total\u00a0Fair Value\nDerivative Assets: |  |  |  |  |  | \nLevel 2: |  |  |  |  |  |  | \nForeign exchange contracts | Other current and non-current assets |  | $ | 867 |  |  | $ | 42 |  |  | $ | 909 | \nOther contracts | Other current and non-current assets |  | 0 |  |  | 52 |  |  | 52 | \nTotal |  |  | $ | 867 |  |  | $ | 94 |  |  | $ | 961 | \nDerivative Liabilities: |  |  |  |  |  | \nLevel 2: |  |  |  |  |  |  | \nForeign exchange contracts | Accrued expenses and other liabilities, current and non-current |  | $ | 8 |  |  | $ | 452 |  |  | $ | 460 | \nOther contracts | Accrued expenses and other liabilities, current and non-current |  | 0 |  |  | 121 |  |  | 121 | \nTotal |  |  | $ | 8 |  |  | $ | 573 |  |  | $ | 581 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | As of March 31, 2022\n | Balance\u00a0Sheet\u00a0Location |  | Fair\u00a0Value\u00a0ofDerivativesDesignated\u00a0asHedging\u00a0Instruments |  | Fair\u00a0Value\u00a0ofDerivatives\u00a0NotDesignated asHedging\u00a0Instruments |  | Total\u00a0Fair Value\nDerivative Assets: |  |  |  |  |  | \nLevel 2: |  |  |  |  |  |  | \nForeign exchange contracts | Other current and non-current assets |  | $ | 705 |  |  | $ | 26 |  |  | $ | 731 | \nOther contracts | Other current and non-current assets |  | 0 |  |  | 76 |  |  | 76 | \nTotal |  |  | $ | 705 |  |  | $ | 102 |  |  | $ | 807 | \nDerivative Liabilities: |  |  |  |  |  | \nLevel 2: |  |  |  |  |  |  | \nForeign exchange contracts | Accrued expenses and other liabilities, current and non-current |  | $ | 163 |  |  | $ | 404 |  |  | $ | 567 | \nOther contracts | Accrued expenses and other liabilities, current and non-current |  | 0 |  |  | 76 |  |  | 76 | \nTotal |  |  | $ | 163 |  |  | $ | 480 |  |  | $ | 643 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | Gains (Losses) Recognized in OCI on Derivatives Before Tax Effect\n |  |  | Three Months Ended\n |  |  | March 31,\n |  |  |  |  | 2021 |  | 2022\nDerivatives in Cash Flow Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount included in the assessment of effectiveness |  |  |  |  | $ | 162 |  |  | $ | 135 | \nAmount excluded from the assessment of effectiveness |  |  |  |  | 49 |  |  | (15) | \n |  |  |  |  |  |  | \nDerivatives in Net Investment Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount included in the assessment of effectiveness |  |  |  |  | 378 |  |  | 149 | \nTotal |  |  |  |  | $ | 589 |  |  | $ | 269 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Gains (Losses) Recognized in Income\n | Three Months Ended\n | March 31,\n | 2021 |  | 2022\n | Revenues |  | Other income (expense), net |  | Revenues |  | Other income (expense), net\nTotal amounts presented in the Consolidated Statements of Income in which the effects of cash flow and fair value hedges are recorded | $ | 55,314 |  |  | $ | 4,846 |  |  | $ | 68,011 |  |  | $ | (1,160) | \n |  |  |  |  |  |  | \nGains (Losses) on Derivatives in Cash Flow Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount of gains (losses) reclassified from AOCI to income | $ | (105) |  |  | $ | 0 |  |  | $ | 297 |  |  | $ | 0 | \nAmount excluded from the assessment of effectiveness recognized in earnings based on an amortization approach | (4) |  |  | 0 |  |  | (19) |  |  | 0 | \nGains (Losses) on Derivatives in Fair Value Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nHedged items | 0 |  |  | 0 |  |  | 0 |  |  | 13 | \nDerivatives designated as hedging instruments | 0 |  |  | 0 |  |  | 0 |  |  | (12) | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 2 |  |  | 0 |  |  | 1 | \nGains (Losses) on Derivatives in Net Investment Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 20 |  |  | 0 |  |  | 12 | \nGains (Losses) on Derivatives Not Designated as Hedging Instruments: |  |  |  |  |  |  | \nForeign exchange contracts | 0 |  |  | (340) |  |  | 0 |  |  | (247) | \nOther Contracts | 0 |  |  | 323 |  |  | 0 |  |  | 38 | \nTotal gains (losses) | $ | (109) |  |  | $ | 5 |  |  | $ | 278 |  |  | $ | (195) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset |  | \n | Gross Amounts of Recognized Assets |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Received |  | Non-Cash Collateral Received |  | Net Assets Exposed\nDerivatives | $ | 999 |  |  | $ | (38) |  |  | $ | 961 |  |  | $ | (434) |  | (1) | $ | (394) |  |  | $ | (12) |  |  | $ | 121 | \n |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of March 31, 2022\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset |  | \n | Gross Amounts of Recognized Assets |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Received |  | Non-Cash Collateral Received |  | Net Assets Exposed\nDerivatives | $ | 894 |  |  | $ | (87) |  |  | $ | 807 |  |  | $ | (427) |  | (1) | $ | (310) |  |  | $ | 0 |  |  | $ | 70 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset |  | \n | Gross Amounts of Recognized Liabilities |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Pledged |  | Non-Cash Collateral Pledged |  | Net Liabilities\nDerivatives | $ | 619 |  |  | $ | (38) |  |  | $ | 581 |  |  | $ | (434) |  | (2) | $ | (4) |  |  | $ | (110) |  |  | $ | 33 | \n |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of March 31, 2022\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | \n | Gross Amounts of Recognized Liabilities |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Pledged |  | Non-Cash Collateral Pledged |  | Net Liabilities\nDerivatives | $ | 730 |  |  | $ | (87) |  |  | $ | 643 |  |  | $ | (427) |  | (2) | $ | (5) |  |  | $ | (49) |  |  | $ | 162 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Maturity |  | Coupon Rate |  | Effective Interest Rate |  | As of December 31, 2021 |  | As ofMarch 31, 2022\nDebt |  |  |  |  |  |  |  |  |  | \n2014-2020 Notes Issuances |  | 2024 - 2060 |  | 0.45% -3.38% |  | 0.57% -3.38% |  | $ | 13,000 |  |  | $ | 13,000 | \nFuture finance lease payments, net and other(1) |  |  |  |  |  |  |  | 2,086 |  |  | 2,125 | \nTotal debt |  |  |  |  |  |  |  | 15,086 |  |  | 15,125 | \nUnamortized discount and debt issuance costs |  |  |  |  |  |  |  | (156) |  |  | (153) | \nLess: Current portion future finance lease payments, net and other current debt(1)(2) |  |  |  |  |  |  |  | (113) |  |  | (181) | \nTotal long-term debt |  |  |  |  |  |  |  | $ | 14,817 |  |  | $ | 14,791 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2021 |  | As ofMarch 31, 2022\nLand and buildings | $ | 58,881 |  |  | $ | 62,869 | \nInformation technology assets | 55,606 |  |  | 57,628 | \nConstruction in progress | 23,172 |  |  | 25,555 | \nLeasehold improvements | 9,146 |  |  | 9,912 | \nFurniture and fixtures | 208 |  |  | 213 | \nProperty and equipment, gross | 147,013 |  |  | 156,177 | \nLess: accumulated depreciation | (49,414) |  |  | (51,959) | \nProperty and equipment, net | $ | 97,599 |  |  | $ | 104,218 |   |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2021 |  | As ofMarch 31, 2022\nEuropean Commission fines(1) | $ | 9,799 |  |  | $ | 9,670 | \nAccrued customer liabilities | 3,505 |  |  | 3,171 | \nAccrued purchases of property and equipment | 2,415 |  |  | 3,175 | \nCurrent operating lease liabilities | 2,189 |  |  | 2,267 | \nOther accrued expenses and current liabilities | 13,328 |  |  | 14,768 | \nAccrued expenses and other current liabilities | $ | 31,236 |  |  | $ | 33,051 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Available-for-Sale Investments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total\nBalance as of December 31, 2020 | $ | (864) |  |  | $ | 1,612 |  |  | $ | (115) |  |  | $ | 633 | \nOther comprehensive income (loss) before reclassifications | (423) |  |  | (488) |  |  | 130 |  |  | (781) | \nAmounts excluded from the assessment of hedge effectiveness recorded in AOCI | 0 |  |  | 0 |  |  | 49 |  |  | 49 | \nAmounts reclassified from AOCI | 0 |  |  | 11 |  |  | 85 |  |  | 96 | \nOther comprehensive income (loss) | (423) |  |  | (477) |  |  | 264 |  |  | (636) | \nBalance as of March 31, 2021 | $ | (1,287) |  |  | $ | 1,135 |  |  | $ | 149 |  |  | $ | (3) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Available-for-Sale Investments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total\nBalance as of December 31, 2021 | $ | (2,306) |  |  | $ | 236 |  |  | $ | 447 |  |  | $ | (1,623) | \nOther comprehensive income (loss) before reclassifications | 39 |  |  | (2,478) |  |  | 129 |  |  | (2,310) | \nAmounts excluded from the assessment of hedge effectiveness recorded in AOCI | 0 |  |  | 0 |  |  | (15) |  |  | (15) | \nAmounts reclassified from AOCI | 0 |  |  | 148 |  |  | (249) |  |  | (101) | \nOther comprehensive income (loss) | 39 |  |  | (2,330) |  |  | (135) |  |  | (2,426) | \nBalance as of March 31, 2022 | $ | (2,267) |  |  | $ | (2,094) |  |  | $ | 312 |  |  | $ | (4,049) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  | Gains (Losses) Reclassified from AOCI to the Consolidated Statements of Income\n |  |  |  |  |  | Three Months Ended\n |  |  |  |  |  | March 31,\nAOCI Components |  | Location |  |  |  |  |  | 2021 |  | 2022\nUnrealized gains (losses) on available-for-sale investments |  |  |  |  |  |  |  | \n |  | Other income (expense), net |  |  |  |  |  | $ | (14) |  |  | $ | (190) | \n |  | Benefit (provision) for income taxes |  |  |  |  |  | 3 |  |  | 42 | \n |  | Net of income tax |  |  |  |  |  | (11) |  |  | (148) | \nUnrealized gains (losses) on cash flow hedges |  |  |  |  |  |  |  | \nForeign exchange contracts |  | Revenue |  |  |  |  |  | (105) |  |  | 297 | \nInterest rate contracts |  | Other income (expense), net |  |  |  |  |  | 1 |  |  | 2 | \n |  | Benefit (provision) for income taxes |  |  |  |  |  | 19 |  |  | (50) | \n |  | Net of income tax |  |  |  |  |  | (85) |  |  | 249 | \nTotal amount reclassified, net of income tax |  |  |  |  |  | $ | (96) |  |  | $ | 101 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\n |  |  | March 31,\n |  |  |  |  | 2021 |  | 2022\nInterest income |  |  |  |  | $ | 345 |  |  | $ | 414 | \nInterest expense(1) |  |  |  |  | (76) |  |  | (83) | \nForeign currency exchange gain (loss), net |  |  |  |  | 113 |  |  | (73) | \nGain (loss) on debt securities, net |  |  |  |  | (86) |  |  | (367) | \nGain (loss) on equity securities, net |  |  |  |  | 4,837 |  |  | (1,070) | \nPerformance fees |  |  |  |  | (665) |  |  | 233 | \nIncome (loss) and impairment from equity method investments, net |  |  |  |  | 5 |  |  | (89) | \nOther |  |  |  |  | 373 |  |  | (125) | \nOther income (expense), net |  |  |  |  | $ | 4,846 |  |  | $ | (1,160) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Google Services |  | Google Cloud |  | Other Bets |  | Total\nBalance as of December 31, 2021 | $ | 19,826 |  |  | $ | 2,337 |  |  | $ | 793 |  |  | $ | 22,956 | \nAcquisitions | 9 |  |  | 86 |  |  | 0 |  |  | 95 | \nForeign currency translation and other adjustments | (36) |  |  | (4) |  |  | (1) |  |  | (41) | \nBalance as of March 31, 2022 | $ | 19,799 |  |  | $ | 2,419 |  |  | $ | 792 |  |  | $ | 23,010 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n | GrossCarryingAmount |  | AccumulatedAmortization |  | NetCarryingAmount\nPatents and developed technology | $ | 4,786 |  |  | $ | 4,112 |  |  | $ | 674 | \nCustomer relationships | 506 |  |  | 140 |  |  | 366 | \nTrade names and other | 534 |  |  | 295 |  |  | 239 | \nTotal definite-lived intangible assets | 5,826 |  |  | 4,547 |  |  | 1,279 | \nIndefinite-lived intangible assets | 138 |  |  | \u2014 |  |  | 138 | \nTotal intangible assets | $ | 5,964 |  |  | $ | 4,547 |  |  | $ | 1,417 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of March 31, 2022\n | GrossCarryingAmount |  | AccumulatedAmortization |  | NetCarryingAmount\nPatents and developed technology | $ | 4,613 |  |  | $ | 4,080 |  |  | $ | 533 | \nCustomer relationships | 506 |  |  | 166 |  |  | 340 | \nTrade names and other | 418 |  |  | 109 |  |  | 309 | \nTotal definite-lived intangible assets | 5,537 |  |  | 4,355 |  |  | 1,182 | \nIndefinite-lived intangible assets | 131 |  |  | 0 |  |  | 131 | \nTotal intangible assets | $ | 5,668 |  |  | $ | 4,355 |  |  | $ | 1,313 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nRemainder of 2022 | $ | 363 | \n2023 | 274 | \n2024 | 244 | \n2025 | 116 | \n2026 | 71 | \nThereafter | 114 | \nTotal | $ | 1,182 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31,\n | 2021 |  | 2022\n | Class A |  | Class B |  | Class C |  | Class A |  | Class B |  | Class C\nBasic net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings | $ | 8,011 |  |  | $ | 1,221 |  |  | $ | 8,698 |  |  | $ | 7,481 |  |  | $ | 1,109 |  |  | $ | 7,846 | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in per share computation | 300,800 |  |  | 45,840 |  |  | 326,580 |  |  | 300,478 |  |  | 44,535 |  |  | 315,158 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nBasic net income per share | $ | 26.63 |  |  | $ | 26.63 |  |  | $ | 26.63 |  |  | $ | 24.90 |  |  | $ | 24.90 |  |  | $ | 24.90 | \nDiluted net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings for basic computation | $ | 8,011 |  |  | $ | 1,221 |  |  | $ | 8,698 |  |  | $ | 7,481 |  |  | $ | 1,109 |  |  | $ | 7,846 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nReallocation of undistributed earnings as a result of conversion of Class B to Class\u00a0A shares | 1,221 |  |  | 0 |  |  | 0 |  |  | 1,109 |  |  | 0 |  |  | 0 | \nReallocation of undistributed earnings | (119) |  |  | (16) |  |  | 119 |  |  | (95) |  |  | (12) |  |  | 95 | \nAllocation of undistributed earnings | $ | 9,113 |  |  | $ | 1,205 |  |  | $ | 8,817 |  |  | $ | 8,495 |  |  | $ | 1,097 |  |  | $ | 7,941 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in basic computation | 300,800 |  |  | 45,840 |  |  | 326,580 |  |  | 300,478 |  |  | 44,535 |  |  | 315,158 | \nWeighted-average effect of dilutive securities |  |  |  |  |  |  |  |  |  |  | \nAdd: |  |  |  |  |  |  |  |  |  |  | \nConversion of Class B to Class\u00a0A shares outstanding | 45,840 |  |  | 0 |  |  | 0 |  |  | 44,535 |  |  | 0 |  |  | 0 | \n |  |  |  |  |  |  |  |  |  |  | \nRestricted stock units and other contingently issuable shares | 18 |  |  | 0 |  |  | 8,833 |  |  | 5 |  |  | 0 |  |  | 7,375 | \nNumber of shares used in per share computation | 346,658 |  |  | 45,840 |  |  | 335,413 |  |  | 345,018 |  |  | 44,535 |  |  | 322,533 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDiluted net income per share | $ | 26.29 |  |  | $ | 26.29 |  |  | $ | 26.29 |  |  | $ | 24.62 |  |  | $ | 24.62 |  |  | $ | 24.62 |   |  |  |  |  |  |  |  |  |  |  | \n | Unvested\u00a0Restricted\u00a0Stock\u00a0Units\n | Number ofShares |  | Weighted-AverageGrant-DateFair Value\nUnvested as of December 31, 2021 | 16,894,713 |  |  | $ | 1,626.13 | \nGranted | 6,698,922 |  |  | $ | 2,758.02 | \nVested | (2,431,649) |  |  | $ | 1,691.60 | \nForfeited/canceled | (536,815) |  |  | $ | 1,848.92 | \nUnvested as of March 31, 2022 | 20,625,171 |  |  | $ | 1,980.24 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\n |  |  | March 31,\n |  |  |  |  | 2021 |  | 2022\nIncome before provision for income taxes |  |  |  |  | $ | 21,283 |  |  | $ | 18,934 | \nProvision for income taxes |  |  |  |  | $ | 3,353 |  |  | $ | 2,498 | \nEffective tax rate |  |  |  |  | 15.8 | % |  | 13.2 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\n |  |  | March 31,\n |  |  |  |  | 2021 |  | 2022\nRevenues: |  |  |  |  |  |  | \nGoogle Services |  |  |  |  | $ | 51,178 |  |  | $ | 61,472 | \nGoogle Cloud |  |  |  |  | 4,047 |  |  | 5,821 | \nOther Bets |  |  |  |  | 198 |  |  | 440 | \nHedging gains (losses) |  |  |  |  | (109) |  |  | 278 | \nTotal revenues |  |  |  |  | $ | 55,314 |  |  | $ | 68,011 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\n |  |  | March 31,\n |  |  |  |  | 2021 |  | 2022\nOperating income (loss): |  |  |  |  |  |  | \nGoogle Services |  |  |  |  | $ | 19,546 |  |  | $ | 22,920 | \nGoogle Cloud |  |  |  |  | (974) |  |  | (931) | \nOther Bets |  |  |  |  | (1,145) |  |  | (1,155) | \nCorporate costs, unallocated |  |  |  |  | (990) |  |  | (740) | \nTotal income from operations |  |  |  |  | $ | 16,437 |  |  | $ | 20,094 |   |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2021 |  | As ofMarch 31, 2022\nLong-lived assets: |  |  | \nUnited States | $ | 80,207 |  |  | $ | 85,341 | \nInternational | 30,351 |  |  | 31,869 | \nTotal long-lived assets | $ | 110,558 |  |  | $ | 117,210 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended |  |  |  | \n | March 31, |  |  |  | \n |  | 2021 |  | 2022 |  | $ Change |  | % Change\nConsolidated revenues |  | $ | 55,314 |  |  | $ | 68,011 |  |  | 12,697 |  |  | 23 | %\nChange in consolidated constant currency revenues |  |  |  |  |  |  |  | 26 | %\n |  |  |  |  |  |  |  | \nCost of revenues |  | $ | 24,103 |  |  | $ | 29,599 |  |  | $ | 5,496 |  |  | 23 | %\nOperating expenses |  | $ | 14,774 |  |  | $ | 18,318 |  |  | $ | 3,544 |  |  | 24 | %\n |  |  |  |  |  |  |  | \nOperating income |  | $ | 16,437 |  |  | $ | 20,094 |  |  | $ | 3,657 |  |  | 22 | %\nOperating margin |  | 30 | % |  | 30 | % |  |  |  | 0 | %\n |  |  |  |  |  |  |  | \nOther income (expense), net |  | $ | 4,846 |  |  | $ | (1,160) |  |  | $ | (6,006) |  |  | (124) | %\n |  |  |  |  |  |  |  | \nNet Income |  | $ | 17,930 |  |  | $ | 16,436 |  |  | $ | (1,494) |  |  | (8) | %\nDiluted EPS |  | $ | 26.29 |  |  | $ | 24.62 |  |  | $ | (1.67) |  |  | (6) | %\n |  |  |  |  |  |  |  | \nNumber of Employees |  | 139,995 |  |  | 163,906 |  | 23,911 |  | 17 | %\n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\n |  |  | March 31,\n |  |  |  |  | 2021 |  | 2022\nGoogle Search & other |  |  |  |  | $ | 31,879 |  |  | $ | 39,618 | \nYouTube ads |  |  |  |  | 6,005 |  |  | 6,869 | \nGoogle Network |  |  |  |  | 6,800 |  |  | 8,174 | \nGoogle advertising |  |  |  |  | 44,684 |  |  | 54,661 | \nGoogle other |  |  |  |  | 6,494 |  |  | 6,811 | \nGoogle Services total |  |  |  |  | 51,178 |  |  | 61,472 | \nGoogle Cloud |  |  |  |  | 4,047 |  |  | 5,821 | \nOther Bets |  |  |  |  | 198 |  |  | 440 | \nHedging gains (losses) |  |  |  |  | (109) |  |  | 278 | \nTotal revenues |  |  |  |  | $ | 55,314 |  |  | $ | 68,011 |   |  |  |  |  |  |  | \n | Three Months Ended March 31, |  | \n | \n | 2022 |  | \n |  |  | \n |  |  | \nPaid clicks change | 16% |  | \nCost-per-click change | 8% |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  | \n |  |  | \n | Three Months Ended March 31, |  | \n | 2022 |  | \nImpressions change | 5% |  | \nCost-per-impression change | 17% |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2021 |  | 2022 |  |  |  | \nUnited States | 45 | % |  | 47 | % |  |  |  | \nEMEA | 31 | % |  | 30 | % |  |  |  | \nAPAC | 19 | % |  | 17 | % |  |  |  | \nOther Americas | 5 | % |  | 6 | % |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  |  |  | \n | March 31, |  |  |  | \n | 2021 |  | 2022 |  | % Change from Prior Year |  |  |  | \nEMEA revenues | $ | 17,031 |  |  | $ | 20,317 |  |  | 19 | % |  |  |  | \nEMEA constant currency revenues |  |  | 21,628 |  |  | 27 | % |  |  |  | \n |  |  |  |  |  |  |  |  | \nAPAC revenues | 10,455 |  |  | 11,841 |  |  | 13 | % |  |  |  | \nAPAC constant currency revenues |  |  | 12,440 |  |  | 19 | % |  |  |  | \n |  |  |  |  |  |  |  |  | \nOther Americas revenues | 2,905 |  |  | 3,842 |  |  | 32 | % |  |  |  | \nOther Americas constant currency revenues |  |  | 3,923 |  |  | 35 | % |  |  |  | \n |  |  |  |  |  |  |  |  | \nUnited States revenues | 25,032 |  |  | 31,733 |  |  | 27 | % |  |  |  | \n |  |  |  |  |  |  |  |  | \nHedging gains (losses) | (109) |  |  | 278 |  |  |  |  |  |  | \nTotal revenues | $ | 55,314 |  |  | $ | 68,011 |  |  | 23 | % |  |  |  | \nRevenues, excluding hedging effect | $ | 55,423 |  |  | $ | 67,733 |  |  |  |  |  |  | \nExchange rate effect |  |  | 1,991 |  |  |  |  |  |  | \nTotal constant currency revenues |  |  | $ | 69,724 |  |  | 26 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2021 |  | 2022 |  |  |  | \nTAC | $ | 9,712 |  |  | $ | 11,990 |  |  |  |  | \nOther cost of revenues | 14,391 |  |  | 17,609 |  |  |  |  | \nTotal cost of revenues | $ | 24,103 |  |  | $ | 29,599 |  |  |  |  | \nTotal cost of revenues as a percentage of revenues | 43.6 | % |  | 43.5 | % |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2021 |  | 2022 |  |  |  | \nResearch and development expenses | $ | 7,485 |  |  | $ | 9,119 |  |  |  |  | \nResearch and development expenses as a percentage of revenues | 13.5 | % |  | 13.4 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2021 |  | 2022 |  |  |  | \nSales and marketing expenses | $ | 4,516 |  |  | $ | 5,825 |  |  |  |  | \nSales and marketing expenses as a percentage of revenues | 8.2 | % |  | 8.6 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2021 |  | 2022 |  |  |  | \nGeneral and administrative expenses | $ | 2,773 |  |  | $ | 3,374 |  |  |  |  | \nGeneral and administrative expenses as a percentage of revenues | 5.0 | % |  | 5.0 | % |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2021 |  | 2022 |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  |  |  | \nOperating income (loss): |  |  |  |  |  |  | \nGoogle Services | $ | 19,546 |  |  | $ | 22,920 |  |  |  |  | \nGoogle Cloud | (974) |  |  | (931) |  |  |  |  | \nOther Bets | (1,145) |  |  | (1,155) |  |  |  |  | \nCorporate costs, unallocated(1) | (990) |  |  | (740) |  |  |  |  | \nTotal income from operations | $ | 16,437 |  |  | $ | 20,094 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2021 |  | 2022 |  |  |  | \nOther income (expense), net | $ | 4,846 |  |  | $ | (1,160) |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2021 |  | 2022 |  |  |  | \nIncome before provision for income taxes | $ | 21,283 |  |  | $ | 18,934 |  |  |  |  | \nProvision for income taxes | $ | 3,353 |  |  | $ | 2,498 |  |  |  |  | \nEffective tax rate | 15.8 | % |  | 13.2 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended\n | March 31,\n | 2021 |  | 2022\nNet cash provided by operating activities | $ | 19,289 |  |  | $ | 25,106 | \nNet cash used in investing activities | $ | (5,383) |  |  | $ | (9,051) | \nNet cash used in financing activities | $ | (13,606) |  |  | $ | (16,214) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | Total Number of Class A Shares Purchased(in thousands)(1) |  | Total Number of Class C Shares Purchased(in thousands)(1) |  | Average Price Paid per Class A Share(2) |  | Average Price Paid per Class C Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Programs(in thousands)(1) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program(in millions)\nJanuary 1 - 31 |  | 81 |  |  | 1,642 |  |  | $ | 2,758.20 |  |  | $ | 2,722.40 |  |  | 1,723 |  |  | $ | 12,679 | \nFebruary 1 - 28 |  | 4 |  |  | 1,469 |  |  | $ | 2,666.27 |  |  | $ | 2,719.33 |  |  | 1,473 |  |  | $ | 8,672 | \nMarch 1 - 31 |  | 160 |  |  | 1,557 |  |  | $ | 2,665.14 |  |  | $ | 2,681.53 |  |  | 1,717 |  |  | $ | 4,071 | \nTotal |  | 245 |  |  | 4,668 |  |  |  |  |  |  | 4,913 |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nExhibitNumber |  | Description |  | Incorporated\u00a0by\u00a0reference\u00a0herein\n | Form |  | Date\n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n31.01 | * | Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n31.02 | * | Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n32.01 | \u2021 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18\u00a0U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n |  |  |  |  |  | \n101.INS | * | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |  |  |  | \n101.SCH | * | Inline XBRL Taxonomy Extension Schema Document |  |  |  | \n101.CAL | * | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  |  |  | \n101.DEF | * | Inline XBRL Taxonomy Extension Definition Linkbase Document |  |  |  | \n101.LAB | * | Inline XBRL Taxonomy Extension Label Linkbase Document |  |  |  | \n101.PRE | * | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  |  |  | \n104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |  |  |  |   |  |  |  |  | \n | \n | \n* | Filed herewith.\n\u2021 | Furnished herewith.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  | \n |  | ALPHABET INC.\nApril 26, 2022 | By: | /s/\u00a0\u00a0\u00a0\u00a0RUTH M. PORAT\n |  | Ruth M. Porat\n |  | Senior Vice President and Chief Financial Officer  |  |  |  |  |  |  |  | \n |  | ALPHABET INC.\nApril 26, 2022 | By: | /s/\u00a0\u00a0\u00a0\u00a0AMIE THUENER O'TOOLE\n |  | Amie Thuener O'Toole\n |  | Vice President and Chief Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Google, in 2022 Q2, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION\u00a013 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \nDelaware | 61-1767919\n(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number)  |  |  |  |  |  |  |  | \nSecurities registered pursuant to Section\u00a012(b) of the Act:\nTitle of each class | Trading Symbol(s) | Name of each exchange on which registered\nClass\u00a0A Common Stock, $0.001 par value | GOOGL | Nasdaq Stock Market LLC\n |  | (Nasdaq Global Select Market)\nClass C Capital Stock, $0.001 par value | GOOG | Nasdaq Stock Market LLC\n |  | (Nasdaq Global Select Market)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 |  | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 |  | Smaller reporting company | \u2610\nEmerging growth company | \u2610 |  |  |   |  | \n  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  | \n |  | Page\u00a0No.\nNote About Forward-Looking Statements | 3\n\nPART I. FINANCIAL INFORMATION\nItem\u00a01 | Financial Statements | 5\n | Consolidated Balance Sheets- December\u00a031, 2021 and June\u00a030, 2022 | 5\n | Consolidated Statements of Income -Three and Six Months Ended June 30,2021and2022 | 6\n | Consolidated Statements of Comprehensive Income -Three and Six Months Ended June 30,2021and2022 | 7\n | Consolidated Statements of Stockholders' Equity -Three and Six Months Ended June 30,2021and2022 | 8\n | Consolidated Statements of Cash Flows -Six Months Ended June 30,2021and2022 | 10\n | Notes to Consolidated Financial Statements | 11\nItem\u00a02 | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 33\nItem\u00a03 | Quantitative and Qualitative Disclosures About Market Risk | 46\nItem\u00a04 | Controls and Procedures | 46\n |  | \nPART II. OTHER INFORMATION\nItem\u00a01 | Legal Proceedings | 47\nItem\u00a01A | Risk Factors | 47\nItem 2 | Unregistered Sales of Equity Securities and Use of Proceeds | 47\n |  | \n |  | \nItem\u00a06 | Exhibits | 48\nSignatures | 49  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2021 |  | As ofJune 30, 2022\n |  |  | (unaudited)\nAssets |  |  | \nCurrent assets: |  |  | \nCash and cash equivalents | $ | 20,945 |  |  | $ | 17,936 | \nMarketable securities | 118,704 |  |  | 107,061 | \nTotal cash, cash equivalents, and marketable securities | 139,649 |  |  | 124,997 | \nAccounts receivable, net | 39,304 |  |  | 35,707 | \nIncome taxes receivable, net | 966 |  |  | 1,366 | \nInventory | 1,170 |  |  | 1,980 | \nOther current assets | 7,054 |  |  | 8,321 | \nTotal current assets | 188,143 |  |  | 172,371 | \nNon-marketable securities | 29,549 |  |  | 30,665 | \nDeferred income taxes | 1,284 |  |  | 1,490 | \nProperty and equipment, net | 97,599 |  |  | 106,223 | \nOperating lease assets | 12,959 |  |  | 13,398 | \nIntangible assets, net | 1,417 |  |  | 1,377 | \nGoodwill | 22,956 |  |  | 23,949 | \nOther non-current assets | 5,361 |  |  | 5,712 | \nTotal assets | $ | 359,268 |  |  | $ | 355,185 | \nLiabilities and Stockholders\u2019 Equity |  |  | \nCurrent liabilities: |  |  | \nAccounts payable | $ | 6,037 |  |  | $ | 4,409 | \n |  |  | \nAccrued compensation and benefits | 13,889 |  |  | 10,852 | \nAccrued expenses and other current liabilities | 31,236 |  |  | 32,976 | \nAccrued revenue share | 8,996 |  |  | 7,889 | \nDeferred revenue | 3,288 |  |  | 3,272 | \nIncome taxes payable, net | 808 |  |  | 1,956 | \nTotal current liabilities | 64,254 |  |  | 61,354 | \nLong-term debt | 14,817 |  |  | 14,734 | \nDeferred revenue, non-current | 535 |  |  | 472 | \nIncome taxes payable, non-current | 9,176 |  |  | 8,163 | \nDeferred income taxes | 5,257 |  |  | 924 | \nOperating lease liabilities | 11,389 |  |  | 11,697 | \nOther long-term liabilities | 2,205 |  |  | 2,422 | \nTotal liabilities | 107,633 |  |  | 99,766 | \nContingencies (Note 9) |  |  | \nStockholders\u2019 equity: |  |  | \nPreferred stock, $0.001par value per share,100shares authorized;noshares issued and outstanding | 0 |  |  | 0 | \nClass\u00a0A, Class B, and Class C stock and additional paid-in capital, $0.001par value per share:300,000shares authorized\u00a0(Class\u00a0A180,000, Class B60,000, Class C60,000);13,242(Class\u00a0A6,015, Class B893, Class C6,334) and13,078(Class\u00a0A6,002, Class B885, Class C6,191) shares issued and outstanding | 61,774 |  |  | 64,402 | \nAccumulated other comprehensive income (loss) | (1,623) |  |  | (5,828) | \nRetained earnings | 191,484 |  |  | 196,845 | \nTotal stockholders\u2019 equity | 251,635 |  |  | 255,419 | \nTotal liabilities and stockholders\u2019 equity | $ | 359,268 |  |  | $ | 355,185 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nRevenues | $ | 61,880 |  |  | $ | 69,685 |  |  | $ | 117,194 |  |  | $ | 137,696 | \nCosts and expenses: |  |  |  |  |  |  | \nCost of revenues | 26,227 |  |  | 30,104 |  |  | 50,330 |  |  | 59,703 | \nResearch and development | 7,675 |  |  | 9,841 |  |  | 15,160 |  |  | 18,960 | \nSales and marketing | 5,276 |  |  | 6,630 |  |  | 9,792 |  |  | 12,455 | \nGeneral and administrative | 3,341 |  |  | 3,657 |  |  | 6,114 |  |  | 7,031 | \nTotal costs and expenses | 42,519 |  |  | 50,232 |  |  | 81,396 |  |  | 98,149 | \nIncome from operations | 19,361 |  |  | 19,453 |  |  | 35,798 |  |  | 39,547 | \nOther income (expense), net | 2,624 |  |  | (439) |  |  | 7,470 |  |  | (1,599) | \nIncome before income taxes | 21,985 |  |  | 19,014 |  |  | 43,268 |  |  | 37,948 | \nProvision for income taxes | 3,460 |  |  | 3,012 |  |  | 6,813 |  |  | 5,510 | \nNet income | $ | 18,525 |  |  | $ | 16,002 |  |  | $ | 36,455 |  |  | $ | 32,438 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income per share of Class A, Class B, and Class C stock | $ | 1.38 |  |  | $ | 1.22 |  |  | $ | 2.72 |  |  | $ | 2.46 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nDiluted net income per share of Class A, Class B, and Class C stock | $ | 1.36 |  |  | $ | 1.21 |  |  | $ | 2.68 |  |  | $ | 2.44 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nNet income | $ | 18,525 |  |  | $ | 16,002 |  |  | $ | 36,455 |  |  | $ | 32,438 | \nOther comprehensive income (loss): |  |  |  |  |  |  | \nChange in foreign currency translation adjustment | 366 |  |  | (1,665) |  |  | (57) |  |  | (1,626) | \nAvailable-for-sale investments: |  |  |  |  |  |  | \nChange in net unrealized gains (losses) | (52) |  |  | (926) |  |  | (540) |  |  | (3,404) | \nLess: reclassification adjustment for net (gains) losses included in net income | (75) |  |  | 233 |  |  | (64) |  |  | 381 | \nNet change, net of income tax benefit (expense) of $37,$227,$172and$860 | (127) |  |  | (693) |  |  | (604) |  |  | (3,023) | \nCash flow hedges: |  |  |  |  |  |  | \nChange in net unrealized gains (losses) | (42) |  |  | 915 |  |  | 137 |  |  | 1,029 | \nLess: reclassification adjustment for net (gains) losses included in net income | (4) |  |  | (336) |  |  | 81 |  |  | (585) | \nNet change, net of income tax benefit (expense) of $15, $(113), $(35) and $(69) | (46) |  |  | 579 |  |  | 218 |  |  | 444 | \nOther comprehensive income (loss) | 193 |  |  | (1,779) |  |  | (443) |  |  | (4,205) | \nComprehensive income | $ | 18,718 |  |  | $ | 14,223 |  |  | $ | 36,012 |  |  | $ | 28,233 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, 2021\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of March 31, 2021 | 13,422 |  |  | $ | 59,436 |  |  | $ | (3) |  |  | $ | 170,580 |  |  | $ | 230,013 | \nStock issued | 39 |  |  | 1 |  |  | 0 |  |  | 0 |  |  | 1 | \nStock-based compensation expense | 0 |  |  | 3,844 |  |  | 0 |  |  | 0 |  |  | 3,844 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (2,515) |  |  | 0 |  |  | 0 |  |  | (2,515) | \nRepurchases of stock | (108) |  |  | (630) |  |  | 0 |  |  | (12,166) |  |  | (12,796) | \nSale of interest in consolidated entities | 0 |  |  | 300 |  |  | 0 |  |  | 0 |  |  | 300 | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 18,525 |  |  | 18,525 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | 193 |  |  | 0 |  |  | 193 | \nBalance as of June 30, 2021 | 13,353 |  |  | $ | 60,436 |  |  | $ | 190 |  |  | $ | 176,939 |  |  | $ | 237,565 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended June 30, 2021\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of December 31, 2020 | 13,504 |  |  | $ | 58,510 |  |  | $ | 633 |  |  | $ | 163,401 |  |  | $ | 222,544 | \nStock issued | 70 |  |  | 7 |  |  | 0 |  |  | 0 |  |  | 7 | \nStock-based compensation expense | 0 |  |  | 7,632 |  |  | 0 |  |  | 0 |  |  | 7,632 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (4,749) |  |  | 0 |  |  | 0 |  |  | (4,749) | \nRepurchases of stock | (221) |  |  | (1,274) |  |  | 0 |  |  | (22,917) |  |  | (24,191) | \nSale of interest in consolidated entities | 0 |  |  | 310 |  |  | 0 |  |  | 0 |  |  | 310 | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 36,455 |  |  | 36,455 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | (443) |  |  | 0 |  |  | (443) | \nBalance as of June 30, 2021 | 13,353 |  |  | $ | 60,436 |  |  | $ | 190 |  |  | $ | 176,939 |  |  | $ | 237,565 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, 2022\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of March 31, 2022 | 13,175 |  |  | $ | 62,832 |  |  | $ | (4,049) |  |  | $ | 195,221 |  |  | $ | 254,004 | \nStock issued | 36 |  |  | 1 |  |  | 0 |  |  | 0 |  |  | 1 | \nStock-based compensation expense | 0 |  |  | 4,823 |  |  | 0 |  |  | 0 |  |  | 4,823 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (2,434) |  |  | 0 |  |  | (1) |  |  | (2,435) | \nRepurchases of stock | (133) |  |  | (820) |  |  | 0 |  |  | (14,377) |  |  | (15,197) | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 16,002 |  |  | 16,002 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | (1,779) |  |  | 0 |  |  | (1,779) | \nBalance as of June 30, 2022 | 13,078 |  |  | $ | 64,402 |  |  | $ | (5,828) |  |  | $ | 196,845 |  |  | $ | 255,419 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended June 30, 2022\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of December 31, 2021 | 13,242 |  |  | $ | 61,774 |  |  | $ | (1,623) |  |  | $ | 191,484 |  |  | $ | 251,635 | \nStock issued | 67 |  |  | 8 |  |  | 0 |  |  | 0 |  |  | 8 | \nStock-based compensation expense | 0 |  |  | 9,370 |  |  | 0 |  |  | 0 |  |  | 9,370 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (5,329) |  |  | 0 |  |  | (1) |  |  | (5,330) | \nRepurchases of stock | (231) |  |  | (1,421) |  |  | 0 |  |  | (27,076) |  |  | (28,497) | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 32,438 |  |  | 32,438 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | (4,205) |  |  | 0 |  |  | (4,205) | \nBalance as of June 30, 2022 | 13,078 |  |  | $ | 64,402 |  |  | $ | (5,828) |  |  | $ | 196,845 |  |  | $ | 255,419 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended\n | June 30,\n | 2021 |  | 2022\nOperating activities |  |  | \nNet income | $ | 36,455 |  |  | $ | 32,438 | \nAdjustments: |  |  | \nDepreciation and impairment of property and equipment | 5,255 |  |  | 7,289 | \nAmortization and impairment of intangible assets | 443 |  |  | 392 | \nStock-based compensation expense | 7,548 |  |  | 9,286 | \nDeferred income taxes | 1,479 |  |  | (4,237) | \n(Gain) loss on debt and equity securities, net | (7,634) |  |  | 2,478 | \nOther | (263) |  |  | 202 | \nChanges in assets and liabilities, net of effects of acquisitions: |  |  | \nAccounts receivable | (867) |  |  | 2,395 | \nIncome taxes, net | (297) |  |  | (253) | \nOther assets | (192) |  |  | (1,621) | \nAccounts payable | (1,112) |  |  | (1,172) | \nAccrued expenses and other liabilities | 201 |  |  | (1,719) | \nAccrued revenue share | 29 |  |  | (942) | \nDeferred revenue | 134 |  |  | (8) | \nNet cash provided by operating activities | 41,179 |  |  | 44,528 | \nInvesting activities |  |  | \nPurchases of property and equipment | (11,438) |  |  | (16,614) | \nPurchases of marketable securities | (60,609) |  |  | (50,199) | \nMaturities and sales of marketable securities | 60,667 |  |  | 55,374 | \nPurchases of non-marketable securities | (1,412) |  |  | (1,264) | \nMaturities and sales of non-marketable securities | 256 |  |  | 125 | \n |  |  | \n |  |  | \nAcquisitions, net of cash acquired, and purchases of intangible assets | (1,974) |  |  | (1,236) | \nOther investing activities | 53 |  |  | 576 | \n |  |  | \nNet cash used in investing activities | (14,457) |  |  | (13,238) | \nFinancing activities |  |  | \nNet payments related to stock-based award activities | (4,637) |  |  | (5,180) | \n |  |  | \nRepurchases of stock | (24,191) |  |  | (28,497) | \nProceeds from issuance of debt, net of costs | 7,599 |  |  | 29,228 | \nRepayments of debt | (8,678) |  |  | (29,582) | \nProceeds from sale of interest in consolidated entities, net | 310 |  |  | 0 | \nNet cash used in financing activities | (29,597) |  |  | (34,031) | \nEffect of exchange rate changes on cash and cash equivalents | 40 |  |  | (268) | \nNet decrease in cash and cash equivalents | (2,835) |  |  | (3,009) | \nCash and cash equivalents at beginning of period | 26,465 |  |  | 20,945 | \nCash and cash equivalents at end of period | $ | 23,630 |  |  | $ | 17,936 | \n |  |  | \n |  |  | \n |  |  | \n |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nGoogle Search & other | $ | 35,845 |  |  | $ | 40,689 |  |  | $ | 67,724 |  |  | $ | 80,307 | \nYouTube ads | 7,002 |  |  | 7,340 |  |  | 13,007 |  |  | 14,209 | \nGoogle Network | 7,597 |  |  | 8,259 |  |  | 14,397 |  |  | 16,433 | \nGoogle advertising | 50,444 |  |  | 56,288 |  |  | 95,128 |  |  | 110,949 | \nGoogle other | 6,623 |  |  | 6,553 |  |  | 13,117 |  |  | 13,364 | \nGoogle Services total | 57,067 |  |  | 62,841 |  |  | 108,245 |  |  | 124,313 | \nGoogle Cloud | 4,628 |  |  | 6,276 |  |  | 8,675 |  |  | 12,097 | \nOther Bets | 192 |  |  | 193 |  |  | 390 |  |  | 633 | \nHedging gains (losses) | (7) |  |  | 375 |  |  | (116) |  |  | 653 | \nTotal revenues | $ | 61,880 |  |  | $ | 69,685 |  |  | $ | 117,194 |  |  | $ | 137,696 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nUnited States | $ | 28,208 |  |  | 46 | % |  | $ | 32,727 |  |  | 47 | % |  | $ | 53,240 |  |  | 45 | % |  | $ | 64,460 |  |  | 47 | %\nEMEA(1) | 19,084 |  |  | 31 |  |  | 20,533 |  |  | 29 |  |  | 36,115 |  |  | 31 |  |  | 40,850 |  |  | 30 | \nAPAC(1) | 11,231 |  |  | 18 |  |  | 11,710 |  |  | 17 |  |  | 21,686 |  |  | 19 |  |  | 23,551 |  |  | 17 | \nOther Americas(1) | 3,364 |  |  | 5 |  |  | 4,340 |  |  | 6 |  |  | 6,269 |  |  | 5 |  |  | 8,182 |  |  | 6 | \nHedging gains (losses) | (7) |  |  | 0 |  |  | 375 |  |  | 1 |  |  | (116) |  |  | 0 |  |  | 653 |  |  | 0 | \nTotal revenues | $ | 61,880 |  |  | 100 | % |  | $ | 69,685 |  |  | 100 | % |  | $ | 117,194 |  |  | 100 | % |  | $ | 137,696 |  |  | 100 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n | AdjustedCost |  | GrossUnrealizedGains |  | GrossUnrealizedLosses |  | FairValue |  | Cash and CashEquivalents |  | MarketableSecurities\nLevel 2: |  |  |  |  |  |  |  |  |  |  | \nTime deposits(1) | $ | 5,133 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 5,133 |  |  | $ | 5,133 |  |  | $ | 0 | \nGovernment bonds | 53,288 |  |  | 258 |  |  | (238) |  |  | 53,308 |  |  | 5 |  |  | 53,303 | \nCorporate debt securities | 35,605 |  |  | 194 |  |  | (223) |  |  | 35,576 |  |  | 12 |  |  | 35,564 | \nMortgage-backed and asset-backed securities | 18,829 |  |  | 96 |  |  | (112) |  |  | 18,813 |  |  | 0 |  |  | 18,813 | \nTotal | $ | 112,855 |  |  | $ | 548 |  |  | $ | (573) |  |  | $ | 112,830 |  |  | $ | 5,150 |  |  | $ | 107,680 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of June 30, 2022\n | AdjustedCost |  | GrossUnrealizedGains |  | GrossUnrealizedLosses |  | FairValue |  | Cash and CashEquivalents |  | MarketableSecurities\nLevel 2: |  |  |  |  |  |  |  |  |  |  | \nTime deposits(1) | $ | 4,054 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 4,054 |  |  | $ | 4,054 |  |  | $ | 0 | \nGovernment bonds | 46,782 |  |  | 36 |  |  | (1,575) |  |  | 45,243 |  |  | 45 |  |  | 45,198 | \nCorporate debt securities | 35,486 |  |  | 6 |  |  | (1,449) |  |  | 34,043 |  |  | 0 |  |  | 34,043 | \nMortgage-backed and asset-backed securities | 18,426 |  |  | 1 |  |  | (903) |  |  | 17,524 |  |  | 0 |  |  | 17,524 | \nTotal | $ | 104,748 |  |  | $ | 43 |  |  | $ | (3,927) |  |  | $ | 100,864 |  |  | $ | 4,099 |  |  | $ | 96,765 |   |  |  |  |  | \n | As ofJune 30, 2022\nDue in 1 year or less | $ | 12,374 | \nDue in 1 year through 5 years | 73,397 | \nDue in 5 years through 10 years | 4,795 | \nDue after 10 years | 12,210 | \nTotal | $ | 102,776 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n | Less\u00a0than\u00a012 Months |  | 12 Months or Greater |  | Total\n | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss\nGovernment bonds | $ | 32,843 |  |  | $ | (236) |  |  | $ | 71 |  |  | $ | (2) |  |  | $ | 32,914 |  |  | $ | (238) | \nCorporate debt securities | 22,737 |  |  | (152) |  |  | 303 |  |  | (5) |  |  | 23,040 |  |  | (157) | \nMortgage-backed and asset-backed securities | 11,502 |  |  | (106) |  |  | 248 |  |  | (6) |  |  | 11,750 |  |  | (112) | \nTotal | $ | 67,082 |  |  | $ | (494) |  |  | $ | 622 |  |  | $ | (13) |  |  | $ | 67,704 |  |  | $ | (507) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of June 30, 2022\n | Less\u00a0than\u00a012 Months |  | 12 Months or Greater |  | Total\n | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss\nGovernment bonds | $ | 36,141 |  |  | $ | (1,390) |  |  | $ | 3,525 |  |  | $ | (185) |  |  | $ | 39,666 |  |  | $ | (1,575) | \nCorporate debt securities | 29,241 |  |  | (1,136) |  |  | 3,111 |  |  | (235) |  |  | 32,352 |  |  | (1,371) | \nMortgage-backed and asset-backed securities | 15,453 |  |  | (796) |  |  | 1,648 |  |  | (107) |  |  | 17,101 |  |  | (903) | \nTotal | $ | 80,835 |  |  | $ | (3,322) |  |  | $ | 8,284 |  |  | $ | (527) |  |  | $ | 89,119 |  |  | $ | (3,849) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nNet gain (loss) on equity securities sold during the period | $ | 138 |  |  | $ | 26 |  |  | $ | 506 |  |  | $ | (230) | \nNet unrealized gain (loss) on equity securities held as of the end of the period | 2,634 |  |  | (277) |  |  | 7,103 |  |  | (1,091) | \nTotal gain (loss) recognized in other income (expense), net | $ | 2,772 |  |  | $ | (251) |  |  | $ | 7,609 |  |  | $ | (1,321) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Equity Securities Sold\n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nTotal sale price | $ | 2,629 |  |  | $ | 645 |  |  | $ | 3,353 |  |  | $ | 1,335 | \nTotal initial cost | 409 |  |  | 168 |  |  | 766 |  |  | 428 | \nCumulative net gains(1) | $ | 2,220 |  |  | $ | 477 |  |  | $ | 2,587 |  |  | $ | 907 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n | Marketable Securities |  | Non-Marketable Securities |  | Total\nTotal initial cost | $ | 4,211 |  |  | $ | 15,135 |  |  | $ | 19,346 | \nCumulative net gain (loss)(1) | 3,587 |  |  | 12,436 |  |  | 16,023 | \nCarrying value(2) | $ | 7,798 |  |  | $ | 27,571 |  |  | $ | 35,369 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of June 30, 2022\n | Marketable Securities |  | Non-Marketable Securities |  | Total\nTotal initial cost | $ | 5,451 |  |  | $ | 15,262 |  |  | $ | 20,713 | \nCumulative net gain (loss)(1) | 146 |  |  | 13,595 |  |  | 13,741 | \nCarrying value(2) | $ | 5,597 |  |  | $ | 28,857 |  |  | $ | 34,454 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021 |  | As of June 30, 2022\n | Cash and Cash Equivalents |  | MarketableSecurities |  | Cash and Cash Equivalents |  | MarketableSecurities\nLevel 1: |  |  |  |  | \nMoney market funds | $ | 7,499 |  |  | $ | 0 |  |  | $ | 6,593 |  |  | $ | 0 | \nMarketable equity securities(1)(2) | 0 |  |  | 7,447 |  |  | 0 |  |  | 5,242 | \n | 7,499 |  |  | 7,447 |  |  | 6,593 |  |  | 5,242 | \nLevel 2: |  |  |  |  |  |  | \nMutual funds | 0 |  |  | 351 |  |  | 0 |  |  | 355 | \nTotal | $ | 7,499 |  |  | $ | 7,798 |  |  | $ | 6,593 |  |  | $ | 5,597 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nUnrealized gains on non-marketable equity securities | $ | 1,852 |  |  | $ | 2,179 |  |  | $ | 5,128 |  |  | $ | 3,016 | \nUnrealized losses on non-marketable equity securities (including impairments) | (65) |  |  | (1,268) |  |  | (67) |  |  | (1,645) | \nTotal unrealized gain (loss) recognized on non-marketable equity securities | $ | 1,787 |  |  | $ | 911 |  |  | $ | 5,061 |  |  | $ | 1,371 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021 |  | As of June 30, 2022\nDerivatives Designated as Hedging Instruments: |  | \nForeign exchange contracts |  |  | \nCash flow hedges | $ | 16,362 |  |  | $ | 17,871 | \nFair value hedges | $ | 2,556 |  |  | $ | 2,151 | \nNet investment hedges | $ | 10,159 |  |  | $ | 9,801 | \nDerivatives Not Designated as Hedging Instruments: |  | \nForeign exchange contracts | $ | 41,031 |  |  | $ | 42,270 | \nOther contracts | $ | 4,275 |  |  | $ | 7,347 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | As of December 31, 2021\n | Balance\u00a0Sheet\u00a0Location |  | Fair\u00a0Value\u00a0ofDerivativesDesignated\u00a0asHedging\u00a0Instruments |  | Fair\u00a0Value\u00a0ofDerivatives\u00a0NotDesignated asHedging\u00a0Instruments |  | Total\u00a0Fair Value\nDerivative Assets: |  |  |  |  |  | \nLevel 2: |  |  |  |  |  |  | \nForeign exchange contracts | Other current and non-current assets |  | $ | 867 |  |  | $ | 42 |  |  | $ | 909 | \nOther contracts | Other current and non-current assets |  | 0 |  |  | 52 |  |  | 52 | \nTotal |  |  | $ | 867 |  |  | $ | 94 |  |  | $ | 961 | \nDerivative Liabilities: |  |  |  |  |  | \nLevel 2: |  |  |  |  |  |  | \nForeign exchange contracts | Accrued expenses and other liabilities, current and non-current |  | $ | 8 |  |  | $ | 452 |  |  | $ | 460 | \nOther contracts | Accrued expenses and other liabilities, current and non-current |  | 0 |  |  | 121 |  |  | 121 | \nTotal |  |  | $ | 8 |  |  | $ | 573 |  |  | $ | 581 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | As of June 30, 2022\n | Balance\u00a0Sheet\u00a0Location |  | Fair\u00a0Value\u00a0ofDerivativesDesignated\u00a0asHedging\u00a0Instruments |  | Fair\u00a0Value\u00a0ofDerivatives\u00a0NotDesignated asHedging\u00a0Instruments |  | Total\u00a0Fair Value\nDerivative Assets: |  |  |  |  |  | \nLevel 2: |  |  |  |  |  |  | \nForeign exchange contracts | Other current and non-current assets |  | $ | 1,540 |  |  | $ | 77 |  |  | $ | 1,617 | \nOther contracts | Other current and non-current assets |  | 0 |  |  | 80 |  |  | 80 | \nTotal |  |  | $ | 1,540 |  |  | $ | 157 |  |  | $ | 1,697 | \nDerivative Liabilities: |  |  |  |  |  | \nLevel 2: |  |  |  |  |  |  | \nForeign exchange contracts | Accrued expenses and other liabilities, current and non-current |  | $ | 36 |  |  | $ | 749 |  |  | $ | 785 | \nOther contracts | Accrued expenses and other liabilities, current and non-current |  | 0 |  |  | 56 |  |  | 56 | \nTotal |  |  | $ | 36 |  |  | $ | 805 |  |  | $ | 841 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Gains (Losses) Recognized in OCI on Derivatives Before Tax Effect\n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nDerivatives in Cash Flow Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount included in the assessment of effectiveness | $ | (60) |  |  | $ | 1,131 |  |  | $ | 102 |  |  | $ | 1,266 | \nAmount excluded from the assessment of effectiveness | (4) |  |  | (39) |  |  | 45 |  |  | (54) | \n |  |  |  |  |  |  | \nDerivatives in Net Investment Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount included in the assessment of effectiveness | (179) |  |  | 509 |  |  | 199 |  |  | 658 | \nTotal | $ | (243) |  |  | $ | 1,601 |  |  | $ | 346 |  |  | $ | 1,870 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Gains (Losses) Recognized in Income\n | Three Months Ended\n | June 30,\n | 2021 |  | 2022\n | Revenues |  | Other income (expense), net |  | Revenues |  | Other income (expense), net\nTotal amounts presented in the Consolidated Statements of Income in which the effects of cash flow and fair value hedges are recorded | $ | 61,880 |  |  | $ | 2,624 |  |  | $ | 69,685 |  |  | $ | (439) | \n |  |  |  |  |  |  | \nGains (Losses) on Derivatives in Cash Flow Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount of gains (losses) reclassified from AOCI to income | $ | (3) |  |  | $ | 0 |  |  | $ | 400 |  |  | $ | 0 | \nAmount excluded from the assessment of effectiveness recognized in earnings based on an amortization approach | (4) |  |  | 0 |  |  | (24) |  |  | 0 | \nGains (Losses) on Derivatives in Fair Value Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nHedged items | 0 |  |  | 28 |  |  | 0 |  |  | (136) | \nDerivatives designated as hedging instruments | 0 |  |  | (28) |  |  | 0 |  |  | 136 | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 2 |  |  | 0 |  |  | 2 | \nGains (Losses) on Derivatives in Net Investment Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 21 |  |  | 0 |  |  | 28 | \nGains (Losses) on Derivatives Not Designated as Hedging Instruments: |  |  |  |  |  |  | \nForeign exchange contracts | 0 |  |  | (64) |  |  | 0 |  |  | (149) | \nOther Contracts | 0 |  |  | (142) |  |  | 0 |  |  | 86 | \nTotal gains (losses) | $ | (7) |  |  | $ | (183) |  |  | $ | 376 |  |  | $ | (33) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Gains (Losses) Recognized in Income\n | Six Months Ended\n | June 30,\n | 2021 |  | 2022\n | Revenues |  | Other income (expense), net |  | Revenues |  | Other income (expense), net\nTotal amounts presented in the Consolidated Statements of Income in which the effects of cash flow and fair value hedges are recorded | $ | 117,194 |  |  | $ | 7,470 |  |  | $ | 137,696 |  |  | $ | (1,599) | \n |  |  |  |  |  |  | \nGains (Losses) on Derivatives in Cash Flow Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount of gains (losses) reclassified from AOCI to income | $ | (108) |  |  | $ | 0 |  |  | $ | 697 |  |  | $ | 0 | \nAmount excluded from the assessment of effectiveness recognized in earnings based on an amortization approach | (8) |  |  | 0 |  |  | (43) |  |  | 0 | \nGains (Losses) on Derivatives in Fair Value Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nHedged items | 0 |  |  | 28 |  |  | 0 |  |  | (123) | \nDerivatives designated as hedging instruments | 0 |  |  | (28) |  |  | 0 |  |  | 124 | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 4 |  |  | 0 |  |  | 3 | \nGains (Losses) on Derivatives in Net Investment Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 41 |  |  | 0 |  |  | 40 | \nGains (Losses) on Derivatives Not Designated as Hedging Instruments: |  |  |  |  |  |  | \nForeign exchange contracts | 0 |  |  | (404) |  |  | 0 |  |  | (396) | \nOther Contracts | 0 |  |  | 181 |  |  | 0 |  |  | 124 | \nTotal gains (losses) | $ | (116) |  |  | $ | (178) |  |  | $ | 654 |  |  | $ | (228) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset |  | \n | Gross Amounts of Recognized Assets |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Received |  | Non-Cash Collateral Received |  | Net Assets Exposed\nDerivatives | $ | 999 |  |  | $ | (38) |  |  | $ | 961 |  |  | $ | (434) |  | (1) | $ | (394) |  |  | $ | (12) |  |  | $ | 121 | \n |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of June 30, 2022\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset |  | \n | Gross Amounts of Recognized Assets |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Received |  | Non-Cash Collateral Received |  | Net Assets Exposed\nDerivatives | $ | 1,773 |  |  | $ | (76) |  |  | $ | 1,697 |  |  | $ | (736) |  | (1) | $ | (880) |  |  | $ | (18) |  |  | $ | 63 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset |  | \n | Gross Amounts of Recognized Liabilities |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Pledged |  | Non-Cash Collateral Pledged |  | Net Liabilities\nDerivatives | $ | 619 |  |  | $ | (38) |  |  | $ | 581 |  |  | $ | (434) |  | (2) | $ | (4) |  |  | $ | (110) |  |  | $ | 33 | \n |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of June 30, 2022\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | \n | Gross Amounts of Recognized Liabilities |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Pledged |  | Non-Cash Collateral Pledged |  | Net Liabilities\nDerivatives | $ | 917 |  |  | $ | (76) |  |  | $ | 841 |  |  | $ | (736) |  | (2) | $ | (13) |  |  | $ | (1) |  |  | $ | 91 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Maturity |  | Coupon Rate |  | Effective Interest Rate |  | As of December 31, 2021 |  | As ofJune 30, 2022\nDebt |  |  |  |  |  |  |  |  |  | \n2014-2020 Notes Issuances |  | 2024 - 2060 |  | 0.45% -3.38% |  | 0.57% -3.38% |  | $ | 13,000 |  |  | $ | 13,000 | \nFuture finance lease payments, net and other(1) |  |  |  |  |  |  |  | 2,086 |  |  | 1,966 | \nTotal debt |  |  |  |  |  |  |  | 15,086 |  |  | 14,966 | \nUnamortized discount and debt issuance costs |  |  |  |  |  |  |  | (156) |  |  | (150) | \nLess: Current portion future finance lease payments, net and other current debt(1)(2) |  |  |  |  |  |  |  | (113) |  |  | (82) | \nTotal long-term debt |  |  |  |  |  |  |  | $ | 14,817 |  |  | $ | 14,734 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2021 |  | As ofJune 30, 2022\nLand and buildings | $ | 58,881 |  |  | $ | 65,015 | \nInformation technology assets | 55,606 |  |  | 59,643 | \nConstruction in progress | 23,172 |  |  | 25,341 | \nLeasehold improvements | 9,146 |  |  | 9,992 | \nFurniture and fixtures | 208 |  |  | 267 | \nProperty and equipment, gross | 147,013 |  |  | 160,258 | \nLess: accumulated depreciation | (49,414) |  |  | (54,035) | \nProperty and equipment, net | $ | 97,599 |  |  | $ | 106,223 |   |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2021 |  | As ofJune 30, 2022\nEuropean Commission fines(1) | $ | 9,799 |  |  | $ | 9,191 | \nAccrued customer liabilities | 3,505 |  |  | 2,948 | \nAccrued purchases of property and equipment | 2,415 |  |  | 2,797 | \nCurrent operating lease liabilities | 2,189 |  |  | 2,297 | \nOther accrued expenses and current liabilities | 13,328 |  |  | 15,743 | \nAccrued expenses and other current liabilities | $ | 31,236 |  |  | $ | 32,976 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Available-for-Sale Investments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total\nBalance as of December 31, 2020 | $ | (864) |  |  | $ | 1,612 |  |  | $ | (115) |  |  | $ | 633 | \nOther comprehensive income (loss) before reclassifications | (57) |  |  | (540) |  |  | 92 |  |  | (505) | \nAmounts excluded from the assessment of hedge effectiveness recorded in AOCI | 0 |  |  | 0 |  |  | 45 |  |  | 45 | \nAmounts reclassified from AOCI | 0 |  |  | (64) |  |  | 81 |  |  | 17 | \nOther comprehensive income (loss) | (57) |  |  | (604) |  |  | 218 |  |  | (443) | \nBalance as of June 30, 2021 | $ | (921) |  |  | $ | 1,008 |  |  | $ | 103 |  |  | $ | 190 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Available-for-Sale Investments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total\nBalance as of December 31, 2021 | $ | (2,306) |  |  | $ | 236 |  |  | $ | 447 |  |  | $ | (1,623) | \nOther comprehensive income (loss) before reclassifications | (1,626) |  |  | (3,404) |  |  | 1,083 |  |  | (3,947) | \nAmounts excluded from the assessment of hedge effectiveness recorded in AOCI | 0 |  |  | 0 |  |  | (54) |  |  | (54) | \nAmounts reclassified from AOCI | 0 |  |  | 381 |  |  | (585) |  |  | (204) | \nOther comprehensive income (loss) | (1,626) |  |  | (3,023) |  |  | 444 |  |  | (4,205) | \nBalance as of June 30, 2022 | $ | (3,932) |  |  | $ | (2,787) |  |  | $ | 891 |  |  | $ | (5,828) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | Gains (Losses) Reclassified from AOCI to the Consolidated Statements of Income\n |  |  |  | Three Months Ended |  | Six Months Ended\n |  |  |  | June 30, |  | June 30,\nAOCI Components |  | Location |  | 2021 |  | 2022 |  | 2021 |  | 2022\nUnrealized gains (losses) on available-for-sale investments |  |  |  |  |  |  |  | \n |  | Other income (expense), net |  | $ | 96 |  |  | $ | (299) |  |  | $ | 82 |  |  | $ | (489) | \n |  | Benefit (provision) for income taxes |  | (21) |  |  | 66 |  |  | (18) |  |  | 108 | \n |  | Net of income tax |  | 75 |  |  | (233) |  |  | 64 |  |  | (381) | \nUnrealized gains (losses) on cash flow hedges |  |  |  |  |  |  |  | \nForeign exchange contracts |  | Revenue |  | (3) |  |  | 400 |  |  | (108) |  |  | 697 | \nInterest rate contracts |  | Other income (expense), net |  | 2 |  |  | 1 |  |  | 3 |  |  | 3 | \n |  | Benefit (provision) for income taxes |  | 5 |  |  | (65) |  |  | 24 |  |  | (115) | \n |  | Net of income tax |  | 4 |  |  | 336 |  |  | (81) |  |  | 585 | \nTotal amount reclassified, net of income tax |  | $ | 79 |  |  | $ | 103 |  |  | $ | (17) |  |  | $ | 204 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nInterest income | $ | 389 |  |  | $ | 486 |  |  | $ | 734 |  |  | $ | 900 | \nInterest expense(1) | (76) |  |  | (83) |  |  | (152) |  |  | (166) | \nForeign currency exchange gain (loss), net | (51) |  |  | (260) |  |  | 62 |  |  | (333) | \nGain (loss) on debt securities, net | 111 |  |  | (790) |  |  | 25 |  |  | (1,157) | \nGain (loss) on equity securities, net | 2,772 |  |  | (251) |  |  | 7,609 |  |  | (1,321) | \nPerformance fees | (523) |  |  | 318 |  |  | (1,188) |  |  | 551 | \nIncome (loss) and impairment from equity method investments, net | 92 |  |  | (118) |  |  | 97 |  |  | (207) | \nOther | (90) |  |  | 259 |  |  | 283 |  |  | 134 | \nOther income (expense), net | $ | 2,624 |  |  | $ | (439) |  |  | $ | 7,470 |  |  | $ | (1,599) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Google Services |  | Google Cloud |  | Other Bets |  | Total\nBalance as of December 31, 2021 | $ | 19,826 |  |  | $ | 2,337 |  |  | $ | 793 |  |  | $ | 22,956 | \nAcquisitions | 896 |  |  | 103 |  |  | 113 |  |  | 1,112 | \nForeign currency translation and other adjustments | (104) |  |  | (12) |  |  | (3) |  |  | (119) | \nBalance as of June 30, 2022 | $ | 20,618 |  |  | $ | 2,428 |  |  | $ | 903 |  |  | $ | 23,949 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n | GrossCarryingAmount |  | AccumulatedAmortization |  | NetCarryingAmount\nPatents and developed technology | $ | 4,786 |  |  | $ | 4,112 |  |  | $ | 674 | \nCustomer relationships | 506 |  |  | 140 |  |  | 366 | \nTrade names and other | 534 |  |  | 295 |  |  | 239 | \nTotal definite-lived intangible assets | 5,826 |  |  | 4,547 |  |  | 1,279 | \nIndefinite-lived intangible assets | 138 |  |  | \u2014 |  |  | 138 | \nTotal intangible assets | $ | 5,964 |  |  | $ | 4,547 |  |  | $ | 1,417 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of June 30, 2022\n | GrossCarryingAmount |  | AccumulatedAmortization |  | NetCarryingAmount\nPatents and developed technology | $ | 962 |  |  | $ | 462 |  |  | $ | 500 | \nCustomer relationships | 521 |  |  | 193 |  |  | 328 | \nTrade names and other | 408 |  |  | 97 |  |  | 311 | \nTotal definite-lived intangible assets | 1,891 |  |  | 752 |  |  | 1,139 | \nIndefinite-lived intangible assets | 238 |  |  | 0 |  |  | 238 | \nTotal intangible assets | $ | 2,129 |  |  | $ | 752 |  |  | $ | 1,377 |   |  |  |  |  | \nRemainder of 2022 | $ | 193 | \n2023 | 294 | \n2024 | 275 | \n2025 | 145 | \n2026 | 99 | \nThereafter | 133 | \nTotal | $ | 1,139 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30,\n | 2021 |  | 2022\n | Class A |  | Class B |  | Class C |  | Class A |  | Class B |  | Class C\nBasic net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings | $ | 8,321 |  |  | $ | 1,265 |  |  | $ | 8,939 |  |  | $ | 7,329 |  |  | $ | 1,081 |  |  | $ | 7,592 | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in per share computation | 6,009 |  |  | 914 |  |  | 6,456 |  |  | 6,015 |  |  | 887 |  |  | 6,231 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nBasic net income per share | $ | 1.38 |  |  | $ | 1.38 |  |  | $ | 1.38 |  |  | $ | 1.22 |  |  | $ | 1.22 |  |  | $ | 1.22 | \nDiluted net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings for basic computation | $ | 8,321 |  |  | $ | 1,265 |  |  | $ | 8,939 |  |  | $ | 7,329 |  |  | $ | 1,081 |  |  | $ | 7,592 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nReallocation of undistributed earnings as a result of conversion of Class B to Class\u00a0A shares | 1,265 |  |  | 0 |  |  | 0 |  |  | 1,081 |  |  | 0 |  |  | 0 | \nReallocation of undistributed earnings | (149) |  |  | (19) |  |  | 149 |  |  | (68) |  |  | (9) |  |  | 68 | \nAllocation of undistributed earnings | $ | 9,437 |  |  | $ | 1,246 |  |  | $ | 9,088 |  |  | $ | 8,342 |  |  | $ | 1,072 |  |  | $ | 7,660 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in basic computation | 6,009 |  |  | 914 |  |  | 6,456 |  |  | 6,015 |  |  | 887 |  |  | 6,231 | \nWeighted-average effect of dilutive securities |  |  |  |  |  |  |  |  |  |  | \nAdd: |  |  |  |  |  |  |  |  |  |  | \nConversion of Class B to Class\u00a0A shares outstanding | 914 |  |  | 0 |  |  | 0 |  |  | 887 |  |  | 0 |  |  | 0 | \n |  |  |  |  |  |  |  |  |  |  | \nRestricted stock units and other contingently issuable shares | 0 |  |  | 0 |  |  | 213 |  |  | 0 |  |  | 0 |  |  | 106 | \nNumber of shares used in per share computation | 6,923 |  |  | 914 |  |  | 6,669 |  |  | 6,902 |  |  | 887 |  |  | 6,337 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDiluted net income per share | $ | 1.36 |  |  | $ | 1.36 |  |  | $ | 1.36 |  |  | $ | 1.21 |  |  | $ | 1.21 |  |  | $ | 1.21 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended June 30,\n | 2021 |  | 2022\n | Class A |  | Class B |  | Class C |  | Class A |  | Class B |  | Class C\nBasic net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings | $ | 16,330 |  |  | $ | 2,485 |  |  | $ | 17,640 |  |  | $ | 14,812 |  |  | $ | 2,190 |  |  | $ | 15,436 | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in per share computation | 6,012 |  |  | 915 |  |  | 6,495 |  |  | 6,013 |  |  | 889 |  |  | 6,266 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nBasic net income per share | $ | 2.72 |  |  | $ | 2.72 |  |  | $ | 2.72 |  |  | $ | 2.46 |  |  | $ | 2.46 |  |  | $ | 2.46 | \nDiluted net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings for basic computation | $ | 16,330 |  |  | $ | 2,485 |  |  | $ | 17,640 |  |  | $ | 14,812 |  |  | $ | 2,190 |  |  | $ | 15,436 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nReallocation of undistributed earnings as a result of conversion of Class B to Class\u00a0A shares | 2,485 |  |  | 0 |  |  | 0 |  |  | 2,190 |  |  | 0 |  |  | 0 | \nReallocation of undistributed earnings | (269) |  |  | (36) |  |  | 269 |  |  | (162) |  |  | (21) |  |  | 162 | \nAllocation of undistributed earnings | $ | 18,546 |  |  | $ | 2,449 |  |  | $ | 17,909 |  |  | $ | 16,840 |  |  | $ | 2,169 |  |  | $ | 15,598 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in basic computation | 6,012 |  |  | 915 |  |  | 6,495 |  |  | 6,013 |  |  | 889 |  |  | 6,266 | \nWeighted-average effect of dilutive securities |  |  |  |  |  |  |  |  |  |  | \nAdd: |  |  |  |  |  |  |  |  |  |  | \nConversion of Class B to Class\u00a0A shares outstanding | 915 |  |  | 0 |  |  | 0 |  |  | 889 |  |  | 0 |  |  | 0 | \n |  |  |  |  |  |  |  |  |  |  | \nRestricted stock units and other contingently issuable shares | 0 |  |  | 0 |  |  | 195 |  |  | 0 |  |  | 0 |  |  | 127 | \nNumber of shares used in per share computation | 6,927 |  |  | 915 |  |  | 6,690 |  |  | 6,902 |  |  | 889 |  |  | 6,393 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDiluted net income per share | $ | 2.68 |  |  | $ | 2.68 |  |  | $ | 2.68 |  |  | $ | 2.44 |  |  | $ | 2.44 |  |  | $ | 2.44 |   |  |  |  |  |  |  |  |  |  |  | \n | Unvested\u00a0Restricted\u00a0Stock\u00a0Units\n | Number ofShares |  | Weighted-AverageGrant-DateFair Value\nUnvested as of December 31, 2021 | 338 |  |  | $ | 81.31 | \nGranted | 163 |  |  | $ | 135.49 | \nVested | (103) |  |  | $ | 85.45 | \nForfeited/canceled | (19) |  |  | $ | 94.47 | \nUnvested as of June 30, 2022 | 379 |  |  | $ | 102.80 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nIncome before provision for income taxes | $ | 21,985 |  |  | $ | 19,014 |  |  | $ | 43,268 |  |  | $ | 37,948 | \nProvision for income taxes | $ | 3,460 |  |  | $ | 3,012 |  |  | $ | 6,813 |  |  | $ | 5,510 | \nEffective tax rate | 15.7 | % |  | 15.8 | % |  | 15.7 | % |  | 14.5 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nRevenues: |  |  |  |  |  |  | \nGoogle Services | $ | 57,067 |  |  | $ | 62,841 |  |  | $ | 108,245 |  |  | $ | 124,313 | \nGoogle Cloud | 4,628 |  |  | 6,276 |  |  | 8,675 |  |  | 12,097 | \nOther Bets | 192 |  |  | 193 |  |  | 390 |  |  | 633 | \nHedging gains (losses) | (7) |  |  | 375 |  |  | (116) |  |  | 653 | \nTotal revenues | $ | 61,880 |  |  | $ | 69,685 |  |  | $ | 117,194 |  |  | $ | 137,696 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nOperating income (loss): |  |  |  |  |  |  | \nGoogle Services | $ | 22,343 |  |  | $ | 22,770 |  |  | $ | 41,889 |  |  | $ | 45,690 | \nGoogle Cloud | (591) |  |  | (858) |  |  | (1,565) |  |  | (1,789) | \nOther Bets | (1,398) |  |  | (1,686) |  |  | (2,543) |  |  | (2,841) | \nCorporate costs, unallocated | (993) |  |  | (773) |  |  | (1,983) |  |  | (1,513) | \nTotal income from operations | $ | 19,361 |  |  | $ | 19,453 |  |  | $ | 35,798 |  |  | $ | 39,547 |   |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2021 |  | As ofJune 30, 2022\nLong-lived assets: |  |  | \nUnited States | $ | 80,207 |  |  | $ | 88,044 | \nInternational | 30,351 |  |  | 31,577 | \nTotal long-lived assets | $ | 110,558 |  |  | $ | 119,621 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended |  |  |  | \n | June 30, |  |  |  | \n |  | 2021 |  | 2022 |  | $ Change |  | % Change\nConsolidated revenues(1) |  | $ | 61,880 |  |  | $ | 69,685 |  |  | $ | 7,805 |  |  | 13 | %\nChange in consolidated constant currency revenues(1) |  |  |  |  |  |  |  | 16 | %\n |  |  |  |  |  |  |  | \nCost of revenues |  | $ | 26,227 |  |  | $ | 30,104 |  |  | $ | 3,877 |  |  | 15 | %\nOperating expenses |  | $ | 16,292 |  |  | $ | 20,128 |  |  | $ | 3,836 |  |  | 24 | %\n |  |  |  |  |  |  |  | \nOperating income |  | $ | 19,361 |  |  | $ | 19,453 |  |  | $ | 92 |  |  | 0 | %\nOperating margin |  | 31 | % |  | 28 | % |  |  |  | (3) | %\n |  |  |  |  |  |  |  | \nOther income (expense), net |  | $ | 2,624 |  |  | $ | (439) |  |  | $ | (3,063) |  |  | (117) | %\n |  |  |  |  |  |  |  | \nNet Income |  | $ | 18,525 |  |  | $ | 16,002 |  |  | $ | (2,523) |  |  | (14) | %\nDiluted EPS |  | $ | 1.36 |  |  | $ | 1.21 |  |  | $ | (0.15) |  |  | (11) | %\n |  |  |  |  |  |  |  | \nNumber of Employees |  | 144,056 |  |  | 174,014 |  | 29,958 |  | 21 | %\n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nGoogle Search & other | $ | 35,845 |  |  | $ | 40,689 |  |  | $ | 67,724 |  |  | $ | 80,307 | \nYouTube ads | 7,002 |  |  | 7,340 |  |  | 13,007 |  |  | 14,209 | \nGoogle Network | 7,597 |  |  | 8,259 |  |  | 14,397 |  |  | 16,433 | \nGoogle advertising | 50,444 |  |  | 56,288 |  |  | 95,128 |  |  | 110,949 | \nGoogle other | 6,623 |  |  | 6,553 |  |  | 13,117 |  |  | 13,364 | \nGoogle Services total | 57,067 |  |  | 62,841 |  |  | 108,245 |  |  | 124,313 | \nGoogle Cloud | 4,628 |  |  | 6,276 |  |  | 8,675 |  |  | 12,097 | \nOther Bets | 192 |  |  | 193 |  |  | 390 |  |  | 633 | \nHedging gains (losses) | (7) |  |  | 375 |  |  | (116) |  |  | 653 | \nTotal revenues | $ | 61,880 |  |  | $ | 69,685 |  |  | $ | 117,194 |  |  | $ | 137,696 |   |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | \n | 2022 |  | 2022\n |  |  | \n |  |  | \nPaid clicks change | 12% |  | 14%\nCost-per-click change | \u2014% |  | 4%  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2022 |  | 2022\nImpressions change | 6% |  | 6%\nCost-per-impression change | 2% |  | 9%  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nUnited States | 46 | % |  | 47 | % |  | 45 | % |  | 47 | %\nEMEA | 31 | % |  | 29 | % |  | 31 | % |  | 30 | %\nAPAC | 18 | % |  | 17 | % |  | 19 | % |  | 17 | %\nOther Americas | 5 | % |  | 6 | % |  | 5 | % |  | 6 | %\nHedging gains (losses) | 0 | % |  | 1 | % |  | 0 | % |  | 0 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  |  |  | Six Months Ended |  | \n | June 30, |  |  |  | June 30, |  | \n | 2021 |  | 2022 |  | % Change from Prior Year |  | 2021 |  | 2022 |  | % Change from Prior Year\nEMEA revenues | $ | 19,084 |  |  | $ | 20,533 |  |  | 8 | % |  | $ | 36,115 |  |  | $ | 40,850 |  |  | 13 | %\nEMEA constant currency revenues |  |  | 22,489 |  |  | 18 | % |  |  |  | $ | 44,117 |  |  | 22 | %\n |  |  |  |  |  |  |  |  |  |  | \nAPAC revenues | 11,231 |  |  | 11,710 |  |  | 4 | % |  | $ | 21,686 |  |  | $ | 23,551 |  |  | 9 | %\nAPAC constant currency revenues |  |  | 12,466 |  |  | 11 | % |  |  |  | $ | 24,906 |  |  | 15 | %\n |  |  |  |  |  |  |  |  |  |  | \nOther Americas revenues | 3,364 |  |  | 4,340 |  |  | 29 | % |  | $ | 6,269 |  |  | $ | 8,182 |  |  | 31 | %\nOther Americas constant currency revenues |  |  | 4,310 |  |  | 28 | % |  |  |  | $ | 8,233 |  |  | 31 | %\n |  |  |  |  |  |  |  |  |  |  | \nUnited States revenues | 28,208 |  |  | 32,727 |  |  | 16 | % |  | $ | 53,240 |  |  | $ | 64,460 |  |  | 21 | %\n |  |  |  |  |  |  |  |  |  |  | \nHedging gains (losses) | (7) |  |  | 375 |  |  |  |  | $ | (116) |  |  | $ | 653 |  |  | \nTotal revenues | $ | 61,880 |  |  | $ | 69,685 |  |  | 13 | % |  | $ | 117,194 |  |  | $ | 137,696 |  |  | 17 | %\nRevenues, excluding hedging effect | $ | 61,887 |  |  | $ | 69,310 |  |  |  |  | $ | 117,310 |  |  | $ | 137,043 |  |  | \nExchange rate effect |  |  | 2,682 |  |  |  |  |  |  | 4,673 |  |  | \nTotal constant currency revenues |  |  | $ | 71,992 |  |  | 16 | % |  |  |  | $ | 141,716 |  |  | 21 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nTAC | $ | 10,929 |  |  | $ | 12,214 |  |  | $ | 20,641 |  |  | $ | 24,204 | \nOther cost of revenues | 15,298 |  |  | 17,890 |  |  | 29,689 |  |  | 35,499 | \nTotal cost of revenues | $ | 26,227 |  |  | $ | 30,104 |  |  | $ | 50,330 |  |  | $ | 59,703 | \nTotal cost of revenues as a percentage of revenues | 42.4 | % |  | 43.2 | % |  | 42.9 | % |  | 43.4 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nResearch and development expenses | $ | 7,675 |  |  | $ | 9,841 |  |  | $ | 15,160 |  |  | $ | 18,960 | \nResearch and development expenses as a percentage of revenues | 12.4 | % |  | 14.1 | % |  | 12.9 | % |  | 13.8 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nSales and marketing expenses | $ | 5,276 |  |  | $ | 6,630 |  |  | $ | 9,792 |  |  | $ | 12,455 | \nSales and marketing expenses as a percentage of revenues | 8.5 | % |  | 9.5 | % |  | 8.4 | % |  | 9.0 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nGeneral and administrative expenses | $ | 3,341 |  |  | $ | 3,657 |  |  | $ | 6,114 |  |  | $ | 7,031 | \nGeneral and administrative expenses as a percentage of revenues | 5.4 | % |  | 5.2 | % |  | 5.2 | % |  | 5.1 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  |  |  | \nOperating income (loss): |  |  |  |  |  |  | \nGoogle Services | $ | 22,343 |  |  | $ | 22,770 |  |  | $ | 41,889 |  |  | $ | 45,690 | \nGoogle Cloud | (591) |  |  | (858) |  |  | (1,565) |  |  | (1,789) | \nOther Bets | (1,398) |  |  | (1,686) |  |  | (2,543) |  |  | (2,841) | \nCorporate costs, unallocated(1) | (993) |  |  | (773) |  |  | (1,983) |  |  | (1,513) | \nTotal income from operations | $ | 19,361 |  |  | $ | 19,453 |  |  | $ | 35,798 |  |  | $ | 39,547 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nOther income (expense), net | $ | 2,624 |  |  | $ | (439) |  |  | $ | 7,470 |  |  | $ | (1,599) | \n |  |  |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nIncome before provision for income taxes | $ | 21,985 |  |  | $ | 19,014 |  |  | $ | 43,268 |  |  | $ | 37,948 | \nProvision for income taxes | $ | 3,460 |  |  | $ | 3,012 |  |  | $ | 6,813 |  |  | $ | 5,510 | \nEffective tax rate | 15.7 | % |  | 15.8 | % |  | 15.7 | % |  | 14.5 | %  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended\n | June 30,\n | 2021 |  | 2022\nNet cash provided by operating activities | $ | 41,179 |  |  | $ | 44,528 | \nNet cash used in investing activities | $ | (14,457) |  |  | $ | (13,238) | \nNet cash used in financing activities | $ | (29,597) |  |  | $ | (34,031) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | Total Number of Class A Shares Purchased(in thousands)(1) |  | Total Number of Class C Shares Purchased(in thousands)(1) |  | Average Price Paid per Class A Share(2) |  | Average Price Paid per Class C Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Programs(in thousands)(1) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program(in millions)\nApril 1 - 30 |  | 2,125 |  |  | 11,469 |  |  | $ | 124.95 |  |  | $ | 126.62 |  |  | 13,594 |  |  | $ | 72,353 | \nMay 1 - 31 |  | 7,712 |  |  | 54,160 |  |  | $ | 113.20 |  |  | $ | 113.01 |  |  | 61,872 |  |  | $ | 65,360 | \nJune 1 - 30 |  | 6,470 |  |  | 50,882 |  |  | $ | 111.33 |  |  | $ | 113.31 |  |  | 57,352 |  |  | $ | 58,874 | \nTotal |  | 16,307 |  |  | 116,511 |  |  |  |  |  |  | 132,818 |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nExhibitNumber |  | Description |  | Incorporated\u00a0by\u00a0reference\u00a0herein\n | Form |  | Date\n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n3.01 |  | Amended and Restated Certificate of Incorporation of Alphabet Inc. |  | Current Report on Form 8-K (File No. 001-37580) |  | June 3, 2022\n10.01 | * | Alphabet Inc. Amended and Restated 2021 Stock Plan |  | Current Report on Form 8-K (File No. 001-37580) |  | June 3, 2022\n10.02 | * | Letter Agreement, dated July 11, 2022, between R. Martin Ch\u00e1vez and Alphabet Inc. |  | Current Report on Form 8-K (File No. 001-37580) |  | July 14, 2022\n31.01 | ** | Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n31.02 | ** | Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n32.01 | \u2021 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18\u00a0U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n |  |  |  |  |  | \n101.INS | ** | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |  |  |  | \n101.SCH | ** | Inline XBRL Taxonomy Extension Schema Document |  |  |  | \n101.CAL | ** | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  |  |  | \n101.DEF | ** | Inline XBRL Taxonomy Extension Definition Linkbase Document |  |  |  | \n101.LAB | ** | Inline XBRL Taxonomy Extension Label Linkbase Document |  |  |  | \n101.PRE | ** | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  |  |  | \n104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |  |  |  |   |  |  |  |  | \n | \n | \n* | Indicates management contract or compensatory plan or arrangement.\n** | Filed herewith.\n\u2021 | Furnished herewith.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  | \n |  | ALPHABET INC.\nJuly 26, 2022 | By: | /s/\u00a0\u00a0\u00a0\u00a0RUTH M. PORAT\n |  | Ruth M. Porat\n |  | Senior Vice President and Chief Financial Officer  |  |  |  |  |  |  |  | \n |  | ALPHABET INC.\nJuly 26, 2022 | By: | /s/\u00a0\u00a0\u00a0\u00a0AMIE THUENER O'TOOLE\n |  | Amie Thuener O'Toole\n |  | Vice President and Chief Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Google, in 2022 Q3, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION\u00a013 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \nDelaware | 61-1767919\n(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number)  |  |  |  |  |  |  |  | \nSecurities registered pursuant to Section\u00a012(b) of the Act:\nTitle of each class | Trading Symbol(s) | Name of each exchange on which registered\nClass\u00a0A Common Stock, $0.001 par value | GOOGL | Nasdaq Stock Market LLC\n |  | (Nasdaq Global Select Market)\nClass C Capital Stock, $0.001 par value | GOOG | Nasdaq Stock Market LLC\n |  | (Nasdaq Global Select Market)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 |  | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 |  | Smaller reporting company | \u2610\nEmerging growth company | \u2610 |  |  |   |  | \n  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  | \n |  | Page\u00a0No.\nNote About Forward-Looking Statements | 3\n\nPART I. FINANCIAL INFORMATION\nItem\u00a01 | Financial Statements | 5\n | Consolidated Balance Sheets- December\u00a031, 2021 and September\u00a030, 2022 | 5\n | Consolidated Statements of Income -Three and Nine Months Ended September 30,2021and2022 | 6\n | Consolidated Statements of Comprehensive Income -Three and Nine Months Ended September 30,2021and2022 | 7\n | Consolidated Statements of Stockholders' Equity -Three and Nine Months Ended September 30,2021and2022 | 8\n | Consolidated Statements of Cash Flows -Nine Months Ended September 30,2021and2022 | 10\n | Notes to Consolidated Financial Statements | 11\nItem\u00a02 | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 34\nItem\u00a03 | Quantitative and Qualitative Disclosures About Market Risk | 47\nItem\u00a04 | Controls and Procedures | 47\n |  | \nPART II. OTHER INFORMATION\nItem\u00a01 | Legal Proceedings | 49\nItem\u00a01A | Risk Factors | 49\nItem 2 | Unregistered Sales of Equity Securities and Use of Proceeds | 50\n |  | \n |  | \nItem\u00a05 | Other Information | 49\nItem\u00a06 | Exhibits | 52\nSignatures | 53  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2021 |  | As ofSeptember 30, 2022\n |  |  | (unaudited)\nAssets |  |  | \nCurrent assets: |  |  | \nCash and cash equivalents | $ | 20,945 |  |  | $ | 21,984 | \nMarketable securities | 118,704 |  |  | 94,275 | \nTotal cash, cash equivalents, and marketable securities | 139,649 |  |  | 116,259 | \nAccounts receivable, net | 39,304 |  |  | 34,697 | \nIncome taxes receivable, net | 966 |  |  | 1,479 | \nInventory | 1,170 |  |  | 3,156 | \nOther current assets | 7,054 |  |  | 10,518 | \nTotal current assets | 188,143 |  |  | 166,109 | \nNon-marketable securities | 29,549 |  |  | 30,419 | \nDeferred income taxes | 1,284 |  |  | 2,991 | \nProperty and equipment, net | 97,599 |  |  | 108,363 | \nOperating lease assets | 12,959 |  |  | 13,677 | \nIntangible assets, net | 1,417 |  |  | 2,192 | \nGoodwill | 22,956 |  |  | 28,834 | \nOther non-current assets | 5,361 |  |  | 5,670 | \nTotal assets | $ | 359,268 |  |  | $ | 358,255 | \nLiabilities and Stockholders\u2019 Equity |  |  | \nCurrent liabilities: |  |  | \nAccounts payable | $ | 6,037 |  |  | $ | 6,303 | \n |  |  | \nAccrued compensation and benefits | 13,889 |  |  | 12,366 | \nAccrued expenses and other current liabilities | 31,236 |  |  | 35,038 | \nAccrued revenue share | 8,996 |  |  | 7,662 | \nDeferred revenue | 3,288 |  |  | 3,585 | \nIncome taxes payable, net | 808 |  |  | 1,025 | \nTotal current liabilities | 64,254 |  |  | 65,979 | \nLong-term debt | 14,817 |  |  | 14,653 | \nDeferred revenue, non-current | 535 |  |  | 594 | \nIncome taxes payable, non-current | 9,176 |  |  | 8,572 | \nDeferred income taxes | 5,257 |  |  | 476 | \nOperating lease liabilities | 11,389 |  |  | 11,984 | \nOther long-term liabilities | 2,205 |  |  | 2,371 | \nTotal liabilities | 107,633 |  |  | 104,629 | \nContingencies (Note 9) |  |  | \nStockholders\u2019 equity: |  |  | \nPreferred stock, $0.001par value per share,100shares authorized;noshares issued and outstanding | 0 |  |  | 0 | \nClass\u00a0A, Class B, and Class C stock and additional paid-in capital, $0.001par value per share:300,000shares authorized\u00a0(Class\u00a0A180,000, Class B60,000, Class C60,000);13,242(Class\u00a0A6,015, Class B893, Class C6,334) and12,971(Class\u00a0A5,978, Class B884, Class C6,109) shares issued and outstanding | 61,774 |  |  | 66,258 | \nAccumulated other comprehensive income (loss) | (1,623) |  |  | (8,852) | \nRetained earnings | 191,484 |  |  | 196,220 | \nTotal stockholders\u2019 equity | 251,635 |  |  | 253,626 | \nTotal liabilities and stockholders\u2019 equity | $ | 359,268 |  |  | $ | 358,255 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nRevenues | $ | 65,118 |  |  | $ | 69,092 |  |  | $ | 182,312 |  |  | $ | 206,788 | \nCosts and expenses: |  |  |  |  |  |  | \nCost of revenues | 27,621 |  |  | 31,158 |  |  | 77,951 |  |  | 90,861 | \nResearch and development | 7,694 |  |  | 10,273 |  |  | 22,854 |  |  | 29,233 | \nSales and marketing | 5,516 |  |  | 6,929 |  |  | 15,308 |  |  | 19,384 | \nGeneral and administrative | 3,256 |  |  | 3,597 |  |  | 9,370 |  |  | 10,628 | \nTotal costs and expenses | 44,087 |  |  | 51,957 |  |  | 125,483 |  |  | 150,106 | \nIncome from operations | 21,031 |  |  | 17,135 |  |  | 56,829 |  |  | 56,682 | \nOther income (expense), net | 2,033 |  |  | (902) |  |  | 9,503 |  |  | (2,501) | \nIncome before income taxes | 23,064 |  |  | 16,233 |  |  | 66,332 |  |  | 54,181 | \nProvision for income taxes | 4,128 |  |  | 2,323 |  |  | 10,941 |  |  | 7,833 | \nNet income | $ | 18,936 |  |  | $ | 13,910 |  |  | $ | 55,391 |  |  | $ | 46,348 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income per share of Class A, Class B, and Class C stock | $ | 1.42 |  |  | $ | 1.07 |  |  | $ | 4.14 |  |  | $ | 3.53 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nDiluted net income per share of Class A, Class B, and Class C stock | $ | 1.40 |  |  | $ | 1.06 |  |  | $ | 4.08 |  |  | $ | 3.50 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nNet income | $ | 18,936 |  |  | $ | 13,910 |  |  | $ | 55,391 |  |  | $ | 46,348 | \nOther comprehensive loss: |  |  |  |  |  |  | \nChange in foreign currency translation adjustment | (614) |  |  | (2,175) |  |  | (671) |  |  | (3,801) | \nAvailable-for-sale investments: |  |  |  |  |  |  | \nChange in net unrealized gains (losses) | (159) |  |  | (1,800) |  |  | (699) |  |  | (5,204) | \nLess: reclassification adjustment for net (gains) losses included in net income | (57) |  |  | 362 |  |  | (121) |  |  | 743 | \nNet change, net of income tax benefit (expense) of $63, $409, $235and $1,269 | (216) |  |  | (1,438) |  |  | (820) |  |  | (4,461) | \nCash flow hedges: |  |  |  |  |  |  | \nChange in net unrealized gains (losses) | 292 |  |  | 1,136 |  |  | 429 |  |  | 2,165 | \nLess: reclassification adjustment for net (gains) losses included in net income | (60) |  |  | (547) |  |  | 21 |  |  | (1,132) | \nNet change, net of income tax benefit (expense) of $(54), $(159), $(89) and $(228) | 232 |  |  | 589 |  |  | 450 |  |  | 1,033 | \nOther comprehensive loss | (598) |  |  | (3,024) |  |  | (1,041) |  |  | (7,229) | \nComprehensive income | $ | 18,338 |  |  | $ | 10,886 |  |  | $ | 54,350 |  |  | $ | 39,119 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, 2021\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of June 30, 2021 | 13,353 |  |  | $ | 60,436 |  |  | $ | 190 |  |  | $ | 176,939 |  |  | $ | 237,565 | \nStock issued | 33 |  |  | 1 |  |  | 0 |  |  | 0 |  |  | 1 | \nStock-based compensation expense | 0 |  |  | 3,914 |  |  | 0 |  |  | 0 |  |  | 3,914 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (2,641) |  |  | 0 |  |  | 0 |  |  | (2,641) | \nRepurchases of stock | (92) |  |  | (517) |  |  | 0 |  |  | (12,093) |  |  | (12,610) | \nSale of interest in consolidated entities | 0 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 18,936 |  |  | 18,936 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | (598) |  |  | 0 |  |  | (598) | \nBalance as of September 30, 2021 | 13,294 |  |  | $ | 61,193 |  |  | $ | (408) |  |  | $ | 183,782 |  |  | $ | 244,567 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended September 30, 2021\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of December 31, 2020 | 13,504 |  |  | $ | 58,510 |  |  | $ | 633 |  |  | $ | 163,401 |  |  | $ | 222,544 | \nStock issued | 103 |  |  | 8 |  |  | 0 |  |  | 0 |  |  | 8 | \nStock-based compensation expense | 0 |  |  | 11,546 |  |  | 0 |  |  | 0 |  |  | 11,546 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (7,390) |  |  | 0 |  |  | 0 |  |  | (7,390) | \nRepurchases of stock | (313) |  |  | (1,791) |  |  | 0 |  |  | (35,010) |  |  | (36,801) | \nSale of interest in consolidated entities | 0 |  |  | 310 |  |  | 0 |  |  | 0 |  |  | 310 | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 55,391 |  |  | 55,391 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | (1,041) |  |  | 0 |  |  | (1,041) | \nBalance as of September 30, 2021 | 13,294 |  |  | $ | 61,193 |  |  | $ | (408) |  |  | $ | 183,782 |  |  | $ | 244,567 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, 2022\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of June 30, 2022 | 13,078 |  |  | $ | 64,402 |  |  | $ | (5,828) |  |  | $ | 196,845 |  |  | $ | 255,419 | \nStock issued | 31 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 | \nStock-based compensation expense | 0 |  |  | 5,018 |  |  | 0 |  |  | 0 |  |  | 5,018 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (2,315) |  |  | 0 |  |  | 0 |  |  | (2,315) | \nRepurchases of stock | (138) |  |  | (857) |  |  | 0 |  |  | (14,535) |  |  | (15,392) | \nSale of interest in consolidated entities | 0 |  |  | 10 |  |  | 0 |  |  | 0 |  |  | 10 | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 13,910 |  |  | 13,910 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | (3,024) |  |  | 0 |  |  | (3,024) | \nBalance as of September 30, 2022 | 12,971 |  |  | $ | 66,258 |  |  | $ | (8,852) |  |  | $ | 196,220 |  |  | $ | 253,626 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended September 30, 2022\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of December 31, 2021 | 13,242 |  |  | $ | 61,774 |  |  | $ | (1,623) |  |  | $ | 191,484 |  |  | $ | 251,635 | \nStock issued | 98 |  |  | 8 |  |  | 0 |  |  | 0 |  |  | 8 | \nStock-based compensation expense | 0 |  |  | 14,388 |  |  | 0 |  |  | 0 |  |  | 14,388 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (7,644) |  |  | 0 |  |  | (1) |  |  | (7,645) | \nRepurchases of stock | (369) |  |  | (2,278) |  |  | 0 |  |  | (41,611) |  |  | (43,889) | \nSale of interest in consolidated entities | 0 |  |  | 10 |  |  | 0 |  |  | 0 |  |  | 10 | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 46,348 |  |  | 46,348 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | (7,229) |  |  | 0 |  |  | (7,229) | \nBalance as of September 30, 2022 | 12,971 |  |  | $ | 66,258 |  |  | $ | (8,852) |  |  | $ | 196,220 |  |  | $ | 253,626 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended\n | September 30,\n | 2021 |  | 2022\nOperating activities |  |  | \nNet income | $ | 55,391 |  |  | $ | 46,348 | \nAdjustments: |  |  | \nDepreciation and impairment of property and equipment | 8,340 |  |  | 11,222 | \nAmortization and impairment of intangible assets | 662 |  |  | 505 | \nStock-based compensation expense | 11,422 |  |  | 14,262 | \nDeferred income taxes | 192 |  |  | (6,157) | \n(Gain) loss on debt and equity securities, net | (9,792) |  |  | 3,856 | \nOther | (199) |  |  | 369 | \nChanges in assets and liabilities, net of effects of acquisitions: |  |  | \nAccounts receivable | (3,276) |  |  | 2,298 | \nIncome taxes, net | 2,744 |  |  | (862) | \nOther assets | (1,447) |  |  | (4,268) | \nAccounts payable | (874) |  |  | 735 | \nAccrued expenses and other liabilities | 2,763 |  |  | 491 | \nAccrued revenue share | 386 |  |  | (1,022) | \nDeferred revenue | 406 |  |  | 104 | \nNet cash provided by operating activities | 66,718 |  |  | 67,881 | \nInvesting activities |  |  | \nPurchases of property and equipment | (18,257) |  |  | (23,890) | \nPurchases of marketable securities | (95,106) |  |  | (67,253) | \nMaturities and sales of marketable securities | 92,126 |  |  | 84,087 | \nPurchases of non-marketable securities | (2,068) |  |  | (1,628) | \nMaturities and sales of non-marketable securities | 590 |  |  | 131 | \n |  |  | \n |  |  | \nAcquisitions, net of cash acquired, and purchases of intangible assets | (2,233) |  |  | (6,885) | \nOther investing activities | 441 |  |  | 1,367 | \n |  |  | \nNet cash used in investing activities | (24,507) |  |  | (14,071) | \nFinancing activities |  |  | \nNet payments related to stock-based award activities | (7,239) |  |  | (7,221) | \n |  |  | \nRepurchases of stock | (36,801) |  |  | (43,889) | \nProceeds from issuance of debt, net of costs | 13,949 |  |  | 44,322 | \nRepayments of debt | (15,070) |  |  | (45,350) | \nProceeds from sale of interest in consolidated entities, net | 310 |  |  | 10 | \nNet cash used in financing activities | (44,851) |  |  | (52,128) | \nEffect of exchange rate changes on cash and cash equivalents | (106) |  |  | (643) | \nNet increase (decrease) in cash and cash equivalents | (2,746) |  |  | 1,039 | \nCash and cash equivalents at beginning of period | 26,465 |  |  | 20,945 | \nCash and cash equivalents at end of period | $ | 23,719 |  |  | $ | 21,984 | \n |  |  | \n |  |  | \n |  |  | \n |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nGoogle Search & other | $ | 37,926 |  |  | $ | 39,539 |  |  | $ | 105,650 |  |  | $ | 119,846 | \nYouTube ads | 7,205 |  |  | 7,071 |  |  | 20,212 |  |  | 21,280 | \nGoogle Network | 7,999 |  |  | 7,872 |  |  | 22,396 |  |  | 24,305 | \nGoogle advertising | 53,130 |  |  | 54,482 |  |  | 148,258 |  |  | 165,431 | \nGoogle other | 6,754 |  |  | 6,895 |  |  | 19,871 |  |  | 20,259 | \nGoogle Services total | 59,884 |  |  | 61,377 |  |  | 168,129 |  |  | 185,690 | \nGoogle Cloud | 4,990 |  |  | 6,868 |  |  | 13,665 |  |  | 18,965 | \nOther Bets | 182 |  |  | 209 |  |  | 572 |  |  | 842 | \nHedging gains (losses) | 62 |  |  | 638 |  |  | (54) |  |  | 1,291 | \nTotal revenues | $ | 65,118 |  |  | $ | 69,092 |  |  | $ | 182,312 |  |  | $ | 206,788 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nUnited States | $ | 29,824 |  |  | 46 | % |  | $ | 33,372 |  |  | 48 | % |  | $ | 83,064 |  |  | 46 | % |  | $ | 97,832 |  |  | 47 | %\nEMEA(1) | 19,839 |  |  | 30 |  |  | 19,450 |  |  | 28 |  |  | 55,954 |  |  | 31 |  |  | 60,300 |  |  | 29 | \nAPAC(1) | 11,705 |  |  | 18 |  |  | 11,494 |  |  | 17 |  |  | 33,391 |  |  | 18 |  |  | 35,045 |  |  | 17 | \nOther Americas(1) | 3,688 |  |  | 6 |  |  | 4,138 |  |  | 6 |  |  | 9,957 |  |  | 5 |  |  | 12,320 |  |  | 6 | \nHedging gains (losses) | 62 |  |  | 0 |  |  | 638 |  |  | 1 |  |  | (54) |  |  | 0 |  |  | 1,291 |  |  | 1 | \nTotal revenues | $ | 65,118 |  |  | 100 | % |  | $ | 69,092 |  |  | 100 | % |  | $ | 182,312 |  |  | 100 | % |  | $ | 206,788 |  |  | 100 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n | AdjustedCost |  | GrossUnrealizedGains |  | GrossUnrealizedLosses |  | FairValue |  | Cash and CashEquivalents |  | MarketableSecurities\nLevel 2: |  |  |  |  |  |  |  |  |  |  | \nTime deposits(1) | $ | 5,133 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 5,133 |  |  | $ | 5,133 |  |  | $ | 0 | \nGovernment bonds | 53,288 |  |  | 258 |  |  | (238) |  |  | 53,308 |  |  | 5 |  |  | 53,303 | \nCorporate debt securities | 35,605 |  |  | 194 |  |  | (223) |  |  | 35,576 |  |  | 12 |  |  | 35,564 | \nMortgage-backed and asset-backed securities | 18,829 |  |  | 96 |  |  | (112) |  |  | 18,813 |  |  | 0 |  |  | 18,813 | \nTotal | $ | 112,855 |  |  | $ | 548 |  |  | $ | (573) |  |  | $ | 112,830 |  |  | $ | 5,150 |  |  | $ | 107,680 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of September 30, 2022\n | AdjustedCost |  | GrossUnrealizedGains |  | GrossUnrealizedLosses |  | FairValue |  | Cash and CashEquivalents |  | MarketableSecurities\nLevel 2: |  |  |  |  |  |  |  |  |  |  | \nTime deposits(1) | $ | 4,925 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 4,925 |  |  | $ | 4,920 |  |  | $ | 5 | \nGovernment bonds | 42,863 |  |  | 0 |  |  | (2,523) |  |  | 40,340 |  |  | 93 |  |  | 40,247 | \nCorporate debt securities | 29,397 |  |  | 0 |  |  | (1,833) |  |  | 27,564 |  |  | 179 |  |  | 27,385 | \nMortgage-backed and asset-backed securities | 16,599 |  |  | 0 |  |  | (1,376) |  |  | 15,223 |  |  | 0 |  |  | 15,223 | \nTotal | $ | 93,784 |  |  | $ | 0 |  |  | $ | (5,732) |  |  | $ | 88,052 |  |  | $ | 5,192 |  |  | $ | 82,860 |   |  |  |  |  | \n | As ofSeptember 30, 2022\nDue in 1 year or less | $ | 7,998 | \nDue in 1 year through 5 years | 58,061 | \nDue in 5 years through 10 years | 11,848 | \nDue after 10 years | 11,353 | \nTotal | $ | 89,260 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n | Less\u00a0than\u00a012 Months |  | 12 Months or Greater |  | Total\n | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss\nGovernment bonds | $ | 32,843 |  |  | $ | (236) |  |  | $ | 71 |  |  | $ | (2) |  |  | $ | 32,914 |  |  | $ | (238) | \nCorporate debt securities | 22,737 |  |  | (152) |  |  | 303 |  |  | (5) |  |  | 23,040 |  |  | (157) | \nMortgage-backed and asset-backed securities | 11,502 |  |  | (106) |  |  | 248 |  |  | (6) |  |  | 11,750 |  |  | (112) | \nTotal | $ | 67,082 |  |  | $ | (494) |  |  | $ | 622 |  |  | $ | (13) |  |  | $ | 67,704 |  |  | $ | (507) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of September 30, 2022\n | Less\u00a0than\u00a012 Months |  | 12 Months or Greater |  | Total\n | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss\nGovernment bonds | $ | 31,685 |  |  | $ | (1,864) |  |  | $ | 8,064 |  |  | $ | (659) |  |  | $ | 39,749 |  |  | $ | (2,523) | \nCorporate debt securities | 19,378 |  |  | (1,042) |  |  | 7,431 |  |  | (697) |  |  | 26,809 |  |  | (1,739) | \nMortgage-backed and asset-backed securities | 11,316 |  |  | (992) |  |  | 3,886 |  |  | (384) |  |  | 15,202 |  |  | (1,376) | \nTotal | $ | 62,379 |  |  | $ | (3,898) |  |  | $ | 19,381 |  |  | $ | (1,740) |  |  | $ | 81,760 |  |  | $ | (5,638) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nNet gain (loss) on equity securities sold during the period | $ | (36) |  |  | $ | (73) |  |  | $ | 545 |  |  | $ | (355) | \nNet unrealized gain (loss) on equity securities held as of the end of the period | 2,157 |  |  | (574) |  |  | 9,185 |  |  | (1,613) | \nTotal gain (loss) recognized in other income (expense), net | $ | 2,121 |  |  | $ | (647) |  |  | $ | 9,730 |  |  | $ | (1,968) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Equity Securities Sold\n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nTotal sale price | $ | 1,199 |  |  | $ | 296 |  |  | $ | 4,553 |  |  | $ | 1,631 | \nTotal initial cost | 188 |  |  | 310 |  |  | 955 |  |  | 738 | \nCumulative net gain (loss)(1) | $ | 1,011 |  |  | $ | (14) |  |  | $ | 3,598 |  |  | $ | 893 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n | Marketable Securities |  | Non-Marketable Securities |  | Total\nTotal initial cost | $ | 4,211 |  |  | $ | 15,135 |  |  | $ | 19,346 | \nCumulative net gain (loss)(1) | 3,587 |  |  | 12,436 |  |  | 16,023 | \nCarrying value(2) | $ | 7,798 |  |  | $ | 27,571 |  |  | $ | 35,369 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of September 30, 2022\n | Marketable Securities |  | Non-Marketable Securities |  | Total\nTotal initial cost | $ | 5,752 |  |  | $ | 15,540 |  |  | $ | 21,292 | \nCumulative net gain (loss)(1) | 104 |  |  | 13,104 |  |  | 13,208 | \nCarrying value(2) | $ | 5,856 |  |  | $ | 28,644 |  |  | $ | 34,500 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021 |  | As of September 30, 2022\n | Cash and Cash Equivalents |  | MarketableSecurities |  | Cash and Cash Equivalents |  | MarketableSecurities\nLevel 1: |  |  |  |  | \nMoney market funds | $ | 7,499 |  |  | $ | 0 |  |  | $ | 8,318 |  |  | $ | 0 | \nMarketable equity securities(1)(2) | 0 |  |  | 7,447 |  |  | 0 |  |  | 5,509 | \n | 7,499 |  |  | 7,447 |  |  | 8,318 |  |  | 5,509 | \nLevel 2: |  |  |  |  |  |  | \nMutual funds | 0 |  |  | 351 |  |  | 0 |  |  | 347 | \nTotal | $ | 7,499 |  |  | $ | 7,798 |  |  | $ | 8,318 |  |  | $ | 5,856 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nUnrealized gains on non-marketable equity securities | $ | 1,260 |  |  | $ | 219 |  |  | $ | 6,245 |  |  | $ | 3,234 | \nUnrealized losses on non-marketable equity securities (including impairments) | (37) |  |  | (707) |  |  | (98) |  |  | (2,353) | \nTotal unrealized gain (loss) recognized on non-marketable equity securities | $ | 1,223 |  |  | $ | (488) |  |  | $ | 6,147 |  |  | $ | 881 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021 |  | As of September 30, 2022\nDerivatives Designated as Hedging Instruments: |  | \nForeign exchange contracts |  |  | \nCash flow hedges | $ | 16,362 |  |  | $ | 17,513 | \nFair value hedges | $ | 2,556 |  |  | $ | 2,435 | \nNet investment hedges | $ | 10,159 |  |  | $ | 8,993 | \nDerivatives Not Designated as Hedging Instruments: |  | \nForeign exchange contracts | $ | 41,031 |  |  | $ | 36,988 | \nOther contracts | $ | 4,275 |  |  | $ | 6,728 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | As of December 31, 2021\n | Balance\u00a0Sheet\u00a0Location |  | Fair\u00a0Value\u00a0ofDerivativesDesignated\u00a0asHedging\u00a0Instruments |  | Fair\u00a0Value\u00a0ofDerivatives\u00a0NotDesignated asHedging\u00a0Instruments |  | Total\u00a0Fair Value\nDerivative Assets: |  |  |  |  |  | \nLevel 2: |  |  |  |  |  |  | \nForeign exchange contracts | Other current and non-current assets |  | $ | 867 |  |  | $ | 42 |  |  | $ | 909 | \nOther contracts | Other current and non-current assets |  | 0 |  |  | 52 |  |  | 52 | \nTotal |  |  | $ | 867 |  |  | $ | 94 |  |  | $ | 961 | \nDerivative Liabilities: |  |  |  |  |  | \nLevel 2: |  |  |  |  |  |  | \nForeign exchange contracts | Accrued expenses and other liabilities, current and non-current |  | $ | 8 |  |  | $ | 452 |  |  | $ | 460 | \nOther contracts | Accrued expenses and other liabilities, current and non-current |  | 0 |  |  | 121 |  |  | 121 | \nTotal |  |  | $ | 8 |  |  | $ | 573 |  |  | $ | 581 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | As of September 30, 2022\n | Balance\u00a0Sheet\u00a0Location |  | Fair\u00a0Value\u00a0ofDerivativesDesignated\u00a0asHedging\u00a0Instruments |  | Fair\u00a0Value\u00a0ofDerivatives\u00a0NotDesignated asHedging\u00a0Instruments |  | Total\u00a0Fair Value\nDerivative Assets: |  |  |  |  |  | \nLevel 2: |  |  |  |  |  |  | \nForeign exchange contracts | Other current and non-current assets |  | $ | 2,317 |  |  | $ | 226 |  |  | $ | 2,543 | \nOther contracts | Other current and non-current assets |  | 0 |  |  | 46 |  |  | 46 | \nTotal |  |  | $ | 2,317 |  |  | $ | 272 |  |  | $ | 2,589 | \nDerivative Liabilities: |  |  |  |  |  | \nLevel 2: |  |  |  |  |  |  | \nForeign exchange contracts | Accrued expenses and other liabilities, current and non-current |  | $ | 13 |  |  | $ | 820 |  |  | $ | 833 | \nOther contracts | Accrued expenses and other liabilities, current and non-current |  | 0 |  |  | 45 |  |  | 45 | \nTotal |  |  | $ | 13 |  |  | $ | 865 |  |  | $ | 878 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Gains (Losses) Recognized in OCI on Derivatives Before Tax Effect\n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nDerivatives in Cash Flow Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount included in the assessment of effectiveness | $ | 336 |  |  | $ | 1,486 |  |  | $ | 438 |  |  | $ | 2,752 | \nAmount excluded from the assessment of effectiveness | 18 |  |  | (77) |  |  | 63 |  |  | (131) | \n |  |  |  |  |  |  | \nDerivatives in Net Investment Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount included in the assessment of effectiveness | 212 |  |  | 760 |  |  | 411 |  |  | 1,418 | \nTotal | $ | 566 |  |  | $ | 2,169 |  |  | $ | 912 |  |  | $ | 4,039 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Gains (Losses) Recognized in Income\n | Three Months Ended\n | September 30,\n | 2021 |  | 2022\n | Revenues |  | Other income (expense), net |  | Revenues |  | Other income (expense), net\nTotal amounts presented in the Consolidated Statements of Income in which the effects of cash flow and fair value hedges are recorded | $ | 65,118 |  |  | $ | 2,033 |  |  | $ | 69,092 |  |  | $ | (902) | \n |  |  |  |  |  |  | \nGains (Losses) on Derivatives in Cash Flow Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount of gains (losses) reclassified from AOCI to income | $ | 65 |  |  | $ | 0 |  |  | $ | 658 |  |  | $ | 0 | \nAmount excluded from the assessment of effectiveness recognized in earnings based on an amortization approach | (3) |  |  | 0 |  |  | (20) |  |  | 0 | \nGains (Losses) on Derivatives in Fair Value Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nHedged items | 0 |  |  | (69) |  |  | 0 |  |  | (226) | \nDerivatives designated as hedging instruments | 0 |  |  | 69 |  |  | 0 |  |  | 226 | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 2 |  |  | 0 |  |  | 6 | \nGains (Losses) on Derivatives in Net Investment Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 19 |  |  | 0 |  |  | 59 | \nGains (Losses) on Derivatives Not Designated as Hedging Instruments: |  |  |  |  |  |  | \nForeign exchange contracts | 0 |  |  | (148) |  |  | 0 |  |  | (495) | \nOther Contracts | 0 |  |  | (88) |  |  | 0 |  |  | 34 | \nTotal gains (losses) | $ | 62 |  |  | $ | (215) |  |  | $ | 638 |  |  | $ | (396) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Gains (Losses) Recognized in Income\n | Nine Months Ended\n | September 30,\n | 2021 |  | 2022\n | Revenues |  | Other income (expense), net |  | Revenues |  | Other income (expense), net\nTotal amounts presented in the Consolidated Statements of Income in which the effects of cash flow and fair value hedges are recorded | $ | 182,312 |  |  | $ | 9,503 |  |  | $ | 206,788 |  |  | $ | (2,501) | \n |  |  |  |  |  |  | \nGains (Losses) on Derivatives in Cash Flow Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount of gains (losses) reclassified from AOCI to income | $ | (43) |  |  | $ | 0 |  |  | $ | 1,355 |  |  | $ | 0 | \nAmount excluded from the assessment of effectiveness recognized in earnings based on an amortization approach | (11) |  |  | 0 |  |  | (63) |  |  | 0 | \nGains (Losses) on Derivatives in Fair Value Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nHedged items | 0 |  |  | (41) |  |  | 0 |  |  | (349) | \nDerivatives designated as hedging instruments | 0 |  |  | 41 |  |  | 0 |  |  | 350 | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 6 |  |  | 0 |  |  | 9 | \nGains (Losses) on Derivatives in Net Investment Hedging Relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 60 |  |  | 0 |  |  | 99 | \nGains (Losses) on Derivatives Not Designated as Hedging Instruments: |  |  |  |  |  |  | \nForeign exchange contracts | 0 |  |  | (552) |  |  | 0 |  |  | (891) | \nOther Contracts | 0 |  |  | 93 |  |  | 0 |  |  | 158 | \nTotal gains (losses) | $ | (54) |  |  | $ | (393) |  |  | $ | 1,292 |  |  | $ | (624) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset |  | \n | Gross Amounts of Recognized Assets |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Received |  | Non-Cash Collateral Received |  | Net Assets Exposed\nDerivatives | $ | 999 |  |  | $ | (38) |  |  | $ | 961 |  |  | $ | (434) |  | (1) | $ | (394) |  |  | $ | (12) |  |  | $ | 121 | \n |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of September 30, 2022\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset |  | \n | Gross Amounts of Recognized Assets |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Received |  | Non-Cash Collateral Received |  | Net Assets Exposed\nDerivatives | $ | 2,639 |  |  | $ | (50) |  |  | $ | 2,589 |  |  | $ | (755) |  | (1) | $ | (1,609) |  |  | $ | (32) |  |  | $ | 193 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset |  | \n | Gross Amounts of Recognized Liabilities |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Pledged |  | Non-Cash Collateral Pledged |  | Net Liabilities\nDerivatives | $ | 619 |  |  | $ | (38) |  |  | $ | 581 |  |  | $ | (434) |  | (2) | $ | (4) |  |  | $ | (110) |  |  | $ | 33 | \n |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of September 30, 2022\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | \n | Gross Amounts of Recognized Liabilities |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Pledged |  | Non-Cash Collateral Pledged |  | Net Liabilities\nDerivatives | $ | 928 |  |  | $ | (50) |  |  | $ | 878 |  |  | $ | (755) |  | (2) | $ | (15) |  |  | $ | (2) |  |  | $ | 106 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Maturity |  | Coupon Rate |  | Effective Interest Rate |  | As of December 31, 2021 |  | As ofSeptember 30, 2022\nDebt |  |  |  |  |  |  |  |  |  | \n2014-2020 Notes Issuances |  | 2024 - 2060 |  | 0.45% -3.38% |  | 0.57% -3.38% |  | $ | 13,000 |  |  | $ | 13,000 | \nFuture finance lease payments, net and other(1) |  |  |  |  |  |  |  | 2,086 |  |  | 2,213 | \nTotal debt |  |  |  |  |  |  |  | 15,086 |  |  | 15,213 | \nUnamortized discount and debt issuance costs |  |  |  |  |  |  |  | (156) |  |  | (146) | \nLess: Current portion future finance lease payments, net and other current debt(1)(2) |  |  |  |  |  |  |  | (113) |  |  | (414) | \nTotal long-term debt |  |  |  |  |  |  |  | $ | 14,817 |  |  | $ | 14,653 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2021 |  | As ofSeptember 30, 2022\nLand and buildings | $ | 58,881 |  |  | $ | 64,679 | \nInformation technology assets | 55,606 |  |  | 61,938 | \nConstruction in progress | 23,172 |  |  | 26,899 | \nLeasehold improvements | 9,146 |  |  | 10,062 | \nFurniture and fixtures | 208 |  |  | 297 | \nProperty and equipment, gross | 147,013 |  |  | 163,875 | \nLess: accumulated depreciation | (49,414) |  |  | (55,512) | \nProperty and equipment, net | $ | 97,599 |  |  | $ | 108,363 |   |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2021 |  | As ofSeptember 30, 2022\nEuropean Commission fines(1) | $ | 9,799 |  |  | $ | 8,264 | \nAccrued customer liabilities | 3,505 |  |  | 2,943 | \nAccrued purchases of property and equipment | 2,415 |  |  | 3,255 | \nCurrent operating lease liabilities | 2,189 |  |  | 2,285 | \nOther accrued expenses and current liabilities | 13,328 |  |  | 18,291 | \nAccrued expenses and other current liabilities | $ | 31,236 |  |  | $ | 35,038 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Available-for-Sale Investments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total\nBalance as of December 31, 2020 | $ | (864) |  |  | $ | 1,612 |  |  | $ | (115) |  |  | $ | 633 | \nOther comprehensive income (loss) before reclassifications | (671) |  |  | (699) |  |  | 366 |  |  | (1,004) | \nAmounts excluded from the assessment of hedge effectiveness recorded in AOCI | 0 |  |  | 0 |  |  | 63 |  |  | 63 | \nAmounts reclassified from AOCI | 0 |  |  | (121) |  |  | 21 |  |  | (100) | \nOther comprehensive income (loss) | (671) |  |  | (820) |  |  | 450 |  |  | (1,041) | \nBalance as of September 30, 2021 | $ | (1,535) |  |  | $ | 792 |  |  | $ | 335 |  |  | $ | (408) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Available-for-Sale Investments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total\nBalance as of December 31, 2021 | $ | (2,306) |  |  | $ | 236 |  |  | $ | 447 |  |  | $ | (1,623) | \nOther comprehensive income (loss) before reclassifications | (3,801) |  |  | (5,204) |  |  | 2,296 |  |  | (6,709) | \nAmounts excluded from the assessment of hedge effectiveness recorded in AOCI | 0 |  |  | 0 |  |  | (131) |  |  | (131) | \nAmounts reclassified from AOCI | 0 |  |  | 743 |  |  | (1,132) |  |  | (389) | \nOther comprehensive income (loss) | (3,801) |  |  | (4,461) |  |  | 1,033 |  |  | (7,229) | \nBalance as of September 30, 2022 | $ | (6,107) |  |  | $ | (4,225) |  |  | $ | 1,480 |  |  | $ | (8,852) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | Gains (Losses) Reclassified from AOCI to the Consolidated Statements of Income\n |  |  |  | Three Months Ended |  | Nine Months Ended\n |  |  |  | September 30, |  | September 30,\nAOCI Components |  | Location |  | 2021 |  | 2022 |  | 2021 |  | 2022\nUnrealized gains (losses) on available-for-sale investments |  |  |  |  |  |  |  | \n |  | Other income (expense), net |  | $ | 73 |  |  | $ | (464) |  |  | $ | 155 |  |  | $ | (953) | \n |  | Benefit (provision) for income taxes |  | (16) |  |  | 102 |  |  | (34) |  |  | 210 | \n |  | Net of income tax |  | 57 |  |  | (362) |  |  | 121 |  |  | (743) | \nUnrealized gains (losses) on cash flow hedges |  |  |  |  |  |  |  | \nForeign exchange contracts |  | Revenue |  | 65 |  |  | 658 |  |  | (43) |  |  | 1,355 | \nInterest rate contracts |  | Other income (expense), net |  | 1 |  |  | 2 |  |  | 4 |  |  | 5 | \n |  | Benefit (provision) for income taxes |  | (6) |  |  | (113) |  |  | 18 |  |  | (228) | \n |  | Net of income tax |  | 60 |  |  | 547 |  |  | (21) |  |  | 1,132 | \nTotal amount reclassified, net of income tax |  | $ | 117 |  |  | $ | 185 |  |  | $ | 100 |  |  | $ | 389 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nInterest income | $ | 387 |  |  | $ | 615 |  |  | $ | 1,121 |  |  | $ | 1,515 | \nInterest expense(1) | (77) |  |  | (101) |  |  | (229) |  |  | (267) | \nForeign currency exchange gain (loss), net | (139) |  |  | (136) |  |  | (77) |  |  | (469) | \nGain (loss) on debt securities, net | 37 |  |  | (731) |  |  | 62 |  |  | (1,888) | \nGain (loss) on equity securities, net | 2,121 |  |  | (647) |  |  | 9,730 |  |  | (1,968) | \nPerformance fees | (492) |  |  | 54 |  |  | (1,680) |  |  | 605 | \nIncome (loss) and impairment from equity method investments, net | 188 |  |  | (99) |  |  | 285 |  |  | (306) | \nOther | 8 |  |  | 143 |  |  | 291 |  |  | 277 | \nOther income (expense), net | $ | 2,033 |  |  | $ | (902) |  |  | $ | 9,503 |  |  | $ | (2,501) |   |  |  |  |  | \nIntangible assets | $ | 840 | \nGoodwill(1) | 4,772 | \nNet assets acquired(2) | 489 | \nTotal purchase price | $ | 6,101 |   |  |  |  |  |  |  |  |  |  |  | \n | Amount(in millions) |  | Weighted-Average Useful Life(in years)\nPatents and developed technology | $ | 349 |  |  | 4.8\nCustomer relationships | 366 |  |  | 8.0\nTrade names and other | 125 |  |  | 5.9\nTotal intangible assets | $ | 840 |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Google Services |  | Google Cloud |  | Other Bets |  | Total\nBalance as of December 31, 2021 | $ | 19,826 |  |  | $ | 2,337 |  |  | $ | 793 |  |  | $ | 22,956 | \nAcquisitions | 1,146 |  |  | 4,875 |  |  | 113 |  |  | 6,134 | \nForeign currency translation and other adjustments | (227) |  |  | (23) |  |  | (6) |  |  | (256) | \nBalance as of September 30, 2022 | $ | 20,745 |  |  | $ | 7,189 |  |  | $ | 900 |  |  | $ | 28,834 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2021\n | GrossCarryingAmount |  | AccumulatedAmortization |  | NetCarryingAmount\nPatents and developed technology | $ | 4,786 |  |  | $ | 4,112 |  |  | $ | 674 | \nCustomer relationships | 506 |  |  | 140 |  |  | 366 | \nTrade names and other | 534 |  |  | 295 |  |  | 239 | \nTotal definite-lived intangible assets | 5,826 |  |  | 4,547 |  |  | 1,279 | \nIndefinite-lived intangible assets | 138 |  |  | 0 |  |  | 138 | \nTotal intangible assets | $ | 5,964 |  |  | $ | 4,547 |  |  | $ | 1,417 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of September 30, 2022\n | GrossCarryingAmount |  | AccumulatedAmortization |  | NetCarryingAmount\nPatents and developed technology | $ | 1,364 |  |  | $ | 491 |  |  | $ | 873 | \nCustomer relationships | 891 |  |  | 224 |  |  | 667 | \nTrade names and other | 528 |  |  | 110 |  |  | 418 | \nTotal definite-lived intangible assets | 2,783 |  |  | 825 |  |  | 1,958 | \nIndefinite-lived intangible assets | 234 |  |  | 0 |  |  | 234 | \nTotal intangible assets | $ | 3,017 |  |  | $ | 825 |  |  | $ | 2,192 |   |  |  |  |  | \nRemainder of 2022 | $ | 134 | \n2023 | 458 | \n2024 | 439 | \n2025 | 309 | \n2026 | 232 | \nThereafter | 386 | \nTotal | $ | 1,958 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30,\n | 2021 |  | 2022\n | Class A |  | Class B |  | Class C |  | Class A |  | Class B |  | Class C\nBasic net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings | $ | 8,548 |  |  | $ | 1,291 |  |  | $ | 9,097 |  |  | $ | 6,393 |  |  | $ | 946 |  |  | $ | 6,571 | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in per share computation | 6,010 |  |  | 908 |  |  | 6,397 |  |  | 5,983 |  |  | 885 |  |  | 6,150 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nBasic net income per share | $ | 1.42 |  |  | $ | 1.42 |  |  | $ | 1.42 |  |  | $ | 1.07 |  |  | $ | 1.07 |  |  | $ | 1.07 | \nDiluted net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings for basic computation | $ | 8,548 |  |  | $ | 1,291 |  |  | $ | 9,097 |  |  | $ | 6,393 |  |  | $ | 946 |  |  | $ | 6,571 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nReallocation of undistributed earnings as a result of conversion of Class B to Class\u00a0A shares | 1,291 |  |  | 0 |  |  | 0 |  |  | 946 |  |  | 0 |  |  | 0 | \nReallocation of undistributed earnings | (156) |  |  | (20) |  |  | 156 |  |  | (45) |  |  | (6) |  |  | 45 | \nAllocation of undistributed earnings | $ | 9,683 |  |  | $ | 1,271 |  |  | $ | 9,253 |  |  | $ | 7,294 |  |  | $ | 940 |  |  | $ | 6,616 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in basic computation | 6,010 |  |  | 908 |  |  | 6,397 |  |  | 5,983 |  |  | 885 |  |  | 6,150 | \nWeighted-average effect of dilutive securities |  |  |  |  |  |  |  |  |  |  | \nAdd: |  |  |  |  |  |  |  |  |  |  | \nConversion of Class B to Class\u00a0A shares outstanding | 908 |  |  | 0 |  |  | 0 |  |  | 885 |  |  | 0 |  |  | 0 | \n |  |  |  |  |  |  |  |  |  |  | \nRestricted stock units and other contingently issuable shares | 0 |  |  | 0 |  |  | 215 |  |  | 0 |  |  | 0 |  |  | 79 | \nNumber of shares used in per share computation | 6,918 |  |  | 908 |  |  | 6,612 |  |  | 6,868 |  |  | 885 |  |  | 6,229 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDiluted net income per share | $ | 1.40 |  |  | $ | 1.40 |  |  | $ | 1.40 |  |  | $ | 1.06 |  |  | $ | 1.06 |  |  | $ | 1.06 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended September 30,\n | 2021 |  | 2022\n | Class A |  | Class B |  | Class C |  | Class A |  | Class B |  | Class C\nBasic net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings | $ | 24,867 |  |  | $ | 3,776 |  |  | $ | 26,748 |  |  | $ | 21,213 |  |  | $ | 3,137 |  |  | $ | 21,998 | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in per share computation | 6,010 |  |  | 912 |  |  | 6,464 |  |  | 6,004 |  |  | 888 |  |  | 6,226 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nBasic net income per share | $ | 4.14 |  |  | $ | 4.14 |  |  | $ | 4.14 |  |  | $ | 3.53 |  |  | $ | 3.53 |  |  | $ | 3.53 | \nDiluted net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings for basic computation | $ | 24,867 |  |  | $ | 3,776 |  |  | $ | 26,748 |  |  | $ | 21,213 |  |  | $ | 3,137 |  |  | $ | 21,998 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nReallocation of undistributed earnings as a result of conversion of Class B to Class\u00a0A shares | 3,776 |  |  | 0 |  |  | 0 |  |  | 3,137 |  |  | 0 |  |  | 0 | \nReallocation of undistributed earnings | (424) |  |  | (56) |  |  | 424 |  |  | (204) |  |  | (26) |  |  | 204 | \nAllocation of undistributed earnings | $ | 28,219 |  |  | $ | 3,720 |  |  | $ | 27,172 |  |  | $ | 24,146 |  |  | $ | 3,111 |  |  | $ | 22,202 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in basic computation | 6,010 |  |  | 912 |  |  | 6,464 |  |  | 6,004 |  |  | 888 |  |  | 6,226 | \nWeighted-average effect of dilutive securities |  |  |  |  |  |  |  |  |  |  | \nAdd: |  |  |  |  |  |  |  |  |  |  | \nConversion of Class B to Class\u00a0A shares outstanding | 912 |  |  | 0 |  |  | 0 |  |  | 888 |  |  | 0 |  |  | 0 | \n |  |  |  |  |  |  |  |  |  |  | \nRestricted stock units and other contingently issuable shares | 0 |  |  | 0 |  |  | 202 |  |  | 0 |  |  | 0 |  |  | 111 | \nNumber of shares used in per share computation | 6,922 |  |  | 912 |  |  | 6,666 |  |  | 6,892 |  |  | 888 |  |  | 6,337 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDiluted net income per share | $ | 4.08 |  |  | $ | 4.08 |  |  | $ | 4.08 |  |  | $ | 3.50 |  |  | $ | 3.50 |  |  | $ | 3.50 |   |  |  |  |  |  |  |  |  |  |  | \n | Unvested\u00a0Restricted\u00a0Stock\u00a0Units\n | Number ofShares |  | Weighted-AverageGrant-DateFair Value\nUnvested as of December 31, 2021 | 338 |  |  | $ | 81.31 | \nGranted | 199 |  |  | $ | 131.77 | \nVested | (152) |  |  | $ | 87.13 | \nForfeited/canceled | (25) |  |  | $ | 96.04 | \nUnvested as of September 30, 2022 | 360 |  |  | $ | 105.70 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nIncome before provision for income taxes | $ | 23,064 |  |  | $ | 16,233 |  |  | $ | 66,332 |  |  | $ | 54,181 | \nProvision for income taxes | $ | 4,128 |  |  | $ | 2,323 |  |  | $ | 10,941 |  |  | $ | 7,833 | \nEffective tax rate | 17.9 | % |  | 14.3 | % |  | 16.5 | % |  | 14.5 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nRevenues: |  |  |  |  |  |  | \nGoogle Services | $ | 59,884 |  |  | $ | 61,377 |  |  | $ | 168,129 |  |  | $ | 185,690 | \nGoogle Cloud | 4,990 |  |  | 6,868 |  |  | 13,665 |  |  | 18,965 | \nOther Bets | 182 |  |  | 209 |  |  | 572 |  |  | 842 | \nHedging gains (losses) | 62 |  |  | 638 |  |  | (54) |  |  | 1,291 | \nTotal revenues | $ | 65,118 |  |  | $ | 69,092 |  |  | $ | 182,312 |  |  | $ | 206,788 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nOperating income (loss): |  |  |  |  |  |  | \nGoogle Services | $ | 23,973 |  |  | $ | 19,781 |  |  | $ | 65,862 |  |  | $ | 65,471 | \nGoogle Cloud | (644) |  |  | (699) |  |  | (2,209) |  |  | (2,488) | \nOther Bets | (1,288) |  |  | (1,611) |  |  | (3,831) |  |  | (4,452) | \nCorporate costs, unallocated | (1,010) |  |  | (336) |  |  | (2,993) |  |  | (1,849) | \nTotal income from operations | $ | 21,031 |  |  | $ | 17,135 |  |  | $ | 56,829 |  |  | $ | 56,682 |   |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2021 |  | As ofSeptember 30, 2022\nLong-lived assets: |  |  | \nUnited States | $ | 80,207 |  |  | $ | 91,632 | \nInternational | 30,351 |  |  | 30,408 | \nTotal long-lived assets | $ | 110,558 |  |  | $ | 122,040 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended |  |  |  | \n | September 30, |  |  |  | \n |  | 2021 |  | 2022 |  | $ Change |  | % Change\nConsolidated revenues |  | $ | 65,118 |  |  | $ | 69,092 |  |  | $ | 3,974 |  |  | 6 | %\nChange in consolidated constant currency revenues |  |  |  |  |  |  |  | 11 | %\n |  |  |  |  |  |  |  | \nCost of revenues |  | $ | 27,621 |  |  | $ | 31,158 |  |  | $ | 3,537 |  |  | 13 | %\nOperating expenses |  | $ | 16,466 |  |  | $ | 20,799 |  |  | $ | 4,333 |  |  | 26 | %\n |  |  |  |  |  |  |  | \nOperating income |  | $ | 21,031 |  |  | $ | 17,135 |  |  | $ | (3,896) |  |  | (19) | %\nOperating margin |  | 32 | % |  | 25 | % |  |  |  | (7) | %\n |  |  |  |  |  |  |  | \nOther income (expense), net |  | $ | 2,033 |  |  | $ | (902) |  |  | $ | (2,935) |  |  | (144) | %\n |  |  |  |  |  |  |  | \nNet Income |  | $ | 18,936 |  |  | $ | 13,910 |  |  | $ | (5,026) |  |  | (27) | %\nDiluted EPS |  | $ | 1.40 |  |  | $ | 1.06 |  |  | $ | (0.34) |  |  | (24) | %\n |  |  |  |  |  |  |  | \nNumber of Employees |  | 150,028 |  |  | 186,779 |  | 36,751 |  | 24 | %\n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nGoogle Search & other | $ | 37,926 |  |  | $ | 39,539 |  |  | $ | 105,650 |  |  | $ | 119,846 | \nYouTube ads | 7,205 |  |  | 7,071 |  |  | 20,212 |  |  | 21,280 | \nGoogle Network | 7,999 |  |  | 7,872 |  |  | 22,396 |  |  | 24,305 | \nGoogle advertising | 53,130 |  |  | 54,482 |  |  | 148,258 |  |  | 165,431 | \nGoogle other | 6,754 |  |  | 6,895 |  |  | 19,871 |  |  | 20,259 | \nGoogle Services total | 59,884 |  |  | 61,377 |  |  | 168,129 |  |  | 185,690 | \nGoogle Cloud | 4,990 |  |  | 6,868 |  |  | 13,665 |  |  | 18,965 | \nOther Bets | 182 |  |  | 209 |  |  | 572 |  |  | 842 | \nHedging gains (losses) | 62 |  |  | 638 |  |  | (54) |  |  | 1,291 | \nTotal revenues | $ | 65,118 |  |  | $ | 69,092 |  |  | $ | 182,312 |  |  | $ | 206,788 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | \n | 2022 |  | 2022\n |  |  | \n |  |  | \nPaid clicks change | 8% |  | 12%\nCost-per-click change | (5)% |  | 1%  |  |  |  |  |  |  |  |  |  |  | \n |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2022 |  | 2022\nImpressions change | 3% |  | 5%\nCost-per-impression change | (5)% |  | 4%  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nUnited States | 46 | % |  | 48 | % |  | 46 | % |  | 47 | %\nEMEA | 30 | % |  | 28 | % |  | 31 | % |  | 29 | %\nAPAC | 18 | % |  | 17 | % |  | 18 | % |  | 17 | %\nOther Americas | 6 | % |  | 6 | % |  | 5 | % |  | 6 | %\nHedging gains (losses) | 0 | % |  | 1 | % |  | 0 | % |  | 1 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  |  |  | Nine Months Ended |  | \n | September 30, |  |  |  | September 30, |  | \n | 2021 |  | 2022 |  | % Change from Prior Year |  | 2021 |  | 2022 |  | % Change from Prior Year\nEMEA revenues | $ | 19,839 |  |  | $ | 19,450 |  |  | (2) | % |  | $ | 55,954 |  |  | $ | 60,300 |  |  | 8 | %\nEMEA constant currency revenues |  |  | 22,093 |  |  | 11 | % |  |  |  | $ | 66,210 |  |  | 18 | %\n |  |  |  |  |  |  |  |  |  |  | \nAPAC revenues | 11,705 |  |  | 11,494 |  |  | (2) | % |  | $ | 33,391 |  |  | $ | 35,045 |  |  | 5 | %\nAPAC constant currency revenues |  |  | 12,604 |  |  | 8 | % |  |  |  | $ | 37,510 |  |  | 12 | %\n |  |  |  |  |  |  |  |  |  |  | \nOther Americas revenues | 3,688 |  |  | 4,138 |  |  | 12 | % |  | $ | 9,957 |  |  | $ | 12,320 |  |  | 24 | %\nOther Americas constant currency revenues |  |  | 4,303 |  |  | 17 | % |  |  |  | $ | 12,536 |  |  | 26 | %\n |  |  |  |  |  |  |  |  |  |  | \nUnited States revenues | 29,824 |  |  | 33,372 |  |  | 12 | % |  | $ | 83,064 |  |  | $ | 97,832 |  |  | 18 | %\n |  |  |  |  |  |  |  |  |  |  | \nHedging gains (losses) | 62 |  |  | 638 |  |  |  |  | $ | (54) |  |  | $ | 1,291 |  |  | \nTotal revenues | $ | 65,118 |  |  | $ | 69,092 |  |  | 6 | % |  | $ | 182,312 |  |  | $ | 206,788 |  |  | 13 | %\nRevenues, excluding hedging effect | $ | 65,056 |  |  | $ | 68,454 |  |  |  |  | $ | 182,366 |  |  | $ | 205,497 |  |  | \nExchange rate effect |  |  | 3,918 |  |  |  |  |  |  | 8,591 |  |  | \nTotal constant currency revenues |  |  | $ | 72,372 |  |  | 11 | % |  |  |  | $ | 214,088 |  |  | 17 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nTAC | $ | 11,498 |  |  | $ | 11,826 |  |  | $ | 32,139 |  |  | $ | 36,030 | \nOther cost of revenues | 16,123 |  |  | 19,332 |  |  | 45,812 |  |  | 54,831 | \nTotal cost of revenues | $ | 27,621 |  |  | $ | 31,158 |  |  | $ | 77,951 |  |  | $ | 90,861 | \nTotal cost of revenues as a percentage of revenues | 42.4 | % |  | 45.1 | % |  | 42.8 | % |  | 43.9 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nResearch and development expenses | $ | 7,694 |  |  | $ | 10,273 |  |  | $ | 22,854 |  |  | $ | 29,233 | \nResearch and development expenses as a percentage of revenues | 11.8 | % |  | 14.9 | % |  | 12.5 | % |  | 14.1 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nSales and marketing expenses | $ | 5,516 |  |  | $ | 6,929 |  |  | $ | 15,308 |  |  | $ | 19,384 | \nSales and marketing expenses as a percentage of revenues | 8.5 | % |  | 10.0 | % |  | 8.4 | % |  | 9.4 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nGeneral and administrative expenses | $ | 3,256 |  |  | $ | 3,597 |  |  | $ | 9,370 |  |  | $ | 10,628 | \nGeneral and administrative expenses as a percentage of revenues | 5.0 | % |  | 5.2 | % |  | 5.1 | % |  | 5.1 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  |  |  | \nOperating income (loss): |  |  |  |  |  |  | \nGoogle Services | $ | 23,973 |  |  | $ | 19,781 |  |  | $ | 65,862 |  |  | $ | 65,471 | \nGoogle Cloud | (644) |  |  | (699) |  |  | (2,209) |  |  | (2,488) | \nOther Bets | (1,288) |  |  | (1,611) |  |  | (3,831) |  |  | (4,452) | \nCorporate costs, unallocated(1) | (1,010) |  |  | (336) |  |  | (2,993) |  |  | (1,849) | \nTotal income from operations | $ | 21,031 |  |  | $ | 17,135 |  |  | $ | 56,829 |  |  | $ | 56,682 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nOther income (expense), net | $ | 2,033 |  |  | $ | (902) |  |  | $ | 9,503 |  |  | $ | (2,501) | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2021 |  | 2022 |  | 2021 |  | 2022\nIncome before provision for income taxes | $ | 23,064 |  |  | $ | 16,233 |  |  | $ | 66,332 |  |  | $ | 54,181 | \nProvision for income taxes | $ | 4,128 |  |  | $ | 2,323 |  |  | $ | 10,941 |  |  | $ | 7,833 | \nEffective tax rate | 17.9 | % |  | 14.3 | % |  | 16.5 | % |  | 14.5 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended\n | September 30,\n | 2021 |  | 2022\nNet cash provided by operating activities | $ | 66,718 |  |  | $ | 67,881 | \nNet cash used in investing activities | $ | (24,507) |  |  | $ | (14,071) | \nNet cash used in financing activities | $ | (44,851) |  |  | $ | (52,128) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | Total Number of Class A Shares Purchased(in thousands)(1) |  | Total Number of Class C Shares Purchased(in thousands)(1) |  | Average Price Paid per Class A Share(2) |  | Average Price Paid per Class C Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Programs(in thousands)(1) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program(in millions)\nJuly 1 - 31 |  | 8,479 |  |  | 37,461 |  |  | $ | 112.62 |  |  | $ | 113.29 |  |  | 45,940 |  |  | $ | 53,675 | \nAugust 1 - 31 |  | 8,477 |  |  | 39,176 |  |  | $ | 115.95 |  |  | $ | 117.10 |  |  | 47,653 |  |  | $ | 48,104 | \nSeptember 1 - 30 |  | 7,583 |  |  | 36,588 |  |  | $ | 104.57 |  |  | $ | 104.66 |  |  | 44,171 |  |  | $ | 43,482 | \nTotal |  | 24,539 |  |  | 113,225 |  |  |  |  |  |  | 137,764 |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nExhibitNumber |  | Description |  | Incorporated\u00a0by\u00a0reference\u00a0herein\n | Form |  | Date\n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n31.01 | * | Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n31.02 | * | Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n32.01 | \u2021 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18\u00a0U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n101.INS | * | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |  |  |  | \n101.SCH | * | Inline XBRL Taxonomy Extension Schema Document |  |  |  | \n101.CAL | * | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  |  |  | \n101.DEF | * | Inline XBRL Taxonomy Extension Definition Linkbase Document |  |  |  | \n101.LAB | * | Inline XBRL Taxonomy Extension Label Linkbase Document |  |  |  | \n101.PRE | * | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  |  |  | \n104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |  |  |  |   |  |  |  |  | \n | \n | \n* | Filed herewith.\n\u2021 | Furnished herewith.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  | \n |  | ALPHABET INC.\nOctober 25, 2022 | By: | /s/\u00a0\u00a0\u00a0\u00a0RUTH M. PORAT\n |  | Ruth M. Porat\n |  | Senior Vice President and Chief Financial Officer  |  |  |  |  |  |  |  | \n |  | ALPHABET INC.\nOctober 25, 2022 | By: | /s/\u00a0\u00a0\u00a0\u00a0AMIE THUENER O'TOOLE\n |  | Amie Thuener O'Toole\n |  | Vice President and Chief Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Google, in 2023 Q1, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION\u00a013 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \nDelaware | 61-1767919\n(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number)  |  |  |  |  |  |  |  | \nSecurities registered pursuant to Section\u00a012(b) of the Act:\nTitle of each class | Trading Symbol(s) | Name of each exchange on which registered\nClass\u00a0A Common Stock, $0.001 par value | GOOGL | Nasdaq Stock Market LLC\n |  | (Nasdaq Global Select Market)\nClass C Capital Stock, $0.001 par value | GOOG | Nasdaq Stock Market LLC\n |  | (Nasdaq Global Select Market)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 |  | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 |  | Smaller reporting company | \u2610\nEmerging growth company | \u2610 |  |  |   |  | \n  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  | \n |  | Page\u00a0No.\nNote About Forward-Looking Statements | 3\n\nPART I. FINANCIAL INFORMATION\nItem\u00a01 | Financial Statements | 5\n | Consolidated Balance Sheets- December\u00a031, 2022 and March\u00a031, 2023 | 5\n | Consolidated Statements of Income -Three Months Ended March 31,2022and2023 | 6\n | Consolidated Statements of Comprehensive Income -Three Months Ended March 31,2022and2023 | 7\n | Consolidated Statements of Stockholders' Equity -Three Months Ended March 31,2022and2023 | 8\n | Consolidated Statements of Cash Flows -Three Months Ended March 31,2022and2023 | 9\n | Notes to Consolidated Financial Statements | 10\nItem\u00a02 | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 30\nItem\u00a03 | Quantitative and Qualitative Disclosures About Market Risk | 43\nItem\u00a04 | Controls and Procedures | 43\n |  | \nPART II. OTHER INFORMATION\nItem\u00a01 | Legal Proceedings | 44\nItem\u00a01A | Risk Factors | 44\nItem 2 | Unregistered Sales of Equity Securities and Use of Proceeds | 44\n |  | \n |  | \nItem\u00a05 | Other Information | 49\nItem\u00a06 | Exhibits | 45\nSignatures | 46  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2022 |  | As ofMarch 31, 2023\n |  |  | (unaudited)\nAssets |  |  | \nCurrent assets: |  |  | \nCash and cash equivalents | $ | 21,879 |  |  | $ | 25,924 | \nMarketable securities | 91,883 |  |  | 89,178 | \nTotal cash, cash equivalents, and marketable securities | 113,762 |  |  | 115,102 | \nAccounts receivable, net | 40,258 |  |  | 36,036 | \nInventory | 2,670 |  |  | 2,315 | \nOther current assets | 8,105 |  |  | 8,532 | \nTotal current assets | 164,795 |  |  | 161,985 | \nNon-marketable securities | 30,492 |  |  | 31,213 | \nDeferred income taxes | 5,261 |  |  | 6,885 | \nProperty and equipment, net | 112,668 |  |  | 117,560 | \nOperating lease assets | 14,381 |  |  | 14,447 | \nIntangible assets, net | 2,084 |  |  | 1,968 | \nGoodwill | 28,960 |  |  | 28,994 | \nOther non-current assets | 6,623 |  |  | 6,439 | \nTotal assets | $ | 365,264 |  |  | $ | 369,491 | \nLiabilities and Stockholders\u2019 Equity |  |  | \nCurrent liabilities: |  |  | \nAccounts payable | $ | 5,128 |  |  | $ | 4,184 | \n |  |  | \nAccrued compensation and benefits | 14,028 |  |  | 9,954 | \nAccrued expenses and other current liabilities | 37,866 |  |  | 43,185 | \nAccrued revenue share | 8,370 |  |  | 7,816 | \nDeferred revenue | 3,908 |  |  | 3,715 | \nTotal current liabilities | 69,300 |  |  | 68,854 | \nLong-term debt | 14,701 |  |  | 13,697 | \nDeferred revenue, non-current | 599 |  |  | 610 | \nIncome taxes payable, non-current | 9,258 |  |  | 9,722 | \nDeferred income taxes | 514 |  |  | 542 | \nOperating lease liabilities | 12,501 |  |  | 12,799 | \nOther long-term liabilities | 2,247 |  |  | 2,373 | \nTotal liabilities | 109,120 |  |  | 108,597 | \nCommitments and contingencies (Note 9) |  |  | \nStockholders\u2019 equity: |  |  | \nPreferred stock, $0.001par value per share,100shares authorized;noshares issued and outstanding | 0 |  |  | 0 | \nClass\u00a0A, Class B, and Class C stock and additional paid-in capital, $0.001par value per share:300,000shares authorized\u00a0(Class\u00a0A180,000, Class B60,000, Class C60,000);12,849(Class\u00a0A5,964, Class B883, Class C6,002) and12,722(Class\u00a0A5,943, Class B883, Class C5,896)shares issued and outstanding | 68,184 |  |  | 70,269 | \nAccumulated other comprehensive income (loss) | (7,603) |  |  | (6,000) | \nRetained earnings | 195,563 |  |  | 196,625 | \nTotal stockholders\u2019 equity | 256,144 |  |  | 260,894 | \nTotal liabilities and stockholders\u2019 equity | $ | 365,264 |  |  | $ | 369,491 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nRevenues | $ | 68,011 |  |  | $ | 69,787 |  |  |  |  | \nCosts and expenses: |  |  |  |  |  |  | \nCost of revenues | 29,599 |  |  | 30,612 |  |  |  |  | \nResearch and development | 9,119 |  |  | 11,468 |  |  |  |  | \nSales and marketing | 5,825 |  |  | 6,533 |  |  |  |  | \nGeneral and administrative | 3,374 |  |  | 3,759 |  |  |  |  | \nTotal costs and expenses | 47,917 |  |  | 52,372 |  |  |  |  | \nIncome from operations | 20,094 |  |  | 17,415 |  |  |  |  | \nOther income (expense), net | (1,160) |  |  | 790 |  |  |  |  | \nIncome before income taxes | 18,934 |  |  | 18,205 |  |  |  |  | \nProvision for income taxes | 2,498 |  |  | 3,154 |  |  |  |  | \nNet income | $ | 16,436 |  |  | $ | 15,051 |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income per share of Class A, Class B, and Class C stock | $ | 1.24 |  |  | $ | 1.18 |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nDiluted net income per share of Class A, Class B, and Class C stock | $ | 1.23 |  |  | $ | 1.17 |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nNet income | $ | 16,436 |  |  | $ | 15,051 |  |  |  |  | \nOther comprehensive income (loss): |  |  |  |  |  |  | \nChange in foreign currency translation adjustment | 39 |  |  | 596 |  |  |  |  | \nAvailable-for-sale investments: |  |  |  |  |  |  | \nChange in net unrealized gains (losses) | (2,478) |  |  | 866 |  |  |  |  | \nLess: reclassification adjustment for net (gains) losses included in net income | 148 |  |  | 292 |  |  |  |  | \nNet change, net of income tax benefit (expense) of $633and$(330) | (2,330) |  |  | 1,158 |  |  |  |  | \nCash flow hedges: |  |  |  |  |  |  | \nChange in net unrealized gains (losses) | 114 |  |  | (74) |  |  |  |  | \nLess: reclassification adjustment for net (gains) losses included in net income | (249) |  |  | (77) |  |  |  |  | \nNet change, net of income tax benefit (expense) of $44and $30 | (135) |  |  | (151) |  |  |  |  | \nOther comprehensive income (loss) | (2,426) |  |  | 1,603 |  |  |  |  | \nComprehensive income | $ | 14,010 |  |  | $ | 16,654 |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, 2022\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of December 31, 2021 | 13,242 |  |  | $ | 61,774 |  |  | $ | (1,623) |  |  | $ | 191,484 |  |  | $ | 251,635 | \nStock issued | 31 |  |  | 7 |  |  | 0 |  |  | 0 |  |  | 7 | \nStock-based compensation expense | 0 |  |  | 4,547 |  |  | 0 |  |  | 0 |  |  | 4,547 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (2,895) |  |  | 0 |  |  | 0 |  |  | (2,895) | \nRepurchases of stock | (98) |  |  | (601) |  |  | 0 |  |  | (12,699) |  |  | (13,300) | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 16,436 |  |  | 16,436 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | (2,426) |  |  | 0 |  |  | (2,426) | \nBalance as of March 31, 2022 | 13,175 |  |  | $ | 62,832 |  |  | $ | (4,049) |  |  | $ | 195,221 |  |  | $ | 254,004 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, 2023\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of December 31, 2022 | 12,849 |  |  | $ | 68,184 |  |  | $ | (7,603) |  |  | $ | 195,563 |  |  | $ | 256,144 | \nStock issued | 30 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 | \nStock-based compensation expense | 0 |  |  | 5,313 |  |  | 0 |  |  | 0 |  |  | 5,313 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (2,093) |  |  | 0 |  |  | 0 |  |  | (2,093) | \nRepurchases of stock | (157) |  |  | (1,135) |  |  | 0 |  |  | (13,989) |  |  | (15,124) | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 15,051 |  |  | 15,051 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | 1,603 |  |  | 0 |  |  | 1,603 | \nBalance as of March 31, 2023 | 12,722 |  |  | $ | 70,269 |  |  | $ | (6,000) |  |  | $ | 196,625 |  |  | $ | 260,894 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended\n | March 31,\n | 2022 |  | 2023\nOperating activities |  |  | \nNet income | $ | 16,436 |  |  | $ | 15,051 | \nAdjustments: |  |  | \nDepreciation and impairment of property and equipment | 3,591 |  |  | 3,060 | \nAmortization and impairment of intangible assets | 191 |  |  | 126 | \nStock-based compensation expense | 4,504 |  |  | 5,284 | \nDeferred income taxes | (2,090) |  |  | (1,854) | \nLoss (gain) on debt and equity securities, net | 1,437 |  |  | (84) | \nOther | 140 |  |  | 553 | \nChanges in assets and liabilities, net of effects of acquisitions: |  |  | \nAccounts receivable, net | 4,364 |  |  | 4,454 | \nIncome taxes, net | 3,820 |  |  | 4,069 | \nOther assets | (776) |  |  | (746) | \nAccounts payable | (2,373) |  |  | (1,105) | \nAccrued expenses and other liabilities | (3,216) |  |  | (4,496) | \nAccrued revenue share | (828) |  |  | (602) | \nDeferred revenue | (94) |  |  | (201) | \nNet cash provided by operating activities | 25,106 |  |  | 23,509 | \nInvesting activities |  |  | \nPurchases of property and equipment | (9,786) |  |  | (6,289) | \nPurchases of marketable securities | (28,462) |  |  | (14,227) | \nMaturities and sales of marketable securities | 29,779 |  |  | 18,327 | \nPurchases of non-marketable securities | (776) |  |  | (626) | \nMaturities and sales of non-marketable securities | 12 |  |  | 36 | \n |  |  | \n |  |  | \nAcquisitions, net of cash acquired, and purchases of intangible assets | (173) |  |  | (42) | \nOther investing activities | 355 |  |  | (125) | \n |  |  | \nNet cash used in investing activities | (9,051) |  |  | (2,946) | \nFinancing activities |  |  | \nNet payments related to stock-based award activities | (2,916) |  |  | (1,989) | \n |  |  | \nRepurchases of stock | (13,300) |  |  | (14,557) | \nProceeds from issuance of debt, net of costs | 16,422 |  |  | 6,927 | \nRepayments of debt | (16,420) |  |  | (6,952) | \nProceeds from sale of interest in consolidated entities, net | 0 |  |  | 3 | \nNet cash used in financing activities | (16,214) |  |  | (16,568) | \nEffect of exchange rate changes on cash and cash equivalents | 100 |  |  | 50 | \nNet increase (decrease) in cash and cash equivalents | (59) |  |  | 4,045 | \nCash and cash equivalents at beginning of period | 20,945 |  |  | 21,879 | \nCash and cash equivalents at end of period | $ | 20,886 |  |  | $ | 25,924 | \n |  |  | \n |  |  | \n |  |  | \n |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nGoogle Search & other | $ | 39,618 |  |  | $ | 40,359 |  |  |  |  | \nYouTube ads | 6,869 |  |  | 6,693 |  |  |  |  | \nGoogle Network | 8,174 |  |  | 7,496 |  |  |  |  | \nGoogle advertising | 54,661 |  |  | 54,548 |  |  |  |  | \nGoogle other | 6,811 |  |  | 7,413 |  |  |  |  | \nGoogle Services total | 61,472 |  |  | 61,961 |  |  |  |  | \nGoogle Cloud | 5,821 |  |  | 7,454 |  |  |  |  | \nOther Bets | 440 |  |  | 288 |  |  |  |  | \nHedging gains (losses) | 278 |  |  | 84 |  |  |  |  | \nTotal revenues | $ | 68,011 |  |  | $ | 69,787 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nUnited States | $ | 31,733 |  |  | 47 | % |  | $ | 32,864 |  |  | 47 | % |  |  |  |  |  |  |  | \nEMEA(1) | 20,317 |  |  | 30 |  |  | 21,078 |  |  | 30 |  |  |  |  |  |  |  |  | \nAPAC(1) | 11,841 |  |  | 17 |  |  | 11,681 |  |  | 17 |  |  |  |  |  |  |  |  | \nOther Americas(1) | 3,842 |  |  | 6 |  |  | 4,080 |  |  | 6 |  |  |  |  |  |  |  |  | \nHedging gains (losses) | 278 |  |  | 0 |  |  | 84 |  |  | 0 |  |  |  |  |  |  |  |  | \nTotal revenues | $ | 68,011 |  |  | 100 | % |  | $ | 69,787 |  |  | 100 | % |  |  |  |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | As of December 31, 2022\n |  | Fair Value Hierarchy |  | Adjusted Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Fair Value |  | Cash and Cash Equivalents |  | Marketable Securities\nFair value changes recorded in other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTime deposits(1) |  | Level 2 |  | $ | 5,297 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 5,297 |  |  | $ | 5,293 |  |  | $ | 4 | \nGovernment bonds |  | Level 2 |  | 41,036 |  | 64 |  |  | (2,045) |  |  | 39,055 |  |  | 283 |  |  | 38,772 | \nCorporate debt securities |  | Level 2 |  | 28,578 |  | 8 |  |  | (1,569) |  |  | 27,017 |  |  | 1 |  |  | 27,016 | \nMortgage-backed and asset-backed securities |  | Level 2 |  | 16,176 |  | 5 |  |  | (1,242) |  |  | 14,939 |  |  | 0 |  |  | 14,939 | \nTotal investments with fair value change reflected in other comprehensive income(2) |  |  |  | $ | 91,087 |  |  | $ | 77 |  |  | $ | (4,856) |  |  | $ | 86,308 |  |  | $ | 5,577 |  |  | $ | 80,731 | \nFair value adjustments recorded in net income |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMoney market funds |  | Level 1 |  |  |  |  |  |  |  | $ | 7,234 |  |  | $ | 7,234 |  |  | $ | 0 | \nCurrent marketable equity securities(3) |  | Level 1 |  |  |  |  |  |  |  | 4,013 |  |  | 0 |  |  | 4,013 | \nMutual funds |  | Level 2 |  |  |  |  |  |  |  | 339 |  |  | 0 |  |  | 339 | \nGovernment bonds |  | Level 2 |  |  |  |  |  |  |  | 1,877 |  |  | 440 |  |  | 1,437 | \nCorporate debt securities |  | Level 2 |  |  |  |  |  |  |  | 3,744 |  |  | 65 |  |  | 3,679 | \nMortgage-backed and asset-backed securities |  | Level 2 |  |  |  |  |  |  |  | 1,686 |  |  | 2 |  |  | 1,684 | \nTotal investments with fair value change recorded in net income |  |  |  |  |  |  |  |  |  | $ | 18,893 |  |  | $ | 7,741 |  |  | $ | 11,152 | \nCash |  |  |  |  |  |  |  |  |  | 0 |  |  | 8,561 |  |  | 0 | \nTotal |  |  |  | $ | 91,087 |  |  | $ | 77 |  |  | $ | (4,856) |  |  | $ | 105,201 |  |  | $ | 21,879 |  |  | $ | 91,883 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | As of March 31, 2023\n |  | Fair Value Hierarchy |  | Adjusted Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Fair Value |  | Cash and Cash Equivalents |  | Marketable Securities\nFair value changes recorded in other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTime deposits |  | Level 2 |  | $ | 2,880 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 2,880 |  |  | $ | 2,880 |  |  | $ | 0 | \nGovernment bonds |  | Level 2 |  | 40,970 |  |  | 179 |  |  | (1,230) |  |  | 39,919 |  |  | 2,045 |  |  | 37,874 | \nCorporate debt securities |  | Level 2 |  | 26,301 |  |  | 28 |  |  | (1,244) |  |  | 25,085 |  |  | 1 |  |  | 25,084 | \nMortgage-backed and asset-backed securities |  | Level 2 |  | 16,371 |  |  | 15 |  |  | (1,039) |  |  | 15,347 |  |  | 0 |  |  | 15,347 | \nTotal investments with fair value change reflected in other comprehensive income(1) |  |  |  | $ | 86,522 |  |  | $ | 222 |  |  | $ | (3,513) |  |  | $ | 83,231 |  |  | $ | 4,926 |  |  | $ | 78,305 | \nFair value adjustments recorded in net income |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMoney market funds |  | Level 1 |  |  |  |  |  |  |  | $ | 10,604 |  |  | $ | 10,604 |  |  | $ | 0 | \nCurrent marketable equity securities(2) |  | Level 1 |  |  |  |  |  |  |  | 3,907 |  |  | 0 |  |  | 3,907 | \nMutual funds |  | Level 2 |  |  |  |  |  |  |  | 315 |  | 0 |  |  | 315\nGovernment bonds |  | Level 2 |  |  |  |  |  |  |  | 2,006 |  | 672 |  |  | 1,334\nCorporate debt securities |  | Level 2 |  |  |  |  |  |  |  | 3,660 |  | 31 |  |  | 3,629\nMortgage-backed and asset-backed securities |  | Level 2 |  |  |  |  |  |  |  | 1,688 |  | 0 |  |  | 1,688\nTotal investments with fair value change recorded in net income |  |  |  |  |  |  |  |  |  | $ | 22,180 |  |  | $ | 11,307 |  |  | $ | 10,873 | \nCash |  |  |  |  |  |  |  |  |  | 0 |  |  | 9,691 |  |  | 0 | \nTotal |  |  |  | $ | 86,522 |  |  | $ | 222 |  |  | $ | (3,513) |  |  | $ | 105,411 |  |  | $ | 25,924 |  |  | $ | 89,178 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \n | As ofMarch 31, 2023\nDue in 1 year or less | $ | 11,712 | \nDue in 1 year through 5 years | 46,052 | \nDue in 5 years through 10 years | 15,228 | \nDue after 10 years | 11,964 | \nTotal | $ | 84,956 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022\n | Less\u00a0than\u00a012 Months |  | 12 Months or Greater |  | Total\n | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss\nGovernment bonds | $ | 21,039 |  |  | $ | (1,004) |  |  | $ | 13,438 |  |  | $ | (1,041) |  |  | $ | 34,477 |  |  | $ | (2,045) | \nCorporate debt securities | 11,228 |  |  | (440) |  |  | 15,125 |  |  | (1,052) |  |  | 26,353 |  |  | (1,492) | \nMortgage-backed and asset-backed securities | 7,725 |  |  | (585) |  |  | 6,964 |  |  | (657) |  |  | 14,689 |  |  | (1,242) | \nTotal | $ | 39,992 |  |  | $ | (2,029) |  |  | $ | 35,527 |  |  | $ | (2,750) |  |  | $ | 75,519 |  |  | $ | (4,779) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of March 31, 2023\n | Less\u00a0than\u00a012 Months |  | 12 Months or Greater |  | Total\n | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss\nGovernment bonds | $ | 12,234 |  |  | $ | (312) |  |  | $ | 14,159 |  |  | $ | (918) |  |  | $ | 26,393 |  |  | $ | (1,230) | \nCorporate debt securities | 4,427 |  |  | (93) |  |  | 19,011 |  |  | (1,072) |  |  | 23,438 |  |  | (1,165) | \nMortgage-backed and asset-backed securities | 2,597 |  |  | (94) |  |  | 11,212 |  |  | (944) |  |  | 13,809 |  |  | (1,038) | \nTotal | $ | 19,258 |  |  | $ | (499) |  |  | $ | 44,382 |  |  | $ | (2,934) |  |  | $ | 63,640 |  |  | $ | (3,433) |   |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended\n | March 31,\n | 2022 |  | 2023\nUnrealized gain (loss) on fair value option debt securities | $ | (202) |  |  | $ | 145 | \nGross realized gain on debt securities | 40 |  |  | 57 | \nGross realized loss on debt securities | (271) |  |  | (492) | \n(Increase)/decrease in allowance for credit losses | 66 |  |  | (3) | \nTotal gain (loss) on debt securities recognized in other income (expense), net | $ | (367) |  |  | $ | (293) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022 |  | As of March 31, 2023\n | Marketable Equity Securities |  | Non-Marketable Equity Securities |  | Total |  | Marketable Equity Securities |  | Non-Marketable Equity Securities |  | Total\nTotal initial cost | $ | 5,764 |  |  | $ | 16,157 |  |  | $ | 21,921 |  |  | $ | 5,720 |  |  | $ | 16,509 |  |  | $ | 22,229 | \nCumulative net gain (loss)(1) | (608) |  |  | 12,372 |  |  | 11,764 |  |  | (578) |  |  | 12,613 |  |  | 12,035 | \nCarrying value | $ | 5,156 |  |  | $ | 28,529 |  |  | $ | 33,685 |  |  | $ | 5,142 |  |  | $ | 29,122 |  |  | $ | 34,264 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nRealized net gain (loss) on equity securities sold during the period | $ | (74) |  |  | $ | 105 |  |  |  |  | \nUnrealized net gain (loss) on marketable equity securities | (1,456) |  |  | 51 |  |  |  |  | \nUnrealized net gain (loss) on non-marketable equity securities(1) | 460 |  |  | 221 |  |  |  |  | \nTotal gain (loss) on equity securities in other income (expense), net | $ | (1,070) |  |  | $ | 377 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Equity Securities Sold\n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nTotal sale price | $ | 364 |  |  | $ | 312 |  |  |  |  | \nTotal initial cost | 260 |  |  | 211 |  |  |  |  | \nCumulative net gain (loss) | $ | 104 |  |  | $ | 101 |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022 |  | As of March 31, 2023\nDerivatives designated as hedging instruments: |  | \nForeign exchange contracts |  |  | \nCash flow hedges | $ | 15,972 |  |  | $ | 17,140 | \nFair value hedges | $ | 2,117 |  |  | $ | 1,439 | \nNet investment hedges | $ | 8,751 |  |  | $ | 9,036 | \nDerivatives not designated as hedging instruments: |  | \nForeign exchange contracts | $ | 34,979 |  |  | $ | 33,715 | \nOther contracts | $ | 7,932 |  |  | $ | 8,423 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022 |  | As of March 31, 2023\n | Assets(1) |  | Liabilities(2) |  | Assets(1) |  | Liabilities(2)\nDerivatives designated as hedging instruments: |  |  |  |  |  |  | \nForeign exchange contracts | $ | 271 |  |  | $ | 556 |  |  | $ | 111 |  |  | $ | 510 | \n |  |  |  |  |  |  | \nDerivatives not designated as hedging instruments: |  |  |  |  |  |  | \nForeign exchange contracts | 365 |  | 207 |  | 284 |  | 201\nOther contracts | 40 |  | 47 |  | 48 |  | 65\nTotal derivatives not designated as hedging instruments | 405 |  |  | 254 |  |  | 332 |  |  | 266 | \nTotal | $ | 676 |  |  | $ | 810 |  |  | $ | 443 |  |  | $ | 776 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Gains (Losses) Recognized in OCI on Derivatives Before Tax Effect\n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nDerivatives in cash flow hedging relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount included in the assessment of effectiveness | $ | 135 |  |  | $ | (138) |  |  |  |  | \nAmount excluded from the assessment of effectiveness | (15) |  |  | 47 |  |  |  |  | \n |  |  |  |  |  |  | \nDerivatives in net investment hedging relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount included in the assessment of effectiveness | 149 |  |  | (215) |  |  |  |  | \nTotal | $ | 269 |  |  | $ | (306) |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Gains (Losses) Recognized in Income\n | Three Months Ended\n | March 31,\n | 2022 |  | 2023\n | Revenues |  | Other income (expense), net |  | Revenues |  | Other income (expense), net\nTotal amounts in the Consolidated Statements of Income | $ | 68,011 |  |  | $ | (1,160) |  |  | $ | 69,787 |  |  | $ | 790 | \n |  |  |  |  |  |  | \nEffect of cash flow hedges: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount reclassified from AOCI to income | $ | 297 |  |  | $ | 0 |  |  | $ | 88 |  |  | $ | 0 | \nAmount excluded from the assessment of effectiveness (amortized) | (19) |  |  | 0 |  |  | (4) |  |  | 0 | \nEffect of fair value hedges: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nHedged items | 0 |  |  | 13 |  |  | 0 |  |  | 32 | \nDerivatives designated as hedging instruments | 0 |  |  | (12) |  |  | 0 |  |  | (32) | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 1 |  |  | 0 |  |  | 5 | \nEffect of net investment hedges: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 12 |  |  | 0 |  |  | 51 | \nEffect of non designated hedges: |  |  |  |  |  |  | \nForeign exchange contracts | 0 |  |  | (247) |  |  | 0 |  |  | 30 | \nOther contracts | 0 |  |  | 38 |  |  | 0 |  |  | 3 | \nTotal gains (losses) | $ | 278 |  |  | $ | (195) |  |  | $ | 84 |  |  | $ | 89 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset |  | \n | Gross Amounts Recognized |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Amounts  Presented in the Consolidated Balance Sheets |  | Financial Instruments(1) |  | Cash and Non-Cash Collateral Received or Pledged |  | Net Amounts\nDerivatives assets | $ | 760 |  |  | $ | (84) |  |  | $ | 676 |  |  | $ | (463) |  |  | $ | (132) |  |  | $ | 81 | \nDerivatives liabilities | $ | 894 |  |  | $ | (84) |  |  | $ | 810 |  |  | $ | (463) |  |  | $ | (28) |  |  | $ | 319 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of March 31, 2023\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset |  | \n | Gross Amounts Recognized |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Amounts  Presented in the Consolidated Balance Sheets |  | Financial Instruments(1) |  | Cash and Non-Cash Collateral Received or Pledged |  | Net Amounts\nDerivatives assets | $ | 525 |  |  | $ | (82) |  |  | $ | 443 |  |  | $ | (368) |  |  | $ | (34) |  |  | $ | 41 | \nDerivatives liabilities | $ | 858 |  |  | $ | (82) |  |  | $ | 776 |  |  | $ | (368) |  |  | $ | (24) |  |  | $ | 384 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Maturity |  | Coupon Rate |  | Effective Interest Rate |  | As of December 31, 2022 |  | As ofMarch 31, 2023\nDebt |  |  |  |  |  |  |  |  |  | \n2014-2020 Notes issuances |  | 2024 - 2060 |  | 0.45% -3.38% |  | 0.57% -3.38% |  | $ | 13,000 |  |  | $ | 13,000 | \nFuture finance lease payments, net and other(1) |  |  |  |  |  |  |  | 2,142 |  |  | 2,208 | \nTotal debt |  |  |  |  |  |  |  | 15,142 |  |  | 15,208 | \nUnamortized discount and debt issuance costs |  |  |  |  |  |  |  | (143) |  |  | (140) | \nLess: Current portion of long-term notes(2) |  |  |  |  |  |  |  | 0 |  |  | (999) | \nLess: Current portion future finance lease payments, net and other current debt(1)(2) |  |  |  |  |  |  |  | (298) |  |  | (372) | \nTotal long-term debt |  |  |  |  |  |  |  | $ | 14,701 |  |  | $ | 13,697 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2022 |  | As ofMarch 31, 2023\nLand and buildings | $ | 66,897 |  |  | $ | 67,948 | \nInformation technology assets | 66,267 |  |  | 68,577 | \nConstruction in progress | 27,657 |  |  | 30,573 | \nLeasehold improvements | 10,575 |  |  | 11,011 | \nFurniture and fixtures | 314 |  |  | 326 | \nProperty and equipment, gross | 171,710 |  |  | 178,435 | \nLess: accumulated depreciation | (59,042) |  |  | (60,875) | \nProperty and equipment, net | $ | 112,668 |  |  | $ | 117,560 |   |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2022 |  | As ofMarch 31, 2023\nEuropean Commission fines(1) | $ | 9,106 |  |  | $ | 9,354 | \nIncome taxes payable, net | 1,632 |  |  | 5,217 | \nAccrued customer liabilities | 3,619 |  |  | 3,486 | \nAccrued purchases of property and equipment | 3,019 |  |  | 3,807 | \nCurrent operating lease liabilities | 2,477 |  |  | 2,625 | \nOther accrued expenses and current liabilities | 18,013 |  |  | 18,696 | \nAccrued expenses and other current liabilities | $ | 37,866 |  |  | $ | 43,185 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Available-for-Sale Investments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total\nBalance as of December 31, 2021 | $ | (2,306) |  |  | $ | 236 |  |  | $ | 447 |  |  | $ | (1,623) | \nOther comprehensive income (loss) before reclassifications | 39 |  |  | (2,478) |  |  | 129 |  |  | (2,310) | \nAmounts excluded from the assessment of hedge effectiveness recorded in AOCI | 0 |  |  | 0 |  |  | (15) |  |  | (15) | \nAmounts reclassified from AOCI | 0 |  |  | 148 |  |  | (249) |  |  | (101) | \nOther comprehensive income (loss) | 39 |  |  | (2,330) |  |  | (135) |  |  | (2,426) | \nBalance as of March 31, 2022 | $ | (2,267) |  |  | $ | (2,094) |  |  | $ | 312 |  |  | $ | (4,049) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Available-for-Sale Investments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total\nBalance as of December 31, 2022 | $ | (4,142) |  |  | $ | (3,477) |  |  | $ | 16 |  |  | $ | (7,603) | \nOther comprehensive income (loss) before reclassifications | 596 |  |  | 866 |  |  | (121) |  |  | 1,341 | \nAmounts excluded from the assessment of hedge effectiveness recorded in AOCI | 0 |  |  | 0 |  |  | 47 |  |  | 47 | \nAmounts reclassified from AOCI | 0 |  |  | 292 |  |  | (77) |  |  | 215 | \nOther comprehensive income (loss) | 596 |  |  | 1,158 |  |  | (151) |  |  | 1,603 | \nBalance as of March 31, 2023 | $ | (3,546) |  |  | $ | (2,319) |  |  | $ | (135) |  |  | $ | (6,000) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Gains (Losses) Reclassified from AOCI to the Consolidated Statements of Income\n |  |  | Three Months Ended |  | \n |  |  | March 31, |  | \nAOCI Components |  | Location | 2022 |  | 2023 |  |  |  | \nUnrealized gains (losses) on available-for-sale investments |  |  |  |  |  |  | \n |  | Other income (expense), net | $ | (190) |  |  | $ | (374) |  |  |  |  | \n |  | Benefit (provision) for income taxes | 42 |  |  | 82 |  |  |  |  | \n |  | Net of income tax | (148) |  |  | (292) |  |  |  |  | \nUnrealized gains (losses) on cash flow hedges |  |  |  |  |  |  | \nForeign exchange contracts |  | Revenue | 297 |  |  | 88 |  |  |  |  | \nInterest rate contracts |  | Other income (expense), net | 2 |  |  | 2 |  |  |  |  | \n |  | Benefit (provision) for income taxes | (50) |  |  | (13) |  |  |  |  | \n |  | Net of income tax | 249 |  |  | 77 |  |  |  |  | \nTotal amount reclassified, net of income tax | $ | 101 |  |  | $ | (215) |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nInterest income | $ | 414 |  |  | $ | 797 |  |  |  |  | \nInterest expense(1) | (83) |  |  | (80) |  |  |  |  | \nForeign currency exchange gain (loss), net | (73) |  |  | (210) |  |  |  |  | \nGain (loss) on debt securities, net | (367) |  |  | (293) |  |  |  |  | \nGain (loss) on equity securities, net | (1,070) |  |  | 377 |  |  |  |  | \nPerformance fees | 233 |  |  | 118 |  |  |  |  | \nIncome (loss) and impairment from equity method investments, net | (89) |  |  | (51) |  |  |  |  | \nOther | (125) |  |  | 132 |  |  |  |  | \nOther income (expense), net | $ | (1,160) |  |  | $ | 790 |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Severance and Related(1) |  | Office Space |  | Total\nCost of revenues | $ | 461 |  |  | $ | 220 |  |  | $ | 681 | \nResearch and development | 835 |  |  | 247 |  |  | 1,082 | \nSales and marketing | 445 |  |  | 35 |  |  | 480 | \nGeneral and administrative | 253 |  |  | 62 |  |  | 315 | \nTotal charges | $ | 1,994 |  |  | $ | 564 |  |  | $ | 2,558 |   |  |  |  |  | \n | Severance and Related\nBalance as of December 31, 2022 | $ | 0 | \nCharges(1) | 1,582 | \nCash payments | (396) | \nBalance as of March 31, 2023(2) | $ | 1,186 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Google Services |  | Google Cloud |  | Other Bets |  | Total\nBalance as of December 31, 2022 | $ | 20,847 |  |  | $ | 7,205 |  |  | $ | 908 |  |  | $ | 28,960 | \nAcquisitions | 11 |  |  | 0 |  |  | 0 |  |  | 11 | \nForeign currency translation and other adjustments | 50 |  |  | 2 |  |  | (29) |  |  | 23 | \nBalance as of March 31, 2023 | $ | 20,908 |  |  | $ | 7,207 |  |  | $ | 879 |  |  | $ | 28,994 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022 |  | As of March 31, 2023\n | GrossCarryingAmount |  | AccumulatedAmortization |  | NetCarryingAmount |  | GrossCarryingAmount |  | AccumulatedAmortization |  | NetCarryingAmount |  | \nPatents and developed technology | $ | 1,164 |  |  | $ | 354 |  |  | $ | 810 |  |  | $ | 1,110 |  |  | $ | 366 |  |  | $ | 744 |  |  | \nCustomer relationships | 862 |  |  | 235 |  |  | 627 |  |  | 862 |  |  | 270 |  |  | 592 |  |  | \nTrade names and other | 527 |  |  | 120 |  |  | 407 |  |  | 528 |  |  | 138 |  |  | 390 |  |  | \nTotal definite-lived intangible assets | 2,553 |  |  | 709 |  |  | 1,844 |  |  | 2,500 |  |  | 774 |  |  | 1,726 |  |  | \nIndefinite-lived intangible assets | 240 |  |  | 0 |  |  | 240 |  |  | 242 |  |  | 0 |  |  | 242 |  |  | \nTotal intangible assets | $ | 2,793 |  |  | $ | 709 |  |  | $ | 2,084 |  |  | $ | 2,742 |  |  | $ | 774 |  |  | $ | 1,968 |  |  |   |  |  |  |  | \nRemainder of 2023 | $ | 343 | \n2024 | 443 | \n2025 | 314 | \n2026 | 236 | \n2027 | 153 | \nThereafter | 237 | \nTotal | $ | 1,726 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31, 2023 |  | \n | Shares |  | Amount |  |  |  | \nClass A share repurchases | 21 |  |  | $ | 2,011 |  |  |  |  | \nClass C share repurchases | 136 |  |  | 13,113 |  |  |  |  | \nTotal share repurchases(1) | 157 |  |  | $ | 15,124 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended March 31,\n | 2022 |  | 2023\n | Class A |  | Class B |  | Class C |  | Class A |  | Class B |  | Class C\nBasic net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings | $ | 7,481 |  |  | $ | 1,109 |  |  | $ | 7,846 |  |  | $ | 7,006 |  |  | $ | 1,040 |  |  | $ | 7,005 | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in per share computation | 6,009 |  |  | 891 |  |  | 6,303 |  |  | 5,949 |  |  | 883 |  |  | 5,949 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nBasic net income per share | $ | 1.24 |  |  | $ | 1.24 |  |  | $ | 1.24 |  |  | $ | 1.18 |  |  | $ | 1.18 |  |  | $ | 1.18 | \nDiluted net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings for basic computation | $ | 7,481 |  |  | $ | 1,109 |  |  | $ | 7,846 |  |  | $ | 7,006 |  |  | $ | 1,040 |  |  | $ | 7,005 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nReallocation of undistributed earnings as a result of conversion of Class B to Class\u00a0A shares | 1,109 |  |  | 0 |  |  | 0 |  |  | 1,040 |  |  | 0 |  |  | 0 | \nReallocation of undistributed earnings | (95) |  |  | (12) |  |  | 95 |  |  | (27) |  |  | (4) |  |  | 27 | \nAllocation of undistributed earnings | $ | 8,495 |  |  | $ | 1,097 |  |  | $ | 7,941 |  |  | $ | 8,019 |  |  | $ | 1,036 |  |  | $ | 7,032 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in basic computation | 6,009 |  |  | 891 |  |  | 6,303 |  |  | 5,949 |  |  | 883 |  |  | 5,949 | \nWeighted-average effect of dilutive securities |  |  |  |  |  |  |  |  |  |  | \nAdd: |  |  |  |  |  |  |  |  |  |  | \nConversion of Class B to Class\u00a0A shares outstanding | 891 |  |  | 0 |  |  | 0 |  |  | 883 |  |  | 0 |  |  | 0 | \n |  |  |  |  |  |  |  |  |  |  | \nRestricted stock units and other contingently issuable shares | 0 |  |  | 0 |  |  | 148 |  |  | 0 |  |  | 0 |  |  | 42 | \nNumber of shares used in per share computation | 6,900 |  |  | 891 |  |  | 6,451 |  |  | 6,832 |  |  | 883 |  |  | 5,991 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDiluted net income per share | $ | 1.23 |  |  | $ | 1.23 |  |  | $ | 1.23 |  |  | $ | 1.17 |  |  | $ | 1.17 |  |  | $ | 1.17 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | Unvested\u00a0Restricted\u00a0Stock\u00a0Units\n | Number ofShares |  | Weighted-AverageGrant-DateFair Value\nUnvested as of December 31, 2022 | 324 |  |  | $ | 107.98 | \nGranted | 234 |  |  | $ | 94.51 | \nVested | (48) |  |  | $ | 100.25 | \nForfeited/canceled | (10) |  |  | $ | 110.60 | \nUnvested as of March 31, 2023 | 500 |  |  | $ | 102.36 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nIncome before provision for income taxes | $ | 18,934 |  |  | $ | 18,205 |  |  |  |  | \nProvision for income taxes | $ | 2,498 |  |  | $ | 3,154 |  |  |  |  | \nEffective tax rate | 13.2 | % |  | 17.3 | % |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nRevenues: |  |  |  |  |  |  | \nGoogle Services | $ | 61,472 |  |  | $ | 61,961 |  |  |  |  | \nGoogle Cloud | 5,821 |  |  | 7,454 |  |  |  |  | \nOther Bets | 440 |  |  | 288 |  |  |  |  | \nHedging gains (losses) | 278 |  |  | 84 |  |  |  |  | \nTotal revenues | $ | 68,011 |  |  | $ | 69,787 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nOperating income (loss): |  |  |  |  |  |  | \nGoogle Services | $ | 21,973 |  |  | $ | 21,737 |  |  |  |  | \nGoogle Cloud | (706) |  |  | 191 |  |  |  |  | \nOther Bets | (835) |  |  | (1,225) |  |  |  |  | \nCorporate costs, unallocated | (338) |  |  | (3,288) |  |  |  |  | \nTotal income from operations | $ | 20,094 |  |  | $ | 17,415 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2022 |  | As ofMarch 31, 2023\nLong-lived assets: |  |  | \nUnited States | $ | 93,565 |  |  | $ | 96,519 | \nInternational | 33,484 |  |  | 35,488 | \nTotal long-lived assets | $ | 127,049 |  |  | $ | 132,007 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended |  |  |  | \n | March 31, |  |  |  | \n |  | 2022 |  | 2023 |  | $ Change |  | % Change\nConsolidated revenues |  | $ | 68,011 |  |  | $ | 69,787 |  |  | $ | 1,776 |  |  | 3 | %\nChange in consolidated constant currency revenues(1) |  |  |  |  |  |  |  | 6 | %\n |  |  |  |  |  |  |  | \nCost of revenues |  | $ | 29,599 |  |  | $ | 30,612 |  |  | $ | 1,013 |  |  | 3 | %\nOperating expenses |  | $ | 18,318 |  |  | $ | 21,760 |  |  | $ | 3,442 |  |  | 19 | %\n |  |  |  |  |  |  |  | \nOperating income |  | $ | 20,094 |  |  | $ | 17,415 |  |  | $ | (2,679) |  |  | (13) | %\nOperating margin |  | 30 | % |  | 25 | % |  |  |  | (5) | %\n |  |  |  |  |  |  |  | \nOther income (expense), net |  | $ | (1,160) |  |  | $ | 790 |  |  | $ | 1,950 |  |  | NM\n |  |  |  |  |  |  |  | \nNet Income |  | $ | 16,436 |  |  | $ | 15,051 |  |  | $ | (1,385) |  |  | (8) | %\nDiluted EPS |  | $ | 1.23 |  |  | $ | 1.17 |  |  | $ | (0.06) |  |  | (5) | %\n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nGoogle Search & other | $ | 39,618 |  |  | $ | 40,359 |  |  |  |  | \nYouTube ads | 6,869 |  |  | 6,693 |  |  |  |  | \nGoogle Network | 8,174 |  |  | 7,496 |  |  |  |  | \nGoogle advertising | 54,661 |  |  | 54,548 |  |  |  |  | \nGoogle other | 6,811 |  |  | 7,413 |  |  |  |  | \nGoogle Services total | 61,472 |  |  | 61,961 |  |  |  |  | \nGoogle Cloud | 5,821 |  |  | 7,454 |  |  |  |  | \nOther Bets | 440 |  |  | 288 |  |  |  |  | \nHedging gains (losses) | 278 |  |  | 84 |  |  |  |  | \nTotal revenues | $ | 68,011 |  |  | $ | 69,787 |  |  |  |  |   |  |  |  |  |  |  | \n |  |  | \n |  |  | \nPaid clicks change | 8% |  | \nCost-per-click change | (7)% |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  | \n |  |  | \nImpressions change | (5)% |  | \nCost-per-impression change | (5)% |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nUnited States | 47 | % |  | 47 | % |  |  |  | \nEMEA | 30 | % |  | 30 | % |  |  |  | \nAPAC | 17 | % |  | 17 | % |  |  |  | \nOther Americas | 6 | % |  | 6 | % |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | Three Months Ended March 31, 2023\n |  |  |  |  |  |  |  |  | % Change from Prior Period\n | Three Months Ended March 31, |  | Less FX Effect |  | Constant Currency Revenues |  | As Reported |  | Less Hedging Effect |  | Less FX Effect |  | Constant Currency Revenues\n | 2022 |  | 2023 |  |  |  |  |  | \nUnited States | $ | 31,733 |  |  | $ | 32,864 |  |  | $ | 0 |  |  | $ | 32,864 |  |  | 4 | % |  |  |  | 0 | % |  | 4 | %\nEMEA | 20,317 |  |  | 21,078 |  |  | (1,173) |  |  | 22,251 |  |  | 4 | % |  |  |  | (6) | % |  | 10 | %\nAPAC | 11,841 |  |  | 11,681 |  |  | (834) |  |  | 12,515 |  |  | (1) | % |  |  |  | (7) | % |  | 6 | %\nOther Americas | 3,842 |  |  | 4,080 |  |  | (167) |  |  | 4,247 |  |  | 6 | % |  |  |  | (5) | % |  | 11 | %\nRevenues, excluding hedging effect | 67,733 |  |  | 69,703 |  |  | (2,174) |  |  | 71,877 |  |  | 3 | % |  |  |  | (3) | % |  | 6 | %\nHedging gains (losses) | 278 |  |  | 84 |  |  |  |  |  |  |  |  |  |  |  |  | \nTotal revenues(1) | $ | 68,011 |  |  | $ | 69,787 |  |  |  |  | $ | 71,877 |  |  | 3 | % |  | 0 | % |  | (3) | % |  | 6 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nTAC | $ | 11,990 |  |  | $ | 11,721 |  |  |  |  | \nOther cost of revenues | 17,609 |  |  | 18,891 |  |  |  |  | \nTotal cost of revenues | $ | 29,599 |  |  | $ | 30,612 |  |  |  |  | \nTotal cost of revenues as a percentage of revenues | 44 | % |  | 44 | % |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nResearch and development expenses | $ | 9,119 |  |  | $ | 11,468 |  |  |  |  | \nResearch and development expenses as a percentage of revenues | 13 | % |  | 16 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nSales and marketing expenses | $ | 5,825 |  |  | $ | 6,533 |  |  |  |  | \nSales and marketing expenses as a percentage of revenues | 9 | % |  | 9 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nGeneral and administrative expenses | $ | 3,374 |  |  | $ | 3,759 |  |  |  |  | \nGeneral and administrative expenses as a percentage of revenues | 5 | % |  | 5 | % |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  |  |  | \nOperating income (loss): |  |  |  |  |  |  | \nGoogle Services | $ | 21,973 |  |  | $ | 21,737 |  |  |  |  | \nGoogle Cloud | (706) |  |  | 191 |  |  |  |  | \nOther Bets | (835) |  |  | (1,225) |  |  |  |  | \nCorporate costs, unallocated(1) | (338) |  |  | (3,288) |  |  |  |  | \nTotal income from operations | $ | 20,094 |  |  | $ | 17,415 |  |  |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nOther income (expense), net | $ | (1,160) |  |  | $ | 790 |  |  |  |  | \n |  |  |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \n | March 31, |  | \n | 2022 |  | 2023 |  |  |  | \nIncome before provision for income taxes | $ | 18,934 |  |  | $ | 18,205 |  |  |  |  | \nProvision for income taxes | $ | 2,498 |  |  | $ | 3,154 |  |  |  |  | \nEffective tax rate | 13.2 | % |  | 17.3 | % |  |  |  |   |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended\n | March 31,\n | 2022 |  | 2023\nNet cash provided by operating activities | $ | 25,106 |  |  | $ | 23,509 | \nNet cash used in investing activities | $ | (9,051) |  |  | $ | (2,946) | \nNet cash used in financing activities | $ | (16,214) |  |  | $ | (16,568) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | Total Number of Class A Shares Purchased(in thousands)(1) |  | Total Number of Class C Shares Purchased(in thousands)(1) |  | Average Price Paid per Class A Share(2) |  | Average Price Paid per Class C Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Programs(in thousands)(1) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program(in millions)\nJanuary 1 - 31 |  | 10,755 |  |  | 44,981 |  |  | $ | 93.98 |  |  | $ | 94.17 |  |  | 55,736 |  |  | $ | 22,877 | \nFebruary 1 - 28 |  | 3,820 |  |  | 41,996 |  |  | $ | 96.98 |  |  | $ | 95.84 |  |  | 45,816 |  |  | $ | 18,519 | \nMarch 1 - 31 |  | 6,290 |  |  | 49,352 |  |  | $ | 100.21 |  |  | $ | 98.30 |  |  | 55,642 |  |  | $ | 13,077 | \nTotal |  | 20,865 |  |  | 136,329 |  |  |  |  |  |  | 157,194 |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nExhibitNumber |  | Description |  | Incorporated\u00a0by\u00a0reference\u00a0herein\n | Form |  | Date\n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n |  |  |  |  |  | \n31.01 | * | Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n31.02 | * | Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n32.01 | \u2021 | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18\u00a0U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n101.INS | * | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |  |  |  | \n101.SCH | * | Inline XBRL Taxonomy Extension Schema Document |  |  |  | \n101.CAL | * | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  |  |  | \n101.DEF | * | Inline XBRL Taxonomy Extension Definition Linkbase Document |  |  |  | \n101.LAB | * | Inline XBRL Taxonomy Extension Label Linkbase Document |  |  |  | \n101.PRE | * | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  |  |  | \n104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |  |  |  |   |  |  |  |  | \n | \n | \n* | Filed herewith.\n\u2021 | Furnished herewith.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  | \n |  | ALPHABET INC.\nApril 25, 2023 | By: | /s/\u00a0\u00a0\u00a0\u00a0RUTH M. PORAT\n |  | Ruth M. Porat\n |  | Senior Vice President and Chief Financial Officer  |  |  |  |  |  |  |  | \n |  | ALPHABET INC.\nApril 25, 2023 | By: | /s/\u00a0\u00a0\u00a0\u00a0AMIE THUENER O'TOOLE\n |  | Amie Thuener O'Toole\n |  | Vice President and Principal Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Google, in 2023 Q2, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION\u00a013 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \nDelaware | 61-1767919\n(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number)  |  |  |  |  |  |  |  | \nSecurities registered pursuant to Section\u00a012(b) of the Act:\nTitle of each class | Trading Symbol(s) | Name of each exchange on which registered\nClass\u00a0A Common Stock, $0.001 par value | GOOGL | Nasdaq Stock Market LLC\n |  | (Nasdaq Global Select Market)\nClass C Capital Stock, $0.001 par value | GOOG | Nasdaq Stock Market LLC\n |  | (Nasdaq Global Select Market)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 |  | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 |  | Smaller reporting company | \u2610\nEmerging growth company | \u2610 |  |  |   |  | \n  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  | \n |  | Page\u00a0No.\nNote About Forward-Looking Statements | 3\n\nPART I. FINANCIAL INFORMATION\nItem\u00a01 | Financial Statements | 5\n | Consolidated Balance Sheets- December\u00a031, 2022 and June\u00a030, 2023 | 5\n | Consolidated Statements of Income -Three and Six Months Ended June 30,2022and2023 | 6\n | Consolidated Statements of Comprehensive Income -Three and Six Months Ended June 30,2022and2023 | 7\n | Consolidated Statements of Stockholders' Equity -Three and Six Months Ended June 30,2022and2023 | 8\n | Consolidated Statements of Cash Flows -Six Months Ended June 30,2022and2023 | 10\n | Notes to Consolidated Financial Statements | 11\nItem\u00a02 | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 33\nItem\u00a03 | Quantitative and Qualitative Disclosures About Market Risk | 48\nItem\u00a04 | Controls and Procedures | 48\n |  | \nPART II. OTHER INFORMATION\nItem\u00a01 | Legal Proceedings | 50\nItem\u00a01A | Risk Factors | 50\nItem 2 | Unregistered Sales of Equity Securities and Use of Proceeds | 50\n |  | \n |  | \nItem\u00a05 | Other Information | 49\nItem\u00a06 | Exhibits | 52\nSignatures | 53  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2022 |  | As ofJune 30, 2023\n |  |  | (unaudited)\nAssets |  |  | \nCurrent assets: |  |  | \nCash and cash equivalents | $ | 21,879 |  |  | $ | 25,929 | \nMarketable securities | 91,883 |  |  | 92,403 | \nTotal cash, cash equivalents, and marketable securities | 113,762 |  |  | 118,332 | \nAccounts receivable, net | 40,258 |  |  | 38,804 | \nInventory | 2,670 |  |  | 2,231 | \nOther current assets | 8,105 |  |  | 9,421 | \nTotal current assets | 164,795 |  |  | 168,788 | \nNon-marketable securities | 30,492 |  |  | 31,224 | \nDeferred income taxes | 5,261 |  |  | 9,357 | \nProperty and equipment, net | 112,668 |  |  | 121,208 | \nOperating lease assets | 14,381 |  |  | 14,469 | \nIntangible assets, net | 2,084 |  |  | 1,966 | \nGoodwill | 28,960 |  |  | 29,210 | \nOther non-current assets | 6,623 |  |  | 6,822 | \nTotal assets | $ | 365,264 |  |  | $ | 383,044 | \nLiabilities and Stockholders\u2019 Equity |  |  | \nCurrent liabilities: |  |  | \nAccounts payable | $ | 5,128 |  |  | $ | 5,313 | \n |  |  | \nAccrued compensation and benefits | 14,028 |  |  | 11,260 | \nAccrued expenses and other current liabilities | 37,866 |  |  | 49,300 | \nAccrued revenue share | 8,370 |  |  | 7,990 | \nDeferred revenue | 3,908 |  |  | 3,846 | \nTotal current liabilities | 69,300 |  |  | 77,709 | \nLong-term debt | 14,701 |  |  | 13,705 | \nDeferred revenue, non-current | 599 |  |  | 667 | \nIncome taxes payable, non-current | 9,258 |  |  | 8,753 | \nDeferred income taxes | 514 |  |  | 558 | \nOperating lease liabilities | 12,501 |  |  | 12,746 | \nOther long-term liabilities | 2,247 |  |  | 1,765 | \nTotal liabilities | 109,120 |  |  | 115,903 | \nCommitments and contingencies (Note 9) |  |  | \nStockholders\u2019 equity: |  |  | \nPreferred stock, $0.001par value per share,100shares authorized;noshares issued and outstanding | 0 |  |  | 0 | \nClass\u00a0A, Class B, and Class C stock and additional paid-in capital, $0.001par value per share:300,000shares authorized\u00a0(Class\u00a0A180,000, Class B60,000, Class C60,000);12,849(Class\u00a0A5,964, Class B883, Class C6,002) and12,629(Class\u00a0A5,934, Class B876, Class C5,819)shares issued and outstanding | 68,184 |  |  | 72,248 | \nAccumulated other comprehensive income (loss) | (7,603) |  |  | (5,991) | \nRetained earnings | 195,563 |  |  | 200,884 | \nTotal stockholders\u2019 equity | 256,144 |  |  | 267,141 | \nTotal liabilities and stockholders\u2019 equity | $ | 365,264 |  |  | $ | 383,044 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nRevenues | $ | 69,685 |  |  | $ | 74,604 |  |  | $ | 137,696 |  |  | $ | 144,391 | \nCosts and expenses: |  |  |  |  |  |  | \nCost of revenues | 30,104 |  |  | 31,916 |  |  | 59,703 |  |  | 62,528 | \nResearch and development | 9,841 |  |  | 10,588 |  |  | 18,960 |  |  | 22,056 | \nSales and marketing | 6,630 |  |  | 6,781 |  |  | 12,455 |  |  | 13,314 | \nGeneral and administrative | 3,657 |  |  | 3,481 |  |  | 7,031 |  |  | 7,240 | \nTotal costs and expenses | 50,232 |  |  | 52,766 |  |  | 98,149 |  |  | 105,138 | \nIncome from operations | 19,453 |  |  | 21,838 |  |  | 39,547 |  |  | 39,253 | \nOther income (expense), net | (439) |  |  | 65 |  |  | (1,599) |  |  | 855 | \nIncome before income taxes | 19,014 |  |  | 21,903 |  |  | 37,948 |  |  | 40,108 | \nProvision for income taxes | 3,012 |  |  | 3,535 |  |  | 5,510 |  |  | 6,689 | \nNet income | $ | 16,002 |  |  | $ | 18,368 |  |  | $ | 32,438 |  |  | $ | 33,419 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income per share of Class A, Class B, and Class C stock | $ | 1.22 |  |  | $ | 1.45 |  |  | $ | 2.46 |  |  | $ | 2.63 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nDiluted net income per share of Class A, Class B, and Class C stock | $ | 1.21 |  |  | $ | 1.44 |  |  | $ | 2.44 |  |  | $ | 2.61 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nNet income | $ | 16,002 |  |  | $ | 18,368 |  |  | $ | 32,438 |  |  | $ | 33,419 | \nOther comprehensive income (loss): |  |  |  |  |  |  | \nChange in foreign currency translation adjustment | (1,665) |  |  | 235 |  |  | (1,626) |  |  | 831 | \nAvailable-for-sale investments: |  |  |  |  |  |  | \nChange in net unrealized gains (losses) | (926) |  |  | (570) |  |  | (3,404) |  |  | 296 | \nLess: reclassification adjustment for net (gains) losses included in net income | 233 |  |  | 198 |  |  | 381 |  |  | 490 | \nNet change, net of income tax benefit (expense) of $227, $106, $860and $(224) | (693) |  |  | (372) |  |  | (3,023) |  |  | 786 | \nCash flow hedges: |  |  |  |  |  |  | \nChange in net unrealized gains (losses) | 915 |  |  | 151 |  |  | 1,029 |  |  | 77 | \nLess: reclassification adjustment for net (gains) losses included in net income | (336) |  |  | (5) |  |  | (585) |  |  | (82) | \nNet change, net of income tax benefit (expense) of $(113), $(11), $(69) and $19 | 579 |  |  | 146 |  |  | 444 |  |  | (5) | \nOther comprehensive income (loss) | (1,779) |  |  | 9 |  |  | (4,205) |  |  | 1,612 | \nComprehensive income | $ | 14,223 |  |  | $ | 18,377 |  |  | $ | 28,233 |  |  | $ | 35,031 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, 2022\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of March 31, 2022 | 13,175 |  |  | $ | 62,832 |  |  | $ | (4,049) |  |  | $ | 195,221 |  |  | $ | 254,004 | \nStock issued | 36 |  |  | 1 |  |  | 0 |  |  | 0 |  |  | 1 | \nStock-based compensation expense | 0 |  |  | 4,823 |  |  | 0 |  |  | 0 |  |  | 4,823 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (2,434) |  |  | 0 |  |  | (1) |  |  | (2,435) | \nRepurchases of stock | (133) |  |  | (820) |  |  | 0 |  |  | (14,377) |  |  | (15,197) | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 16,002 |  |  | 16,002 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | (1,779) |  |  | 0 |  |  | (1,779) | \nBalance as of June 30, 2022 | 13,078 |  |  | $ | 64,402 |  |  | $ | (5,828) |  |  | $ | 196,845 |  |  | $ | 255,419 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended June 30, 2022\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of December 31, 2021 | 13,242 |  |  | $ | 61,774 |  |  | $ | (1,623) |  |  | $ | 191,484 |  |  | $ | 251,635 | \nStock issued | 67 |  |  | 8 |  |  | 0 |  |  | 0 |  |  | 8 | \nStock-based compensation expense | 0 |  |  | 9,370 |  |  | 0 |  |  | 0 |  |  | 9,370 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (5,329) |  |  | 0 |  |  | (1) |  |  | (5,330) | \nRepurchases of stock | (231) |  |  | (1,421) |  |  | 0 |  |  | (27,076) |  |  | (28,497) | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 32,438 |  |  | 32,438 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | (4,205) |  |  | 0 |  |  | (4,205) | \nBalance as of June 30, 2022 | 13,078 |  |  | $ | 64,402 |  |  | $ | (5,828) |  |  | $ | 196,845 |  |  | $ | 255,419 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, 2023\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of March 31, 2023 | 12,722 |  |  | $ | 70,269 |  |  | $ | (6,000) |  |  | $ | 196,625 |  |  | $ | 260,894 | \nStock issued | 38 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 | \nStock-based compensation expense | 0 |  |  | 5,815 |  |  | 0 |  |  | 0 |  |  | 5,815 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (2,831) |  |  | 0 |  |  | 0 |  |  | (2,831) | \nRepurchases of stock | (131) |  |  | (1,005) |  |  | 0 |  |  | (14,109) |  |  | (15,114) | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 18,368 |  |  | 18,368 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | 9 |  |  | 0 |  |  | 9 | \nBalance as of June 30, 2023 | 12,629 |  |  | $ | 72,248 |  |  | $ | (5,991) |  |  | $ | 200,884 |  |  | $ | 267,141 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended June 30, 2023\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of December 31, 2022 | 12,849 |  |  | $ | 68,184 |  |  | $ | (7,603) |  |  | $ | 195,563 |  |  | $ | 256,144 | \nStock issued | 68 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 | \nStock-based compensation expense | 0 |  |  | 11,128 |  |  | 0 |  |  | 0 |  |  | 11,128 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (4,924) |  |  | 0 |  |  | 0 |  |  | (4,924) | \nRepurchases of stock | (288) |  |  | (2,140) |  |  | 0 |  |  | (28,098) |  |  | (30,238) | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 33,419 |  |  | 33,419 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | 1,612 |  |  | 0 |  |  | 1,612 | \nBalance as of June 30, 2023 | 12,629 |  |  | $ | 72,248 |  |  | $ | (5,991) |  |  | $ | 200,884 |  |  | $ | 267,141 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended\n | June 30,\n | 2022 |  | 2023\nOperating activities |  |  | \nNet income | $ | 32,438 |  |  | $ | 33,419 | \nAdjustments: |  |  | \nDepreciation and impairment of property and equipment | 7,289 |  |  | 6,339 | \nAmortization and impairment of intangible assets | 392 |  |  | 244 | \nStock-based compensation expense | 9,286 |  |  | 11,058 | \nDeferred income taxes | (4,237) |  |  | (4,269) | \nLoss (gain) on debt and equity securities, net | 2,478 |  |  | 425 | \nOther | 202 |  |  | 650 | \nChanges in assets and liabilities, net of effects of acquisitions: |  |  | \nAccounts receivable, net | 2,395 |  |  | 1,506 | \nIncome taxes, net | (253) |  |  | 8,520 | \nOther assets | (1,621) |  |  | (1,259) | \nAccounts payable | (1,172) |  |  | 14 | \nAccrued expenses and other liabilities | (1,719) |  |  | (4,037) | \nAccrued revenue share | (942) |  |  | (418) | \nDeferred revenue | (8) |  |  | (17) | \nNet cash provided by operating activities | 44,528 |  |  | 52,175 | \nInvesting activities |  |  | \nPurchases of property and equipment | (16,614) |  |  | (13,177) | \nPurchases of marketable securities | (50,199) |  |  | (35,589) | \nMaturities and sales of marketable securities | 55,374 |  |  | 37,049 | \nPurchases of non-marketable securities | (1,264) |  |  | (1,513) | \nMaturities and sales of non-marketable securities | 125 |  |  | 181 | \n |  |  | \n |  |  | \nAcquisitions, net of cash acquired, and purchases of intangible assets | (1,236) |  |  | (340) | \nOther investing activities | 576 |  |  | (357) | \n |  |  | \nNet cash used in investing activities | (13,238) |  |  | (13,746) | \nFinancing activities |  |  | \nNet payments related to stock-based award activities | (5,180) |  |  | (4,725) | \n |  |  | \nRepurchases of stock | (28,497) |  |  | (29,526) | \nProceeds from issuance of debt, net of costs | 29,228 |  |  | 8,050 | \nRepayments of debt | (29,582) |  |  | (8,207) | \nProceeds from sale of interest in consolidated entities, net | 0 |  |  | 5 | \nNet cash used in financing activities | (34,031) |  |  | (34,403) | \nEffect of exchange rate changes on cash and cash equivalents | (268) |  |  | 24 | \nNet increase (decrease) in cash and cash equivalents | (3,009) |  |  | 4,050 | \nCash and cash equivalents at beginning of period | 20,945 |  |  | 21,879 | \nCash and cash equivalents at end of period | $ | 17,936 |  |  | $ | 25,929 | \n |  |  | \n |  |  | \n |  |  | \n |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nGoogle Search & other | $ | 40,689 |  |  | $ | 42,628 |  |  | $ | 80,307 |  |  | $ | 82,987 | \nYouTube ads | 7,340 |  |  | 7,665 |  |  | 14,209 |  |  | 14,358 | \nGoogle Network | 8,259 |  |  | 7,850 |  |  | 16,433 |  |  | 15,346 | \nGoogle advertising | 56,288 |  |  | 58,143 |  |  | 110,949 |  |  | 112,691 | \nGoogle other | 6,553 |  |  | 8,142 |  |  | 13,364 |  |  | 15,555 | \nGoogle Services total | 62,841 |  |  | 66,285 |  |  | 124,313 |  |  | 128,246 | \nGoogle Cloud | 6,276 |  |  | 8,031 |  |  | 12,097 |  |  | 15,485 | \nOther Bets | 193 |  |  | 285 |  |  | 633 |  |  | 573 | \nHedging gains (losses) | 375 |  |  | 3 |  |  | 653 |  |  | 87 | \nTotal revenues | $ | 69,685 |  |  | $ | 74,604 |  |  | $ | 137,696 |  |  | $ | 144,391 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nUnited States | $ | 32,727 |  |  | 47 | % |  | $ | 35,073 |  |  | 47 | % |  | $ | 64,460 |  |  | 47 | % |  | $ | 67,937 |  |  | 47 | %\nEMEA(1) | 20,533 |  |  | 29 |  |  | 22,289 |  |  | 30 |  |  | 40,850 |  |  | 30 |  |  | 43,367 |  |  | 30 | \nAPAC(1) | 11,710 |  |  | 17 |  |  | 12,728 |  |  | 17 |  |  | 23,551 |  |  | 17 |  |  | 24,409 |  |  | 17 | \nOther Americas(1) | 4,340 |  |  | 6 |  |  | 4,511 |  |  | 6 |  |  | 8,182 |  |  | 6 |  |  | 8,591 |  |  | 6 | \nHedging gains (losses) | 375 |  |  | 1 |  |  | 3 |  |  | 0 |  |  | 653 |  |  | 0 |  |  | 87 |  |  | 0 | \nTotal revenues | $ | 69,685 |  |  | 100 | % |  | $ | 74,604 |  |  | 100 | % |  | $ | 137,696 |  |  | 100 | % |  | $ | 144,391 |  |  | 100 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | As of December 31, 2022\n |  | Fair Value Hierarchy |  | Adjusted Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Fair Value |  | Cash and Cash Equivalents |  | Marketable Securities\nFair value changes recorded in other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTime deposits |  | Level 2 |  | $ | 5,297 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 5,297 |  |  | $ | 5,293 |  |  | $ | 4 | \nGovernment bonds |  | Level 2 |  | 41,036 |  | 64 |  |  | (2,045) |  |  | 39,055 |  |  | 283 |  |  | 38,772 | \nCorporate debt securities |  | Level 2 |  | 28,578 |  | 8 |  |  | (1,569) |  |  | 27,017 |  |  | 1 |  |  | 27,016 | \nMortgage-backed and asset-backed securities |  | Level 2 |  | 16,176 |  | 5 |  |  | (1,242) |  |  | 14,939 |  |  | 0 |  |  | 14,939 | \nTotal investments with fair value change reflected in other comprehensive income(1) |  |  |  | $ | 91,087 |  |  | $ | 77 |  |  | $ | (4,856) |  |  | $ | 86,308 |  |  | $ | 5,577 |  |  | $ | 80,731 | \nFair value adjustments recorded in net income |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMoney market funds |  | Level 1 |  |  |  |  |  |  |  | $ | 7,234 |  |  | $ | 7,234 |  |  | $ | 0 | \nCurrent marketable equity securities(2) |  | Level 1 |  |  |  |  |  |  |  | 4,013 |  |  | 0 |  |  | 4,013 | \nMutual funds |  | Level 2 |  |  |  |  |  |  |  | 339 |  |  | 0 |  |  | 339 | \nGovernment bonds |  | Level 2 |  |  |  |  |  |  |  | 1,877 |  |  | 440 |  |  | 1,437 | \nCorporate debt securities |  | Level 2 |  |  |  |  |  |  |  | 3,744 |  |  | 65 |  |  | 3,679 | \nMortgage-backed and asset-backed securities |  | Level 2 |  |  |  |  |  |  |  | 1,686 |  |  | 2 |  |  | 1,684 | \nTotal investments with fair value change recorded in net income |  |  |  |  |  |  |  |  |  | $ | 18,893 |  |  | $ | 7,741 |  |  | $ | 11,152 | \nCash |  |  |  |  |  |  |  |  |  | 0 |  |  | 8,561 |  |  | 0 | \nTotal |  |  |  | $ | 91,087 |  |  | $ | 77 |  |  | $ | (4,856) |  |  | $ | 105,201 |  |  | $ | 21,879 |  |  | $ | 91,883 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | As of June 30, 2023\n |  | Fair Value Hierarchy |  | Adjusted Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Fair Value |  | Cash and Cash Equivalents |  | Marketable Securities\nFair value changes recorded in other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTime deposits |  | Level 2 |  | $ | 2,913 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 2,913 |  |  | $ | 2,913 |  |  | $ | 0 | \nGovernment bonds |  | Level 2 |  | 45,339 |  |  | 49 |  |  | (1,588) |  |  | 43,800 |  |  | 2,481 |  |  | 41,319 | \nCorporate debt securities |  | Level 2 |  | 23,480 |  |  | 8 |  |  | (1,162) |  |  | 22,326 |  |  | 0 |  |  | 22,326 | \nMortgage-backed and asset-backed securities |  | Level 2 |  | 18,047 |  |  | 4 |  |  | (1,092) |  |  | 16,959 |  |  | 0 |  |  | 16,959 | \nTotal investments with fair value change reflected in other comprehensive income(1) |  |  |  | $ | 89,779 |  |  | $ | 61 |  |  | $ | (3,842) |  |  | $ | 85,998 |  |  | $ | 5,394 |  |  | $ | 80,604 | \nFair value adjustments recorded in net income |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMoney market funds |  | Level 1 |  |  |  |  |  |  |  | $ | 9,472 |  |  | $ | 9,472 |  |  | $ | 0 | \nCurrent marketable equity securities(2) |  | Level 1 |  |  |  |  |  |  |  | 4,088 |  |  | 0 |  |  | 4,088 | \nMutual funds |  | Level 2 |  |  |  |  |  |  |  | 315 |  | 0 |  |  | 315\nGovernment bonds |  | Level 2 |  |  |  |  |  |  |  | 2,158 |  | 546 |  |  | 1,612\nCorporate debt securities |  | Level 2 |  |  |  |  |  |  |  | 3,831 |  | 2 |  |  | 3,829\nMortgage-backed and asset-backed securities |  | Level 2 |  |  |  |  |  |  |  | 1,955 |  | 0 |  |  | 1,955\nTotal investments with fair value change recorded in net income |  |  |  |  |  |  |  |  |  | $ | 21,819 |  |  | $ | 10,020 |  |  | $ | 11,799 | \nCash |  |  |  |  |  |  |  |  |  | 0 |  |  | 10,515 |  |  | 0 | \nTotal |  |  |  | $ | 89,779 |  |  | $ | 61 |  |  | $ | (3,842) |  |  | $ | 107,817 |  |  | $ | 25,929 |  |  | $ | 92,403 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  | \n | As ofJune 30, 2023 | \nDue in 1 year or less | $ | 15,403 |  | \nDue in 1 year through 5 years | 43,749 |  | \nDue in 5 years through 10 years | 15,162 |  | \nDue after 10 years | 13,686 |  | \nTotal | $ | 88,000 |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022\n | Less\u00a0than\u00a012 Months |  | 12 Months or Greater |  | Total\n | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss\nGovernment bonds | $ | 21,039 |  |  | $ | (1,004) |  |  | $ | 13,438 |  |  | $ | (1,041) |  |  | $ | 34,477 |  |  | $ | (2,045) | \nCorporate debt securities | 11,228 |  |  | (440) |  |  | 15,125 |  |  | (1,052) |  |  | 26,353 |  |  | (1,492) | \nMortgage-backed and asset-backed securities | 7,725 |  |  | (585) |  |  | 6,964 |  |  | (657) |  |  | 14,689 |  |  | (1,242) | \nTotal | $ | 39,992 |  |  | $ | (2,029) |  |  | $ | 35,527 |  |  | $ | (2,750) |  |  | $ | 75,519 |  |  | $ | (4,779) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of June 30, 2023\n | Less\u00a0than\u00a012 Months |  | 12 Months or Greater |  | Total\n | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss\nGovernment bonds | $ | 19,195 |  |  | $ | (580) |  |  | $ | 13,976 |  |  | $ | (1,008) |  |  | $ | 33,171 |  |  | $ | (1,588) | \nCorporate debt securities | 3,915 |  |  | (69) |  |  | 17,573 |  |  | (1,008) |  |  | 21,488 |  |  | (1,077) | \nMortgage-backed and asset-backed securities | 6,352 |  |  | (153) |  |  | 10,095 |  |  | (939) |  |  | 16,447 |  |  | (1,092) | \nTotal | $ | 29,462 |  |  | $ | (802) |  |  | $ | 41,644 |  |  | $ | (2,955) |  |  | $ | 71,106 |  |  | $ | (3,757) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nUnrealized gain (loss) on fair value option debt securities | $ | (367) |  |  | $ | (24) |  |  | $ | (569) |  |  | $ | 121 | \nGross realized gain on debt securities | 29 |  |  | 28 |  |  | 69 |  |  | 85 | \nGross realized loss on debt securities | (368) |  |  | (303) |  |  | (639) |  |  | (795) | \n(Increase) decrease in allowance for credit losses | (84) |  |  | (5) |  |  | (18) |  |  | (8) | \nTotal gain (loss) on debt securities recognized in other income (expense), net | $ | (790) |  |  | $ | (304) |  |  | $ | (1,157) |  |  | $ | (597) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022 |  | As of June 30, 2023\n | Marketable Equity Securities |  | Non-Marketable Equity Securities |  | Total |  | Marketable Equity Securities |  | Non-Marketable Equity Securities |  | Total\nTotal initial cost | $ | 5,764 |  |  | $ | 16,157 |  |  | $ | 21,921 |  |  | $ | 5,647 |  |  | $ | 17,261 |  |  | $ | 22,908 | \nCumulative net gain (loss)(1) | (608) |  |  | 12,372 |  |  | 11,764 |  |  | (352) |  |  | 11,868 |  |  | 11,516 | \nCarrying value | $ | 5,156 |  |  | $ | 28,529 |  |  | $ | 33,685 |  |  | $ | 5,295 |  |  | $ | 29,129 |  |  | $ | 34,424 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nRealized net gain (loss) on equity securities sold during the period | $ | 26 |  |  | $ | 87 |  |  | $ | (230) |  |  | $ | 292 | \nUnrealized net gain (loss) on marketable equity securities | (1,188) |  |  | 397 |  |  | (2,462) |  |  | 349 | \nUnrealized net gain (loss) on non-marketable equity securities(1) | 911 |  |  | (689) |  |  | 1,371 |  |  | (469) | \nTotal gain (loss) on equity securities in other income (expense), net | $ | (251) |  |  | $ | (205) |  |  | $ | (1,321) |  |  | $ | 172 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Equity Securities Sold\n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nTotal sale price | $ | 645 |  |  | $ | 427 |  |  | $ | 1,335 |  |  | $ | 739 | \nTotal initial cost | 168 |  |  | 156 |  |  | 428 |  |  | 367 | \nCumulative net gain (loss) | $ | 477 |  |  | $ | 271 |  |  | $ | 907 |  |  | $ | 372 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022 |  | As of June 30, 2023\nDerivatives designated as hedging instruments: |  | \nForeign exchange contracts |  |  | \nCash flow hedges | $ | 15,972 |  |  | $ | 15,823 | \nFair value hedges | $ | 2,117 |  |  | $ | 1,472 | \nNet investment hedges | $ | 8,751 |  |  | $ | 9,371 | \nDerivatives not designated as hedging instruments: |  | \nForeign exchange contracts | $ | 34,979 |  |  | $ | 34,185 | \nOther contracts | $ | 7,932 |  |  | $ | 9,133 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022 |  | As of June 30, 2023\n | Assets(1) |  | Liabilities(2) |  | Assets(1) |  | Liabilities(2)\nDerivatives designated as hedging instruments: |  |  |  |  |  |  | \nForeign exchange contracts | $ | 271 |  |  | $ | 556 |  |  | $ | 228 |  |  | $ | 201 | \n |  |  |  |  |  |  | \nDerivatives not designated as hedging instruments: |  |  |  |  |  |  | \nForeign exchange contracts | 365 |  | 207 |  | 130 |  | 136\nOther contracts | 40 |  | 47 |  | 39 |  | 67\nTotal derivatives not designated as hedging instruments | 405 |  |  | 254 |  |  | 169 |  |  | 203 | \nTotal | $ | 676 |  |  | $ | 810 |  |  | $ | 397 |  |  | $ | 404 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Gains (Losses) Recognized in OCI on Derivatives Before Tax Effect\n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nDerivatives in cash flow hedging relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount included in the assessment of effectiveness | $ | 1,131 |  |  | $ | 77 |  |  | $ | 1,266 |  |  | $ | (61) | \nAmount excluded from the assessment of effectiveness | (39) |  |  | 80 |  |  | (54) |  |  | 127 | \n |  |  |  |  |  |  | \nDerivatives in net investment hedging relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount included in the assessment of effectiveness | 509 |  |  | (59) |  |  | 658 |  |  | (274) | \nTotal | $ | 1,601 |  |  | $ | 98 |  |  | $ | 1,870 |  |  | $ | (208) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Gains (Losses) Recognized in Income\n | Three Months Ended\n | June 30,\n | 2022 |  | 2023\n | Revenues |  | Other income (expense), net |  | Revenues |  | Other income (expense), net\nTotal amounts in the Consolidated Statements of Income | $ | 69,685 |  |  | $ | (439) |  |  | $ | 74,604 |  |  | $ | 65 | \n |  |  |  |  |  |  | \nEffect of cash flow hedges: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount reclassified from AOCI to income | $ | 400 |  |  | $ | 0 |  |  | $ | (2) |  |  | $ | 0 | \nAmount excluded from the assessment of effectiveness (amortized) | (24) |  |  | 0 |  |  | 6 |  |  | 0 | \nEffect of fair value hedges: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nHedged items | 0 |  |  | (136) |  |  | 0 |  |  | 22 | \nDerivatives designated as hedging instruments | 0 |  |  | 136 |  |  | 0 |  |  | (22) | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 2 |  |  | 0 |  |  | 5 | \nEffect of net investment hedges: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 28 |  |  | 0 |  |  | 72 | \nEffect of non designated hedges: |  |  |  |  |  |  | \nForeign exchange contracts | 0 |  |  | (149) |  |  | 0 |  |  | 124 | \nOther contracts | 0 |  |  | 86 |  |  | 0 |  |  | (4) | \nTotal gains (losses) | $ | 376 |  |  | $ | (33) |  |  | $ | 4 |  |  | $ | 197 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Gains (Losses) Recognized in Income\n | Six Months Ended\n | June 30,\n | 2022 |  | 2023\n | Revenues |  | Other income (expense), net |  | Revenues |  | Other income (expense), net\nTotal amounts in the Consolidated Statements of Income | $ | 137,696 |  |  | $ | (1,599) |  |  | $ | 144,391 |  |  | $ | 855 | \n |  |  |  |  |  |  | \nEffect of cash flow hedges: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount of gains (losses) reclassified from AOCI to income | $ | 697 |  |  | $ | 0 |  |  | $ | 86 |  |  | $ | 0 | \nAmount excluded from the assessment of effectiveness (amortized) | (43) |  |  | 0 |  |  | 2 |  |  | 0 | \nEffect of fair value hedges: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nHedged items | 0 |  |  | (123) |  |  | 0 |  |  | 54 | \nDerivatives designated as hedging instruments | 0 |  |  | 124 |  |  | 0 |  |  | (54) | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 3 |  |  | 0 |  |  | 10 | \nEffect of net investment hedges: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 40 |  |  | 0 |  |  | 123 | \nEffect of non designated hedges: |  |  |  |  |  |  | \nForeign exchange contracts | 0 |  |  | (396) |  |  | 0 |  |  | 154 | \nOther Contracts | 0 |  |  | 124 |  |  | 0 |  |  | (1) | \nTotal gains (losses) | $ | 654 |  |  | $ | (228) |  |  | $ | 88 |  |  | $ | 286 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset |  | \n | Gross Amounts Recognized |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Amounts Presented in the Consolidated Balance Sheets |  | Financial Instruments(1) |  | Cash and Non-Cash Collateral Received or Pledged |  | Net Amounts\nDerivatives assets | $ | 760 |  |  | $ | (84) |  |  | $ | 676 |  |  | $ | (463) |  |  | $ | (132) |  |  | $ | 81 | \nDerivatives liabilities | $ | 894 |  |  | $ | (84) |  |  | $ | 810 |  |  | $ | (463) |  |  | $ | (28) |  |  | $ | 319 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of June 30, 2023\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset |  | \n | Gross Amounts Recognized |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Amounts Presented in the Consolidated Balance Sheets |  | Financial Instruments(1) |  | Cash and Non-Cash Collateral Received or Pledged |  | Net Amounts\nDerivatives assets | $ | 444 |  |  | $ | (47) |  |  | $ | 397 |  |  | $ | (138) |  |  | $ | (226) |  |  | $ | 33 | \nDerivatives liabilities | $ | 451 |  |  | $ | (47) |  |  | $ | 404 |  |  | $ | (138) |  |  | $ | (34) |  |  | $ | 232 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Maturity |  | Coupon Rate |  | Effective Interest Rate |  | As of December 31, 2022 |  | As ofJune 30, 2023\nDebt |  |  |  |  |  |  |  |  |  | \n2014-2020 Notes issuances |  | 2024 - 2060 |  | 0.45% -3.38% |  | 0.57% -3.38% |  | $ | 13,000 |  |  | $ | 13,000 | \nFuture finance lease payments, net and other(1) |  |  |  |  |  |  |  | 2,142 |  |  | 2,159 | \nTotal debt |  |  |  |  |  |  |  | 15,142 |  |  | 15,159 | \nUnamortized discount and debt issuance costs |  |  |  |  |  |  |  | (143) |  |  | (137) | \nLess: Current portion of long-term notes(2) |  |  |  |  |  |  |  | 0 |  |  | (999) | \nLess: Current portion future finance lease payments, net and other current debt(1)(2) |  |  |  |  |  |  |  | (298) |  |  | (318) | \nTotal long-term debt |  |  |  |  |  |  |  | $ | 14,701 |  |  | $ | 13,705 |   |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2022 |  | As ofJune 30, 2023\nLand and buildings | $ | 66,897 |  |  | $ | 68,890 | \nInformation technology assets | 66,267 |  |  | 71,592 | \nConstruction in progress | 27,657 |  |  | 32,019 | \nLeasehold improvements | 10,575 |  |  | 11,286 | \nFurniture and fixtures | 314 |  |  | 338 | \nProperty and equipment, gross | 171,710 |  |  | 184,125 | \nLess: accumulated depreciation | (59,042) |  |  | (62,917) | \nProperty and equipment, net | $ | 112,668 |  |  | $ | 121,208 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2022 |  | As ofJune 30, 2023\nEuropean Commission fines(1) | $ | 9,106 |  |  | $ | 9,446 | \nIncome taxes payable, net(2) | 1,632 |  |  | 10,870 | \nAccrued customer liabilities | 3,619 |  |  | 3,498 | \nAccrued purchases of property and equipment | 3,019 |  |  | 3,380 | \nCurrent operating lease liabilities | 2,477 |  |  | 2,663 | \nOther accrued expenses and current liabilities | 18,013 |  |  | 19,443 | \nAccrued expenses and other current liabilities | $ | 37,866 |  |  | $ | 49,300 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Available-for-Sale Investments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total\nBalance as of December 31, 2021 | $ | (2,306) |  |  | $ | 236 |  |  | $ | 447 |  |  | $ | (1,623) | \nOther comprehensive income (loss) before reclassifications | (1,626) |  |  | (3,404) |  |  | 1,083 |  |  | (3,947) | \nAmounts excluded from the assessment of hedge effectiveness recorded in AOCI | 0 |  |  | 0 |  |  | (54) |  |  | (54) | \nAmounts reclassified from AOCI | 0 |  |  | 381 |  |  | (585) |  |  | (204) | \nOther comprehensive income (loss) | (1,626) |  |  | (3,023) |  |  | 444 |  |  | (4,205) | \nBalance as of June 30, 2022 | $ | (3,932) |  |  | $ | (2,787) |  |  | $ | 891 |  |  | $ | (5,828) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Available-for-Sale Investments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total\nBalance as of December 31, 2022 | $ | (4,142) |  |  | $ | (3,477) |  |  | $ | 16 |  |  | $ | (7,603) | \nOther comprehensive income (loss) before reclassifications | 831 |  |  | 296 |  |  | (50) |  |  | 1,077 | \nAmounts excluded from the assessment of hedge effectiveness recorded in AOCI | 0 |  |  | 0 |  |  | 127 |  |  | 127 | \nAmounts reclassified from AOCI | 0 |  |  | 490 |  |  | (82) |  |  | 408 | \nOther comprehensive income (loss) | 831 |  |  | 786 |  |  | (5) |  |  | 1,612 | \nBalance as of June 30, 2023 | $ | (3,311) |  |  | $ | (2,691) |  |  | $ | 11 |  |  | $ | (5,991) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Gains (Losses) Reclassified from AOCI to the Consolidated Statements of Income\n |  |  | Three Months Ended |  | Six Months Ended\n |  |  | June 30, |  | June 30,\nAOCI Components |  | Location | 2022 |  | 2023 |  | 2022 |  | 2023\nUnrealized gains (losses) on available-for-sale investments |  |  |  |  |  |  | \n |  | Other income (expense), net | $ | (299) |  |  | $ | (254) |  |  | $ | (489) |  |  | $ | (628) | \n |  | Benefit (provision) for income taxes | 66 |  |  | 56 |  |  | 108 |  |  | 138 | \n |  | Net of income tax | (233) |  |  | (198) |  |  | (381) |  |  | (490) | \nUnrealized gains (losses) on cash flow hedges |  |  |  |  |  |  | \nForeign exchange contracts |  | Revenue | 400 |  |  | (2) |  |  | 697 |  |  | 86 | \nInterest rate contracts |  | Other income (expense), net | 1 |  |  | 1 |  |  | 3 |  |  | 3 | \n |  | Benefit (provision) for income taxes | (65) |  |  | 6 |  |  | (115) |  |  | (7) | \n |  | Net of income tax | 336 |  |  | 5 |  |  | 585 |  |  | 82 | \nTotal amount reclassified, net of income tax | $ | 103 |  |  | $ | (193) |  |  | $ | 204 |  |  | $ | (408) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nInterest income | $ | 486 |  |  | $ | 892 |  |  | $ | 900 |  |  | $ | 1,689 | \nInterest expense(1) | (83) |  |  | (43) |  |  | (166) |  |  | (123) | \nForeign currency exchange gain (loss), net | (260) |  |  | (268) |  |  | (333) |  |  | (478) | \nGain (loss) on debt securities, net | (790) |  |  | (304) |  |  | (1,157) |  |  | (597) | \nGain (loss) on equity securities, net | (251) |  |  | (205) |  |  | (1,321) |  |  | 172 | \nPerformance fees | 318 |  |  | 5 |  |  | 551 |  |  | 123 | \nIncome (loss) and impairment from equity method investments, net | (118) |  |  | (106) |  |  | (207) |  |  | (157) | \nOther | 259 |  |  | 94 |  |  | 134 |  |  | 226 | \nOther income (expense), net | $ | (439) |  |  | $ | 65 |  |  | $ | (1,599) |  |  | $ | 855 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, 2023 |  | Six Months Ended June 30, 2023\n | Severance and Related(1) |  | Office Space |  | Total |  | Severance and Related(1) |  | Office Space |  | Total\nCost of revenues | $ | (1) |  |  | $ | 20 |  |  | $ | 19 |  |  | $ | 460 |  |  | $ | 240 |  |  | $ | 700 | \nResearch and development | (3) |  |  | 14 |  |  | 11 |  |  | 832 |  |  | 261 |  |  | 1,093 | \nSales and marketing | (1) |  |  | 23 |  |  | 22 |  |  | 444 |  |  | 58 |  |  | 502 | \nGeneral and administrative | 6 |  |  | 12 |  |  | 18 |  |  | 259 |  |  | 74 |  |  | 333 | \nTotal charges | $ | 1 |  |  | $ | 69 |  |  | $ | 70 |  |  | $ | 1,995 |  |  | $ | 633 |  |  | $ | 2,628 |   |  |  |  |  | \n | Severance and Related\nBalance as of December 31, 2022 | $ | 0 | \nCharges(1) | 1,566 | \nCash payments | (1,423) | \nBalance as of June 30, 2023(2) | $ | 143 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Google Services |  | Google Cloud |  | Other Bets |  | Total\nBalance as of December 31, 2022 | $ | 20,847 |  |  | $ | 7,205 |  |  | $ | 908 |  |  | $ | 28,960 | \nAcquisitions | 240 |  |  | 0 |  |  | 0 |  |  | 240 | \nForeign currency translation and other adjustments | 37 |  |  | 1 |  |  | (28) |  |  | 10 | \nBalance as of June 30, 2023 | $ | 21,124 |  |  | $ | 7,206 |  |  | $ | 880 |  |  | $ | 29,210 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022 |  | As of June 30, 2023\n | GrossCarryingAmount |  | AccumulatedAmortization |  | NetCarryingAmount |  | GrossCarryingAmount |  | AccumulatedAmortization |  | NetCarryingAmount |  | \nPatents and developed technology | $ | 1,164 |  |  | $ | 354 |  |  | $ | 810 |  |  | $ | 1,181 |  |  | $ | 420 |  |  | $ | 761 |  |  | \nCustomer relationships | 862 |  |  | 235 |  |  | 627 |  |  | 884 |  |  | 306 |  |  | 578 |  |  | \nTrade names and other | 527 |  |  | 120 |  |  | 407 |  |  | 536 |  |  | 145 |  |  | 391 |  |  | \nTotal definite-lived intangible assets | 2,553 |  |  | 709 |  |  | 1,844 |  |  | 2,601 |  |  | 871 |  |  | 1,730 |  |  | \nIndefinite-lived intangible assets | 240 |  |  | 0 |  |  | 240 |  |  | 236 |  |  | 0 |  |  | 236 |  |  | \nTotal intangible assets | $ | 2,793 |  |  | $ | 709 |  |  | $ | 2,084 |  |  | $ | 2,837 |  |  | $ | 871 |  |  | $ | 1,966 |  |  |   |  |  |  |  | \nRemainder of 2023 | $ | 239 | \n2024 | 468 | \n2025 | 338 | \n2026 | 261 | \n2027 | 176 | \nThereafter | 248 | \nTotal | $ | 1,730 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, 2023 |  | Six Months Ended June 30, 2023\n | Shares |  | Amount |  | Shares |  | Amount\nClass A share repurchases | 17 |  |  | $ | 1,908 |  |  | 37 |  |  | $ | 3,919 | \nClass C share repurchases | 114 |  |  | 13,206 |  |  | 251 |  |  | 26,319 | \nTotal share repurchases(1) | 131 |  |  | $ | 15,114 |  |  | 288 |  |  | $ | 30,238 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30,\n | 2022 |  | 2023\n | Class A |  | Class B |  | Class C |  | Class A |  | Class B |  | Class C\nBasic net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings | $ | 7,329 |  |  | $ | 1,081 |  |  | $ | 7,592 |  |  | $ | 8,600 |  |  | $ | 1,275 |  |  | $ | 8,493 | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in per share computation | 6,015 |  |  | 887 |  |  | 6,231 |  |  | 5,931 |  |  | 879 |  |  | 5,858 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nBasic net income per share | $ | 1.22 |  |  | $ | 1.22 |  |  | $ | 1.22 |  |  | $ | 1.45 |  |  | $ | 1.45 |  |  | $ | 1.45 | \nDiluted net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings for basic computation | $ | 7,329 |  |  | $ | 1,081 |  |  | $ | 7,592 |  |  | $ | 8,600 |  |  | $ | 1,275 |  |  | $ | 8,493 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nReallocation of undistributed earnings as a result of conversion of Class B to Class\u00a0A shares | 1,081 |  |  | 0 |  |  | 0 |  |  | 1,275 |  |  | 0 |  |  | 0 | \nReallocation of undistributed earnings | (68) |  |  | (9) |  |  | 68 |  |  | (75) |  |  | (10) |  |  | 75 | \nAllocation of undistributed earnings | $ | 8,342 |  |  | $ | 1,072 |  |  | $ | 7,660 |  |  | $ | 9,800 |  |  | $ | 1,265 |  |  | $ | 8,568 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in basic computation | 6,015 |  |  | 887 |  |  | 6,231 |  |  | 5,931 |  |  | 879 |  |  | 5,858 | \nWeighted-average effect of dilutive securities |  |  |  |  |  |  |  |  |  |  | \nAdd: |  |  |  |  |  |  |  |  |  |  | \nConversion of Class B to Class\u00a0A shares outstanding | 887 |  |  | 0 |  |  | 0 |  |  | 879 |  |  | 0 |  |  | 0 | \n |  |  |  |  |  |  |  |  |  |  | \nRestricted stock units and other contingently issuable shares | 0 |  |  | 0 |  |  | 106 |  |  | 0 |  |  | 0 |  |  | 96 | \nNumber of shares used in per share computation | 6,902 |  |  | 887 |  |  | 6,337 |  |  | 6,810 |  |  | 879 |  |  | 5,954 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDiluted net income per share | $ | 1.21 |  |  | $ | 1.21 |  |  | $ | 1.21 |  |  | $ | 1.44 |  |  | $ | 1.44 |  |  | $ | 1.44 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended June 30,\n | 2022 |  | 2023\n | Class A |  | Class B |  | Class C |  | Class A |  | Class B |  | Class C\nBasic net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings | $ | 14,812 |  |  | $ | 2,190 |  |  | $ | 15,436 |  |  | $ | 15,597 |  |  | $ | 2,311 |  |  | $ | 15,511 | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in per share computation | 6,013 |  |  | 889 |  |  | 6,266 |  |  | 5,939 |  |  | 880 |  |  | 5,906 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nBasic net income per share | $ | 2.46 |  |  | $ | 2.46 |  |  | $ | 2.46 |  |  | $ | 2.63 |  |  | $ | 2.63 |  |  | $ | 2.63 | \nDiluted net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings for basic computation | $ | 14,812 |  |  | $ | 2,190 |  |  | $ | 15,436 |  |  | $ | 15,597 |  |  | $ | 2,311 |  |  | $ | 15,511 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nReallocation of undistributed earnings as a result of conversion of Class B to Class\u00a0A shares | 2,190 |  |  | 0 |  |  | 0 |  |  | 2,311 |  |  | 0 |  |  | 0 | \nReallocation of undistributed earnings | (162) |  |  | (21) |  |  | 162 |  |  | (96) |  |  | (12) |  |  | 96 | \nAllocation of undistributed earnings | $ | 16,840 |  |  | $ | 2,169 |  |  | $ | 15,598 |  |  | $ | 17,812 |  |  | $ | 2,299 |  |  | $ | 15,607 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in basic computation | 6,013 |  |  | 889 |  |  | 6,266 |  |  | 5,939 |  |  | 880 |  |  | 5,906 | \nWeighted-average effect of dilutive securities |  |  |  |  |  |  |  |  |  |  | \nAdd: |  |  |  |  |  |  |  |  |  |  | \nConversion of Class B to Class\u00a0A shares outstanding | 889 |  |  | 0 |  |  | 0 |  |  | 880 |  |  | 0 |  |  | 0 | \n |  |  |  |  |  |  |  |  |  |  | \nRestricted stock units and other contingently issuable shares | 0 |  |  | 0 |  |  | 127 |  |  | 0 |  |  | 0 |  |  | 69 | \nNumber of shares used in per share computation | 6,902 |  |  | 889 |  |  | 6,393 |  |  | 6,819 |  |  | 880 |  |  | 5,975 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDiluted net income per share | $ | 2.44 |  |  | $ | 2.44 |  |  | $ | 2.44 |  |  | $ | 2.61 |  |  | $ | 2.61 |  |  | $ | 2.61 |   |  |  |  |  |  |  |  |  |  |  | \n | Unvested\u00a0Restricted\u00a0Stock\u00a0Units\n | Number ofShares |  | Weighted-AverageGrant-DateFair Value\nUnvested as of December 31, 2022 | 324 |  |  | $ | 107.98 | \nGranted | 246 |  |  | $ | 95.30 | \nVested | (109) |  |  | $ | 99.65 | \nForfeited/canceled | (19) |  |  | $ | 108.30 | \nUnvested as of June 30, 2023 | 442 |  |  | $ | 102.97 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nIncome before provision for income taxes | $ | 19,014 |  |  | $ | 21,903 |  |  | $ | 37,948 |  |  | $ | 40,108 | \nProvision for income taxes | $ | 3,012 |  |  | $ | 3,535 |  |  | $ | 5,510 |  |  | $ | 6,689 | \nEffective tax rate | 15.8 | % |  | 16.1 | % |  | 14.5 | % |  | 16.7 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nRevenues: |  |  |  |  |  |  | \nGoogle Services | $ | 62,841 |  |  | $ | 66,285 |  |  | $ | 124,313 |  |  | $ | 128,246 | \nGoogle Cloud | 6,276 |  |  | 8,031 |  |  | 12,097 |  |  | 15,485 | \nOther Bets | 193 |  |  | 285 |  |  | 633 |  |  | 573 | \nHedging gains (losses) | 375 |  |  | 3 |  |  | 653 |  |  | 87 | \nTotal revenues | $ | 69,685 |  |  | $ | 74,604 |  |  | $ | 137,696 |  |  | $ | 144,391 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nOperating income (loss): |  |  |  |  |  |  | \nGoogle Services | $ | 21,621 |  |  | $ | 23,454 |  |  | $ | 43,594 |  |  | $ | 45,191 | \nGoogle Cloud | (590) |  |  | 395 |  |  | (1,296) |  |  | 586 | \nOther Bets | (1,339) |  |  | (813) |  |  | (2,174) |  |  | (2,038) | \nCorporate costs, unallocated | (239) |  |  | (1,198) |  |  | (577) |  |  | (4,486) | \nTotal income from operations | $ | 19,453 |  |  | $ | 21,838 |  |  | $ | 39,547 |  |  | $ | 39,253 |   |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2022 |  | As ofJune 30, 2023\nLong-lived assets: |  |  | \nUnited States | $ | 93,565 |  |  | $ | 99,714 | \nInternational | 33,484 |  |  | 35,963 | \nTotal long-lived assets | $ | 127,049 |  |  | $ | 135,677 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended |  |  |  | \n | June 30, |  |  |  | \n |  | 2022 |  | 2023 |  | $ Change |  | % Change\nConsolidated revenues |  | $ | 69,685 |  |  | $ | 74,604 |  |  | $ | 4,919 |  |  | 7 | %\nChange in consolidated constant currency revenues(1) |  |  |  |  |  |  |  | 9 | %\n |  |  |  |  |  |  |  | \nCost of revenues |  | $ | 30,104 |  |  | $ | 31,916 |  |  | $ | 1,812 |  |  | 6 | %\nOperating expenses |  | $ | 20,128 |  |  | $ | 20,850 |  |  | $ | 722 |  |  | 4 | %\n |  |  |  |  |  |  |  | \nOperating income |  | $ | 19,453 |  |  | $ | 21,838 |  |  | $ | 2,385 |  |  | 12 | %\nOperating margin |  | 28 | % |  | 29 | % |  |  |  | 1 | %\n |  |  |  |  |  |  |  | \nOther income (expense), net |  | $ | (439) |  |  | $ | 65 |  |  | $ | 504 |  |  | NM\n |  |  |  |  |  |  |  | \nNet Income |  | $ | 16,002 |  |  | $ | 18,368 |  |  | $ | 2,366 |  |  | 15 | %\nDiluted EPS |  | $ | 1.21 |  |  | $ | 1.44 |  |  | $ | 0.23 |  |  | 19 | %\n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nGoogle Search & other | $ | 40,689 |  |  | $ | 42,628 |  |  | $ | 80,307 |  |  | $ | 82,987 | \nYouTube ads | 7,340 |  |  | 7,665 |  |  | 14,209 |  |  | 14,358 | \nGoogle Network | 8,259 |  |  | 7,850 |  |  | 16,433 |  |  | 15,346 | \nGoogle advertising | 56,288 |  |  | 58,143 |  |  | 110,949 |  |  | 112,691 | \nGoogle other | 6,553 |  |  | 8,142 |  |  | 13,364 |  |  | 15,555 | \nGoogle Services total | 62,841 |  |  | 66,285 |  |  | 124,313 |  |  | 128,246 | \nGoogle Cloud | 6,276 |  |  | 8,031 |  |  | 12,097 |  |  | 15,485 | \nOther Bets | 193 |  |  | 285 |  |  | 633 |  |  | 573 | \nHedging gains (losses) | 375 |  |  | 3 |  |  | 653 |  |  | 87 | \nTotal revenues | $ | 69,685 |  |  | $ | 74,604 |  |  | $ | 137,696 |  |  | $ | 144,391 |   |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2023 |  | 2023\nPaid clicks change | 8% |  | 8%\nCost-per-click change | (3)% |  | (5)%  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended June 30, |  | Six Months Ended June 30,\n | 2023 |  | 2023\nImpressions change | 0% |  | (2)%\nCost-per-impression change | (5)% |  | (5)%  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nUnited States | 47 | % |  | 47 | % |  | 47 | % |  | 47 | %\nEMEA | 29 | % |  | 30 | % |  | 30 | % |  | 30 | %\nAPAC | 17 | % |  | 17 | % |  | 17 | % |  | 17 | %\nOther Americas | 6 | % |  | 6 | % |  | 6 | % |  | 6 | %\nHedging gains (losses) | 1 | % |  | 0 | % |  | 0 | % |  | 0 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | Three Months Ended June 30, 2023\n |  |  |  |  |  |  |  |  | % Change from Prior Period\n | Three Months Ended June 30, |  | Less FX Effect |  | Constant Currency Revenues |  | As Reported |  | Less Hedging Effect |  | Less FX Effect |  | Constant Currency Revenues\n | 2022 |  | 2023 |  |  |  |  |  | \nUnited States | $ | 32,727 |  |  | $ | 35,073 |  |  | $ | 0 |  |  | $ | 35,073 |  |  | 7 | % |  |  |  | 0 | % |  | 7 | %\nEMEA | 20,533 |  |  | 22,289 |  |  | (275) |  |  | 22,564 |  |  | 9 | % |  |  |  | (1) | % |  | 10 | %\nAPAC | 11,710 |  |  | 12,728 |  |  | (565) |  |  | 13,293 |  |  | 9 | % |  |  |  | (5) | % |  | 14 | %\nOther Americas | 4,340 |  |  | 4,511 |  |  | (306) |  |  | 4,817 |  |  | 4 | % |  |  |  | (7) | % |  | 11 | %\nRevenues, excluding hedging effect | 69,310 |  |  | 74,601 |  |  | (1,146) |  |  | 75,747 |  |  | 8 | % |  |  |  | (1) | % |  | 9 | %\nHedging gains (losses) | 375 |  |  | 3 |  |  |  |  |  |  |  |  |  |  |  |  | \nTotal revenues(1) | $ | 69,685 |  |  | $ | 74,604 |  |  |  |  | $ | 75,747 |  |  | 7 | % |  | (1) | % |  | (1) | % |  | 9 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | Six Months Ended June 30, 2023\n |  |  |  |  |  |  |  |  | % Change from Prior Period\n | Six Months Ended June 30, |  | Less FX Effect |  | Constant Currency Revenues |  | As Reported |  | Less Hedging Effect |  | Less FX Effect |  | Constant Currency Revenues\n | 2022 |  | 2023 |  |  |  |  |  | \nUnited States | $ | 64,460 |  |  | $ | 67,937 |  |  | $ | 0 |  |  | $ | 67,937 |  |  | 5 | % |  |  |  | 0 | % |  | 5 | %\nEMEA | 40,850 |  |  | 43,367 |  |  | (1,448) |  |  | 44,815 |  |  | 6 | % |  |  |  | (4) | % |  | 10 | %\nAPAC | 23,551 |  |  | 24,409 |  |  | (1,399) |  |  | 25,808 |  |  | 4 | % |  |  |  | (6) | % |  | 10 | %\nOther Americas | 8,182 |  |  | 8,591 |  |  | (473) |  |  | 9,064 |  |  | 5 | % |  |  |  | (6) | % |  | 11 | %\nRevenues, excluding hedging effect | 137,043 |  |  | 144,304 |  |  | (3,320) |  |  | 147,624 |  |  | 5 | % |  |  |  | (3) | % |  | 8 | %\nHedging gains (losses) | 653 |  |  | 87 |  |  |  |  |  |  |  |  |  |  |  |  | \nTotal revenues(1) | $ | 137,696 |  |  | $ | 144,391 |  |  |  |  | $ | 147,624 |  |  | 5 | % |  | 0 | % |  | (3) | % |  | 8 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nTAC | $ | 12,214 |  |  | $ | 12,537 |  |  | $ | 24,204 |  |  | $ | 24,258 | \nOther cost of revenues | 17,890 |  |  | 19,379 |  |  | 35,499 |  |  | 38,270 | \nTotal cost of revenues | $ | 30,104 |  |  | $ | 31,916 |  |  | $ | 59,703 |  |  | $ | 62,528 | \nTotal cost of revenues as a percentage of revenues | 43 | % |  | 43 | % |  | 43 | % |  | 43 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nResearch and development expenses | $ | 9,841 |  |  | $ | 10,588 |  |  | $ | 18,960 |  |  | $ | 22,056 | \nResearch and development expenses as a percentage of revenues | 14 | % |  | 14 | % |  | 14 | % |  | 15 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nSales and marketing expenses | $ | 6,630 |  |  | $ | 6,781 |  |  | $ | 12,455 |  |  | $ | 13,314 | \nSales and marketing expenses as a percentage of revenues | 10 | % |  | 9 | % |  | 9 | % |  | 9 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nGeneral and administrative expenses | $ | 3,657 |  |  | $ | 3,481 |  |  | $ | 7,031 |  |  | $ | 7,240 | \nGeneral and administrative expenses as a percentage of revenues | 5 | % |  | 5 | % |  | 5 | % |  | 5 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  |  |  | \nOperating income (loss): |  |  |  |  |  |  | \nGoogle Services | $ | 21,621 |  |  | $ | 23,454 |  |  | $ | 43,594 |  |  | $ | 45,191 | \nGoogle Cloud | (590) |  |  | 395 |  |  | (1,296) |  |  | 586 | \nOther Bets | (1,339) |  |  | (813) |  |  | (2,174) |  |  | (2,038) | \nCorporate costs, unallocated(1) | (239) |  |  | (1,198) |  |  | (577) |  |  | (4,486) | \nTotal income from operations | $ | 19,453 |  |  | $ | 21,838 |  |  | $ | 39,547 |  |  | $ | 39,253 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nOther income (expense), net | $ | (439) |  |  | $ | 65 |  |  | $ | (1,599) |  |  | $ | 855 | \n |  |  |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\n | June 30, |  | June 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nIncome before provision for income taxes | $ | 19,014 |  |  | $ | 21,903 |  |  | $ | 37,948 |  |  | $ | 40,108 | \nProvision for income taxes | $ | 3,012 |  |  | $ | 3,535 |  |  | $ | 5,510 |  |  | $ | 6,689 | \nEffective tax rate | 15.8 | % |  | 16.1 | % |  | 14.5 | % |  | 16.7 | %  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended\n | June 30,\n | 2022 |  | 2023\nNet cash provided by operating activities | $ | 44,528 |  |  | $ | 52,175 | \nNet cash used in investing activities | $ | (13,238) |  |  | $ | (13,746) | \nNet cash used in financing activities | $ | (34,031) |  |  | $ | (34,403) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | Total Number of Class A Shares Purchased(in thousands)(1) |  | Total Number of Class C Shares Purchased(in thousands)(1) |  | Average Price Paid per Class A Share(2) |  | Average Price Paid per Class C Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Programs(in thousands)(1) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program(in millions)\nApril 1 - 30 |  | 6,163 |  |  | 41,151 |  |  | $ | 106.53 |  |  | $ | 106.94 |  |  | 47,314 |  |  | $ | 78,059 | \nMay 1 - 31 |  | 5,490 |  |  | 38,571 |  |  | $ | 116.89 |  |  | $ | 116.97 |  |  | 44,061 |  |  | $ | 72,945 | \nJune 1 - 30 |  | 4,941 |  |  | 34,664 |  |  | $ | 123.29 |  |  | $ | 123.88 |  |  | 39,605 |  |  | $ | 68,070 | \nTotal |  | 16,594 |  |  | 114,386 |  |  |  |  |  |  | 130,980 |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nExhibitNumber |  |  | Description |  | Incorporated\u00a0by\u00a0reference\u00a0herein\n |  | Form |  | Date\n10.01 | \u2b25 |  | Alphabet Inc. Amended and Restated 2021 Stock Plan |  | Current Report on Form 8-K (File No. 001-37580) |  | June 8, 2023\n10.02 | \u2b25 | * | Alphabet Inc. Amended and Restated 2021 Stock Plan - Form of Alphabet 2023 Non-CEO Performance Stock Unit Agreement |  |  |  | \n10.03 | \u2b25 | * | Alphabet Inc. Amended and Restated 2021 Stock Plan - Form of Alphabet Restricted Stock Unit Agreement |  |  |  | \n31.01 | * |  | Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n31.02 | * |  | Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n32.01 | \u2021 |  | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18\u00a0U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n101.INS | * |  | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |  |  |  | \n101.SCH | * |  | Inline XBRL Taxonomy Extension Schema Document |  |  |  | \n101.CAL | * |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  |  |  | \n101.DEF | * |  | Inline XBRL Taxonomy Extension Definition Linkbase Document |  |  |  | \n101.LAB | * |  | Inline XBRL Taxonomy Extension Label Linkbase Document |  |  |  | \n101.PRE | * |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  |  |  | \n104 |  |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |  |  |  |   |  |  |  |  | \n\u2b25 | Indicates management compensatory plan, contract, or arrangement.\n* | Filed herewith.\n\u2021 | Furnished herewith.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  | \n |  | ALPHABET INC.\nJuly 25, 2023 | By: | /s/\u00a0\u00a0\u00a0\u00a0RUTH M. PORAT\n |  | Ruth M. Porat\n |  | Senior Vice President and Chief Financial Officer  |  |  |  |  |  |  |  | \n |  | ALPHABET INC.\nJuly 25, 2023 | By: | /s/\u00a0\u00a0\u00a0\u00a0AMIE THUENER O'TOOLE\n |  | Amie Thuener O'Toole\n |  | Vice President, Corporate Controller and Principal Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Google, in 2023 Q3, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  | \n\u2612 | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \n\u2610 | TRANSITION REPORT PURSUANT TO SECTION\u00a013 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |  |  |  |  | \nDelaware | 61-1767919\n(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number)  |  |  |  |  |  |  |  | \nSecurities registered pursuant to Section\u00a012(b) of the Act:\nTitle of each class | Trading Symbol(s) | Name of each exchange on which registered\nClass\u00a0A Common Stock, $0.001 par value | GOOGL | Nasdaq Stock Market LLC\n |  | (Nasdaq Global Select Market)\nClass C Capital Stock, $0.001 par value | GOOG | Nasdaq Stock Market LLC\n |  | (Nasdaq Global Select Market)  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nLarge accelerated filer | \u2612 |  | Accelerated filer | \u2610\nNon-accelerated filer | \u2610 |  | Smaller reporting company | \u2610\nEmerging growth company | \u2610 |  |  |   |  | \n  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  | \n |  | Page\u00a0No.\nNote About Forward-Looking Statements | 3\n\nPART I. FINANCIAL INFORMATION\nItem\u00a01 | Financial Statements | 5\n | Consolidated Balance Sheets- December\u00a031, 2022 and September\u00a030, 2023 | 5\n | Consolidated Statements of Income -Three and Nine Months Ended September 30,2022and2023 | 6\n | Consolidated Statements of Comprehensive Income -Three and Nine Months Ended September 30,2022and2023 | 7\n | Consolidated Statements of Stockholders' Equity -Three and Nine Months Ended September 30,2022and2023 | 8\n | Consolidated Statements of Cash Flows -Nine Months Ended September 30,2022and2023 | 10\n | Notes to Consolidated Financial Statements | 11\nItem\u00a02 | Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations | 34\nItem\u00a03 | Quantitative and Qualitative Disclosures About Market Risk | 49\nItem\u00a04 | Controls and Procedures | 49\n |  | \nPART II. OTHER INFORMATION\nItem\u00a01 | Legal Proceedings | 51\nItem\u00a01A | Risk Factors | 51\nItem 2 | Unregistered Sales of Equity Securities and Use of Proceeds | 51\nItem\u00a05 | Other Information | 51\nItem\u00a06 | Exhibits | 52\nSignatures | 53  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2022 |  | As ofSeptember 30, 2023\n |  |  | (unaudited)\nAssets |  |  | \nCurrent assets: |  |  | \nCash and cash equivalents | $ | 21,879 |  |  | $ | 30,702 | \nMarketable securities | 91,883 |  |  | 89,233 | \nTotal cash, cash equivalents, and marketable securities | 113,762 |  |  | 119,935 | \nAccounts receivable, net | 40,258 |  |  | 41,020 | \nInventory | 2,670 |  |  | 2,957 | \nOther current assets | 8,105 |  |  | 12,398 | \nTotal current assets | 164,795 |  |  | 176,310 | \nNon-marketable securities | 30,492 |  |  | 30,907 | \nDeferred income taxes | 5,261 |  |  | 10,983 | \nProperty and equipment, net | 112,668 |  |  | 125,705 | \nOperating lease assets | 14,381 |  |  | 14,199 | \nIntangible assets, net | 2,084 |  |  | 1,833 | \nGoodwill | 28,960 |  |  | 29,146 | \nOther non-current assets | 6,623 |  |  | 7,628 | \nTotal assets | $ | 365,264 |  |  | $ | 396,711 | \nLiabilities and Stockholders\u2019 Equity |  |  | \nCurrent liabilities: |  |  | \nAccounts payable | $ | 5,128 |  |  | $ | 5,803 | \n |  |  | \nAccrued compensation and benefits | 14,028 |  |  | 12,562 | \nAccrued expenses and other current liabilities | 37,866 |  |  | 55,602 | \nAccrued revenue share | 8,370 |  |  | 8,025 | \nDeferred revenue | 3,908 |  |  | 4,303 | \nTotal current liabilities | 69,300 |  |  | 86,295 | \nLong-term debt | 14,701 |  |  | 13,781 | \nDeferred revenue, non-current | 599 |  |  | 884 | \nIncome taxes payable, non-current | 9,258 |  |  | 8,038 | \nDeferred income taxes | 514 |  |  | 528 | \nOperating lease liabilities | 12,501 |  |  | 12,550 | \nOther long-term liabilities | 2,247 |  |  | 1,433 | \nTotal liabilities | 109,120 |  |  | 123,509 | \nCommitments and contingencies (Note 9) |  |  | \nStockholders\u2019 equity: |  |  | \nPreferred stock, $0.001par value per share,100shares authorized;noshares issued and outstanding | 0 |  |  | 0 | \nClass\u00a0A, Class B, and Class C stock and additional paid-in capital, $0.001par value per share:300,000shares authorized\u00a0(Class\u00a0A180,000, Class B60,000, Class C60,000);12,849(Class\u00a0A5,964, Class B883, Class C6,002) and12,541(Class\u00a0A5,922, Class B874, Class C5,745)shares issued and outstanding | 68,184 |  |  | 74,591 | \nAccumulated other comprehensive income (loss) | (7,603) |  |  | (7,036) | \nRetained earnings | 195,563 |  |  | 205,647 | \nTotal stockholders\u2019 equity | 256,144 |  |  | 273,202 | \nTotal liabilities and stockholders\u2019 equity | $ | 365,264 |  |  | $ | 396,711 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nRevenues | $ | 69,092 |  |  | $ | 76,693 |  |  | $ | 206,788 |  |  | $ | 221,084 | \nCosts and expenses: |  |  |  |  |  |  | \nCost of revenues | 31,158 |  |  | 33,229 |  |  | 90,861 |  |  | 95,757 | \nResearch and development | 10,273 |  |  | 11,258 |  |  | 29,233 |  |  | 33,314 | \nSales and marketing | 6,929 |  |  | 6,884 |  |  | 19,384 |  |  | 20,198 | \nGeneral and administrative | 3,597 |  |  | 3,979 |  |  | 10,628 |  |  | 11,219 | \nTotal costs and expenses | 51,957 |  |  | 55,350 |  |  | 150,106 |  |  | 160,488 | \nIncome from operations | 17,135 |  |  | 21,343 |  |  | 56,682 |  |  | 60,596 | \nOther income (expense), net | (902) |  |  | (146) |  |  | (2,501) |  |  | 709 | \nIncome before income taxes | 16,233 |  |  | 21,197 |  |  | 54,181 |  |  | 61,305 | \nProvision for income taxes | 2,323 |  |  | 1,508 |  |  | 7,833 |  |  | 8,197 | \nNet income | $ | 13,910 |  |  | $ | 19,689 |  |  | $ | 46,348 |  |  | $ | 53,108 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nBasic net income per share of Class A, Class B, and Class C stock | $ | 1.07 |  |  | $ | 1.56 |  |  | $ | 3.53 |  |  | $ | 4.19 | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \nDiluted net income per share of Class A, Class B, and Class C stock | $ | 1.06 |  |  | $ | 1.55 |  |  | $ | 3.50 |  |  | $ | 4.16 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nNet income | $ | 13,910 |  |  | $ | 19,689 |  |  | $ | 46,348 |  |  | $ | 53,108 | \nOther comprehensive income (loss): |  |  |  |  |  |  | \nChange in foreign currency translation adjustment | (2,175) |  |  | (1,169) |  |  | (3,801) |  |  | (338) | \nAvailable-for-sale investments: |  |  |  |  |  |  | \nChange in net unrealized gains (losses) | (1,800) |  |  | (678) |  |  | (5,204) |  |  | (382) | \nLess: reclassification adjustment for net (gains) losses included in net income | 362 |  |  | 255 |  |  | 743 |  |  | 745 | \nNet change, net of income tax benefit (expense) of $409, $120, $1,269and $(104) | (1,438) |  |  | (423) |  |  | (4,461) |  |  | 363 | \nCash flow hedges: |  |  |  |  |  |  | \nChange in net unrealized gains (losses) | 1,136 |  |  | 550 |  |  | 2,165 |  |  | 627 | \nLess: reclassification adjustment for net (gains) losses included in net income | (547) |  |  | (3) |  |  | (1,132) |  |  | (85) | \nNet change, net of income tax benefit (expense) of $(159), $(134), $(228) and $(115) | 589 |  |  | 547 |  |  | 1,033 |  |  | 542 | \nOther comprehensive income (loss) | (3,024) |  |  | (1,045) |  |  | (7,229) |  |  | 567 | \nComprehensive income | $ | 10,886 |  |  | $ | 18,644 |  |  | $ | 39,119 |  |  | $ | 53,675 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, 2022\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of June 30, 2022 | 13,078 |  |  | $ | 64,402 |  |  | $ | (5,828) |  |  | $ | 196,845 |  |  | $ | 255,419 | \nStock issued | 31 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 | \nStock-based compensation expense | 0 |  |  | 5,018 |  |  | 0 |  |  | 0 |  |  | 5,018 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (2,315) |  |  | 0 |  |  | 0 |  |  | (2,315) | \nRepurchases of stock | (138) |  |  | (857) |  |  | 0 |  |  | (14,535) |  |  | (15,392) | \nSale of interest in consolidated entities | 0 |  |  | 10 |  |  | 0 |  |  | 0 |  |  | 10 | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 13,910 |  |  | 13,910 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | (3,024) |  |  | 0 |  |  | (3,024) | \nBalance as of September 30, 2022 | 12,971 |  |  | $ | 66,258 |  |  | $ | (8,852) |  |  | $ | 196,220 |  |  | $ | 253,626 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended September 30, 2022\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of December 31, 2021 | 13,242 |  |  | $ | 61,774 |  |  | $ | (1,623) |  |  | $ | 191,484 |  |  | $ | 251,635 | \nStock issued | 98 |  |  | 8 |  |  | 0 |  |  | 0 |  |  | 8 | \nStock-based compensation expense | 0 |  |  | 14,388 |  |  | 0 |  |  | 0 |  |  | 14,388 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (7,644) |  |  | 0 |  |  | (1) |  |  | (7,645) | \nRepurchases of stock | (369) |  |  | (2,278) |  |  | 0 |  |  | (41,611) |  |  | (43,889) | \nSale of interest in consolidated entities | 0 |  |  | 10 |  |  | 0 |  |  | 0 |  |  | 10 | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 46,348 |  |  | 46,348 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | (7,229) |  |  | 0 |  |  | (7,229) | \nBalance as of September 30, 2022 | 12,971 |  |  | $ | 66,258 |  |  | $ | (8,852) |  |  | $ | 196,220 |  |  | $ | 253,626 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, 2023\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of June 30, 2023 | 12,629 |  |  | $ | 72,248 |  |  | $ | (5,991) |  |  | $ | 200,884 |  |  | $ | 267,141 | \nStock issued | 34 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 | \nStock-based compensation expense | 0 |  |  | 5,777 |  |  | 0 |  |  | 0 |  |  | 5,777 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (2,442) |  |  | 0 |  |  | 0 |  |  | (2,442) | \nRepurchases of stock | (122) |  |  | (992) |  |  | 0 |  |  | (14,926) |  |  | (15,918) | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 19,689 |  |  | 19,689 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | (1,045) |  |  | 0 |  |  | (1,045) | \nBalance as of September 30, 2023 | 12,541 |  |  | $ | 74,591 |  |  | $ | (7,036) |  |  | $ | 205,647 |  |  | $ | 273,202 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended September 30, 2023\n | Class\u00a0A,\u00a0Class\u00a0B, Class C Stock and Additional\u00a0Paid-In\u00a0Capital |  | AccumulatedOtherComprehensiveIncome (Loss) |  | RetainedEarnings |  | TotalStockholders\u2019Equity\n | Shares |  | Amount | \nBalance as of December 31, 2022 | 12,849 |  |  | $ | 68,184 |  |  | $ | (7,603) |  |  | $ | 195,563 |  |  | $ | 256,144 | \nStock issued | 102 |  |  | 0 |  |  | 0 |  |  | 0 |  |  | 0 | \nStock-based compensation expense | 0 |  |  | 16,905 |  |  | 0 |  |  | 0 |  |  | 16,905 | \nTax withholding related to vesting of restricted stock units and other | 0 |  |  | (7,366) |  |  | 0 |  |  | 0 |  |  | (7,366) | \nRepurchases of stock | (410) |  |  | (3,132) |  |  | 0 |  |  | (43,024) |  |  | (46,156) | \nNet income | 0 |  |  | 0 |  |  | 0 |  |  | 53,108 |  |  | 53,108 | \nOther comprehensive income (loss) | 0 |  |  | 0 |  |  | 567 |  |  | 0 |  |  | 567 | \nBalance as of September 30, 2023 | 12,541 |  |  | $ | 74,591 |  |  | $ | (7,036) |  |  | $ | 205,647 |  |  | $ | 273,202 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended\n | September 30,\n | 2022 |  | 2023\nOperating activities |  |  | \nNet income | $ | 46,348 |  |  | $ | 53,108 | \nAdjustments: |  |  | \nDepreciation and impairment of property and equipment | 11,222 |  |  | 10,010 | \nAmortization and impairment of intangible assets | 505 |  |  | 373 | \nStock-based compensation expense | 14,262 |  |  | 16,801 | \nDeferred income taxes | (6,157) |  |  | (6,093) | \nLoss (gain) on debt and equity securities, net | 3,856 |  |  | 1,294 | \nOther | 369 |  |  | 912 | \nChanges in assets and liabilities, net of effects of acquisitions: |  |  | \nAccounts receivable, net | 2,298 |  |  | (1,315) | \nIncome taxes, net | (862) |  |  | 10,392 | \nOther assets | (4,268) |  |  | (2,883) | \nAccounts payable | 735 |  |  | 237 | \nAccrued expenses and other liabilities | 491 |  |  | (380) | \nAccrued revenue share | (1,022) |  |  | (315) | \nDeferred revenue | 104 |  |  | 690 | \nNet cash provided by operating activities | 67,881 |  |  | 82,831 | \nInvesting activities |  |  | \nPurchases of property and equipment | (23,890) |  |  | (21,232) | \nPurchases of marketable securities | (67,253) |  |  | (49,422) | \nMaturities and sales of marketable securities | 84,087 |  |  | 52,642 | \nPurchases of non-marketable securities | (1,628) |  |  | (2,176) | \nMaturities and sales of non-marketable securities | 131 |  |  | 743 | \n |  |  | \n |  |  | \nAcquisitions, net of cash acquired, and purchases of intangible assets | (6,885) |  |  | (466) | \nOther investing activities | 1,367 |  |  | (985) | \n |  |  | \nNet cash used in investing activities | (14,071) |  |  | (20,896) | \nFinancing activities |  |  | \nNet payments related to stock-based award activities | (7,221) |  |  | (7,157) | \n |  |  | \nRepurchases of stock | (43,889) |  |  | (45,313) | \nProceeds from issuance of debt, net of costs | 44,322 |  |  | 9,298 | \nRepayments of debt | (45,350) |  |  | (9,621) | \nProceeds from sale of interest in consolidated entities, net | 10 |  |  | 8 | \nNet cash used in financing activities | (52,128) |  |  | (52,785) | \nEffect of exchange rate changes on cash and cash equivalents | (643) |  |  | (327) | \nNet increase in cash and cash equivalents | 1,039 |  |  | 8,823 | \nCash and cash equivalents at beginning of period | 20,945 |  |  | 21,879 | \nCash and cash equivalents at end of period | $ | 21,984 |  |  | $ | 30,702 | \n |  |  | \n |  |  | \n |  |  | \n |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nGoogle Search & other | $ | 39,539 |  |  | $ | 44,026 |  |  | $ | 119,846 |  |  | $ | 127,013 | \nYouTube ads | 7,071 |  |  | 7,952 |  |  | 21,280 |  |  | 22,310 | \nGoogle Network | 7,872 |  |  | 7,669 |  |  | 24,305 |  |  | 23,015 | \nGoogle advertising | 54,482 |  |  | 59,647 |  |  | 165,431 |  |  | 172,338 | \nGoogle other | 6,895 |  |  | 8,339 |  |  | 20,259 |  |  | 23,894 | \nGoogle Services total | 61,377 |  |  | 67,986 |  |  | 185,690 |  |  | 196,232 | \nGoogle Cloud | 6,868 |  |  | 8,411 |  |  | 18,965 |  |  | 23,896 | \nOther Bets | 209 |  |  | 297 |  |  | 842 |  |  | 870 | \nHedging gains (losses) | 638 |  |  | (1) |  |  | 1,291 |  |  | 86 | \nTotal revenues | $ | 69,092 |  |  | $ | 76,693 |  |  | $ | 206,788 |  |  | $ | 221,084 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nUnited States | $ | 33,372 |  |  | 48 | % |  | $ | 36,354 |  |  | 47 | % |  | $ | 97,832 |  |  | 47 | % |  | $ | 104,291 |  |  | 47 | %\nEMEA(1) | 19,450 |  |  | 28 |  |  | 22,661 |  |  | 30 |  |  | 60,300 |  |  | 29 |  |  | 66,028 |  |  | 30 | \nAPAC(1) | 11,494 |  |  | 17 |  |  | 13,126 |  |  | 17 |  |  | 35,045 |  |  | 17 |  |  | 37,535 |  |  | 17 | \nOther Americas(1) | 4,138 |  |  | 6 |  |  | 4,553 |  |  | 6 |  |  | 12,320 |  |  | 6 |  |  | 13,144 |  |  | 6 | \nHedging gains (losses) | 638 |  |  | 1 |  |  | (1) |  |  | 0 |  |  | 1,291 |  |  | 1 |  |  | 86 |  |  | 0 | \nTotal revenues | $ | 69,092 |  |  | 100 | % |  | $ | 76,693 |  |  | 100 | % |  | $ | 206,788 |  |  | 100 | % |  | $ | 221,084 |  |  | 100 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | As of December 31, 2022\n |  | Fair Value Hierarchy |  | Adjusted Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Fair Value |  | Cash and Cash Equivalents |  | Marketable Securities\nFair value changes recorded in other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTime deposits |  | Level 2 |  | $ | 5,297 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 5,297 |  |  | $ | 5,293 |  |  | $ | 4 | \nGovernment bonds |  | Level 2 |  | 41,036 |  | 64 |  |  | (2,045) |  |  | 39,055 |  |  | 283 |  |  | 38,772 | \nCorporate debt securities |  | Level 2 |  | 28,578 |  | 8 |  |  | (1,569) |  |  | 27,017 |  |  | 1 |  |  | 27,016 | \nMortgage-backed and asset-backed securities |  | Level 2 |  | 16,176 |  | 5 |  |  | (1,242) |  |  | 14,939 |  |  | 0 |  |  | 14,939 | \nTotal investments with fair value change reflected in other comprehensive income(1) |  |  |  | $ | 91,087 |  |  | $ | 77 |  |  | $ | (4,856) |  |  | $ | 86,308 |  |  | $ | 5,577 |  |  | $ | 80,731 | \nFair value adjustments recorded in net income |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMoney market funds |  | Level 1 |  |  |  |  |  |  |  | $ | 7,234 |  |  | $ | 7,234 |  |  | $ | 0 | \nCurrent marketable equity securities(2) |  | Level 1 |  |  |  |  |  |  |  | 4,013 |  |  | 0 |  |  | 4,013 | \nMutual funds |  | Level 2 |  |  |  |  |  |  |  | 339 |  |  | 0 |  |  | 339 | \nGovernment bonds |  | Level 2 |  |  |  |  |  |  |  | 1,877 |  |  | 440 |  |  | 1,437 | \nCorporate debt securities |  | Level 2 |  |  |  |  |  |  |  | 3,744 |  |  | 65 |  |  | 3,679 | \nMortgage-backed and asset-backed securities |  | Level 2 |  |  |  |  |  |  |  | 1,686 |  |  | 2 |  |  | 1,684 | \nTotal investments with fair value change recorded in net income |  |  |  |  |  |  |  |  |  | $ | 18,893 |  |  | $ | 7,741 |  |  | $ | 11,152 | \nCash |  |  |  |  |  |  |  |  |  | 0 |  |  | 8,561 |  |  | 0 | \nTotal |  |  |  | $ | 91,087 |  |  | $ | 77 |  |  | $ | (4,856) |  |  | $ | 105,201 |  |  | $ | 21,879 |  |  | $ | 91,883 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  | As of September 30, 2023\n |  | Fair Value Hierarchy |  | Adjusted Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Fair Value |  | Cash and Cash Equivalents |  | Marketable Securities\nFair value changes recorded in other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  | \nTime deposits |  | Level 2 |  | $ | 2,987 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 2,987 |  |  | $ | 2,987 |  |  | $ | 0 | \nGovernment bonds |  | Level 2 |  | 50,369 |  |  | 2 |  |  | (1,916) |  |  | 48,455 |  |  | 8,505 |  |  | 39,950 | \nCorporate debt securities |  | Level 2 |  | 22,746 |  |  | 2 |  |  | (1,081) |  |  | 21,667 |  |  | 0 |  |  | 21,667 | \nMortgage-backed and asset-backed securities |  | Level 2 |  | 17,652 |  |  | 1 |  |  | (1,333) |  |  | 16,320 |  |  | 0 |  |  | 16,320 | \nTotal investments with fair value change reflected in other comprehensive income(1) |  |  |  | $ | 93,754 |  |  | $ | 5 |  |  | $ | (4,330) |  |  | $ | 89,429 |  |  | $ | 11,492 |  |  | $ | 77,937 | \nFair value adjustments recorded in net income |  |  |  |  |  |  |  |  |  |  |  |  |  | \nMoney market funds |  | Level 1 |  |  |  |  |  |  |  | $ | 9,268 |  |  | $ | 9,268 |  |  | $ | 0 | \nCurrent marketable equity securities(2) |  | Level 1 |  |  |  |  |  |  |  | 3,706 |  |  | 0 |  |  | 3,706 | \nMutual funds |  | Level 2 |  |  |  |  |  |  |  | 309 |  | 0 |  |  | 309\nGovernment bonds |  | Level 2 |  |  |  |  |  |  |  | 2,141 |  | 555 |  |  | 1,586\nCorporate debt securities |  | Level 2 |  |  |  |  |  |  |  | 3,483 |  | 93 |  |  | 3,390\nMortgage-backed and asset-backed securities |  | Level 2 |  |  |  |  |  |  |  | 2,305 |  | 0 |  |  | 2,305\nTotal investments with fair value change recorded in net income |  |  |  |  |  |  |  |  |  | $ | 21,212 |  |  | $ | 9,916 |  |  | $ | 11,296 | \nCash |  |  |  |  |  |  |  |  |  | 0 |  |  | 9,294 |  |  | 0 | \nTotal |  |  |  | $ | 93,754 |  |  | $ | 5 |  |  | $ | (4,330) |  |  | $ | 110,641 |  |  | $ | 30,702 |  |  | $ | 89,233 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \n | As ofSeptember 30, 2023\nDue in 1 year or less | $ | 13,958 | \nDue in 1 year through 5 years | 42,554 | \nDue in 5 years through 10 years | 15,114 | \nDue after 10 years | 13,592 | \nTotal | $ | 85,218 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022\n | Less\u00a0than\u00a012 Months |  | 12 Months or Greater |  | Total\n | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss\nGovernment bonds | $ | 21,039 |  |  | $ | (1,004) |  |  | $ | 13,438 |  |  | $ | (1,041) |  |  | $ | 34,477 |  |  | $ | (2,045) | \nCorporate debt securities | 11,228 |  |  | (440) |  |  | 15,125 |  |  | (1,052) |  |  | 26,353 |  |  | (1,492) | \nMortgage-backed and asset-backed securities | 7,725 |  |  | (585) |  |  | 6,964 |  |  | (657) |  |  | 14,689 |  |  | (1,242) | \nTotal | $ | 39,992 |  |  | $ | (2,029) |  |  | $ | 35,527 |  |  | $ | (2,750) |  |  | $ | 75,519 |  |  | $ | (4,779) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of September 30, 2023\n | Less\u00a0than\u00a012 Months |  | 12 Months or Greater |  | Total\n | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss |  | Fair\u00a0Value |  | UnrealizedLoss\nGovernment bonds | $ | 15,506 |  |  | $ | (463) |  |  | $ | 19,121 |  |  | $ | (1,453) |  |  | $ | 34,627 |  |  | $ | (1,916) | \nCorporate debt securities | 4,163 |  |  | (60) |  |  | 17,162 |  |  | (935) |  |  | 21,325 |  |  | (995) | \nMortgage-backed and asset-backed securities | 6,888 |  |  | (239) |  |  | 9,212 |  |  | (1,094) |  |  | 16,100 |  |  | (1,333) | \nTotal | $ | 26,557 |  |  | $ | (762) |  |  | $ | 45,495 |  |  | $ | (3,482) |  |  | $ | 72,052 |  |  | $ | (4,244) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nUnrealized gain (loss) on fair value option debt securities | $ | (177) |  |  | $ | (86) |  |  | $ | (746) |  |  | $ | 35 | \nGross realized gain on debt securities | 14 |  |  | 8 |  |  | 83 |  |  | 93 | \nGross realized loss on debt securities | (551) |  |  | (402) |  |  | (1,190) |  |  | (1,197) | \n(Increase) decrease in allowance for credit losses | (17) |  |  | (23) |  |  | (35) |  |  | (31) | \nTotal gain (loss) on debt securities recognized in other income (expense), net | $ | (731) |  |  | $ | (503) |  |  | $ | (1,888) |  |  | $ | (1,100) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022 |  | As of September 30, 2023\n | Marketable Equity Securities |  | Non-Marketable Equity Securities |  | Total |  | Marketable Equity Securities |  | Non-Marketable Equity Securities |  | Total\nTotal initial cost | $ | 5,764 |  |  | $ | 16,157 |  |  | $ | 21,921 |  |  | $ | 5,331 |  |  | $ | 17,504 |  |  | $ | 22,835 | \nCumulative net gain (loss)(1) | (608) |  |  | 12,372 |  |  | 11,764 |  |  | (358) |  |  | 11,317 |  |  | 10,959 | \nCarrying value | $ | 5,156 |  |  | $ | 28,529 |  |  | $ | 33,685 |  |  | $ | 4,973 |  |  | $ | 28,821 |  |  | $ | 33,794 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nRealized net gain (loss) on equity securities sold during the period | $ | (73) |  |  | $ | 42 |  |  | $ | (355) |  |  | $ | 348 | \nUnrealized net gain (loss) on marketable equity securities | (86) |  |  | (224) |  |  | (2,494) |  |  | 136 | \nUnrealized net gain (loss) on non-marketable equity securities(1) | (488) |  |  | (184) |  |  | 881 |  |  | (678) | \nTotal gain (loss) on equity securities in other income (expense), net | $ | (647) |  |  | $ | (366) |  |  | $ | (1,968) |  |  | $ | (194) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Equity Securities Sold\n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nTotal sale price | $ | 296 |  |  | $ | 736 |  |  | $ | 1,631 |  |  | $ | 1,475 | \nTotal initial cost | 310 |  |  | 549 |  |  | 738 |  |  | 916 | \nCumulative net gain (loss) | $ | (14) |  |  | $ | 187 |  |  | $ | 893 |  |  | $ | 559 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022 |  | As of September 30, 2023\nDerivatives designated as hedging instruments: |  | \nForeign exchange contracts |  |  | \nCash flow hedges | $ | 15,972 |  |  | $ | 17,225 | \nFair value hedges | $ | 2,117 |  |  | $ | 1,384 | \nNet investment hedges | $ | 8,751 |  |  | $ | 9,547 | \nDerivatives not designated as hedging instruments: |  | \nForeign exchange contracts | $ | 34,979 |  |  | $ | 36,585 | \nOther contracts | $ | 7,932 |  |  | $ | 11,572 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022 |  | As of September 30, 2023\n | Assets(1) |  | Liabilities(2) |  | Assets(1) |  | Liabilities(2)\nDerivatives designated as hedging instruments: |  |  |  |  |  |  | \nForeign exchange contracts | $ | 271 |  |  | $ | 556 |  |  | $ | 1,102 |  |  | $ | 14 | \n |  |  |  |  |  |  | \nDerivatives not designated as hedging instruments: |  |  |  |  |  |  | \nForeign exchange contracts | 365 |  | 207 |  | 123 |  | 496\nOther contracts | 40 |  | 47 |  | 149 |  | 85\nTotal derivatives not designated as hedging instruments | 405 |  |  | 254 |  |  | 272 |  |  | 581 | \nTotal | $ | 676 |  |  | $ | 810 |  |  | $ | 1,374 |  |  | $ | 595 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Gains (Losses) Recognized in OCI on Derivatives Before Tax Effect\n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nDerivatives in cash flow hedging relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount included in the assessment of effectiveness | $ | 1,486 |  |  | $ | 652 |  |  | $ | 2,752 |  |  | $ | 591 | \nAmount excluded from the assessment of effectiveness | (77) |  |  | 16 |  |  | (131) |  |  | 143 | \n |  |  |  |  |  |  | \nDerivatives in net investment hedging relationship: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount included in the assessment of effectiveness | 760 |  |  | 336 |  |  | 1,418 |  |  | 62 | \nTotal | $ | 2,169 |  |  | $ | 1,004 |  |  | $ | 4,039 |  |  | $ | 796 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Gains (Losses) Recognized in Income\n | Three Months Ended\n | September 30,\n | 2022 |  | 2023\n | Revenues |  | Other income (expense), net |  | Revenues |  | Other income (expense), net\nTotal amounts in the Consolidated Statements of Income | $ | 69,092 |  |  | $ | (902) |  |  | $ | 76,693 |  |  | $ | (146) | \n |  |  |  |  |  |  | \nEffect of cash flow hedges: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount reclassified from AOCI to income | $ | 658 |  |  | $ | 0 |  |  | $ | (15) |  |  | $ | 0 | \nAmount excluded from the assessment of effectiveness (amortized) | (20) |  |  | 0 |  |  | 14 |  |  | 0 | \nEffect of fair value hedges: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nHedged items | 0 |  |  | (226) |  |  | 0 |  |  | (48) | \nDerivatives designated as hedging instruments | 0 |  |  | 226 |  |  | 0 |  |  | 48 | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 6 |  |  | 0 |  |  | 2 | \nEffect of net investment hedges: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 59 |  |  | 0 |  |  | 13 | \nEffect of non designated hedges: |  |  |  |  |  |  | \nForeign exchange contracts | 0 |  |  | (495) |  |  | 0 |  |  | (340) | \nOther contracts | 0 |  |  | 34 |  |  | 0 |  |  | 83 | \nTotal gains (losses) | $ | 638 |  |  | $ | (396) |  |  | $ | (1) |  |  | $ | (242) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Gains (Losses) Recognized in Income\n | Nine Months Ended\n | September 30,\n | 2022 |  | 2023\n | Revenues |  | Other income (expense), net |  | Revenues |  | Other income (expense), net\nTotal amounts in the Consolidated Statements of Income | $ | 206,788 |  |  | $ | (2,501) |  |  | $ | 221,084 |  |  | $ | 709 | \n |  |  |  |  |  |  | \nEffect of cash flow hedges: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount of gains (losses) reclassified from AOCI to income | $ | 1,355 |  |  | $ | 0 |  |  | $ | 71 |  |  | $ | 0 | \nAmount excluded from the assessment of effectiveness (amortized) | (63) |  |  | 0 |  |  | 16 |  |  | 0 | \nEffect of fair value hedges: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nHedged items | 0 |  |  | (349) |  |  | 0 |  |  | 6 | \nDerivatives designated as hedging instruments | 0 |  |  | 350 |  |  | 0 |  |  | (6) | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 9 |  |  | 0 |  |  | 12 | \nEffect of net investment hedges: |  |  |  |  |  |  | \nForeign exchange contracts |  |  |  |  |  |  | \nAmount excluded from the assessment of effectiveness | 0 |  |  | 99 |  |  | 0 |  |  | 136 | \nEffect of non designated hedges: |  |  |  |  |  |  | \nForeign exchange contracts | 0 |  |  | (891) |  |  | 0 |  |  | (186) | \nOther contracts | 0 |  |  | 158 |  |  | 0 |  |  | 82 | \nTotal gains (losses) | $ | 1,292 |  |  | $ | (624) |  |  | $ | 87 |  |  | $ | 44 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset |  | \n | Gross Amounts Recognized |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Amounts Presented in the Consolidated Balance Sheets |  | Financial Instruments(1) |  | Cash and Non-Cash Collateral Received or Pledged |  | Net Amounts\nDerivatives assets | $ | 760 |  |  | $ | (84) |  |  | $ | 676 |  |  | $ | (463) |  |  | $ | (132) |  |  | $ | 81 | \nDerivatives liabilities | $ | 894 |  |  | $ | (84) |  |  | $ | 810 |  |  | $ | (463) |  |  | $ | (28) |  |  | $ | 319 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of September 30, 2023\n |  |  |  |  |  |  | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset |  | \n | Gross Amounts Recognized |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Amounts Presented in the Consolidated Balance Sheets |  | Financial Instruments(1) |  | Cash and Non-Cash Collateral Received or Pledged |  | Net Amounts\nDerivatives assets | $ | 1,396 |  |  | $ | (22) |  |  | $ | 1,374 |  |  | $ | (448) |  |  | $ | (730) |  |  | $ | 196 | \nDerivatives liabilities | $ | 617 |  |  | $ | (22) |  |  | $ | 595 |  |  | $ | (448) |  |  | $ | (25) |  |  | $ | 122 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Maturity |  | Coupon Rate |  | Effective Interest Rate |  | As of December 31, 2022 |  | As ofSeptember 30, 2023\nDebt |  |  |  |  |  |  |  |  |  | \n2014-2020 Notes issuances |  | 2024 - 2060 |  | 0.45% -3.38% |  | 0.57% -3.38% |  | $ | 13,000 |  |  | $ | 13,000 | \nFuture finance lease payments, net and other(1) |  |  |  |  |  |  |  | 2,142 |  |  | 2,314 | \nTotal debt |  |  |  |  |  |  |  | 15,142 |  |  | 15,314 | \nUnamortized discount and debt issuance costs |  |  |  |  |  |  |  | (143) |  |  | (133) | \nLess: Current portion of long-term notes(2) |  |  |  |  |  |  |  | 0 |  |  | (1,000) | \nLess: Current portion of future finance lease payments, net and other current debt(1)(2) |  |  |  |  |  |  |  | (298) |  |  | (400) | \nTotal long-term debt |  |  |  |  |  |  |  | $ | 14,701 |  |  | $ | 13,781 |   |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2022 |  | As ofSeptember 30, 2023\nLand and buildings | $ | 66,897 |  |  | $ | 71,357 | \nInformation technology assets | 66,267 |  |  | 74,928 | \nConstruction in progress | 27,657 |  |  | 32,305 | \nLeasehold improvements | 10,575 |  |  | 11,441 | \nFurniture and fixtures | 314 |  |  | 424 | \nProperty and equipment, gross | 171,710 |  |  | 190,455 | \nLess: accumulated depreciation | (59,042) |  |  | (64,750) | \nProperty and equipment, net | $ | 112,668 |  |  | $ | 125,705 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2022 |  | As ofSeptember 30, 2023\nEuropean Commission fines(1) | $ | 9,106 |  |  | $ | 9,143 | \nIncome taxes payable, net(2) | 1,632 |  |  | 13,528 | \nAccrued customer liabilities | 3,619 |  |  | 3,595 | \nAccrued purchases of property and equipment | 3,019 |  |  | 4,090 | \nCurrent operating lease liabilities | 2,477 |  |  | 2,715 | \nOther accrued expenses and current liabilities | 18,013 |  |  | 22,531 | \nAccrued expenses and other current liabilities | $ | 37,866 |  |  | $ | 55,602 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Available-for-Sale Investments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total\nBalance as of December 31, 2021 | $ | (2,306) |  |  | $ | 236 |  |  | $ | 447 |  |  | $ | (1,623) | \nOther comprehensive income (loss) before reclassifications | (3,801) |  |  | (5,204) |  |  | 2,296 |  |  | (6,709) | \nAmounts excluded from the assessment of hedge effectiveness recorded in AOCI | 0 |  |  | 0 |  |  | (131) |  |  | (131) | \nAmounts reclassified from AOCI | 0 |  |  | 743 |  |  | (1,132) |  |  | (389) | \nOther comprehensive income (loss) | (3,801) |  |  | (4,461) |  |  | 1,033 |  |  | (7,229) | \nBalance as of September 30, 2022 | $ | (6,107) |  |  | $ | (4,225) |  |  | $ | 1,480 |  |  | $ | (8,852) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Foreign Currency Translation Adjustments |  | Unrealized Gains (Losses) on Available-for-Sale Investments |  | Unrealized Gains (Losses) on Cash Flow Hedges |  | Total\nBalance as of December 31, 2022 | $ | (4,142) |  |  | $ | (3,477) |  |  | $ | 16 |  |  | $ | (7,603) | \nOther comprehensive income (loss) before reclassifications | (338) |  |  | (382) |  |  | 484 |  |  | (236) | \nAmounts excluded from the assessment of hedge effectiveness recorded in AOCI | 0 |  |  | 0 |  |  | 143 |  |  | 143 | \nAmounts reclassified from AOCI | 0 |  |  | 745 |  |  | (85) |  |  | 660 | \nOther comprehensive income (loss) | (338) |  |  | 363 |  |  | 542 |  |  | 567 | \nBalance as of September 30, 2023 | $ | (4,480) |  |  | $ | (3,114) |  |  | $ | 558 |  |  | $ | (7,036) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Gains (Losses) Reclassified from AOCI to the Consolidated Statements of Income\n |  |  | Three Months Ended |  | Nine Months Ended\n |  |  | September 30, |  | September 30,\nAOCI Components |  | Location | 2022 |  | 2023 |  | 2022 |  | 2023\nUnrealized gains (losses) on available-for-sale investments |  |  |  |  |  |  | \n |  | Other income (expense), net | $ | (464) |  |  | $ | (327) |  |  | $ | (953) |  |  | $ | (955) | \n |  | Benefit (provision) for income taxes | 102 |  |  | 72 |  |  | 210 |  |  | 210 | \n |  | Net of income tax | (362) |  |  | (255) |  |  | (743) |  |  | (745) | \nUnrealized gains (losses) on cash flow hedges |  |  |  |  |  |  | \nForeign exchange contracts |  | Revenue | 658 |  |  | (15) |  |  | 1,355 |  |  | 71 | \nInterest rate contracts |  | Other income (expense), net | 2 |  |  | 2 |  |  | 5 |  |  | 5 | \n |  | Benefit (provision) for income taxes | (113) |  |  | 16 |  |  | (228) |  |  | 9 | \n |  | Net of income tax | 547 |  |  | 3 |  |  | 1,132 |  |  | 85 | \nTotal amount reclassified, net of income tax | $ | 185 |  |  | $ | (252) |  |  | $ | 389 |  |  | $ | (660) |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nInterest income | $ | 615 |  |  | $ | 1,066 |  |  | $ | 1,515 |  |  | $ | 2,755 | \nInterest expense(1) | (101) |  |  | (116) |  |  | (267) |  |  | (239) | \nForeign currency exchange gain (loss), net | (136) |  |  | (311) |  |  | (469) |  |  | (789) | \nGain (loss) on debt securities, net | (731) |  |  | (503) |  |  | (1,888) |  |  | (1,100) | \nGain (loss) on equity securities, net | (647) |  |  | (366) |  |  | (1,968) |  |  | (194) | \nPerformance fees | 54 |  |  | 179 |  |  | 605 |  |  | 302 | \nIncome (loss) and impairment from equity method investments, net | (99) |  |  | (215) |  |  | (306) |  |  | (372) | \nOther | 143 |  |  | 120 |  |  | 277 |  |  | 346 | \nOther income (expense), net | $ | (902) |  |  | $ | (146) |  |  | $ | (2,501) |  |  | $ | 709 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, 2023 |  | Nine Months Ended September 30, 2023\n | Severance and Related(1) |  | Office Space |  | Total |  | Severance and Related(1) |  | Office Space |  | Total\nCost of revenues | $ | 17 |  |  | $ | 6 |  |  | $ | 23 |  |  | $ | 477 |  |  | $ | 246 |  |  | $ | 723 | \nResearch and development | 15 |  |  | 7 |  |  | 22 |  |  | 847 |  | 268 |  |  | 1,115 | \nSales and marketing | 50 |  |  | 1 |  |  | 51 |  |  | 494 |  | 59 |  |  | 553 | \nGeneral and administrative | 4 |  |  | 2 |  |  | 6 |  |  | 263 |  | 76 |  |  | 339 | \nTotal charges | $ | 86 |  |  | $ | 16 |  |  | $ | 102 |  |  | $ | 2,081 |  |  | $ | 649 |  |  | $ | 2,730 |   |  |  |  |  | \n | Severance and Related\nBalance as of December 31, 2022 | $ | 0 | \nCharges(1) | 1,652 | \nCash payments | (1,547) | \nBalance as of September 30, 2023(2) | $ | 105 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Google Services |  | Google Cloud |  | Other Bets |  | Total\nBalance as of December 31, 2022 | $ | 20,847 |  |  | $ | 7,205 |  |  | $ | 908 |  |  | $ | 28,960 | \nAcquisitions | 240 |  |  | 3 |  |  | 0 |  |  | 243 | \nForeign currency translation and other adjustments | (15) |  |  | (13) |  |  | (29) |  |  | (57) | \nBalance as of September 30, 2023 | $ | 21,072 |  |  | $ | 7,195 |  |  | $ | 879 |  |  | $ | 29,146 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | As of December 31, 2022 |  | As of September 30, 2023\n | GrossCarryingAmount |  | AccumulatedAmortization |  | NetCarryingAmount |  | GrossCarryingAmount |  | AccumulatedAmortization |  | NetCarryingAmount |  | \nPatents and developed technology | $ | 1,164 |  |  | $ | 354 |  |  | $ | 810 |  |  | $ | 1,152 |  |  | $ | 453 |  |  | $ | 699 |  |  | \nCustomer relationships | 862 |  |  | 235 |  |  | 627 |  |  | 868 |  |  | 335 |  |  | 533 |  |  | \nTrade names and other | 527 |  |  | 120 |  |  | 407 |  |  | 528 |  |  | 161 |  |  | 367 |  |  | \nTotal definite-lived intangible assets | 2,553 |  |  | 709 |  |  | 1,844 |  |  | 2,548 |  |  | 949 |  |  | 1,599 |  |  | \nIndefinite-lived intangible assets | 240 |  |  | 0 |  |  | 240 |  |  | 234 |  |  | 0 |  |  | 234 |  |  | \nTotal intangible assets | $ | 2,793 |  |  | $ | 709 |  |  | $ | 2,084 |  |  | $ | 2,782 |  |  | $ | 949 |  |  | $ | 1,833 |  |  |   |  |  |  |  | \nRemainder of 2023 | $ | 118 | \n2024 | 466 | \n2025 | 335 | \n2026 | 257 | \n2027 | 174 | \nThereafter | 249 | \nTotal | $ | 1,599 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, 2023 |  | Nine Months Ended September 30, 2023\n | Shares |  | Amount |  | Shares |  | Amount\nClass A share repurchases | 14 |  |  | $ | 1,805 |  |  | 51 |  |  | $ | 5,724 | \nClass C share repurchases | 108 |  |  | 14,113 |  |  | 359 |  |  | 40,432 | \nTotal share repurchases(1) | 122 |  |  | $ | 15,918 |  |  | 410 |  |  | $ | 46,156 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30,\n | 2022 |  | 2023\n | Class A |  | Class B |  | Class C |  | Class A |  | Class B |  | Class C\nBasic net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings | $ | 6,393 |  |  | $ | 946 |  |  | $ | 6,571 |  |  | $ | 9,271 |  |  | $ | 1,369 |  |  | $ | 9,049 | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in per share computation | 5,983 |  |  | 885 |  |  | 6,150 |  |  | 5,924 |  |  | 875 |  |  | 5,782 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nBasic net income per share | $ | 1.07 |  |  | $ | 1.07 |  |  | $ | 1.07 |  |  | $ | 1.56 |  |  | $ | 1.56 |  |  | $ | 1.56 | \nDiluted net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings for basic computation | $ | 6,393 |  |  | $ | 946 |  |  | $ | 6,571 |  |  | $ | 9,271 |  |  | $ | 1,369 |  |  | $ | 9,049 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nReallocation of undistributed earnings as a result of conversion of Class B to Class\u00a0A shares | 946 |  |  | 0 |  |  | 0 |  |  | 1,369 |  |  | 0 |  |  | 0 | \nReallocation of undistributed earnings | (45) |  |  | (6) |  |  | 45 |  |  | (96) |  |  | (12) |  |  | 96 | \nAllocation of undistributed earnings | $ | 7,294 |  |  | $ | 940 |  |  | $ | 6,616 |  |  | $ | 10,544 |  |  | $ | 1,357 |  |  | $ | 9,145 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in basic computation | 5,983 |  |  | 885 |  |  | 6,150 |  |  | 5,924 |  |  | 875 |  |  | 5,782 | \nWeighted-average effect of dilutive securities |  |  |  |  |  |  |  |  |  |  | \nAdd: |  |  |  |  |  |  |  |  |  |  | \nConversion of Class B to Class\u00a0A shares outstanding | 885 |  |  | 0 |  |  | 0 |  |  | 875 |  |  | 0 |  |  | 0 | \n |  |  |  |  |  |  |  |  |  |  | \nRestricted stock units and other contingently issuable shares | 0 |  |  | 0 |  |  | 79 |  |  | 0 |  |  | 0 |  |  | 115 | \nNumber of shares used in per share computation | 6,868 |  |  | 885 |  |  | 6,229 |  |  | 6,799 |  |  | 875 |  |  | 5,897 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDiluted net income per share | $ | 1.06 |  |  | $ | 1.06 |  |  | $ | 1.06 |  |  | $ | 1.55 |  |  | $ | 1.55 |  |  | $ | 1.55 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended September 30,\n | 2022 |  | 2023\n | Class A |  | Class B |  | Class C |  | Class A |  | Class B |  | Class C\nBasic net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings | $ | 21,213 |  |  | $ | 3,137 |  |  | $ | 21,998 |  |  | $ | 24,851 |  |  | $ | 3,682 |  |  | $ | 24,575 | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in per share computation | 6,004 |  |  | 888 |  |  | 6,226 |  |  | 5,932 |  |  | 879 |  |  | 5,866 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nBasic net income per share | $ | 3.53 |  |  | $ | 3.53 |  |  | $ | 3.53 |  |  | $ | 4.19 |  |  | $ | 4.19 |  |  | $ | 4.19 | \nDiluted net income per share: |  |  |  |  |  |  |  |  |  |  | \nNumerator |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nAllocation of undistributed earnings for basic computation | $ | 21,213 |  |  | $ | 3,137 |  |  | $ | 21,998 |  |  | $ | 24,851 |  |  | $ | 3,682 |  |  | $ | 24,575 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nReallocation of undistributed earnings as a result of conversion of Class B to Class\u00a0A shares | 3,137 |  |  | 0 |  |  | 0 |  |  | 3,682 |  |  | 0 |  |  | 0 | \nReallocation of undistributed earnings | (204) |  |  | (26) |  |  | 204 |  |  | (187) |  |  | (24) |  |  | 187 | \nAllocation of undistributed earnings | $ | 24,146 |  |  | $ | 3,111 |  |  | $ | 22,202 |  |  | $ | 28,346 |  |  | $ | 3,658 |  |  | $ | 24,762 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDenominator |  |  |  |  |  |  |  |  |  |  | \nNumber of shares used in basic computation | 6,004 |  |  | 888 |  |  | 6,226 |  |  | 5,932 |  |  | 879 |  |  | 5,866 | \nWeighted-average effect of dilutive securities |  |  |  |  |  |  |  |  |  |  | \nAdd: |  |  |  |  |  |  |  |  |  |  | \nConversion of Class B to Class\u00a0A shares outstanding | 888 |  |  | 0 |  |  | 0 |  |  | 879 |  |  | 0 |  |  | 0 | \n |  |  |  |  |  |  |  |  |  |  | \nRestricted stock units and other contingently issuable shares | 0 |  |  | 0 |  |  | 111 |  |  | 0 |  |  | 0 |  |  | 84 | \nNumber of shares used in per share computation | 6,892 |  |  | 888 |  |  | 6,337 |  |  | 6,811 |  |  | 879 |  |  | 5,950 | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |  |  |  | \nDiluted net income per share | $ | 3.50 |  |  | $ | 3.50 |  |  | $ | 3.50 |  |  | $ | 4.16 |  |  | $ | 4.16 |  |  | $ | 4.16 |   |  |  |  |  |  |  |  |  |  |  | \n | Unvested\u00a0Restricted\u00a0Stock\u00a0Units\n | Number ofShares |  | Weighted-AverageGrant-DateFair Value\nUnvested as of December 31, 2022 | 324 |  |  | $ | 107.98 | \nGranted | 255 |  |  | $ | 96.49 | \nVested | (160) |  |  | $ | 100.31 | \nForfeited/canceled | (26) |  |  | $ | 107.27 | \nUnvested as of September 30, 2023 | 393 |  |  | $ | 103.71 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nIncome before provision for income taxes | $ | 16,233 |  |  | $ | 21,197 |  |  | $ | 54,181 |  |  | $ | 61,305 | \nProvision for income taxes | $ | 2,323 |  |  | $ | 1,508 |  |  | $ | 7,833 |  |  | $ | 8,197 | \nEffective tax rate | 14.3 | % |  | 7.1 | % |  | 14.5 | % |  | 13.4 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nRevenues: |  |  |  |  |  |  | \nGoogle Services | $ | 61,377 |  |  | $ | 67,986 |  |  | $ | 185,690 |  |  | $ | 196,232 | \nGoogle Cloud | 6,868 |  |  | 8,411 |  |  | 18,965 |  |  | 23,896 | \nOther Bets | 209 |  |  | 297 |  |  | 842 |  |  | 870 | \nHedging gains (losses) | 638 |  |  | (1) |  |  | 1,291 |  |  | 86 | \nTotal revenues | $ | 69,092 |  |  | $ | 76,693 |  |  | $ | 206,788 |  |  | $ | 221,084 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nOperating income (loss): |  |  |  |  |  |  | \nGoogle Services | $ | 18,883 |  |  | $ | 23,937 |  |  | $ | 62,477 |  |  | $ | 69,128 | \nGoogle Cloud | (440) |  |  | 266 |  |  | (1,736) |  |  | 852 | \nOther Bets | (1,225) |  |  | (1,194) |  |  | (3,399) |  |  | (3,232) | \nCorporate costs, unallocated | (83) |  |  | (1,666) |  |  | (660) |  |  | (6,152) | \nTotal income from operations | $ | 17,135 |  |  | $ | 21,343 |  |  | $ | 56,682 |  |  | $ | 60,596 |   |  |  |  |  |  |  |  |  |  |  | \n | As ofDecember 31, 2022 |  | As ofSeptember 30, 2023\nLong-lived assets: |  |  | \nUnited States | $ | 93,565 |  |  | $ | 104,113 | \nInternational | 33,484 |  |  | 35,791 | \nTotal long-lived assets | $ | 127,049 |  |  | $ | 139,904 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Three Months Ended |  |  |  | \n | September 30, |  |  |  | \n |  | 2022 |  | 2023 |  | $ Change |  | % Change\nConsolidated revenues |  | $ | 69,092 |  |  | $ | 76,693 |  |  | $ | 7,601 |  |  | 11 | %\nChange in consolidated constant currency revenues(1) |  |  |  |  |  |  |  | 11 | %\n |  |  |  |  |  |  |  | \nCost of revenues |  | $ | 31,158 |  |  | $ | 33,229 |  |  | $ | 2,071 |  |  | 7 | %\nOperating expenses |  | $ | 20,799 |  |  | $ | 22,121 |  |  | $ | 1,322 |  |  | 6 | %\n |  |  |  |  |  |  |  | \nOperating income |  | $ | 17,135 |  |  | $ | 21,343 |  |  | $ | 4,208 |  |  | 25 | %\nOperating margin |  | 25 | % |  | 28 | % |  |  |  | 3 | %\n |  |  |  |  |  |  |  | \nOther income (expense), net |  | $ | (902) |  |  | $ | (146) |  |  | $ | 756 |  |  | (84) | %\n |  |  |  |  |  |  |  | \nNet Income |  | $ | 13,910 |  |  | $ | 19,689 |  |  | $ | 5,779 |  |  | 42 | %\nDiluted EPS |  | $ | 1.06 |  |  | $ | 1.55 |  |  | $ | 0.49 |  |  | 46 | %\n |  |  |  |  |  |  |  | \n |  |  |  |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nGoogle Search & other | $ | 39,539 |  |  | $ | 44,026 |  |  | $ | 119,846 |  |  | $ | 127,013 | \nYouTube ads | 7,071 |  |  | 7,952 |  |  | 21,280 |  |  | 22,310 | \nGoogle Network | 7,872 |  |  | 7,669 |  |  | 24,305 |  |  | 23,015 | \nGoogle advertising | 54,482 |  |  | 59,647 |  |  | 165,431 |  |  | 172,338 | \nGoogle other | 6,895 |  |  | 8,339 |  |  | 20,259 |  |  | 23,894 | \nGoogle Services total | 61,377 |  |  | 67,986 |  |  | 185,690 |  |  | 196,232 | \nGoogle Cloud | 6,868 |  |  | 8,411 |  |  | 18,965 |  |  | 23,896 | \nOther Bets | 209 |  |  | 297 |  |  | 842 |  |  | 870 | \nHedging gains (losses) | 638 |  |  | (1) |  |  | 1,291 |  |  | 86 | \nTotal revenues | $ | 69,092 |  |  | $ | 76,693 |  |  | $ | 206,788 |  |  | $ | 221,084 |   |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2023 |  | 2023\nPaid clicks change | 7% |  | 8%\nCost-per-click change | 4% |  | (2)%  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended September 30, |  | Nine Months Ended September 30,\n | 2023 |  | 2023\nImpressions change | (3)% |  | (2)%\nCost-per-impression change | 1% |  | (3)%  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nUnited States | 48 | % |  | 47 | % |  | 47 | % |  | 47 | %\nEMEA | 28 | % |  | 30 | % |  | 29 | % |  | 30 | %\nAPAC | 17 | % |  | 17 | % |  | 17 | % |  | 17 | %\nOther Americas | 6 | % |  | 6 | % |  | 6 | % |  | 6 | %\nHedging gains (losses) | 1 | % |  | 0 | % |  | 1 | % |  | 0 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | Three Months Ended September 30, 2023\n |  |  |  |  |  |  |  |  | % Change from Prior Period\n | Three Months Ended September 30, |  | Less FX Effect |  | Constant Currency Revenues |  | As Reported |  | Less Hedging Effect |  | Less FX Effect |  | Constant Currency Revenues\n | 2022 |  | 2023 |  |  |  |  |  | \nUnited States | $ | 33,372 |  |  | $ | 36,354 |  |  | $ | 0 |  |  | $ | 36,354 |  |  | 9 | % |  |  |  | 0 | % |  | 9 | %\nEMEA | 19,450 |  |  | 22,661 |  |  | 803 |  |  | 21,858 |  |  | 17 | % |  |  |  | 5 | % |  | 12 | %\nAPAC | 11,494 |  |  | 13,126 |  |  | (270) |  |  | 13,396 |  |  | 14 | % |  |  |  | (3) | % |  | 17 | %\nOther Americas | 4,138 |  |  | 4,553 |  |  | (106) |  |  | 4,659 |  |  | 10 | % |  |  |  | (3) | % |  | 13 | %\nRevenues, excluding hedging effect | 68,454 |  |  | 76,694 |  |  | 427 |  |  | 76,267 |  |  | 12 | % |  |  |  | 1 | % |  | 11 | %\nHedging gains (losses) | 638 |  |  | (1) |  |  |  |  |  |  |  |  |  |  |  |  | \nTotal revenues(1) | $ | 69,092 |  |  | $ | 76,693 |  |  |  |  | $ | 76,267 |  |  | 11 | % |  | (1) | % |  | 1 | % |  | 11 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  |  |  | Nine Months Ended September 30, 2023\n |  |  |  |  |  |  |  |  | % Change from Prior Period\n | Nine Months Ended September 30, |  | Less FX Effect |  | Constant Currency Revenues |  | As Reported |  | Less Hedging Effect |  | Less FX Effect |  | Constant Currency Revenues\n | 2022 |  | 2023 |  |  |  |  |  | \nUnited States | $ | 97,832 |  |  | $ | 104,291 |  |  | $ | 0 |  |  | $ | 104,291 |  |  | 7 | % |  |  |  | 0 | % |  | 7 | %\nEMEA | 60,300 |  |  | 66,028 |  |  | (645) |  |  | 66,673 |  |  | 9 | % |  |  |  | (2) | % |  | 11 | %\nAPAC | 35,045 |  |  | 37,535 |  |  | (1,669) |  |  | 39,204 |  |  | 7 | % |  |  |  | (5) | % |  | 12 | %\nOther Americas | 12,320 |  |  | 13,144 |  |  | (579) |  |  | 13,723 |  |  | 7 | % |  |  |  | (4) | % |  | 11 | %\nRevenues, excluding hedging effect | 205,497 |  |  | 220,998 |  |  | (2,893) |  |  | 223,891 |  |  | 8 | % |  |  |  | (1) | % |  | 9 | %\nHedging gains (losses) | 1,291 |  |  | 86 |  |  |  |  |  |  |  |  |  |  |  |  | \nTotal revenues(1) | $ | 206,788 |  |  | $ | 221,084 |  |  |  |  | $ | 223,891 |  |  | 7 | % |  | (1) | % |  | (1) | % |  | 9 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nTAC | $ | 11,826 |  |  | $ | 12,642 |  |  | $ | 36,030 |  |  | $ | 36,900 | \nOther cost of revenues | 19,332 |  |  | 20,587 |  |  | 54,831 |  |  | 58,857 | \nTotal cost of revenues | $ | 31,158 |  |  | $ | 33,229 |  |  | $ | 90,861 |  |  | $ | 95,757 | \nTotal cost of revenues as a percentage of revenues | 45 | % |  | 43 | % |  | 44 | % |  | 43 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nResearch and development expenses | $ | 10,273 |  |  | $ | 11,258 |  |  | $ | 29,233 |  |  | $ | 33,314 | \nResearch and development expenses as a percentage of revenues | 15 | % |  | 15 | % |  | 14 | % |  | 15 | %  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nSales and marketing expenses | $ | 6,929 |  |  | $ | 6,884 |  |  | $ | 19,384 |  |  | $ | 20,198 | \nSales and marketing expenses as a percentage of revenues | 10 | % |  | 9 | % |  | 9 | % |  | 9 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nGeneral and administrative expenses | $ | 3,597 |  |  | $ | 3,979 |  |  | $ | 10,628 |  |  | $ | 11,219 | \nGeneral and administrative expenses as a percentage of revenues | 5 | % |  | 5 | % |  | 5 | % |  | 5 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  |  |  | \n |  |  |  |  | \n |  |  |  |  |  |  | \nOperating income (loss): |  |  |  |  |  |  | \nGoogle Services | $ | 18,883 |  |  | $ | 23,937 |  |  | $ | 62,477 |  |  | $ | 69,128 | \nGoogle Cloud | (440) |  |  | 266 |  |  | (1,736) |  |  | 852 | \nOther Bets | (1,225) |  |  | (1,194) |  |  | (3,399) |  |  | (3,232) | \nCorporate costs, unallocated(1) | (83) |  |  | (1,666) |  |  | (660) |  |  | (6,152) | \nTotal income from operations | $ | 17,135 |  |  | $ | 21,343 |  |  | $ | 56,682 |  |  | $ | 60,596 |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nOther income (expense), net | $ | (902) |  |  | $ | (146) |  |  | $ | (2,501) |  |  | $ | 709 | \n |  |  |  |  |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\n | September 30, |  | September 30,\n | 2022 |  | 2023 |  | 2022 |  | 2023\nIncome before provision for income taxes | $ | 16,233 |  |  | $ | 21,197 |  |  | $ | 54,181 |  |  | $ | 61,305 | \nProvision for income taxes | $ | 2,323 |  |  | $ | 1,508 |  |  | $ | 7,833 |  |  | $ | 8,197 | \nEffective tax rate | 14.3 | % |  | 7.1 | % |  | 14.5 | % |  | 13.4 | %  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended\n | September 30,\n | 2022 |  | 2023\nNet cash provided by operating activities | $ | 67,881 |  |  | $ | 82,831 | \nNet cash used in investing activities | $ | (14,071) |  |  | $ | (20,896) | \nNet cash used in financing activities | $ | (52,128) |  |  | $ | (52,785) |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | Total Number of Class A Shares Purchased(in thousands)(1) |  | Total Number of Class C Shares Purchased(in thousands)(1) |  | Average Price Paid per Class A Share(2) |  | Average Price Paid per Class C Share(2) |  | Total Number of Shares Purchased as Part of Publicly Announced Programs(in thousands)(1) |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program(in millions)\nJuly 1 - 31 |  | 3,647 |  |  | 36,664 |  |  | $ | 124.11 |  |  | $ | 125.22 |  |  | 40,311 |  |  | $ | 63,066 | \nAugust 1 - 31 |  | 4,043 |  |  | 39,758 |  |  | $ | 132.61 |  |  | $ | 132.16 |  |  | 43,801 |  |  | $ | 57,320 | \nSeptember 1 - 30 |  | 6,028 |  |  | 31,408 |  |  | $ | 135.44 |  |  | $ | 135.90 |  |  | 37,436 |  |  | $ | 52,267 | \nTotal |  | 13,718 |  |  | 107,830 |  |  |  |  |  |  | 121,548 |  |  |   |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nExhibitNumber |  |  | Description |  | Incorporated\u00a0by\u00a0reference\u00a0herein\n |  | Form |  | Date\n31.01 | * |  | Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n31.02 | * |  | Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n32.01 | \u2021 |  | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18\u00a0U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |  |  |  | \n101.INS | * |  | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |  |  |  | \n101.SCH | * |  | Inline XBRL Taxonomy Extension Schema Document |  |  |  | \n101.CAL | * |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  |  |  | \n101.DEF | * |  | Inline XBRL Taxonomy Extension Definition Linkbase Document |  |  |  | \n101.LAB | * |  | Inline XBRL Taxonomy Extension Label Linkbase Document |  |  |  | \n101.PRE | * |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  |  |  | \n104 |  |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |  |  |  |   |  |  |  |  | \n | \n* | Filed herewith.\n\u2021 | Furnished herewith.  |  |  |  |  | \nTable of Contents | Alphabet Inc.  |  |  |  |  |  |  |  | \n |  | ALPHABET INC.\nOctober 24, 2023 | By: | /s/\u00a0\u00a0\u00a0\u00a0RUTH M. PORAT\n |  | Ruth M. Porat\n |  | President and Chief Investment Officer; Chief Financial Officer  |  |  |  |  |  |  |  | \n |  | ALPHABET INC.\nOctober 24, 2023 | By: | /s/\u00a0\u00a0\u00a0\u00a0AMIE THUENER O'TOOLE\n |  | Amie Thuener O'Toole\n |  | Vice President, Corporate Controller and Principal Accounting Officer"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Home Depot, in 2022 Q2, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nDelaware |  |  |  | 95-3261426\n(State or other jurisdiction of incorporation or organization) |  |  |  | (I.R.S. Employer Identification No.)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n2455 Paces Ferry Road |  |  |  | \nAtlanta, | Georgia |  |  |  | 30339\n(Address of principal executive offices) |  |  |  | (Zip Code)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSecurities registered pursuant to Section 12(b) of the Act:\nTitle of each class |  | Trading Symbol |  | Name of each exchange on which registered\nCommon Stock, $0.05 Par Value Per Share |  | HD |  | New York Stock Exchange  |  | \n  |  |  |  |  |  |  |  | \nCommonly Used or Defined Terms | ii\nForward-Looking Statements | iii\n |  | \nPART I \u2013 FINANCIAL INFORMATION | 1\nItem\u00a01. | Financial Statements. | 1\n | Consolidated Balance Sheets | 1\n | Consolidated Statements of Earnings | 2\n | Consolidated Statements of Comprehensive Income | 3\n | Consolidated Statements of Stockholders' Equity | 4\n | Consolidated Statements of Cash Flows | 5\n | Notes to Consolidated Financial Statements | 6\n | Note 1. Summary of Significant Accounting Policies | 6\n | Note 2. Net Sales | 6\n | Note 3. Property and Leases | 7\n | Note 4. Debtand Derivative Instruments | 8\n | Note 5. Stockholders' Equity | 9\n | Note 6. Fair Value Measurements | 10\n | Note 7. Weighted Average Common Shares | 11\n | Note 8.Contingencies | 11\n |  | \n | Report of Independent Registered Public Accounting Firm | 12\nItem\u00a02. | Management's Discussion and Analysis of Financial Condition and Results of Operations. | 13\nItem\u00a03. | Quantitative and Qualitative Disclosures About Market Risk. | 18\nItem\u00a04. | Controls and Procedures. | 18\n |  | \nPART II \u2013 OTHER INFORMATION | 18\n |  | \nItem 1A. | Risk Factors. | 18\nItem\u00a02. | Unregistered Sales of Equity Securities and Use of Proceeds. | 18\nItem\u00a06. | Exhibits. | 19\n |  | \nSIGNATURES | 20  |  |  |  |  |  |  |  | \nTerm |  | Definition\n |  | \nComparable sales |  | As defined in theResults of Operationssection of MD&A\nExchange Act |  | Securities Exchange Act of 1934, as amended\nfiscal 2021 |  | Fiscal year ended January 30, 2022\nfiscal 2022 |  | Fiscal year ending January 29, 2023\nGAAP |  | U.S. generally accepted accounting principles\nMD&A |  | Management's Discussion and Analysis of Financial Condition and Results of Operations\nNOPAT |  | Net operating profit after tax\nRestoration Plan |  | Home Depot FutureBuilder Restoration Plan\nROIC |  | Return on invested capital\nSEC |  | Securities and Exchange Commission\nSecurities Act |  | Securities Act of 1933, as amended\nSG&A |  | Selling, general and administrative\n2021 Form 10-K |  | Annual Report on Form 10-K for fiscal 2021 as filed with the SEC on March 23, 2022  |  |  |  |  |  |  |  |  |  |  | \nin millions, except per share data | May 1,2022 |  | January 30,2022\nAssets |  |  | \nCurrent assets: |  |  | \nCash and cash equivalents | $ | 2,844 |  |  | $ | 2,343 | \nReceivables, net | 3,936 |  |  | 3,426 | \nMerchandise inventories | 25,297 |  |  | 22,068 | \nOther current assets | 1,790 |  |  | 1,218 | \nTotal current assets | 33,867 |  |  | 29,055 | \nNet property and equipment | 25,166 |  |  | 25,199 | \nOperating lease right-of-use assets | 5,980 |  |  | 5,968 | \nGoodwill | 7,450 |  |  | 7,449 | \nOther assets | 4,104 |  |  | 4,205 | \nTotal assets | $ | 76,567 |  |  | $ | 71,876 | \n |  |  | \nLiabilities and Stockholders' Equity |  |  | \nCurrent liabilities: |  |  | \nShort-term debt | $ | \u2014 |  |  | $ | 1,035 | \nAccounts payable | 15,367 |  |  | 13,462 | \nAccrued salaries and related expenses | 2,008 |  |  | 2,426 | \nSales taxes payable | 1,139 |  |  | 848 | \nDeferred revenue | 3,675 |  |  | 3,596 | \nCurrent installments of long-term debt | 2,463 |  |  | 2,447 | \nCurrent operating lease liabilities | 859 |  |  | 830 | \nOther accrued expenses | 4,876 |  |  | 4,049 | \nTotal current liabilities | 30,387 |  |  | 28,693 | \nLong-term debt, excluding current installments | 39,158 |  |  | 36,604 | \nLong-term operating lease liabilities | 5,335 |  |  | 5,353 | \nOther long-term liabilities | 3,396 |  |  | 2,922 | \nTotal liabilities | 78,276 |  |  | 73,572 | \n |  |  | \nCommon stock, par value $0.05; authorized:10,000shares; issued:1,793shares at May\u00a01, 2022 and1,792shares at January\u00a030, 2022; outstanding:1,029shares at May\u00a01, 2022 and1,035shares at January\u00a030, 2022 | 90 |  |  | 90 | \nPaid-in capital | 12,079 |  |  | 12,132 | \nRetained earnings | 69,849 |  |  | 67,580 | \nAccumulated other comprehensive loss | (683) |  |  | (704) | \nTreasury stock, at cost,764shares at May\u00a01, 2022 and757shares at January\u00a030, 2022 | (83,044) |  |  | (80,794) | \nTotal stockholders\u2019 (deficit) equity | (1,709) |  |  | (1,696) | \nTotal liabilities and stockholders\u2019 equity | $ | 76,567 |  |  | $ | 71,876 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\nin millions, except per share data |  |  |  |  | May 1,2022 |  | May 2,2021\nNet sales |  |  |  |  | $ | 38,908 |  |  | $ | 37,500 | \nCost of sales |  |  |  |  | 25,763 |  |  | 24,758 | \nGross profit |  |  |  |  | 13,145 |  |  | 12,742 | \nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative |  |  |  |  | 6,610 |  |  | 6,374 | \nDepreciation and amortization |  |  |  |  | 606 |  |  | 587 | \nTotal operating expenses |  |  |  |  | 7,216 |  |  | 6,961 | \nOperating income |  |  |  |  | 5,929 |  |  | 5,781 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net |  |  |  |  | (3) |  |  | (6) | \nInterest expense |  |  |  |  | 372 |  |  | 339 | \nInterest and other, net |  |  |  |  | 369 |  |  | 333 | \nEarnings before provision for income taxes |  |  |  |  | 5,560 |  |  | 5,448 | \nProvision for income taxes |  |  |  |  | 1,329 |  |  | 1,303 | \nNet earnings |  |  |  |  | $ | 4,231 |  |  | $ | 4,145 | \n |  |  |  |  |  |  | \nBasic weighted average common shares |  |  |  |  | 1,030 |  |  | 1,071 | \nBasic earnings per share |  |  |  |  | $ | 4.11 |  |  | $ | 3.87 | \n |  |  |  |  |  |  | \nDiluted weighted average common shares |  |  |  |  | 1,034 |  |  | 1,075 | \nDiluted earnings per share |  |  |  |  | $ | 4.09 |  |  | $ | 3.86 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\nin millions |  |  |  |  | May 1,2022 |  | May 2,2021\nNet earnings |  |  |  |  | $ | 4,231 |  |  | $ | 4,145 | \nOther comprehensive income (loss), net of tax: |  |  |  |  |  |  | \nForeign currency translation adjustments |  |  |  |  | 20 |  |  | 34 | \nCash flow hedges |  |  |  |  | 1 |  |  | 2 | \nOther |  |  |  |  | \u2014 |  |  | 27 | \nTotal other comprehensive income (loss), net of tax |  |  |  |  | 21 |  |  | 63 | \nComprehensive income |  |  |  |  | $ | 4,252 |  |  | $ | 4,208 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\nin millions |  |  |  |  | May 1,2022 |  | May 2,2021\nCommon Stock: |  |  |  |  |  |  | \nBalance at beginning of period |  |  |  |  | $ | 90 |  |  | $ | 89 | \nShares issued under employee stock plans |  |  |  |  | \u2014 |  |  | 1 | \nBalance at end of period |  |  |  |  | 90 |  |  | 90 | \n |  |  |  |  |  |  | \nPaid-in Capital: |  |  |  |  |  |  | \nBalance at beginning of period |  |  |  |  | 12,132 |  |  | 11,540 | \nShares issued under employee stock plans |  |  |  |  | (154) |  |  | (117) | \n |  |  |  |  |  |  | \nStock-based compensation expense |  |  |  |  | 101 |  |  | 132 | \n |  |  |  |  |  |  | \nBalance at end of period |  |  |  |  | 12,079 |  |  | 11,555 | \n |  |  |  |  |  |  | \nRetained Earnings: |  |  |  |  |  |  | \nBalance at beginning of period |  |  |  |  | 67,580 |  |  | 58,134 | \n |  |  |  |  |  |  | \nNet earnings |  |  |  |  | 4,231 |  |  | 4,145 | \nCash dividends |  |  |  |  | (1,962) |  |  | (1,775) | \n |  |  |  |  |  |  | \nBalance at end of period |  |  |  |  | 69,849 |  |  | 60,504 | \n |  |  |  |  |  |  | \nAccumulated Other Comprehensive Income (Loss): |  |  |  |  |  |  | \nBalance at beginning of period |  |  |  |  | (704) |  |  | (671) | \n |  |  |  |  |  |  | \nForeign currency translation adjustments, net of tax |  |  |  |  | 20 |  |  | 34 | \nCash flow hedges, net of tax |  |  |  |  | 1 |  |  | 2 | \nOther, net of tax |  |  |  |  | \u2014 |  |  | 27 | \nBalance at end of period |  |  |  |  | (683) |  |  | (608) | \n |  |  |  |  |  |  | \nTreasury Stock: |  |  |  |  |  |  | \nBalance at beginning of period |  |  |  |  | (80,794) |  |  | (65,793) | \nRepurchases of common stock |  |  |  |  | (2,250) |  |  | (4,000) | \nBalance at end of period |  |  |  |  | (83,044) |  |  | (69,793) | \nTotal stockholders' (deficit) equity |  |  |  |  | $ | (1,709) |  |  | $ | 1,748 |   |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended\nin millions | May 1,2022 |  | May 2,2021\nCash Flows from Operating Activities: |  |  | \nNet earnings | $ | 4,231 |  |  | $ | 4,145 | \nReconciliation of net earnings to net cash provided by operating activities: |  |  | \nDepreciation and amortization | 727 |  |  | 703 | \nStock-based compensation expense | 115 |  |  | 146 | \nChanges in receivables, net | (489) |  |  | (640) | \nChanges in merchandise inventories | (3,226) |  |  | (2,519) | \nChanges in other current assets | (589) |  |  | (277) | \nChanges in accounts payable and accrued expenses | 1,744 |  |  | 3,013 | \nChanges in deferred revenue | 79 |  |  | 586 | \nChanges in income taxes payable | 1,121 |  |  | 1,138 | \nChanges in deferred income taxes | (44) |  |  | (87) | \nOther operating activities | 120 |  |  | 102 | \nNet cash provided by operating activities | 3,789 |  |  | 6,310 | \n |  |  | \nCash Flows from Investing Activities: |  |  | \nCapital expenditures | (704) |  |  | (524) | \n |  |  | \nOther investing activities | 3 |  |  | (4) | \nNet cash used in investing activities | (701) |  |  | (528) | \n |  |  | \nCash Flows from Financing Activities: |  |  | \nRepayments of short-term debt, net | (1,035) |  |  | \u2014 | \nProceeds from long-term debt, net of discounts | 3,957 |  |  | \u2014 | \nRepayments of long-term debt | (1,054) |  |  | (1,390) | \nRepurchases of common stock | (2,308) |  |  | (3,788) | \nProceeds from sales of common stock | 5 |  |  | 13 | \nCash dividends | (1,962) |  |  | (1,775) | \nOther financing activities | (182) |  |  | (130) | \nNet cash used in financing activities | (2,579) |  |  | (7,070) | \nChange in cash and cash equivalents | 509 |  |  | (1,288) | \nEffect of exchange rate changes on cash and cash equivalents | (8) |  |  | 41 | \nCash and cash equivalents at beginning of period | 2,343 |  |  | 7,895 | \nCash and cash equivalents at end of period | $ | 2,844 |  |  | $ | 6,648 | \n |  |  | \nSupplemental Disclosures: |  |  | \nCash paid for interest, net of interest capitalized | $ | 415 |  |  | $ | 382 | \nCash paid for income taxes | 213 |  |  | 226 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\nin millions |  |  |  |  | May 1,2022 |  | May 2,2021\nNet sales \u2013 in the U.S. |  |  |  |  | $ | 36,006 |  |  | $ | 34,717 | \nNet sales \u2013 outside the U.S. |  |  |  |  | 2,902 |  |  | 2,783 | \nNet sales |  |  |  |  | $ | 38,908 |  |  | $ | 37,500 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\nin millions |  |  |  |  | May 1,2022 |  | May 2,2021\nNet sales \u2013 products |  |  |  |  | $ | 37,465 |  |  | $ | 36,271 | \nNet sales \u2013 services |  |  |  |  | 1,443 |  |  | 1,229 | \nNet sales |  |  |  |  | $ | 38,908 |  |  | $ | 37,500 |   |  |  |  |  |  |  |  | \nMajor Product Line |  | Merchandising Departments\nBuilding Materials |  | Building Materials, Electrical/Lighting, Lumber, Millwork, and Plumbing\nD\u00e9cor |  | Appliances, D\u00e9cor/Storage, Flooring, Kitchen and Bath, and Paint\nHardlines |  | Hardware, Indoor Garden, Outdoor Garden, and Tools  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\nin millions |  |  |  |  | May 1,2022 |  | May 2,2021\nBuilding Materials |  |  |  |  | $ | 14,869 |  |  | $ | 13,660 | \nD\u00e9cor |  |  |  |  | 12,874 |  |  | 11,882 | \nHardlines |  |  |  |  | 11,165 |  |  | 11,958 | \nNet sales |  |  |  |  | $ | 38,908 |  |  | $ | 37,500 |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions | Consolidated Balance Sheet Classification | May 1,2022 |  | January 30,2022\nAssets: |  |  |  | \nOperating lease assets | Operating lease right-of-use assets | $ | 5,980 |  |  | $ | 5,968 | \nFinance lease assets(1) | Net property and equipment | 2,972 |  |  | 2,896 | \nTotal lease assets |  | $ | 8,952 |  |  | $ | 8,864 | \n |  |  |  | \nLiabilities: |  |  |  | \nCurrent: |  |  |  | \nOperating lease liabilities | Current operating lease liabilities | $ | 859 |  |  | $ | 830 | \nFinance lease liabilities | Current installments of long-term debt | 214 |  |  | 198 | \nLong-term: |  |  |  | \nOperating lease liabilities | Long-term operating lease liabilities | 5,335 |  |  | 5,353 | \nFinance lease liabilities | Long-term debt, excluding current installments | 3,112 |  |  | 3,038 | \nTotal lease liabilities |  | $ | 9,520 |  |  | $ | 9,419 |   |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended\nin millions | May 1,2022 |  | May 2,2021\nLease assets obtained in exchange for new operating lease liabilities | $ | 256 |  |  | $ | 164 | \nLease assets obtained in exchange for new finance lease liabilities | 148 |  |  | 200 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nshares in millions |  |  | Three Months Ended\n |  |  |  | May 1,2022 |  | May 2,2021\nCommon stock: |  |  |  |  |  |  | \nBalance at beginning of period |  |  |  |  | 1,792 |  |  | 1,789 | \nShares issued under employee stock plans |  |  |  |  | 1 |  |  | 1 | \nBalance at end of period |  |  |  |  | 1,793 |  |  | 1,790 | \nTreasury stock: |  |  |  |  |  |  | \nBalance at beginning of period |  |  |  |  | (757) |  |  | (712) | \nRepurchases of common stock |  |  |  |  | (7) |  |  | (13) | \nBalance at end of period |  |  |  |  | (764) |  |  | (725) | \nShares outstanding at end of period |  |  |  |  | 1,029 |  |  | 1,065 | \n |  |  |  |  |  |  | \nCash dividends per share |  |  |  |  | $ | 1.90 |  |  | $ | 1.65 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions |  |  | Three Months Ended\n |  |  |  | May 1,2022 |  | May 2,2021\nTotal number of shares repurchased |  |  |  |  | 7 |  |  | 13 | \nTotal cost of shares repurchased |  |  |  |  | $ | 2,250 |  |  | $ | 4,000 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | May 1, 2022 |  | January 30, 2022\nin millions | Level\u00a01 |  | Level\u00a02 |  | Level\u00a03 |  | Level\u00a01 |  | Level\u00a02 |  | Level\u00a03\nDerivative agreements \u2013 assets | $ | \u2014 |  |  | $ | 8 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 58 |  |  | $ | \u2014 | \nDerivative agreements \u2013 liabilities | \u2014 |  |  | (661) |  |  | \u2014 |  |  | \u2014 |  |  | (249) |  |  | \u2014 | \nTotal | $ | \u2014 |  |  | $ | (653) |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | (191) |  |  | $ | \u2014 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | May 1, 2022 |  | January 30, 2022\nin millions | Fair Value(Level 1) |  | CarryingValue |  | Fair Value(Level 1) |  | CarryingValue\nSenior notes | $ | 36,896 |  |  | $ | 38,295 |  |  | $ | 39,397 |  |  | $ | 35,815 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\nin millions |  |  |  |  | May 1,2022 |  | May 2,2021\nBasic weighted average common shares |  |  |  |  | 1,030 |  |  | 1,071 | \nEffect of potentially dilutive securities(1) |  |  |  |  | 4 |  |  | 4 | \nDiluted weighted average common shares |  |  |  |  | 1,034 |  |  | 1,075 | \n |  |  |  |  |  |  | \nAnti-dilutive securities excluded from diluted weighted average common shares |  |  |  |  | 1 |  |  | \u2014 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \ndollars in millions, except per share data |  |  | Three Months Ended\n |  |  |  | May 1,2022 |  | May 2,2021\nNet sales |  |  |  |  | $ | 38,908 |  |  | $ | 37,500 | \nNet earnings |  |  |  |  | 4,231 |  |  | 4,145 | \n |  |  |  |  |  |  | \nDiluted earnings per share |  |  |  |  | $ | 4.09 |  |  | $ | 3.86 | \n |  |  |  |  |  |  | \nNet cash provided by operating activities |  |  |  |  | $ | 3,789 |  |  | $ | 6,310 | \nProceeds from long-term debt, net of discounts |  |  |  |  | 3,957 |  |  | \u2014 | \nRepayments of long-term debt |  |  |  |  | 1,054 |  |  | 1,390 | \nRepurchases of common stock |  |  |  |  | 2,308 |  |  | 3,788 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended\n | May 1,2022 |  | May 2,2021\ndollars in millions | $ |  | % ofNet Sales |  | $ |  | % ofNet Sales\nNet sales | $ | 38,908 |  |  |  |  | $ | 37,500 |  |  | \nGross profit | 13,145 |  |  | 33.8 | % |  | 12,742 |  |  | 34.0 | %\nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative | 6,610 |  |  | 17.0 |  |  | 6,374 |  |  | 17.0 | \nDepreciation and amortization | 606 |  |  | 1.6 |  |  | 587 |  |  | 1.6 | \nTotal operating expenses | 7,216 |  |  | 18.5 |  |  | 6,961 |  |  | 18.6 | \nOperating income | 5,929 |  |  | 15.2 |  |  | 5,781 |  |  | 15.4 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net | (3) |  |  | \u2014 |  |  | (6) |  |  | \u2014 | \nInterest expense | 372 |  |  | 1.0 |  |  | 339 |  |  | 0.9 | \nInterest and other, net | 369 |  |  | 0.9 |  |  | 333 |  |  | 0.9 | \nEarnings before provision for income taxes | 5,560 |  |  | 14.3 |  |  | 5,448 |  |  | 14.5 | \nProvision for income taxes | 1,329 |  |  | 3.4 |  |  | 1,303 |  |  | 3.5 | \nNet earnings | $ | 4,231 |  |  | 10.9 | % |  | $ | 4,145 |  |  | 11.1 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \nSelected financial and sales data: | May 1,2022 |  | May 2,2021 |  | % Change\nComparable sales (% change) | 2.2 | % |  | 31.0 | % |  | N/A\nComparable customer transactions (% change)(1) | (8.4) | % |  | 19.1 | % |  | N/A\nComparable average ticket (% change)(1) | 11.2 | % |  | 10.3 | % |  | N/A\nCustomer transactions (in millions)(1) | 410.7 |  |  | 447.2 |  |  | (8.2) | %\nAverage ticket(1) (2) | $ | 91.72 |  |  | $ | 82.37 |  |  | 11.4 | %\nSales per retail square foot(1) (3) | $ | 621.99 |  |  | $ | 605.60 |  |  | 2.7 | %\nDiluted earnings per share | $ | 4.09 |  |  | $ | 3.86 |  |  | 6.0 | %  |  |  |  |  |  |  |  |  |  |  |  | \n |  | Twelve Months Ended\ndollars in millions |  | May 1,2022 |  | May 2,2021\nNet earnings |  | $ | 16,519 |  |  | $ | 14,766 | \nInterest and other, net |  | 1,339 |  |  | 1,326 | \nProvision for income taxes |  | 5,330 |  |  | 4,691 | \nOperating income |  | 23,188 |  |  | 20,783 | \nIncome tax adjustment(1) |  | (5,628) |  |  | (5,012) | \nNOPAT |  | $ | 17,560 |  |  | $ | 15,771 | \n |  |  |  | \nAverage debt and equity |  | $ | 38,761 |  |  | $ | 34,970 | \n |  |  |  | \nROIC |  | 45.3 | % |  | 45.1 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | Total Number of Shares Purchased(1) |  | Average Price Paid Per\u00a0Share(1) |  | Total Number of Shares\u00a0Purchased\u00a0as Part of Publicly Announced\u00a0Program(2) |  | Dollar Value of Shares\u00a0that\u00a0May\u00a0Yet Be\u00a0Purchased\u00a0Under the Program(2)\nJanuary 31, 2022 \u2013 February 27, 2022 |  | 1,645,383 |  |  | $ | 347.07 |  |  | 1,626,917 |  |  | $ | 9,053,183,815 | \nFebruary 28, 2022 \u2013 March 27, 2022 |  | 627,670 |  |  | 319.18 |  |  | 279,283 |  |  | 8,963,898,777 | \nMarch 28, 2022 \u2013 May 1, 2022 |  | 5,209,451 |  |  | 306.35 |  |  | 5,208,219 |  |  | 7,368,369,778 | \nTotal |  | 7,482,504 |  |  | 316.38 |  |  | 7,114,419 |  |  |   |  |  |  |  |  |  |  | \nExhibit |  | Description\n3.1 | * | Amended and Restated Certificate of Incorporation of The Home Depot, Inc.\n[Form 10-Q filed on September 1, 2011, Exhibit 3.1]\n3.2 | * | By-Laws of The Home Depot, Inc. (Amended and Restated Effective February 28, 2019)\n[Form 8-K filed on March 4, 2019, Exhibit 3.2]\n4.1 | * | Formof2.700% Note due April 15, 2025[Form 8-K filed on March 28, 2022, Exhibit 4.2]\n4.2 | * | Formof2.875% Note due April 15, 2027[Form 8-K filed on March 28, 2022, Exhibit 4.3]\n4.3 | * | Formof3.250% Note due April 15, 2032[Form 8-K filed on March 28, 2022, Exhibit 4.4]\n4.4 | * | Formof3.625% Note due April 15, 2052[Form 8-K filed on March 28, 2022, Exhibit 4.5]\n10.1 | \u2020 | Employment Arrangement between Edward P. Decker and The Home Depot, Inc., dated February 24, 2022\n10.2 | \u2020 | Employment Arrangement between Craig A. Menear and The Home Depot, Inc., dated February 24, 2022\n10.3 | \u2020 | Employment Arrangement between Matthew A. Carey and The Home Depot, Inc., dated April 19, 2022\n15.1 |  | Acknowledgement of Independent Registered Public Accounting Firm\n31.1 |  | Certification oftheChief Executive Officerand Presidentpursuant to Rule 13a-14(a)\n31.2 |  | Certification of the Executive Vice President and Chief Financial Officer pursuant to Rule\u00a013a-14(a)\n32.1 |  | Certification oftheChief Executive Officerand Presidentfurnished pursuant to Section\u00a0906 of the Sarbanes-Oxley Act of 2002\n32.2 |  | Certification of the Executive Vice President and Chief Financial Officer furnished pursuant to Section\u00a0906 of the Sarbanes-Oxley Act of 2002\n101.INS |  | XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document\n101.SCH |  | Inline XBRL Taxonomy Extension Schema Document\n101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document\n101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document\n101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document\n101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document\n104 |  | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)  |  |  |  |  | \nTHE HOME DEPOT, INC.(Registrant)\n | \nBy: | /s/ EDWARDP. DECKER\n | Edward P. Decker, Chief Executive Officer and President (Principal Executive Officer)\n\n | /s/ RICHARDV. MCPHAIL\n | Richard V. McPhail, Executive Vice President and Chief Financial Officer (Principal Financial Officer)\n | \n | /s/ STEPHENL. GIBBS\n | Stephen L. Gibbs, Vice President, Chief Accounting Officer and Corporate Controller (Principal Accounting Officer)\n\nDate: | May 23, 2022"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Home Depot, in 2022 Q3, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nDelaware |  |  |  | 95-3261426\n(State or other jurisdiction of incorporation or organization) |  |  |  | (I.R.S. Employer Identification No.)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n2455 Paces Ferry Road |  |  |  | \nAtlanta, | Georgia |  |  |  | 30339\n(Address of principal executive offices) |  |  |  | (Zip Code)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSecurities registered pursuant to Section 12(b) of the Act:\nTitle of each class |  | Trading Symbol |  | Name of each exchange on which registered\nCommon Stock, $0.05 Par Value Per Share |  | HD |  | New York Stock Exchange  |  | \n  |  |  |  |  |  |  |  | \nCommonly Used or Defined Terms | ii\nForward-Looking Statements | iii\n |  | \nPART I \u2013 FINANCIAL INFORMATION | 1\nItem\u00a01. | Financial Statements. | 1\n | Consolidated Balance Sheets | 1\n | Consolidated Statements of Earnings | 2\n | Consolidated Statements of Comprehensive Income | 3\n | Consolidated Statements of Stockholders' Equity | 4\n | Consolidated Statements of Cash Flows | 5\n | Notes to Consolidated Financial Statements | 6\n | Note 1. Summary of Significant Accounting Policies | 6\n | Note 2. Net Sales | 6\n | Note 3. Property and Leases | 7\n | Note 4. Debtand Derivative Instruments | 8\n | Note 5. Stockholders' Equity | 9\n | Note 6. Fair Value Measurements | 10\n | Note 7. Weighted Average Common Shares | 11\n | Note 8.Contingencies | 11\n |  | \n | Report of Independent Registered Public Accounting Firm | 12\nItem\u00a02. | Management's Discussion and Analysis of Financial Condition and Results of Operations. | 13\nItem\u00a03. | Quantitative and Qualitative Disclosures About Market Risk. | 20\nItem\u00a04. | Controls and Procedures. | 20\n |  | \nPART II \u2013 OTHER INFORMATION | 20\n |  | \nItem 1A. | Risk Factors. | 20\nItem\u00a02. | Unregistered Sales of Equity Securities and Use of Proceeds. | 21\nItem\u00a06. | Exhibits. | 22\n |  | \nSIGNATURES | 23  |  |  |  |  |  |  |  | \nTerm |  | Definition\n |  | \nComparable sales |  | As defined in theResults of Operationssection of MD&A\nExchange Act |  | Securities Exchange Act of 1934, as amended\nfiscal 2021 |  | Fiscal year ended January 30, 2022\nfiscal 2022 |  | Fiscal year ending January 29, 2023\nGAAP |  | U.S. generally accepted accounting principles\nMD&A |  | Management's Discussion and Analysis of Financial Condition and Results of Operations\nNOPAT |  | Net operating profit after tax\nRestoration Plan |  | Home Depot FutureBuilder Restoration Plan\nROIC |  | Return on invested capital\nSEC |  | Securities and Exchange Commission\nSecurities Act |  | Securities Act of 1933, as amended\nSG&A |  | Selling, general and administrative\n2021 Form 10-K |  | Annual Report on Form 10-K for fiscal 2021 as filed with the SEC on March 23, 2022  |  |  |  |  |  |  |  |  |  |  | \nin millions, except per share data | July 31,2022 |  | January 30,2022\nAssets |  |  | \nCurrent assets: |  |  | \nCash and cash equivalents | $ | 1,259 |  |  | $ | 2,343 | \nReceivables, net | 3,725 |  |  | 3,426 | \nMerchandise inventories | 26,088 |  |  | 22,068 | \nOther current assets | 1,869 |  |  | 1,218 | \nTotal current assets | 32,941 |  |  | 29,055 | \nNet property and equipment | 25,247 |  |  | 25,199 | \nOperating lease right-of-use assets | 6,132 |  |  | 5,968 | \nGoodwill | 7,451 |  |  | 7,449 | \nOther assets | 4,054 |  |  | 4,205 | \nTotal assets | $ | 75,825 |  |  | $ | 71,876 | \n |  |  | \nLiabilities and Stockholders' Equity |  |  | \nCurrent liabilities: |  |  | \nShort-term debt | $ | 539 |  |  | $ | 1,035 | \nAccounts payable | 14,348 |  |  | 13,462 | \nAccrued salaries and related expenses | 2,204 |  |  | 2,426 | \nSales taxes payable | 1,076 |  |  | 848 | \nDeferred revenue | 3,539 |  |  | 3,596 | \nCurrent installments of long-term debt | 1,218 |  |  | 2,447 | \nCurrent operating lease liabilities | 919 |  |  | 830 | \nOther accrued expenses | 3,991 |  |  | 4,049 | \nTotal current liabilities | 27,834 |  |  | 28,693 | \nLong-term debt, excluding current installments | 39,271 |  |  | 36,604 | \nLong-term operating lease liabilities | 5,431 |  |  | 5,353 | \nOther long-term liabilities | 3,052 |  |  | 2,922 | \nTotal liabilities | 75,588 |  |  | 73,572 | \n |  |  | \nCommon stock, par value $0.05; authorized:10,000shares; issued:1,793shares at July\u00a031, 2022 and1,792shares at January\u00a030, 2022; outstanding:1,024shares at July\u00a031, 2022 and1,035shares at January\u00a030, 2022 | 90 |  |  | 90 | \nPaid-in capital | 12,309 |  |  | 12,132 | \nRetained earnings | 73,074 |  |  | 67,580 | \nAccumulated other comprehensive loss | (672) |  |  | (704) | \nTreasury stock, at cost,769shares at July\u00a031, 2022 and757shares at January\u00a030, 2022 | (84,564) |  |  | (80,794) | \nTotal stockholders\u2019 equity (deficit) | 237 |  |  | (1,696) | \nTotal liabilities and stockholders\u2019 equity | $ | 75,825 |  |  | $ | 71,876 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\nin millions, except per share data | July 31,2022 |  | August 1,2021 |  | July 31,2022 |  | August 1,2021\nNet sales | $ | 43,792 |  |  | $ | 41,118 |  |  | $ | 82,700 |  |  | $ | 78,618 | \nCost of sales | 29,309 |  |  | 27,453 |  |  | 55,072 |  |  | 52,211 | \nGross profit | 14,483 |  |  | 13,665 |  |  | 27,628 |  |  | 26,407 | \nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative | 6,657 |  |  | 6,433 |  |  | 13,267 |  |  | 12,807 | \nDepreciation and amortization | 616 |  |  | 593 |  |  | 1,222 |  |  | 1,180 | \nTotal operating expenses | 7,273 |  |  | 7,026 |  |  | 14,489 |  |  | 13,987 | \nOperating income | 7,210 |  |  | 6,639 |  |  | 13,139 |  |  | 12,420 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net | (2) |  |  | (5) |  |  | (5) |  |  | (11) | \nInterest expense | 381 |  |  | 326 |  |  | 753 |  |  | 665 | \nInterest and other, net | 379 |  |  | 321 |  |  | 748 |  |  | 654 | \nEarnings before provision for income taxes | 6,831 |  |  | 6,318 |  |  | 12,391 |  |  | 11,766 | \nProvision for income taxes | 1,658 |  |  | 1,511 |  |  | 2,987 |  |  | 2,814 | \nNet earnings | $ | 5,173 |  |  | $ | 4,807 |  |  | $ | 9,404 |  |  | $ | 8,952 | \n |  |  |  |  |  |  | \nBasic weighted average common shares | 1,023 |  |  | 1,058 |  |  | 1,026 |  |  | 1,064 | \nBasic earnings per share | $ | 5.06 |  |  | $ | 4.54 |  |  | $ | 9.17 |  |  | $ | 8.41 | \n |  |  |  |  |  |  | \nDiluted weighted average common shares | 1,025 |  |  | 1,062 |  |  | 1,030 |  |  | 1,068 | \nDiluted earnings per share | $ | 5.05 |  |  | $ | 4.53 |  |  | $ | 9.13 |  |  | $ | 8.38 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\nin millions | July 31,2022 |  | August 1,2021 |  | July 31,2022 |  | August 1,2021\nNet earnings | $ | 5,173 |  |  | $ | 4,807 |  |  | $ | 9,404 |  |  | $ | 8,952 | \nOther comprehensive income (loss), net of tax: |  |  |  |  |  |  | \nForeign currency translation adjustments | 9 |  |  | 21 |  |  | 29 |  |  | 55 | \nCash flow hedges | 2 |  |  | 2 |  |  | 3 |  |  | 4 | \nOther | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 27 | \nTotal other comprehensive income (loss), net of tax | 11 |  |  | 23 |  |  | 32 |  |  | 86 | \nComprehensive income | $ | 5,184 |  |  | $ | 4,830 |  |  | $ | 9,436 |  |  | $ | 9,038 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\nin millions | July 31,2022 |  | August 1,2021 |  | July 31,2022 |  | August 1,2021\nCommon Stock: |  |  |  |  |  |  | \nBalance at beginning of period | $ | 90 |  |  | $ | 90 |  |  | $ | 90 |  |  | $ | 89 | \nShares issued under employee stock plans | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1 | \nBalance at end of period | 90 |  |  | 90 |  |  | 90 |  |  | 90 | \n |  |  |  |  |  |  | \nPaid-in Capital: |  |  |  |  |  |  | \nBalance at beginning of period | 12,079 |  |  | 11,555 |  |  | 12,132 |  |  | 11,540 | \nShares issued under employee stock plans | 135 |  |  | 149 |  |  | (19) |  |  | 32 | \n |  |  |  |  |  |  | \nStock-based compensation expense | 95 |  |  | 93 |  |  | 196 |  |  | 225 | \n |  |  |  |  |  |  | \nBalance at end of period | 12,309 |  |  | 11,797 |  |  | 12,309 |  |  | 11,797 | \n |  |  |  |  |  |  | \nRetained Earnings: |  |  |  |  |  |  | \nBalance at beginning of period | 69,849 |  |  | 60,504 |  |  | 67,580 |  |  | 58,134 | \n |  |  |  |  |  |  | \nNet earnings | 5,173 |  |  | 4,807 |  |  | 9,404 |  |  | 8,952 | \nCash dividends | (1,948) |  |  | (1,751) |  |  | (3,910) |  |  | (3,526) | \n |  |  |  |  |  |  | \nBalance at end of period | 73,074 |  |  | 63,560 |  |  | 73,074 |  |  | 63,560 | \n |  |  |  |  |  |  | \nAccumulated Other Comprehensive Income (Loss): |  |  |  |  |  |  | \nBalance at beginning of period | (683) |  |  | (608) |  |  | (704) |  |  | (671) | \n |  |  |  |  |  |  | \nForeign currency translation adjustments, net of tax | 9 |  |  | 21 |  |  | 29 |  |  | 55 | \nCash flow hedges, net of tax | 2 |  |  | 2 |  |  | 3 |  |  | 4 | \nOther, net of tax | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 27 | \nBalance at end of period | (672) |  |  | (585) |  |  | (672) |  |  | (585) | \n |  |  |  |  |  |  | \nTreasury Stock: |  |  |  |  |  |  | \nBalance at beginning of period | (83,044) |  |  | (69,793) |  |  | (80,794) |  |  | (65,793) | \nRepurchases of common stock | (1,520) |  |  | (3,000) |  |  | (3,770) |  |  | (7,000) | \nBalance at end of period | (84,564) |  |  | (72,793) |  |  | (84,564) |  |  | (72,793) | \nTotal stockholders' equity | $ | 237 |  |  | $ | 2,069 |  |  | $ | 237 |  |  | $ | 2,069 |   |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended\nin millions | July 31,2022 |  | August 1,2021\nCash Flows from Operating Activities: |  |  | \nNet earnings | $ | 9,404 |  |  | $ | 8,952 | \nReconciliation of net earnings to net cash provided by operating activities: |  |  | \nDepreciation and amortization | 1,473 |  |  | 1,414 | \nStock-based compensation expense | 196 |  |  | 226 | \nChanges in receivables, net | (295) |  |  | (321) | \nChanges in merchandise inventories | (4,009) |  |  | (2,191) | \nChanges in other current assets | (668) |  |  | (574) | \nChanges in accounts payable and accrued expenses | 1,079 |  |  | 1,658 | \nChanges in deferred revenue | (57) |  |  | 671 | \nChanges in income taxes payable | 61 |  |  | 154 | \nChanges in deferred income taxes | (95) |  |  | (116) | \nOther operating activities | 93 |  |  | 74 | \nNet cash provided by operating activities | 7,182 |  |  | 9,947 | \n |  |  | \nCash Flows from Investing Activities: |  |  | \nCapital expenditures | (1,447) |  |  | (1,042) | \nPayments for businesses acquired, net | \u2014 |  |  | (416) | \nOther investing activities | (14) |  |  | \u2014 | \nNet cash used in investing activities | (1,461) |  |  | (1,458) | \n |  |  | \nCash Flows from Financing Activities: |  |  | \nRepayments of short-term debt, net | (496) |  |  | \u2014 | \nProceeds from long-term debt, net of discounts | 3,957 |  |  | \u2014 | \nRepayments of long-term debt | (2,366) |  |  | (1,434) | \nRepurchases of common stock | (3,962) |  |  | (6,905) | \nProceeds from sales of common stock | 142 |  |  | 167 | \nCash dividends | (3,910) |  |  | (3,526) | \nOther financing activities | (163) |  |  | (136) | \nNet cash used in financing activities | (6,798) |  |  | (11,834) | \nChange in cash and cash equivalents | (1,077) |  |  | (3,345) | \nEffect of exchange rate changes on cash and cash equivalents | (7) |  |  | 16 | \nCash and cash equivalents at beginning of period | 2,343 |  |  | 7,895 | \nCash and cash equivalents at end of period | $ | 1,259 |  |  | $ | 4,566 | \n |  |  | \nSupplemental Disclosures: |  |  | \nCash paid for interest, net of interest capitalized | $ | 665 |  |  | $ | 626 | \nCash paid for income taxes | 3,105 |  |  | 2,913 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\nin millions | July 31,2022 |  | August 1,2021 |  | July 31,2022 |  | August 1,2021\nNet sales \u2013 in the U.S. | $ | 40,044 |  |  | $ | 37,642 |  |  | $ | 76,050 |  |  | $ | 72,359 | \nNet sales \u2013 outside the U.S. | 3,748 |  |  | 3,476 |  |  | 6,650 |  |  | 6,259 | \nNet sales | $ | 43,792 |  |  | $ | 41,118 |  |  | $ | 82,700 |  |  | $ | 78,618 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\nin millions | July 31,2022 |  | August 1,2021 |  | July 31,2022 |  | August 1,2021\nNet sales \u2013 products | $ | 42,348 |  |  | $ | 39,717 |  |  | $ | 79,813 |  |  | $ | 75,988 | \nNet sales \u2013 services | 1,444 |  |  | 1,401 |  |  | 2,887 |  |  | 2,630 | \nNet sales | $ | 43,792 |  |  | $ | 41,118 |  |  | $ | 82,700 |  |  | $ | 78,618 |   |  |  |  |  |  |  |  | \nMajor Product Line |  | Merchandising Departments\nBuilding Materials |  | Building Materials, Electrical/Lighting, Lumber, Millwork, and Plumbing\nD\u00e9cor |  | Appliances, D\u00e9cor/Storage, Flooring, Kitchen and Bath, and Paint\nHardlines |  | Hardware, Indoor Garden, Outdoor Garden, and Tools  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\nin millions | July 31,2022 |  | August 1,2021 |  | July 31,2022 |  | August 1,2021\nBuilding Materials | $ | 15,883 |  |  | $ | 14,411 |  |  | $ | 30,752 |  |  | $ | 28,071 | \nD\u00e9cor | 14,096 |  |  | 13,395 |  |  | 26,970 |  |  | 25,277 | \nHardlines | 13,813 |  |  | 13,312 |  |  | 24,978 |  |  | 25,270 | \nNet sales | $ | 43,792 |  |  | $ | 41,118 |  |  | $ | 82,700 |  |  | $ | 78,618 |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions | Consolidated Balance Sheet Classification | July 31,2022 |  | January 30,2022\nAssets: |  |  |  | \nOperating lease assets | Operating lease right-of-use assets | $ | 6,132 |  |  | $ | 5,968 | \nFinance lease assets(1) | Net property and equipment | 2,923 |  |  | 2,896 | \nTotal lease assets |  | $ | 9,055 |  |  | $ | 8,864 | \n |  |  |  | \nLiabilities: |  |  |  | \nCurrent: |  |  |  | \nOperating lease liabilities | Current operating lease liabilities | $ | 919 |  |  | $ | 830 | \nFinance lease liabilities | Current installments of long-term debt | 219 |  |  | 198 | \nLong-term: |  |  |  | \nOperating lease liabilities | Long-term operating lease liabilities | 5,431 |  |  | 5,353 | \nFinance lease liabilities | Long-term debt, excluding current installments | 3,082 |  |  | 3,038 | \nTotal lease liabilities |  | $ | 9,651 |  |  | $ | 9,419 |   |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended\nin millions | July 31,2022 |  | August 1,2021\nLease assets obtained in exchange for new operating lease liabilities | $ | 646 |  |  | $ | 429 | \nLease assets obtained in exchange for new finance lease liabilities | 202 |  |  | 417 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nshares in millions | Three Months Ended |  | Six Months Ended\nJuly 31,2022 |  | August 1,2021 |  | July 31,2022 |  | August 1,2021\nCommon stock: |  |  |  |  |  |  | \nBalance at beginning of period | 1,793 |  |  | 1,790 |  |  | 1,792 |  |  | 1,789 | \nShares issued under employee stock plans | \u2014 |  |  | 1 |  |  | 1 |  |  | 2 | \nBalance at end of period | 1,793 |  |  | 1,791 |  |  | 1,793 |  |  | 1,791 | \nTreasury stock: |  |  |  |  |  |  | \nBalance at beginning of period | (764) |  |  | (725) |  |  | (757) |  |  | (712) | \nRepurchases of common stock | (5) |  |  | (10) |  |  | (12) |  |  | (23) | \nBalance at end of period | (769) |  |  | (735) |  |  | (769) |  |  | (735) | \nShares outstanding at end of period | 1,024 |  |  | 1,056 |  |  | 1,024 |  |  | 1,056 | \n |  |  |  |  |  |  | \nCash dividends per share | $ | 1.90 |  |  | $ | 1.65 |  |  | $ | 3.80 |  |  | $ | 3.30 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions | Three Months Ended |  | Six Months Ended\nJuly 31,2022 |  | August 1,2021 |  | July 31,2022 |  | August 1,2021\nTotal number of shares repurchased | 5 |  |  | 10 |  |  | 12 |  |  | 23 | \nTotal cost of shares repurchased | $ | 1,520 |  |  | $ | 3,000 |  |  | $ | 3,770 |  |  | $ | 7,000 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | July 31, 2022 |  | January 30, 2022\nin millions | Level\u00a01 |  | Level\u00a02 |  | Level\u00a03 |  | Level\u00a01 |  | Level\u00a02 |  | Level\u00a03\nDerivative agreements \u2013 assets | $ | \u2014 |  |  | $ | 13 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 58 |  |  | $ | \u2014 | \nDerivative agreements \u2013 liabilities | \u2014 |  |  | (529) |  |  | \u2014 |  |  | \u2014 |  |  | (249) |  |  | \u2014 | \nTotal | $ | \u2014 |  |  | $ | (516) |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | (191) |  |  | $ | \u2014 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | July 31, 2022 |  | January 30, 2022\nin millions | Fair Value(Level 1) |  | CarryingValue |  | Fair Value(Level 1) |  | CarryingValue\nSenior notes | $ | 36,858 |  |  | $ | 37,188 |  |  | $ | 39,397 |  |  | $ | 35,815 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\nin millions | July 31,2022 |  | August 1,2021 |  | July 31,2022 |  | August 1,2021\nBasic weighted average common shares | 1,023 |  |  | 1,058 |  |  | 1,026 |  |  | 1,064 | \nEffect of potentially dilutive securities(1) | 2 |  |  | 4 |  |  | 4 |  |  | 4 | \nDiluted weighted average common shares | 1,025 |  |  | 1,062 |  |  | 1,030 |  |  | 1,068 | \n |  |  |  |  |  |  | \nAnti-dilutive securities excluded from diluted weighted average common shares | 1 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \ndollars in millions, except per share data | Three Months Ended |  | Six Months Ended\nJuly 31,2022 |  | August 1,2021 |  | July 31,2022 |  | August 1,2021\nNet sales | $ | 43,792 |  |  | $ | 41,118 |  |  | $ | 82,700 |  |  | $ | 78,618 | \nNet earnings | 5,173 |  |  | 4,807 |  |  | 9,404 |  |  | 8,952 | \n |  |  |  |  |  |  | \nDiluted earnings per share | $ | 5.05 |  |  | $ | 4.53 |  |  | $ | 9.13 |  |  | $ | 8.38 | \n |  |  |  |  |  |  | \nNet cash provided by operating activities |  |  |  |  | $ | 7,182 |  |  | $ | 9,947 | \nProceeds from long-term debt, net of discounts |  |  |  |  | 3,957 |  |  | \u2014 | \nRepayments of long-term debt |  |  |  |  | 2,366 |  |  | 1,434 | \nRepurchases of common stock |  |  |  |  | 3,962 |  |  | 6,905 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended\n | July 31, 2022 |  | August 1, 2021\ndollars in millions | $ |  | % ofNet Sales |  | $ |  | % ofNet Sales\nNet sales | $ | 43,792 |  |  |  |  | $ | 41,118 |  |  | \nGross profit | 14,483 |  |  | 33.1 | % |  | 13,665 |  |  | 33.2 | %\nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative | 6,657 |  |  | 15.2 |  |  | 6,433 |  |  | 15.6 | \nDepreciation and amortization | 616 |  |  | 1.4 |  |  | 593 |  |  | 1.4 | \nTotal operating expenses | 7,273 |  |  | 16.6 |  |  | 7,026 |  |  | 17.1 | \nOperating income | 7,210 |  |  | 16.5 |  |  | 6,639 |  |  | 16.1 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net | (2) |  |  | \u2014 |  |  | (5) |  |  | \u2014 | \nInterest expense | 381 |  |  | 0.9 |  |  | 326 |  |  | 0.8 | \nInterest and other, net | 379 |  |  | 0.9 |  |  | 321 |  |  | 0.8 | \nEarnings before provision for income taxes | 6,831 |  |  | 15.6 |  |  | 6,318 |  |  | 15.4 | \nProvision for income taxes | 1,658 |  |  | 3.8 |  |  | 1,511 |  |  | 3.7 | \nNet earnings | $ | 5,173 |  |  | 11.8 | % |  | $ | 4,807 |  |  | 11.7 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \nSelected financial and sales data: | July 31,2022 |  | August 1,2021 |  | % Change\nComparable sales (% change) | 5.8 | % |  | 4.5 | % |  | N/A\nComparable customer transactions (% change)(1) | (3.1) | % |  | (6.0) | % |  | N/A\nComparable average ticket (% change)(1) | 9.0 | % |  | 11.3 | % |  | N/A\nCustomer transactions (in millions)(1) | 467.4 |  |  | 481.7 |  |  | (3.0) | %\nAverage ticket(1) (2) | $ | 90.02 |  |  | $ | 82.48 |  |  | 9.1 | %\nSales per retail square foot(1) (3) | $ | 700.62 |  |  | $ | 663.05 |  |  | 5.7 | %\nDiluted earnings per share | $ | 5.05 |  |  | $ | 4.53 |  |  | 11.5 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended\n | July 31, 2022 |  | August 1, 2021\ndollars in millions | $ |  | % ofNet Sales |  | $ |  | % ofNet Sales\nNet sales | $ | 82,700 |  |  |  |  | $ | 78,618 |  |  | \nGross profit | 27,628 |  |  | 33.4 | % |  | 26,407 |  |  | 33.6 | %\nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative | 13,267 |  |  | 16.0 |  |  | 12,807 |  |  | 16.3 | \nDepreciation and amortization | 1,222 |  |  | 1.5 |  |  | 1,180 |  |  | 1.5 | \nTotal operating expenses | 14,489 |  |  | 17.5 |  |  | 13,987 |  |  | 17.8 | \nOperating income | 13,139 |  |  | 15.9 |  |  | 12,420 |  |  | 15.8 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net | (5) |  |  | \u2014 |  |  | (11) |  |  | \u2014 | \nInterest expense | 753 |  |  | 0.9 |  |  | 665 |  |  | 0.8 | \nInterest and other, net | 748 |  |  | 0.9 |  |  | 654 |  |  | 0.8 | \nEarnings before provision for income taxes | 12,391 |  |  | 15.0 |  |  | 11,766 |  |  | 15.0 | \nProvision for income taxes | 2,987 |  |  | 3.6 |  |  | 2,814 |  |  | 3.6 | \nNet earnings | $ | 9,404 |  |  | 11.4 | % |  | $ | 8,952 |  |  | 11.4 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended |  | \nSelected financial and sales data: | July 31,2022 |  | August 1,2021 |  | % Change\nComparable sales (% change) | 4.1 | % |  | 15.8 | % |  | N/A\nComparable customer transactions (% change)(1) | (5.7) | % |  | 4.6 | % |  | N/A\nComparable average ticket (% change)(1) | 10.0 | % |  | 10.9 | % |  | N/A\nCustomer transactions (in millions)(1) | 878.1 |  |  | 928.9 |  |  | (5.5) | %\nAverage ticket(1) (2) | $ | 90.82 |  |  | $ | 82.43 |  |  | 10.2 | %\nSales per retail square foot(1) (3) | $ | 661.27 |  |  | $ | 634.30 |  |  | 4.3 | %\nDiluted earnings per share | $ | 9.13 |  |  | $ | 8.38 |  |  | 8.9 | %  |  |  |  |  |  |  |  |  |  |  | \n | Twelve Months Ended\ndollars in millions | July 31,2022 |  | August 1,2021\nNet earnings | $ | 16,885 |  |  | $ | 15,241 | \nInterest and other, net | 1,397 |  |  | 1,310 | \nProvision for income taxes | 5,477 |  |  | 4,804 | \nOperating income | 23,759 |  |  | 21,355 | \nIncome tax adjustment(1) | (5,758) |  |  | (5,130) | \nNOPAT | $ | 18,001 |  |  | $ | 16,225 | \n |  |  | \nAverage debt and equity | $ | 39,485 |  |  | $ | 36,338 | \n |  |  | \nROIC | 45.6 | % |  | 44.7 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | Total Number of Shares Purchased(1) |  | Average Price Paid Per\u00a0Share(1) |  | Total Number of Shares\u00a0Purchased\u00a0as Part of Publicly Announced\u00a0Program(2) |  | Dollar Value of Shares\u00a0that\u00a0May\u00a0Yet Be\u00a0Purchased\u00a0Under the Program(2)\nMay 2, 2022 \u2013 May 29, 2022 |  | 2,837,144 |  |  | $ | 293.86 |  |  | 2,832,302 |  |  | $ | 6,536,088,542 | \nMay 30, 2022 \u2013 June 26, 2022 |  | 2,333,969 |  |  | 294.96 |  |  | 2,332,673 |  |  | 5,848,043,676 | \nJune 27, 2022 \u2013 July 31, 2022 |  | 2,905 |  |  | 293.49 |  |  | \u2014 |  |  | 5,848,043,676 | \nTotal |  | 5,174,018 |  |  | 294.36 |  |  | 5,164,975 |  |  |   |  |  |  |  |  |  |  | \nExhibit |  | Description\n3.1 | * | Amended and Restated Certificate of Incorporation of The Home Depot, Inc.\n[Form 10-Q filed on September 1, 2011, Exhibit 3.1]\n3.2 | * | By-Laws of The Home Depot, Inc. (Amended and Restated Effective February 28, 2019)\n[Form 8-K filed on March 4, 2019, Exhibit 3.2]\n10.1 | \u2020 | The Home Depot, Inc. Omnibus Stock Incentive Plan, as Amended and Restated May 19, 2022\n10.2 | *\u2020 | The Home Depot Amended and Restated Management Incentive Plan[Form 8-K filed on May 24, 2022, Exhibit 10.1]\n10.3 | *\u2020 | Form of Executive Officer Equity Award Agreement (Performance Shares, Performance-Based Restricted Stock and Nonqualified Stock Options) Pursuant to The Home Depot, Inc. Omnibus Stock Incentive Plan, as Amended and Restated May 19, 2022[Form 8-K filed on May 24, 2022, Exhibit 10.2]\n10.4 | *\u2020 | Form of Executive Officer Equity Award Agreement (Restricted Stock and Nonqualified Stock Options) Pursuant to The Home Depot, Inc. Omnibus Stock Incentive Plan, as Amended and Restated May 19, 2022[Form 8-K filed on May 24, 2022, Exhibit 10.3]\n10.5 | *\u2020 | Form of Nonemployee Director Deferred Share Award Agreement Pursuant to The Home Depot, Inc. Omnibus Stock Incentive Plan, as Amended and Restated May 19, 2022[Form 8-K filed on May 24, 2022, Exhibit 10.4]\n15.1 |  | Acknowledgement of Independent Registered Public Accounting Firm\n31.1 |  | Certification oftheChief Executive Officerand Presidentpursuant to Rule 13a-14(a)\n31.2 |  | Certification of the Executive Vice President and Chief Financial Officer pursuant to Rule\u00a013a-14(a)\n32.1 |  | Certification oftheChief Executive Officerand Presidentfurnished pursuant to Section\u00a0906 of the Sarbanes-Oxley Act of 2002\n32.2 |  | Certification of the Executive Vice President and Chief Financial Officer furnished pursuant to Section\u00a0906 of the Sarbanes-Oxley Act of 2002\n101.INS |  | XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document\n101.SCH |  | Inline XBRL Taxonomy Extension Schema Document\n101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document\n101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document\n101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document\n101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document\n104 |  | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)  |  |  |  |  | \nTHE HOME DEPOT, INC.(Registrant)\n | \nBy: | /s/ EDWARD P. DECKER\n | Edward P. Decker, Chief Executive Officer and President (Principal Executive Officer)\n\n | /s/ RICHARD V. MCPHAIL\n | Richard V. McPhail, Executive Vice President and Chief Financial Officer (Principal Financial Officer)\n | \n | /s/ STEPHEN L. GIBBS\n | Stephen L. Gibbs, Vice President, Chief Accounting Officer and Corporate Controller (Principal Accounting Officer)\n\nDate: | August 22, 2022"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Home Depot, in 2022 Q4, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nDelaware |  |  |  | 95-3261426\n(State or other jurisdiction of incorporation or organization) |  |  |  | (I.R.S. Employer Identification No.)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n2455 Paces Ferry Road |  |  |  | \nAtlanta, | Georgia |  |  |  | 30339\n(Address of principal executive offices) |  |  |  | (Zip Code)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSecurities registered pursuant to Section 12(b) of the Act:\nTitle of each class |  | Trading Symbol |  | Name of each exchange on which registered\nCommon Stock, $0.05 Par Value Per Share |  | HD |  | New York Stock Exchange  |  | \n  |  |  |  |  |  |  |  | \nCommonly Used or Defined Terms | ii\nForward-Looking Statements | iii\n |  | \nPART I \u2013 FINANCIAL INFORMATION | 1\nItem\u00a01. | Financial Statements. | 1\n | Consolidated Balance Sheets | 1\n | Consolidated Statements of Earnings | 2\n | Consolidated Statements of Comprehensive Income | 3\n | Consolidated Statements of Stockholders' Equity | 4\n | Consolidated Statements of Cash Flows | 5\n | Notes to Consolidated Financial Statements | 6\n | Note 1. Summary of Significant Accounting Policies | 6\n | Note 2. Net Sales | 7\n | Note 3. Property and Leases | 7\n | Note 4. Debtand Derivative Instruments | 8\n | Note 5. Stockholders' Equity | 10\n | Note 6. Fair Value Measurements | 10\n | Note 7. Weighted Average Common Shares | 11\n | Note 8.Contingencies | 11\n |  | \n | Report of Independent Registered Public Accounting Firm | 12\nItem\u00a02. | Management's Discussion and Analysis of Financial Condition and Results of Operations. | 13\nItem\u00a03. | Quantitative and Qualitative Disclosures About Market Risk. | 20\nItem\u00a04. | Controls and Procedures. | 20\n |  | \nPART II \u2013 OTHER INFORMATION | 20\n |  | \nItem 1A. | Risk Factors. | 20\nItem\u00a02. | Unregistered Sales of Equity Securities and Use of Proceeds. | 21\nItem\u00a06. | Exhibits. | 22\n |  | \nSIGNATURES | 23  |  |  |  |  |  |  |  | \nTerm |  | Definition\n |  | \nASU |  | Accounting Standards Update\nComparable sales |  | As defined in theResults of Operationssection of MD&A\nExchange Act |  | Securities Exchange Act of 1934, as amended\nFASB |  | Financial Accounting Standards Board\nfiscal 2021 |  | Fiscal year ended January 30, 2022\nfiscal 2022 |  | Fiscal year ending January 29, 2023\nGAAP |  | U.S. generally accepted accounting principles\nMD&A |  | Management's Discussion and Analysis of Financial Condition and Results of Operations\nNOPAT |  | Net operating profit after tax\nRestoration Plan |  | Home Depot FutureBuilder Restoration Plan\nROIC |  | Return on invested capital\nSEC |  | Securities and Exchange Commission\nSecurities Act |  | Securities Act of 1933, as amended\nSG&A |  | Selling, general and administrative\n2021 Form 10-K |  | Annual Report on Form 10-K for fiscal 2021 as filed with the SEC on March 23, 2022  |  |  |  |  |  |  |  |  |  |  | \nin millions, except per share data | October 30,2022 |  | January 30,2022\nAssets |  |  | \nCurrent assets: |  |  | \nCash and cash equivalents | $ | 2,462 |  |  | $ | 2,343 | \nReceivables, net | 3,732 |  |  | 3,426 | \nMerchandise inventories | 25,719 |  |  | 22,068 | \nOther current assets | 1,768 |  |  | 1,218 | \nTotal current assets | 33,681 |  |  | 29,055 | \nNet property and equipment | 25,240 |  |  | 25,199 | \nOperating lease right-of-use assets | 6,523 |  |  | 5,968 | \nGoodwill | 7,434 |  |  | 7,449 | \nOther assets | 3,988 |  |  | 4,205 | \nTotal assets | $ | 76,866 |  |  | $ | 71,876 | \n |  |  | \nLiabilities and Stockholders' Equity |  |  | \nCurrent liabilities: |  |  | \nShort-term debt | $ | \u2014 |  |  | $ | 1,035 | \nAccounts payable | 12,402 |  |  | 13,462 | \nAccrued salaries and related expenses | 1,934 |  |  | 2,426 | \nSales taxes payable | 640 |  |  | 848 | \nDeferred revenue | 3,173 |  |  | 3,596 | \nCurrent installments of long-term debt | 1,224 |  |  | 2,447 | \nCurrent operating lease liabilities | 942 |  |  | 830 | \nOther accrued expenses | 3,965 |  |  | 4,049 | \nTotal current liabilities | 24,280 |  |  | 28,693 | \nLong-term debt, excluding current installments | 41,740 |  |  | 36,604 | \nLong-term operating lease liabilities | 5,807 |  |  | 5,353 | \nOther long-term liabilities | 3,741 |  |  | 2,922 | \nTotal liabilities | 75,568 |  |  | 73,572 | \n |  |  | \nCommon stock, par value $0.05; authorized:10,000shares; issued:1,793shares at October\u00a030, 2022 and1,792shares at January\u00a030, 2022; outstanding:1,020shares at October\u00a030, 2022 and1,035shares at January\u00a030, 2022 | 90 |  |  | 90 | \nPaid-in capital | 12,385 |  |  | 12,132 | \nRetained earnings | 75,467 |  |  | 67,580 | \nAccumulated other comprehensive loss | (856) |  |  | (704) | \nTreasury stock, at cost,773shares at October\u00a030, 2022 and757shares at January\u00a030, 2022 | (85,788) |  |  | (80,794) | \nTotal stockholders\u2019 equity (deficit) | 1,298 |  |  | (1,696) | \nTotal liabilities and stockholders\u2019 equity | $ | 76,866 |  |  | $ | 71,876 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\nin millions, except per share data | October 30,2022 |  | October 31,2021 |  | October 30,2022 |  | October 31,2021\nNet sales | $ | 38,872 |  |  | $ | 36,820 |  |  | $ | 121,572 |  |  | $ | 115,438 | \nCost of sales | 25,648 |  |  | 24,257 |  |  | 80,720 |  |  | 76,468 | \nGross profit | 13,224 |  |  | 12,563 |  |  | 40,852 |  |  | 38,970 | \nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative | 6,468 |  |  | 6,168 |  |  | 19,735 |  |  | 18,975 | \nDepreciation and amortization | 608 |  |  | 600 |  |  | 1,830 |  |  | 1,780 | \nTotal operating expenses | 7,076 |  |  | 6,768 |  |  | 21,565 |  |  | 20,755 | \nOperating income | 6,148 |  |  | 5,795 |  |  | 19,287 |  |  | 18,215 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net | (7) |  |  | (15) |  |  | (12) |  |  | (26) | \nInterest expense | 413 |  |  | 341 |  |  | 1,166 |  |  | 1,006 | \nInterest and other, net | 406 |  |  | 326 |  |  | 1,154 |  |  | 980 | \nEarnings before provision for income taxes | 5,742 |  |  | 5,469 |  |  | 18,133 |  |  | 17,235 | \nProvision for income taxes | 1,403 |  |  | 1,340 |  |  | 4,390 |  |  | 4,154 | \nNet earnings | $ | 4,339 |  |  | $ | 4,129 |  |  | $ | 13,743 |  |  | $ | 13,081 | \n |  |  |  |  |  |  | \nBasic weighted average common shares | 1,020 |  |  | 1,049 |  |  | 1,024 |  |  | 1,059 | \nBasic earnings per share | $ | 4.25 |  |  | $ | 3.94 |  |  | $ | 13.42 |  |  | $ | 12.35 | \n |  |  |  |  |  |  | \nDiluted weighted average common shares | 1,023 |  |  | 1,053 |  |  | 1,028 |  |  | 1,063 | \nDiluted earnings per share | $ | 4.24 |  |  | $ | 3.92 |  |  | $ | 13.37 |  |  | $ | 12.31 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\nin millions | October 30,2022 |  | October 31,2021 |  | October 30,2022 |  | October 31,2021\nNet earnings | $ | 4,339 |  |  | $ | 4,129 |  |  | $ | 13,743 |  |  | $ | 13,081 | \nOther comprehensive income (loss), net of tax: |  |  |  |  |  |  | \nForeign currency translation adjustments | (187) |  |  | (20) |  |  | (158) |  |  | 35 | \nCash flow hedges | 3 |  |  | 3 |  |  | 6 |  |  | 7 | \nOther | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 27 | \nTotal other comprehensive income (loss), net of tax | (184) |  |  | (17) |  |  | (152) |  |  | 69 | \nComprehensive income | $ | 4,155 |  |  | $ | 4,112 |  |  | $ | 13,591 |  |  | $ | 13,150 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\nin millions | October 30,2022 |  | October 31,2021 |  | October 30,2022 |  | October 31,2021\nCommon Stock: |  |  |  |  |  |  | \nBalance at beginning of period | $ | 90 |  |  | $ | 90 |  |  | $ | 90 |  |  | $ | 89 | \nShares issued under employee stock plans | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 1 | \nBalance at end of period | 90 |  |  | 90 |  |  | 90 |  |  | 90 | \n |  |  |  |  |  |  | \nPaid-in Capital: |  |  |  |  |  |  | \nBalance at beginning of period | 12,309 |  |  | 11,797 |  |  | 12,132 |  |  | 11,540 | \nShares issued under employee stock plans | (2) |  |  | 18 |  |  | (21) |  |  | 50 | \n |  |  |  |  |  |  | \nStock-based compensation expense | 78 |  |  | 74 |  |  | 274 |  |  | 299 | \n |  |  |  |  |  |  | \nBalance at end of period | 12,385 |  |  | 11,889 |  |  | 12,385 |  |  | 11,889 | \n |  |  |  |  |  |  | \nRetained Earnings: |  |  |  |  |  |  | \nBalance at beginning of period | 73,074 |  |  | 63,560 |  |  | 67,580 |  |  | 58,134 | \n |  |  |  |  |  |  | \nNet earnings | 4,339 |  |  | 4,129 |  |  | 13,743 |  |  | 13,081 | \nCash dividends | (1,946) |  |  | (1,738) |  |  | (5,856) |  |  | (5,264) | \n |  |  |  |  |  |  | \nBalance at end of period | 75,467 |  |  | 65,951 |  |  | 75,467 |  |  | 65,951 | \n |  |  |  |  |  |  | \nAccumulated Other Comprehensive Income (Loss): |  |  |  |  |  |  | \nBalance at beginning of period | (672) |  |  | (585) |  |  | (704) |  |  | (671) | \n |  |  |  |  |  |  | \nForeign currency translation adjustments, net of tax | (187) |  |  | (20) |  |  | (158) |  |  | 35 | \nCash flow hedges, net of tax | 3 |  |  | 3 |  |  | 6 |  |  | 7 | \nOther, net of tax | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | 27 | \nBalance at end of period | (856) |  |  | (602) |  |  | (856) |  |  | (602) | \n |  |  |  |  |  |  | \nTreasury Stock: |  |  |  |  |  |  | \nBalance at beginning of period | (84,564) |  |  | (72,793) |  |  | (80,794) |  |  | (65,793) | \nRepurchases of common stock | (1,224) |  |  | (3,500) |  |  | (4,994) |  |  | (10,500) | \nBalance at end of period | (85,788) |  |  | (76,293) |  |  | (85,788) |  |  | (76,293) | \nTotal stockholders' equity | $ | 1,298 |  |  | $ | 1,035 |  |  | $ | 1,298 |  |  | $ | 1,035 |   |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended\nin millions | October 30,2022 |  | October 31,2021\nCash Flows from Operating Activities: |  |  | \nNet earnings | $ | 13,743 |  |  | $ | 13,081 | \nReconciliation of net earnings to net cash provided by operating activities: |  |  | \nDepreciation and amortization | 2,216 |  |  | 2,128 | \nStock-based compensation expense | 286 |  |  | 312 | \nChanges in receivables, net | (312) |  |  | (533) | \nChanges in merchandise inventories | (3,748) |  |  | (3,871) | \nChanges in other current assets | (568) |  |  | (375) | \nChanges in accounts payable and accrued expenses | (1,568) |  |  | 1,918 | \nChanges in deferred revenue | (413) |  |  | 672 | \nChanges in income taxes payable | 30 |  |  | (10) | \nChanges in deferred income taxes | 129 |  |  | (73) | \nOther operating activities | 226 |  |  | 137 | \nNet cash provided by operating activities | 10,021 |  |  | 13,386 | \n |  |  | \nCash Flows from Investing Activities: |  |  | \nCapital expenditures | (2,216) |  |  | (1,737) | \nPayments for businesses acquired, net | \u2014 |  |  | (416) | \nOther investing activities | (29) |  |  | 21 | \nNet cash used in investing activities | (2,245) |  |  | (2,132) | \n |  |  | \nCash Flows from Financing Activities: |  |  | \nRepayments of short-term debt, net | (1,035) |  |  | \u2014 | \nProceeds from long-term debt, net of discounts | 6,942 |  |  | 2,979 | \nRepayments of long-term debt | (2,423) |  |  | (1,480) | \nRepurchases of common stock | (5,136) |  |  | (10,374) | \nProceeds from sales of common stock | 146 |  |  | 190 | \nCash dividends | (5,856) |  |  | (5,264) | \nOther financing activities | (185) |  |  | (160) | \nNet cash used in financing activities | (7,547) |  |  | (14,109) | \nChange in cash and cash equivalents | 229 |  |  | (2,855) | \nEffect of exchange rate changes on cash and cash equivalents | (110) |  |  | 27 | \nCash and cash equivalents at beginning of period | 2,343 |  |  | 7,895 | \nCash and cash equivalents at end of period | $ | 2,462 |  |  | $ | 5,067 | \n |  |  | \nSupplemental Disclosures: |  |  | \nCash paid for interest, net of interest capitalized | $ | 1,160 |  |  | $ | 1,021 | \nCash paid for income taxes | 4,173 |  |  | 4,170 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\nin millions | October 30,2022 |  | October 31,2021 |  | October 30,2022 |  | October 31,2021\nNet sales \u2013 in the U.S. | $ | 35,784 |  |  | $ | 33,736 |  |  | $ | 111,834 |  |  | $ | 106,095 | \nNet sales \u2013 outside the U.S. | 3,088 |  |  | 3,084 |  |  | 9,738 |  |  | 9,343 | \nNet sales | $ | 38,872 |  |  | $ | 36,820 |  |  | $ | 121,572 |  |  | $ | 115,438 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\nin millions | October 30,2022 |  | October 31,2021 |  | October 30,2022 |  | October 31,2021\nNet sales \u2013 products | $ | 37,448 |  |  | $ | 35,383 |  |  | $ | 117,261 |  |  | $ | 111,371 | \nNet sales \u2013 services | 1,424 |  |  | 1,437 |  |  | 4,311 |  |  | 4,067 | \nNet sales | $ | 38,872 |  |  | $ | 36,820 |  |  | $ | 121,572 |  |  | $ | 115,438 |   |  |  |  |  |  |  |  | \nMajor Product Line |  | Merchandising Departments\nBuilding Materials |  | Building Materials, Electrical/Lighting, Lumber, Millwork, and Plumbing\nD\u00e9cor |  | Appliances, D\u00e9cor/Storage, Flooring, Kitchen and Bath, and Paint\nHardlines |  | Hardware, Indoor Garden, Outdoor Garden, and Tools  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\nin millions | October 30,2022 |  | October 31,2021 |  | October 30,2022 |  | October 31,2021\nBuilding Materials | $ | 15,343 |  |  | $ | 13,809 |  |  | $ | 46,095 |  |  | $ | 41,880 | \nD\u00e9cor | 13,070 |  |  | 12,783 |  |  | 40,040 |  |  | 38,060 | \nHardlines | 10,459 |  |  | 10,228 |  |  | 35,437 |  |  | 35,498 | \nNet sales | $ | 38,872 |  |  | $ | 36,820 |  |  | $ | 121,572 |  |  | $ | 115,438 |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions | Consolidated Balance Sheet Classification | October 30,2022 |  | January 30,2022\nAssets: |  |  |  | \nOperating lease assets | Operating lease right-of-use assets | $ | 6,523 |  |  | $ | 5,968 | \nFinance lease assets(1) | Net property and equipment | 2,890 |  |  | 2,896 | \nTotal lease assets |  | $ | 9,413 |  |  | $ | 8,864 | \n |  |  |  | \nLiabilities: |  |  |  | \nCurrent: |  |  |  | \nOperating lease liabilities | Current operating lease liabilities | $ | 942 |  |  | $ | 830 | \nFinance lease liabilities | Current installments of long-term debt | 224 |  |  | 198 | \nLong-term: |  |  |  | \nOperating lease liabilities | Long-term operating lease liabilities | 5,807 |  |  | 5,353 | \nFinance lease liabilities | Long-term debt, excluding current installments | 3,038 |  |  | 3,038 | \nTotal lease liabilities |  | $ | 10,011 |  |  | $ | 9,419 |   |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended\nin millions | October 30,2022 |  | October 31,2021\nLease assets obtained in exchange for new operating lease liabilities | $ | 1,308 |  |  | $ | 637 | \nLease assets obtained in exchange for new finance lease liabilities | 234 |  |  | 581 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nshares in millions | Three Months Ended |  | Nine Months Ended\nOctober 30,2022 |  | October 31,2021 |  | October 30,2022 |  | October 31,2021\nCommon stock: |  |  |  |  |  |  | \nBalance at beginning of period | 1,793 |  |  | 1,791 |  |  | 1,792 |  |  | 1,789 | \nShares issued under employee stock plans | \u2014 |  |  | \u2014 |  |  | 1 |  |  | 2 | \nBalance at end of period | 1,793 |  |  | 1,791 |  |  | 1,793 |  |  | 1,791 | \nTreasury stock: |  |  |  |  |  |  | \nBalance at beginning of period | (769) |  |  | (735) |  |  | (757) |  |  | (712) | \nRepurchases of common stock | (4) |  |  | (10) |  |  | (16) |  |  | (33) | \nBalance at end of period | (773) |  |  | (745) |  |  | (773) |  |  | (745) | \nShares outstanding at end of period | 1,020 |  |  | 1,046 |  |  | 1,020 |  |  | 1,046 | \n |  |  |  |  |  |  | \nCash dividends per share | $ | 1.90 |  |  | $ | 1.65 |  |  | $ | 5.70 |  |  | $ | 4.95 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions | Three Months Ended |  | Nine Months Ended\nOctober 30,2022 |  | October 31,2021 |  | October 30,2022 |  | October 31,2021\nTotal number of shares repurchased | 4 |  |  | 10 |  |  | 16 |  |  | 33 | \nTotal cost of shares repurchased | $ | 1,224 |  |  | $ | 3,500 |  |  | $ | 4,994 |  |  | $ | 10,500 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | October 30, 2022 |  | January 30, 2022\nin millions | Level\u00a01 |  | Level\u00a02 |  | Level\u00a03 |  | Level\u00a01 |  | Level\u00a02 |  | Level\u00a03\nDerivative agreements \u2013 assets | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | 58 |  |  | $ | \u2014 | \nDerivative agreements \u2013 liabilities | \u2014 |  |  | (977) |  |  | \u2014 |  |  | \u2014 |  |  | (249) |  |  | \u2014 | \nTotal | $ | \u2014 |  |  | $ | (977) |  |  | $ | \u2014 |  |  | $ | \u2014 |  |  | $ | (191) |  |  | $ | \u2014 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | October 30, 2022 |  | January 30, 2022\nin millions | Fair Value(Level 1) |  | CarryingValue |  | Fair Value(Level 1) |  | CarryingValue\nSenior notes | $ | 35,453 |  |  | $ | 39,702 |  |  | $ | 39,397 |  |  | $ | 35,815 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions | Three Months Ended |  | Nine Months Ended\nOctober 30,2022 |  | October 31,2021 |  | October 30,2022 |  | October 31,2021\nBasic weighted average common shares | 1,020 |  |  | 1,049 |  |  | 1,024 |  |  | 1,059 | \nEffect of potentially dilutive securities(1) | 3 |  |  | 4 |  |  | 4 |  |  | 4 | \nDiluted weighted average common shares | 1,023 |  |  | 1,053 |  |  | 1,028 |  |  | 1,063 | \n |  |  |  |  |  |  | \nAnti-dilutive securities excluded from diluted weighted average common shares | 1 |  |  | \u2014 |  |  | 1 |  |  | \u2014 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \ndollars in millions, except per share data | Three Months Ended |  | Nine Months Ended\nOctober 30,2022 |  | October 31,2021 |  | October 30,2022 |  | October 31,2021\nNet sales | $ | 38,872 |  |  | $ | 36,820 |  |  | $ | 121,572 |  |  | $ | 115,438 | \nNet earnings | 4,339 |  |  | 4,129 |  |  | 13,743 |  |  | 13,081 | \n |  |  |  |  |  |  | \nDiluted earnings per share | $ | 4.24 |  |  | $ | 3.92 |  |  | $ | 13.37 |  |  | $ | 12.31 | \n |  |  |  |  |  |  | \nNet cash provided by operating activities |  |  |  |  | $ | 10,021 |  |  | $ | 13,386 | \nProceeds from long-term debt, net of discounts |  |  |  |  | 6,942 |  |  | 2,979 | \nRepayments of long-term debt |  |  |  |  | 2,423 |  |  | 1,480 | \nRepurchases of common stock |  |  |  |  | 5,136 |  |  | 10,374 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended\n | October 30, 2022 |  | October 31, 2021\ndollars in millions | $ |  | % ofNet Sales |  | $ |  | % ofNet Sales\nNet sales | $ | 38,872 |  |  |  |  | $ | 36,820 |  |  | \nGross profit | 13,224 |  |  | 34.0 | % |  | 12,563 |  |  | 34.1 | %\nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative | 6,468 |  |  | 16.6 |  |  | 6,168 |  |  | 16.8 | \nDepreciation and amortization | 608 |  |  | 1.6 |  |  | 600 |  |  | 1.6 | \nTotal operating expenses | 7,076 |  |  | 18.2 |  |  | 6,768 |  |  | 18.4 | \nOperating income | 6,148 |  |  | 15.8 |  |  | 5,795 |  |  | 15.7 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net | (7) |  |  | \u2014 |  |  | (15) |  |  | \u2014 | \nInterest expense | 413 |  |  | 1.1 |  |  | 341 |  |  | 0.9 | \nInterest and other, net | 406 |  |  | 1.0 |  |  | 326 |  |  | 0.9 | \nEarnings before provision for income taxes | 5,742 |  |  | 14.8 |  |  | 5,469 |  |  | 14.9 | \nProvision for income taxes | 1,403 |  |  | 3.6 |  |  | 1,340 |  |  | 3.6 | \nNet earnings | $ | 4,339 |  |  | 11.2 | % |  | $ | 4,129 |  |  | 11.2 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \nSelected financial and sales data: | October 30,2022 |  | October 31,2021 |  | % Change\nComparable sales (% change) | 4.3 | % |  | 6.1 | % |  | N/A\nComparable customer transactions (% change)(1) | (4.4) | % |  | (5.8) | % |  | N/A\nComparable average ticket (% change)(1) | 8.8 | % |  | 12.7 | % |  | N/A\nCustomer transactions (in millions)(1) | 409.8 |  |  | 428.2 |  |  | (4.3) | %\nAverage ticket(1) (2) | $ | 89.67 |  |  | $ | 82.38 |  |  | 8.8 | %\nSales per retail square foot(1) (3) | $ | 618.50 |  |  | $ | 587.28 |  |  | 5.3 | %\nDiluted earnings per share | $ | 4.24 |  |  | $ | 3.92 |  |  | 8.2 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended\n | October 30, 2022 |  | October 31, 2021\ndollars in millions | $ |  | % ofNet Sales |  | $ |  | % ofNet Sales\nNet sales | $ | 121,572 |  |  |  |  | $ | 115,438 |  |  | \nGross profit | 40,852 |  |  | 33.6 | % |  | 38,970 |  |  | 33.8 | %\nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative | 19,735 |  |  | 16.2 |  |  | 18,975 |  |  | 16.4 | \nDepreciation and amortization | 1,830 |  |  | 1.5 |  |  | 1,780 |  |  | 1.5 | \nTotal operating expenses | 21,565 |  |  | 17.7 |  |  | 20,755 |  |  | 18.0 | \nOperating income | 19,287 |  |  | 15.9 |  |  | 18,215 |  |  | 15.8 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net | (12) |  |  | \u2014 |  |  | (26) |  |  | \u2014 | \nInterest expense | 1,166 |  |  | 1.0 |  |  | 1,006 |  |  | 0.9 | \nInterest and other, net | 1,154 |  |  | 0.9 |  |  | 980 |  |  | 0.8 | \nEarnings before provision for income taxes | 18,133 |  |  | 14.9 |  |  | 17,235 |  |  | 14.9 | \nProvision for income taxes | 4,390 |  |  | 3.6 |  |  | 4,154 |  |  | 3.6 | \nNet earnings | $ | 13,743 |  |  | 11.3 | % |  | $ | 13,081 |  |  | 11.3 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended |  | \nSelected financial and sales data: | October 30,2022 |  | October 31,2021 |  | % Change\nComparable sales (% change) | 4.2 | % |  | 12.5 | % |  | N/A\nComparable customer transactions (% change)(1) | (5.3) | % |  | 1.1 | % |  | N/A\nComparable average ticket (% change)(1) | 9.7 | % |  | 11.5 | % |  | N/A\nCustomer transactions (in millions)(1) | 1,287.9 |  |  | 1,357.2 |  |  | (5.1) | %\nAverage ticket(1) (2) | $ | 90.45 |  |  | $ | 82.43 |  |  | 9.7 | %\nSales per retail square foot(1) (3) | $ | 646.81 |  |  | $ | 615.98 |  |  | 5.0 | %\nDiluted earnings per share | $ | 13.37 |  |  | $ | 12.31 |  |  | 8.6 | %  |  |  |  |  |  |  |  |  |  |  | \n | Twelve Months Ended\ndollars in millions | October 30,2022 |  | October 31,2021\nNet earnings | $ | 17,095 |  |  | $ | 15,938 | \nInterest and other, net | 1,477 |  |  | 1,307 | \nProvision for income taxes | 5,540 |  |  | 5,053 | \nOperating income | 24,112 |  |  | 22,298 | \nIncome tax adjustment(1) | (5,844) |  |  | (5,378) | \nNOPAT | $ | 18,268 |  |  | $ | 16,920 | \n |  |  | \nAverage debt and equity | $ | 42,222 |  |  | $ | 38,519 | \n |  |  | \nROIC | 43.3 | % |  | 43.9 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | Total Number of Shares Purchased(1) |  | Average Price Paid Per\u00a0Share(1) |  | Total Number of Shares\u00a0Purchased\u00a0as Part of Publicly Announced\u00a0Program(2) |  | Dollar Value of Shares\u00a0that\u00a0May\u00a0Yet Be\u00a0Purchased\u00a0Under the Program(2)\nAugust 1, 2022 \u2013 August 28, 2022 |  | 1,006,934 |  |  | $ | 311.63 |  |  | 1,002,575 |  |  | $ | 14,906,250,890 | \nAugust 29, 2022 \u2013 September 25, 2022 |  | 1,042,671 |  |  | 285.15 |  |  | 1,041,201 |  |  | 14,609,360,775 | \nSeptember 26, 2022 \u2013 October 30, 2022 |  | 2,192,077 |  |  | 282.02 |  |  | 2,179,438 |  |  | 13,994,589,035 | \n |  | 4,241,682 |  |  | 289.82 |  |  | 4,223,214 |  |  |   |  |  |  |  |  |  |  | \nExhibit |  | Description\n3.1 | * | Amended and Restated Certificate of Incorporation of The Home Depot, Inc.[Form 10-Q filed on September 1, 2011, Exhibit 3.1]\n3.2 | * | By-Laws of The Home Depot, Inc. (Amended and Restated Effective February 28, 2019)[Form 8-K filed on March 4, 2019, Exhibit 3.2]\n4.1 | * | Form of 4.000% Note due September 15, 2025[Form 8-K filed on September 19, 2022, Exhibit 4.2]\n4.2 | * | Form of 4.500% Note due September 15, 2032[Form 8-K filed on September 19, 2022, Exhibit 4.3]\n4.3 | * | Form of 4.950% Note due September 15, 2052[Form 8-K filed on September 19, 2022, Exhibit 4.4]\n15.1 |  | Acknowledgement of Independent Registered Public Accounting Firm\n31.1 |  | Certification of theChair,President and Chief Executive Officer pursuant to Rule 13a-14(a)\n31.2 |  | Certification of the Executive Vice President and Chief Financial Officer pursuant to Rule\u00a013a-14(a)\n32.1 |  | Certification of the Chair, President and Chief Executive Officer furnished pursuant to Section\u00a0906 of the Sarbanes-Oxley Act of 2002\n32.2 |  | Certification of the Executive Vice President and Chief Financial Officer furnished pursuant to Section\u00a0906 of the Sarbanes-Oxley Act of 2002\n101.INS |  | XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document\n101.SCH |  | Inline XBRL Taxonomy Extension Schema Document\n101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document\n101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document\n101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document\n101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document\n104 |  | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)  |  |  |  |  | \nTHE HOME DEPOT, INC.(Registrant)\n | \nBy: | /s/ EDWARD P. DECKER\n | Edward P. Decker, Chair, President and Chief Executive Officer (Principal Executive Officer)\n\n | /s/ RICHARD V. MCPHAIL\n | Richard V. McPhail, Executive Vice President and Chief Financial Officer (Principal Financial Officer)\n | \n | /s/ STEPHEN L. GIBBS\n | Stephen L. Gibbs, Vice President, Chief Accounting Officer and Corporate Controller (Principal Accounting Officer)\n\nDate: | November 21, 2022"}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Home Depot, in 2023 Q2, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nDelaware |  |  |  | 95-3261426\n(State or other jurisdiction of incorporation or organization) |  |  |  | (I.R.S. Employer Identification No.)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n2455 Paces Ferry Road |  |  |  | \nAtlanta, | Georgia |  |  |  | 30339\n(Address of principal executive offices) |  |  |  | (Zip Code)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSecurities registered pursuant to Section 12(b) of the Act:\nTitle of each class |  | Trading Symbol |  | Name of each exchange on which registered\nCommon Stock, $0.05 Par Value Per Share |  | HD |  | New York Stock Exchange  |  | \n  |  |  |  |  |  |  |  | \nCommonly Used or Defined Terms | ii\nForward-Looking Statements | iii\n |  | \nPART I \u2013 FINANCIAL INFORMATION | 1\nItem\u00a01. | Financial Statements. | 1\n | Consolidated Balance Sheets | 1\n | Consolidated Statements of Earnings | 2\n | Consolidated Statements of Comprehensive Income | 3\n | Consolidated Statements of Stockholders' Equity | 4\n | Consolidated Statements of Cash Flows | 5\n | Notes to Consolidated Financial Statements | 6\n | Note 1. Summary of Significant Accounting Policies | 6\n | Note 2. Net Sales | 7\n | Note 3. Property and Leases | 8\n | Note 4. Debt and Derivative Instruments | 8\n | Note 5. Stockholders' Equity | 9\n | Note 6. Fair Value Measurements | 10\n | Note 7. Weighted Average Common Shares | 11\n | Note 8. Contingencies | 11\n |  | \n | Report of Independent Registered Public Accounting Firm | 12\nItem\u00a02. | Management's Discussion and Analysis of Financial Condition and Results of Operations. | 13\nItem\u00a03. | Quantitative and Qualitative Disclosures About Market Risk. | 18\nItem\u00a04. | Controls and Procedures. | 18\n |  | \nPART II \u2013 OTHER INFORMATION | 18\nItem 1. | Legal Proceedings. | 18\nItem 1A. | Risk Factors. | 19\nItem\u00a02. | Unregistered Sales of Equity Securities and Use of Proceeds. | 19\nItem\u00a06. | Exhibits. | 20\n |  | \nSIGNATURES | 21  |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | i |   |  |  |  |  |  |  |  | \nTerm |  | Definition\nASU |  | Accounting Standards Update\nComparable sales |  | As defined in theResults of Operationssection of MD&A\nExchange Act |  | Securities Exchange Act of 1934, as amended\nESG |  | Environmental, social, and governance\nFASB |  | Financial Accounting Standards Board\nfiscal 2022 |  | Fiscal year ended January 29, 2023\nfiscal 2023 |  | Fiscal year ending January 28, 2024\nGAAP |  | U.S. generally accepted accounting principles\nMD&A |  | Management's Discussion and Analysis of Financial Condition and Results of Operations\nNOPAT |  | Net operating profit after tax\nRestoration Plans |  | Home Depot FutureBuilder Restoration Plan and HD Supply Restoration Plan\nROIC |  | Return on invested capital\nSEC |  | Securities and Exchange Commission\nSecurities Act |  | Securities Act of 1933, as amended\nSG&A |  | Selling, general and administrative\n2022 Form 10-K |  | Annual Report on Form 10-K for fiscal 2022 as filed with the SEC on March 15, 2023  |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | ii |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | iii |   |  |  |  |  |  |  |  |  |  |  | \nin millions, except per share data | April 30,2023 |  | January 29,2023\nAssets |  |  | \nCurrent assets: |  |  | \nCash and cash equivalents | $ | 1,260 |  |  | $ | 2,757 | \nReceivables, net | 4,213 |  |  | 3,317 | \nMerchandise inventories | 25,371 |  |  | 24,886 | \nOther current assets | 1,579 |  |  | 1,511 | \nTotal current assets | 32,423 |  |  | 32,471 | \nNet property and equipment | 25,674 |  |  | 25,631 | \nOperating lease right-of-use assets | 6,931 |  |  | 6,941 | \nGoodwill | 7,447 |  |  | 7,444 | \nOther assets | 3,911 |  |  | 3,958 | \nTotal assets | $ | 76,386 |  |  | $ | 76,445 | \n |  |  | \nLiabilities and Stockholders' Equity |  |  | \nCurrent liabilities: |  |  | \n |  |  | \nAccounts payable | $ | 12,630 |  |  | $ | 11,443 | \nAccrued salaries and related expenses | 1,931 |  |  | 1,991 | \nSales taxes payable | 683 |  |  | 528 | \nDeferred revenue | 3,119 |  |  | 3,064 | \nIncome taxes payable | 1,054 |  |  | 50 | \nCurrent installments of long-term debt | 1,338 |  |  | 1,231 | \nCurrent operating lease liabilities | 966 |  |  | 945 | \nOther accrued expenses | 3,725 |  |  | 3,858 | \nTotal current liabilities | 25,446 |  |  | 23,110 | \nLong-term debt, excluding current installments | 40,915 |  |  | 41,962 | \nLong-term operating lease liabilities | 6,209 |  |  | 6,226 | \nDeferred income taxes | 954 |  |  | 1,019 | \nOther long-term liabilities | 2,500 |  |  | 2,566 | \nTotal liabilities | 76,024 |  |  | 74,883 | \nContingencies (Note 8) |  |  | \nCommon stock, par value $0.05; authorized:10,000shares; issued:1,795shares at April\u00a030, 2023 and1,794shares at January\u00a029, 2023; outstanding:1,007shares at April\u00a030, 2023 and1,016shares at January\u00a029, 2023 | 90 |  |  | 90 | \nPaid-in capital | 12,584 |  |  | 12,592 | \nRetained earnings | 78,651 |  |  | 76,896 | \nAccumulated other comprehensive loss | (637) |  |  | (718) | \nTreasury stock, at cost,788shares at April\u00a030, 2023 and778shares at January\u00a029, 2023 | (90,326) |  |  | (87,298) | \nTotal stockholders\u2019 equity | 362 |  |  | 1,562 | \nTotal liabilities and stockholders\u2019 equity | $ | 76,386 |  |  | $ | 76,445 |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 1 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\nin millions, except per share data |  |  |  |  | April 30,2023 |  | May 1,2022\nNet sales |  |  |  |  | $ | 37,257 |  |  | $ | 38,908 | \nCost of sales |  |  |  |  | 24,700 |  |  | 25,763 | \nGross profit |  |  |  |  | 12,557 |  |  | 13,145 | \nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative |  |  |  |  | 6,355 |  |  | 6,610 | \nDepreciation and amortization |  |  |  |  | 651 |  |  | 606 | \nTotal operating expenses |  |  |  |  | 7,006 |  |  | 7,216 | \nOperating income |  |  |  |  | 5,551 |  |  | 5,929 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net |  |  |  |  | (33) |  |  | (3) | \nInterest expense |  |  |  |  | 474 |  |  | 372 | \nInterest and other, net |  |  |  |  | 441 |  |  | 369 | \nEarnings before provision for income taxes |  |  |  |  | 5,110 |  |  | 5,560 | \nProvision for income taxes |  |  |  |  | 1,237 |  |  | 1,329 | \nNet earnings |  |  |  |  | $ | 3,873 |  |  | $ | 4,231 | \n |  |  |  |  |  |  | \nBasic weighted average common shares |  |  |  |  | 1,010 |  |  | 1,030 | \nBasic earnings per share |  |  |  |  | $ | 3.83 |  |  | $ | 4.11 | \n |  |  |  |  |  |  | \nDiluted weighted average common shares |  |  |  |  | 1,013 |  |  | 1,034 | \nDiluted earnings per share |  |  |  |  | $ | 3.82 |  |  | $ | 4.09 |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\nin millions |  |  |  |  | April 30,2023 |  | May 1,2022\nNet earnings |  |  |  |  | $ | 3,873 |  |  | $ | 4,231 | \nOther comprehensive income (loss), net of tax: |  |  |  |  |  |  | \nForeign currency translation adjustments |  |  |  |  | 79 |  |  | 20 | \nCash flow hedges |  |  |  |  | 2 |  |  | 1 | \n |  |  |  |  |  |  | \nTotal other comprehensive income (loss), net of tax |  |  |  |  | 81 |  |  | 21 | \nComprehensive income |  |  |  |  | $ | 3,954 |  |  | $ | 4,252 |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 3 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\nin millions |  |  |  |  | April 30,2023 |  | May 1,2022\nCommon Stock: |  |  |  |  |  |  | \nBalance at beginning of period |  |  |  |  | $ | 90 |  |  | $ | 90 | \nShares issued under employee stock plans, net |  |  |  |  | \u2014 |  |  | \u2014 | \nBalance at end of period |  |  |  |  | 90 |  |  | 90 | \n |  |  |  |  |  |  | \nPaid-in Capital: |  |  |  |  |  |  | \nBalance at beginning of period |  |  |  |  | 12,592 |  |  | 12,132 | \nShares issued under employee stock plans, net |  |  |  |  | (119) |  |  | (154) | \n |  |  |  |  |  |  | \nStock-based compensation expense |  |  |  |  | 111 |  |  | 101 | \n |  |  |  |  |  |  | \nBalance at end of period |  |  |  |  | 12,584 |  |  | 12,079 | \n |  |  |  |  |  |  | \nRetained Earnings: |  |  |  |  |  |  | \nBalance at beginning of period |  |  |  |  | 76,896 |  |  | 67,580 | \n |  |  |  |  |  |  | \nNet earnings |  |  |  |  | 3,873 |  |  | 4,231 | \nCash dividends |  |  |  |  | (2,118) |  |  | (1,962) | \n |  |  |  |  |  |  | \nBalance at end of period |  |  |  |  | 78,651 |  |  | 69,849 | \n |  |  |  |  |  |  | \nAccumulated Other Comprehensive Income (Loss): |  |  |  |  |  |  | \nBalance at beginning of period |  |  |  |  | (718) |  |  | (704) | \n |  |  |  |  |  |  | \nForeign currency translation adjustments, net of tax |  |  |  |  | 79 |  |  | 20 | \nCash flow hedges, net of tax |  |  |  |  | 2 |  |  | 1 | \n |  |  |  |  |  |  | \nBalance at end of period |  |  |  |  | (637) |  |  | (683) | \n |  |  |  |  |  |  | \nTreasury Stock: |  |  |  |  |  |  | \nBalance at beginning of period |  |  |  |  | (87,298) |  |  | (80,794) | \nRepurchases of common stock |  |  |  |  | (3,028) |  |  | (2,250) | \nBalance at end of period |  |  |  |  | (90,326) |  |  | (83,044) | \nTotal stockholders' equity (deficit) |  |  |  |  | $ | 362 |  |  | $ | (1,709) |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 4 |   |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended\nin millions | April 30,2023 |  | May 1,2022\nCash Flows from Operating Activities: |  |  | \nNet earnings | $ | 3,873 |  |  | $ | 4,231 | \nReconciliation of net earnings to net cash provided by operating activities: |  |  | \nDepreciation and amortization | 793 |  |  | 727 | \nStock-based compensation expense | 124 |  |  | 115 | \nChanges in receivables, net | (893) |  |  | (489) | \nChanges in merchandise inventories | (457) |  |  | (3,226) | \nChanges in other current assets | (60) |  |  | (589) | \nChanges in accounts payable and accrued expenses | 1,158 |  |  | 1,744 | \nChanges in deferred revenue | 57 |  |  | 79 | \nChanges in income taxes payable | 1,004 |  |  | 1,121 | \nChanges in deferred income taxes | (59) |  |  | (44) | \nOther operating activities | 74 |  |  | 120 | \nNet cash provided by operating activities | 5,614 |  |  | 3,789 | \n |  |  | \nCash Flows from Investing Activities: |  |  | \nCapital expenditures | (905) |  |  | (704) | \n |  |  | \nOther investing activities | 2 |  |  | 3 | \nNet cash used in investing activities | (903) |  |  | (701) | \n |  |  | \nCash Flows from Financing Activities: |  |  | \nRepayments of short-term debt, net | \u2014 |  |  | (1,035) | \nProceeds from long-term debt, net of discounts | \u2014 |  |  | 3,957 | \nRepayments of long-term debt | (1,063) |  |  | (1,054) | \nRepurchases of common stock | (2,887) |  |  | (2,308) | \nProceeds from sales of common stock | 15 |  |  | 5 | \nCash dividends | (2,118) |  |  | (1,962) | \nOther financing activities | (135) |  |  | (182) | \nNet cash used in financing activities | (6,188) |  |  | (2,579) | \nChange in cash and cash equivalents | (1,477) |  |  | 509 | \nEffect of exchange rate changes on cash and cash equivalents | (20) |  |  | (8) | \nCash and cash equivalents at beginning of period | 2,757 |  |  | 2,343 | \nCash and cash equivalents at end of period | $ | 1,260 |  |  | $ | 2,844 | \n |  |  | \nSupplemental Disclosures: |  |  | \nCash paid for interest, net of interest capitalized | $ | 596 |  |  | $ | 415 | \nCash paid for income taxes | 185 |  |  | 213 |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 5 |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 6 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\nin millions |  |  |  |  | April 30,2023 |  | May 1,2022\nNet sales \u2013 in the U.S. |  |  |  |  | $ | 34,507 |  |  | $ | 36,006 | \nNet sales \u2013 outside the U.S. |  |  |  |  | 2,750 |  |  | 2,902 | \nNet sales |  |  |  |  | $ | 37,257 |  |  | $ | 38,908 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\nin millions |  |  |  |  | April 30,2023 |  | May 1,2022\nNet sales \u2013 products |  |  |  |  | $ | 35,888 |  |  | $ | 37,465 | \nNet sales \u2013 services |  |  |  |  | 1,369 |  |  | 1,443 | \nNet sales |  |  |  |  | $ | 37,257 |  |  | $ | 38,908 |   |  |  |  |  |  |  |  | \nMajor Product Line |  | Merchandising Departments\nBuilding Materials |  | Building Materials, Electrical/Lighting, Lumber, Millwork, and Plumbing\nD\u00e9cor |  | Appliances, D\u00e9cor/Storage, Flooring, Kitchen and Bath, and Paint\nHardlines |  | Hardware, Indoor Garden, Outdoor Garden, and Tools  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | Three Months Ended\nin millions |  |  |  |  | April 30,2023 |  | May 1,2022\nBuilding Materials |  |  |  |  | $ | 14,079 |  |  | $ | 14,869 | \nD\u00e9cor |  |  |  |  | 12,251 |  |  | 12,874 | \nHardlines |  |  |  |  | 10,927 |  |  | 11,165 | \nNet sales |  |  |  |  | $ | 37,257 |  |  | $ | 38,908 |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 7 |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions | Consolidated Balance Sheet Classification | April 30,2023 |  | January 29,2023\nAssets: |  |  |  | \nOperating lease assets | Operating lease right-of-use assets | $ | 6,931 |  |  | $ | 6,941 | \nFinance lease assets(1) | Net property and equipment | 2,879 |  |  | 2,899 | \nTotal lease assets |  | $ | 9,810 |  |  | $ | 9,840 | \nLiabilities: |  |  |  | \nCurrent: |  |  |  | \nOperating lease liabilities | Current operating lease liabilities | $ | 966 |  |  | $ | 945 | \nFinance lease liabilities | Current installments of long-term debt | 239 |  |  | 231 | \nLong-term: |  |  |  | \nOperating lease liabilities | Long-term operating lease liabilities | 6,209 |  |  | 6,226 | \nFinance lease liabilities | Long-term debt, excluding current installments | 3,060 |  |  | 3,054 | \nTotal lease liabilities |  | $ | 10,474 |  |  | $ | 10,456 |   |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended\nin millions | April 30,2023 |  | May 1,2022\nLease assets obtained in exchange for new operating lease liabilities | $ | 254 |  |  | $ | 256 | \nLease assets obtained in exchange for new finance lease liabilities | 114 |  |  | 148 |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 8 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nshares in millions |  |  | Three Months Ended\n |  |  |  | April 30,2023 |  | May 1,2022\nCommon stock: |  |  |  |  |  |  | \nShares at beginning of period |  |  |  |  | 1,794 |  |  | 1,792 | \nShares issued under employee stock plans, net |  |  |  |  | 1 |  |  | 1 | \nShares at end of period |  |  |  |  | 1,795 |  |  | 1,793 | \nTreasury stock: |  |  |  |  |  |  | \nShares at beginning of period |  |  |  |  | (778) |  |  | (757) | \nRepurchases of common stock |  |  |  |  | (10) |  |  | (7) | \nShares at end of period |  |  |  |  | (788) |  |  | (764) | \nShares outstanding at end of period |  |  |  |  | 1,007 |  |  | 1,029 | \n |  |  |  |  |  |  | \nCash dividends per share |  |  |  |  | $ | 2.09 |  |  | $ | 1.90 |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 9 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions |  |  | Three Months Ended\n |  |  |  | April 30,2023 |  | May 1,2022\nTotal number of shares repurchased |  |  |  |  | 10 |  |  | 7 | \nTotal cost of shares repurchased(1) |  |  |  |  | $ | 3,028 |  |  | $ | 2,250 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | April 30, 2023 |  |  |  | January 29, 2023\nin millions |  |  | Fair Value(Level\u00a02) |  |  |  |  |  | Fair Value(Level\u00a02) |  | \nDerivative agreements \u2013 assets |  |  | $ | \u2014 |  |  |  |  |  |  | $ | \u2014 |  |  | \nDerivative agreements \u2013 liabilities |  |  | (740) |  |  |  |  |  |  | (778) |  |  | \nTotal |  |  | $ | (740) |  |  |  |  |  |  | $ | (778) |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | April 30, 2023 |  | January 29, 2023\nin millions | Fair Value(Level 1) |  | CarryingValue |  | Fair Value(Level 1) |  | CarryingValue\nSenior notes | $ | 36,992 |  |  | $ | 38,954 |  |  | $ | 38,537 |  |  | $ | 39,908 |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 10 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions |  |  | Three Months Ended\n |  |  |  | April 30,2023 |  | May 1,2022\nBasic weighted average common shares |  |  |  |  | 1,010 |  |  | 1,030 | \nEffect of potentially dilutive securities(1) |  |  |  |  | 3 |  |  | 4 | \nDiluted weighted average common shares |  |  |  |  | 1,013 |  |  | 1,034 | \n |  |  |  |  |  |  | \nAnti-dilutive securities excluded from diluted weighted average common shares |  |  |  |  | 1 |  |  | 1 |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 11 |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 12 |   |  |  |  |  | \nExecutive Summary | 13\nResults of Operations | 14\nLiquidity and Capital Resources | 16\nCritical Accounting Estimates | 18  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \ndollars in millions, except per share data |  |  | Three Months Ended\n |  |  |  | April 30,2023 |  | May 1,2022\nNet sales |  |  |  |  | $ | 37,257 |  |  | $ | 38,908 | \nNet earnings |  |  |  |  | 3,873 |  |  | 4,231 | \nDiluted earnings per share |  |  |  |  | $ | 3.82 |  |  | $ | 4.09 | \n |  |  |  |  |  |  | \nNet cash provided by operating activities |  |  |  |  | $ | 5,614 |  |  | $ | 3,789 | \nProceeds from long-term debt, net of discounts |  |  |  |  | \u2014 |  |  | 3,957 | \nRepayments of long-term debt |  |  |  |  | 1,063 |  |  | 1,054 | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 13 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended\n | April 30, 2023 |  | May 1, 2022\ndollars in millions | $ |  | % ofNet Sales |  | $ |  | % ofNet Sales\nNet sales | $ | 37,257 |  |  |  |  | $ | 38,908 |  |  | \nGross profit | 12,557 |  |  | 33.7 | % |  | 13,145 |  |  | 33.8 | %\nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative | 6,355 |  |  | 17.1 |  |  | 6,610 |  |  | 17.0 | \nDepreciation and amortization | 651 |  |  | 1.7 |  |  | 606 |  |  | 1.6 | \nTotal operating expenses | 7,006 |  |  | 18.8 |  |  | 7,216 |  |  | 18.5 | \nOperating income | 5,551 |  |  | 14.9 |  |  | 5,929 |  |  | 15.2 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net | (33) |  |  | (0.1) |  |  | (3) |  |  | \u2014 | \nInterest expense | 474 |  |  | 1.3 |  |  | 372 |  |  | 1.0 | \nInterest and other, net | 441 |  |  | 1.2 |  |  | 369 |  |  | 0.9 | \nEarnings before provision for income taxes | 5,110 |  |  | 13.7 |  |  | 5,560 |  |  | 14.3 | \nProvision for income taxes | 1,237 |  |  | 3.3 |  |  | 1,329 |  |  | 3.4 | \nNet earnings | $ | 3,873 |  |  | 10.4 | % |  | $ | 4,231 |  |  | 10.9 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \nSelected financial and sales data: | April 30,2023 |  | May 1,2022 |  | % Change\nComparable sales (% change) | (4.5) | % |  | 2.2 | % |  | N/A\nComparable customer transactions (% change)(1) | (5.0) | % |  | (8.4) | % |  | N/A\nComparable average ticket (% change)(1) | 0.2 | % |  | 11.2 | % |  | N/A\nCustomer transactions (in millions)(1) | 390.9 |  |  | 410.7 |  |  | (4.8) | %\nAverage ticket(1) (2) | $ | 91.92 |  |  | $ | 91.72 |  |  | 0.2 | %\nSales per retail square foot(1) (3) | $ | 592.94 |  |  | $ | 621.99 |  |  | (4.7) | %\nDiluted earnings per share | $ | 3.82 |  |  | $ | 4.09 |  |  | (6.6) | %  |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 14 |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 15 |   |  |  |  |  |  |  |  |  |  |  | \n | Twelve Months Ended\ndollars in millions | April 30,2023 |  | May 1,2022\nNet earnings | $ | 16,747 |  |  | $ | 16,519 | \nInterest and other, net | 1,634 |  |  | 1,339 | \nProvision for income taxes | 5,280 |  |  | 5,330 | \nOperating income | 23,661 |  |  | 23,188 | \nIncome tax adjustment(1) | (5,671) |  |  | (5,628) | \nNOPAT | $ | 17,990 |  |  | $ | 17,560 | \n |  |  | \nAverage debt and equity | $ | 41,264 |  |  | $ | 38,761 | \n |  |  | \nROIC | 43.6 | % |  | 45.3 | %  |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 16 |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 17 |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 18 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | Total Number of Shares Purchased(1) |  | Average Price Paid Per Share(1)(3) |  | Total Number of Shares\u00a0Purchased\u00a0as Part of Publicly Announced\u00a0Program(2) |  | Dollar Value of Shares\u00a0that\u00a0May\u00a0Yet Be\u00a0Purchased\u00a0Under the Program(2)(3)\nJanuary 30, 2023 \u2013 February 26, 2023 |  | 761,056 |  |  | $ | 297.20 |  |  | 752,155 |  |  | $ | 12,261,016,857 | \nFebruary 27, 2023 \u2013 March 26, 2023 |  | 5,036,836 |  |  | 290.08 |  |  | 4,886,377 |  |  | 10,842,617,132 | \nMarch 27, 2023 \u2013 April 30, 2023 |  | 4,806,516 |  |  | 292.16 |  |  | 4,643,569 |  |  | 9,484,220,818 | \n |  | 10,604,408 |  |  | 291.53 |  |  | 10,282,101 |  |  |   |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 19 |   |  |  |  |  |  |  |  | \nExhibit |  | Description\n3.1 | * | Amended and Restated Certificate of Incorporation of The Home Depot, Inc.[Form 10-Q filed on September 1, 2011, Exhibit 3.1]\n3.2 | * | By-Laws of The Home Depot, Inc. (AsAmended and Restated Effective February 23, 2023)[Form 8-K filed on February 28, 2023, Exhibit 3.2]\n10.1 | *\u2020 | Form of Executive Officer Equity Award Agreement (Performance Shares, Performance-Based Restricted Stock and Nonqualified Stock Options) Pursuant to The Home Depot, Inc. Omnibus Stock Incentive Plan, as Amended and Restated May 19, 2022[Form 8-K filed on February 28, 2023, Exhibit 10.1]\n10.2 | *\u2020 | Form of Executive Officer Equity Award Agreement (Restricted Stock and Nonqualified Stock Options) Pursuant to The Home Depot, Inc. Omnibus Stock Incentive Plan, as Amended and Restated May 19, 2022[Form 8-K filed on February 28, 2023, Exhibit 10.2]\n10.3 | \u2020 | Separation Agreement between Jeffery G. Kinnaird and The Home Depot, Inc., dated April 17, 2023\n15.1 |  | Acknowledgement of Independent Registered Public Accounting Firm\n31.1 |  | Certification of the Chair, President and Chief Executive Officer pursuant to Rule 13a-14(a)\n31.2 |  | Certification of the Executive Vice President and Chief Financial Officer pursuant to Rule\u00a013a-14(a)\n32.1 |  | Certification of the Chair, President and Chief Executive Officer furnished pursuant to Section\u00a0906 of the Sarbanes-Oxley Act of 2002\n32.2 |  | Certification of the Executive Vice President and Chief Financial Officer furnished pursuant to Section\u00a0906 of the Sarbanes-Oxley Act of 2002\n101.INS |  | XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document\n101.SCH |  | Inline XBRL Taxonomy Extension Schema Document\n101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document\n101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document\n101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document\n101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document\n104 |  | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)  |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 20 |   |  |  |  |  | \nTHE HOME DEPOT, INC.(Registrant)\n | \nBy: | /s/ EDWARD P. DECKER\n | Edward P. Decker, Chair, President and Chief Executive Officer (Principal Executive Officer)\n\n | /s/ RICHARD V. MCPHAIL\n | Richard V. McPhail, Executive Vice President and Chief Financial Officer (Principal Financial Officer)\n | \n | /s/ STEPHEN L. GIBBS\n | Stephen L. Gibbs, Vice President, Chief Accounting Officer and Corporate Controller (Principal Accounting Officer)\n\nDate: | May 22, 2023  |  |  |  |  |  |  |  | \nFiscal Q1 2023 Form 10-Q | 21 | "}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Home Depot, in 2023 Q3, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nDelaware |  |  |  | 95-3261426\n(State or other jurisdiction of incorporation or organization) |  |  |  | (I.R.S. Employer Identification No.)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n2455 Paces Ferry Road |  |  |  | \nAtlanta, | Georgia |  |  |  | 30339\n(Address of principal executive offices) |  |  |  | (Zip Code)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSecurities registered pursuant to Section 12(b) of the Act:\nTitle of each class |  | Trading Symbol |  | Name of each exchange on which registered\nCommon Stock, $0.05 Par Value Per Share |  | HD |  | New York Stock Exchange  |  | \n  |  |  |  |  |  |  |  | \nCommonly Used or Defined Terms | ii\nForward-Looking Statements | iii\n |  | \nPART I \u2013 FINANCIAL INFORMATION | 1\nItem\u00a01. | Financial Statements. | 1\n | Consolidated Balance Sheets | 1\n | Consolidated Statements of Earnings | 2\n | Consolidated Statements of Comprehensive Income | 3\n | Consolidated Statements of Stockholders' Equity | 4\n | Consolidated Statements of Cash Flows | 5\n | Notes to Consolidated Financial Statements | 6\n | Note 1. Summary of Significant Accounting Policies | 6\n | Note 2. Net Sales | 7\n | Note 3. Property and Leases | 8\n | Note 4. Debt and Derivative Instruments | 9\n | Note 5. Stockholders' Equity | 10\n | Note 6. Fair Value Measurements | 10\n | Note 7. Weighted Average Common Shares | 11\n | Note 8. Contingencies | 11\n |  | \n | Report of Independent Registered Public Accounting Firm | 12\nItem\u00a02. | Management's Discussion and Analysis of Financial Condition and Results of Operations. | 13\nItem\u00a03. | Quantitative and Qualitative Disclosures About Market Risk. | 20\nItem\u00a04. | Controls and Procedures. | 20\n |  | \nPART II \u2013 OTHER INFORMATION | 20\nItem 1. | Legal Proceedings. | 20\nItem 1A. | Risk Factors. | 21\nItem\u00a02. | Unregistered Sales of Equity Securities and Use of Proceeds. | 21\nItem 5. | Other Information. | 21\nItem\u00a06. | Exhibits. | 22\n |  | \nSIGNATURES | 23  |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | i |   |  |  |  |  |  |  |  | \nTerm |  | Definition\nASU |  | Accounting Standards Update\nComparable sales |  | As defined in theResults of Operationssection of MD&A\nExchange Act |  | Securities Exchange Act of 1934, as amended\nFASB |  | Financial Accounting Standards Board\nfiscal 2022 |  | Fiscal year ended January 29, 2023\nfiscal 2023 |  | Fiscal year ending January 28, 2024\nGAAP |  | U.S. generally accepted accounting principles\nMD&A |  | Management's Discussion and Analysis of Financial Condition and Results of Operations\nNOPAT |  | Net operating profit after tax\nRestoration Plans |  | Home Depot FutureBuilder Restoration Plan and HD Supply Restoration Plan\nROIC |  | Return on invested capital\nSEC |  | Securities and Exchange Commission\nSecurities Act |  | Securities Act of 1933, as amended\nSG&A |  | Selling, general and administrative\n2022 Form 10-K |  | Annual Report on Form 10-K for fiscal 2022 as filed with the SEC on March 15, 2023  |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | ii |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | iii |   |  |  |  |  |  |  |  |  |  |  | \nin millions, except per share data | July 30,2023 |  | January 29,2023\nAssets |  |  | \nCurrent assets: |  |  | \nCash and cash equivalents | $ | 2,814 |  |  | $ | 2,757 | \nReceivables, net | 3,836 |  |  | 3,317 | \nMerchandise inventories | 23,265 |  |  | 24,886 | \nOther current assets | 1,915 |  |  | 1,511 | \nTotal current assets | 31,830 |  |  | 32,471 | \nNet property and equipment | 25,879 |  |  | 25,631 | \nOperating lease right-of-use assets | 7,139 |  |  | 6,941 | \nGoodwill | 7,664 |  |  | 7,444 | \nOther assets | 3,875 |  |  | 3,958 | \nTotal assets | $ | 76,387 |  |  | $ | 76,445 | \n |  |  | \nLiabilities and Stockholders' Equity |  |  | \nCurrent liabilities: |  |  | \n |  |  | \nAccounts payable | $ | 12,104 |  |  | $ | 11,443 | \nAccrued salaries and related expenses | 2,022 |  |  | 1,991 | \nSales taxes payable | 631 |  |  | 528 | \nDeferred revenue | 3,079 |  |  | 3,064 | \nIncome taxes payable | 19 |  |  | 50 | \nCurrent installments of long-term debt | 1,352 |  |  | 1,231 | \nCurrent operating lease liabilities | 1,011 |  |  | 945 | \nOther accrued expenses | 4,009 |  |  | 3,858 | \nTotal current liabilities | 24,227 |  |  | 23,110 | \nLong-term debt, excluding current installments | 40,754 |  |  | 41,962 | \nLong-term operating lease liabilities | 6,376 |  |  | 6,226 | \nDeferred income taxes | 956 |  |  | 1,019 | \nOther long-term liabilities | 2,739 |  |  | 2,566 | \nTotal liabilities | 75,052 |  |  | 74,883 | \nContingencies (Note 8) |  |  | \nCommon stock, par value $0.05; authorized:10,000shares; issued:1,796shares at July\u00a030, 2023 and1,794shares at January\u00a029, 2023; outstanding:1,001shares at July\u00a030, 2023 and1,016shares at January\u00a029, 2023 | 90 |  |  | 90 | \nPaid-in capital | 12,842 |  |  | 12,592 | \nRetained earnings | 81,213 |  |  | 76,896 | \nAccumulated other comprehensive loss | (467) |  |  | (718) | \nTreasury stock, at cost,795shares at July\u00a030, 2023 and778shares at January\u00a029, 2023 | (92,343) |  |  | (87,298) | \nTotal stockholders\u2019 equity | 1,335 |  |  | 1,562 | \nTotal liabilities and stockholders\u2019 equity | $ | 76,387 |  |  | $ | 76,445 |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 1 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\nin millions, except per share data | July 30,2023 |  | July 31,2022 |  | July 30,2023 |  | July 31,2022\nNet sales | $ | 42,916 |  |  | $ | 43,792 |  |  | $ | 80,173 |  |  | $ | 82,700 | \nCost of sales | 28,759 |  |  | 29,309 |  |  | 53,459 |  |  | 55,072 | \nGross profit | 14,157 |  |  | 14,483 |  |  | 26,714 |  |  | 27,628 | \nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative | 6,915 |  |  | 6,657 |  |  | 13,270 |  |  | 13,267 | \nDepreciation and amortization | 653 |  |  | 616 |  |  | 1,304 |  |  | 1,222 | \nTotal operating expenses | 7,568 |  |  | 7,273 |  |  | 14,574 |  |  | 14,489 | \nOperating income | 6,589 |  |  | 7,210 |  |  | 12,140 |  |  | 13,139 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net | (41) |  |  | (2) |  |  | (74) |  |  | (5) | \nInterest expense | 469 |  |  | 381 |  |  | 943 |  |  | 753 | \nInterest and other, net | 428 |  |  | 379 |  |  | 869 |  |  | 748 | \nEarnings before provision for income taxes | 6,161 |  |  | 6,831 |  |  | 11,271 |  |  | 12,391 | \nProvision for income taxes | 1,502 |  |  | 1,658 |  |  | 2,739 |  |  | 2,987 | \nNet earnings | $ | 4,659 |  |  | $ | 5,173 |  |  | $ | 8,532 |  |  | $ | 9,404 | \n |  |  |  |  |  |  | \nBasic weighted average common shares | 1,000 |  |  | 1,023 |  |  | 1,005 |  |  | 1,026 | \nBasic earnings per share | $ | 4.66 |  |  | $ | 5.06 |  |  | $ | 8.49 |  |  | $ | 9.17 | \n |  |  |  |  |  |  | \nDiluted weighted average common shares | 1,003 |  |  | 1,025 |  |  | 1,008 |  |  | 1,030 | \nDiluted earnings per share | $ | 4.65 |  |  | $ | 5.05 |  |  | $ | 8.46 |  |  | $ | 9.13 |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\nin millions | July 30,2023 |  | July 31,2022 |  | July 30,2023 |  | July 31,2022\nNet earnings | $ | 4,659 |  |  | $ | 5,173 |  |  | $ | 8,532 |  |  | $ | 9,404 | \nOther comprehensive income (loss), net of tax: |  |  |  |  |  |  | \nForeign currency translation adjustments | 168 |  |  | 9 |  |  | 247 |  |  | 29 | \nCash flow hedges | 2 |  |  | 2 |  |  | 4 |  |  | 3 | \n |  |  |  |  |  |  | \nTotal other comprehensive income (loss), net of tax | 170 |  |  | 11 |  |  | 251 |  |  | 32 | \nComprehensive income | $ | 4,829 |  |  | $ | 5,184 |  |  | $ | 8,783 |  |  | $ | 9,436 |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 3 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\nin millions | July 30,2023 |  | July 31,2022 |  | July 30,2023 |  | July 31,2022\nCommon Stock: |  |  |  |  |  |  | \nBalance at beginning of period | $ | 90 |  |  | $ | 90 |  |  | $ | 90 |  |  | $ | 90 | \nShares issued under employee stock plans, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nBalance at end of period | 90 |  |  | 90 |  |  | 90 |  |  | 90 | \n |  |  |  |  |  |  | \nPaid-in Capital: |  |  |  |  |  |  | \nBalance at beginning of period | 12,584 |  |  | 12,079 |  |  | 12,592 |  |  | 12,132 | \nShares issued under employee stock plans, net | 154 |  |  | 135 |  |  | 35 |  |  | (19) | \n |  |  |  |  |  |  | \nStock-based compensation expense | 104 |  |  | 95 |  |  | 215 |  |  | 196 | \n |  |  |  |  |  |  | \nBalance at end of period | 12,842 |  |  | 12,309 |  |  | 12,842 |  |  | 12,309 | \n |  |  |  |  |  |  | \nRetained Earnings: |  |  |  |  |  |  | \nBalance at beginning of period | 78,651 |  |  | 69,849 |  |  | 76,896 |  |  | 67,580 | \n |  |  |  |  |  |  | \nNet earnings | 4,659 |  |  | 5,173 |  |  | 8,532 |  |  | 9,404 | \nCash dividends | (2,097) |  |  | (1,948) |  |  | (4,215) |  |  | (3,910) | \n |  |  |  |  |  |  | \nBalance at end of period | 81,213 |  |  | 73,074 |  |  | 81,213 |  |  | 73,074 | \n |  |  |  |  |  |  | \nAccumulated Other Comprehensive Income (Loss): |  |  |  |  |  |  | \nBalance at beginning of period | (637) |  |  | (683) |  |  | (718) |  |  | (704) | \n |  |  |  |  |  |  | \nForeign currency translation adjustments, net of tax | 168 |  |  | 9 |  |  | 247 |  |  | 29 | \nCash flow hedges, net of tax | 2 |  |  | 2 |  |  | 4 |  |  | 3 | \n |  |  |  |  |  |  | \nBalance at end of period | (467) |  |  | (672) |  |  | (467) |  |  | (672) | \n |  |  |  |  |  |  | \nTreasury Stock: |  |  |  |  |  |  | \nBalance at beginning of period | (90,326) |  |  | (83,044) |  |  | (87,298) |  |  | (80,794) | \nRepurchases of common stock | (2,017) |  |  | (1,520) |  |  | (5,045) |  |  | (3,770) | \nBalance at end of period | (92,343) |  |  | (84,564) |  |  | (92,343) |  |  | (84,564) | \nTotal stockholders' equity | $ | 1,335 |  |  | $ | 237 |  |  | $ | 1,335 |  |  | $ | 237 |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 4 |   |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended\nin millions | July 30,2023 |  | July 31,2022\nCash Flows from Operating Activities: |  |  | \nNet earnings | $ | 8,532 |  |  | $ | 9,404 | \nReconciliation of net earnings to net cash provided by operating activities: |  |  | \nDepreciation and amortization | 1,588 |  |  | 1,473 | \nStock-based compensation expense | 215 |  |  | 196 | \nChanges in receivables, net | (492) |  |  | (295) | \nChanges in merchandise inventories | 1,751 |  |  | (4,009) | \nChanges in other current assets | (392) |  |  | (668) | \nChanges in accounts payable and accrued expenses | 929 |  |  | 1,079 | \nChanges in deferred revenue | 10 |  |  | (57) | \nChanges in income taxes payable | (32) |  |  | 61 | \nChanges in deferred income taxes | (48) |  |  | (95) | \nOther operating activities | 144 |  |  | 93 | \nNet cash provided by operating activities | 12,205 |  |  | 7,182 | \n |  |  | \nCash Flows from Investing Activities: |  |  | \nCapital expenditures | (1,697) |  |  | (1,447) | \nPayments for businesses acquired, net | (215) |  |  | \u2014 | \nOther investing activities | 10 |  |  | (14) | \nNet cash used in investing activities | (1,902) |  |  | (1,461) | \n |  |  | \nCash Flows from Financing Activities: |  |  | \nRepayments of short-term debt, net | \u2014 |  |  | (496) | \nProceeds from long-term debt, net of discounts | \u2014 |  |  | 3,957 | \nRepayments of long-term debt | (1,130) |  |  | (2,366) | \nRepurchases of common stock | (4,954) |  |  | (3,962) | \nProceeds from sales of common stock | 175 |  |  | 142 | \nCash dividends | (4,215) |  |  | (3,910) | \nOther financing activities | (142) |  |  | (163) | \nNet cash used in financing activities | (10,266) |  |  | (6,798) | \nChange in cash and cash equivalents | 37 |  |  | (1,077) | \nEffect of exchange rate changes on cash and cash equivalents | 20 |  |  | (7) | \nCash and cash equivalents at beginning of period | 2,757 |  |  | 2,343 | \nCash and cash equivalents at end of period | $ | 2,814 |  |  | $ | 1,259 | \n |  |  | \nSupplemental Disclosures: |  |  | \nCash paid for interest, net of interest capitalized | $ | 900 |  |  | $ | 665 | \nCash paid for income taxes | 2,894 |  |  | 3,105 |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 5 |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 6 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\nin millions | July 30,2023 |  | July 31,2022 |  | July 30,2023 |  | July 31,2022\nNet sales \u2013 in the U.S. | $ | 39,191 |  |  | $ | 40,044 |  |  | $ | 73,698 |  |  | $ | 76,050 | \nNet sales \u2013 outside the U.S. | 3,725 |  |  | 3,748 |  |  | 6,475 |  |  | 6,650 | \nNet sales | $ | 42,916 |  |  | $ | 43,792 |  |  | $ | 80,173 |  |  | $ | 82,700 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\nin millions | July 30,2023 |  | July 31,2022 |  | July 30,2023 |  | July 31,2022\nNet sales \u2013 products | $ | 41,361 |  |  | $ | 42,348 |  |  | $ | 77,249 |  |  | $ | 79,813 | \nNet sales \u2013 services | 1,555 |  |  | 1,444 |  |  | 2,924 |  |  | 2,887 | \nNet sales | $ | 42,916 |  |  | $ | 43,792 |  |  | $ | 80,173 |  |  | $ | 82,700 |   |  |  |  |  |  |  |  | \nMajor Product Line |  | Merchandising Departments\nBuilding Materials |  | Building Materials, Electrical/Lighting, Lumber, Millwork, and Plumbing\nD\u00e9cor |  | Appliances, D\u00e9cor/Storage, Flooring, Kitchen and Bath, and Paint\nHardlines |  | Hardware, Indoor Garden, Outdoor Garden, and Tools  |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 7 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Six Months Ended\nin millions | July 30,2023 |  | July 31,2022 |  | July 30,2023 |  | July 31,2022\nBuilding Materials | $ | 15,391 |  |  | $ | 15,883 |  |  | $ | 29,470 |  |  | $ | 30,752 | \nD\u00e9cor | 13,411 |  |  | 14,096 |  |  | 25,662 |  |  | 26,970 | \nHardlines | 14,114 |  |  | 13,813 |  |  | 25,041 |  |  | 24,978 | \nNet sales | $ | 42,916 |  |  | $ | 43,792 |  |  | $ | 80,173 |  |  | $ | 82,700 |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions | Consolidated Balance Sheet Classification | July 30,2023 |  | January 29,2023\nAssets: |  |  |  | \nOperating lease assets | Operating lease right-of-use assets | $ | 7,139 |  |  | $ | 6,941 | \nFinance lease assets(1) | Net property and equipment | 2,881 |  |  | 2,899 | \nTotal lease assets |  | $ | 10,020 |  |  | $ | 9,840 | \nLiabilities: |  |  |  | \nCurrent: |  |  |  | \nOperating lease liabilities | Current operating lease liabilities | $ | 1,011 |  |  | $ | 945 | \nFinance lease liabilities | Current installments of long-term debt | 252 |  |  | 231 | \nLong-term: |  |  |  | \nOperating lease liabilities | Long-term operating lease liabilities | 6,376 |  |  | 6,226 | \nFinance lease liabilities | Long-term debt, excluding current installments | 3,058 |  |  | 3,054 | \nTotal lease liabilities |  | $ | 10,697 |  |  | $ | 10,456 |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 8 |   |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended\nin millions | July 30,2023 |  | July 31,2022\nLease assets obtained in exchange for new operating lease liabilities | $ | 583 |  |  | $ | 646 | \nLease assets obtained in exchange for new finance lease liabilities | 192 |  |  | 202 |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 9 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nshares in millions | Three Months Ended |  | Six Months Ended\nJuly 30,2023 |  | July 31,2022 |  | July 30,2023 |  | July 31,2022\nCommon stock: |  |  |  |  |  |  | \nShares at beginning of period | 1,795 |  |  | 1,793 |  |  | 1,794 |  |  | 1,792 | \nShares issued under employee stock plans, net | 1 |  |  | \u2014 |  |  | 2 |  |  | 1 | \nShares at end of period | 1,796 |  |  | 1,793 |  |  | 1,796 |  |  | 1,793 | \nTreasury stock: |  |  |  |  |  |  | \nShares at beginning of period | (788) |  |  | (764) |  |  | (778) |  |  | (757) | \nRepurchases of common stock | (7) |  |  | (5) |  |  | (17) |  |  | (12) | \nShares at end of period | (795) |  |  | (769) |  |  | (795) |  |  | (769) | \nShares outstanding at end of period | 1,001 |  |  | 1,024 |  |  | 1,001 |  |  | 1,024 | \n |  |  |  |  |  |  | \nCash dividends per share | $ | 2.09 |  |  | $ | 1.90 |  |  | $ | 4.18 |  |  | $ | 3.80 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions | Three Months Ended |  | Six Months Ended\nJuly 30,2023 |  | July 31,2022 |  | July 30,2023 |  | July 31,2022\nTotal number of shares repurchased | 7 |  |  | 5 |  |  | 17 |  |  | 12 | \nTotal cost of shares repurchased(1) | $ | 2,017 |  |  | $ | 1,520 |  |  | $ | 5,045 |  |  | $ | 3,770 |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 10 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | July 30, 2023 |  |  |  | January 29, 2023\nin millions |  |  | Fair Value(Level\u00a02) |  |  |  |  |  | Fair Value(Level\u00a02) |  | \nDerivative agreements \u2013 assets |  |  | $ | \u2014 |  |  |  |  |  |  | $ | \u2014 |  |  | \nDerivative agreements \u2013 liabilities |  |  | (904) |  |  |  |  |  |  | (778) |  |  | \nTotal |  |  | $ | (904) |  |  |  |  |  |  | $ | (778) |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | July 30, 2023 |  | January 29, 2023\nin millions | Fair Value(Level 1) |  | CarryingValue |  | Fair Value(Level 1) |  | CarryingValue\nSenior notes | $ | 36,118 |  |  | $ | 38,796 |  |  | $ | 38,537 |  |  | $ | 39,908 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions | Three Months Ended |  | Six Months Ended\nJuly 30,2023 |  | July 31,2022 |  | July 30,2023 |  | July 31,2022\nBasic weighted average common shares | 1,000 |  |  | 1,023 |  |  | 1,005 |  |  | 1,026 | \nEffect of potentially dilutive securities(1) | 3 |  |  | 2 |  |  | 3 |  |  | 4 | \nDiluted weighted average common shares | 1,003 |  |  | 1,025 |  |  | 1,008 |  |  | 1,030 | \n |  |  |  |  |  |  | \nAnti-dilutive securities excluded from diluted weighted average common shares | 1 |  |  | 1 |  |  | 1 |  |  | 1 |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 11 |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 12 |   |  |  |  |  | \nExecutive Summary | 13\nResults of Operations | 14\nLiquidity and Capital Resources | 18\nCritical Accounting Estimates | 20  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \ndollars in millions, except per share data | Three Months Ended |  | Six Months Ended\nJuly 30,2023 |  | July 31,2022 |  | July 30,2023 |  | July 31,2022\nNet sales | $ | 42,916 |  |  | $ | 43,792 |  |  | $ | 80,173 |  |  | $ | 82,700 | \nNet earnings | $ | 4,659 |  |  | $ | 5,173 |  |  | $ | 8,532 |  |  | $ | 9,404 | \n |  |  |  |  |  |  | \nDiluted earnings per share | $ | 4.65 |  |  | $ | 5.05 |  |  | $ | 8.46 |  |  | $ | 9.13 | \n |  |  |  |  |  |  | \nNet cash provided by operating activities |  |  |  |  | $ | 12,205 |  |  | $ | 7,182 | \nProceeds from long-term debt, net of discounts |  |  |  |  | $ | \u2014 |  |  | $ | 3,957 | \nRepayments of long-term debt |  |  |  |  | $ | 1,130 |  |  | $ | 2,366 | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 13 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended\n | July 30, 2023 |  | July 31, 2022\ndollars in millions | $ |  | % ofNet Sales |  | $ |  | % ofNet Sales\nNet sales | $ | 42,916 |  |  |  |  | $ | 43,792 |  |  | \nGross profit | 14,157 |  |  | 33.0 | % |  | 14,483 |  |  | 33.1 | %\nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative | 6,915 |  |  | 16.1 |  |  | 6,657 |  |  | 15.2 | \nDepreciation and amortization | 653 |  |  | 1.5 |  |  | 616 |  |  | 1.4 | \nTotal operating expenses | 7,568 |  |  | 17.6 |  |  | 7,273 |  |  | 16.6 | \nOperating income | 6,589 |  |  | 15.4 |  |  | 7,210 |  |  | 16.5 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net | (41) |  |  | (0.1) |  |  | (2) |  |  | \u2014 | \nInterest expense | 469 |  |  | 1.1 |  |  | 381 |  |  | 0.9 | \nInterest and other, net | 428 |  |  | 1.0 |  |  | 379 |  |  | 0.9 | \nEarnings before provision for income taxes | 6,161 |  |  | 14.4 |  |  | 6,831 |  |  | 15.6 | \nProvision for income taxes | 1,502 |  |  | 3.5 |  |  | 1,658 |  |  | 3.8 | \nNet earnings | $ | 4,659 |  |  | 10.9 | % |  | $ | 5,173 |  |  | 11.8 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \nSelected financial and sales data: | July 30,2023 |  | July 31,2022 |  | % Change\nComparable sales (% change) | (2.0) | % |  | 5.8 | % |  | N/A\nComparable customer transactions (% change)(1) | (2.0) | % |  | (3.1) | % |  | N/A\nComparable average ticket (% change)(1) | 0.1 | % |  | 9.0 | % |  | N/A\nCustomer transactions (in millions)(1) | 459.1 |  |  | 467.4 |  |  | (1.8) | %\nAverage ticket(1) (2) | $ | 90.07 |  |  | $ | 90.02 |  |  | 0.1 | %\nSales per retail square foot(1) (3) | $ | 684.65 |  |  | $ | 700.62 |  |  | (2.3) | %\nDiluted earnings per share | $ | 4.65 |  |  | $ | 5.05 |  |  | (7.9) | %  |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 14 |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 15 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended\n | July 30, 2023 |  | July 31, 2022\ndollars in millions | $ |  | % ofNet Sales |  | $ |  | % ofNet Sales\nNet sales | $ | 80,173 |  |  |  |  | $ | 82,700 |  |  | \nGross profit | 26,714 |  |  | 33.3 | % |  | 27,628 |  |  | 33.4 | %\nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative | 13,270 |  |  | 16.6 |  |  | 13,267 |  |  | 16.0 | \nDepreciation and amortization | 1,304 |  |  | 1.6 |  |  | 1,222 |  |  | 1.5 | \nTotal operating expenses | 14,574 |  |  | 18.2 |  |  | 14,489 |  |  | 17.5 | \nOperating income | 12,140 |  |  | 15.1 |  |  | 13,139 |  |  | 15.9 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net | (74) |  |  | (0.1) |  |  | (5) |  |  | \u2014 | \nInterest expense | 943 |  |  | 1.2 |  |  | 753 |  |  | 0.9 | \nInterest and other, net | 869 |  |  | 1.1 |  |  | 748 |  |  | 0.9 | \nEarnings before provision for income taxes | 11,271 |  |  | 14.1 |  |  | 12,391 |  |  | 15.0 | \nProvision for income taxes | 2,739 |  |  | 3.4 |  |  | 2,987 |  |  | 3.6 | \nNet earnings | $ | 8,532 |  |  | 10.6 | % |  | $ | 9,404 |  |  | 11.4 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Six Months Ended |  | \nSelected financial and sales data: | July 30,2023 |  | July 31,2022 |  | % Change\nComparable sales (% change) | (3.2) | % |  | 4.1 | % |  | N/A\nComparable customer transactions (% change)(1) | (3.4) | % |  | (5.7) | % |  | N/A\nComparable average ticket (% change)(1) | 0.1 | % |  | 10.0 | % |  | N/A\nCustomer transactions (in millions)(1) | 850.1 |  | 878.1 |  | (3.2) | %\nAverage ticket(1) (2) | $90.92 |  | $90.82 |  | 0.1 | %\nSales per retail square foot(1) (3) | $638.50 |  | $661.27 |  | (3.4) | %\nDiluted earnings per share | $8.46 |  | $9.13 |  | (7.3) | %  |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 16 |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 17 |   |  |  |  |  |  |  |  |  |  |  | \n | Twelve Months Ended\ndollars in millions | July 30,2023 |  | July 31,2022\nNet earnings | $ | 16,233 |  |  | $ | 16,885 | \nInterest and other, net | 1,683 |  |  | 1,397 | \nProvision for income taxes | 5,124 |  |  | 5,477 | \nOperating income | 23,040 |  |  | 23,759 | \nIncome tax adjustment(1) | (5,555) |  |  | (5,758) | \nNOPAT | $ | 17,485 |  |  | $ | 18,001 | \n |  |  | \nAverage debt and equity | $ | 42,084 |  |  | $ | 39,485 | \n |  |  | \nROIC | 41.5 | % |  | 45.6 | %  |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 18 |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 19 |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 20 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | Total Number of Shares Purchased(1) |  | Average Price Paid Per Share(1)(3) |  | Total Number of Shares\u00a0Purchased\u00a0as Part of Publicly Announced\u00a0Program(2) |  | Dollar Value of Shares\u00a0that\u00a0May\u00a0Yet Be\u00a0Purchased\u00a0Under the Program(2)(3)\nMay 1, 2023 \u2013 May 28, 2023 |  | 2,790,953 |  |  | $ | 290.49 |  |  | 2,774,542 |  |  | $ | 8,678,223,515 | \nMay 29, 2023 \u2013 June 25, 2023 |  | 2,155,085 |  |  | 296.88 |  |  | 2,153,723 |  |  | 8,038,825,194 | \nJune 26, 2023 \u2013 July 30, 2023 |  | 1,760,231 |  |  | 315.52 |  |  | 1,757,036 |  |  | 7,484,425,270 | \n |  | 6,706,269 |  |  | 299.12 |  |  | 6,685,301 |  |  |   |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 21 |   |  |  |  |  |  |  |  | \nExhibit |  | Description\n3.1 | * | Amended and Restated Certificate of Incorporation of The Home Depot, Inc.[Form 10-Q filed on September 1, 2011, Exhibit 3.1]\n3.2 | * | By-Laws of The Home Depot, Inc. (As Amended and Restated Effective February 23, 2023)[Form 8-K filed on February 28, 2023, Exhibit 3.2]\n15.1 |  | Acknowledgement of Independent Registered Public Accounting Firm\n31.1 |  | Certification of the Chair, President and Chief Executive Officer pursuant to Rule 13a-14(a)\n31.2 |  | Certification of the Executive Vice President and Chief Financial Officer pursuant to Rule\u00a013a-14(a)\n32.1 |  | Certification of the Chair, President and Chief Executive Officer furnished pursuant to Section\u00a0906 of the Sarbanes-Oxley Act of 2002\n32.2 |  | Certification of the Executive Vice President and Chief Financial Officer furnished pursuant to Section\u00a0906 of the Sarbanes-Oxley Act of 2002\n101.INS |  | XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document\n101.SCH |  | Inline XBRL Taxonomy Extension Schema Document\n101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document\n101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document\n101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document\n101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document\n104 |  | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)  |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 22 |   |  |  |  |  | \nTHE HOME DEPOT, INC.(Registrant)\n | \nBy: | /s/ EDWARD P. DECKER\n | Edward P. Decker, Chair, President and Chief Executive Officer (Principal Executive Officer)\n\n | /s/ RICHARD V. MCPHAIL\n | Richard V. McPhail, Executive Vice President and Chief Financial Officer (Principal Financial Officer)\n | \n | /s/ KIMBERLY R. SCARDINO\n | Kimberly R. Scardino, Senior Vice President \u2013 Finance, Chief Accounting Officer and Controller (Principal Accounting Officer)\n\nDate: | August 21, 2023  |  |  |  |  |  |  |  | \nFiscal Q2 2023 Form 10-Q | 23 | "}]}
{"messages": [{"role": "system", "content": "You are a financial AI that is trained on the top 30 companies in the S&P500, specially their 10Q forms."}, {"role": "user", "content": "For Home Depot, in 2023 Q4, what is its Quarterly Report?"}, {"role": "assistant", "content": " |  | \n  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nDelaware |  |  |  | 95-3261426\n(State or other jurisdiction of incorporation or organization) |  |  |  | (I.R.S. Employer Identification No.)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n2455 Paces Ferry Road |  |  |  | \nAtlanta, | Georgia |  |  |  | 30339\n(Address of principal executive offices) |  |  |  | (Zip Code)  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nSecurities registered pursuant to Section 12(b) of the Act:\nTitle of each class |  | Trading Symbol |  | Name of each exchange on which registered\nCommon Stock, $0.05 Par Value Per Share |  | HD |  | New York Stock Exchange  |  | \n  |  |  |  |  |  |  |  | \nCommonly Used or Defined Terms | ii\nForward-Looking Statements | iii\n |  | \nPART I \u2013 FINANCIAL INFORMATION | 1\nItem\u00a01. | Financial Statements. | 1\n | Consolidated Balance Sheets | 1\n | Consolidated Statements of Earnings | 2\n | Consolidated Statements of Comprehensive Income | 3\n | Consolidated Statements of Stockholders' Equity | 4\n | Consolidated Statements of Cash Flows | 5\n | Notes to Consolidated Financial Statements | 6\n | Note 1. Summary of Significant Accounting Policies | 6\n | Note 2. Net Sales | 7\n | Note 3. Property and Leases | 8\n | Note 4. Debt and Derivative Instruments | 9\n | Note 5. Stockholders' Equity | 10\n | Note 6. Fair Value Measurements | 10\n | Note 7. Weighted Average Common Shares | 11\n | Note 8. Contingencies | 12\n |  | \n | Report of Independent Registered Public Accounting Firm | 13\nItem\u00a02. | Management's Discussion and Analysis of Financial Condition and Results of Operations. | 14\nItem\u00a03. | Quantitative and Qualitative Disclosures About Market Risk. | 21\nItem\u00a04. | Controls and Procedures. | 21\n |  | \nPART II \u2013 OTHER INFORMATION | 21\nItem 1. | Legal Proceedings. | 21\nItem 1A. | Risk Factors. | 22\nItem\u00a02. | Unregistered Sales of Equity Securities, Use of Proceeds,andIssuer Purchases ofEquity Securities. | 22\nItem 5. | Other Information. | 22\nItem\u00a06. | Exhibits. | 23\n |  | \nSIGNATURES | 24  |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | i |   |  |  |  |  |  |  |  | \nTerm |  | Definition\nASU |  | Accounting Standards Update\nComparable sales |  | As defined in theResults of Operationssection of MD&A\nExchange Act |  | Securities Exchange Act of 1934, as amended\nFASB |  | Financial Accounting Standards Board\nfiscal 2022 |  | Fiscal year ended January 29, 2023\nfiscal 2023 |  | Fiscal year ending January 28, 2024\nGAAP |  | U.S. generally accepted accounting principles\nMD&A |  | Management's Discussion and Analysis of Financial Condition and Results of Operations\nNOPAT |  | Net operating profit after tax\nRestoration Plans |  | Home Depot FutureBuilder Restoration Plan and HD Supply Restoration Plan\nROIC |  | Return on invested capital\nSEC |  | Securities and Exchange Commission\nSecurities Act |  | Securities Act of 1933, as amended\nSG&A |  | Selling, general and administrative\n2022 Form 10-K |  | Annual Report on Form 10-K for fiscal 2022 as filed with the SEC on March 15, 2023  |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | ii |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | iii |   |  |  |  |  |  |  |  |  |  |  | \nin millions, except per share data | October 29,2023 |  | January 29,2023\nAssets |  |  | \nCurrent assets: |  |  | \nCash and cash equivalents | $ | 2,058 |  |  | $ | 2,757 | \nReceivables, net | 3,932 |  |  | 3,317 | \nMerchandise inventories | 22,805 |  |  | 24,886 | \nOther current assets | 1,887 |  |  | 1,511 | \nTotal current assets | 30,682 |  |  | 32,471 | \nNet property and equipment | 25,735 |  |  | 25,631 | \nOperating lease right-of-use assets | 7,071 |  |  | 6,941 | \nGoodwill | 7,937 |  |  | 7,444 | \nOther assets | 4,152 |  |  | 3,958 | \nTotal assets | $ | 75,577 |  |  | $ | 76,445 | \n |  |  | \nLiabilities and Stockholders' Equity |  |  | \nCurrent liabilities: |  |  | \n |  |  | \nAccounts payable | $ | 11,478 |  |  | $ | 11,443 | \nAccrued salaries and related expenses | 2,034 |  |  | 1,991 | \nSales taxes payable | 590 |  |  | 528 | \nDeferred revenue | 2,784 |  |  | 3,064 | \nIncome taxes payable | 304 |  |  | 50 | \nCurrent installments of long-term debt | 1,362 |  |  | 1,231 | \nCurrent operating lease liabilities | 1,026 |  |  | 945 | \nOther accrued expenses | 3,994 |  |  | 3,858 | \nTotal current liabilities | 23,572 |  |  | 23,110 | \nLong-term debt, excluding current installments | 40,567 |  |  | 41,962 | \nLong-term operating lease liabilities | 6,300 |  |  | 6,226 | \nDeferred income taxes | 753 |  |  | 1,019 | \nOther long-term liabilities | 2,955 |  |  | 2,566 | \nTotal liabilities | 74,147 |  |  | 74,883 | \nContingencies (Note 8) |  |  | \nCommon stock, par value $0.05; authorized:10,000shares; issued:1,796shares at October\u00a029, 2023 and1,794shares at January\u00a029, 2023; outstanding:996shares at October\u00a029, 2023 and1,016shares at January\u00a029, 2023 | 90 |  |  | 90 | \nPaid-in capital | 12,927 |  |  | 12,592 | \nRetained earnings | 82,934 |  |  | 76,896 | \nAccumulated other comprehensive loss | (662) |  |  | (718) | \nTreasury stock, at cost,800shares at October\u00a029, 2023 and778shares at January\u00a029, 2023 | (93,859) |  |  | (87,298) | \nTotal stockholders\u2019 equity | 1,430 |  |  | 1,562 | \nTotal liabilities and stockholders\u2019 equity | $ | 75,577 |  |  | $ | 76,445 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 1 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\nin millions, except per share data | October 29,2023 |  | October 30,2022 |  | October 29,2023 |  | October 30,2022\nNet sales | $ | 37,710 |  |  | $ | 38,872 |  |  | $ | 117,883 |  |  | $ | 121,572 | \nCost of sales | 24,972 |  |  | 25,648 |  |  | 78,431 |  |  | 80,720 | \nGross profit | 12,738 |  |  | 13,224 |  |  | 39,452 |  |  | 40,852 | \nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative | 6,649 |  |  | 6,468 |  |  | 19,919 |  |  | 19,735 | \nDepreciation and amortization | 683 |  |  | 608 |  |  | 1,987 |  |  | 1,830 | \nTotal operating expenses | 7,332 |  |  | 7,076 |  |  | 21,906 |  |  | 21,565 | \nOperating income | 5,406 |  |  | 6,148 |  |  | 17,546 |  |  | 19,287 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net | (49) |  |  | (7) |  |  | (123) |  |  | (12) | \nInterest expense | 487 |  |  | 413 |  |  | 1,430 |  |  | 1,166 | \nInterest and other, net | 438 |  |  | 406 |  |  | 1,307 |  |  | 1,154 | \nEarnings before provision for income taxes | 4,968 |  |  | 5,742 |  |  | 16,239 |  |  | 18,133 | \nProvision for income taxes | 1,158 |  |  | 1,403 |  |  | 3,897 |  |  | 4,390 | \nNet earnings | $ | 3,810 |  |  | $ | 4,339 |  |  | $ | 12,342 |  |  | $ | 13,743 | \n |  |  |  |  |  |  | \nBasic weighted average common shares | 996 |  |  | 1,020 |  |  | 1,002 |  |  | 1,024 | \nBasic earnings per share | $ | 3.83 |  |  | $ | 4.25 |  |  | $ | 12.32 |  |  | $ | 13.42 | \n |  |  |  |  |  |  | \nDiluted weighted average common shares | 999 |  |  | 1,023 |  |  | 1,005 |  |  | 1,028 | \nDiluted earnings per share | $ | 3.81 |  |  | $ | 4.24 |  |  | $ | 12.28 |  |  | $ | 13.37 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 2 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\nin millions | October 29,2023 |  | October 30,2022 |  | October 29,2023 |  | October 30,2022\nNet earnings | $ | 3,810 |  |  | $ | 4,339 |  |  | $ | 12,342 |  |  | $ | 13,743 | \nOther comprehensive income (loss), net of tax: |  |  |  |  |  |  | \nForeign currency translation adjustments | (196) |  |  | (187) |  |  | 51 |  |  | (158) | \nCash flow hedges | 1 |  |  | 3 |  |  | 5 |  |  | 6 | \n |  |  |  |  |  |  | \nTotal other comprehensive income (loss), net of tax | (195) |  |  | (184) |  |  | 56 |  |  | (152) | \nComprehensive income | $ | 3,615 |  |  | $ | 4,155 |  |  | $ | 12,398 |  |  | $ | 13,591 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 3 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\nin millions | October 29,2023 |  | October 30,2022 |  | October 29,2023 |  | October 30,2022\nCommon Stock: |  |  |  |  |  |  | \nBalance at beginning of period | $ | 90 |  |  | $ | 90 |  |  | $ | 90 |  |  | $ | 90 | \nShares issued under employee stock plans, net | \u2014 |  |  | \u2014 |  |  | \u2014 |  |  | \u2014 | \nBalance at end of period | 90 |  |  | 90 |  |  | 90 |  |  | 90 | \n |  |  |  |  |  |  | \nPaid-in Capital: |  |  |  |  |  |  | \nBalance at beginning of period | 12,842 |  |  | 12,309 |  |  | 12,592 |  |  | 12,132 | \nShares issued under employee stock plans, net | 11 |  |  | (2) |  |  | 46 |  |  | (21) | \n |  |  |  |  |  |  | \nStock-based compensation expense | 74 |  |  | 78 |  |  | 289 |  |  | 274 | \n |  |  |  |  |  |  | \nBalance at end of period | 12,927 |  |  | 12,385 |  |  | 12,927 |  |  | 12,385 | \n |  |  |  |  |  |  | \nRetained Earnings: |  |  |  |  |  |  | \nBalance at beginning of period | 81,213 |  |  | 73,074 |  |  | 76,896 |  |  | 67,580 | \n |  |  |  |  |  |  | \nNet earnings | 3,810 |  |  | 4,339 |  |  | 12,342 |  |  | 13,743 | \nCash dividends | (2,089) |  |  | (1,946) |  |  | (6,304) |  |  | (5,856) | \n |  |  |  |  |  |  | \nBalance at end of period | 82,934 |  |  | 75,467 |  |  | 82,934 |  |  | 75,467 | \n |  |  |  |  |  |  | \nAccumulated Other Comprehensive Income (Loss): |  |  |  |  |  |  | \nBalance at beginning of period | (467) |  |  | (672) |  |  | (718) |  |  | (704) | \n |  |  |  |  |  |  | \nForeign currency translation adjustments, net of tax | (196) |  |  | (187) |  |  | 51 |  |  | (158) | \nCash flow hedges, net of tax | 1 |  |  | 3 |  |  | 5 |  |  | 6 | \n |  |  |  |  |  |  | \nBalance at end of period | (662) |  |  | (856) |  |  | (662) |  |  | (856) | \n |  |  |  |  |  |  | \nTreasury Stock: |  |  |  |  |  |  | \nBalance at beginning of period | (92,343) |  |  | (84,564) |  |  | (87,298) |  |  | (80,794) | \nRepurchases of common stock | (1,516) |  |  | (1,224) |  |  | (6,561) |  |  | (4,994) | \nBalance at end of period | (93,859) |  |  | (85,788) |  |  | (93,859) |  |  | (85,788) | \nTotal stockholders' equity | $ | 1,430 |  |  | $ | 1,298 |  |  | $ | 1,430 |  |  | $ | 1,298 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 4 |   |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended\nin millions | October 29,2023 |  | October 30,2022\nCash Flows from Operating Activities: |  |  | \nNet earnings | $ | 12,342 |  |  | $ | 13,743 | \nReconciliation of net earnings to net cash provided by operating activities: |  |  | \nDepreciation and amortization | 2,415 |  |  | 2,216 | \nStock-based compensation expense | 300 |  |  | 286 | \nChanges in receivables, net | (538) |  |  | (312) | \nChanges in merchandise inventories | 2,131 |  |  | (3,748) | \nChanges in other current assets | (365) |  |  | (568) | \nChanges in accounts payable and accrued expenses | 187 |  |  | (1,568) | \nChanges in deferred revenue | (276) |  |  | (413) | \nChanges in income taxes payable | 252 |  |  | 30 | \nChanges in deferred income taxes | (310) |  |  | 129 | \nOther operating activities | 301 |  |  | 226 | \nNet cash provided by operating activities | 16,439 |  |  | 10,021 | \n |  |  | \nCash Flows from Investing Activities: |  |  | \nCapital expenditures | (2,368) |  |  | (2,216) | \nPayments for businesses acquired, net | (795) |  |  | \u2014 | \nOther investing activities | 15 |  |  | (29) | \nNet cash used in investing activities | (3,148) |  |  | (2,245) | \n |  |  | \nCash Flows from Financing Activities: |  |  | \nRepayments of short-term debt, net | \u2014 |  |  | (1,035) | \nProceeds from long-term debt, net of discounts | \u2014 |  |  | 6,942 | \nRepayments of long-term debt | (1,200) |  |  | (2,423) | \nRepurchases of common stock | (6,465) |  |  | (5,136) | \nProceeds from sales of common stock | 192 |  |  | 146 | \nCash dividends | (6,304) |  |  | (5,856) | \nOther financing activities | (146) |  |  | (185) | \nNet cash used in financing activities | (13,923) |  |  | (7,547) | \nChange in cash and cash equivalents | (632) |  |  | 229 | \nEffect of exchange rate changes on cash and cash equivalents | (67) |  |  | (110) | \nCash and cash equivalents at beginning of period | 2,757 |  |  | 2,343 | \nCash and cash equivalents at end of period | $ | 2,058 |  |  | $ | 2,462 | \n |  |  | \nSupplemental Disclosures: |  |  | \nCash paid for interest, net of interest capitalized | $ | 1,504 |  |  | $ | 1,160 | \nCash paid for income taxes | 3,817 |  |  | 4,173 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 5 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 6 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\nin millions | October 29,2023 |  | October 30,2022 |  | October 29,2023 |  | October 30,2022\nNet sales \u2013 in the U.S. | $ | 34,544 |  |  | $ | 35,784 |  |  | $ | 108,242 |  |  | $ | 111,834 | \nNet sales \u2013 outside the U.S. | 3,166 |  |  | 3,088 |  |  | 9,641 |  |  | 9,738 | \nNet sales | $ | 37,710 |  |  | $ | 38,872 |  |  | $ | 117,883 |  |  | $ | 121,572 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\nin millions | October 29,2023 |  | October 30,2022 |  | October 29,2023 |  | October 30,2022\nNet sales \u2013 products | $ | 36,156 |  |  | $ | 37,448 |  |  | $ | 113,405 |  |  | $ | 117,261 | \nNet sales \u2013 services | 1,554 |  |  | 1,424 |  |  | 4,478 |  |  | 4,311 | \nNet sales | $ | 37,710 |  |  | $ | 38,872 |  |  | $ | 117,883 |  |  | $ | 121,572 |   |  |  |  |  |  |  |  | \nMajor Product Line |  | Merchandising Departments\nBuilding Materials |  | Building Materials, Electrical/Lighting, Lumber, Millwork, and Plumbing\nD\u00e9cor |  | Appliances, D\u00e9cor/Storage, Flooring, Kitchen and Bath, and Paint\nHardlines |  | Hardware, Indoor Garden, Outdoor Garden, and Tools  |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 7 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | Nine Months Ended\nin millions | October 29,2023 |  | October 30,2022 |  | October 29,2023 |  | October 30,2022\nBuilding Materials | $ | 14,744 |  |  | $ | 15,343 |  |  | $ | 44,214 |  |  | $ | 46,095 | \nD\u00e9cor | 12,653 |  |  | 13,070 |  |  | 38,315 |  |  | 40,040 | \nHardlines | 10,313 |  |  | 10,459 |  |  | 35,354 |  |  | 35,437 | \nNet sales | $ | 37,710 |  |  | $ | 38,872 |  |  | $ | 117,883 |  |  | $ | 121,572 |   |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions | Consolidated Balance Sheet Classification | October 29,2023 |  | January 29,2023\nAssets: |  |  |  | \nOperating lease assets | Operating lease right-of-use assets | $ | 7,071 |  |  | $ | 6,941 | \nFinance lease assets(1) | Net property and equipment | 2,860 |  |  | 2,899 | \nTotal lease assets |  | $ | 9,931 |  |  | $ | 9,840 | \nLiabilities: |  |  |  | \nCurrent: |  |  |  | \nOperating lease liabilities | Current operating lease liabilities | $ | 1,026 |  |  | $ | 945 | \nFinance lease liabilities | Current installments of long-term debt | 262 |  |  | 231 | \nLong-term: |  |  |  | \nOperating lease liabilities | Long-term operating lease liabilities | 6,300 |  |  | 6,226 | \nFinance lease liabilities | Long-term debt, excluding current installments | 3,032 |  |  | 3,054 | \nTotal lease liabilities |  | $ | 10,620 |  |  | $ | 10,456 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 8 |   |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended\nin millions | October 29,2023 |  | October 30,2022\nLease assets obtained in exchange for new operating lease liabilities | $ | 791 |  |  | $ | 1,308 | \nLease assets obtained in exchange for new finance lease liabilities | 261 |  |  | 234 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 9 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nshares in millions | Three Months Ended |  | Nine Months Ended\nOctober 29,2023 |  | October 30,2022 |  | October 29,2023 |  | October 30,2022\nCommon stock: |  |  |  |  |  |  | \nShares at beginning of period | 1,796 |  |  | 1,793 |  |  | 1,794 |  |  | 1,792 | \nShares issued under employee stock plans, net | \u2014 |  |  | \u2014 |  |  | 2 |  |  | 1 | \nShares at end of period | 1,796 |  |  | 1,793 |  |  | 1,796 |  |  | 1,793 | \nTreasury stock: |  |  |  |  |  |  | \nShares at beginning of period | (795) |  |  | (769) |  |  | (778) |  |  | (757) | \nRepurchases of common stock | (5) |  |  | (4) |  |  | (22) |  |  | (16) | \nShares at end of period | (800) |  |  | (773) |  |  | (800) |  |  | (773) | \nShares outstanding at end of period | 996 |  |  | 1,020 |  |  | 996 |  |  | 1,020 | \n |  |  |  |  |  |  | \nCash dividends per share | $ | 2.09 |  |  | $ | 1.90 |  |  | $ | 6.27 |  |  | $ | 5.70 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions | Three Months Ended |  | Nine Months Ended\nOctober 29,2023 |  | October 30,2022 |  | October 29,2023 |  | October 30,2022\nTotal number of shares repurchased | 5 |  |  | 4 |  |  | 22 |  |  | 16 | \nTotal cost of shares repurchased(1) | $ | 1,516 |  |  | $ | 1,224 |  |  | $ | 6,561 |  |  | $ | 4,994 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 10 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n |  |  | October 29, 2023 |  |  |  | January 29, 2023\nin millions |  |  | Fair Value(Level\u00a02) |  |  |  |  |  | Fair Value(Level\u00a02) |  | \nDerivative agreements \u2013 assets |  |  | $ | \u2014 |  |  |  |  |  |  | $ | \u2014 |  |  | \nDerivative agreements \u2013 liabilities |  |  | (1,073) |  |  |  |  |  |  | (778) |  |  | \nTotal |  |  | $ | (1,073) |  |  |  |  |  |  | $ | (778) |  |  |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | October 29, 2023 |  | January 29, 2023\nin millions | Fair Value(Level 1) |  | CarryingValue |  | Fair Value(Level 1) |  | CarryingValue\nSenior notes | $ | 33,135 |  |  | $ | 38,635 |  |  | $ | 38,537 |  |  | $ | 39,908 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nin millions | Three Months Ended |  | Nine Months Ended\nOctober 29,2023 |  | October 30,2022 |  | October 29,2023 |  | October 30,2022\nBasic weighted average common shares | 996 |  |  | 1,020 |  |  | 1,002 |  |  | 1,024 | \nEffect of potentially dilutive securities(1) | 3 |  |  | 3 |  |  | 3 |  |  | 4 | \nDiluted weighted average common shares | 999 |  |  | 1,023 |  |  | 1,005 |  |  | 1,028 | \n |  |  |  |  |  |  | \nAnti-dilutive securities excluded from diluted weighted average common shares | 1 |  |  | 1 |  |  | 1 |  |  | 1 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 11 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 12 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 13 |   |  |  |  |  | \nExecutive Summary | 14\nResults of Operations | 15\nLiquidity and Capital Resources | 19\nCritical Accounting Estimates | 21  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \ndollars in millions, except per share data | Three Months Ended |  | Nine Months Ended\nOctober 29,2023 |  | October 30,2022 |  | October 29,2023 |  | October 30,2022\nNet sales | $ | 37,710 |  |  | $ | 38,872 |  |  | $ | 117,883 |  |  | $ | 121,572 | \nNet earnings | $ | 3,810 |  |  | $ | 4,339 |  |  | $ | 12,342 |  |  | $ | 13,743 | \n |  |  |  |  |  |  | \nDiluted earnings per share | $ | 3.81 |  |  | $ | 4.24 |  |  | $ | 12.28 |  |  | $ | 13.37 | \n |  |  |  |  |  |  | \nNet cash provided by operating activities |  |  |  |  | $ | 16,439 |  |  | $ | 10,021 | \nProceeds from long-term debt, net of discounts |  |  |  |  | $ | \u2014 |  |  | $ | 6,942 | \nRepayments of long-term debt |  |  |  |  | $ | 1,200 |  |  | $ | 2,423 | \n |  |  |  |  |  |  |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 14 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended\n | October 29, 2023 |  | October 30, 2022\ndollars in millions | $ |  | % ofNet Sales |  | $ |  | % ofNet Sales\nNet sales | $ | 37,710 |  |  |  |  | $ | 38,872 |  |  | \nGross profit | 12,738 |  |  | 33.8 | % |  | 13,224 |  |  | 34.0 | %\nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative | 6,649 |  |  | 17.6 |  |  | 6,468 |  |  | 16.6 | \nDepreciation and amortization | 683 |  |  | 1.8 |  |  | 608 |  |  | 1.6 | \nTotal operating expenses | 7,332 |  |  | 19.4 |  |  | 7,076 |  |  | 18.2 | \nOperating income | 5,406 |  |  | 14.3 |  |  | 6,148 |  |  | 15.8 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net | (49) |  |  | (0.1) |  |  | (7) |  |  | \u2014 | \nInterest expense | 487 |  |  | 1.3 |  |  | 413 |  |  | 1.1 | \nInterest and other, net | 438 |  |  | 1.2 |  |  | 406 |  |  | 1.0 | \nEarnings before provision for income taxes | 4,968 |  |  | 13.2 |  |  | 5,742 |  |  | 14.8 | \nProvision for income taxes | 1,158 |  |  | 3.1 |  |  | 1,403 |  |  | 3.6 | \nNet earnings | $ | 3,810 |  |  | 10.1 | % |  | $ | 4,339 |  |  | 11.2 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Three Months Ended |  | \nSelected financial and sales data: | October 29,2023 |  | October 30,2022 |  | % Change\nComparable sales (% change) | (3.1) | % |  | 4.3 | % |  | N/A\nComparable customer transactions (% change)(1) | (2.7) | % |  | (4.4) | % |  | N/A\nComparable average ticket (% change)(1) | (0.3) | % |  | 8.8 | % |  | N/A\nCustomer transactions (in millions)(1) | 399.8 |  |  | 409.8 |  |  | (2.4) | %\nAverage ticket(1) (2) | $ | 89.36 |  |  | $ | 89.67 |  |  | (0.3) | %\nSales per retail square foot(1) (3) | $ | 595.71 |  |  | $ | 618.50 |  |  | (3.7) | %\nDiluted earnings per share | $ | 3.81 |  |  | $ | 4.24 |  |  | (10.1) | %  |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 15 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 16 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended\n | October 29, 2023 |  | October 30, 2022\ndollars in millions | $ |  | % ofNet Sales |  | $ |  | % ofNet Sales\nNet sales | $ | 117,883 |  |  |  |  | $ | 121,572 |  |  | \nGross profit | 39,452 |  |  | 33.5 | % |  | 40,852 |  |  | 33.6 | %\nOperating expenses: |  |  |  |  |  |  | \nSelling, general and administrative | 19,919 |  |  | 16.9 |  |  | 19,735 |  |  | 16.2 | \nDepreciation and amortization | 1,987 |  |  | 1.7 |  |  | 1,830 |  |  | 1.5 | \nTotal operating expenses | 21,906 |  |  | 18.6 |  |  | 21,565 |  |  | 17.7 | \nOperating income | 17,546 |  |  | 14.9 |  |  | 19,287 |  |  | 15.9 | \nInterest and other (income) expense: |  |  |  |  |  |  | \nInterest income and other, net | (123) |  |  | (0.1) |  |  | (12) |  |  | \u2014 | \nInterest expense | 1,430 |  |  | 1.2 |  |  | 1,166 |  |  | 1.0 | \nInterest and other, net | 1,307 |  |  | 1.1 |  |  | 1,154 |  |  | 0.9 | \nEarnings before provision for income taxes | 16,239 |  |  | 13.8 |  |  | 18,133 |  |  | 14.9 | \nProvision for income taxes | 3,897 |  |  | 3.3 |  |  | 4,390 |  |  | 3.6 | \nNet earnings | $ | 12,342 |  |  | 10.5 | % |  | $ | 13,743 |  |  | 11.3 | %  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \n | Nine Months Ended |  | \nSelected financial and sales data: | October 29,2023 |  | October 30,2022 |  | % Change\nComparable sales (% change) | (3.2) | % |  | 4.2 | % |  | N/A\nComparable customer transactions (% change)(1) | (3.2) | % |  | (5.3) | % |  | N/A\nComparable average ticket (% change)(1) | \u2014 | % |  | 9.7 | % |  | N/A\nCustomer transactions (in millions)(1) | 1,249.8 |  |  | 1,287.9 |  |  | (3.0) | %\nAverage ticket(1) (2) | $ | 90.42 |  |  | $ | 90.45 |  |  | \u2014 | \nSales per retail square foot(1) (3) | $ | 623.17 |  |  | $ | 646.81 |  |  | (3.7) | %\nDiluted earnings per share | $ | 12.28 |  |  | $ | 13.37 |  |  | (8.2) | %  |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 17 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 18 |   |  |  |  |  |  |  |  |  |  |  | \n | Twelve Months Ended\ndollars in millions | October 29,2023 |  | October 30,2022\nNet earnings | $ | 15,704 |  |  | $ | 17,095 | \nInterest and other, net | 1,715 |  |  | 1,477 | \nProvision for income taxes | 4,879 |  |  | 5,540 | \nOperating income | 22,298 |  |  | 24,112 | \nIncome tax adjustment(1) | (5,347) |  |  | (5,844) | \nNOPAT | $ | 16,951 |  |  | $ | 18,268 | \n |  |  | \nAverage debt and equity | $ | 43,810 |  |  | $ | 42,222 | \n |  |  | \nROIC | 38.7 | % |  | 43.3 | %  |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 19 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 20 |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 21 |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | \nPeriod |  | Total Number of Shares Purchased(1) |  | Average Price Paid Per Share(1)(3) |  | Total Number of Shares\u00a0Purchased\u00a0as Part of Publicly Announced\u00a0Program(2) |  | Dollar Value of Shares\u00a0that\u00a0May\u00a0Yet Be\u00a0Purchased\u00a0Under the Program(2)(3)\nJuly 31, 2023 \u2013 August 27, 2023 |  | 1,549,939 |  |  | $ | 328.70 |  |  | 1,546,953 |  |  | $ | 14,748,903,852 | \nAugust 28, 2023 \u2013 September 24, 2023 |  | 1,642,254 |  |  | 324.92 |  |  | 1,640,096 |  |  | 14,216,012,142 | \nSeptember 25, 2023 \u2013 October 29, 2023 |  | 1,579,519 |  |  | 292.96 |  |  | 1,570,423 |  |  | 13,756,031,773 | \n |  | 4,771,712 |  |  | 315.57 |  |  | 4,757,472 |  |  |   |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 22 |   |  |  |  |  |  |  |  | \nExhibit |  | Description\n3.1 | * | Amended and Restated Certificate of Incorporation of The Home Depot, Inc.[Form 10-Q filed on September 1, 2011, Exhibit 3.1]\n3.2 | * | By-Laws of The Home Depot, Inc. (As Amended and Restated Effective February 23, 2023)[Form 8-K filed on February 28, 2023, Exhibit 3.2]\n10.1 | \u2020 | Employment Arrangement between Ann-Marie Campbelland The Home Depot, Inc.dated October 25, 2023\n15.1 |  | Acknowledgement of Independent Registered Public Accounting Firm\n31.1 |  | Certification of the Chair, President and Chief Executive Officer pursuant to Rule 13a-14(a)\n31.2 |  | Certification of the Executive Vice President and Chief Financial Officer pursuant to Rule\u00a013a-14(a)\n32.1 |  | Certification of the Chair, President and Chief Executive Officer furnished pursuant to Section\u00a0906 of the Sarbanes-Oxley Act of 2002\n32.2 |  | Certification of the Executive Vice President and Chief Financial Officer furnished pursuant to Section\u00a0906 of the Sarbanes-Oxley Act of 2002\n101.INS |  | XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document\n101.SCH |  | Inline XBRL Taxonomy Extension Schema Document\n101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document\n101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document\n101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document\n101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document\n104 |  | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)  |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 23 |   |  |  |  |  | \nTHE HOME DEPOT, INC.(Registrant)\n | \nBy: | /s/ EDWARD P. DECKER\n | Edward P. Decker, Chair, President and Chief Executive Officer (Principal Executive Officer)\n\n | /s/ RICHARD V. MCPHAIL\n | Richard V. McPhail, Executive Vice President and Chief Financial Officer (Principal Financial Officer)\n | \n | /s/ KIMBERLY R. SCARDINO\n | Kimberly R. Scardino, Senior Vice President \u2013 Finance, Chief Accounting Officer and Controller (Principal Accounting Officer)\n\nDate: | November 20, 2023  |  |  |  |  |  |  |  | \nFiscal Q3 2023 Form 10-Q | 24 | "}]}
